PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lu, BX; Su, YH; Das, S; Wang, HK; Wang, Y; Liu, J; Ren, DJ				Lu, Boxun; Su, Yanhua; Das, Sudipto; Wang, Haikun; Wang, Yan; Liu, Jin; Ren, Dejian			Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80	NATURE			English	Article							LOCUS-CERULEUS NEURONS; SUBSTANCE-P; TRP CHANNELS; SYMPATHETIC NEURONS; DOPAMINE NEURONS; RAT; EXCITATION; RECEPTORS; PROTEIN; TRANSMITTERS	Several neurotransmitters act through G- protein- coupled receptors to evoke a 'slow' excitation of neurons(1,2). These include peptides, such as substance P and neurotensin, as well as acetylcholine and noradrenaline. Unlike the fast ( approximately millisecond) ionotropic actions of small- molecule neurotransmitters, the slow excitation is not well understood at themolecular level, but can be mainly attributed to suppressing K+ currents and/or activating a nonselective cation channel(3-9). The molecular identity of this cation channel has yet to be determined; similarly, how the channel is activated and its relative contribution to neuronal excitability induced by the neuropeptides are unknown. Here we show that, in the mouse hippocampal and ventral tegmental area neurons, substance P and neurotensin activate a channel complex containing NALCN and a large previously unknown protein UNC-80. The activation by substance P through TACR1 (a G- protein- coupled receptor for substance P) occurs by means of a unique mechanism: it does not require G- protein activation but is dependent on Src family kinases. These findings identify NALCN as the cation channel activated by substance P receptor, and suggest that UNC- 80 and Src family kinases, rather than a G protein, are involved in the coupling from receptor to channel.	[Lu, Boxun; Su, Yanhua; Das, Sudipto; Wang, Haikun; Wang, Yan; Liu, Jin; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 S University Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu		wang, hai kun/0000-0002-4714-4672	American Heart Association; NIH; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055293] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Clapham, C. Deutsch, I. Medina, B. Novarro, M. Schmidt and H. Xu for critically reading earlier versions of the manuscript, J. Xia for help with experiments, H. Yu and L. Yue for cDNA constructs, and Sanofi- Aventis for the gift of SR48692. This work was supported, in part, by funding from American Heart Association, the NIH and the University of Pennsylvania Research Foundation.	Aosaki T, 1996, J NEUROSCI, V16, P5141; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Farkas RH, 1996, J NEUROPHYSIOL, V76, P1968, DOI 10.1152/jn.1996.76.3.1968; GRACE AA, 1989, J NEUROSCI, V9, P3463; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; HILLE B, 2001, CHANNELS EXCITABLE M, P201; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; INOUE K, 1995, J NEUROPHYSIOL, V73, P736, DOI 10.1152/jn.1995.73.2.736; JAN YN, 1980, P NATL ACAD SCI-BIOL, V77, P5008, DOI 10.1073/pnas.77.8.5008; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; KANDEL E, 2000, PRINCIPLES NEURAL SC, P229; KUBA K, 1978, PROG NEUROBIOL, V11, P77, DOI 10.1016/0301-0082(78)90010-2; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MASUKO S, 1992, NEUROSCIENCE, V49, P347, DOI 10.1016/0306-4522(92)90101-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Oh EJ, 2003, J NEUROPHYSIOL, V90, P2069, DOI 10.1152/jn.00026.2003; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SHEN KZ, 1993, J PHYSIOL-LONDON, V462, P483, DOI 10.1113/jphysiol.1993.sp019565; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	33	113	117	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					741	U10		10.1038/nature07579	http://dx.doi.org/10.1038/nature07579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19092807	Green Accepted			2022-12-24	WOS:000263064700045
J	Grossman, D				Grossman, Daniel			Should the contraceptive pill be available without prescription? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORAL-CONTRACEPTIVES; HORMONAL CONTRACEPTION; NATIONAL-SURVEY; UNITED-STATES; WOMENS; ACCESS; MEXICO; GUIDELINES; ATTITUDES; FAILURE		[Grossman, Daniel] Ibis Reprod Hlth, San Francisco, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grossman, D (corresponding author), Ibis Reprod Hlth, San Francisco, CA USA.	DGrossman@ibisreproductivehealth.org	Potter, Joseph E/A-3122-2008					Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Editorial, 2008, LANCET, V371, P275; Foster DG, 2006, OBSTET GYNECOL, V108, P1107, DOI 10.1097/01.AOG.0000239122.98508.39; Gardner JS, 2008, J AM PHARM ASSOC, V48, P212, DOI 10.1331/JAPhA.2008.07138; Gianfrancesco F., 2002, DRUG BENEFIT TRENDS, V14, P13; Gianfrancesco F, 2002, DRUG BENEFIT TRENDS, V14, P44; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Grossman D, 2006, AM J PUBLIC HEALTH, V96, P791, DOI 10.2105/AJPH.2004.040774; Grossman D, 2008, OBSTET GYNECOL, V112, P572, DOI 10.1097/AOG.0b013e31818345f0; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Landau SC, 2006, CONTRACEPTION, V74, P463, DOI 10.1016/j.contraception.2006.07.006; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; *NAT I REPR HLTH, EXP MED COV EC STAT; *POP REF BUR, FAM PLANN WORLDW 200; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; Shah MA, 2001, INT J GYNECOL OBSTET, V73, P243, DOI 10.1016/S0020-7292(01)00375-7; Shotorbani S, 2006, CONTRACEPTION, V73, P501, DOI 10.1016/j.contraception.2005.12.001; Smith JD, 2005, J MIDWIFERY WOM HEAL, V50, P380, DOI 10.1016/j.jmwh.2005.01.011; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; Tatum C, 2005, CONTRACEPTION, V71, P208, DOI 10.1016/j.contraception.2004.08.018; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; WHO, 2004, MED EL CRIT CONTR US, V3; Yeatman SE, 2006, STUD FAMILY PLANN, V37, P197, DOI 10.1111/j.1728-4465.2006.00098.x; ZAVALA AS, 1987, STUD FAMILY PLANN, V18, P284, DOI 10.2307/1966857	24	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 23	2008	337								a3044	10.1136/bmj.a3044	http://dx.doi.org/10.1136/bmj.a3044			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394EL	19106138				2022-12-24	WOS:000262428400003
J	Ehlmann, BL; Mustard, JF; Murchie, SL; Poulet, F; Bishop, JL; Brown, AJ; Calvin, WM; Clark, RN; Des Marais, DJ; Milliken, RE; Roach, LH; Roush, TL; Swayze, GA; Wray, JJ				Ehlmann, Bethany L.; Mustard, John F.; Murchie, Scott L.; Poulet, Francois; Bishop, Janice L.; Brown, Adrian J.; Calvin, Wendy M.; Clark, Roger N.; Des Marais, David J.; Milliken, Ralph E.; Roach, Leah H.; Roush, Ted L.; Swayze, Gregg A.; Wray, James J.			Orbital Identification of Carbonate-Bearing Rocks on Mars	SCIENCE			English	Article							MINERALS; CLIMATE; TEMPERATURE; PRODUCTS; SULFATES; OLIVINE; SYSTEM; MODEL	Geochemical models for Mars predict carbonate formation during aqueous alteration. Carbonate- bearing rocks had not previously been detected on Mars' surface, but Mars Reconnaissance Orbiter mapping reveals a regional rock layer with near- infrared spectral characteristics that are consistent with the presence of magnesium carbonate in the Nili Fossae region. The carbonate is closely associated with both phyllosilicate- bearing and olivine- rich rock units and probably formed during the Noachian or early Hesperian era from the alteration of olivine by either hydrothermal fluids or near- surface water. The presence of carbonate as well as accompanying clays suggests that waters were neutral to alkaline at the time of its formation and that acidic weathering, proposed to be characteristic of Hesperian Mars, did not destroy these carbonates and thus did not dominate all aqueous environments.	[Ehlmann, Bethany L.; Mustard, John F.; Roach, Leah H.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Poulet, Francois] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Bishop, Janice L.; Brown, Adrian J.] SETI Inst, Mountain View, CA 94043 USA; [Bishop, Janice L.; Brown, Adrian J.; Des Marais, David J.; Roush, Ted L.] NASA, Ames Res Ctr, Mountain View, CA 94043 USA; [Calvin, Wendy M.] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA; [Clark, Roger N.; Swayze, Gregg A.] US Geol Survey, Lakewood, CO 80225 USA; [Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Wray, James J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Brown University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University	Ehlmann, BL (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Brown, Adrian Jon/AAC-5047-2022; Wray, James J/B-8457-2008; Murchie, Scott L/E-8030-2015	Wray, James J/0000-0001-5559-2179; Murchie, Scott L/0000-0002-1616-8751; Bishop, Janice/0000-0002-6681-9954; Calvin, Wendy/0000-0002-6097-9586	NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database	NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database(National Aeronautics & Space Administration (NASA))	We thank R. Arvidson, R. Morris, N. Mangold, A. Baldridge, J.-P. Bibring, D. Jouglet, A. Fraeman, S. Wiseman, A. McEwen, G. Marzo, P. McGuire, and M. Wyatt for thoughtful discussions during manuscript preparation and E. Cloutis and others who have made quality spectral libraries available and contributed to the building of the NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database. We are grateful for the ongoing efforts of the MRO science and engineering teams, in particular the CRISM team, which enable these discoveries.	Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BLANEY DL, 1989, J GEOPHYS RES-SOLID, V94, P10159, DOI 10.1029/JB094iB08p10159; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Bullock MA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030688; Burns R. G, 1993, MINERALOGICAL APPL C; CALVIN WM, 1994, J GEOPHYS RES-PLANET, V99, P14659, DOI 10.1029/94JE01090; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chevrier V, 2007, NATURE, V448, P60, DOI 10.1038/nature05961; CHRISTENSEN PR, 2003, 6 INT C MARS LUN PLA; Clark R.N., 2007, USGS DIGITAL DATA SE, V231; CLOUTIS EA, 2000, LUNAR PLANET SCI C, V31; Ehlmann BL, 2008, NAT GEOSCI, V1, P355, DOI 10.1038/ngeo207; EHLMANN BL, 2007, 7 INT C MARS LUN PLA; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; GAFFEY SJ, 1987, J GEOPHYS RES-SOLID, V92, P1429, DOI 10.1029/JB092iB02p01429; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; Greeley R., 1987, GEOLOGICAL MAP E EQU; Hanchen M, 2008, CHEM ENG SCI, V63, P1012, DOI 10.1016/j.ces.2007.09.052; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Hamilton VE, 2005, GEOLOGY, V33, P433, DOI 10.1130/G21258.1; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Hunt G. R., 1971, Modern Geology, V2, P23; Hurowitz JA, 2007, EARTH PLANET SC LETT, V260, P432, DOI 10.1016/j.epsl.2007.05.043; JOUGLET D, 2007, 7 INT C MARS LUN PLA; JULL AJT, 1988, SCIENCE, V242, P417, DOI 10.1126/science.242.4877.417; Koeppen WC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002984; Konigsberger E, 1999, GEOCHIM COSMOCHIM AC, V63, P3105, DOI 10.1016/S0016-7037(99)00238-0; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; Mangold N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002835; Melezhik VA, 2001, SEDIMENTOLOGY, V48, P379, DOI 10.1046/j.1365-3091.2001.00369.x; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002834; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Parente M., 2008, LUNAR PLANET SCI C, VXXXIX; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Poulet F, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002840; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Poulet F., 2007, 7 INT C MARS LUN PLA; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Tornabene LL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002988; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; Wagner C, 1996, ICARUS, V123, P256, DOI 10.1006/icar.1996.0156	45	476	483	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1828	1832		10.1126/science.1164759	http://dx.doi.org/10.1126/science.1164759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095939				2022-12-24	WOS:000261799400050
J	Lebreton, A; Tomecki, R; Dziembowski, A; Seraphin, B				Lebreton, Alice; Tomecki, Rafal; Dziembowski, Andrzej; Seraphin, Bertrand			Endonucleolytic RNA cleavage by a eukaryotic exosome	NATURE			English	Article							MESSENGER-RNA; QUALITY-CONTROL; YEAST EXOSOME; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; ESCHERICHIA-COLI; COMPLEX; DEGRADATION; NUCLEASE; SUBUNIT	The exosome is a major eukaryotic nuclease located in both the nucleus and the cytoplasm that contributes to the processing, quality control and/ or turnover of a large number of cellular RNAs(1-6). This large macromolecular assembly has been described as a 3 '-> 5 ' exonuclease(1) and shown to contain a nine- subunit ring structure evolutionarily related to archaeal exosome- like complexes and bacterial polynucleotide phosphorylases. Recent results have shown that, unlike its prokaryotic counterparts, the yeast and human ring structures are catalytically inactive. In contrast, the exonucleolytic activity of the yeast exosome core was shown to be mediated by the RNB domain of the eukaryote- specific Dis3 subunit(7-9). Here we show, using in vitro assays, that yeast Dis3 has an additional endoribonuclease activity mediated by the PIN domain located at the amino terminus of this multidomain protein. Simultaneous inactivation of the endonucleolytic and exonucleolytic activities of the exosome core generates a synthetic growth phenotype in vivo, supporting a physiological function for the PIN domain. This activity is responsible for the cleavage of some natural exosome substrates, independently of exonucleolytic degradation. In contrast with current models, our results show that eukaryotic exosome cores have both endonucleolytic and exonucleolytic activities, mediated by two distinct domains of the Dis3 subunit. The mode of action of eukaryotic exosome cores in RNA processing and degradation should be reconsidered, taking into account the cooperation between its multiple ribonucleolytic activities.	[Tomecki, Rafal; Dziembowski, Andrzej] Warsaw Univ, Dept Genet & Biotechnol, Fac Biol, PL-02106 Warsaw, Poland; [Tomecki, Rafal; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Lebreton, Alice; Seraphin, Bertrand] CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France; [Lebreton, Alice; Seraphin, Bertrand] Univ Paris 11, F-91405 Orsay, France; [Lebreton, Alice; Seraphin, Bertrand] Univ Paris 06, F-75005 Paris, France	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Dziembowski, A (corresponding author), Warsaw Univ, Dept Genet & Biotechnol, Fac Biol, PL-02106 Warsaw, Poland.	andrzejd@ibb.waw.pl; seraphin@cgm.cnrs-gif.fr	Lebreton, Alice/M-8764-2015; Tomecki, Rafal/Y-8438-2019	Lebreton, Alice/0000-0002-6643-902X; Tomecki, Rafał/0000-0003-2880-0555; Tomecki, Rafal/0000-0003-2473-5004; Dziembowski, Andrzej/0000-0001-8492-7572; Seraphin, Bertrand/0000-0002-5168-1921	La Ligue contre le Cancer (Equipe Labellisee 2008); Agence Nationale de la Recherche project CUTs; CNRS; ESF RNA Quality program (project EUxosome); FP6 EU; Foundation for Polish Science; Faculty of Biology, University of Warsaw	La Ligue contre le Cancer (Equipe Labellisee 2008); Agence Nationale de la Recherche project CUTs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ESF RNA Quality program (project EUxosome); FP6 EU(European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Faculty of Biology, University of Warsaw	We thank E. Conti and J. Basquin for providing the Dis3 PIN domain expression construct and 6xHis- SUMO protease, and E. Conti, E. Lorentzen, J. Kufel and members of our groups for insightful discussions. This work was supported by La Ligue contre le Cancer (Equipe Labellisee 2008), Agence Nationale de la Recherche project CUTs, CNRS, ESF RNA Quality program (project EUxosome) and the FP6 EU grant 3D repertoire, and an EMBO installation grant. R. T. is the recipient of the Stipend for Young Researchers from the Foundation for Polish Science and was supported through a Faculty of Biology, University of Warsaw intramural grant.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; EBERLE AB, NATURE STRU IN PRESS; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; LIU Q, 2003, CELL, V127, P1223; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; SCHAEFFER D, NATURE STRU IN PRESS; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	29	245	248	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					993	U87		10.1038/nature07480	http://dx.doi.org/10.1038/nature07480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19060886	Green Submitted			2022-12-24	WOS:000261768300055
J	Trost, BM; Dong, GB				Trost, Barry M.; Dong, Guangbin			Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches	NATURE			English	Article							ANALOGS; ALCOHOLS; ESTERS	Of the concepts used to improve the efficiency of organic syntheses, two have been especially effective: atom economy(1) ( the use of routes in which most of the atoms present in the reactants also end up in the product) and chemoselectivity(2) ( the use of reactions that take place only at desired positions in a molecule). Synthesis of complex natural products is the most demanding arena in which to explore such principles. The bryostatin family of compounds are especially interesting targets, because they combine structural complexity with promising biological activity(3-7). Furthermore, synthetic routes to some bryostatins have already been reported(9-12), providing a benchmark against which new syntheses can be measured. Here we report a concise total synthesis of bryostatin 16 ( 1), a parent structure from which almost all other bryostatins could in principle be accessed. Application of atom-economical and chemoselective reactions currently under development provides ready access to polyhydropyran motifs in the molecule, which are common structural features of many other natural products. The most notable transformations are two transition-metal- catalysed reactions. The first is a palladium- catalysed reaction of two different alkynes to form a large ring. The product of this step is then converted into a dihydropyran ( the 'C ring' of bryostatins) in the second key reaction, which is catalysed by a gold compound. Analogues of bryostatin that do not exist in nature could be readily made by following this route, which might allow the biological activity of bryostatins to be fine- tuned.	[Trost, Barry M.; Dong, Guangbin] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Trost, BM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bmtrost@stanford.edu			National Institutes of Health [GM 13598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013598, R37GM013598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the National Institutes of Health (GM 13598) for their support of our programs. G. D. is a Stanford Graduate Fellow. We thank H. Yang for discussions and for help characterizing compound 21, and we additionally thank him and C. S. Brindle for providing synthetic intermediates. Palladium and ruthenium salts were supplied by Johnson Matthey. We acknowledge S. R. Lynch for his help with two-dimensional nuclear magnetic resonance analysis. We also thank the Wender group's assistance with reverse-phase high-performance liquid chromatography.	Ball M, 2006, TETRAHEDRON LETT, V47, P2223, DOI 10.1016/j.tetlet.2006.01.097; BROWN HC, 1983, J AM CHEM SOC, V105, P2092, DOI 10.1021/ja00345a085; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO;2-Z; DELLAQUILA ML, 1988, CANCER RES, V48, P3702; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Dowlati A, 2003, CLIN CANCER RES, V9, P5929; Evans DA, 1999, J AM CHEM SOC, V121, P7540, DOI 10.1021/ja990860j; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989; KAGEYAMA M, 1990, J AM CHEM SOC, V112, P7407, DOI 10.1021/ja00176a058; Keck GE, 2008, J AM CHEM SOC, V130, P6660, DOI 10.1021/ja8022169; Lin MJ, 2003, J AM CHEM SOC, V125, P13042, DOI 10.1021/ja037410i; Liu YH, 2005, ORG LETT, V7, P5409, DOI 10.1021/ol052160r; Manaviazar S, 2006, ORG LETT, V8, P4477, DOI 10.1021/ol061626i; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1378, DOI 10.1002/anie.200462207; Ohmori K, 2000, ANGEW CHEM INT EDIT, V39, P2290; Pettit GR, 1996, J NAT PROD, V59, P286, DOI 10.1021/np960100b; PETTIT GR, 1991, CAN J CHEM, V69, P856, DOI 10.1139/v91-126; Roth GJ, 2004, SYNTHESIS-STUTTGART, P59, DOI 10.1055/s-2003-44346; SCHAUFELBERGER DE, 1991, J NAT PROD, V54, P1265, DOI 10.1021/np50077a004; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Trost BM, 2007, J AM CHEM SOC, V129, P2206, DOI 10.1021/ja067305j; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Trost BM, 2005, ORG LETT, V7, P4761, DOI 10.1021/ol0520065; TROST BM, 1989, J AM CHEM SOC, V111, P8745, DOI 10.1021/ja00205a041; TROST BM, 1983, SCIENCE, V219, P245, DOI 10.1126/science.219.4582.245; Wender PA, 2008, ORG LETT, V10, P3331, DOI 10.1021/ol801235h; Wender PA, 2008, J AM CHEM SOC, V130, P6658, DOI 10.1021/ja8015632	30	198	200	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					485	488		10.1038/nature07543	http://dx.doi.org/10.1038/nature07543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	376FW	19037312	Green Accepted			2022-12-24	WOS:000261170500034
J	Matos, J; Lipp, JJ; Bogdanova, A; Guillot, S; Okaz, E; Junqueira, M; Shevchenko, A; Zachariae, WG				Matos, Joao; Lipp, Jesse J.; Bogdanova, Aliona; Guillot, Sylvine; Okaz, Elwy; Junqueira, Magno; Shevchenko, Andrej; Zachariae, Wolfgang			Dbf4-Dependent Cdc7 Kinase Links DNA Replication to the Segregation of Homologous Chromosomes in Meiosis I	CELL			English	Article							MEIOTIC RECOMBINATION; YEAST MEIOSIS; S-PHASE; CENTROMERIC COHESION; SYNAPTONEMAL COMPLEX; MONOPOLAR ATTACHMENT; MOLECULAR-BIOLOGY; FISSION YEAST; PROTEIN; INITIATION	Meiosis differs from mitosis in that DNA replication is followed by the segregation of homologous chromosomes but not sister chromatids. This depends on the formation of interhomolog connections through crossover recombination and on the attachment of sister kinetochores to microtubules emanating from the same spindle pole. We show that in yeast, the Dbf4-dependent Cdc7 kinase (DDK) provides a link between premeiotic S phase, recombination, and monopolar attachment. Independently from its established role in initiating DNA replication, DDK promotes double-strand break formation, the first step of recombination, and the recruitment of the monopolin complex to kinetochores, which is essential for monopolar attachment. DDK regulates monopolin localization together with the polo-kinase Cdc5 bound to Spo13, probably through phosphorylation of the monopolin subunit Lrs4. Thus, activation of DDK both initiates DNA replication and commits meiotic cells to reductional chromosome segregation in the first division of meiosis.	[Matos, Joao; Lipp, Jesse J.; Bogdanova, Aliona; Guillot, Sylvine; Okaz, Elwy; Junqueira, Magno; Shevchenko, Andrej; Zachariae, Wolfgang] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Zachariae, WG (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zachariae@mpi-cbg.de	Matos, Joao/C-1488-2014; Junqueira, Magno/A-7495-2012	Matos, Joao/0000-0002-3754-3709; Junqueira, Magno/0000-0002-7036-0728				Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Ogino K, 2006, P NATL ACAD SCI USA, V103, P8131, DOI 10.1073/pnas.0602498103; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Sclafani RA, 2000, J CELL SCI, V113, P2111; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Valentin G, 2006, J BIOL CHEM, V281, P2828, DOI 10.1074/jbc.M510626200; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	42	115	116	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					662	678		10.1016/j.cell.2008.10.026	http://dx.doi.org/10.1016/j.cell.2008.10.026			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013276	Bronze			2022-12-24	WOS:000260886900017
J	Klein, J				Klein, Jacob			CHEMISTRY Repair or Replacement-A Joint Perspective	SCIENCE			English	Editorial Material							MATERIALS SCIENCE; LUBRICATION; CARTILAGE; BIOMATERIALS; POLYMER		[Klein, Jacob] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Klein, J (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	jacob.klein@weizmann.ac.il						Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; Byrne JA, 2008, HUM MOL GENET, V17, pR37, DOI 10.1093/hmg/ddn053; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Chen FH, 2008, CURR RHEUMATOL REV, V4, P161, DOI 10.2174/157339708785133550; Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005; Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McCutchen C. W., 1962, WEAR, V5, P1, DOI [10.1016/0043-1648(62)90176-X, DOI 10.1016/0043-1648(62)90176-X]; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; 2008, ROYAL SOC CHEM C CHE	18	167	175	10	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					47	48		10.1126/science.1166753	http://dx.doi.org/10.1126/science.1166753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119205				2022-12-24	WOS:000262104100029
J	Ingelfinger, JR				Ingelfinger, Julie R.			Melamine and the Global Implications of Food Contamination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chen K., 2007, PUBLIC HLTH SECURITY, P169; *FOOD DRUG ADM, 2008, MEL CONT CHIN; HAUGE MD, 1992, INVEST NEW DRUG, V10, P299, DOI 10.1007/BF00944184; TURNIPSEED S, 2008, LAB INFORMATION B, V4421	5	251	256	3	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2745	2748		10.1056/NEJMp0808410	http://dx.doi.org/10.1056/NEJMp0808410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109571				2022-12-24	WOS:000261950800001
J	Sankaran, VG; Menne, TF; Xu, J; Akie, TE; Lettre, G; Van Handel, B; Mikkola, HKA; Hirschhorn, JN; Cantor, AB; Orkin, SH				Sankaran, Vijay G.; Menne, Tobias F.; Xu, Jian; Akie, Thomas E.; Lettre, Guillaume; Van Handel, Ben; Mikkola, Hanna K. A.; Hirschhorn, Joel N.; Cantor, Alan B.; Orkin, Stuart H.			Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; LOCUS-CONTROL REGION; ZINC-FINGER PROTEIN; BETA-THALASSEMIA; COMPLEX; DIFFERENTIATION; VARIANTS; RECRUITS; DISEASE; LINEAGE	Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the beta-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high- HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full- length forms of BCL11A is developmentally restricted to adult erythroid cells. Down- regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the beta- globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in beta- hemoglobin disorders.	[Sankaran, Vijay G.; Menne, Tobias F.; Xu, Jian; Akie, Thomas E.; Cantor, Alan B.; Orkin, Stuart H.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Sankaran, Vijay G.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Childrens Hosp, Div Genet Endocrinol, Boston, MA 02115 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Van Handel, Ben; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of California System; University of California Los Angeles; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu		Cantor, Alan/0000-0002-5136-028X	National Heart, Lung, and Blood Institute; NIH [HL32262-26, HL32259-27]; Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases; Howard Hughes Medical Institute; Leukaemia Research and Kay Kendall Leukaemia Funds; Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259, P01HL032262] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leukaemia Research and Kay Kendall Leukaemia Funds; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Snow, P. Tucker, G. Ippolito, B. Lee, M. Leid, T. Nakamura, D. Altshuler, E. Choy, and S. Bonakdar for providing reagents and suggestions. We are grateful to D. Nathan and A. Michelson for critical comments; D. Shao, N. Yudanin, and A. Soriano for experimental assistance; and C. Chen and V. Sankaran for assistance with data analysis. This work was supported by grants from the National Heart, Lung, and Blood Institute, NIH (HL32262-26 and HL32259-27), a Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases, NIH, and the Howard Hughes Medical Institute. T. F. M. was supported by the Leukaemia Research and Kay Kendall Leukaemia Funds. V. G. S. was supported by a Medical Scientist Training Program grant from the NIH. Array datasets are deposited at Gene Expression Omnibus (accession no. GSE 13285). A patent application related to this work was filed, and V.G.S. and S.H.O. are inventors on this patent.	Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; GARLICK RL, 1981, J BIOL CHEM, V256, P1727; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; PAPAYANNOPOULOU T, 1986, CELL, V46, P469, DOI 10.1016/0092-8674(86)90667-7; PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0; Quek L, 2007, BRIT J HAEMATOL, V136, P353, DOI 10.1111/j.1365-2141.2006.06408.x; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	26	598	648	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1839	1842		10.1126/science.1165409	http://dx.doi.org/10.1126/science.1165409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056937				2022-12-24	WOS:000261799400053
J	Alenghat, T; Meyers, K; Mullican, SE; Leitner, K; Adeniji-Adele, A; Avila, J; Bucan, M; Ahima, RS; Kaestner, KH; Lazar, MA				Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Adeniji-Adele, Adetoun; Avila, Jacqueline; Bucan, Maja; Ahima, Rexford S.; Kaestner, Klaus H.; Lazar, Mitchell A.			Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology	NATURE			English	Article							REV-ERB-ALPHA; THYROID-HORMONE RECEPTOR; GENE-EXPRESSION; GLUCOSE-HOMEOSTASIS; CLOCK; TRANSCRIPTION; REPRESSION; PROMOTER; DELETION; ELEMENTS	Rhythmic changes in histone acetylation at circadian clock genes suggest that temporal modulation of gene expression is regulated by chromatin modifications(1-3). Furthermore, recent studies demonstrate a critical relationship between circadian and metabolic physiology(4-7). The nuclear receptor corepressor 1 (Ncor1) functions as an activating subunit for the chromatin modifying enzyme histone deacetylase 3 (Hdac3)(8). Lack of Ncor1 is incompatible with life, and hence it is unknown whether Ncor1, and particularly its regulation of Hdac3, is critical for adult mammalian physiology(9). Here we show that specific, genetic disruption of the Ncor1-Hdac3 interaction in mice causes aberrant regulation of clock genes and results in abnormal circadian behaviour. These mice are also leaner and more insulin- sensitive owing to increased energy expenditure. Unexpectedly, loss of a functional Ncor1-Hdac3 complex in vivo does not lead to sustained increases in known catabolic genes, but instead significantly alters the oscillatory patterns of several metabolic genes, demonstrating that circadian regulation of metabolism is critical for normal energy balance. These findings indicate that activation of Hdac3 by Ncor1 is a nodal point in the epigenetic regulation of circadian and metabolic physiology.	[Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Avila, Jacqueline; Ahima, Rexford S.; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Avila, Jacqueline; Ahima, Rexford S.; Kaestner, Klaus H.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Adeniji-Adele, Adetoun; Bucan, Maja; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019; Ahima, Rexford/W-1394-2019		National Institutes of Health [DK43806]; National Research Training Grant in Developmental Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK050306, R37DK043806, P30DK019525, R01DK043806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Training Grant in Developmental Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Pear for providing EIIa-CreC57BL/6 mice, G. Barnes and J. Rusche for providing MS-275, P. White and J. Tobias for bioinformatics assistance, and L. Yin, S.-H. You, M. Qatanani and other members of the Lazar laboratory for helpful discussions. We also thank J. Richa and The Transgenic Mouse Core, H. Collins and the Radioimmunoassay/Biomarkers Core, R. Dhir and the Metabolic Phenotyping Core of the Penn Diabetes and Endocrinology Research Center (DK19525), H. Fu and the Mouse Embryonic Stem Cell Core (DK49210) and the Morphology Core of the Center for Molecular Studies in Digestive and Liver Disease (DK50306 and DK49210) for consultation and services. This work was supported by National Institutes of Health grant DK43806 (to M.A.L.), and T.A. was supported by a National Research Training Grant in Developmental Biology.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; LEONE TC, 1995, J BIOL CHEM, V270, P16308, DOI 10.1074/jbc.270.27.16308; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	34	200	213	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					997	U88		10.1038/nature07541	http://dx.doi.org/10.1038/nature07541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19037247	Green Accepted			2022-12-24	WOS:000261768300056
J	Deutman, ABC; Monnereau, C; Elemans, JAAW; Ercolani, G; Nolte, RJM; Rowan, AE				Deutman, Alexander B. C.; Monnereau, Cyrille; Elemans, Johannes A. A. W.; Ercolani, Gianfranco; Nolte, Roeland J. M.; Rowan, Alan E.			Mechanism of Threading a Polymer Through a Macrocyclic Ring	SCIENCE			English	Article							PROTEIN TRANSLOCATION; MOLECULAR SHUTTLE; ROTAXANE; THERMODYNAMICS; MEMBRANES; MACHINES; KINETICS	The translocation of biopolymers through pores and channels plays a fundamental role in numerous biological processes. We describe here the mechanism of the threading of a series of polymer chains through a synthetic macrocycle, which mimics these natural processes. The threading of polymers involves a kinetically favorable "entron" effect, which is associated with the initial filling of the cavity by the end of the polymer. A preassociation between the outside of the macrocycle and the polymer induces a process in which the polymer end loops back into the cavity of the macrocycle. This looping mechanism results in accelerated threading rates and unidirectional motion and is reminiscent of the protein translocation through membrane pores.	[Deutman, Alexander B. C.; Monnereau, Cyrille; Elemans, Johannes A. A. W.; Nolte, Roeland J. M.; Rowan, Alan E.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Ercolani, Gianfranco] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy	Radboud University Nijmegen; University of Rome Tor Vergata	Nolte, RJM (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	r.nolte@science.ru.nl; a.rowan@science.ru.nl	Rowan, Alan E/F-9702-2015; Elemans, Johannes/D-4334-2012; Ercolani, Gianfranco/AAH-2449-2019; Nolte, Roeland/C-9930-2013	Rowan, Alan E/0000-0003-0728-3851; Ercolani, Gianfranco/0000-0003-2437-3429; Nolte, Roeland/0000-0002-5612-7815; Elemans, Johannes/0000-0003-3825-7218	National Research School Combination Catalysis Controlled by Chemical Design; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni; Vidi and Vici; Koninklijke Nederlandse Akademie van Wetenschappen; Nanoned	National Research School Combination Catalysis Controlled by Chemical Design; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni(Netherlands Organization for Scientific Research (NWO)); Vidi and Vici; Koninklijke Nederlandse Akademie van Wetenschappen; Nanoned	This research was supported by a National Research School Combination Catalysis Controlled by Chemical Design grant, Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni, Vidi and Vici grants (J.A.A.W.E. and A.E.R.), a Koninklijke Nederlandse Akademie van Wetenschappen grant (R.J.M.N.), and a Nanoned grant (A.E.R. and R.J.M.N.).	Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Coumans RGE, 2006, P NATL ACAD SCI USA, V103, P19647, DOI 10.1073/pnas.0603036103; Galli C, 2000, EUR J ORG CHEM, V2000, P3117; HAMMETT LP, 1970, PHYS ORGANIC CHEM, P112; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Herrmann W, 1997, MACROMOLECULES, V30, P4966, DOI 10.1021/ma961373g; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kay ER, 2006, NATURE, V440, P286, DOI 10.1038/440286a; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Kolomeisky AB, 2008, BIOPHYS J, V94, P1547, DOI 10.1529/biophysj.107.122770; Liu Y, 2005, J AM CHEM SOC, V127, P9745, DOI 10.1021/ja051088p; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mandolini L., 1986, ADV PHYS ORG CHEM, V22, P1; Meller A, 2001, PHYS REV LETT, V86, P3435, DOI 10.1103/PhysRevLett.86.3435; Ramos PH, 2007, J AM CHEM SOC, V129, P5699, DOI 10.1021/ja068714i; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Slonkina E, 2003, J CHEM PHYS, V118, P7112, DOI 10.1063/1.1560932; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Thordarson P, 2003, J AM CHEM SOC, V125, P1186, DOI 10.1021/ja028463n; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752	25	84	87	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1668	1671		10.1126/science.1164647	http://dx.doi.org/10.1126/science.1164647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074344				2022-12-24	WOS:000261608300038
J	Lovell, JF; Billen, LP; Bindner, S; Shamas-Din, A; Fradin, C; Leber, B; Andrews, DW				Lovell, Jonathan F.; Billen, Lieven P.; Bindner, Scott; Shamas-Din, Aisha; Fradin, Cecile; Leber, Brian; Andrews, David W.			Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax	CELL			English	Article							MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY; CONFORMATIONAL-CHANGE; APOPTOSIS; DEATH; DOMAIN; IDENTIFICATION; INDUCTION; MEMBERS	In normal circumstances, the Bcl-2 family dutifully governs when cells die. However, the rules of engagement between the pro- and antiapoptotic family members are still contested, and how Bax is transformed from a cytosolic monomer to an outer mitochondrial membrane-permeabilizing oligomer is unclear. With fluorescence techniques and an in vitro system, the combination of tBid and Bax produced dramatic membrane permeabilization. The membrane is not a passive partner in this process beause membranes are required for the protein-protein interactions to occur. Simultaneous measurements of these interactions revealed an ordered series of steps required for outer membrane permeabilization: ( 1) tBid rapidly binds to membranes, where ( 2) tBid interacts with Bax, causing ( 3) Bax insertion into membranes and ( 4) oligomerization, culminating in ( 5) membrane permeabilization. Bcl-XL prevents membrane- bound tBid from binding Bax. Bad releases tBid from Bcl-XL, restoring both tBid binding to Bax and membrane permeabilization.	[Lovell, Jonathan F.; Billen, Lieven P.; Bindner, Scott; Shamas-Din, Aisha; Fradin, Cecile; Leber, Brian; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Fradin, Cecile] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8N 3Z5, Canada; [Leber, Brian] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Andrews, DW (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	andrewsd@mcmaster.ca	Fradin, Cécile/D-9302-2011	Fradin, Cécile/0000-0001-8329-4953; Leber, Brian/0000-0001-5502-1480; Lovell, Jonathan/0000-0002-9052-884X; Andrews, David/0000-0002-9266-7157	Canadian Institute of Health Research (CIHR) [FRN12517]; Tier I Canada Research Chair in Membrane Biogenesis	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier I Canada Research Chair in Membrane Biogenesis(Canada Research Chairs)	This work was supported by grant FRN12517 from the Canadian Institute of Health Research (CIHR) to D. W. A. and B. L. and a Tier I Canada Research Chair in Membrane Biogenesis to D. W. A. L. P. B. is recipient of a CIHR Canada Graduate Scholarship.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim M, 2005, BIOCHEM BIOPH RES CO, V338, P1834, DOI 10.1016/j.bbrc.2005.10.155; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	25	447	455	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1074	1084		10.1016/j.cell.2008.11.010	http://dx.doi.org/10.1016/j.cell.2008.11.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19062087	Bronze			2022-12-24	WOS:000261642800023
J	Yu, RC; Pesce, CG; Colman-Lerner, A; Lok, L; Pincus, D; Serra, E; Holl, M; Benjamin, K; Gordon, A; Brent, R				Yu, Richard C.; Pesce, C. Gustavo; Colman-Lerner, Alejandro; Lok, Larry; Pincus, David; Serra, Eduard; Holl, Mark; Benjamin, Kirsten; Gordon, Andrew; Brent, Roger			Negative feedback that improves information transmission in yeast signalling	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; MATING PATHWAY; PROTEIN-KINASE; STE5 SCAFFOLD; GENE NETWORKS; PHEROMONE; RECEPTOR; BINDING; TRANSDUCTION	Haploid Saccharomyces cerevisiae yeast cells use a prototypic cell signalling system to transmit information about the extracellular concentration of mating pheromone secreted by potential mating partners. The ability of cells to respond distinguishably to different pheromone concentrations depends on how much information about pheromone concentration the system can transmit. Here we show that the mitogen- activated protein kinase Fus3 mediates fast- acting negative feedback that adjusts the dose response of the downstream system response to match the dose response of receptor- ligand binding. This ` dose - response alignment', defined by a linear relationship between receptor occupancy and downstream response, can improve the fidelity of information transmission by making downstream responses corresponding to different receptor occupancies more distinguishable and reducing amplification of stochastic noise during signal transmission. We also show that one target of the feedback is a previously uncharacterized signal- promoting function of the regulator of G- protein signalling protein Sst2. Our work suggests that negative feedback is a general mechanism used in signalling systems to align dose responses and thereby increase the fidelity of information transmission.	[Yu, Richard C.; Pesce, C. Gustavo; Colman-Lerner, Alejandro; Lok, Larry; Pincus, David; Serra, Eduard; Benjamin, Kirsten; Gordon, Andrew; Brent, Roger] Inst Mol Sci, Berkeley, CA 94704 USA; [Holl, Mark] Univ Washington, Microscale Life Sci Ctr, Seattle, WA 98195 USA	The Molecular Sciences Institute; University of Washington; University of Washington Seattle	Yu, RC (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	ryu@molsci.org; brent@molsci.org	Colman-Lerner, Alejandro/ABC-3808-2020; Serra, Eduard/K-1332-2013	Colman-Lerner, Alejandro/0000-0002-2557-8883; Serra, Eduard/0000-0003-2895-9857; Benjamin, Kirsten/0000-0003-4267-1972	Alpha Project at the Center for Quantitative Genome Function; NIH Center of Excellence in Genomic Science [P50 HG02370]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097479] Funding Source: NIH RePORTER	Alpha Project at the Center for Quantitative Genome Function; NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Abola, S. Andrews, A. Arkin, M. Bowen, L. Buck, C. Denby, A. Gann, D. Meldrum, T. Mitchison, C. Pabo, M. Ptashne, M. Reese, O. Resnekov, C. Ryan, M. Snyder, T. Thomson, A. E. Tsong and M. Wilson for discussions and/or comments on the manuscript, and O. Resnekov for help in articulating the requirements for fluidic induction devices. Work, including that of M. H. at the University of Washington, was supported by the Alpha Project at the Center for Quantitative Genome Function, an NIH Center of Excellence in Genomic Science under grant P50 HG02370 from the National Human Genome Research Institute to R. B.	AMIR SM, 1973, J BIOL CHEM, V248, P4092; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Black H., 1934, ELECTRON ENG, V53, P114; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLOOM E, 1980, J STEROID BIOCHEM, V12, P175, DOI 10.1016/0022-4731(80)90267-8; BRUN R, 1989, PAW PHYS ANAL WORKST; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; CUATRECASAS P, 1971, P NATL ACAD SCI USA, V68, P1264, DOI 10.1073/pnas.68.6.1264; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guthrie C., 1991, METHODS ENZYMOLOGY G; HEXIMER SP, 2007, SCI STKE, pPE2; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; KASAI M, 1971, J MEMBRANE BIOL, V6, P58, DOI 10.1007/BF01874114; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; LIN SY, 1970, AM J PHYSIOL, V218, P1319, DOI 10.1152/ajplegacy.1970.218.5.1319; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rousseau G G, 1979, Monogr Endocrinol, V12, P49; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schrick K, 1997, GENETICS, V147, P19; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; SHANNON CE, 1948, BELL SYST TECH J, V27, P423; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; SIMONS SS, 1992, MOL ENDOCRINOL, V6, P995, DOI 10.1210/me.6.7.995; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100	47	160	162	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					755	761		10.1038/nature07513	http://dx.doi.org/10.1038/nature07513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079053	Green Accepted			2022-12-24	WOS:000261559900041
J	Arroll, B; Fernando, A; Falloon, K				Arroll, Bruce; Fernando, Antonio, III; Falloon, Karen			10-Minute Consultation Sleep disorder (insomnia)	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arroll, Bruce; Fernando, Antonio, III; Falloon, Karen] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz						Holbrook AM, 2004, BRIT MED J, V329, P1198, DOI 10.1136/bmj.329.7476.1198; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5	2	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 28	2008	337								a1245	10.1136/bmj.a1245	http://dx.doi.org/10.1136/bmj.a1245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042934				2022-12-24	WOS:000261827800001
J	van Leeuwen, JFN; Froyd, CA; van der Knaap, WO; Coffey, EE; Tye, A; Willis, KJ				van Leeuwen, Jacqueline F. N.; Froyd, Cynthia A.; van der Knaap, W. O.; Coffey, Emily E.; Tye, Alan; Willis, Katherine J.			Fossil Pollen as a Guide to Conservation in the Galapagos	SCIENCE			English	Article									[Froyd, Cynthia A.; Coffey, Emily E.; Willis, Katherine J.] Univ Oxford, Ctr Environm, Long Term Ecol Lab, Oxford OX1 3QY, England; [van Leeuwen, Jacqueline F. N.; van der Knaap, W. O.] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [van Leeuwen, Jacqueline F. N.; van der Knaap, W. O.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3013 Bern, Switzerland; [Tye, Alan] Charles Darwin Res Stn, Galapagos, Ecuador; [Willis, Katherine J.] Univ Bergen, Dept Biol, N-5007 Bergen, Norway	University of Oxford; University of Bern; University of Bern; University of Bergen	Froyd, CA (corresponding author), Univ Oxford, Ctr Environm, Long Term Ecol Lab, S Parks Rd, Oxford OX1 3QY, England.	cynthia.froyd@ouce.ox.ac.uk	Froyd, Cynthia/A-8488-2012	Froyd, Cynthia/0000-0001-5291-9156; Willis, Katherine/0000-0002-6763-2489	UK Natural Environment Research Council [NE/C510667/1]; National Geographic Society; Swiss Association of Friends of the Galapagos Islands; European Commission [017008-2]; Natural Environment Research Council [NE/C510667/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic Society(National Geographic Society); Swiss Association of Friends of the Galapagos Islands; European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank I. Robertson for helpful comments on the manuscript, the Galapagos National Park Service, and I. Flett and P.Q. Dresser for radiocarbon dates. This research was supported by the UK Natural Environment Research Council (grant NE/C510667/1 awarded to K.J.W. and C.A.F.), the National Geographic Society and the Swiss Association of Friends of the Galapagos Islands (W.O.v.d.K.), and European Commission grant 017008-2.	LAWESSON JE, 1987, REPORTS BOT I U AARH, V16, P1; Magee J, 2001, SCIENCE, V294, P1279; Porter D. M., 1983, PATTERNS EVOLUTION G, P33; SUGGS RC, 1967, Z ETHNOL, V92, P239	4	74	77	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1206	1206		10.1126/science.1163454	http://dx.doi.org/10.1126/science.1163454			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023075				2022-12-24	WOS:000261033400030
J	Coffin, JM				Coffin, John M.			Attenuation by a Thousand Cuts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		[Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University	Coffin, JM (corresponding author), Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.				NCI NIH HHS [R37 CA089441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA089441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; GRAHAM BS, 2007, FIELDS VIROLOGY, P487; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06	4	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2283	2285		10.1056/NEJMcibr0805820	http://dx.doi.org/10.1056/NEJMcibr0805820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020330				2022-12-24	WOS:000260994000014
J	Grande, C; Patel, NH				Grande, Cristina; Patel, Nipam H.			Nodal signalling is involved in left-right asymmetry in snails	NATURE			English	Article							SEA-URCHIN EMBRYO; CONSERVED ROLE; EXPRESSION; DEUTEROSTOMES; ESTABLISHMENT; INHERITANCE; EVOLUTION; INVERSUS; LIMNAEA; AXES	Many animals display specific internal or external features with left right asymmetry. In vertebrates, the molecular pathway that leads to this asymmetry uses the signalling molecule Nodal, a member of the transforming growth factor-beta superfamily(1), which is expressed in the left lateral plate mesoderm(2), and loss of nodal function produces a randomization of the left - right asymmetry of visceral organs(3,4). Orthologues of nodal have also been described in other deuterostomes, including ascidians and sea urchins(5,6), but no nodal orthologue has been reported in the other two main clades of Bilateria: Ecdysozoa ( including flies and nematodes) and Lophotrochozoa ( including snails and annelids). Here we report the first evidence for a nodal orthologue in a non- deuterostome group. We isolated nodal and Pitx ( one of the targets of Nodal signalling) in two species of snails and found that the side of the embryo that expresses nodal and Pitx is related to body chirality: both genes are expressed on the right side of the embryo in the dextral ( right- handed) species Lottia gigantea and on the left side in the sinistral ( left- handed) species Biomphalaria glabrata. We pharmacologically inhibited the Nodal pathway and found that nodal acts upstream of Pitx, and that some treated animals developed with a loss of shell chirality. These results indicate that the involvement of the Nodal pathway in left - right asymmetry might have been an ancestral feature of the Bilateria.	[Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Patel, NH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nipam@uclink.berkeley.edu	; Grande Pardo, Maria Cristina/N-8956-2015	Patel, Nipam/0000-0003-4328-654X; Grande Pardo, Maria Cristina/0000-0002-5659-8967	Ministerio de Educacion y Ciencia (Spain); Center for Integrative Genomics	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Center for Integrative Genomics	We thank E. Begovic, E.E. Gonzales and I. Martinez-Solano for help collecting and fertilizing L. gigantea. A. Almeida helped with the drug experiments. D. R. Lindberg provided the Busycon pulleyi specimen. The NIAID Schistosomiasis Resource Center provided adults of B. glabrata. We thank M. Levine, D. R. Lindberg, P. Liu, M. Modrell, S. Nichols, M. Protas and J.Rehm for comments on the manuscript, and I. Hariharan for suggesting the experiments with rapamycin. C.G. was sponsored by a postdoctoral fellowship of the Ministerio de Educacion y Ciencia (Spain) and the Center for Integrative Genomics. N.H.P. is an Investigator of the Howard Hughes Medical Institute.	Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; CAMEY T, 1970, Netherlands Journal of Zoology, V20, P93; Christiaen L, 2007, SEMIN CELL DEV BIOL, V18, P502, DOI 10.1016/j.semcdb.2007.06.002; Dictus WJAG, 1997, MECH DEVELOP, V62, P213, DOI 10.1016/S0925-4773(97)00666-7; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Duboc V, 2008, J EXP ZOOL PART B, V310B, P41, DOI 10.1002/jez.b.21121; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Gould MC, 2001, J EXP ZOOL, V290, P411, DOI 10.1002/jez.1082; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hibino T, 2006, DEV GROWTH DIFFER, V48, P587, DOI 10.1111/j.1440-169x.2006.00892.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lartillot N, 2002, DEVELOPMENT, V129, P1411; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morokuma J, 2002, DEV GENES EVOL, V212, P439, DOI 10.1007/s00427-002-0242-3; Nederbragt AJ, 2002, NATURE, V417, P811, DOI 10.1038/417811b; Nogi T, 2005, LATERALITY, V10, P193, DOI 10.1080/1357650054200001440; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oviedo NJ, 2007, CELL, V129, P645, DOI 10.1016/j.cell.2007.05.005; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Price AL, 2008, J EXP ZOOL PART B, V310B, P24, DOI 10.1002/jez.b.21135; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; VandenBiggelaar J, 1996, NETH J ZOOL, V46, P8	28	192	194	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1007	1011		10.1038/nature07603	http://dx.doi.org/10.1038/nature07603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19098895	Green Accepted, Green Submitted			2022-12-24	WOS:000263425400041
J	Marchetti, A; Parker, MS; Moccia, LP; Lin, EO; Arrieta, AL; Ribalet, F; Murphy, MEP; Maldonado, MT; Armbrust, EV				Marchetti, Adrian; Parker, Micaela S.; Moccia, Lauren P.; Lin, Ellen O.; Arrieta, Angele L.; Ribalet, Francois; Murphy, Michael E. P.; Maldonado, Maria T.; Armbrust, E. Virginia			Ferritin is used for iron storage in bloom-forming marine pennate diatoms	NATURE			English	Article							SOUTHERN-OCEAN; PHYTOPLANKTON; GROWTH; REQUIREMENTS; HYDROLYSIS; LIMITATION; CHEMISTRY; EVOLUTION; OXIDATION; PACIFIC	Primary productivity in 30 - 40% of the world's oceans is limited by availability of the micronutrient iron(1,2). Regions with chronically low iron concentrations are sporadically pulsed with new iron inputs by way of dust(3) or lateral advection from continental margins(4). Addition of iron to surface waters in these areas induces massive phytoplankton blooms dominated primarily by pennate diatoms(5,6). Here we provide evidence that the bloom- forming pennate diatoms Pseudo- nitzschia and Fragilariopsis use the iron- concentrating protein, ferritin, to safely store iron. Ferritin has not been reported previously in any member of the Stramenopiles, a diverse eukaryotic lineage that includes unicellular algae, macroalgae and plant parasites. Phylogenetic analyses suggest that ferritin may have arisen in this small subset of diatoms through a lateral gene transfer. The crystal structure and functional assays of recombinant ferritin derived from Pseudo- nitzschia multiseries reveal a maxi- ferritin that exhibits ferroxidase activity and binds iron. The protein is predicted to be targeted to the chloroplast to control the distribution and storage of iron for proper functioning of the photosynthetic machinery. Abundance of Pseudo- nitzschia ferritin transcripts is regulated by iron nutritional status, and is closely tied to the loss and recovery of photosynthetic competence. Enhanced iron storage with ferritin allows the oceanic diatom Pseudo- nitzschia granii to undergo several more cell divisions in the absence of iron than the comparably sized, oceanic centric diatom Thalassiosira oceanica. Ferritin in pennate diatoms probably contributes to their success in chronically low- iron regions that receive intermittent iron inputs, and provides an explanation for the importance of these organisms in regulating oceanic CO2 over geological timescales(7,8).	[Marchetti, Adrian; Parker, Micaela S.; Lin, Ellen O.; Ribalet, Francois; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Moccia, Lauren P.; Maldonado, Maria T.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Arrieta, Angele L.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of Washington; University of Washington Seattle; University of British Columbia; University of British Columbia	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu	ribalet, francois/C-2626-2011; Murphy, Michael/R-6805-2017; Maldonado, Maria T/N-2877-2017	ribalet, francois/0000-0002-7431-0234; Murphy, Michael/0000-0003-2589-0014; Maldonado, Maria T/0000-0001-8134-9375; Marchetti, Adrian/0000-0003-4608-4775; Parker, Micaela/0000-0003-1007-4612	Gordon and Betty Moore Foundation Marine Microbiology Investigator Award; National Science Foundation; National Institute of Environmental Health Sciences; National Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Center for Research Resources; Biomedical Technology Program; National Institute of General Medical Sciences	Gordon and Betty Moore Foundation Marine Microbiology Investigator Award; National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. S. Bates for providing P. multiseries CLN-47 and CLN-17 isolates used in this study, and T. Rynearson for sea water from OSP in which P. granii (UWOSP36) was isolated. We are grateful to K.R. Boissonneault for providing P. multiseries actin sequences, R. Marohl and I. Oleinkov for assistance with culture maintenance and sample analyses, and W.C. Lee for assistance with X-ray diffraction data collection. This study was supported by a Gordon and Betty Moore Foundation Marine Microbiology Investigator Award, National Science Foundation grants and a National Institute of Environmental Health Sciences grant to E.V.A.; a National Sciences and Engineering Research Council of Canada grant to M.T.M.; and a Canadian Institutes of Health Research grant to M.E.P.M. Portions of this research were carried out at the Canadian Light Source (CLS) and the Stanford Synchrotron Radiation Laboratory (SSRL). SSRL is a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BI X, 1991, J BIOL CHEM, V266, P19965; Bou-Abdallah F, 2002, J BIOL CHEM, V277, P37064, DOI 10.1074/jbc.M205712200; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Cortese G, 2007, EARTH PLANET SC LETT, V257, P526, DOI 10.1016/j.epsl.2007.03.021; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Katsuki K, 2005, DEEP-SEA RES PT II, V52, P2110, DOI 10.1016/j.dsr2.2005.07.001; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Lam PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033294; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2095, DOI 10.1016/j.dsr2.2006.05.038; Marchetti A, 2006, LIMNOL OCEANOGR, V51, P2092, DOI 10.4319/lo.2006.51.5.2092; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XK, 2000, BIOCHEM J, V349, P783, DOI 10.1042/bj3490783; 2006, PHAEODACTYLUM TRICOR	26	234	242	6	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					467	470		10.1038/nature07539	http://dx.doi.org/10.1038/nature07539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19037243				2022-12-24	WOS:000262519200044
J	Simon, T; Verstuyft, C; Mary-Krause, M; Quteineh, L; Drouet, E; Meneveau, N; Steg, PG; Ferrieres, J; Danchin, N; Becquemont, L				Simon, Tabassome; Verstuyft, Celine; Mary-Krause, Murielle; Quteineh, Lina; Drouet, Elodie; Meneveau, Nicolas; Steg, P. Gabriel; Ferrieres, Jean; Danchin, Nicolas; Becquemont, Laurent		French Registry Acute ST-Elevation	Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; OF-FUNCTION POLYMORPHISM; SEQUENCE VARIATIONS; P-GLYCOPROTEIN; DUODENAL ENTEROCYTES; DRUG RESPONSE; ST-ELEVATION; MDR1 GENE; ASPIRIN	Background: Pharmacogenetic determinants of the response of patients to clopidogrel contribute to variability in the biologic antiplatelet activity of the drug. The effect of these determinants on clinical outcomes after an acute myocardial infarction is unknown. Methods: We consecutively enrolled 2208 patients presenting with an acute myocardial infarction in a nationwide French registry and receiving clopidogrel therapy. We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up. Results: Death occurred in 225 patients, and nonfatal myocardial infarction or stroke in 94 patients, during the follow-up period. None of the selected single-nucleotide polymorphisms (SNPs) in CYP3A5, P2RY12, or ITGB3 were associated with a risk of an adverse outcome. Patients with two variant alleles of ABCB1 (TT at nucleotide 3435) had a higher rate of cardiovascular events at 1 year than those with the ABCB1 wild-type genotype (CC at nucleotide 3435) (15.5% vs. 10.7%; adjusted hazard ratio, 1.72; 95% confidence interval [CI], 1.20 to 2.47). Patients carrying any two CYP2C19 loss-of-function alleles (*2, *3, *4, or *5), had a higher event rate than patients with none (21.5% vs. 13.3%; adjusted hazard ratio, 1.98; 95% CI, 1.10 to 3.58). Among the 1535 patients who underwent percutaneous coronary intervention during hospitalization, the rate of cardiovascular events among patients with two CYP2C19 loss-of-function alleles was 3.58 times the rate among those with none (95% CI, 1.71 to 7.51). Conclusions: Among patients with an acute myocardial infarction who were receiving clopidogrel, those carrying CYP2C19 loss-of-function alleles had a higher rate of subsequent cardiovascular events than those who were not. This effect was particularly marked among the patients undergoing percutaneous coronary intervention. (ClinicalTrials.gov number, NCT00673036.) N Engl J Med 2009;360:363-75.	[Simon, Tabassome; Quteineh, Lina; Drouet, Elodie] Univ Paris 06, Dept Pharmacol, F-75012 Paris, France; [Simon, Tabassome; Quteineh, Lina; Drouet, Elodie] Hop St Antoine, AP HP, F-75571 Paris, France; [Verstuyft, Celine; Becquemont, Laurent] Univ Paris 11, AP HP, Hop Bicetre, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, P. Gabriel] INSERM, Unite 698, Paris, France; [Steg, P. Gabriel] Univ Paris 07, Paris, France; [Danchin, Nicolas] Univ Paris 05, AP HP, Hop Europeen Georges Pompidou, Paris, France; [Meneveau, Nicolas] Ctr Hosp Univ Besancon, F-25030 Besancon, France; [Ferrieres, Jean] Fac Med Toulouse, INSERM, Unite 558, F-31073 Toulouse, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Simon, T (corresponding author), Univ Paris 06, Dept Pharmacol, 27 Rue Chaligny, F-75012 Paris, France.	tabassome.simon@sat.aphp.fr	Danchin, Nicolas/AAN-8291-2020; verstuyft, celine/AAU-3343-2021; STEG, Philippe Gabriel/Z-1567-2019; Ferrieres, Jean/S-7993-2016	verstuyft, celine/0000-0002-8534-224X; Ferrieres, Jean/0000-0001-6144-1297; SIMON, Tabassome/0000-0002-4550-0450; STEG, Philippe Gabriel/0000-0001-6896-2941	Pfizer; Servier; French Caisse Nationale d'Assurance Maladie; Bayer Schering; Pfizer and Eli Lilly; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Endotis; GlaxoSmithKline; MedtronicMerck Sharp Dohme; Nycomed; Sanofi-Aventis; Medicines Company	Pfizer(Pfizer); Servier(Servier); French Caisse Nationale d'Assurance Maladie; Bayer Schering(Bayer AG); Pfizer and Eli Lilly; Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Endotis; GlaxoSmithKline(GlaxoSmithKline); MedtronicMerck Sharp Dohme; Nycomed; Sanofi-Aventis(Sanofi-Aventis); Medicines Company	Supported by unrestricted grants from Pfizer and Servier for FAST-MI, a registry of the French Society of Cardiology, and a research grant from the French Caisse Nationale d'Assurance Maladie.; Dr. Simon reports receiving consulting fees from Bayer Schering, Pfizer and Eli Lilly, lecture fees from Bayer-Schering, and grant support from Pfizer and Servier; Dr. Steg, consulting fees from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Endotis, GlaxoSmithKline, Medtronic, Merck Sharp & Dohme, Nycomed, Sanofi-Aventis, Servier, and the Medicines Company, lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Nycomed, Sanofi-Aventis, Servier, and the Medicines Company, and grant support from Sanofi-Aventis; Dr. Danchin, consulting fees from Servier, Sanofi- Aventis, Eli Lilly, and AstraZeneca, lecture fees from Servier, Sanofi- Aventis, and Bristol-Myers Squibb, and grant support from Pfizer and Servier; and Dr. Becquemont, consulting fees from Sanofi- Aventis, Pfizer, and Servier and lecture fees from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.; We thank the physicians who cared for the patients at the participating institutions, E. Martin and F. Rousseau (IntegraGene, Paris), the International Clinical Trials Association Contract Research Organization (Fontaine-les-Dijon, France), Liliane Dubert (Department of Pharmacology, Universit, Pierre et Marie Curie [UPMC] Paris 06), the Clinical Research Assistant team of Unit, de Recherche Clinique de l'Est Parisien (Assistance Publique-Hopitaux de Paris and UPMC Paris 06), and Benoit Pace and Genevieve Mulak (French Society of Cardiology) for their assistance in designing the electronic case-record form and data management during the follow-up period.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson SD, 2008, CIRCULATION, V117, pE174, DOI 10.1161/CIRCULATIONAHA.107.737551; Angiolillo DJ, 2004, BLOOD COAGUL FIBRIN, V15, P89, DOI 10.1097/00001721-200401000-00014; Angiolillo DJ, 2007, THROMB HAEMOSTASIS, V98, P707, DOI 10.1160/TH07-08-0518; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Antman EM, 2008, J AM COLL CARDIOL, V51, P977, DOI 10.1016/j.jacc.2008.01.007; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cuisset T, 2007, THROMB RES, V120, P893, DOI 10.1016/j.thromres.2007.01.012; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Fontana P, 2008, THROMB RES, V121, P463, DOI 10.1016/j.thromres.2007.06.012; Gerloff T, 2002, BRIT J CLIN PHARMACO, V54, P610, DOI 10.1046/j.1365-2125.2002.01691.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Lev EI, 2007, THROMB RES, V119, P355, DOI 10.1016/j.thromres.2006.02.006; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Mehta RH, 2006, ARCH INTERN MED, V166, P2027, DOI 10.1001/archinte.166.18.2027; Moriya Y, 2002, BIOL PHARM BULL, V25, P1356, DOI 10.1248/bpb.25.1356; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Philippi A, 2005, MOL PSYCHIATR, V10, P950, DOI 10.1038/sj.mp.4001704; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Smith SMG, 2006, PLATELETS, V17, P250, DOI 10.1080/09537100500475844; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Suh JW, 2006, CAN MED ASSOC J, V175, P64, DOI 10.1503/cmaj.060701; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	42	1334	1454	2	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					363	375		10.1056/NEJMoa0808227	http://dx.doi.org/10.1056/NEJMoa0808227			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19106083				2022-12-24	WOS:000262519900008
J	Yang, Q; She, H; Gearing, M; Colla, E; Lee, M; Shacka, JJ; Mao, ZX				Yang, Qian; She, Hua; Gearing, Marla; Colla, Emanuela; Lee, Michael; Shacka, John J.; Mao, Zixu			Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy	SCIENCE			English	Article							MYOCYTE ENHANCER FACTOR-2; TRANSCRIPTION FACTOR MEF2; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; PROTEIN-DEGRADATION; CELL-DEATH; NEURODEGENERATION	Chaperone- mediated autophagy controls the degradation of selective cytosolic proteins and may protect neurons against degeneration. In a neuronal cell line, we found that chaperone- mediated autophagy regulated the activity of myocyte enhancer factor 2D ( MEF2D), a transcription factor required for neuronal survival. MEF2D was observed to continuously shuttle to the cytoplasm, interact with the chaperone Hsc70, and undergo degradation. Inhibition of chaperone- mediated autophagy caused accumulation of inactive MEF2D in the cytoplasm. MEF2D levels were increased in the brains of alpha-synuclein transgenic mice and patients with Parkinson's disease. Wild-type alpha-synuclein and a Parkinson's disease- associated mutant disrupted the MEF2D-Hsc70 binding and led to neuronal death. Thus, chaperone- mediated autophagy modulates the neuronal survival machinery, and dysregulation of this pathway is associated with Parkinson's disease.	[Yang, Qian; She, Hua; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Gearing, Marla; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Colla, Emanuela; Lee, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Shacka, John J.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA	Emory University; Emory University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Colla, Emanuela/H-2483-2013; Lee, Michael K/D-9491-2013	Colla, Emanuela/0000-0002-4755-7450; Lee, Michael K/0000-0001-5865-9682	NIH [NS048254, AG023695, NS038065]; Emory; UAB Alzheimer's Disease Research Center; Robert Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038065, P30NS047466, R01NS038065, P30NS057098, P30NS055077, R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, R01AG023695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory; UAB Alzheimer's Disease Research Center; Robert Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Rees and D. Cooper at Emory Neuroscience NINDS Core Facility (NS055077) and UAB Neuroscience Core Facility (NS47466 and NS57098) for assistance in imaging and immunohistochemistry analysis, and J. Blum and A. M. Cuervo for Hsc70 and Lamp2a constructs. Supported by NIH grants NS048254 (Z.M.), AG023695 (Z.M.), and NS038065 (M.L.) and by Emory and UAB Alzheimer's Disease Research Center pilot grants (Z.M. and J.J.S.) and the Robert Woodruff Health Sciences Center Fund (Z.M.).	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bandhyopadhyay U, 2007, EXP GERONTOL, V42, P120, DOI 10.1016/j.exger.2006.05.019; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gonzalez P, 2007, NEUROSCI LETT, V411, P47, DOI 10.1016/j.neulet.2006.09.055; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200	25	244	255	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					124	127		10.1126/science.1166088	http://dx.doi.org/10.1126/science.1166088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119233	Green Accepted			2022-12-24	WOS:000262104100056
J	Varricchio, DJ; Moore, JR; Erickson, GM; Norell, MA; Jackson, FD; Borkowski, JJ				Varricchio, David J.; Moore, Jason R.; Erickson, Gregory M.; Norell, Mark A.; Jackson, Frankie D.; Borkowski, John J.			Avian Paternal Care Had Dinosaur Origin	SCIENCE			English	Article							PARENTAL-CARE; SEXUAL-MATURITY; EVOLUTION; BIRDS; CLUTCHES; EGGS	The repeated discovery of adult dinosaurs in close association with egg clutches leads to speculation over the type and extent of care exhibited by these extinct animals for their eggs and young. To assess parental care in Cretaceous troodontid and oviraptorid dinosaurs, we examined clutch volume and the bone histology of brooding adults. In comparison to four archosaur care regressions, the relatively large clutch volumes of Troodon, Oviraptor, and Citipati scale most closely with a bird- paternal care model. Clutch- associated adults lack the maternal and reproductively associated histologic features common to extant archosaurs. Large clutch volumes and a suite of reproductive features shared only with birds favor paternal care, possibly within a polygamous mating system. Paternal care in both troodontids and oviraptorids indicates that this care system evolved before the emergence of birds and represents birds' ancestral condition. In extant birds and over most adult sizes, paternal and biparental care correspond to the largest and smallest relative clutch volumes, respectively.	[Varricchio, David J.; Jackson, Frankie D.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Moore, Jason R.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Erickson, Gregory M.] Florida State Univ, Dept Sci Biol, Tallahassee, FL 32306 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Borkowski, John J.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Texas A&M University System; Texas A&M University College Station; State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Montana State University System; Montana State University Bozeman	Varricchio, DJ (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.	djv@montana.edu			NSF [EAR-0418649, DBI-446224]	NSF(National Science Foundation (NSF))	We thank J. Horner, A. Chinsamy-Turan, L. Hall, H. Akashi, J. Rotella, and P.T. Varricchio Sr. Supported by NSF grants EAR-0418649 and DBI-446224 (G.M.E.).	BRANCH W R, 1975, Journal of Herpetology, V9, P243, DOI 10.2307/1563048; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Davies S.J.J.F., 2002, RATITES TINAMOUS; Elzanowski A., 1985, ACT 18 C INT ORN, V1, P178; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Ligon JD, 1999, EVOLUTION AVIAN BREE; Lourdais O, 2007, J COMP PHYSIOL B, V177, P569, DOI 10.1007/s00360-007-0155-6; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Pahl R, 1997, P ROY SOC B-BIOL SCI, V264, P239, DOI 10.1098/rspb.1997.0034; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Shine R, 1988, BIOL REPTILIA, V16, P276; Simkiss K., 1967, CALCIUM REPROD PHYSL; SOMMA LA, 1990, SMITHSONIAN HERPETOL; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; van Mierop L.H.S., 1976, Journal Herpet, V10, P333; VANRHIJN J, 1984, NETH J ZOOL, V34, P103, DOI 10.1163/002829684X00092; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; WINK CS, 1986, J MORPHOL, V189, P183, DOI 10.1002/jmor.1051890208; [No title captured]	28	94	97	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1826	1828		10.1126/science.1163245	http://dx.doi.org/10.1126/science.1163245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095938				2022-12-24	WOS:000261799400049
J	Goswami, D; Gowrishankar, K; Bilgrami, S; Ghosh, S; Raghupathy, R; Chadda, R; Vishwakarma, R; Rao, M; Mayor, S				Goswami, Debanjan; Gowrishankar, Kripa; Bilgrami, Sameera; Ghosh, Subhasri; Raghupathy, Riya; Chadda, Rahul; Vishwakarma, Ram; Rao, Madan; Mayor, Satyajit			Nanoclusters of GPI-Anchored Proteins Are Formed by Cortical Actin-Driven Activity	CELL			English	Article							LIPID RAFTS; PLASMA-MEMBRANE; CELL; CHOLESTEROL; ACTIVATION; ORGANIZATION; MICROSCOPY; CDC42	Several cell-surface lipid-tethered proteins exhibit a concentration-independent, cholesterol-sensitive organization of nanoscale clusters and monomers. To understand the mechanism of formation of these clusters, we investigate the spatial distribution and steady-state dynamics of fluorescently tagged GPI-anchored protein nanoclusters using high-spatial and temporal resolution FRET microscopy. These studies reveal a nonrandom spatial distribution of nanoclusters, concentrated in optically resolvable domains. Monitoring the dynamics of recovery of fluorescence intensity and anisotropy, we find that nanoclusters are immobile, and the dynamics of inter-conversion between nanoclusters and monomers, over a range of temperatures, is spatially heterogeneous and non-Arrhenius, with a sharp crossover coinciding with a reduction in the activity of cortical actin. Cholesterol depletion perturbs cortical actin and the spatial scale and interconversion dynamics of nanoclusters. Direct perturbations of cortical actin activity also affect the construction, dynamics, and spatial organization of nanoclusters. These results suggest a unique mechanism of complexation of cell-surface molecules regulated by cortical actin activity.	[Goswami, Debanjan; Bilgrami, Sameera; Ghosh, Subhasri; Raghupathy, Riya; Chadda, Rahul; Rao, Madan; Mayor, Satyajit] Nat Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; [Gowrishankar, Kripa; Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India; [Vishwakarma, Ram] Natl Inst Immunol, New Delhi 110067, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rao, M (corresponding author), Nat Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	madan@ncbs.res.in; mayor@ncbs.res.in	Chadda, Rahul/AAM-2085-2020; Rao, Madan/E-2927-2012	Ghosh, Subhasri/0000-0002-3907-6366	Central Imaging and Flow Facility at NCBS; HFSP [RGP 0050/ 2005)/DST(SR/S5/NM-36/2005)]	Central Imaging and Flow Facility at NCBS; HFSP(Human Frontier Science Program)	We thank M. Thattai, G. V. Shivashankar, and S. Ramaswamy for a critical reading, N. Periasami ( DCS, TIFR, Mumbai) for the help with time-resolved anistropy analysis, and H. Krishnamurthy and the Central Imaging and Flow Facility at NCBS for their help and support. S. M. acknowledges DST for J C Bose fellowship. S. M. and M. R. acknowledge grants from HFSP(RGP 0050/ 2005)/DST(SR/S5/NM-36/2005)/DBT/Wellcome Trust ( NLO-056727/Z/99/B)and HFSP( RGP26/2007)/IFCPAR, respectively.	[Anonymous], 2007, PRINCIPLES CONDENSED; Becker W, 2005, ADV TIME CORRELATED; Bretscher A, 1997, J CELL SCI, V110, P3011; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hatwalne Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118101; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; ISRAELACHVILI JN, 1992, INTERMOLOLECULAR SUR; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Keller H, 2002, EXP CELL RES, V277, P161, DOI 10.1006/excr.2002.5552; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; PETERS R, 1981, P NATL ACAD SCI-BIOL, V78, P962, DOI 10.1073/pnas.78.2.962; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ramaswamy S, 2001, CR ACAD SCI IV-PHYS, V2, P817, DOI 10.1016/S1296-2147(01)01226-4; Ramaswamy S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/423; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563	36	355	355	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1085	1097		10.1016/j.cell.2008.11.032	http://dx.doi.org/10.1016/j.cell.2008.11.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070578	Bronze			2022-12-24	WOS:000261642800024
J	Roberts, I				Roberts, Ian			Corporate capture and Coca-Cola	LANCET			English	Editorial Material									[Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Ian.Roberts@lshtm.ac.uk						GARCIA P, 2008, COMMUNICATION   1006; KER K, 2003, COCHRANE DB SYST REV, V3; Millstone E, 2008, LANCET, V372, P94, DOI 10.1016/S0140-6736(08)61012-0; PRATS J, 2008, COMMUNICATION   1007; Roberts I, 2007, J ROY SOC MED, V100, P360, DOI 10.1258/jrsm.100.8.360; Yach D, 2008, PUBLIC HEALTH NUTR, V11, P109, DOI 10.1017/S1368980007001619	6	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 6	2008	372	9654					1934	1935		10.1016/S0140-6736(08)61825-5	http://dx.doi.org/10.1016/S0140-6736(08)61825-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19059037				2022-12-24	WOS:000261471600007
J	Price, TAR; Hodgson, DJ; Lewis, Z; Hurst, GDD; Wedell, N				Price, T. A. R.; Hodgson, D. J.; Lewis, Z.; Hurst, G. D. D.; Wedell, N.			Selfish Genetic Elements Promote Polyandry in a Fly	SCIENCE			English	Article							SPERM COMPETITIVE ABILITY; SEX-RATIO; MEIOTIC DRIVE; DROSOPHILA-PSEUDOOBSCURA; FEMALES; SELECTION; CHROMOSOME; STERILITY; INSECT; COMMON	It is unknown why females mate with multiple males when mating is frequently costly and a single copulation often provides enough sperm to fertilize all a female's eggs. One possibility is that remating increases the fitness of offspring, because fertilization success is biased toward the sperm of high- fitness males. We show that female Drosophila pseudoobscura evolved increased remating rates when exposed to the risk of mating with males carrying a deleterious sex ratio- distorting gene that also reduces sperm competitive ability. Because selfish genetic elements that reduce sperm competitive ability are generally associated with low genetic fitness, they may represent a common driver of the evolution of polyandry.	[Price, T. A. R.; Hodgson, D. J.; Wedell, N.] Univ Exeter, Sch Biosci, Penryn TR10 9EZ, England; [Lewis, Z.] Okayama Univ, Grad Sch Environm Sci, Okayama 7008530, Japan; [Hurst, G. D. D.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Exeter; Okayama University; University of Liverpool	Wedell, N (corresponding author), Univ Exeter, Sch Biosci, Cornwall Campus, Penryn TR10 9EZ, England.	n.wedell@exeter.ac.uk	Lewis, Zenobia/T-2928-2019; Hurst, Gregory D D/C-2723-2008	Hurst, Gregory D D/0000-0002-7163-7784; Price, Thomas/0000-0002-4394-6301; Lewis, Zenobia/0000-0001-9464-7638	Funded by a Natural Environment Research Council; Natural Environment Research Council [NER/A/S/2003/00536/2] Funding Source: researchfish	Funded by a Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Isofemale lines were collected with assistance from T. Markow. We thank J. Blount, F. E. Champion de Crespigny, D. J. Hosken, and T. Tregenza for discussion. Funded by a Natural Environment Research Council grant (N.W. and G.H.).	Arnqvist Goran, 2005, pUnpaginated; BEUKEBOOM LW, 1994, EVOL ECOL, V8, P1, DOI 10.1007/BF01237662; Birkhead TR, 1998, SPERM COMPETITION SE; BRYANT SH, 1982, EVOLUTION, V36, P27, DOI 10.1111/j.1558-5646.1982.tb05006.x; Burt A, 2006, GENES CONFLICT BIOL; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; de Crespigny FEC, 2006, P ROY SOC B-BIOL SCI, V273, P1455, DOI 10.1098/rspb.2006.3478; HAIG D, 1995, J EVOLUTION BIOL, V8, P265, DOI 10.1046/j.1420-9101.1995.8030265.x; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; HURST LD, 1991, GENETICS, V128, P841; Jaenike J, 1996, AM NAT, V148, P237, DOI 10.1086/285923; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jiggins FM, 1999, AM NAT, V154, P481, DOI 10.1086/303251; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; POLICANSKY D, 1978, EVOLUTION, V32, P922, DOI 10.1111/j.1558-5646.1978.tb04647.x; Powell J. R., 1997, PROGR PROSPECTS EVOL; Price TAR, 2008, EVOLUTION, V62, P1644, DOI 10.1111/j.1558-5646.2008.00386.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rajendra TK, 2001, J GENET, V80, P97, DOI 10.1007/BF02728335; Rice WR, 2005, EVOLUTION, V59, P682; Simmons L. W., 2001, MG BEH ECOL; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	26	82	83	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1241	1243		10.1126/science.1163766	http://dx.doi.org/10.1126/science.1163766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023079				2022-12-24	WOS:000261033400040
J	Allegranzi, B; Pittet, D				Allegranzi, Benedetta; Pittet, Didier			Preventing infections acquired during health-care delivery	LANCET			English	Editorial Material									[Allegranzi, Benedetta] WHO, Global Patient Safety Challenge 1, World Alliance Patient Safety, CH-1211 Geneva 27, Switzerland; [Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Univ Geneva, Fac Med, Geneva, Switzerland	World Health Organization; University of Geneva; University of Geneva; World Health Organization; University of Geneva	Allegranzi, B (corresponding author), WHO, Global Patient Safety Challenge 1, World Alliance Patient Safety, CH-1211 Geneva 27, Switzerland.	allegranzib@who.int						Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; ALLEGRANZI B, 2008, GENFOR GLOB ACC HLTH; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; *DEP HLTH, SAV LIV DEL PROGR; *HEALTHC COMM, 2008, ANN HLTH CHECK 2007; *HLTH PROT AG, 2008, LAT FIG SHOW MRSA BL; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; *LANC C, 2008, HEALTHC ASS INF MOV; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Pittet D, 2005, LANCET INFECT DIS, V5, P242, DOI 10.1016/S1473-3099(05)70055-4; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; Pittet Didier, 2008, J Infect Public Health, V1, P4, DOI 10.1016/j.jiph.2008.08.006; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; *WHO, 2008, COUNTR COMM ADDR HAI; World Health Organisation (WHO), 2008, GLOB BURD DIS UPD 20	16	42	44	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1719	1720		10.1016/S0140-6736(08)61715-8	http://dx.doi.org/10.1016/S0140-6736(08)61715-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19013310				2022-12-24	WOS:000261077900010
J	Fowler, JH; Schreiber, D				Fowler, James H.; Schreiber, Darren			Biology, Politics, and the Emerging Science of Human Nature	SCIENCE			English	Editorial Material							VOTER TURNOUT; HERITABILITY; BEHAVIOR; FMRI; PARTICIPATION; DEACTIVATE; ATTITUDES; COGNITION; ALTRUISM; AUTISM	In the past 50 years, biologists have learned a tremendous amount about human brain function and its genetic basis. At the same time, political scientists have been intensively studying the effect of the social and institutional environment on mass political attitudes and behaviors. However, these separate fields of inquiry are subject to inherent limitations that may only be resolved through collaboration across disciplines. We describe recent advances and argue that biologists and political scientists must work together to advance a new science of human nature.	[Fowler, James H.; Schreiber, Darren] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhfowler@ucsd.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638				Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Aristotle, 1996, CAMBRIDGE TEXTS HIST; Baker LA, 2006, TWIN RES HUM GENET, V9, P933, DOI 10.1375/twin.9.6.933; BOHEM C, 1999, HIERARCHY FOREST EVO; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Byrne R., 1988, MACHIAVELLIAN INTELL; Campbell Angus., 1960, AM VOTER; CESARINI D, IN PRESS Q J EC; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; DAWES CT, IN PRESS J POLIT; DEWAAL F, 1982, CHIMPANZEE POLITICS; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Fowler JH, 2008, J POLIT, V70, P579, DOI 10.1017/S0022381608080638; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; Fowler JH, 2007, J POLIT, V69, P813, DOI 10.1111/j.1468-2508.2007.00577.x; Fowler JH, 2006, J POLIT, V68, P674, DOI 10.1111/j.1468-2508.2006.00453.x; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hatemi PK, 2007, BEHAV GENET, V37, P435, DOI 10.1007/s10519-006-9138-8; HATEMI PK, IN PRESS POLIT RES Q; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lieberman MD, 2003, POLIT PSYCHOL, V24, P681, DOI 10.1046/j.1467-9221.2003.00347.x; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; Matsusaka JG, 1999, PUBLIC CHOICE, V98, P431, DOI 10.1023/A:1018328621580; MAY RM, 2006, NATURE, V440, P744; Olson JM, 2001, J PERS SOC PSYCHOL, V80, P845, DOI 10.1037/0022-3514.80.6.845; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Plutzer E, 2002, AM POLIT SCI REV, V96, P41, DOI 10.1017/S0003055402004227; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schreiber D, 2007, AFFECT EFFECT DYNAMI, P48; SETTLE JE, IN PRESS POLIT RES Q; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947	37	126	127	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					912	914		10.1126/science.1158188	http://dx.doi.org/10.1126/science.1158188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	369DI	18988845				2022-12-24	WOS:000260674100038
J	de Jong, D; Vasmel, WLE; de Boer, JP; Verhave, G; Barbe, E; Casparie, MK; van Leeuwen, FE				de Jong, Daphne; Vasmel, Wies L. E.; de Boer, Jan Paul; Verhave, Gideon; Barbe, Ellis; Casparie, Mariel K.; van Leeuwen, Flora E.			Anaplastic Large-Cell Lymphoma in Women With Breast Implants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONCERTED ACTION BHM4-CT98-3936; SILICONE; CANCER; NATIONWIDE; PATHOLOGY; ADJACENT; RISK	Context Recently, we identified 2 patients with anaplastic large T- cell lymphoma ( ALCL) negative for tyrosine kinase anaplastic lymphoma kinase ( ALK- negative) in the fibrous capsule of silicone breast prostheses, placed for cosmetic reasons. Similar cases have been reported in the literature. Although an increased risk of ALCL in patients with breast prostheses has been speculated, no studies have been conducted so far. Objective To determine whether ALCL risk is associated with breast prostheses. Design A search for all patients with lymphoma in the breast diagnosed in the Netherlands between 1990 and 2006 was performed through the population- based nationwide pathology database. Subsequently, we performed an individually matched case- control study. Conditional logistic regression analysis was performed to estimate the relative risk of ALCL associated with breast prostheses. Setting and Patients Eleven patients with breast ALCL were identified in the registry. For each case patient with ALCL in the breast, we selected 1 to 5 controls with other lymphomas in the breast, matched on age and year of diagnosis. For all cases and controls ( n= 35), pathological and clinical information was obtained with special emphasis on the presence of a breast prosthesis. Main Outcome Measure Association between breast implants and ALCL of the breast. Results The 11 patients with ALCL of the breast were diagnosed between 1994 and 2006 at a median age of 40 years ( range, 24- 68 years). In 5 of these patients, bilateral silicone breast prostheses had been placed 1 to 23 years before diagnosis. All received prostheses for cosmetic reasons. Lymphoma classes of 35 eligible control patients were 12 diffuse large B- cell lymphomas, including 1 T- cell rich B- cell lymphoma; 5 Burkitt lymphomas; 10 mucosa- associated lymphoid tissue - type lymphoma; 3 follicular lymphomas; 3 peripheral T- cell lymphomas; and 2 indolent B- cell lymphomas, unclassified. One of 35 control patients had a breast implant placed before diagnosis of lymphoma. The odds ratio for ALCL associated with breast prostheses was 18.2 ( 95% confidence interval, 2.1- 156.8). Conclusions These preliminary findings suggest an association between silicone breast prostheses and ALCL, although the absolute risk is exceedingly low due to the rare occurrence of ALCL of the breast ( 11 cases in the Netherlands in 17 years). These findings require confirmation in other studies.	[de Jong, Daphne] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [de Boer, Jan Paul] Netherlands Canc Inst, Dept Hematol, NL-1066 CX Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, NL-1066 CX Amsterdam, Netherlands; [Vasmel, Wies L. E.; Verhave, Gideon] St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Barbe, Ellis] St Lucas Andreas Hosp, Dept Pathol, Amsterdam, Netherlands; [Casparie, Mariel K.] PALGA, Nationwide Network, Utrecht, Netherlands; [Casparie, Mariel K.] PALGA, Registry Histopathol & Cytopathol Netherlands, Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Sint Lucas Andreas Hospital; Sint Lucas Andreas Hospital	de Jong, D (corresponding author), Netherlands Canc Inst, Dept Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.d.jong@nki.nl			Netherlands Cancer Institute	Netherlands Cancer Institute	This study was supported by the Netherlands Cancer Institute without external funding.	Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; BRESLOW NE, 1980, IARC SCI PUBL, V1, P176; Brinton LA, 1997, J NATL CANCER I, V89, P1341, DOI 10.1093/jnci/89.18.1341; Brisson J, 2006, INT J CANCER, V118, P2854, DOI 10.1002/ijc.21711; BRONZHEIM I, 2004, BLOOD, V104, P3358; Casparie M, 2007, CELL ONCOL, V29, P19; COOK PD, 1995, AM J SURG PATHOL, V19, P712, DOI 10.1097/00000478-199506000-00012; DUVIC M, 1995, J AM ACAD DERMATOL, V32, P939, DOI 10.1016/0190-9622(95)91328-9; Evans PAS, 2007, LEUKEMIA, V21, P207, DOI 10.1038/sj.leu.2404479; Fritzsche FR, 2006, VIRCHOWS ARCH, V449, P561, DOI 10.1007/s00428-006-0287-1; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Gaudet G, 2002, LEUKEMIA LYMPHOMA, V43, P115, DOI 10.1080/10428190210189; Jaffe ES, 2001, TUMOURS HAEMATOPOIET; Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105; Keech JA, 1997, PLAST RECONSTR SURG, V100, P554, DOI 10.1097/00006534-199708000-00065; Kleinrock L., 2003, AD HOC NETW, V1, P3; Kraemer DM, 2004, HAEMATOLOGICA, V89, pELT01; McLaughlin JK, 2006, J NATL CANCER I, V98, P557, DOI 10.1093/jnci/djj134; Newman MK, 2008, J PLAST RECONSTR AES, V61, P822, DOI 10.1016/j.bjps.2007.03.027; Roden AC, 2008, MODERN PATHOL, V21, P455, DOI 10.1038/modpathol.3801024; Sahoo Sunati, 2003, Arch Pathol Lab Med, V127, pe115; Said JW, 1996, BLOOD, V88, P3124, DOI 10.1182/blood.V88.8.3124.bloodjournal8883124; Shanklin DR, 1998, IMMUNOL RES, V18, P125, DOI 10.1007/BF02788777; van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467	25	252	257	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2030	2035		10.1001/jama.2008.585	http://dx.doi.org/10.1001/jama.2008.585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984890	Bronze			2022-12-24	WOS:000260605400023
J	Lavik, G; Stuhrmann, T; Bruchert, V; Van der Plas, A; Mohrholz, V; Lam, P; Mussmann, M; Fuchs, BM; Amann, R; Lass, U; Kuypers, MMM				Lavik, Gaute; Stuehrmann, Torben; Bruechert, Volker; Van der Plas, Anja; Mohrholz, Volker; Lam, Phyllis; Mussmann, Marc; Fuchs, Bernhard M.; Amann, Rudolf; Lass, Ulrich; Kuypers, Marcel M. M.			Detoxification of sulphidic African shelf waters by blooming chemolithotrophs	NATURE			English	Article							SULFIDE; BACTERIA; IDENTIFICATION; HYPOXIA; GAS; PHYTOPLANKTON; COMMUNITIES; REDUCTION; OXIDATION; SEDIMENT	Coastal waters support similar to 90 per cent of global fisheries and are therefore an important food reserve for our planet(1). Eutrophication of these waters, due to human activity, leads to severe oxygen depletion and the episodic occurrence of hydrogen sulphide toxic to multi- cellular life - with disastrous consequences for coastal ecosytems(2-5). Here we show that an area of similar to 7,000 km(2) of African shelf, covered by sulphidic water, was detoxified by blooming bacteria that oxidized the biologically harmful sulphide to environmentally harmless colloidal sulphur and sulphate. Combined chemical analyses, stoichiometric modelling, isotopic incubations, comparative 16S ribosomal RNA, functional gene sequence analyses and fluorescence in situ hybridization indicate that the detoxification proceeded by chemolithotrophic oxidation of sulphide with nitrate and was mainly catalysed by two discrete populations of gamma- and epsilon-proteobacteria. Chemolithotrophic bacteria, accounting for similar to 20 per cent of the bacterioplankton in sulphidic waters, created a buffer zone between the toxic sulphidic subsurface waters and the oxic surface waters, where fish and other nekton live. This is the first time that large- scale detoxification of sulphidic waters by chemolithotrophs has been observed in an open- ocean system. The data suggest that sulphide can be completely consumed by bacteria in the subsurface waters and, thus, can be overlooked by remote sensing or monitoring of shallow coastal waters. Consequently, sulphidic bottom waters on continental shelves may be more common than previously believed, and could therefore have an important but as yet neglected effect on benthic communities.	[Lavik, Gaute; Stuehrmann, Torben; Bruechert, Volker; Lam, Phyllis; Fuchs, Bernhard M.; Amann, Rudolf; Kuypers, Marcel M. M.] Max Planck Inst Microbiol, D-28359 Bremen, Germany; [Van der Plas, Anja] Minist Fisheries & Marine Resources, Natl Marine Informat & Res Ctr, Swakopmund, Namibia; [Mohrholz, Volker; Lass, Ulrich] Balt Sea Res Inst Warnemunde, D-18119 Rostock, Germany; [Mussmann, Marc] Univ Vienna, Dept Microbial Ecol, Vienna Ecol Ctr, A-1090 Vienna, Austria	Max Planck Society; University of Vienna	Kuypers, MMM (corresponding author), Max Planck Inst Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de	Lavik, Gaute/F-6578-2013; Mussmann, Marc/AAA-6108-2021; Amann, Rudolf I/C-6534-2014; Mussmann, Marc/A-8649-2017; Lam, Phyllis/D-9574-2011	Amann, Rudolf I/0000-0002-0846-7372; Mussmann, Marc/0000-0003-3102-8703; Lam, Phyllis/0000-0003-2067-171X; Bruchert, Volker/0000-0002-8956-3840; , Marc/0000-0003-2785-2521; Fuchs, Bernhard/0000-0001-9828-1290; Mohrholz, Volker/0000-0003-0778-9182	MPG; BMBF programme Geotechnologien; NAMIBGAS; DFG; BENEFIT; Namibian Ministry of Fisheries and Natural Resources	MPG(Max Planck Society); BMBF programme Geotechnologien(Federal Ministry of Education & Research (BMBF)); NAMIBGAS; DFG(German Research Foundation (DFG)); BENEFIT; Namibian Ministry of Fisheries and Natural Resources	We thank B. Barker Jorgensen, F. Inagaki, C. Hubert, T. Ferdelman and G. Collins for discussions; the Namibian authorities for access to their national waters; the crew of RV Alexander von Humboldt for assistance onboard; S. Kruger for operating the pump-CTD and oceanographic equipment; T. Heene for assistance with the collection of oceanographic data and generating oceanographic plots; and G. Klockgether, J. Sawicka, J. Wulf, S. Lenk, D. Franzke and K. Nkandi for assistance with the analysis. The investigations were supported by the MPG, the BMBF programme Geotechnologien and the project NAMIBGAS, the DFG, BENEFIT and the Namibian Ministry of Fisheries and Natural Resources.	Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Blazejak A, 2006, APPL ENVIRON MICROB, V72, P5527, DOI 10.1128/AEM.02441-05; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Copenhagen, 1953, INVESTIGATIONAL REPO, V14, P1; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Emeis KC, 2004, CONT SHELF RES, V24, P627, DOI 10.1016/j.csr.2004.01.007; Fennel K, 2003, LIMNOL OCEANOGR, V48, P1521, DOI 10.4319/lo.2003.48.4.1521; Gevertz D, 2000, APPL ENVIRON MICROB, V66, P2491, DOI 10.1128/AEM.66.6.2491-2501.2000; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Hart T. J., 1960, Discovery Reports, V31, P123; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kirchman DL, 2001, AQUAT MICROB ECOL, V26, P13, DOI 10.3354/ame026013; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Malakoff D, 1998, SCIENCE, V281, P190, DOI 10.1126/science.281.5374.190; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Ohde T, 2007, CONT SHELF RES, V27, P744, DOI 10.1016/j.csr.2006.11.016; Paerl HW, 2003, ENVIRON MICROBIOL, V5, P1025, DOI 10.1046/j.1462-2920.2003.00504.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	40	236	241	5	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					581	U86		10.1038/nature07588	http://dx.doi.org/10.1038/nature07588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19078958				2022-12-24	WOS:000262852200041
J	Buszczak, M; Paterno, S; Spradling, AC				Buszczak, Michael; Paterno, Shelley; Spradling, Allan C.			Drosophila Stem Cells Share a Common Requirement for the Histone H2B Ubiquitin Protease Scrawny	SCIENCE			English	Article							RNA-POLYMERASE-II; METHYLATION; OVARY; MAINTENANCE; CHROMATIN; DIVISION; COMPASS; COMPLEX; MIDGUT; GENES	Stem cells within diverse tissues share the need for a chromatin configuration that promotes self- renewal, yet few chromatin proteins are known to regulate multiple types of stem cells. We describe a Drosophila gene, scrawny ( scny), encoding a ubiquitin- specific protease, which is required in germline, epithelial, and intestinal stem cells. Like its yeast relative UBP10, Scrawny deubiquitylates histone H2B and functions in gene silencing. Consistent with previous studies of this conserved pathway of chromatin regulation, scny mutant cells have elevated levels of ubiquitinylated H2B and trimethylated H3K4. Our findings suggest that inhibiting H2B ubiquitylation through scny represents a common mechanism within stem cells that is used to repress the premature expression of key differentiation genes, including Notch target genes.	[Buszczak, Michael; Paterno, Shelley; Spradling, Allan C.] Carnegie Inst, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21218 USA	Carnegie Institution for Science	Spradling, AC (corresponding author), Carnegie Inst, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Buszczak, Michael/0000-0001-6361-3654	Howard Hughes Medical Institute; American Cancer Society Fellowship [PF-04-022-01-CSM]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society Fellowship(American Cancer Society)	This work was supported by the Howard Hughes Medical Institute. M. B. was supported in part by American Cancer Society Fellowship PF-04-022-01-CSM. We thank D. McKearin, M. Oren, and the Bloomington Stock Center for reagents; B. Ohlstein for helpful advice and for assisting with the initial characterization of the scny midgut phenotype; and T. Nystul for critical reading of the manuscript.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Li Jianduan, 2008, Int J Med Sci, V5, P133; Lin HF, 1997, DEVELOPMENT, V124, P2463; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	22	93	100	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					248	251		10.1126/science.1165678	http://dx.doi.org/10.1126/science.1165678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039105	Green Accepted			2022-12-24	WOS:000262290600037
J	Katikireddi, SV; Cloud, GC				Katikireddi, Srinivasa Vittal; Cloud, Geoffrey Christopher			Planning a patient's discharge from hospital	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE AUDIT; MEDICAL PATIENTS; READMISSION; CARE; RISK		[Katikireddi, Srinivasa Vittal] NHS Lothian, Edinburgh EH8 9RS, Midlothian, Scotland; [Cloud, Geoffrey Christopher] Univ London St Georges Hosp, Dept Clin Neurosci, London SW17 0QT, England	St Georges University London	Katikireddi, SV (corresponding author), NHS Lothian, Edinburgh EH8 9RS, Midlothian, Scotland.	vkatikireddi@yahoo.co.uk		Katikireddi, Srinivasa/0000-0001-6593-9092; Cloud, Geoffrey/0000-0002-8365-6907				Abramson J S, 1993, Health Soc Work, V18, P57; BOULT C, 1993, J AM GERIATR SOC, V41, P811, DOI 10.1111/j.1532-5415.1993.tb06175.x; Brown A, 1999, J SOC ADMIN PHARM, V16, P199; *CAR ENGL, 2002, HOSP DISCH PRACT BRI; Carers UK, 2007, REAL CHANG NOT SHORT; Chu LW, 1999, GERONTOLOGY, V45, P220, DOI 10.1159/000022091; Dawson R, 1998, ANN ROY COLL SURG, V80, P229; *DEP HLTH, 2007, NAT FRAM NHS CONT HE; *DEP HLTH, 2003, DISCH HOSP PATHW PRO; Kwok T, 1999, J ROY COLL PHYS LOND, V33, P153; Macaulay EM, 1996, BRIT J SURG, V83, P788, DOI 10.1002/bjs.1800830619; Melis RJF, 2004, BRIT MED J, V329, P360, DOI 10.1136/bmj.329.7462.360; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; SACHS SB, 2000, NURS PRACT FORUM, V11, P65; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; *SIGN, 2003, 65 SIGN; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	17	12	13	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 12	2008	337								a2694	10.1136/bmj.a2694	http://dx.doi.org/10.1136/bmj.a2694			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CC	19074562				2022-12-24	WOS:000262777000002
J	Nagano, T; Mitchell, JA; Sanz, LA; Pauler, FM; Ferguson-Smith, AC; Feil, R; Fraser, P				Nagano, Takashi; Mitchell, Jennifer A.; Sanz, Lionel A.; Pauler, Florian M.; Ferguson-Smith, Anne C.; Feil, Robert; Fraser, Peter			The Air Noncoding RNA Epigenetically Silences Transcription by Targeting G9a to Chromatin	SCIENCE			English	Article							IMPRINTED IGF2R; XIST RNA; GENES; PLACENTA; GROWTH; LOCUS; STATE	A number of large noncoding RNAs ( ncRNAs) epigenetically silence genes through unknown mechanisms. The Air ncRNA is imprinted-monoallelically expressed from the paternal allele. Air is required for allele- specific silencing of the cis- linked Slc22a3, Slc22a2, and Igf2r genes in mouse placenta. We show that Air interacts with the Slc22a3 promoter chromatin and the H3K9 histone methyltransferase G9a in placenta. Air accumulates at the Slc22a3 promoter in correlation with localized H3K9 methylation and transcriptional repression. Genetic ablation of G9a results in nonimprinted, biallelic transcription of Slc22a3. Truncated Air fails to accumulate at the Slc22a3 promoter, which results in reduced G9a recruitment and biallelic transcription. Our results suggest that Air, and potentially other large ncRNAs, target repressive histone- modifying activities through molecular interaction with specific chromatin domains to epigenetically silence transcription.	[Nagano, Takashi; Mitchell, Jennifer A.; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England; [Nagano, Takashi] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Cell Biol & Neurosci, Fukui 9101193, Japan; [Sanz, Lionel A.; Feil, Robert] CNRS, Inst Mol Genet, UMR 5535, F-34293 Montpellier, France; [Sanz, Lionel A.; Feil, Robert] Univ Montpellier 2, F-34293 Montpellier, France; [Pauler, Florian M.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna Bioctr, A-1030 Vienna, Austria; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Fukui; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); University of Cambridge	Nagano, T (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB22 3AT, England.	takashi.nagano@bbsrc.ac.uk; peter.fraser@bbsrc.ac.uk	Ferguson-Smith, Anne C/G-7534-2011; Fraser, Peter/B-7549-2009; Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Mitchell, Jennifer/0000-0002-7147-4604; Ferguson-Smith, Anne/0000-0002-7608-5894; Fraser, Peter/0000-0002-0041-1227	Biotechnology and Biological Sciences Research Council, UK; Agence National de la Recherche and Institut National de Cancer, France; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C151, BB/D014050/1, BBS/E/B/0000M232] Funding Source: researchfish; Medical Research Council [G0400156] Funding Source: researchfish; BBSRC [BBS/E/B/0000C151, BB/D014050/1, BBS/E/B/0000M232] Funding Source: UKRI; MRC [G0400156] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence National de la Recherche and Institut National de Cancer, France(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Segonds-Pichon for statistics, G. Kelsey and W. Reik for critical reading, D. Barlow and members of the Fraser lab for discussions. P. F. is a Senior Fellow of the Medical Research Council, UK. This work was supported by the Biotechnology and Biological Sciences Research Council, UK, and by the Agence National de la Recherche and Institut National de Cancer, France. The authors declare that they have no competing financial interests.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pauler FM, 2005, GENOME RES, V15, P1379, DOI 10.1101/gr.3783805; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Wagschal A, 2008, MOL CELL BIOL, V28, P1104, DOI 10.1128/MCB.01111-07; Wutz A, 2001, DEVELOPMENT, V128, P1881; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	19	715	783	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1717	1720		10.1126/science.1163802	http://dx.doi.org/10.1126/science.1163802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	18988810				2022-12-24	WOS:000261608300052
J	Zhang, XQ; Chen, SH; Yoo, S; Chakrabarti, S; Zhang, T; Ke, T; Oberti, C; Yong, SL; Fang, F; Li, L; de la Fuente, R; Wang, LJ; Chen, QY; Wang, QK				Zhang, Xianqin; Chen, Shenghan; Yoo, Shin; Chakrabarti, Susmita; Zhang, Teng; Ke, Tie; Oberti, Carlos; Yong, Sandro L.; Fang, Fang; Li, Lin; de la Fuente, Roberto; Wang, Lejin; Chen, Qiuyun; Wang, Qing Kenneth			Mutation in Nuclear Pore Component NUP155 Leads to Atrial Fibrillation and Early Sudden Cardiac Death	CELL			English	Article							NATRIURETIC-PEPTIDE; COMPLEX PROTEIN; SCN5A MUTATION; MESSENGER-RNA; HEAT-SHOCK; GENE; ASSOCIATION; ENVELOPE; GENOME; HEAT-SHOCK-PROTEIN-70	Atrial fibrillation (AF) is the most common form of sustained clinical arrhythmia. We previously mapped an AF locus to chromosome 5p13 in an AF family with sudden death in early childhood. Here we show that the specific AF gene underlying this linkage is NUP155, which encodes a member of the nucleoporins, the components of the nuclear pore complex (NPC). We have identified a homozygous mutation, R391H, in NUP155 that cosegregates with AF, affects nuclear localization of NUP155, and reduces nuclear envelope permeability. Homozygous NUP155(-/-) knockout mice die before E8.5, but heterozygous NUP155(+/-) mice show the AF phenotype. The R391H mutation and reduction of NUP155 are associated with inhibition of both export of Hsp70 mRNA and nuclear import of Hsp70 protein. These human and mouse studies indicate that loss of NUP155 function causes AF by altering mRNA and protein transport and link the NPC to cardiovascular disease.	[Zhang, Xianqin; Chen, Shenghan; Yoo, Shin; Chakrabarti, Susmita; Zhang, Teng; Ke, Tie; Oberti, Carlos; Yong, Sandro L.; Fang, Fang; Li, Lin; Wang, Lejin; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Lerner Coll Med,Ctr Cardiovasc Genet, Cleveland Clin,Lerner Res Inst,Dept Mol Cardiol, Dept Mol Med,Taussig Canc Ctr,Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Zhang, Xianqin; Ke, Tie; Wang, Lejin; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Zhang, Xianqin; Ke, Tie; Wang, Lejin; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Oberti, Carlos; de la Fuente, Roberto] Osped Italiano Umberto I, Dept Cardiol, Montevideo 11600, Uruguay; [Fang, Fang; Wang, Qing Kenneth] Cleveland State Univ, Dept Chem, Cleveland, OH 44107 USA	Case Western Reserve University; Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Cleveland State University	Wang, QK (corresponding author), Case Western Reserve Univ, Lerner Coll Med,Ctr Cardiovasc Genet, Cleveland Clin,Lerner Res Inst,Dept Mol Cardiol, Dept Mol Med,Taussig Canc Ctr,Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org	Chakrabarti, Susmita/CAH-2331-2022; zhang, xianqin/GYE-0638-2022; Ke, Tie/AIC-5771-2022	Chakrabarti, Susmita/0000-0003-1197-2780; Ke, Tie/0000-0002-8888-8424				Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Chou CC, 2008, CONTEMP CARDIOL, P101, DOI 10.1007/978-1-59745-163-5_8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Ehrlich JR, 2008, CONTEMP CARDIOL, P37, DOI 10.1007/978-1-59745-163-5_4; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grote P, 2006, NAT PROTOC, V1, P3034, DOI 10.1038/nprot.2006.460; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Kampinga HH, 2007, CELL STRESS CHAPERON, V12, P97, DOI 10.1379/CSC-285.1; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Knight BP, 2003, PACE, V26, P1620, DOI 10.1046/j.1460-9592.2003.t01-1-00241.x; Laramie JM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-17; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Oberti C, 2004, CIRCULATION, V110, P3753, DOI 10.1161/01.CIR.0000150333.87176.C7; Peters NS, 2002, LANCET, V359, P593, DOI 10.1016/S0140-6736(02)07748-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RADU A, 1993, J CELL BIOL, V121, P1, DOI 10.1083/jcb.121.1.1; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Savelieva I, 2004, EUROPACE, V5, pS5, DOI 10.1016/j.eupc.2004.07.003; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Van Wagoner DR, 2000, J MOL CELL CARDIOL, V32, P1101, DOI 10.1006/jmcc.2000.1147; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang QK, 2008, CONTEMP CARDIOL, P133, DOI 10.1007/978-1-59745-163-5_10; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170; Zhang XQ, 2002, GENE, V288, P9, DOI 10.1016/S0378-1119(02)00470-5; Zhang XQ, 1999, GENOMICS, V57, P144, DOI 10.1006/geno.1999.5741	45	204	214	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1017	1027		10.1016/j.cell.2008.10.022	http://dx.doi.org/10.1016/j.cell.2008.10.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070573	Bronze			2022-12-24	WOS:000261642800018
J	Donnelly, P				Donnelly, Peter			Progress and challenges in genome-wide association studies in humans	NATURE			English	Article							SUSCEPTIBILITY LOCI; PROSTATE-CANCER; BREAST-CANCER; VARIANTS; DISEASE; RISK; REPLICATION; HEIGHT	After more than a decade of hope and hype, researchers are finally making inroads into understanding the genetic basis of many common human diseases. The use of genome- wide association studies has broken the logjam, enabling genetic variants at specific loci to be associated with particular diseases. Genetic association data are now providing new routes to understanding the aetiology of disease, as well as new footholds on the long and difficult path to better treatment and disease prevention.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	peter.donnelly@well.ox.ac.uk		Donnelly, Peter/0000-0001-9495-3408				Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; ORAHILLY SP, 1986, LANCET, V2, P360; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	20	251	262	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					728	731		10.1038/nature07631	http://dx.doi.org/10.1038/nature07631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079049				2022-12-24	WOS:000261559900036
J	Kesselheim, AS				Kesselheim, Aaron S.			Drug Development for Neglected Diseases - The Trouble with FDA Review Vouchers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEVELOPING-COUNTRIES; MARKET		Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Love J, 2007, CHI KENT L REV, V82, P1519; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7	4	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1981	1983		10.1056/NEJMp0806684	http://dx.doi.org/10.1056/NEJMp0806684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368OW	18987367				2022-12-24	WOS:000260632700002
J	Regard, JB; Sato, IT; Coughlin, SR				Regard, Jean B.; Sato, Isaac T.; Coughlin, Shaun R.			Anatomical Profiling of G Protein-Coupled Receptor Expression	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; NICOTINIC-ACID; FUNCTIONAL EXPRESSION; CHEMOKINE RECEPTOR; MICE LACKING; MOLECULAR-IDENTIFICATION; SACCHAROMYCES-CEREVISIAE; PARATHYROID-HORMONE; GABA(B) RECEPTOR; LYMPHOID ORGANS	G protein-coupled receptors (GPCRs) comprise the largest family of transmembrane signaling molecules and regulate a host of physiological and disease processes. To better understand the functions of GPCRs in vivo, we quantified transcript levels of 353 nonodorant GPCRs in 41 adult mouse tissues. Cluster analysis placed many GPCRs into anticipated anatomical and functional groups and predicted previously unidentified roles for less-studied receptors. From one such prediction, we showed that the Gpr91 ligand succinate can regulate lipolysis in white adipose tissue, suggesting that signaling by this citric acid cycle intermediate may regulate energy homeostasis. We also showed that pairwise analysis of GPCR expression across tissues may help predict drug side effects. This resource will aid studies to understand GPCR function in vivo and may assist in the identification of therapeutic targets.	[Regard, Jean B.; Sato, Isaac T.; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Regard, JB (corresponding author), NHGRI, NIH, Bldg 49,Room 4C60,49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	regardj@mail.nih.gov; shaun.coughlin@ucsf.edu			National Institutes of Health; Sandler Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044907, R01HL065590, R01HL065185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Coughlin lab for valuable discussions, Ivo Cornelissen, Gerard Honig, and Grant Li, for technical assistance in isolating mouse tissues, and Stuart Peirson for sharing qPCR efficiency transformations. We also thank Dale Webster and Joseph Derisi for help with informatics, Silvio Gutkind for providing the Adrb2 construct, and Bryan Roth for critical reading of the manuscript. This work was supported by the National Institutes of Health (S.R.C.) and Sandler Family Foundation (J.B.R.).	Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; BUTCHER RW, 1970, ACTA PHYSIOL SCAND, V79, P559, DOI 10.1111/j.1748-1716.1970.tb04758.x; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Cheng ZQ, 2007, ENDOCRINOLOGY, V148, P4984, DOI 10.1210/en.2007-0653; CHIU MI, 1994, GENOMICS, V21, P440, DOI 10.1006/geno.1994.1292; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Date Y, 2000, MOL BRAIN RES, V76, P1, DOI 10.1016/S0169-328X(99)00317-4; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; HOCHACHKA PW, 1976, EUR J APPL PHYSIOL O, V35, P235, DOI 10.1007/BF00423282; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Joost P, 2002, GENOME BIOL, V3; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; KREBS HA, 1950, ANNU REV BIOCHEM, V19, P409, DOI 10.1146/annurev.bi.19.070150.002205; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kumar U, 1997, ENDOCRINOLOGY, V138, P4473, DOI 10.1210/en.138.10.4473; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kushnir MM, 2001, CLIN CHEM, V47, P1993; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lorsignol A, 1999, J NEUROENDOCRINOL, V11, P171; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Mazella J, 1996, J NEUROSCI, V16, P5613; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; MORENO FJ, 1983, J BIOL CHEM, V258, P938; MOSKOWITZ J, 1969, J CLIN INVEST, V48, P1802, DOI 10.1172/JCI106146; Muller G, 2000, CURR MED CHEM, V7, P861, DOI 10.2174/0929867003374534; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NORDMANN J, 1961, ADV CLIN CHEM, V4, P53, DOI 10.1016/S0065-2423(08)60035-9; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Popova N K, 2007, Neurosci Behav Physiol, V37, P631, DOI 10.1007/s11055-007-0062-z; Rao S, 1999, J BIOL CHEM, V274, P34245, DOI 10.1074/jbc.274.48.34245; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SHUSTER DE, 1995, SCIENCE, V269, P1590, DOI 10.1126/science.7667641; SIMONIN F, 1995, P NATL ACAD SCI USA, V92, P7006, DOI 10.1073/pnas.92.15.7006; SINHA TK, 1976, METABOLISM, V25, P251, DOI 10.1016/0026-0495(76)90083-4; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Soto H, 1998, P NATL ACAD SCI USA, V95, P8205, DOI 10.1073/pnas.95.14.8205; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TSUTSUMI M, 1992, MOL ENDOCRINOL, V6, P1163, DOI 10.1210/me.6.7.1163; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626	94	444	469	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					561	571		10.1016/j.cell.2008.08.040	http://dx.doi.org/10.1016/j.cell.2008.08.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984166	Green Accepted, Bronze			2022-12-24	WOS:000260536300025
J	Stephenson, AE; DeYoreo, JJ; Wu, L; Wu, KJ; Hoyer, J; Dove, PM				Stephenson, A. E.; DeYoreo, J. J.; Wu, L.; Wu, K. J.; Hoyer, J.; Dove, P. M.			Peptides Enhance Magnesium Signature in Calcite: Insights into Origins of Vital Effects	SCIENCE			English	Article							GROWTH; SURFACE; SUPERSATURATION; TEMPERATURE; PRECIPITATION; DESOLVATION; INHIBITION; CARBONATE; PROTEINS; KINETICS	Studies relating the magnesium (Mg) content of calcified skeletons to temperature often report unexplained deviations from the signature expected for inorganically grown calcite. These "vital effects" are believed to have biological origins, but mechanistic bases for measured offsets remain unclear. We show that a simple hydrophilic peptide, with the same carboxyl- rich character as that of macromolecules isolated from sites of calcification, increases calcite Mg content by up to 3 mole percent. Comparisons to previous studies correlating Mg content of carbonate minerals with temperature show that the Mg enhancement due to peptides results in offsets equivalent to 7 degrees to 14 degrees C. The insights also provide a physical basis for anecdotal evidence that organic chemistry modulates the mineralization of inorganic carbonates and suggest an approach to tuning impurity levels in controlled materials synthesis.	[Stephenson, A. E.; Dove, P. M.] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [DeYoreo, J. J.; Wu, L.; Wu, K. J.] Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94551 USA; [Wu, L.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Hoyer, J.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; University of Delaware	Stephenson, AE (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.	aestephe@vt.edu; dove@vt.edu	Wu, Ligang/C-7770-2009; Dove, Patricia M/A-7911-2010; yu, yu/C-7781-2009		NSF [OCE-052667]; U.S. Department of Energy [FG02-00ER15112]	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE))	We thank J.F. Read and D. Rimstidt for thoughtful discussions. This research was supported by awards to P.M.D. from the NSF (grant OCE-052667) and U. S. Department of Energy (grant FG02-00ER15112). This work was also performed under the auspices of the U.S. DOE by an award to J.D.Y. at the University of California, Lawrence Livermore National Laboratory, under Contract No. W-7405-Eng-48. Opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF or DOE.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; ADDADI L, 1990, CROAT CHEM ACTA, V63, P539; Astilleros JM, 2003, GEOCHIM COSMOCHIM AC, V67, P1601, DOI 10.1016/S0016-7037(02)01166-3; Bentov S, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001015; BERNER RA, 1978, AM J SCI, V278, P816, DOI 10.2475/ajs.278.6.816; CARTER PW, 1978, GEOCHIM COSMOCHIM AC, V42, P1231, DOI 10.1016/0016-7037(78)90116-3; Chernov AA, 1998, MATER SCI FORUM, V276-2, P57, DOI 10.4028/www.scientific.net/MSF.276-277.57; CHILINGAR GEORGE V., 1962, BULL SOUTHERN CALIFORNIA ACAD SCI, V61, P45; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; DEYOREO JJ, 2007, 233 ANN M AM CHEM SO; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; EPSTEIN S, 1951, GEOL SOC AM BULL, V62, P417, DOI 10.1130/0016-7606(1951)62[417:CITS]2.0.CO;2; Falini G, 1996, CHEM COMMUN, P1037, DOI 10.1039/cc9960001037; FOLK RL, 1974, J SEDIMENT PETROL, V44, P40; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; FUCHTBAUER H, 1976, GEOL SOC AM ABSTR, V8, P87719; Gledhill DK, 2006, GEOCHIM COSMOCHIM AC, V70, P5802, DOI 10.1016/j.gca.2006.03.024; Huheey J., 1983, INORGANIC CHEM PRINC; KATZ A, 1973, GEOCHIM COSMOCHIM AC, V37, P1563, DOI 10.1016/0016-7037(73)90091-4; Kowacz M, 2007, GEOCHIM COSMOCHIM AC, V71, P5168, DOI 10.1016/j.gca.2007.09.008; Lea D. W., 2003, OCEANS MARINE GEOCHE, DOI DOI 10.1016/B0-08-043751-6/06114-4; LORENS RB, 1981, GEOCHIM COSMOCHIM AC, V45, P553, DOI 10.1016/0016-7037(81)90188-5; MUCCI A, 1987, GEOCHIM COSMOCHIM AC, V51, P1977, DOI 10.1016/0016-7037(87)90186-4; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Piana S, 2006, J AM CHEM SOC, V128, P13568, DOI 10.1021/ja064706q; Prieto M, 2007, AM J SCI, V307, P1034, DOI 10.2475/07.2007.04; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Reeder RJ, 1996, GEOCHIM COSMOCHIM AC, V60, P1543, DOI 10.1016/0016-7037(96)00034-8; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Vinogradov AP., 1953, ELEMENTARY CHEM COMP; Wasylenki LE, 2005, GEOCHIM COSMOCHIM AC, V69, P4227, DOI 10.1016/j.gca.2005.04.006; Weaver ML, 2007, J CRYST GROWTH, V306, P135, DOI 10.1016/j.jcrysgro.2007.04.053	36	120	127	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					724	727		10.1126/science.1159417	http://dx.doi.org/10.1126/science.1159417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974348				2022-12-24	WOS:000260605200043
J	Bidere, N; Ngo, VN; Lee, J; Collins, C; Zheng, LX; Wan, FY; Davis, RE; Lenz, G; Anderson, DE; Arnoult, D; Vazquez, A; Sakai, K; Zhang, J; Meng, ZJ; Veenstra, TD; Staudt, LM; Lenardo, MJ				Bidere, Nicolas; Ngo, Vu N.; Lee, Jeansun; Collins, Cailin; Zheng, Lixin; Wan, Fengyi; Davis, R. Eric; Lenz, Georg; Anderson, D. Eric; Arnoult, Damien; Vazquez, Aime; Sakai, Keiko; Zhang, Jun; Meng, Zhaojing; Veenstra, Timothy D.; Staudt, Louis M.; Lenardo, Michael J.			Casein kinase 1 alpha governs antigen-receptor-induced NF-kappa B activation and human lymphoma cell survival	NATURE			English	Article							T-CELL; CARMA1; REQUIREMENT; PHOSPHORYLATION; BETA; WNT; UBIQUITINATION; PROLIFERATION; ADDICTION; REGULATOR	The transcription factor NF-kappa B is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types(1,2). Antigen receptor stimulation assembles an NF-kappa B activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-kappa B kinase complex(3-12), but signal transduction is not fully understood(1). We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL)(12). Here we report that both screens identified casein kinase 1 alpha (CK1 alpha) as a bifunctional regulator of NF-kappa B. CK1 alpha dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1 alpha kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1 alpha has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-kappa B. ABCDLBCL cells required CK1 alpha for constitutive NF-kappa B activity, indicating that CK1 alpha functions as a conditionally essential malignancy gene-a member of a new class of potential cancer therapeutic targets.	[Bidere, Nicolas; Lee, Jeansun; Zheng, Lixin; Wan, Fengyi; Sakai, Keiko; Zhang, Jun; Lenardo, Michael J.] NIAID, Mol Dev Sect, Immunol Lab, Bethesda, MD 20892 USA; [Ngo, Vu N.; Collins, Cailin; Davis, R. Eric; Lenz, Georg; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Anderson, D. Eric] NIDDK, Proteom & Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; [Arnoult, Damien; Vazquez, Aime] Univ Paris Sud, Hop Paul Brousse, INSERM, U542, F-94800 Villejuif, France; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, LPAT, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Sect, Immunol Lab, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov; lenardo@nih.gov	sakai, Keiko/F-5807-2013; Arnoult, Damien/R-2032-2018; Staudt, Louis/AAC-5324-2019; Lenz, Georg/I-6844-2012; Bidère, Nicolas/K-8887-2015	Bidère, Nicolas/0000-0001-9177-0008; Ngo, Vu/0000-0002-9501-6990	Intramural Research Program of the NIH; NIAID; NCI; NIDDK; Agence Nationale de la Recherche (ANR); NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011007, Z01BC011007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000565, Z01AI000565] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIH, NIAID, NCI, NIDDK and by the Agence Nationale de la Recherche (ANR). We thank M.-T. Auffredou for technical assistance; X. Lin and J. Gavard for reagents; R. Germain, R. Schwartz, U. Siebenlist, P. Schwartzberg, J. Bosco de Oliveira, L. Yu, D. Baltimore, P. Sharp, H. Varmus and A. Snow for discussions and comments; and S. Porcella and the DNA sequencing core facility of the Rocky Mountain Laboratories, NIAID.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027	31	110	124	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					92	U7		10.1038/nature07613	http://dx.doi.org/10.1038/nature07613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19118383	Green Accepted			2022-12-24	WOS:000263836000039
J	Oshima, S; Turer, EE; Callahan, JA; Chai, S; Advincula, R; Barrera, J; Shifrin, N; Lee, B; Yen, B; Woo, T; Malynn, BA; Ma, A				Oshima, Shigeru; Turer, Emre E.; Callahan, Joseph A.; Chai, Sophia; Advincula, Rommel; Barrera, Julio; Shifrin, Nataliya; Lee, Bettina; Yen, Benjamin; Woo, Tammy; Malynn, Barbara A.; Ma, Averil			ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development	NATURE			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; JNK ACTIVATION; MICE; A20; INDUCTION; LETHALITY; APOPTOSIS; RESPONSES; REQUIRES	Proteins that directly regulate tumour necrosis factor receptor ( TNFR) signalling have critical roles in regulating cellular activation and survival. ABIN-1 (A20 binding and inhibitor of NF-kappa B) is a novel protein that is thought to inhibit NF-kappa B signalling(1,2). Here we show that mice deficient for ABIN-1 die during embryogenesis with fetal liver apoptosis, anaemia and hypoplasia. ABIN-1 deficient cells are hypersensitive to tumour necrosis factor (TNF)induced programmed cell death, and TNF deficiency rescues ABIN-1 deficient embryos. ABIN-1 inhibits caspase 8 recruitment to FADD (Fas-associated death domain-containing protein) in TNF-induced signalling complexes, preventing caspase 8 cleavage and programmed cell death. Moreover, ABIN-1 directly binds polyubiquitin chains and this ubiquitin sensing activity is required for ABIN-1's anti-apoptotic activity. These studies provide insights into how ubiquitination and ubiquitin sensing proteins regulate cellular and organismal survival.	[Oshima, Shigeru; Turer, Emre E.; Callahan, Joseph A.; Chai, Sophia; Advincula, Rommel; Barrera, Julio; Shifrin, Nataliya; Lee, Bettina; Yen, Benjamin; Woo, Tammy; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, 513 Parnassus Ave,S-1057, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177	NIH; UCSF Liver Center Pathology and Flow Cytometry Facilities; UCSF Transgenic and Targeted Mutagenesis Core Facility; Crohn's and Colitis Foundation of America; NSF fellowship; Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Liver Center Pathology and Flow Cytometry Facilities; UCSF Transgenic and Targeted Mutagenesis Core Facility; Crohn's and Colitis Foundation of America; NSF fellowship(National Science Foundation (NSF)); Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH (A.M.), UCSF Liver Center Pathology and Flow Cytometry Facilities, UCSF Transgenic and Targeted Mutagenesis Core Facility, a fellowship from the Crohn's and Colitis Foundation of America (S.O.), a pre-doctoral NSF fellowship (J.A.C.) and the Rainin Foundation.	Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; VAN AD, 1996, SCIENCE, V274, P787; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785	24	127	133	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					906	909		10.1038/nature07575	http://dx.doi.org/10.1038/nature07575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19060883	Green Accepted			2022-12-24	WOS:000263266700050
J	Gervas, J; Starfield, B; Heath, I				Gervas, Juan; Starfield, Barbara; Heath, Iona			Is clinical prevention better than cure?	LANCET			English	Editorial Material							HEALTH; CARE		[Gervas, Juan] Equipo CESCA, Med Canencia Sierra Garganta Montes & El Cuadron, Madrid, Spain; [Starfield, Barbara] Johns Hopkins Univ, Baltimore, MD USA; [Heath, Iona] Royal Coll Gen Practitioners, London, England	Novartis; Johns Hopkins University	Gervas, J (corresponding author), Equipo CESCA, Med Canencia Sierra Garganta Montes & El Cuadron, Madrid, Spain.	jgervasc@meditex.es						BARSKY AJ, 1988, NEW ENGL J MED, V318, P414, DOI 10.1056/NEJM198802183180705; Bentzen N, 2003, WONCA DICT GEN FAMIL; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Canadian Health Services Research Foundation, 2004, J Health Serv Res Policy, V9, P191; COCHRANE A L, 1955, R Soc Health J, V75, P584; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Fugelli P, 2006, PATIENT EDUC COUNS, V60, P267, DOI 10.1016/j.pec.2005.11.002; GERVAS J, 2002, EUR J GEN PRACT, V8, P47; Gervas Juan, 2006, Gac Sanit, V20 Suppl 1, P127, DOI 10.1157/13086036; Gray JAM, 1999, LANCET, V354, P1550, DOI 10.1016/S0140-6736(98)08482-7; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Heath I, 2007, BRIT MED J, V334, P19, DOI 10.1136/bmj.39066.541678.B7; HOLTZMAN NA, 1979, INT J HEALTH SERV, V9, P25, DOI 10.2190/9PJP-8R5C-JKJP-LK7A; Ilich I., 1976, MED NEMESIS EXPROPRI; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Steinberg EP, 2005, HEALTH AFFAIR, V24, P80, DOI 10.1377/hlthaff.24.1.80; StewartBrown S, 1997, BRIT MED J, V314, P533, DOI 10.1136/bmj.314.7080.533; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101	22	52	56	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1997	1999		10.1016/S0140-6736(08)61843-7	http://dx.doi.org/10.1016/S0140-6736(08)61843-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19059049				2022-12-24	WOS:000261471600026
J	Katz, IT; Wright, AA				Katz, Ingrid T.; Wright, Alexi A.			Circumcision - A Surgical Strategy for HIV Prevention in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEN						Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007433-19, T32 AI007433] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; WAWER M, 2008, 15 C RETR OPP INF BO	6	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2412	2415		10.1056/NEJMp0805791	http://dx.doi.org/10.1056/NEJMp0805791			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	378MT	19052123	Green Accepted			2022-12-24	WOS:000261325900002
J	Machin, S; Pekkarinen, T				Machin, Stephen; Pekkarinen, Tuomas			ASSESSMENT Global Sex Differences in Test Score Variability	SCIENCE			English	Editorial Material							GENDER; PERFORMANCE; HYPOTHESIS; DIVERSITY; MATH		[Pekkarinen, Tuomas] Helsinki Sch Econ, Dept Econ, Helsinki 00101, Finland; [Pekkarinen, Tuomas] Govt Inst Econ Res VATT, Helsinki 00101, Finland; [Pekkarinen, Tuomas] Abo Akad Univ, Dept Econ & Stat, SF-20500 Turku, Finland; [Machin, Stephen] UCL, Dept Econ, London WC1E 6BT, England	Aalto University; VATT Institute for Economic Research; Abo Akademi University; University of London; University College London	Pekkarinen, T (corresponding author), Helsinki Sch Econ, Dept Econ, Helsinki 00101, Finland.	tuomas.pekkarinen@hse.fi			Economic and Social Research Council [RES-107-28-1001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], PIRLS 2001 USER GUID; Arulampalam W, 2007, IND LABOR RELAT REV, V60, P163, DOI 10.1177/001979390706000201; Bayard K, 2003, J LABOR ECON, V21, P887, DOI 10.1086/377026; Ellis H., 1894, MAN WOMAN STUDY SECO; FEINGOLD A, 1992, REV ED RE, V59, P185; Galton F., 1987, HEREDITARY GENIUS; Guiso L, 2008, SCIENCE, V320, P1164, DOI 10.1126/science.1154094; Hausmann R., 2006, GLOBAL GENDER GAP RE; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; JENSEN AR, 1971, INTELLIGENCE GENETIC; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Leuven E, 2004, ECON J, V114, P466, DOI 10.1111/j.1468-0297.2004.00217.x; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Machin S, 2005, OXFORD REV ECON POL, V21, P357, DOI 10.1093/oxrep/gri021; MARTIN MO, 2005, TIMMS 2003 USER GUID; McGrayne S., 2001, NOBEL PRIZE WOMEN SC, Vsecond edition).; Muller CB, 2005, SCIENCE, V307, P1043; NODDINGS N, 1992, REV EDUC RES, V62, P85, DOI 10.3102/00346543062001085; *PISA, 2003, 2003 ASS FRAM MATH R	21	106	108	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1331	1332		10.1126/science.1162573	http://dx.doi.org/10.1126/science.1162573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	376FX	19039123				2022-12-24	WOS:000261170600021
J	Menon, U; Gentry-Maharaj, A; Ryan, A; Sharma, A; Burnell, M; Hallett, R; Lewis, S; Lopez, A; Godfrey, K; Oram, D; Herod, J; Williamson, K; Seif, M; Scott, I; Mould, T; Woolas, R; Murdoch, J; Dobbs, S; Amso, N; Leeson, S; Cruickshank, D; McGuire, A; Campbell, S; Fallowfield, L; Skates, S; Parmar, M; Jacobs, I				Menon, Usha; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sharma, Aarti; Burnell, Matthew; Hallett, Rachel; Lewis, Sara; Lopez, Alberto; Godfrey, Keith; Oram, David; Herod, Jonathan; Williamson, Karin; Seif, Mourad; Scott, Ian; Mould, Tim; Woolas, Robert; Murdoch, John; Dobbs, Stephen; Amso, Nazar; Leeson, Simon; Cruickshank, Derek; McGuire, Ali; Campbell, Stuart; Fallowfield, Lesley; Skates, Steve; Parmar, Mahesh; Jacobs, Ian			Recruitment to multicentre trials-lessons from UKCTOCS: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; OVARIAN-CANCER; FLEXIBLE SIGMOIDOSCOPY; POSTMENOPAUSAL WOMEN; COLORECTAL-CANCER; CLINICAL-TRIAL; FOLLOW-UP; PROGRAM; DESIGN; COHORT	Objective To describe the factors that contributed to successful recruitment of more than 200 000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest ever randomised controlled trials. Design Descriptive study. Setting 13 NHS trusts in England, Wales, and Northern Ireland. Participants Postmenopausal women aged 50- 74; exclusion criteria included ovarian malignancy, bilateral oophorectomy, increased risk of familial ovarian cancer, active non- ovarian malignancy, and participation in other ovarian cancer screening trials. Main outcome measures Achievement of target recruitment, acceptance rates of invitation, and recruitment rates. Results The trial was set up in 13 centres with 27 adjoining local health authorities. The coordinating centre team was led by one of the senior investigators, who was closely involved in planning and day to day trial management. Of 1 243 282 women invited, 23.2% ( 288 955) replied that they were eligible and would like to participate. Of those sent appointments, 73.6% ( 205 090) attended for recruitment. The acceptance rate varied from 19% to 33% between trial centres. Measures to ensure target recruitment included named coordinating centre staff supporting and monitoring each centre, prompt identification and resolution of logistic problems, varying the volume of invitations by centre, using local nonattendance rates to determine the size of recruitment clinics, and organising large ad hoc clinics supported by coordinating centre staff. The trial randomised 202 638 women in 4.3 years. Conclusions Planning and trial management are as important as trial design and require equal attention from senior investigators. Successful recruitment needs constant monitoring by a committed proactive management team that is willing to explore individual solutions for different centres and use central resources to improve local recruitment. Automation of trial processes with web based trial management systems is crucial in large multicentre randomised controlled trials. Recruitment can be further enhanced by using information videos and group discussions. Trial registration Current Controlled Trials ISRCTN22488978.	[Menon, Usha; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sharma, Aarti; Burnell, Matthew; Hallett, Rachel; Lewis, Sara; Jacobs, Ian] UCL, EGA Inst Womens Hlth, London W1T 7DN, England; [Oram, David] St Bartholomews Hosp, London EC1A 7BE, England; [Herod, Jonathan] Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; [Williamson, Karin] City Hosp Nottingham, Nottingham NG5 1PB, England; [Seif, Mourad] St Marys Hosp, Manchester M13 9WL, Lancs, England; [Scott, Ian] Derby City Hosp, Derby DE22 3NE, England; [Mould, Tim] Royal Free Hosp, London NW3 2QG, England; [Woolas, Robert] St Marys Hosp, Portsmouth PO3 6AD, Hants, England; [Murdoch, John] St Michaels Hosp, Bristol BS2 8EG, Avon, England; [Dobbs, Stephen] Belfast City Hosp, Belfast BT9 7AB, Antrim, North Ireland; [Amso, Nazar] Cardiff Univ, Cardiff CF14 4XN, Wales; [Cruickshank, Derek] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [McGuire, Ali] London Sch Econ, London WC2A 2AE, England; [Campbell, Stuart] Create Hlth Clin, London W1G 6AJ, England; [Fallowfield, Lesley] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Skates, Steve] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Parmar, Mahesh] MRC, Clin Trials Unit, London NW1 2DA, England	University of London; University College London; University of London; Queen Mary University London; University of Liverpool; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Manchester; University of Nottingham; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Belfast City Hospital; Cardiff University; James Cook University Hospital; University of London; London School Economics & Political Science; University of Brighton; University of Sussex; Harvard University; Harvard Medical School; Medical Research Council Clinical Trials Unit	Menon, U (corresponding author), UCL, EGA Inst Womens Hlth, London W1T 7DN, England.	u.menon@ucl.ac.uk	Jacobs, Ian J/F-1743-2013; Menon, Usha/C-4716-2008	Jacobs, Ian J/0000-0002-8112-4624; Menon, Usha/0000-0003-3708-1732; Fallowfield, Lesley/0000-0003-0577-4518; Amso, Nazar/0000-0002-8646-6623; Jacobs, Ian/0000-0002-5005-2672	Medical Research Council; Cancer Research UK; Department of Health; Eve Appeal; Special Trustees of Bart's; London, and Special Trustees of UCLH; MRC [G9901012, G0000735] Funding Source: UKRI; Medical Research Council [G9901012, G0000735] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA086381, P50CA083639] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Department of Health; Eve Appeal; Special Trustees of Bart's; London, and Special Trustees of UCLH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The trial is core funded by the Medical Research Council, Cancer Research UK, and the Department of Health with additional support from the Eve Appeal, Special Trustees of Bart's and the London, and Special Trustees of UCLH. This work was done at UCLH/UCL within the " women's health theme" of the NIHR UCLH/UCL Comprehensive Biomedical Research Centre supported by the Department of Health. The researchers are independent from the funders.	Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Cambron JA, 2001, J MANIP PHYSIOL THER, V24, P79, DOI 10.1067/mmt.2001.112567; Cosgrove N, 1999, CONTROL CLIN TRIALS, V20, P133, DOI 10.1016/S0197-2456(98)00055-5; Denhaerynck K, 2003, AM J PREV MED, V25, P195, DOI 10.1016/S0749-3797(03)00201-0; Eisinger F, 2001, Fam Cancer, V1, P175, DOI 10.1023/A:1021177417531; Farrell B, 1998, BRIT MED J, V317, P1236, DOI 10.1136/bmj.317.7167.1236; Fegan W, 2008, PLOS MED, V5, P347, DOI 10.1371/journal.pmed.0050006; Froom P, 1999, J CLIN EPIDEMIOL, V52, P731, DOI 10.1016/S0895-4356(99)00070-0; Gordon JS, 2006, NICOTINE TOB RES, V8, pS35, DOI 10.1080/14622200601039014; Gray M, 2000, Health Bull (Edinb), V58, P137; Hasson MA, 2000, CONTROL CLIN TRIALS, V21, p329S, DOI 10.1016/S0197-2456(00)00100-8; JACOBS I, 1988, LANCET, V1, P268; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jacobs IJ, 1996, BMJ-BRIT MED J, V313, P1355, DOI 10.1136/bmj.313.7069.1355; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Lindsted KD, 1996, J CLIN EPIDEMIOL, V49, P783, DOI 10.1016/0895-4356(96)00009-1; MacDonald N, 1999, BRIT J CANCER, V80, P1826, DOI 10.1038/sj.bjc.6690605; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2007, MENOPAUSE, V14, P462, DOI 10.1097/01.gme.0000243569.70946.9d; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; *OFF NAT, 2001, H CENS 2001 POP DAT; *OFF NAT STAT, 2004, CANC STAT REG REG CA, P24; Ott CD, 2006, CANCER NURS, V29, P21, DOI 10.1097/00002820-200601000-00004; OTT CD, 2006, CANC NURS, V29, P32; Paine BJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-5; Parkes C A, 1994, J Med Screen, V1, P209; PRESCOTT RJ, 1999, HEALTH TECHNOL ASSES, V3, P65; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomson CA, 2005, J CLIN EPIDEMIOL, V58, P378, DOI 10.1016/j.jclinepi.2004.10.013	33	70	70	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2008	337								a2079	10.1136/bmj.a2079	http://dx.doi.org/10.1136/bmj.a2079			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008269	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-24	WOS:000261784500002
J	Bynum, B				Bynum, Bill			The art of medicine Road maps to health	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk						Glacken Clarence J., 1976, TRACES RHODIAN SHORE; Hamlin C., 1998, PUBLIC HLTH SOCIAL J; Lloyd G.E.R., 1978, HIPPOCRATIC WRITINGS; Ramazzini B., 1940, DIS WORKERS; Virchow R., 1848, COLLECTED ESSAYS PUB	5	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1626	1627		10.1016/S0140-6736(08)61676-1	http://dx.doi.org/10.1016/S0140-6736(08)61676-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	19006814	Bronze			2022-12-24	WOS:000260899900014
J	McDonald, GR; Hudson, AL; Dunn, SMJ; You, HT; Baker, GB; Whittal, RM; Martin, JW; Jha, A; Edmondson, DE; Holt, A				McDonald, G. Reid; Hudson, Alan L.; Dunn, Susan M. J.; You, Haitao; Baker, Glen B.; Whittal, Randy M.; Martin, Jonathan W.; Jha, Amitabh; Edmondson, Dale E.; Holt, Andrew			Bioactive Contaminants Leach from Disposable Laboratory Plasticware	SCIENCE			English	Article									[McDonald, G. Reid; Hudson, Alan L.; Dunn, Susan M. J.; You, Haitao; Holt, Andrew] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2B7, Canada; [Baker, Glen B.] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2R7, Canada; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Martin, Jonathan W.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2G3, Canada; [Jha, Amitabh] Acadia Univ, Dept Chem, Wolfville, NS B4P 2R6, Canada; [Edmondson, Dale E.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Acadia University; Emory University	Holt, A (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2B7, Canada.	aholt@pmcol.ualberta.ca	Jha, Amitabh/B-5452-2010; Jha, Amitabh/AAU-2075-2021; Martin, Jonathan W/J-3824-2013	Jha, Amitabh/0000-0002-6305-0721; Martin, Jonathan W/0000-0001-6265-4294; Hudson, Alan/0000-0003-1105-7646				COOPER I, 1995, FOOD ADDIT CONTAM, V12, P235, DOI 10.1080/02652039509374298; Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x; Maher B, 2008, NATURE, V453, P964, DOI 10.1038/453964a; Shotyk W, 2007, ENVIRON SCI TECHNOL, V41, P1560, DOI 10.1021/es061511+; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010	5	166	167	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					917	917		10.1126/science.1162395	http://dx.doi.org/10.1126/science.1162395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988846				2022-12-24	WOS:000260674100039
J	Brewster, JM; Kaufmann, IM; Hutchison, S; MacWilliam, C				Brewster, Joan M.; Kaufmann, I. Michael; Hutchison, Sarah; MacWilliam, Cynthia			Characteristics and outcomes of doctors in a substance dependence monitoring programme in Canada: prospective descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG PROBLEMS; PHYSICIANS; ALCOHOL; CARE	Objective To describe the characteristics at enrolment and outcomes of doctors in a substance dependence monitoring programme in Canada. Design Prospective descriptive study. Setting Provincial physician health programme, Canada. Participants All 100 doctors consecutively admitted to a substance dependence monitoring programme and followed until completion of monitoring or on leaving the programme. Main outcome measure Relapse during long term monitoring for five years. Results Ninety per cent of the doctors enrolled on the programme were men, 66% were married or living with a partner, 44% had had previous treatment for substance dependence, and 36% had had previous psychiatric treatment. Smokers were over- represented compared with the general population of US doctors ( 38% v 5%). During the monitoring period 71% of participants had no known relapse. An additional 14% went on to complete the programme, after some form of relapse. In total, 85% of the doctors successfully completed the programme. Conclusion In this cohort of doctors enrolled on the Ontario Physician Health Program for substance dependence, most were men who were dependent on alcohol or opioids. Smokers were over- represented compared with the general population of US doctors. Eighty five per cent successfully completed the programme.	[Brewster, Joan M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Kaufmann, I. Michael; Hutchison, Sarah; MacWilliam, Cynthia] Ontario Med Assoc, Ontario Phys Hlth Program, Toronto, ON, Canada	University of Toronto	Brewster, JM (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.	jmbrewster@sympatico.ca			Ontario Physician Health Program	Ontario Physician Health Program	This research was funded by the Ontario Physician Health Program. JMB was paid as a consultant to carry out data analyses and write the paper. The other authors are employees of the Ontario Physician Health Program or the Ontario Medical Association, and their participation in the research was part of their employment. The research interpretation and outcomes are independent of the funding.	Bohigian GM, 1996, SOUTHERN MED J, V89, P1078, DOI 10.1097/00007611-199611000-00010; *BRIT MED ASS, 2008, DOCT HLTH WELLB; *CAN MED ASS, 2008, CAN PHYS HLTH NETW; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; GLASER FB, 1986, CAN FAM PHYSICIAN, V32, P993; Gossop M, 2001, ALCOHOL ALCOHOLISM, V36, P160, DOI 10.1093/alcalc/36.2.160; MANSKY PA, 2003, PSYCHIAT TIMES  0201, P20; Nelson HD, 1996, WESTERN J MED, V165, P31; Reading E G, 1992, Md Med J, V41, P325; Smith DR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-115; 2008, FEDERATION STATE PHY	11	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2008	337								a2098	10.1136/bmj.a2098	http://dx.doi.org/10.1136/bmj.a2098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377EZ	18981018	Green Published, hybrid			2022-12-24	WOS:000261235800001
J	Trompette, A; Divanovic, S; Visintin, A; Blanchard, C; Hegde, RS; Madan, R; Thorne, PS; Wills-Karp, M; Gioannini, TL; Weiss, JP; Karp, CL				Trompette, Aurelien; Divanovic, Senad; Visintin, Alberto; Blanchard, Carine; Hegde, Rashmi S.; Madan, Rajat; Thorne, Peter S.; Wills-Karp, Marsha; Gioannini, Theresa L.; Weiss, Jerry P.; Karp, Christopher L.			Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein	NATURE			English	Article							TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; ALLERGIC DISEASE; CELL ACTIVATION; ENDOTOXIN; MD-2; ASTHMA; LIPOPOLYSACCHARIDE; RESPONSES; EXPOSURE	Aeroallergy results from maladaptive immune responses to ubiquitous, otherwise innocuous environmental proteins(1). Although the proteins targeted by aeroallergic responses represent a tiny fraction of the airborne proteins humans are exposed to, allergenicity is a quite public phenomenon - the same proteins typically behave as aeroallergens across the human population. Why particular proteins tend to act as allergens in susceptible hosts is a fundamental mechanistic question that remains largely unanswered. The main house- dust- mite allergen, Der p 2, has structural homology with MD- 2 ( also known as LY96), the lipopolysaccharide ( LPS)- binding component of the Toll- like receptor ( TLR) 4 signalling complex(2-4). Here we show that Der p 2 also has functional homology, facilitating signalling through direct interactions with the TLR4 complex, and reconstituting LPS- driven TLR4 signalling in the absence of MD- 2. Mirroring this, airway sensitization and challenge with Der p 2 led to experimental allergic asthma in wild type and MD- 2- deficient, but not TLR4- deficient, mice. Our results indicate that Der p 2 tends to be targeted by adaptive immune responses because of its auto-adjuvant properties. The fact that other members of the MD- 2- like lipid- binding family are allergens, and that most defined major allergens are thought to be lipid- binding proteins(5), suggests that intrinsic adjuvant activity by such proteins and their accompanying lipid cargo may have some generality as a mechanism underlying the phenomenon of allergenicity.	[Trompette, Aurelien; Divanovic, Senad; Madan, Rajat; Karp, Christopher L.] Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA; [Blanchard, Carine] Childrens Hosp, Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Hegde, Rashmi S.] Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wills-Karp, Marsha] Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Visintin, Alberto] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01606 USA; [Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Med, Iowa City, IA 52241 USA; [Gioannini, Theresa L.; Weiss, Jerry P.] Univ Iowa, Inflammat Program, Dept Internal Med, Iowa City, IA 52241 USA; [Gioannini, Theresa L.; Weiss, Jerry P.] Vet Affairs Med Ctr, Iowa City, IA 52247 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Karp, CL (corresponding author), Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA.	chris.karp@chmcc.org	Madan, Rajat/V-6168-2019	Madan, Rajat/0000-0002-9821-1257; Karp, Christopher/0000-0002-0832-2659; Thorne, Peter/0000-0002-5045-0929	Sandler Foundation for Asthma Research; National Institute of Allergy and Infectious Diseases; Veteran's Administration; NATIONAL EYE INSTITUTE [R01EY014648] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075159] Funding Source: NIH RePORTER	Sandler Foundation for Asthma Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veteran's Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Vogel for re-purified LPS; E. Kurt-Jones and R. Finberg for HEK293 cells expressing TLR4 complex proteins, N.J. Gay for discussions, and L. Flick and J. Bohnert for technical assistance. This work was funded by grants from the Sandler Foundation for Asthma Research (C.L.K.), the National Institute of Allergy and Infectious Diseases (C.L.K., J.P.W.), and the Veteran's Administration (T.L.G.).	Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; MAUNSELL K, 1968, LANCET, V1, P1267; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park GM, 2000, CLIN EXP ALLERGY, V30, P1293, DOI 10.1046/j.1365-2222.2000.00883.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579	30	537	548	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					585	U91		10.1038/nature07548	http://dx.doi.org/10.1038/nature07548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19060881	Green Accepted			2022-12-24	WOS:000262852200042
J	Bindman, AB; Chattopadhyay, A; Auerback, GM				Bindman, Andrew B.; Chattopadhyay, Arpita; Auerback, Glenna M.			Interruptions in Medicaid Coverage and Risk for Hospitalization for Ambulatory Care-Sensitive Conditions	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-INSURANCE; MANAGED CARE; ENROLLMENT; CANCER	Background: Many low-income U.S. citizens experience interruptions in health insurance coverage. Objective: To determine the rate of hospitalization for ambulatory care-sensitive conditions among Medicaid beneficiaries with interruptions in coverage. Design: Retrospective cohort study. Setting: California Medicaid population. Patients: 4 735 797 adults in California age 18 to 64 years who received a minimum of 1 month of Medicaid coverage between 1998 to 2002. Measurement: Time to hospitalization for an ambulatory care sensitive condition. Results: Sixty-two percent of Medicaid beneficiaries experienced at least 1 interruption in coverage during the study period. The 3 most common ambulatory care-sensitive conditions resulting in a hospitalization were heart failure, diabetes, and chronic obstructive pulmonary disease. Interruptions in coverage were associated with a higher risk for hospitalization for an ambulatory care-sensitive condition (adjusted hazard ratio, 3.66 [95% CI, 3.59 to 3.72]; P < 0.001). In subgroup analyses, the association between interrupted coverage and hospitalization was stronger for beneficiaries eligible through the Temporary Aid to Needy Families program (adjusted hazard ratio, 8.56 [CI, 8.06 to 9.08]) than for beneficiaries eligible through the Supplemental Security Income program (adjusted hazard ratio, 1.72 [CI, 1.67 to 1.76]), who typically retain Medicare coverage even when their Medicaid coverage is interrupted. Limitation: The study lacked information on why interruptions occurred and whether beneficiaries with interruptions transitioned to other insurance coverage. Conclusion: Interruptions in Medicaid coverage are associated with a higher rate of hospitalization for ambulatory care-sensitive conditions. Policies that reduce the frequency of interruptions in Medicaid coverage might prevent some of the health events that trigger hospitalization and high-cost health care spending.	[Bindman, Andrew B.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Bindman, AB (corresponding author), San Francisco Gen Hosp, Bldg 10,Ward 13,1001 Potrero Ave, San Francisco, CA 94110 USA.	abindman@medsfgh.ucsf.edu	Dalla Zuanna, Teresa/G-3133-2015		The Commonwealth Fund; national, private foundation	The Commonwealth Fund; national, private foundation	By The Commonwealth Fund, a national, private foundation that supports independent research on health and social issues.	Agency for Healthcare Research and Quality, 2002, AHRQ QUAL IND GUID P; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bindman AB, 2005, HEALTH SERV RES, V40, P19, DOI 10.1111/j.1475-6773.2005.00340.x; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bradley CJ, 2005, CANCER-AM CANCER SOC, V103, P1712, DOI 10.1002/cncr.20954; Carrasquillo O, 1998, AM J PUBLIC HEALTH, V88, P464, DOI 10.2105/AJPH.88.3.464; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; *ER MARD ASS, 2002, US MARK RES IMPR ENR; FLEMING ST, 1995, MED CARE RES REV, V52, P88, DOI 10.1177/107755879505200106; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Harman JS, 2003, PSYCHIAT SERV, V54, P999, DOI 10.1176/appi.ps.54.7.999; *I MED, 2004, INS AM HLTH; *KAIS COMM, 2001, STAT NAT MED ENR SPE; *KAIS COMM MED UN, 2006, WHO NEEDS MED AID; KLEIN J, 2002, MED CARE STAT SECTIO; Klein K, 2005, ENTRANCES EXITS HLTH, V855, P1; Kruzikas DT, 2004, PREVENTABLE HOSPITAL; PAGE C, 1999, GUIDE MEDICAL PROGRA; Perkins CI, 2001, MED CARE, V39, P1224, DOI 10.1097/00005650-200111000-00009; RAINS J, 2001, OSHPD MEDICAL MATCH; Short PF, 2003, HEALTH AFFAIR, V22, P244, DOI 10.1377/hlthaff.22.6.244; SHORT PF, 2003, CHURN CHURN CHURN IN, V688, P1; *US GOV ACC OFF, 2007, MED STAT REP CIT DOC; YAMAGUCHI K, 1991, EVENT HIST ANAL, P182	24	73	74	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					854	+		10.7326/0003-4819-149-12-200812160-00004	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384VI	19075204				2022-12-24	WOS:000261771900002
J	Tsai, AG; Lu, HH; Raghavan, SC; Muschen, M; Hsieh, CL; Lieber, MR				Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Muschen, Markus; Hsieh, Chih-Lin; Lieber, Michael R.			Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage Specificity	CELL			English	Article							SINGLE-STRANDED-DNA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CLASS SWITCH RECOMBINATION; MAJOR BREAKPOINT REGION; V(D)J RECOMBINATION; CYTOSINE DEAMINATION; TRANSGENIC MICE; EXCISION-REPAIR; RAG COMPLEX; B-CELLS	We have assembled, annotated, and analyzed a database of over 1700 breakpoints from the most common chromosomal rearrangements in human leukemias and lymphomas. Using this database, we show that although the CpG dinucleotide constitutes only 1% of the human genome, it accounts for 40%-70% of breakpoints at pro-B/pre-B stage translocation regions-specifically, those near the bcl-2, bcl-1, and E2A genes. We do not observe CpG hotspots in rearrangements involving lymphoid-myeloid progenitors, mature B cells, or T cells. The stage specificity, lineage specificity, CpG targeting, and unique breakpoint distributions at these cluster regions may be explained by a lesion-specific double-strand breakage mechanism involving the RAG complex acting at AID-deaminated methyl-CpGs.	[Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Urol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Muschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90027 USA; [Muschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Room 5428,1441 Eastlake Ave,MC9176, Los Angeles, CA 90089 USA.	lieber@usc.edu		Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345; Tsai, Albert/0000-0002-6607-3347	NATIONAL CANCER INSTITUTE [R01CA137060, R21CA152497, R01CA139032, R37CA051105, R01CA100504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043236, R01GM056984] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA051105-18, R01 CA139032-01, R01 CA137060, R01 CA100504-06, R01 CA100504, R37 CA051105-20, R21 CA152497, R37 CA051105, R37 CA051105-19, R01 CA139032, R37 CA051105-21] Funding Source: Medline; NIGMS NIH HHS [R01 GM043236-14, R01 GM043236, R01 GM056984, R01 GM056984-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALT FW, 1982, NATURE, V296, P325, DOI 10.1038/296325a0; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Barreto V, 2001, EUR J IMMUNOL, V31, P3763, DOI 10.1002/1521-4141(200112)31:12<3763::AID-IMMU3763>3.0.CO;2-Y; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bassing CH, 2008, BLOOD, V111, P2163, DOI 10.1182/blood-2007-08-104760; Bertoni F, 2004, BRIT J HAEMATOL, V124, P130, DOI 10.1046/j.1365-2141.2003.04761.x; Bestor TH, 2003, ANN NY ACAD SCI, V983, P22, DOI 10.1111/j.1749-6632.2003.tb05959.x; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BURROWS PD, 1983, NATURE, V306, P243, DOI 10.1038/306243a0; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hotfilder M, 2005, CANCER RES, V65, P1442, DOI 10.1158/0008-5472.CAN-04-1356; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; MULLER JR, 1995, CANCER RES, V55, P5012; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pine SR, 2003, LEUKEMIA RES, V27, P155, DOI 10.1016/S0145-2126(02)00183-2; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Schlissel MS, 2006, GENE DEV, V20, P1539, DOI 10.1101/gad.1446506; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; Takai Daiya, 2003, In Silico Biology, V3, P235; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Unniraman S, 2006, DNA REPAIR, V5, P1259, DOI 10.1016/j.dnarep.2006.05.019; WADA M, 1993, BLOOD, V82, P3163; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Weinberg OK, 2007, J MOL DIAGN, V9, P530, DOI 10.2353/jmoldx.2007.070038; Welzel N, 2001, CANCER RES, V61, P1629; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Yang AS, 1996, J MOL BIOL, V258, P240, DOI 10.1006/jmbi.1996.0246; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zhang M, 2008, J BIOL CHEM, V283, P6717, DOI 10.1074/jbc.M710301200	71	176	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1130	1142		10.1016/j.cell.2008.10.035	http://dx.doi.org/10.1016/j.cell.2008.10.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070581	Bronze, Green Accepted			2022-12-24	WOS:000261642800028
J	Fiscella, K; Tancredi, D				Fiscella, Kevin; Tancredi, Daniel			Socioeconomic Status and Coronary Heart Disease Risk Prediction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALL-CAUSE MORTALITY; CARDIOVASCULAR RISK; VALIDATION; PROJECT; SCORE		[Fiscella, Kevin] Univ Rochester, Dept Family Med, Rochester, NY USA; [Fiscella, Kevin] Univ Rochester, Dept Community & Prevent Med, Rochester, NY USA; [Fiscella, Kevin] Univ Rochester, Dept Oncol, Rochester, NY USA; [Tancredi, Daniel] Univ Calif Davis, Dept Pediat, Ctr Healthcare Policy & Res, Davis, CA 95616 USA	University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Davis	Fiscella, K (corresponding author), 1381 South Ave, Rochester, NY 14620 USA.	Kevin_Fiscella@URMC.rochester.edu	Fiscella, Kevin Anthony/AFO-3350-2022; Tancredi, Daniel J/O-3381-2013	Fiscella, Kevin Anthony/0000-0003-3613-8012; Tancredi, Daniel J/0000-0002-3884-7907	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081066] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081066, R01 HL081066-01A2, 1R01 HL081066-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; *C BUDG OFF, 2008, GROW DSP LIF EXP; Claussen B, 2003, J EPIDEMIOL COMMUN H, V57, P40, DOI 10.1136/jech.57.1.40; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fiscella K, 2004, ANN FAM MED, V2, P469, DOI 10.1370/afm.88; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	15	54	57	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2666	2668		10.1001/jama.2008.792	http://dx.doi.org/10.1001/jama.2008.792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066387	Green Accepted			2022-12-24	WOS:000261503000026
J	Driver, JA; Djousse, L; Logroscino, G; Gaziano, JM; Kurth, T				Driver, Jane A.; Djousse, Luc; Logroscino, Giancarlo; Gaziano, J. Michael; Kurth, Tobias			Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; LIFETIME RISK; PHYSICIANS HEALTH; ALZHEIMERS-DISEASE; BETA-CAROTENE; MORTALITY; BURDEN; STROKE; CHOLESTEROL; POPULATION	Objective To investigate the influence of increasing age on the incidence and remaining lifetime risk of cardiovascular disease and cancer in a cohort of older men. Design Prospective cohort study. Setting United States. Participants 22 048 male doctors aged 40- 84 who were free of major disease in 1982. Main outcome measures Incidence and remaining lifetime risk of major cardiovascular disease ( myocardial infarction, stroke, and death from cardiovascular disease) and cancer. Results 3252 major cardiovascular events and 5400 incident cancers were confirmed over 23 years of follow-up. The incidence of major cardiovascular disease continued to increase to age 100. Beginning at age 80, however, major cardiovascular disease was more likely to be diagnosed at death. The incidence of cancer peaked in those aged 80- 89 and then declined. Cancers detected by screening accounted for most of the decline, whereas most cancers for which there was no screening continued to increase to age 100. Unadjusted cumulative incidence overestimated the risk of cardiovascular disease by 16% and cancer by 8.5%. The remaining lifetime risk of cancer at age 40 was 45.1% ( 95% confidence interval 43.8% to 46.3%) and at age 90 was 9.6% ( 7.2% to 11.9%). The remaining lifetime risk of major cardiovascular disease at age 40 was 34.8% ( 33.1% to 36.5%) and at age 90 was 16.7% ( 12.9% to 20.6%). Conclusions In this prospective cohort of men, the incidence of new cardiovascular disease continued to increase after age 80 but was most often diagnosed at death. The decrease in incidence of cancer late in life seemed largely due to a decline in cancers usually detected by screening. These findings suggest that people aged 80 and older have a substantial amount of undiagnosed disease. The remaining lifetime risk of both diseases approached a plateau in the 10th decade. This may be due to decreased detection of disease and reporting of symptoms and increased resistance to disease in those who survive to old age. Accurate estimates of disease risk in an aging population require adjustment for competing risks of mortality.	[Driver, Jane A.; Djousse, Luc; Gaziano, J. Michael; Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02215 USA; [Logroscino, Giancarlo] Univ Bari, Sch Med, Dept Neurol & Psychiat, Bari, Italy; [Gaziano, J. Michael; Kurth, Tobias] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res Informat Ctr, Boston, MA USA; [Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universita degli Studi di Bari Aldo Moro; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Driver, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02215 USA.	jdriver@partners.org	Djousse, Luc/F-5033-2017; Kurth, Tobias/A-9243-2012; LOGROSCINO, GIANCARLO/K-5148-2016	Djousse, Luc/0000-0002-9902-3047; Kurth, Tobias/0000-0001-7169-2620; LOGROSCINO, GIANCARLO/0000-0003-0423-3242	Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School; Eleanor and the Miles Shore 50th anniversary fellowship programme; Harvard Medical School; National Cancer Institute [CA-34944, CA-40360, CA-097193]; National Heart, Lung, and Blood Institute, Bethesda, Maryland [HL-26490, HL-34595]; NATIONAL CANCER INSTITUTE [R01CA040360, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School; Eleanor and the Miles Shore 50th anniversary fellowship programme; Harvard Medical School; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors' work was independent of the funders. JAD received support for this research from the Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School and the Eleanor and the Miles Shore 50th anniversary fellowship programme for scholars in medicine at Harvard Medical School. The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute, and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.	Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; BRODY JA, 1986, J CHRON DIS, V39, P871, DOI 10.1016/0021-9681(86)90035-4; CASTELLI WP, 1989, AM J CARDIOL, V63, P12; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Cook NR, 2000, ARCH INTERN MED, V160, P921, DOI 10.1001/archinte.160.7.921; de Rijke JM, 2000, CANCER, V89, P1121, DOI 10.1002/1097-0142(20000901)89:5<1121::AID-CNCR22>3.3.CO;2-7; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Merrill RM, 2001, ANN EPIDEMIOL, V11, P547, DOI 10.1016/S1047-2797(01)00254-X; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Saltzstein SL, 1998, J AM GERIATR SOC, V46, P994, DOI 10.1111/j.1532-5415.1998.tb02755.x; SCHOUTEN LJ, 1994, J EPIDEMIOL COMMUN H, V48, P596, DOI 10.1136/jech.48.6.596; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; UN Population Division, 2002, WORLD POP AG 1950 20; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; *WHO, 1971, ISCH HEART DIS REG R; *WHO, 2007, TOP 10 CAUS DEATH; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	30	108	112	1	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2008	337								a2467	10.1136/bmj.a2467	http://dx.doi.org/10.1136/bmj.a2467			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066258	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000262776700003
J	Duncan, CW; Watson, DPB; Stein, A				Duncan, C. W.; Watson, D. P. B.; Stein, A.		Guideline Dev Grp	Diagnosis and management of headache in adults: summary of SIGN guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTAL FINDINGS; MIGRAINE; PREVALENCE; PHYSICIAN; BURDEN		[Stein, A.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Duncan, C. W.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Watson, D. P. B.] Hamilton Med Grp, Aberdeen, Scotland	University of Aberdeen	Stein, A (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	ailsa.stein@nhs.net		Hilton Boon, Michele/0000-0002-2240-7923				Boardman HF, 2003, CEPHALALGIA, V23, P129, DOI 10.1046/j.1468-2982.2003.00468.x; *BRIT ASS STUD HEA, 2007, GUID ALL HEALTHC PRO; Diamond ML, 2002, NEUROLOGY, V58, pS3, DOI 10.1212/WNL.58.9_suppl_6.S3; Frishberg BM, 2000, EVIDENCE BASED GUIDE; *INT HEAD SOC HEAD, 2004, CEPHALALGIA S1, V24, P8; Karli N, 2007, CEPHALALGIA, V27, P41, DOI 10.1111/j.1468-2982.2006.01245.x; Katsarava Z, 2004, NEUROLOGY, V62, P788, DOI 10.1212/01.WNL.0000113747.18760.D2; Larner A., 2006, HEADACHE CARE, V3, P1; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; LIPTON RB, 1992, ARCH INTERN MED, V152, P1273, DOI 10.1001/archinte.152.6.1273; Lipton RB, 2002, NEUROLOGY, V58, pA100; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; PATTERSON VH, 1993, J NEUROL NEUROSUR PS, V56, P830, DOI 10.1136/jnnp.56.7.830; *SIGN, 2008, 107 SIGN; SMITH TR, 2004, HEADACHE CARE, V1, P195; Steiner TJ, 2003, CEPHALALGIA, V23, P519, DOI 10.1046/j.1468-2982.2003.00568.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tepper SJ, 2004, HEADACHE, V44, P856, DOI 10.1111/j.1526-4610.2004.04167.x; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Watson DPB, 2008, BRIT J GEN PRACT, V58, P77, DOI 10.3399/bjgp08X264009; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008	21	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2329	10.1136/bmj.a2329	http://dx.doi.org/10.1136/bmj.a2329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HS	19022842				2022-12-24	WOS:000262654100005
J	Dulcis, D; Spitzer, NC				Dulcis, Davide; Spitzer, Nicholas C.			Illumination controls differentiation of dopamine neurons regulating behaviour	NATURE			English	Article							ACTIVITY-DEPENDENT REGULATION; SEASONAL AFFECTIVE-DISORDER; XENOPUS-LAEVIS; MELANOTROPE CELLS; TYROSINE-HYDROXYLASE; SUPRACHIASMATIC NUCLEUS; EXPRESSION; PLASTICITY; ZEBRAFISH; SYSTEM	Specification of the appropriate neurotransmitter is a crucial step in neuronal differentiation because it enables signalling among populations of neurons. Experimental manipulations demonstrate that both autonomous and activity- dependent genetic programs contribute to this process during development, but whether natural environmental stimuli specify transmitter expression in a neuronal population is unknown. We investigated neurons of the ventral suprachiasmatic nucleus that regulate neuroendocrine pituitary function in response to light in teleosts, amphibia and primates. Here we show that altering light exposure, which changes the sensory input to the circuit controlling adaptation of skin pigmentation to background, changes the number of neurons expressing dopamine in larvae of the amphibian Xenopus laevis in a circuit- specific and activity- dependent manner. Neurons newly expressing dopamine then regulate changes in camouflage colouration in response to illumination. Thus, physiological activity alters the numbers of behaviourally relevant amine- transmitter- expressing neurons in the brain at postembryonic stages of development. The results may be pertinent to changes in cognitive states that are regulated by biogenic amines.	[Dulcis, Davide; Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Dulcis, Davide; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Mol Genet, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dulcis, D (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ddulcis@biomail.ucsd.edu	Dulcis, Davide/GSN-9883-2022	Dulcis, Davide/0000-0003-4672-7996; Spitzer, Nicholas/0000-0002-3523-1103	N.C.S.; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015918] Funding Source: NIH RePORTER	N.C.S.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Berg, L. Borodinsky and R. Levine for critical comments on the manuscript and I-T. Hsieh and D. Boassa for technical support. This work was supported by a grant to N.C.S. from the National Institutes of Health.	Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Akopian A, 1996, J NEUROPHYSIOL, V76, P1828, DOI 10.1152/jn.1996.76.3.1828; Baquet ZC, 2005, J NEUROSCI, V25, P6251, DOI 10.1523/JNEUROSCI.4601-04.2005; Berghs CAFM, 1997, J HISTOCHEM CYTOCHEM, V45, P1673, DOI 10.1177/002215549704501211; Borodinsky LN, 2007, P NATL ACAD SCI USA, V104, P335, DOI 10.1073/pnas.0607450104; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; Catalano SM, 1997, J NEUROSCI, V17, P8376; El Majdoubi M, 2000, BIOCHEM CELL BIOL, V78, P317; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; GONZALEZ A, 1991, J COMP NEUROL, V303, P457, DOI 10.1002/cne.903030311; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Green CB, 1999, DEV BRAIN RES, V117, P109, DOI 10.1016/S0165-3806(99)00109-1; HESS EJ, 1991, NEURON, V6, P123, DOI 10.1016/0896-6273(91)90127-L; Jenks BG, 2007, NEUROENDOCRINOLOGY, V85, P177, DOI 10.1159/000101434; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kolk SM, 2001, ENDOCRINOLOGY, V142, P1950, DOI 10.1210/en.142.5.1950; Kramer BMR, 2001, MICROSC RES TECHNIQ, V54, P188, DOI 10.1002/jemt.1132; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lam R., 1999, CANADIAN CONSENSUS G; Lam RW, 2001, NEUROPSYCHOPHARMACOL, V25, pS97, DOI 10.1016/S0893-133X(01)00337-2; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Li L, 2000, J NEUROSCI, V20, P1893; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; Michel S, 2002, J NEUROPHYSIOL, V88, P817, DOI 10.1152/jn.2002.88.2.817; Mueller NK, 2005, ENDOCRINOLOGY, V146, P348, DOI 10.1210/en.2004-0539; NORDLAND JJ, 2006, PIGMENTARY SYSTEM PH; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; OLIVE S, 1995, BRAIN RES, V689, P271, DOI 10.1016/0006-8993(95)00555-5; Roubos EW, 2005, ANN NY ACAD SCI, V1040, P172, DOI 10.1196/annals.1327.022; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; TONOSAKI Y, 1995, ENDOCRINOLOGY, V136, P5260, DOI 10.1210/en.136.12.5260; TUINHOF R, 1994, NEUROSCIENCE, V61, P411, DOI 10.1016/0306-4522(94)90241-0; Ubink R, 1998, J COMP NEUROL, V397, P60; Vazquez-Martinez R, 2001, ENDOCRINOLOGY, V142, P3060, DOI 10.1210/en.142.7.3060; WALICKE PA, 1981, J NEUROSCI, V1, P343; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; Wullimann MF, 2001, DEV BRAIN RES, V131, P173, DOI 10.1016/S0165-3806(01)00270-X; Zhang H, 2008, GEN COMP ENDOCR, V156, P104, DOI 10.1016/j.ygcen.2007.12.005	46	89	90	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					195	U20		10.1038/nature07569	http://dx.doi.org/10.1038/nature07569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005547	Green Accepted			2022-12-24	WOS:000261039300031
J	Gostin, LO				Gostin, Lawrence O.			President's Emergency Plan for AIDS Relief Health Development at the Crossroads	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Oneill Inst Natl Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; GARRETT L, 2008, INT HERALD TRIB 0730; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P225, DOI 10.1001/jama.298.2.225; *GOV ACC OFF, 2008, GLOB HIV AIDS MOR CO; *HJ KAIS FAM FDN, 2008, REAUTH PEPFAR US LEA; *I MED, 2007, PEPFAR IMPL PROGR PR; Jaffe HW, 2008, JAMA-J AM MED ASSOC, V300, P573, DOI 10.1001/jama.300.5.573; *ON CAMP, 2008, DAT REP 2008 KEEP G8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schleber GJ, 2007, HEALTH AFFAIR, V26, P921, DOI 10.1377/hlthaff.26.4.921; *UNAIDS, 2008, UN ACC SCAL PRIOR HI; *UNAIDS, 2005, 3 5 IN TREAT 3 MILL	13	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2046	2048		10.1001/jama.2008.588	http://dx.doi.org/10.1001/jama.2008.588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984892				2022-12-24	WOS:000260605400026
J	Bray, GA				Bray, George A.			Is new hope on the horizon for obesity?	LANCET			English	Editorial Material							PHARMACOTHERAPY; METAANALYSIS; RIMONABANT; OVERWEIGHT; TRIALS		[Bray, George A.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bray, GA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	george.Bray@PBRC.edu						Astrup A, 2008, LANCET, V372, P1906, DOI 10.1016/S0140-6736(08)61525-1; Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805; Bray GA., 2007, BATTLE BULGE; Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; European Medicines Agency, 2008, PUBL STAT BEXTR VALD; Galuska D. A., 2008, Morbidity and Mortality Weekly Report, V57, P765; Haddock CK, 2002, INT J OBESITY, V26, P262, DOI 10.1038/sj.ijo.0801889; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P586, DOI 10.1038/clpt.1992.69	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1859	1860		10.1016/S0140-6736(08)61792-4	http://dx.doi.org/10.1016/S0140-6736(08)61792-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041787				2022-12-24	WOS:000261388700005
J	Hishida, T; Kubota, Y; Carr, AM; Iwasaki, H				Hishida, Takashi; Kubota, Yoshino; Carr, Antony M.; Iwasaki, Hiroshi			RAD6-RAD18-RAD5-pathway-dependent tolerance to chronic low-dose ultraviolet light	NATURE			English	Article							DNA-DAMAGE TOLERANCE; NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; BUDDING YEAST; REPLICATION; CHECKPOINT; PROTEIN; MECHANISMS; UBIQUITIN	In nature, organisms are exposed to chronic low- dose ultraviolet light ( CLUV) as opposed to the acute high doses common to laboratory experiments. Analysis of the cellular response to acute high-dose exposure has delineated the importance of direct DNA repair by the nucleotide excision repair pathway(1) and for checkpoint-induced cell cycle arrest in promoting cell survival(2). Here we examine the response of yeast cells to CLUV and identify a key role for the RAD6-RAD18-RAD5 error- free postreplication repair (RAD6 error-free PRR) pathway(3,4) in promoting cell growth and survival. We show that loss of the RAD6 error- free PRR pathway results in DNA-damage-checkpoint- induced G2 arrest in CLUV-exposed cells, whereas wild-type and nucleotide-excision-repair-deficient cells are largely unaffected. Cell cycle arrest in the absence of the RAD6 error- free PRR pathway was not caused by a repair defect or by the accumulation of ultraviolet-induced photoproducts. Notably, we observed increased replication protein A (RPA) and Rad52 - yellow fluorescent protein foci(5) in the CLUV- exposed rad18 Delta cells and demonstrated that Rad52- mediated homologous recombination is required for the viability of the rad18 Delta cells after release from CLUV- induced G2 arrest. These and other data presented suggest that, in response to environmental levels of ultraviolet exposure, the RAD6 error- free PRR pathway promotes replication of damaged templates without the generation of extensive single- stranded DNA regions. Thus, the error- free PRR pathway is specifically important during chronic low- dose ultraviolet exposure to prevent counter- productive DNA checkpoint activation and allow cells to proliferate normally.	[Hishida, Takashi; Kubota, Yoshino] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Carr, Antony M.] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan	Osaka University; University of Sussex; Yokohama City University	Hishida, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hishida@biken.osaka-u.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Carr, Antony Michael/0000-0002-2028-2389; Hishida, Takashi/0000-0002-9752-6599	Sumitomo foundation; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; MRC (UK) [G0600233]; MRC [G0600233] Funding Source: UKRI; Medical Research Council [G0600233, G0300662B] Funding Source: researchfish	Sumitomo foundation; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Rothstein and H. Araki for strains; T. Matsunaga for anti- thymine dimer monoclonal antibody (designated TDM2 antibody); and T. Ohya for technical assistance. This work was supported by the Sumitomo foundation, by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the MRC (UK) grant G0600233.	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; HARM W, 1969, RADIAT RES, V40, P63, DOI 10.2307/3572983; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Paciotti V, 2000, GENE DEV, V14, P2046; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Schepers A, 2001, J MOL BIOL, V308, P597, DOI 10.1006/jmbi.2001.4637; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	34	64	66	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					612	U124		10.1038/nature07580	http://dx.doi.org/10.1038/nature07580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19079240	Green Accepted			2022-12-24	WOS:000262852200048
J	Rebouissou, S; Amessou, M; Couchy, G; Poussin, K; Imbeaud, S; Pilati, C; Izard, T; Balabaud, C; Bioulac-Sage, P; Zucman-Rossi, J				Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Imbeaud, Sandrine; Pilati, Camilla; Izard, Tina; Balabaud, Charles; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica			Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours	NATURE			English	Article							SIGNAL TRANSDUCER; MOLECULAR-CLONING; CYTOKINE RECEPTOR; IL-6; INTERLEUKIN-6; BINDING; ADENOMA; GENE; CLASSIFICATION; TRANSCRIPTION	Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour hepatocytes(1,2). Here we show a marked activation of the interleukin ( IL)- 6 signalling pathway in this tumour type; sequencing candidate genes pinpointed this response to somatic gain- of- function mutations in the IL6ST gene, which encodes the signalling co- receptor gp130. Indeed, 60% of inflammatory hepatocellular adenomas harbour small in- frame deletions that target the binding site of gp130 for IL- 6, and expression of four different gp130 mutants in hepatocellular cells activates signal transducer and activator of transcription 3 ( STAT3) in the absence of ligand. Furthermore, analysis of hepatocellular carcinomas revealed that rare gp130 alterations are always accompanied by beta-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant conversion of hepatocytes. The recurrent gain- of function gp130 mutations in these human hepatocellular adenomas fully explains activation of the acute inflammatory phase observed in tumourous hepatocytes, and suggests that similar alterations may occur in other inflammatory epithelial tumours with STAT3 activation.	[Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Pilati, Camilla; Zucman-Rossi, Jessica] INSERM, Genom Fonct Tumeurs Solides U674, F-75010 Paris, France; [Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Pilati, Camilla; Zucman-Rossi, Jessica] Univ Paris 07, Inst Univ Hematol, F-75010 Paris, France; [Imbeaud, Sandrine] CNRS, Arrays IMAGE Genexpress Funct Genom & Syst Biol H, UMR 7091, F-94801 Villejuif, France; [Imbeaud, Sandrine] Univ Paris 06, F-94801 Villejuif, France; [Imbeaud, Sandrine] CNRS, Ctr Genet Mol, Gif Orsay DNA Microarray Platform GODMAP, UPR 2167, F-91198 Gif Sur Yvette, France; [Imbeaud, Sandrine] Univ Paris 11, F-91198 Gif Sur Yvette, France; [Izard, Tina] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Balabaud, Charles; Bioulac-Sage, Paulette] INSERM, U889, F-33076 Bordeaux, France; [Balabaud, Charles; Bioulac-Sage, Paulette] Univ Bordeaux 2, IFR66, F-33076 Bordeaux, France; [Balabaud, Charles] Hop St Andre, Serv Hepatol, CHU Bordeaux, F-33076 Bordeaux, France; [Bioulac-Sage, Paulette] Hop Pellegrin, Serv Anat Pathol, CHU Bordeaux, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux	Zucman-Rossi, J (corresponding author), INSERM, Genom Fonct Tumeurs Solides U674, F-75010 Paris, France.	zucman@cephb.fr	zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; Rebouissou, Sandra/O-5938-2017; Imbeaud, Sandrine/P-8780-2017	zucman-rossi, Jessica/0000-0002-5687-0334; j, zucman-rossi/0000-0002-5687-0334; Rebouissou, Sandra/0000-0003-0188-2271; Pilati, Camilla/0000-0002-1781-5180; Imbeaud, Sandrine/0000-0001-8439-6732	Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations); Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program); ARC [5158]; Fondation de France; la Ligue Nationale Contre le Cancer; Inca; Inserm; Bordeaux Hospital; National Institutes of Health [GM071596, AI055894, AI067949]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055894, R01AI067949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071596] Funding Source: NIH RePORTER	Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program); ARC(Australian Research Council); Fondation de France(Fondation de France); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Inca(Institut National du Cancer (INCA) France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Bordeaux Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to P. Bois and O. Bernard for scientific discussion and critical reading of this manuscript. We thank C. Thomas and G. Cubel for their participation to this work. We also thank J. Saric, C. Laurent, A. Sa Cunha, B. Le Bail and A. Rullier for contributing to the tissue collection (CHU Bordeaux). This work was supported by Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations), the Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program), ARC (grant 5158), and the Fondation de France. S.R. and M.A. are supported by a fellowship from la Ligue Nationale Contre le Cancer and the Inca, respectively. J.Z.-R. is supported by an interface contract between Inserm and Bordeaux Hospital. T. I. is supported by the National Institutes of Health grants GM071596, AI055894 and AI067949.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bioulac-Sage P, 2005, GASTROENTEROLOGY, V128, P1211, DOI 10.1053/j.gastro.2005.02.004; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chen YW, 2002, HEPATOLOGY, V36, P927, DOI 10.1053/jhep.2002.36126; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Coulouarn C, 2005, HEPATOLOGY, V42, P946, DOI 10.1002/hep.20848; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Li H, 2002, J VIROL, V76, P5627, DOI 10.1128/JVI.76.11.5627-5636.2002; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Maione D, 1998, EMBO J, V17, P5588, DOI 10.1093/emboj/17.19.5588; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; WARD LD, 1994, J BIOL CHEM, V269, P23286; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	34	341	349	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					200	U96		10.1038/nature07475	http://dx.doi.org/10.1038/nature07475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19020503	Green Submitted, Green Accepted			2022-12-24	WOS:000262360200034
J	King, CR; Knutson, KL; Rathouz, PJ; Sidney, S; Liu, K; Lauderdale, DS				King, Christopher Ryan; Knutson, Kristen L.; Rathouz, Paul J.; Sidney, Steve; Liu, Kiang; Lauderdale, Diane S.			Short Sleep Duration and Incident Coronary Artery Calcification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; COMPUTED-TOMOGRAPHY; APNEA-HYPOPNEA; CALCIUM; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; ACTIGRAPHY; ADULTS; HYPERTENSION	Context Coronary artery calcification is a subclinical predictor of coronary heart disease. Recent studies have found that sleep duration is correlated with established risk factors for calcification including glucose regulation, blood pressure, sex, age, education, and body mass index. Objective To determine whether objective and subjective measures of sleep duration and quality are associated with incidence of calcification over 5 years and whether calcification risk factors mediate the association. Design, Setting, and Participants Observational cohort of home monitoring in a healthy middle- aged population of 495 participants from the Coronary Artery Risk Development in Young Adults ( CARDIA) cohort Chicago site ( black and white men and women aged 35- 47 years at year 15 of the study in 2000- 2001 with follow- up data at year 20 in 2005- 2006). Potential confounders ( age, sex, race, education, apnea risk, smoking status) and mediators ( lipids, blood pressure, body mass index, diabetes, inflammatory markers, alcohol consumption, depression, hostility, selfreported medical conditions) were measured at both baseline and follow- up. Sleep metrics ( wrist actigraphy measured duration and fragmentation, daytime sleepiness, overall quality, self- reported duration) were examined for association with incident calcification. Participants had no detectable calcification at baseline. Main Outcome Measure Coronary artery calcification was measured by computed tomography in 2000- 2001 and 2005- 2006 and incidence of new calcification over that time was the primary outcome. Results Five- year calcification incidence was 12.3% ( n= 61). Longer measured sleep duration was significantly associated with reduced calcification incidence ( adjusted odds ratio, 0.67 per hour [ 95% confidence interval, 0.49- 0.91 per hour]; P=. 01). No potential mediators appreciably altered the magnitude or significance of sleep ( adjusted odds ratio estimates ranged from 0.64 to 0.68 per sleep hour; maximum P=. 02). Alternative sleep metrics were not significantly associated with calcification. Conclusion Longer measured sleep is associated with lower calcification incidence independent of examined potential mediators and confounders.	[King, Christopher Ryan; Knutson, Kristen L.; Rathouz, Paul J.; Lauderdale, Diane S.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Sidney, Steve] Kaiser Permanente, Oakland, CA USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	University of Chicago; Kaiser Permanente; Northwestern University	Lauderdale, DS (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	lauderdale@uchicago.edu		King, Christopher/0000-0002-4574-8616; Knutson, Kristen/0000-0002-2751-6168	National Institute on Aging [AG 11412]; Medical Scientist National Research Service Award [T 32 GM07281]; US Public Health Service [NO1-HC-48047, NO1-HC-48048, NO1-HC48049, NO1-HC-48050]; National Heart, Lung, and Blood Institute [NO1-HC-95095]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048050, N01HC048047, N01HC095095, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL048050, R01HL048049, R01HL048048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Scientist National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research for this study was supported by grant AG 11412 from the National Institute on Aging and the Medical Scientist National Research Service Award T 32 GM07281. The Coronary Artery Risk Development in Young Adults (CARDIA) study is supported by US Public Health Service contracts NO1-HC-48047, NO1-HC-48048, NO1-HC48049, NO1-HC-48050, and NO1-HC-95095 from the National Heart, Lung, and Blood Institute.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; EVANS PD, 1987, J BEHAV MED, V10, P311, DOI 10.1007/BF00846544; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Garcia-Diaz E, 2007, CHEST, V131, P725, DOI 10.1378/chest.06-1604; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Hastings PC, 2006, EUR RESPIR J, V27, P748, DOI 10.1183/09031936.06.00063005; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JeanLouis G, 1997, PERCEPT MOTOR SKILL, V85, P207, DOI 10.2466/pms.1997.85.1.207; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jung HH, 2005, AM J KIDNEY DIS, V45, P875, DOI 10.1053/j.ajkd.2005.01.006; Knutson KL, 2007, SLEEP, V30, P793, DOI 10.1093/sleep/30.6.793; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2006, SLEEP, V29, P878, DOI 10.1093/sleep/29.7.878; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Leproult R, 1997, SLEEP, V20, P865; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Matthews K, 2006, PSYCHOSOM MED, V68, P657, DOI 10.1097/01.psy.0000244071.42939.0e; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; PATEL SR, INT J OBES IN PRESS; Reiner AP, 2006, J THROMB HAEMOST, V4, P1279, DOI 10.1111/j.1538-7836.2006.01907.x; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Silva GE, 2007, J CLIN SLEEP MED, V3, P622; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; STAESSEN J, 1992, AM J HYPERTENS, V5, P386, DOI 10.1093/ajh/5.6.386; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Yoon HC, 2002, RADIOLOGY, V224, P236, DOI 10.1148/radiol.2241011191; Zisapel N, 2007, CELL MOL LIFE SCI, V64, P1174, DOI 10.1007/s00018-007-6529-9; Zou D, 2006, SLEEP, V29, P367, DOI 10.1093/sleep/29.3.367	48	236	242	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2859	2866						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109114	Green Accepted			2022-12-24	WOS:000261920900019
J	Windsor, JS				Windsor, Jeremy S.			Voices in the air	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Windsor, Jeremy S.] UCL, Inst Human Hlth & Performance, London N19 5LW, England	University of London; University College London	Windsor, JS (corresponding author), UCL, Inst Human Hlth & Performance, London N19 5LW, England.	jswindsor@doctors.org.uk						BONINGTON C, 1997, EVEREST HARD WAY, P186; HABELER P, 1979, EVEREST IMPOSSIBLE V, P167; POTTERFIELD P, 2004, MOUNTAINEERS ANTHOLO, P52; VENABLES S, 2000, EVEREST ALONE AUMMIT, P184	4	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 5	2008	337								a2667	10.1136/bmj.a2667	http://dx.doi.org/10.1136/bmj.a2667			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NY	19060106				2022-12-24	WOS:000261891100005
J	Morgan, DO				Morgan, David O.			SnapShot: Cell-Cycle Regulators II	CELL			English	Editorial Material							MACHINE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	5	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					974	U14		10.1016/j.cell.2008.10.040	http://dx.doi.org/10.1016/j.cell.2008.10.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041757	Bronze			2022-12-24	WOS:000261183900026
J	Grabowski, GA				Grabowski, Gregory A.			Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease	LANCET			English	Review							ENZYME REPLACEMENT THERAPY; UNFOLDED PROTEIN RESPONSE; MACROPHAGE-TARGETED GLUCOCEREBROSIDASE; ACID BETA-GLUCOSIDASE; PARKINSONS-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; ENDOPLASMIC-RETICULUM; GENE-THERAPY; GLUCOSYLCERAMIDE SYNTHASE; CHITOTRIOSIDASE ACTIVITY	Gaucher's disease continues to be a model for applications of molecular medicine to clinical delineation, diagnosis, and treatment. Analyses of several thousand affected individuals have broadened the range of the pan-ethnic disease variants, provided initial genotype and phenotype correlations, and established the effectiveness of enzyme therapy. Large numbers of affected individuals worldwide have provided insight into the effect of disease variation related to ethnic origin, prognosis, and outcome. The ability to safely and effectively use enzyme therapy to inhibit or reverse visceral-disease progression and involvement has provided impetus for design of new enzyme therapies, and creation of substrate depletion and pharmacological chaperone strategies. Such innovations could provide interventions that are effective for neuronopathic variants and, potentially, could be more cost effective than other treatments. These developments are novel, clinically important, advancements for patients with other lysosomal storage diseases and genetic diseases.	[Grabowski, Gregory A.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Childrens Hosp Res Fdn, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org			NIDDK NIH HHS [DK36729] Funding Source: Medline; NINDS NIH HHS [NS36681, NS45911] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036681, U01NS045911] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; ABRAHAMOV A, 1995, LANCET, V346, P1000, DOI 10.1016/S0140-6736(95)91688-1; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beutler E, 2000, BLOOD CELL MOL DIS, V26, P303, DOI 10.1006/bcmd.2000.0311; BEUTLER E, 1993, BRIT J HAEMATOL, V85, P401, DOI 10.1111/j.1365-2141.1993.tb03185.x; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BEUTLER E, 1991, BLOOD, V78, P1183; Beutler E, 2000, ACTA HAEMATOL-BASEL, V104, P103, DOI 10.1159/000039760; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bieberich E, 1999, J NEUROCHEM, V72, P1040, DOI 10.1046/j.1471-4159.1999.0721040.x; Bonetta L, 2002, NAT MED, V8, P1189, DOI 10.1038/nm1102-1189; Boven LA, 2004, AM J CLIN PATHOL, V122, P359, DOI 10.1309/BG5VA8JRDQH1M7HN; Brady RO, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e11; Brinkman J, 2005, J INHERIT METAB DIS, V28, P13, DOI 10.1007/s10545-005-4416-9; Clark LN, 2005, MOVEMENT DISORD, V20, P100, DOI 10.1002/mds.20320; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Czartoryska B, 1998, CLIN BIOCHEM, V31, P417, DOI 10.1016/S0009-9120(98)00030-7; de Fost M, 2006, BLOOD, V108, P830, DOI 10.1182/blood-2005-12-5072; DESNICK RJ, 1982, GAUCHER DIS CENTURY; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Elstein D, 2004, J INHERIT METAB DIS, V27, P757, DOI 10.1023/B:BOLI.0000045756.54006.17; Enquist IB, 2006, P NATL ACAD SCI USA, V103, P13819, DOI 10.1073/pnas.0606016103; ERIKSON A, 1990, ACTA PAEDIATR SCAND, V79, P680, DOI 10.1111/j.1651-2227.1990.tb11535.x; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Filocamo M, 2000, BLOOD CELL MOL DIS, V26, P611, DOI 10.1006/bcmd.2000.0341; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; Fredman P, 1998, J INHERIT METAB DIS, V21, P472, DOI 10.1023/A:1005454602454; FUTERMAN T, 2006, GAUCHER DIS; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gaucher PCE, 1882, THESIS PARIS; Ginzburg L, 2004, SEMIN CELL DEV BIOL, V15, P417, DOI 10.1016/j.semcdb.2004.03.003; Giraldo P, 2006, HAEMATOLOGICA, V91, P703; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRABOWSKI GA, 2006, AM J HUM GENET, P427; GRABOWSKI GA, 2006, GAUCHER DIS, P49; Grabowski GA, 2006, METABOLIC MOL BASES; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; HOLLAK CEM, 1995, LANCET, V345, P1474, DOI 10.1016/S0140-6736(95)91037-9; Hruska KS, 2006, GAUCHER DIS, P13; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Kaplan P, 2006, ARCH PEDIAT ADOL MED, V160, P603, DOI 10.1001/archpedi.160.6.603; Kelly JW, 2005, NEW ENGL J MED, V352, P722, DOI 10.1056/NEJMcibr044231; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320; MCEACHERN K, 2006, AM J HUM GENET, P424; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; McEachern KA, 2006, J GENE MED, V8, P719, DOI 10.1002/jgm.901; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mignot C, 2003, AM J MED GENET A, V120A, P338, DOI 10.1002/ajmg.a.20117; Moran MT, 2000, BLOOD, V96, P1969, DOI 10.1182/blood.V96.5.1969.h8001969_1969_1978; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Pastores GM, 2005, CLIN THER, V27, P1215, DOI 10.1016/j.clinthera.2005.08.004; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Pastores GM, 2003, J INHERIT METAB DIS, V26, P641, DOI 10.1023/B:BOLI.0000005623.60471.51; PASTORES GM, 1993, BLOOD, V82, P408; PATTERSON MC, 1993, NEUROLOGY, V43, P1993, DOI 10.1212/WNL.43.10.1993; Platt FM, 2001, J INHERIT METAB DIS, V24, P275, DOI 10.1023/A:1010335505357; POLLACK A, 2003, NY TIMES, pA17; Pollack Andrew, 2003, N Y Times Web, pA17; Rappeport J M, 1986, Birth Defects Orig Artic Ser, V22, P101; RICHARDS SM, 1993, BLOOD, V82, P1402; RINGDEN O, 1988, TRANSPLANTATION, V46, P66, DOI 10.1097/00007890-198807000-00011; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Sato C, 2005, MOVEMENT DISORD, V20, P367, DOI 10.1002/mds.20319; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shayman JA, 2003, GLYCOCONJUGATE J, V20, P25, DOI 10.1023/B:GLYC.0000016739.32089.55; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; SHUKLA GS, 1991, J NEUROCHEM, V56, P2125, DOI 10.1111/j.1471-4159.1991.tb03475.x; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Sobreira E, 2007, MOL GENET METAB, V90, P81, DOI 10.1016/j.ymgme.2006.08.009; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Stone DL, 1999, EUR J HUM GENET, V7, P505, DOI 10.1038/sj.ejhg.5200315; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tylki-Szymanska A, 2006, GENET MED, V8, P8, DOI 10.1097/01.gim.0000196443.42899.25; Weinreb NJ, 2004, SEMIN HEMATOL, V41, P15, DOI 10.1053/j.seminhematol.2004.07.010; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2007, J BONE MINER RES, V22, P119, DOI 10.1359/JBMR.061004; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; XU YH, 2005, AM J HUM GENET, V207, P1413; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao HQ, 2003, BLOOD CELL MOL DIS, V30, P90, DOI 10.1016/S1079-9796(03)00012-3; Zimmer KP, 1999, J PATHOL, V188, P407; ZIMRAN A, 2006, AM J HUM GENET, P428	105	357	409	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1263	1271		10.1016/S0140-6736(08)61522-6	http://dx.doi.org/10.1016/S0140-6736(08)61522-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357YB	19094956				2022-12-24	WOS:000259882000032
J	Vezys, V; Yates, A; Casey, KA; Lanier, G; Ahmed, R; Antia, R; Masopust, D				Vezys, Vaiva; Yates, Andrew; Casey, Kerry A.; Lanier, Gibson; Ahmed, Rafi; Antia, Rustom; Masopust, David			Memory CD8 T-cell compartment grows in size with immunological experience	NATURE			English	Article							VIRAL-INFECTIONS; IMMUNITY; HOMEOSTASIS; VACCINATION; POPULATION; PROTECTION; PHENOTYPE; ATTRITION; SURVIVAL; SUBSETS	Memory CD8 T cells, generated by natural pathogen exposure or intentional vaccination, protect the host against specific viral infections(1). It has long been proposed that the number of memory CD8 T cells in the host is inflexible, and that individual cells are constantly competing for limited space(2,3). Consequently, vaccines that introduce over- abundant quantities of memory CD8 T cells specific for an agent of interest could have catastrophic consequences for the host by displacing memory CD8 T cells specific for all previous infections(4-6). To test this paradigm, we developed a vaccination regimen in mice that introduced as many new long- lived memory CD8 T cells specific for a single vaccine antigen as there were memory CD8 T cells in the host before vaccination. Here we show that, in contrast to expectations, the size of the memory CD8 T- cell compartment doubled to accommodate these new cells, a change due solely to the addition of effector memory CD8 T cells. This increase did not affect the number of CD4 T cells, B cells or naive CD8 T cells, and pre- existing memory CD8 T cells specific for a previously encountered infection were largely preserved. Thus, the number of effector memory CD8 T cells in the mammalian host adapts according to immunological experience. Developing vaccines that abundantly introduce new memory CD8 T cells should not necessarily ablate pre- existing immunity to other infections.	[Vezys, Vaiva; Casey, Kerry A.; Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Vezys, Vaiva; Casey, Kerry A.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Vezys, Vaiva; Lanier, Gibson; Ahmed, Rafi; Masopust, David] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Yates, Andrew; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; Emory University	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Vezys, Vaiva/N-3144-2013; masopust, david/B-5027-2008; Casey, Kerry A/B-5274-2011; Casey, Kerry A/N-1456-2019	Casey, Kerry A/0000-0001-7194-8585; Vezys, Vaiva/0000-0002-2520-809X	University of Minnesota Medical School; NIH [AI30048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	University of Minnesota Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Jameson, E.J. Wherry and A. Haase for critical discussions and reading of the manuscript, and J. W. Yewdell for recombinant vaccinia virus. This research was supported by start-up funds from the University of Minnesota Medical School (V.V. and D.M.) and NIH grant AI30048 (R. Ahmed).	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 2002, MICROBES INFECT, V4, P539, DOI 10.1016/S1286-4579(02)01570-8; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; HUNTER RL, 1995, J IMMUNOL, V154, P1762; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jackola DR, 1998, MECH AGEING DEV, V105, P241, DOI 10.1016/S0047-6374(98)00089-X; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Sad S, 2003, CRIT REV IMMUNOL, V23, P129, DOI 10.1615/CritRevImmunol.v23.i12.70; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009	26	174	176	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					196	U90		10.1038/nature07486	http://dx.doi.org/10.1038/nature07486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19005468				2022-12-24	WOS:000262360200033
J	Lu, JH; Marnell, LL; Marjon, KD; Mold, C; Du Clos, TW; Sun, PD				Lu, Jinghua; Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.; Sun, Peter D.			Structural recognition and functional activation of Fc gamma R by innate pentraxins	NATURE			English	Article							C-REACTIVE PROTEIN; AMYLOID-P-COMPONENT; HUMAN MONOCYTES; CRYSTAL-STRUCTURE; RECEPTOR-II; SERUM; CELLS; RIIA; PHAGOCYTOSIS; EXPRESSION	Pentraxins are a family of ancient innate immune mediators conserved throughout evolution. The classical pentraxins include serum amyloid P component ( SAP) and C- reactive protein, which are two of the acute- phase proteins synthesized in response to infection(1,2). Both recognize microbial pathogens and activate the classical complement pathway through C1q ( refs 3 and 4). More recently, members of the pentraxin family were found to interact with cell- surface Fc gamma receptors (Fc gamma R) and activate leukocyte-mediated phagocytosis(5-8). Here we describe the structural mechanism for pentraxin's binding to Fc gamma R and its functional activation of Fc gamma R- mediated phagocytosis and cytokine secretion. The complex structure between human SAP and Fc gamma RIIa reveals a diagonally bound receptor on each SAP pentamer with both D1 and D2 domains of the receptor contacting the ridge helices from two SAP subunits. The 1: 1 stoichiometry between SAP and Fc gamma RIIa infers the requirement for multivalent pathogen binding for receptor aggregation. Mutational and binding studies show that pentraxins are diverse in their binding specificity for Fc gamma R isoforms but conserved in their recognition structure. The shared binding site for SAP and IgG results in competition for Fc gamma R binding and the inhibition of immune- complex- mediated phagocytosis by soluble pentraxins. These results establish antibody- like functions for pentraxins in the Fc gamma R pathway, suggest an evolutionary overlap between the innate and adaptive immune systems, and have new therapeutic implications for autoimmune diseases.	[Lu, Jinghua; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Vet Adm Med Ctr, Albuquerque, NM 87108 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sun, PD (corresponding author), NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	psun@nih.gov	lu, jinghua/G-5872-2012		US Department of Energy; Basic Energy Sciences; Office of Science [W-31-109-Eng-83]; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Veterans Affairs;  [RO1 AI28358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853, T32AI007538, R01AI028358] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Klinman, G. Cheng, P. W. Dempsey and S. Bolland for providing the bone marrow from the Myd88 2/2, RIP2 2/2 and wild- type C57BL/6 mice, respectively; M. Pancera and B. Dey for technical support in the isothermal titration calorimetry experiments; V. Deretic and S. Master for assistance with confocal microscopy; and B. Bottazzi for providing PTX-3. The X-ray SER-CAT beamlines (www.ser-cat.org/members.html) at the Advanced Photon Source is supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-83. This work was supported by intramural research funding from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by RO1 AI28358 and by the Department of Veterans Affairs.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLES VV, 1994, BLOOD, V84, P3483; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bodman-Smith KB, 2002, IMMUNOLOGY, V107, P252, DOI 10.1046/j.1365-2567.2002.01481.x; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARK MR, 1991, EUR J IMMUNOL, V21, P1911, DOI 10.1002/eji.1830210820; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUCLOS TW, 1989, J IMMUNOL, V143, P2553; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; MARNELL LL, 1995, J IMMUNOL, V155, P2185; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Mold C, 2002, J AUTOIMMUN, V19, P147, DOI 10.1006/jaut.2002.0615; Mold C, 2006, J IMMUNOL, V176, P7598, DOI 10.4049/jimmunol.176.12.7598; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 1999, BIOL CHEM, V380, P717, DOI 10.1515/BC.1999.090; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stein MP, 2000, J CLIN INVEST, V105, P369, DOI 10.1172/JCI7817; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Xia DY, 1997, P NATL ACAD SCI USA, V94, P2575, DOI 10.1073/pnas.94.6.2575; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	41	221	231	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					989	U86		10.1038/nature07468	http://dx.doi.org/10.1038/nature07468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011614	Green Accepted			2022-12-24	WOS:000261768300054
J	Brohawn, SG; Leksa, NC; Spear, ED; Rajashankar, KR; Schwartz, TU				Brohawn, Stephen G.; Leksa, Nina C.; Spear, Eric D.; Rajashankar, Kanagalaghatta R.; Schwartz, Thomas U.			Structural Evidence for Common Ancestry of the Nuclear Pore Complex and Vesicle Coats	SCIENCE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; CELL-CYCLE; NUCLEOPORINS; ORGANIZATION; FOLD; EVOLUTION; MEMBRANE; PROTEINS	Nuclear pore complexes ( NPCs) facilitate nucleocytoplasmic transport. These massive assemblies comprise an eightfold symmetric scaffold of architectural proteins and central- channel phenylalanine- glycine- repeat proteins forming the transport barrier. We determined the nucleoporin 85 (Nup85).Seh1 structure, a module in the heptameric Nup84 complex, at 3.5 angstroms resolution. Structural, biochemical, and genetic analyses position the Nup84 complex in two peripheral NPC rings. We establish a conserved tripartite element, the ancestral coatomer element ACE1, that reoccurs in several nucleoporins and vesicle coat proteins, providing structural evidence of coevolution from a common ancestor. We identified interactions that define the organization of the Nup84 complex on the basis of comparison with vesicle coats and confirmed the sites by mutagenesis. We propose that the NPC scaffold, like vesicle coats, is composed of polygons with vertices and edges forming a membrane- proximal lattice that provides docking sites for additional nucleoporins.	[Brohawn, Stephen G.; Leksa, Nina C.; Spear, Eric D.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Argonne National Laboratory	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Brohawn, Stephen/0000-0001-6768-3406	NIH [GM77537]; Pew Scholar Award; Koch Fellowship Award; Vertex Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537, P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; Koch Fellowship Award; Vertex Scholarship(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank staff at beamlines 24-ID-C/-E at Argonne National Laboratory and X6A at National Synchrotron Light Source for excellent assistance with data collection, R. Sauer and T. Baker for critically reading the manuscript, G. Wink for contributions, members of the Schwartz laboratory for discussions, and the Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (NSF-0070319 and NIH GM68762) for providing instrumentation. Supported by NIH grant GM77537 ( T. U. S.), a Pew Scholar Award ( T. U. S.), a Koch Fellowship Award ( S. G. B.), and a Vertex Scholarship ( S. G. B.). Coordinates and structure factors of the Nup85.Seh1 crystal structure have been deposited in the Protein Data Bank ( PDB) with accession code 3EWE.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drummond SP, 2006, CAN J PHYSIOL PHARM, V84, P423, DOI 10.1139/Y05-148; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	38	154	158	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1369	1373		10.1126/science.1165886	http://dx.doi.org/10.1126/science.1165886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	18974315	Green Accepted			2022-12-24	WOS:000261170600036
J	Shimada, A; Ueguchi-Tanaka, M; Nakatsu, T; Nakajima, M; Naoe, Y; Ohmiya, H; Kato, H; Matsuoka, M				Shimada, Asako; Ueguchi-Tanaka, Miyako; Nakatsu, Toru; Nakajima, Masatoshi; Naoe, Youichi; Ohmiya, Hiroko; Kato, Hiroaki; Matsuoka, Makoto			Structural basis for gibberellin recognition by its receptor GID1	NATURE			English	Article							HORMONE-SENSITIVE LIPASE; PROTEIN; MECHANISM	Gibberellins ( GAs) are phytohormones essential for many developmental processes in plants(1). A nuclear GA receptor, GIBBERELLIN INSENSITIVEDWARF1 ( GID1), has a primary structure similar to that of the hormone- sensitive lipases (HSLs)(2,3). Here we analyse the crystal structure of Oryza sativa GID1 (OsGID1) bound with GA(4) and GA(3) at 1.9 angstrom resolution. The overall structure of both complexes shows an alpha/beta-hydrolase fold similar to that of HSLs except for an amino- terminal lid. The GA- binding pocket corresponds to the substrate- binding site of HSLs. On the basis of the OsGID1 structure, we mutagenized important residues for GA binding and examined their binding activities. Almost all of them showed very little or no activity, confirming that the residues revealed by structural analysis are important for GA binding. The replacement of Ile 133 with Leu or Val - residues corresponding to those of the lycophyte Selaginella moellendorffii GID1s - caused an increase in the binding affinity for GA(34), a 2 beta-hydroxylated GA(4). These observations indicate that GID1 originated from HSL and was further modified to have higher affinity and more strict selectivity for bioactive GAs by adapting the amino acids involved in GA binding in the course of plant evolution.	[Nakatsu, Toru; Naoe, Youichi; Kato, Hiroaki] Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shimada, Asako; Ueguchi-Tanaka, Miyako; Ohmiya, Hiroko; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Nakatsu, Toru; Kato, Hiroaki] RIKEN, Harima Inst SPring 8, Mikazuki, Hyogo 6795148, Japan; [Nakajima, Masatoshi] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Kyoto University; Nagoya University; RIKEN; University of Tokyo	Kato, H (corresponding author), Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	katohiro@pharm.kyoto-u.ac.jp; makoto@nuagr1.agr.nagoya-u.ac.jp		Kato, Hiroaki/0000-0002-5993-4532; Nakatsu, Toru/0000-0002-9582-4023	Target Protein Research Program; Scientific Research; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Target Protein Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Kawamura, M. Hattori, Y. Yamamoto, K. Aya and T. Matsubara for technical assistance; R. L. Ordonio and M. Tanrikulu for editing of this manuscript; and T. Shimizu, RIKEN, and N. Shimizu, JASRI at SPring- 8, for assistance with data collection. This project was funded by the Target Protein Research Program (M.M. and H.K.), Scientific Research ( M.M., and M.U.-T.), and Special Coordination Funds for Promoting Science and Technology (H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by research fellowships from the Japan Society for the Promotion of Science (A.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Davies P.J., 2004, PLANT HORMONES BIOSY; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; HOLM C, 1994, FEBS LETT, V344, P234, DOI 10.1016/0014-5793(94)00403-X; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Itoh H, 2008, INT REV CEL MOL BIO, V268, P191, DOI 10.1016/S1937-6448(08)00806-X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; ROUSSEL A, 1991, SILICON GRAPHICS GEO, V81, P77; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	19	231	257	5	78	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					520	U44		10.1038/nature07546	http://dx.doi.org/10.1038/nature07546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037316				2022-12-24	WOS:000261170500042
J	Smukalla, S; Caldara, M; Pochet, N; Beauvais, A; Guadagnini, S; Yan, C; Vinces, MD; Jansen, A; Prevost, MC; Latge, JP; Fink, GR; Foster, KR; Verstrepen, KJ				Smukalla, Scott; Caldara, Marina; Pochet, Nathalie; Beauvais, Anne; Guadagnini, Stephanie; Yan, Chen; Vinces, Marcelo D.; Jansen, An; Prevost, Marie Christine; Latge, Jean-Paul; Fink, Gerald R.; Foster, Kevin R.; Verstrepen, Kevin J.			FLO1 Is a Variable Green Beard Gene that Drives Biofilm-like Cooperation in Budding Yeast	CELL			English	Article							CANDIDA; EXPRESSION; RESISTANCE; EVOLUTION; GROWTH	The budding yeast, Saccharomyces cerevisiae, has emerged as an archetype of eukaryotic cell biology. Here we show that S. cerevisiae is also a model for the evolution of cooperative behavior by revisiting flocculation, a self-adherence phenotype lacking in most laboratory strains. Expression of the gene FLO1 in the laboratory strain S288C restores flocculation, an altered physiological state, reminiscent of bacterial biofilms. Flocculation protects the FLO1 expressing cells from multiple stresses, including antimicrobials and ethanol. Furthermore, FLO1(+) cells avoid exploitation by nonexpressing flo1 cells by self/non-self recognition: FLO1(+) cells preferentially stick to one another, regardless of genetic relatedness across the rest of the genome. Flocculation, therefore, is driven by one of a few known "green beard genes,'' which direct cooperation toward other carriers of the same gene. Moreover, FLO1 is highly variable among strains both in expression and in sequence, suggesting that flocculation in S. cerevisiae is a dynamic, rapidly evolving social trait.	[Smukalla, Scott; Caldara, Marina; Pochet, Nathalie; Yan, Chen; Vinces, Marcelo D.; Foster, Kevin R.; Verstrepen, Kevin J.] Harvard Univ, FAS Ctr Syst Biol, Northwest Lab, Cambridge, MA 02138 USA; [Pochet, Nathalie] Univ Ghent, Bioinformat & Evolutionary Genom Grp, B-9052 Ghent, Belgium; [Pochet, Nathalie] Univ Ghent, Quantiat Genom Grp, Dept Plant Syst Biol, Flanders Inst Biotechnol VIB, B-9052 Ghent, Belgium; [Pochet, Nathalie] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Beauvais, Anne; Latge, Jean-Paul] Inst Pasteur, Aspergillus Unit, F-75724 Paris, France; [Guadagnini, Stephanie; Prevost, Marie Christine] Inst Pasteur, Elect Microscopy Platform, F-75724 Paris, France; [Jansen, An; Fink, Gerald R.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Jansen, An; Verstrepen, Kevin J.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Mol & Microbial Syst, B-3001 Heverlee, Belgium; [Verstrepen, Kevin J.] Katholieke Univ Leuven, Lab Syst Biol, Flanders Inst Biotechnol VIB, B-3001 Heverlee, Belgium	Harvard University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Massachusetts Institute of Technology (MIT); Whitehead Institute; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Verstrepen, KJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Northwest Lab, 52 Oxford St, Cambridge, MA 02138 USA.	kevin.verstrepen@biw.kuleuven.be	Jansen, An/T-9228-2018; Latge, Jean Paul/C-9846-2014; Beauvais, Anne/A-6358-2012; Pochet, Nathalie/Q-1322-2017; Verstrepen, Kevin/AAA-4343-2021	Jansen, An/0000-0003-2412-0456; Pochet, Nathalie/0000-0003-1820-5656; Yan, Chen/0000-0002-3266-0578; Foster, Kevin/0000-0003-4687-6633; Smukalla, Scott/0000-0002-8260-5606; Verstrepen, Kevin/0000-0002-3077-6219	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM040266] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40266, 5P50GM068763, P50 GM068763, R01 GM040266, P50 GM068763-01, P50 GM068763-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Arthington-Skaggs BA, 2002, ANTIMICROB AGENTS CH, V46, P2477, DOI 10.1128/AAC.46.8.2477-2481.2002; Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; D'Hautcourt O, 1999, J AM SOC BREW CHEM, V57, P123; Dawkins R, 1976, SELFISH GENE; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Foster KR, 2001, ANN ZOOL FENN, V38, P229; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GIMENO CJ, 1993, DIMORPHIC FUNGI BIOL; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Kobayashi O, 1998, J BACTERIOL, V180, P6503, DOI 10.1128/JB.180.24.6503-6510.1998; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; MORTIMER RK, 1986, GENETICS, V113, P35; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; SHERMAN F, 1991, METHODS YEAST GENETI; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson DA, 2006, CURR BIOL, V16, P1581, DOI 10.1016/j.cub.2006.06.070; TREJO WH, 1963, J BACTERIOL, V85, P436, DOI 10.1128/JB.85.2.436-439.1963; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	36	302	311	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					726	737		10.1016/j.cell.2008.09.037	http://dx.doi.org/10.1016/j.cell.2008.09.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013280	Green Accepted, Bronze			2022-12-24	WOS:000260886900022
J	Cameron, A; Ewen, M; Ross-Degnan, D; Ball, D; Laing, R				Cameron, A.; Ewen, M.; Ross-Degnan, D.; Ball, D.; Laing, R.			Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis	LANCET			English	Article							DRUGS	Background WHO and Health Action International (HAI) have developed a standardised method for surveying medicine prices, availability, affordability, and price components in low-income and middle-income countries. Here, we present a secondary analysis of medicine availability in 45 national and subnational surveys done using the WHO/HAI methodology. Methods Data from 45 WHO/HAI surveys in 36 countries were adjusted for inflation or deflation and purchasing power parity. international reference prices from open international procurements for generic products were used as comparators. Results are presented for 15 medicines included in at least 80% of surveys and four individual medicines. Findings Average public sector availability of generic medicines ranged from 29.4% to 54.4% across WHO regions. Median government procurement prices for 15 generic medicines were 1.11 times corresponding international reference prices, although purchasing efficiency ranged from 0 . 09 to 5 . 37 times international reference prices. Low procurement prices did not always translate into low patient prices. Private sector patients paid 9-25 times international reference prices for lowest-priced generic products and over 20 times international reference prices for originator products across WHO regions. Treatments for acute and chronic illness were largely unaffordable in many countries. In the private sector, wholesale mark-ups ranged from 2% to 380%, whereas retail mark-ups ranged from 10% to 552%. In countries where value added tax was applied to medicines, the amount charged varied from 4% to 15%. Interpretation Overall, public and private sector prices for originator and generic medicines were substantially higher than would be expected if purchasing and distribution were efficient and mark-ups were reasonable. Policy options such as promoting generic medicines and alternative financing mechanisms are needed to increase availability reduce prices, and improve affordability. Funding None.	[Cameron, A.; Laing, R.] WHO, CH-1211 Geneva 27, Switzerland; [Ewen, M.] Hlth Act Int, Amsterdam, Netherlands; [Ross-Degnan, D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ross-Degnan, D.] Harvard Pilgrim Hlth Care, Boston, MA USA	World Health Organization; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Cameron, A (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	camerona@who.int			Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development; Open Society Institute; Finnish International Development Agency	Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development(European Commission); Open Society Institute; Finnish International Development Agency	We thank Jean-Marc Guimier, Edson Meza, and Peter Stephens for providing information and data used in the paper, and Kirsten Myhr for providing input into an early draft. We also thank the country teams who undertook surveys of medicine prices and availability, as well as the consultants who provided technical support for data collection, analysis, and interpretation. We also appreciate the support of the WHO Regional Office for Africa and the WHO Department of Technical Cooperation for Essential Drugs and Traditional Medicine for surveys done in Africa. Financial support for the WHO/HAI Project on Medicine Prices and Availability has been provided by: Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development; Open Society Institute; and Finnish International Development Agency.	ANDERSSON F, 1993, PHARMACOECONOMICS, V4, P247, DOI 10.2165/00019053-199304040-00003; [Anonymous], INT DRUG PRIC IND GU; [Anonymous], 2004, WORLD MED SIT; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; BALA K, 1998, HAINEWS          APR, V100, P2; BALA K, 1998, HAINEWS          APR, V100, P13; BALA K, 2000, HAINEWS          APR, V112, P1; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Danzon PM, 1998, PHARMACOECONOMICS, V14, P115, DOI 10.2165/00019053-199814001-00014; Gelders S., 2006, PRICE AVAILABILITY A; *HLTH ACT INT, 2007, HLTH ACT INT MED PRI; *HLTH ACT INT, 2006, COMP PRIC DAT DIFF S; *INT FED PHARM MAN, ACC ACC IN AAI; International Monetary Fund, 2007, WORLD EC OUTL DAT; Laing R., 2005, PHARM TARIFFS WHAT I; MADDEN J, 2003, ESSENTIAL DRUGS MONI, V33, P19; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; MYHR K, COMP PRICES ESSENTIA; *NOV, COART AFR GAIN MOM G; *NOV NORD, SUST REP 2003 WHAT D; Organisation for Economic Co-operation and Development, DRUG SPEND OECD COUN; Ridley DB, 2005, PHARMACOECONOMICS, V23, P651, DOI 10.2165/00019053-200523070-00002; SAGOO K, 2000, HAINEWS          DEC, V110, P1; Vasan A, 2006, B WORLD HEALTH ORGAN, V84, P393, DOI 10.2471/BLT.05.025684; *WHO, 1997, PUBL PRIV ROL PHARM; *WHO, 2001, 54 WORLD HLTH ASS GE, V1; *WHO, 2007, REP REG COMM E MED 5; WHO, 2004, WORLD HLTH REP 2004, P126; *WHO HLTH ACT INT, 2003, MED PRIC NE IN PRESS; *WHO HLTH ACT INT, 2008, SYR AR REP MED PRIC; *WORLD BANK, 2007, COUNTR CLASS; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization and Health Action International, MEAS MED PRIC AV AFF	33	489	505	6	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					240	249		10.1016/S0140-6736(08)61762-6	http://dx.doi.org/10.1016/S0140-6736(08)61762-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19042012				2022-12-24	WOS:000262537500027
J	Boztug, K; Appaswamy, G; Ashikov, A; Schaffer, AA; Salzer, U; Diestelhorst, J; Germeshausen, M; Brandes, G; Lee-Gossler, J; Noyan, F; Gatzke, AK; Minkov, M; Greil, J; Kratz, C; Petropoulou, T; Pellier, I; Bellanne-Chantelot, C; Rezaei, N; Monkemoller, K; Irani-Hakimeh, N; Bakker, H; Gerardy-Schahn, R; Zeidler, C; Grimbacher, B; Welte, K; Klein, C				Boztug, Kaan; Appaswamy, Giridharan; Ashikov, Angel; Schaffer, Alejandro A.; Salzer, Ulrich; Diestelhorst, Jana; Germeshausen, Manuela; Brandes, Gudrun; Lee-Gossler, Jacqueline; Noyan, Fatih; Gatzke, Anna-Katherina; Minkov, Milen; Greil, Johann; Kratz, Christian; Petropoulou, Theoni; Pellier, Isabelle; Bellanne-Chantelot, Christine; Rezaei, Nima; Moenkemoeller, Kirsten; Irani-Hakimeh, Noha; Bakker, Hans; Gerardy-Schahn, Rita; Zeidler, Cornelia; Grimbacher, Bodo; Welte, Karl; Klein, Christoph			A Syndrome with Congenital Neutropenia and Mutations in G6PC3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-STORAGE-DISEASE; SUBUNIT-RELATED PROTEIN; GLUCOSE-LEVELS; GENE; ELASTASE; APOPTOSIS; MCL-1; IDENTIFICATION; DEFICIENCY	Background The main features of severe congenital neutropenia are the onset of severe bacterial infections early in life, a paucity of mature neutrophils, and an increased risk of leukemia. In many patients, the genetic causes of severe congenital neutropenia are unknown. Methods We performed genomewide genotyping and linkage analysis on two consanguineous pedigrees with a total of five children affected with severe congenital neutropenia. Candidate genes from the linkage interval were sequenced. Functional assays and reconstitution experiments were carried out. Results All index patients were susceptible to bacterial infections and had very few mature neutrophils in the bone marrow; structural heart defects, urogenital abnormalities, and venous angiectasia on the trunk and extremities were additional features. Linkage analysis of the two index families yielded a combined multipoint lod score of 5.74 on a linkage interval on chromosome 17q21. Sequencing of G6PC3, the candidate gene encoding glucose- 6- phosphatase, catalytic subunit 3, revealed a homozygous missense mutation in exon 6 that abolished the enzymatic activity of glucose- 6- phosphatase in all affected children in the two families. The patients' neutrophils and fibroblasts had increased susceptibility to apoptosis. The myeloid cells showed evidence of increased endoplasmic reticulum stress and increased activity of glycogen synthase kinase 3 beta (GSK-3 beta). We identified seven additional, unrelated patients who had severe congenital neutropenia with syndromic features and distinct biallelic mutations in G6PC3. Conclusions Defective function of glucose- 6- phosphatase, catalytic subunit 3, underlies a severe congenital neutropenia syndrome associated with cardiac and urogenital malformations.	[Boztug, Kaan; Appaswamy, Giridharan; Ashikov, Angel; Diestelhorst, Jana; Germeshausen, Manuela; Brandes, Gudrun; Lee-Gossler, Jacqueline; Noyan, Fatih; Gatzke, Anna-Katherina; Bakker, Hans; Gerardy-Schahn, Rita; Zeidler, Cornelia; Welte, Karl; Klein, Christoph] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Schaffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Salzer, Ulrich] Univ Med Ctr Freiburg, Freiburg, Germany; [Minkov, Milen] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Greil, Johann] Univ Heidelberg, Childrens Hosp, D-6900 Heidelberg, Germany; [Kratz, Christian] Univ Freiburg, Freiburg, Germany; [Petropoulou, Theoni] Univ Athens, Aghia Sophia Childrens Hosp, Athens, Greece; [Pellier, Isabelle] CHU Angers, Angers, France; [Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Paris, France; [Rezaei, Nima] Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; [Moenkemoeller, Kirsten] Childrens Hosp Amsterdamer Str, Cologne, Germany; [Irani-Hakimeh, Noha] St Georges Univ Hosp, Beirut, Lebanon; [Grimbacher, Bodo] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England	Hannover Medical School; National Institutes of Health (NIH) - USA; University of Freiburg; Saint Anna Children's Hospital; Ruprecht Karls University Heidelberg; University of Freiburg; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences; University of Cologne; University of London; University College London	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Kratz, Christian/AAC-9726-2021; Ashikov, Angel/N-7714-2015; Boztug, Kaan/AAM-4161-2021; Noyan, Fatih/B-9449-2018; Rezaei, Nima/B-4245-2008; Schaffer, Alejandro A/F-2902-2012; Bakker, Hans/A-1787-2017; Schaffer, Alejandro/N-1222-2019; Bakker, Hans/AAA-1623-2020; isabelle, pellier/L-5683-2015	Ashikov, Angel/0000-0001-9679-7955; Boztug, Kaan/0000-0001-8387-9185; Rezaei, Nima/0000-0002-3836-1827; Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154; Minkov, Milen/0000-0001-6471-8423; Salzer, Ulrich/0000-0002-1769-1157	Deutsche Forschungsgemeinschaft [KliFo 110-2]; Junior Research Group "Glycomics"; Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes; European Union [MEXT-CT-2006-042316]; Intramural Research Program of the National Institutes of Health; National Library of Medicine; Else Kroner Memorial Fellowship; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Junior Research Group "Glycomics"; Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Else Kroner Memorial Fellowship; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by grants from the Deutsche Forschungsgemeinschaft (DFG KliFo 110-2, to Dr. Klein), the Junior Research Group "Glycomics" (to Dr. Gerardy-Schahn), the Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes (to Drs. Welte and Klein), and the European Union (MEXT-CT-2006-042316, to Dr. Grimbacher); and by the Intramural Research Program of the National Institutes of Health, National Library of Medicine (for Dr. Schaffer). Dr. Boztug is a recipient of an Else Kroner Memorial Fellowship. Drs. Klein and Gerardy-Schahn are members of REBIRTH, a Deutsche Forschungsgemeinschaft Cluster of Excellence.; Dr. Welte reports owning equity in Amgen and receiving royalties on a patent for rhG-CSF. No other potential conflict of interest relevant to this article was reported.; We thank the patients and their families for supporting our study; all colleagues referring and registering patients at the Severe Chronic Neutropenia International Registry; Francois-Loic Cosset for the kind gift of the RD114 plasmid; Edelgard Odenwald for analysis of bone marrow smears; Thomas Jack for his help with echocardiography; Jessica Pfannstiel, Maren Sievers, Marie Bohm, Marly Dalton, Martina Wackerhahn, Tanja Reinke, and Gwendoline Leroy for technical assistance; and Dr. Jean Donadieu at the Pediatric Hematology Oncology Service, Hopital Trousseau, Paris, and Dr. Roula Farah at the Department of Pediatrics, Saint Georges Hospital, Balamand University, Beirut, Lebanon, for excellent collaboration.	Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; BEAUDET AL, 1980, J PEDIATR-US, V97, P906, DOI 10.1016/S0022-3476(80)80418-5; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Boxer LA, 2007, PEDIATR BLOOD CANCER, V49, P609, DOI 10.1002/pbc.21282; Boztug K, 2008, IMMUNOL ALLERGY CLIN, V28, P259, DOI 10.1016/j.iac.2008.01.007; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Guionie O, 2003, FEBS LETT, V551, P159, DOI 10.1016/S0014-5793(03)00903-7; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Kostmann R., 1950, SVEN KARTDIN, V47, P2861; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Melis D, 2005, EUR J PEDIATR, V164, P501, DOI 10.1007/s00431-005-1657-4; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Wang YD, 2006, J BIOL CHEM, V281, P39982, DOI 10.1074/jbc.M605858200; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	47	248	251	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					32	43		10.1056/NEJMoa0805051	http://dx.doi.org/10.1056/NEJMoa0805051			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118303	Green Accepted, Bronze			2022-12-24	WOS:000262096800005
J	Stotland, NE				Stotland, Naomi E.			Obesity and pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; CESAREAN DELIVERY; MATERNAL OBESITY; BARIATRIC SURGERY; VAGINAL BIRTH; FETAL; OUTCOMES; WOMEN; VISUALIZATION		[Stotland, Naomi E.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Stotland, NE (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 1001 Potrero Ave 6D-1, San Francisco, CA 94110 USA.	stotlandn@obgyn.ucsf.edu						Abodeely A, 2008, SURG OBES RELAT DIS, V4, P464, DOI 10.1016/j.soard.2007.08.018; American College of Obstetricians and Gynecologists (ACOG), 2005, OBSTET GYNECOL, V106, P671, DOI [10.1097/00006250-200509000-00054, DOI 10.1097/00006250-200509000-00054]; Artal R, 2007, APPL PHYSIOL NUTR ME, V32, P596, DOI 10.1139/H07-024; Boulvain M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000451.pub2; Carroll CS, 2003, AM J OBSTET GYNECOL, V188, P1516, DOI 10.1067/mob.2003.472; Catalano PM, 2007, OBSTET GYNECOL, V109, P419, DOI 10.1097/01.AOG.0000253311.44696.85; Chelmow D, 2004, OBSTET GYNECOL, V103, P974, DOI 10.1097/01.AOG.0000124807.76451.47; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a; Durnwald CP, 2004, AM J OBSTET GYNECOL, V191, P954, DOI 10.1016/j.ajog.2004.05.051; Goffman D, 2007, J PERINATOL, V27, P597, DOI 10.1038/sj.jp.7211810; Grimes DA, 2005, CONTRACEPTION, V72, P1, DOI 10.1016/j.contraception.2005.04.002; Gunderson EP, 2001, INT J OBESITY, V25, P853, DOI 10.1038/sj.ijo.0801631; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hendler I, 2005, J ULTRAS MED, V24, P1205, DOI 10.7863/jum.2005.24.9.1205; Hendler I, 2004, AM J OBSTET GYNECOL, V190, P1616, DOI 10.1016/j.ajog.2004.03.064; Hendler I, 2004, INT J OBESITY, V28, P1607, DOI 10.1038/sj.ijo.0802759; Huber LRB, 2007, AM J EPIDEMIOL, V166, P1306, DOI 10.1093/aje/kwm221; Huber LRB, 2005, MATERN CHILD HLTH J, V9, P413, DOI 10.1007/s10995-005-0015-5; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Oddy WH, 2006, J PEDIATR-US, V149, P185, DOI 10.1016/j.jpeds.2006.04.005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Smaill Fiona M, 2019, Cochrane Database Syst Rev, V2019, DOI 10.1002/14651858.CD000490.pub4; Soens MA, 2008, ACTA ANAESTH SCAND, V52, P6, DOI 10.1111/j.1399-6576.2007.01483.x; Stotland NE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.048; Stotland NE, 2005, OBSTET GYNECOL, V105, P633, DOI 10.1097/01.AOG.0000152349.84025.35; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Wax JR, 2007, OBSTET GYNECOL SURV, V62, P595, DOI 10.1097/01.ogx.0000279291.86611.46; Wing RR, 2003, PRIMARY CARE, V30, P375, DOI 10.1016/S0095-4543(03)00009-5; World Health Organization, 2021, OB OV FACT SHEETS	32	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2008	337								a2450	10.1136/bmj.a2450	http://dx.doi.org/10.1136/bmj.a2450			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SS	19074938				2022-12-24	WOS:000262184600004
J	Kwiatkowski, D				Kwiatkowski, Dominic		Malaria Genomic Epidemiology	A global network for investigating the genomic epidemiology of malaria	NATURE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; WIDE ASSOCIATION; INSECTICIDE RESISTANCE; GENETIC-ASSOCIATION; ANOPHELES-GAMBIAE; AFRICAN CHILDREN; SEQUENCE; COLLABORATION; POPULATION; DIVERSITY	Large-scale studies of genomic variation could assist efforts to eliminate malaria. But there are scientific, ethical and practical challenges to carrying out such studies in developing countries, where the burden of disease is greatest. The Malaria Genomic Epidemiology Network (MalariaGEN) is now working to overcome these obstacles, using a consortial approach that brings together researchers from 21 countries.				dominic@sanger.ac.uk	Makani, Julie/E-8525-2017; Deloukas, Panos/B-2922-2013; mangano, valentina/I-2456-2012; Mead, Daniel/AAE-6629-2019; Dunstan, Sarah/AAO-9597-2020; Clark, Taane G./AAM-2570-2020; Makani, Julie/N-9370-2013; Troye-Blomberg, Marita/B-9210-2016	Makani, Julie/0000-0002-4801-6250; Deloukas, Panos/0000-0001-9251-070X; Mead, Daniel/0000-0001-7717-4330; Clark, Taane G./0000-0001-8985-9265; Makani, Julie/0000-0002-4801-6250; Troye-Blomberg, Marita/0000-0002-2804-0325; Kwiatkowski, Dominic/0000-0002-5023-0176; Small, Kerrin/0000-0003-4566-0005; Mangano, Valentina D/0000-0002-2021-6162; Lin, Enmoore/0000-0002-8584-7627; Thera, Mahamadou A/0000-0002-2679-035X; Manske, Magnus/0000-0001-5916-0947; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Ishengoma, Deus/0000-0003-2040-3416; Bull, Susan/0000-0002-9730-091X; Oluoch, Tom/0000-0001-9621-5900; Farrar, Jeremy/0000-0002-2700-623X; Reeder, John/0000-0003-1395-1289; Ragoussis, Ioannis/0000-0002-8515-0934; Apinjoh, Tobias/0000-0001-9889-7271; Allen, Stephen/0000-0001-6675-249X; Dunstan, Sarah/0000-0001-7873-933X; Singhasivanon, Pratap/0000-0002-9759-1702; Conway, David/0000-0002-8711-3037; Hart, Lee/0000-0002-6473-0964; Karunaweera, Nadira/0000-0003-3985-1817; Amodu, Olukemi/0000-0003-1477-4229; Kivinen, Katja/0000-0002-1135-7625; Moyes, Catherine/0000-0002-8028-4079; Bojang, Kalifa/0000-0001-7506-0938; Maslen, Gareth/0000-0001-7318-3678	Medical Research Council [G19/9, G0600718, G0600230(77610), G0200454, G0200454(62635), G0600230] Funding Source: Medline; Wellcome Trust [077383/Z/05/Z, 076934, 077383] Funding Source: Medline; MRC [G19/9, G0200454, G0600718, G0600230] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chokshi DA, 2005, GENOMICS SOC POLICY, V1, P1; Chokshi DA, 2007, PLOS MED, V4, P636, DOI 10.1371/journal.pmed.0040095; Chokshi DA, 2006, B WORLD HEALTH ORGAN, V84, P382, DOI 10.2471/BLT.06.029843; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Teo YY, 2008, NAT METHODS, V5, P279, DOI 10.1038/nmeth0408-279; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	34	112	115	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					732	U39		10.1038/nature07632	http://dx.doi.org/10.1038/nature07632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TX	19079050	Green Accepted, Bronze			2022-12-24	WOS:000261559900037
J	Gardner, MK; Bouck, DC; Paliulis, LV; Meehl, JB; O'Toole, ET; Haase, J; Soubry, A; Joglekar, AP; Winey, M; Salmon, ED; Bloom, K; Odde, DJ				Gardner, Melissa K.; Bouck, David C.; Paliulis, Leocadia V.; Meehl, Janet B.; O'Toole, Eileen T.; Haase, Julian; Soubry, Adelheid; Joglekar, Ajit P.; Winey, Mark; Salmon, Edward D.; Bloom, Kerry; Odde, David J.			Chromosome Congression by Kinesin-5 Motor-Mediated Disassembly of Longer Kinetochore Microtubules	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; NUCLEAR MIGRATION; YEAST; DYNAMICS; PROTEINS; ORIENTATION; REQUIRES; MITOSIS; KIF18A	During mitosis, sister chromatids congress to the spindle equator and are subsequently segregated via attachment to dynamic kinetochore microtubule (kMT) plus ends. A major question is how kMT plus-end assembly is spatially regulated to achieve chromosome congression. Here we find in budding yeast that the widely conserved kinesin-5 sliding motor proteins, Cin8p and Kip1p, mediate chromosome congression by suppressing kMT plus-end assembly of longer kMTs. Of the two, Cin8p is the major effector and its activity requires a functional motor domain. In contrast, the depolymerizing kinesin-8 motor Kip3p plays a minor role in spatial regulation of yeast kMT assembly. Our analysis identified a model where kinesin-5 motors bind to kMTs, move to kMT plus ends, and upon arrival at a growing plus end promote net kMT plus-end disassembly. In conclusion, we find that length-dependent control of net kMT assembly by kinesin-5 motors yields a simple and stable self-organizing mechanism for chromosome congression.	[Gardner, Melissa K.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Bouck, David C.; Paliulis, Leocadia V.; Haase, Julian; Soubry, Adelheid; Joglekar, Ajit P.; Salmon, Edward D.; Bloom, Kerry] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Meehl, Janet B.; O'Toole, Eileen T.; Winey, Mark] Univ Colorado, MCD Biol, Boulder, CO 80301 USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020; Odde, David/H-4925-2011; Bloom, Kerry/AAE-5336-2019	Odde, David/0000-0001-7731-2799; Bloom, Kerry/0000-0002-3457-004X; Joglekar, Ajit/0000-0002-0607-5332; Bouck, David/0000-0002-6281-2544; Haase, Julian/0000-0001-5891-4241	NIH [GM071522, GM32238]; NIH NRSA [EB005568]; SPIRE [GM00678]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB005568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364, K12GM000678, R37GM032238, R01GM071522, R01GM032238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPIRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dominique Seetapun for providing matlab kymograph code, Drs. Tom Hays and Leah Gheber for helpful discussions, Dr. Jeff Molk for comments on the manuscript, and Marybeth Anderson for assistance with bim1 Delta images. Plasmids and strains were kindly provided by Drs. S. Reed, B. Errede, M. A. Hoyt, L. Gheber, and D. Pellman. This work was supported by NIH grant GM071522 to D. J. O. K. B. is supported by NIH grant GM32238 and M. K. G. is supported by NIH NRSA grant EB005568. E. T. O. is supported in part by grant RR-00592 from the National Center for Research Resources of the NIH to A. Hoenger. L. V. P. is supported by a SPIRE fellowship (GM00678).	Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; de Gramont A, 2007, CELL CYCLE, V6, P1231, DOI 10.4161/cc.6.10.4181; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gardner MK, 2007, METHODS, V41, P232, DOI 10.1016/j.ymeth.2006.08.002; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Huang BY, 2006, J CELL BIOL, V175, P17, DOI 10.1083/jcb.200606021; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; O'Toole ET, 2002, METHOD ENZYMOL, V351, P81; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	43	131	131	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					894	906		10.1016/j.cell.2008.09.046	http://dx.doi.org/10.1016/j.cell.2008.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041752	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000261183900020
J	Creager, ANH				Creager, Angela N. H.			Atomic transfiguration	LANCET			English	Editorial Material									[Creager, Angela N. H.] Princeton Univ, Dept Hist, Princeton, NJ 08544 USA; [Creager, Angela N. H.] Princeton Univ, Program Hist Sci, Princeton, NJ 08544 USA	Princeton University; Princeton University	Creager, ANH (corresponding author), Princeton Univ, Dept Hist, Princeton, NJ 08544 USA.	creager@princeton.edu		Creager, Angela/0000-0002-7763-6432	NLM NIH HHS [5G13LM009100-2, G13 LM009100-02, G13 LM009100] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [G13LM009100] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Creager ANH, 2006, J HIST BIOL, V39, P649, DOI 10.1007/s10739-006-9108-2; Heilbron J., 1989, LAWRENCE HIS LAB HIS, DOI DOI 10.1525/9780520341081; Rentetzi M, 2007, TRAFFICKING MAT GEND; Walker J. Samuel, 2000, PERMISSIBLE DOSE HIS; Welsome Eileen, 1999, PLUTONIUM FILES AM S	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1726	1727		10.1016/S0140-6736(08)61721-3	http://dx.doi.org/10.1016/S0140-6736(08)61721-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19018613	Green Accepted			2022-12-24	WOS:000261077900013
J	Takahashi, JS; Shimomura, K; Kumar, V				Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek			Searching for Genes Underlying Behavior: Lessons from Circadian Rhythms	SCIENCE			English	Editorial Material							DROSOPHILA PERIOD GENE; INDIVIDUAL FIBROBLASTS; PHENOTYPIC VARIATION; REVEALS PERSISTENT; CLOCK GENE; MOUSE; MICE; MUTAGENESIS; EXPRESSION; CLONING	The success of forward genetic ( from phenotype to gene) approaches to uncover genes that drive the molecular mechanism of circadian clocks and control circadian behavior has been unprecedented. Links among genes, cells, neural circuits, and circadian behavior have been uncovered in the Drosophila and mammalian systems, demonstrating the feasibility of finding single genes that have major effects on behavior. Why was this approach so successful in the elucidation of circadian rhythms? This article explores the answers to this question and describes how the methods used successfully for identifying the molecular basis of circadian rhythms can be applied to other behaviors such as anxiety, addiction, and learning and memory.	[Takahashi, Joseph S.; Kumar, Vivek] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Northwestern University	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078024, P50MH074924, U01MH061915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [F32 DA024556] Funding Source: Medline; NIMH NIH HHS [R01 MH078024, P50 MH074924, U01 MH61915, U01 MH061915] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kile BT, 2005, NAT REV GENET, V6, P557, DOI 10.1038/nrg1636; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Matynia A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002121; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P971, DOI 10.1152/jn.2000.83.2.971; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Strunk KE, 2004, GENETICS, V167, P1821, DOI 10.1534/genetics.103.020495; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thomsen M, 2007, BEHAV GENET, V37, P101, DOI 10.1007/s10519-006-9097-0; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	43	70	72	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					909	912		10.1126/science.1158822	http://dx.doi.org/10.1126/science.1158822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988844	Green Accepted			2022-12-24	WOS:000260674100037
J	McCauley, E; Nelson, WA; Nisbet, RM				McCauley, Edward; Nelson, William A.; Nisbet, Roger M.			Small-amplitude cycles emerge from stage-structured interactions in Daphnia-algal systems	NATURE			English	Article							PREY; POPULATION; DYNAMICS; MODEL; ENVIRONMENTS; ZOOPLANKTON; MECHANISMS; PLANKTON	A long-standing issue in ecology is reconciling the apparent stability of many populations with robust predictions of large-amplitude population cycles from general theory on consumer resource interactions(1). Even when consumers are decoupled from dynamic resources, large- amplitude cycles can theoretically emerge from delayed feedback processes found in many consumers(2,3). Here we show that resource- dependent mortality and a dynamic developmental delay in consumers produces a new type of small- amplitude cycle that coexists with large- amplitude fluctuations in coupled consumer - resource systems. A distinctive characteristic of the small- amplitude cycles is slow juvenile development for consumers, leading to a developmental delay that is longer than the cycle period. By contrast, the period exceeds the delay in large-amplitude cycles. These theoretical predictions may explain previous empirical results on coexisting attractors found in Daphnia algal systems(4,5). To test this, we used bioassay experiments that measure the growth rates of individuals in populations exhibiting each type of cycle. The results were consistent with predictions. Together, the new theory and experiments establish that two very general features of consumers - a resource- dependent juvenile stage duration and resource- dependent mortality - combine to produce small- amplitude resource - consumer cycles. This phenomenon may contribute to the prevalence of small- amplitude fluctuations in many other consumer - resource populations(6,7).	[McCauley, Edward] Univ Calgary, Dept Biol Sci, Ecol & Evolut Grp, Calgary, AB T2N 1N4, Canada; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of Calgary; Queens University - Canada; University of California System; University of California Santa Barbara	McCauley, E (corresponding author), Univ Calgary, Dept Biol Sci, Ecol & Evolut Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	mccauley@ucalgary.ca	Nelson, William A/D-1405-2013; Nisbet, Roger M/B-6951-2014		NSERC ( Discovery Grants and Accelerator Award); Canada Foundation for Innovation; Canada Research Chairs Program; Alberta Ingenuity; US National Science Foundation [DEB- 0717259]	NSERC ( Discovery Grants and Accelerator Award)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Alberta Ingenuity; US National Science Foundation(National Science Foundation (NSF))	We acknowledge feedback from A. de Roos, J. Fox, J. Casas, L. Persson and C. Briggs. A. Potapov provided advice on the bifurcation analysis. Experiments and theoretical analysis were supported by NSERC (Discovery Grants and Accelerator Award), Canada Foundation for Innovation, and the Canada Research Chairs Program to E. M. W. A. N. acknowledges support from Alberta Ingenuity. R. M. N. acknowledges support from the US National Science Foundation (Grant DEB- 0717259).	Abrams PA, 2002, THEOR POPUL BIOL, V62, P281, DOI 10.1006/tpbi.2002.1614; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; DEROOS AM, 1990, J MATH BIOL, V28, P609, DOI 10.1007/BF00160229; GROVER JP, 1994, AM NAT, V143, P258, DOI 10.1086/285603; HASTINGS A, 1982, THEOR POPUL BIOL, V21, P44, DOI 10.1016/0040-5809(82)90005-3; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; KRETZSCHMAR M, 1993, THEOR POPUL BIOL, V44, P32, DOI 10.1006/tpbi.1993.1017; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; MCCAULEY E, 1990, NATURE, V343, P455, DOI 10.1038/343455a0; Medvinsky AB, 2004, CR BIOL, V327, P277, DOI 10.1016/j.crvi.2003.11.013; Murdoch W.W., 2003, CONSUMER RESOURCE DY; MURDOCH WW, 1985, NATURE, V316, P628, DOI 10.1038/316628a0; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; Nelson WA, 2007, EVOL ECOL, V21, P499, DOI 10.1007/s10682-006-9131-y; Nisbet RM, 2004, ECOLOGY, V85, P3132, DOI 10.1890/03-0429; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	24	59	61	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1240	1243		10.1038/nature07220	http://dx.doi.org/10.1038/nature07220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972019				2022-12-24	WOS:000260462100044
J	Scott, FL; Stec, B; Pop, C; Dobaczewska, MK; Lee, JJ; Monosov, E; Robinson, H; Salvesen, GS; Schwarzenbacher, R; Riedl, SJ				Scott, Fiona L.; Stec, Boguslaw; Pop, Cristina; Dobaczewska, Malgorzata K.; Lee, JeongEun J.; Monosov, Edward; Robinson, Howard; Salvesen, Guy S.; Schwarzenbacher, Robert; Riedl, Stefan J.			The Fas-FADD death domain complex structure unravels signalling by receptor clustering	NATURE			English	Article							CELL-DEATH; MUTATIONAL ANALYSIS; APOPTOSIS; CD95; ARCHITECTURE; INFLAMMATION; INTERFACES; SPOTS	The death inducing signalling complex ( DISC) formed by Fas receptor, FADD( Fas- associated death domain protein) and caspase 8 is a pivotal trigger of apoptosis(1-3). The Fas - FADD DISC represents a receptor platform, which once assembled initiates the induction of programmed cell death. A highly oligomeric network of homotypic protein interactions comprised of the death domains of Fas and FADD is at the centre of DISC formation(4,5). Thus, characterizing the mechanistic basis for the Fas - FADD interaction is crucial for understanding DISC signalling but has remained unclear largely because of a lack of structural data. We have successfully formed and isolated the human Fas - FADD death domain complex and report the 2.7 angstrom crystal structure. The complex shows a tetrameric arrangement of four FADD death domains bound to four Fas death domains. We show that an opening of the Fas death domain exposes the FADD binding site and simultaneously generates a Fas - Fas bridge. The result is a regulatory Fas - FADD complex bridge governed by weak protein - protein interactions revealing a model where the complex itself functions as a mechanistic switch. This switch prevents accidental DISC assembly, yet allows for highly processive DISC formation and clustering upon a sufficient stimulus. In addition to depicting a previously unknown mode of death domain interactions, these results further uncover a mechanism for receptor signalling solely by oligomerization and clustering events.	[Scott, Fiona L.; Stec, Boguslaw; Pop, Cristina; Dobaczewska, Malgorzata K.; Lee, JeongEun J.; Monosov, Edward; Salvesen, Guy S.; Riedl, Stefan J.] Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Brookhaven National Laboratory; Salzburg University	Riedl, SJ (corresponding author), Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA.	robert.schwarzenbacher@sbg.ac.at; sriedl@burnham.org		Stec, Boguslaw/0000-0002-8696-0349	cancer center grant [P30 CA030199]; Biological and Environmental Research DOE; National Center for Research Resources NIH; LLS scholarship;  [R01AA017238];  [PO1CA69381];  [MCEXT-033534]; NATIONAL CANCER INSTITUTE [P30CA030199, P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017238] Funding Source: NIH RePORTER	cancer center grant; Biological and Environmental Research DOE(United States Department of Energy (DOE)); National Center for Research Resources NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); LLS scholarship; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Snipas for protein sequencing and technical assistance, J. Reed for providing Fas cDNA and A. Bobkov for the AUC. This work was supported by a P30 CA030199 cancer center grant and R01AA017238 to S.J.R.; PO1CA69381 to G. S. S.; and MCEXT-033534 to R. S. Data measured at beamline X29 of the National Synchrotron Light Source were also supported by Biological and Environmental Research DOE, and National Center for Research Resources NIH. Earlier stages of the work were supported by a LLS scholarship to S.J.R. S.J.R. is currently a V Foundation scholar.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Ferguson BJ, 2007, CELL DEATH DIFFER, V14, P1717, DOI 10.1038/sj.cdd.4402191; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Festjens N, 2006, BIOL CHEM, V387, P1005, DOI 10.1515/BC.2006.124; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Huxford T, 2002, J MOL BIOL, V324, P587, DOI 10.1016/S0022-2836(02)01149-X; ITOH N, 1993, J BIOL CHEM, V268, P10932; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Werner MH, 2006, CELL CYCLE, V5, P2332, DOI 10.4161/cc.5.20.3385	30	261	274	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1019	1022		10.1038/nature07606	http://dx.doi.org/10.1038/nature07606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19118384	Green Accepted			2022-12-24	WOS:000263425400044
J	Sasaki, S; Mello, CC; Shimada, A; Nakatani, Y; Hashimoto, SI; Ogawa, M; Matsushima, K; Gu, SGP; Kasahara, M; Ahsan, B; Sasaki, A; Saito, T; Suzuki, Y; Sugano, S; Kohara, Y; Takeda, H; Fire, A; Morishita, S				Sasaki, Shin; Mello, Cecilia C.; Shimada, Atsuko; Nakatani, Yoichiro; Hashimoto, Shin-ichi; Ogawa, Masako; Matsushima, Kouji; Gu, Sam Guoping; Kasahara, Masahiro; Ahsan, Budrul; Sasaki, Atsushi; Saito, Taro; Suzuki, Yutaka; Sugano, Sumio; Kohara, Yuji; Takeda, Hiroyuki; Fire, Andrew; Morishita, Shinichi			Chromatin-Associated Periodicity in Genetic Variation Downstream of Transcriptional Start Sites	SCIENCE			English	Article							NUCLEOSOME POSITIONS; HIGH-RESOLUTION; HUMAN GENOME; DNA-REPAIR; EVOLUTION; YEAST; PROMOTERS; STRAND	Might DNA sequence variation reflect germline genetic activity and underlying chromatin structure? We investigated this question using medaka (Japanese killifish, Oryzias latipes), by comparing the genomic sequences of two strains (Hd-rR and HNI) and by mapping similar to 37.3 million nucleosome cores from Hd-rR blastulae and 11,654 representative transcription start sites from six embryonic stages. We observed a distinctive similar to 200-base pair (bp) periodic pattern of genetic variation downstream of transcription start sites; the rate of insertions and deletions longer than 1 bp peaked at positions of approximately +200, +400, and +600 bp, whereas the point mutation rate showed corresponding valleys. This similar to 200-bp periodicity was correlated with the chromatin structure, with nucleosome occupancy minimized at positions 0, +200, +400, and +600 bp. These data exemplify the potential for genetic activity (transcription) and chromatin structure to contribute to molding the DNA sequence on an evolutionary time scale.	[Mello, Cecilia C.; Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Mello, Cecilia C.; Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Sasaki, Shin; Nakatani, Yoichiro; Kasahara, Masahiro; Ahsan, Budrul; Sasaki, Atsushi; Saito, Taro; Morishita, Shinichi] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan; [Shimada, Atsuko; Takeda, Hiroyuki] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Hashimoto, Shin-ichi; Ogawa, Masako; Matsushima, Kouji] Univ Tokyo, Dept Mol Prevent Med, Sch Med, Tokyo 1130033, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Kohara, Yuji] Res Org Informat & Syst, Ctr Genet Resources Informat, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Morishita, Shinichi] Japan Sci & Technol Agcy, Tokyo 1028666, Japan	Stanford University; Stanford University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Fire, A (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	afire@stanford.edu; moris@cb.k.u-tokyo.ac.jp	TAKEDA, HIROYUKI/G-4950-2014; Pillay, Nischalan/F-9536-2012	Kasahara, Masahiro/0000-0001-8430-1414; Fire, Andrew/0000-0001-6217-8312; Nakatani, Yoichiro/0000-0001-7604-0242; Morishita, Shinichi/0000-0002-6201-8885	Monbukagakusho; Japan Science and Technology Agency; NIH [T32 CA09151, R01 GM37706]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (C) from the Monbukagakusho: MEXT, by the Japan Science and Technology Agency, and by the NIH (T32 CA09151 to C. C. M.; R01 GM37706 to A. F.). Computational time was provided by the Human Genome Center and the Information Technology Center, the University of Tokyo. We thank A. Sidow, A. Valouev, S. Johnson, J. Ford, and J. Cai for specific advice over the course of this work, and our colleagues at each institution for their help and suggestions. All sequence data are deposited at NCBI Short Read Archive (accession number SRA002449).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Higasa K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-66; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Suter B, 1997, EMBO J, V16, P2150, DOI 10.1093/emboj/16.8.2150; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Tijsterman M, 1999, MOL CELL BIOL, V19, P934; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Washietl S, 2008, TRENDS GENET, V24, P583, DOI 10.1016/j.tig.2008.09.003; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391	23	100	102	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					401	404		10.1126/science.1163183	http://dx.doi.org/10.1126/science.1163183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074313	Green Accepted			2022-12-24	WOS:000262481400044
J	Watts, G				Watts, Geoff			Google watches over flu	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						GINSBERG J, 2008, NATURE          1119; *HLTH PROT AG, SOURC UK FLU DAT	2	7	9	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 31	2008	337								a3076	10.1136/bmj.a3076	http://dx.doi.org/10.1136/bmj.a3076			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MZ	19118085				2022-12-24	WOS:000262946300002
J	Mendenhall, GS				Mendenhall, G. Stuart			Death and Taxes	ANNALS OF INTERNAL MEDICINE			English	Article							POSTPONEMENT; OCCASIONS	Tax incentives can provide a large financial impetus to change behavior. Current U. S. law establishes a substantial discontinuity in the amount of estate tax that many patients will have to pay in 2010: During this year only, the tax rate drops to zero. This article discusses concerns regarding the sharp change in tax rate and the incentives it creates for persons who are nearing the end of life and provides estimates of the number of people affected by this issue.	Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mendenhall, GS (corresponding author), Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Scaife Hall S-553,200 Lothrop St, Pittsburgh, PA 15213 USA.	gsmenden@post.harvard.edu						*CBO CTR BUDG POL, 2006, STAT EST TAX 2006; *CDC NAT CTR HLTH, 2007, BIRTHS MARR DIV DEAT; Clotfelter CT., 1990, W3273 NBER; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; *US CENS BUR, 2006, S1101 US CENS BUR AM; Young DC, 2004, JAMA-J AM MED ASSOC, V292, P3012, DOI 10.1001/jama.292.24.3012; [No title captured]	9	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					822	824		10.7326/0003-4819-149-11-200812020-00010	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047030				2022-12-24	WOS:000261645300007
J	Vale, RD				Vale, Ronald D.			Microscopes for Fluorimeters: The Era of Single Molecule Measurements	CELL			English	Article							LOCALIZATION MICROSCOPY; DYNAMIC INSTABILITY; RNA-POLYMERASE; LIVING CELLS; PROTEIN; MICROTUBULES; F-1-ATPASE; COMPLEXES; FILAMENT; MOVEMENT	As transforming as the first atomic resolution view of myoglobin in the late 1950s, scientists can now use a suite of single molecule technologies to watch protein macromolecular machines executing their functions "in real time." This Essay highlights applications and challenges of single molecule studies in structural biology, cell biology, and biotechnology.	[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	vale@cmp.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM038499-17, R01 GM038499] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howarth M, 2008, NAT METHODS, V5, P397, DOI [10.1038/nmeth.1206, 10.1038/NMETH.1206]; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	33	17	19	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					779	785		10.1016/j.cell.2008.11.009	http://dx.doi.org/10.1016/j.cell.2008.11.009			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041739	Bronze, Green Accepted			2022-12-24	WOS:000261183900006
J	Vernes, SC; Newbury, DF; Abrahams, BS; Winchester, L; Nicod, J; Groszer, M; Alarcon, M; Oliver, PL; Davies, KE; Geschwind, DH; Monaco, AP; Fisher, SE				Vernes, Sonja C.; Newbury, Dianne F.; Abrahams, Brett S.; Winchester, Laura; Nicod, Jerome; Groszer, Matthias; Alarcon, Maricela; Oliver, Peter L.; Davies, Kay E.; Geschwind, Daniel H.; Monaco, Anthony P.; Fisher, Simon E.			A Functional Genetic Link between Distinct Developmental Language Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONWORD REPETITION; FOXP2 EXPRESSION; SEVERE SPEECH; HUMAN BRAIN; IMPAIRMENT; AUTISM; ASSOCIATION; PREVALENCE; CHILDREN; CNTNAP2	Background: Rare mutations affecting the FOXP2 transcription factor cause a monogenic speech and language disorder. We hypothesized that neural pathways downstream of FOXP2 influence more common phenotypes, such as specific language impairment. Methods: We performed genomic screening for regions bound by FOXP2 using chromatin immunoprecipitation, which led us to focus on one particular gene that was a strong candidate for involvement in language impairments. We then tested for associations between single-nucleotide polymorphisms (SNPs) in this gene and language deficits in a well-characterized set of 184 families affected with specific language impairment. Results: We found that FOXP2 binds to and dramatically down-regulates CNTNAP2, a gene that encodes a neurexin and is expressed in the developing human cortex. On analyzing CNTNAP2 polymorphisms in children with typical specific language impairment, we detected significant quantitative associations with nonsense-word repetition, a heritable behavioral marker of this disorder (peak association, P=5.0 x 10(-5) at SNP rs17236239). Intriguingly, this region coincides with one associated with language delays in children with autism. Conclusions: The FOXP2-CNTNAP2 pathway provides a mechanistic link between clinically distinct syndromes involving disrupted language.	[Vernes, Sonja C.; Newbury, Dianne F.; Winchester, Laura; Nicod, Jerome; Groszer, Matthias; Monaco, Anthony P.; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Vernes, Sonja C.; Oliver, Peter L.; Davies, Kay E.] Univ Oxford, Med Res Council Funct Genom Unit, Oxford OX3 7BN, England; [Abrahams, Brett S.; Alarcon, Maricela; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fisher, SE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	simon.fisher@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Oliver, Peter/F-1453-2010; Groszer, Matthias/P-6291-2017; Vernes, Sonja/E-8454-2012; Fisher, Simon E./E-9130-2012; Simonoff, Emily A/B-7593-2011	Monaco, Anthony P/0000-0001-7480-3197; Vernes, Sonja/0000-0003-0305-4584; Fisher, Simon E./0000-0002-3132-1996; Groszer, Matthias/0000-0002-6209-305X; Oliver, Peter/0000-0003-3347-2461	Wellcome Trust; Autism Speaks; National Institute of Mental Health [MH75028-R21, MH081754-RO1, MH60233-R37, HD055784-P50]; Christopher Welch Biological Sciences Scholarship; University of Oxford; Tourette Syndrome Association; Marie Curie Intra-European Fellowship; Wellcome Trust Principal Research Fellow; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH060233, R01MH060233, R01MH081754, R21MH075028, R37MH060233] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Christopher Welch Biological Sciences Scholarship; University of Oxford; Tourette Syndrome Association; Marie Curie Intra-European Fellowship(European Commission); Wellcome Trust Principal Research Fellow(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by project and program grants from the Wellcome Trust (to Drs. Fisher and Monaco, respectively), a pilot grant from Autism Speaks (to Dr. Fisher), awards (MH75028-R21, MH081754-RO1, MH60233-R37, and HD055784-P50) from the National Institute of Mental Health (to Dr. Geschwind), a Christopher Welch Biological Sciences Scholarship from the University of Oxford (to Dr. Vernes), a postdoctoral fellowship from the Tourette Syndrome Association (to Dr. Abrahams), and a Marie Curie Intra-European Fellowship (to Dr. Nicod). Dr. Monaco is a Wellcome Trust Principal Research Fellow, and Dr. Fisher is a Royal Society Research Fellow. Drs. Newbury, Monaco, and Fisher and Ms. Winchester are members of the Specific Language Impairment Consortium.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bishop DVM, 2003, NOVART FDN SYMP, V251, P213; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Burden V, 1996, DEV MED CHILD NEUROL, V38, P613; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Clark A, 2007, ARCH DIS CHILD, V92, P614, DOI 10.1136/adc.2006.101758; COHEN NJ, 2001, LANGUAGE IMPAIRMENT; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G, 2006, J CHILD PSYCHOL PSYC, V47, P621, DOI 10.1111/j.1469-7610.2005.01584.x; De Fosse L, 2004, ANN NEUROL, V56, P757, DOI 10.1002/ana.20275; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Harel S, 1996, PEDIATR NEUROL, V15, P305, DOI 10.1016/S0887-8994(96)00222-6; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Newbury DF, 2005, TRENDS COGN SCI, V9, P528, DOI 10.1016/j.tics.2005.09.002; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rasband MN, 2004, J NEUROSCI RES, V76, P749, DOI 10.1002/jnr.20073; Semel EM, 1992, CLIN EVALUATION LANG; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	45	471	486	2	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2337	2345		10.1056/NEJMoa0802828	http://dx.doi.org/10.1056/NEJMoa0802828			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	18987363	Green Published, Green Accepted			2022-12-24	WOS:000261270300005
J	Moldoveanu, T; Gehring, K; Green, DR				Moldoveanu, Tudor; Gehring, Kalle; Green, Douglas R.			Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains	NATURE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; DOMAIN-VI; ACTIVATION; REVEALS; PEPTIDE; ENZYME; COMPLEXES	The Ca2+-dependent cysteine proteases, calpains, regulate cell migration(1), cell death(2), insulin secretion(3), synaptic function(4) and muscle homeostasis(5). Their endogenous inhibitor, calpastatin, consists of four inhibitory repeats, each of which neutralizes an activated calpain with exquisite specificity and potency(6). Despite the physiological importance of this interaction, the structural basis of calpain inhibition by calpastatin is unknown(7). Here we report the 3.0 angstrom structure of Ca2+-bound m-calpain in complex with the first calpastatin repeat, both from rat, revealing the mechanism of exclusive specificity. The structure highlights the complexity of calpain activation by Ca2+ illustrating key residues in a peripheral domain that serve to stabilize the protease core on Ca2+ binding. Fully activated calpain binds ten Ca2+ atoms, resulting in several conformational changes allowing recognition by calpastatin. Calpain inhibition is mediated by the intimate contact with three critical regions of calpastatin. Two regions target the penta- EF- hand domains of calpain and the third occupies the substrate- binding cleft, projecting a loop around the active site thiol to evade proteolysis.	[Moldoveanu, Tudor; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	St Jude Children's Research Hospital; McGill University	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Gehring, Kalle/I-4403-2013; Green, Douglas R/N-8083-2018; Gehring, Kalle/N-2945-2019; Moldoveanu, Tudor/N-8173-2018	Gehring, Kalle/0000-0001-6500-1184; Green, Douglas R/0000-0002-7332-1417; Gehring, Kalle/0000-0001-6500-1184; Moldoveanu, Tudor/0000-0003-0791-318X	US National Institute of Health; National Cancer Institute; Canadian Institute of Health Research; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828, R01AI047891, R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. L. Davies for facilitating the initial stages of this work and for sharing the coordinates for the calpastatin repeat 4 - calpain complex, M. Osborne for help with the NMR analysis, B. Schulman for collecting the ALS synchrotron data, the staff at Brookhaven National Light Source beam X29 and APS SERCAT for help with data collection, S. White and D. Miller for advice and sharing of synchrotron time, and C. Hosfield, A. Tocilj and R. Kriwacki for reviewing our manuscript. Funding was provided by the US National Institute of Health and National Cancer Institute, the Canadian Institute of Health Research and the American Lebanese Syrian Associated Charities.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Betts R, 2004, BIOCHEMISTRY-US, V43, P2596, DOI 10.1021/bi0359832; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Cuerrier D, 2007, J BIOL CHEM, V282, P9600, DOI 10.1074/jbc.M610372200; Davis TL, 2007, J MOL BIOL, V366, P216, DOI 10.1016/j.jmb.2006.11.037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutt P, 2000, BIOCHEM J, V348, P37, DOI 10.1042/0264-6021:3480037; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Pal GP, 2003, STRUCTURE, V11, P1521, DOI 10.1016/j.str.2003.11.007; Reverter D, 2002, BIOL CHEM, V383, P1415, DOI 10.1515/BC.2002.160; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	37	112	121	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					404	U73		10.1038/nature07353	http://dx.doi.org/10.1038/nature07353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020622	Green Accepted			2022-12-24	WOS:000261039600047
J	Levens, ED; DeCherney, AH				Levens, Eric D.; DeCherney, Alan H.			Human Oocyte Research The Ethics of Donation and Donor Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IVF		[Levens, Eric D.; DeCherney, Alan H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Levens, ED (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bldg 10,CRC,Room E1-3140,10 Ctr Dr, Bethesda, MD 20892 USA.	levense@mail.nih.gov	DeCherney, Alan H/AAS-2944-2020		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		*AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS38; Blyth E, 2002, HUM REPROD, V17, P3254, DOI 10.1093/humrep/17.12.3254; BROOM H, 1875, W BLACKSTONE COLLECT; Byrd Louise M, 2002, Hum Fertil (Camb), V5, P175, DOI 10.1080/1464727022000199082; Covington SN, 2007, FERTIL STERIL, V87, P1001, DOI 10.1016/j.fertnstert.2006.12.037; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Holder AR, 2008, J ADOLESCENT HEALTH, V42, P1, DOI 10.1016/j.jadohealth.2007.10.014; Institute of Medicine, 2007, ASS MED RISKS HUM OO; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Moreno JD, 2005, NAT BIOTECHNOL, V23, P793, DOI 10.1038/nbt0705-793; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Roberts C, 2008, SOC SCI MED, V66, P159, DOI 10.1016/j.socscimed.2007.08.011; Robertson JA, 2006, FERTIL STERIL, V86, P1573, DOI 10.1016/j.fertnstert.2006.08.084	15	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2174	2176		10.1001/jama.2008.601	http://dx.doi.org/10.1001/jama.2008.601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001629				2022-12-24	WOS:000260793800028
J	de Waal, A				de Waal, Alex			The art of medicine On famine crimes and tragedies	LANCET			English	Editorial Material									[de Waal, Alex] Social Sci Res Council, New York, NY 10019 USA; [de Waal, Alex] Harvard Humanitarian Initiat, Cambridge, MA 02138 USA	Harvard University	de Waal, A (corresponding author), Social Sci Res Council, New York, NY 10019 USA.	dewaal@ssrc.org							0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1538	1539		10.1016/S0140-6736(08)61641-4	http://dx.doi.org/10.1016/S0140-6736(08)61641-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18988330	Bronze			2022-12-24	WOS:000260590500013
J	Werdin, F; Tenenhaus, M; Rennekampff, HO				Werdin, Frank; Tenenhaus, Mayer; Rennekampff, Hans-Oliver			Chronic wound care	LANCET			English	Editorial Material							PERIPHERAL ARTERIAL-DISEASE; THERAPY		[Werdin, Frank] Univ Tubingen, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-72076 Tubingen, Germany; [Tenenhaus, Mayer] Univ Calif San Diego, Sch Med, Div Plast Surg, San Diego, CA 92103 USA; [Rennekampff, Hans-Oliver] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany	Eberhard Karls University of Tubingen; University of California System; University of California San Diego; Hannover Medical School	Werdin, F (corresponding author), Univ Tubingen, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-72076 Tubingen, Germany.	fwerdin@gmx.de						Ayello EA, 2004, NURSING, V34, P26; Chaby G, 2007, ARCH DERMATOL, V143, P1297, DOI 10.1001/archderm.143.10.1297; Dissemond J., 2007, HAUTARZT, V12, P1; Gohel MS, 2007, BMJ-BRIT MED J, V335, P83, DOI 10.1136/bmj.39216.542442.BE; Hiatt WR, 2002, J VASC SURG, V36, P1283, DOI 10.1067/mva.2002.129654; JULL A, 2007, COCHRANE DB SYST REV, V1; McInnes E, 1998, Nurs Stand, V13, P61; MIELL JM, 1999, WOUND REPAIR REGEN, V7, P335; Norman PE, 2004, MED J AUSTRALIA, V181, P150, DOI 10.5694/j.1326-5377.2004.tb06206.x; Padberg FT, 2004, J VASC SURG, V39, P79, DOI 10.1016/j.jvs.2003.09.036; Press E, 2010, CLIN PRACTICE GUIDEL; Royal College of Nursing (RCN), 2006, CLIN PRACTICE GUIDEL; Steed DL, 2004, AM J SURG, V187, p71S, DOI 10.1016/S0002-9610(03)00307-6; Vaneau M, 2007, ARCH DERMATOL, V143, P1291, DOI 10.1001/archderm.143.10.1291; Wraight PR, 2005, DIABETIC MED, V22, P127, DOI 10.1111/j.1464-5491.2004.01363.x	15	74	82	2	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1860	1862		10.1016/S0140-6736(08)61793-6	http://dx.doi.org/10.1016/S0140-6736(08)61793-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041788				2022-12-24	WOS:000261388700006
J	Chan, EYY; Griffiths, SM; Chan, CW				Chan, E. Y. Y.; Griffiths, S. M.; Chan, C. W.			Public-health risks of melamine in milk products	LANCET			English	Editorial Material									[Chan, E. Y. Y.; Griffiths, S. M.] Chinese Univ Hong Kong, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China; [Chan, C. W.] Int Pediat Assoc, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, EYY (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093				*CDCP, 2008, MEL CHIN MAN INF FOR; Chen K., 2007, PUBLIC HLTH SECURITY, P169; CHEN S, 2008, S CHINA MORNING 0922, pA4; *CTR FOOD SAF, FREQ ASK QUEST; FAN LW, 2007, PUBLIC HLTH LAW SURV, P332; *FOOD STAND AG, 2008, CHIN MILK ADV; GRIFFITHS S, 2008, S CHINA MORNING 1001, pA10; Parry J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1802; World Health Organization, 2008, MEL CYAN AC TOX PREL; XIAOFENG G, 2008, CHINA DAILY HON 1010, P3; 2008, CHINA DAILY     0916	11	179	190	3	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1444	1445		10.1016/S0140-6736(08)61604-9	http://dx.doi.org/10.1016/S0140-6736(08)61604-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18970965	Green Published, Bronze			2022-12-24	WOS:000260801300006
J	Branzei, D; Vanoli, F; Foiani, M				Branzei, Dana; Vanoli, Fabio; Foiani, Marco			SUMOylation regulates Rad18-mediated template switch	NATURE			English	Article							DEFECTIVE POSTREPLICATION REPAIR; UV-DAMAGED DNA; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; GROUP GENES; UBIQUITIN; REPLICATION; HELICASE; RAD18	Replication by template switch is thought to mediate DNA damage- bypass and fillings of gaps. Gap- filling repair requires homologous recombination as well as Rad18- and Rad5- mediated proliferating cell nuclear antigen ( PCNA) polyubiquitylation. However, it is unclear whether these processes are coordinated, and the physical evidence for Rad18 - Rad5- dependent template switch at replication forks is still elusive. Here we show, using genetic and physical approaches, that in budding yeast ( Saccharomyces cerevisiae) Rad18 is required for the formation of X- shaped sister chromatid junctions ( SCJs) at damaged replication forks through a process involving PCNA polyubiquitylation and the ubiquitin- conjugating enzymes Mms2 and Ubc13. The Rad18 - Mms2- mediated damage- bypass through SCJs requires the small ubiquitin- like modifier ( SUMO)- conjugating enzyme Ubc9 and SUMOylated PCNA, and is coordinated with Rad51- dependent recombination events. We propose that the Rad18 - Rad5 - Mms2- dependent SCJs represent template switch events. Altogether, our results unmask a role for PCNA ubiquitylation and SUMOylation pathways in promoting transient damage- induced replication- coupled recombination events involving sister chromatids at replication forks.	[Branzei, Dana; Vanoli, Fabio; Foiani, Marco] IFOM IEO, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Foiani, Marco] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Branzei, D (corresponding author), IFOM IEO, FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	dana.branzei@ifom-ieo-campus.it	Foiani, Marco/M-8234-2014; Branzei, Dana/GOG-9093-2022; Branzei, Dana/A-2806-2015	Foiani, Marco/0000-0003-4795-834X; Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888	Associazione Italiana per la Ricerca sul Cancro; Association for International Cancer Research; European Community GENICA; European Community DNA Repair; Telethon; MIUR; Ministry of Health; Buzzati-Traverso foundation	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; European Community GENICA(European Commission); European Community DNA Repair; Telethon(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); Ministry of Health; Buzzati-Traverso foundation	We thank S. Jentsch and H. Ulrich for yeast strains, T. Enomoto for critical reading, and all members of our laboratories for helpful discussions. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro to D. B., Association for International Cancer Research and European Community GENICA grant to M. F. and D. B., and partly by European Community DNA Repair grant, Telethon, MIUR, and Ministry of Health to M. F. D. B. was partly supported by the Buzzati-Traverso foundation.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Branzei D, 2004, GENES CELLS, V9, P1031, DOI 10.1111/j.1365-2443.2004.00787.x; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2007, CELL, V131, P1228, DOI 10.1016/j.cell.2007.12.007; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Motegi A, 2006, MOL CELL BIOL, V26, P1424, DOI 10.1128/MCB.26.4.1424-1433.2006; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; Otsuki M, 2007, J CELL BIOL, V179, P53, DOI 10.1083/jcb.200702183; PALLADINO F, 1992, GENETICS, V132, P23; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; SCHIESTL RH, 1990, GENETICS, V124, P817; Shekhar MPV, 2002, CANCER RES, V62, P2115; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	50	207	210	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					915	920		10.1038/nature07587	http://dx.doi.org/10.1038/nature07587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092928				2022-12-24	WOS:000261768300037
J	Malcolmson, SJ; Meek, SJ; Sattely, ES; Schrock, RR; Hoveyda, AH				Malcolmson, Steven J.; Meek, Simon J.; Sattely, Elizabeth S.; Schrock, Richard R.; Hoveyda, Amir H.			Highly efficient molybdenum-based catalysts for enantioselective alkene metathesis	NATURE			English	Article							RING-CLOSING METATHESIS; IMIDO ALKYLIDENE COMPLEXES; OLEFIN-METATHESIS; METAL-COMPLEXES; TUNGSTEN; AMINES; ETHERS; LIGAND	Discovery of efficient catalysts is one of the most compelling objectives of modern chemistry. Chiral catalysts are in particularly high demand, as they facilitate synthesis of enantiomerically enriched small molecules that are critical to developments in medicine, biology and materials science(1). Especially noteworthy are catalysts that promote - with otherwise inaccessible efficiency and selectivity levels - reactions demonstrated to be of great utility in chemical synthesis. Here we report a class of chiral catalysts that initiate alkene metathesis(1) with very high efficiency and enantioselectivity. Such attributes arise from structural fluxionality of the chiral catalysts and the central role that enhanced electronic factors have in the catalytic cycle. The new catalysts have a stereogenic metal centre and carry only monodentate ligands; the molybdenum- based complexes are prepared stereoselectively by a ligand exchange process involving an enantiomerically pure aryloxide, a class of ligands scarcely used in enantioselective catalysis(2,3). We demonstrate the application of the new catalysts in an enantioselective synthesis of the Aspidosperma alkaloid, quebrachamine, through an alkene metathesis reaction that cannot be promoted by any of the previously reported chiral catalysts.	[Malcolmson, Steven J.; Meek, Simon J.; Sattely, Elizabeth S.; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Malcolmson, Steven/C-6220-2015		US National Institutes of Health; Institute of General Medical Sciences [GM-59426]; US National Science Foundation [DBI-0619576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (grant GM-59426 to A.H.H. and R.R.S.). We are grateful to B. C. Bailey and K. Wampler for assistance in obtaining the X-ray structure of the major diastereomer of molybdenum complex 13b. We thank A. R. Zhugralin for numerous discussions regarding the mechanistic aspects of these investigations and R. Singh for experimental suggestions. Mass spectrometry facilities at Boston College are supported by the US National Science Foundation (grant DBI-0619576).	Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; BRUNNER H, 1990, ANGEW CHEM INT EDIT, V29, P1131, DOI 10.1002/anie.199011311; Brunner H, 1999, ANGEW CHEM INT EDIT, V38, P1195, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1194::AID-ANIE1194>3.0.CO;2-X; Brunner H, 1998, TETRAHEDRON-ASYMMETR, V9, P3231, DOI 10.1016/S0957-4166(98)00329-2; DEUTSCH HF, 1994, J PHARMACEUT BIOMED, V12, P1283, DOI 10.1016/0731-7085(94)00066-2; Dolman SJ, 2002, J AM CHEM SOC, V124, P6991, DOI 10.1021/ja012534l; Faller JW, 2001, J AM CHEM SOC, V123, P2525, DOI 10.1021/ja003528c; Fontecave M, 2005, TOP ORGANOMETAL CHEM, V15, P271; Fournier PA, 2007, ORGANOMETALLICS, V26, P2945, DOI 10.1021/om700312c; Funk TW, 2006, J AM CHEM SOC, V128, P1840, DOI 10.1021/ja055994d; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Grubbs R. H., 2003, HDB METATHESIS; HASHIMOTO S, 1979, J CHEM SOC CHEM COMM, P437, DOI 10.1039/c39790000437; Hock AS, 2006, J AM CHEM SOC, V128, P16373, DOI 10.1021/ja0665904; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Kiely AF, 2002, J AM CHEM SOC, V124, P2868, DOI 10.1021/ja012679s; Kozmin SA, 2002, J AM CHEM SOC, V124, P4628, DOI 10.1021/ja017863s; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Poater A, 2007, J AM CHEM SOC, V129, P8207, DOI 10.1021/ja070625y; Sattely ES, 2005, J AM CHEM SOC, V127, P8526, DOI 10.1021/ja051330s; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875, DOI 10.1021/ja00166a023; Singh R, 2007, J AM CHEM SOC, V129, P12654, DOI 10.1021/ja075569f; Solans-Monfort X, 2005, J AM CHEM SOC, V127, P14015, DOI 10.1021/ja053528i; Stewart IC, 2008, ORG LETT, V10, P441, DOI 10.1021/ol702624n; Tayama E, 2002, TETRAHEDRON, V58, P8307, DOI 10.1016/S0040-4020(02)00981-X; Tsang WCP, 2003, J AM CHEM SOC, V125, P2652, DOI 10.1021/ja0210603; Van Veldhuizen JJ, 2005, J AM CHEM SOC, V127, P6877, DOI 10.1021/ja050179j; Van Veldhuizen JJ, 2003, J AM CHEM SOC, V125, P12502, DOI 10.1021/ja0302228	29	213	232	1	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					933	937		10.1038/nature07594	http://dx.doi.org/10.1038/nature07594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	384TY	19011612	Green Accepted			2022-12-24	WOS:000261768300041
J	Cecil, JE; Tavendale, R; Watt, P; Hetherington, MM; Palmer, CNA				Cecil, Joanne E.; Tavendale, Roger; Watt, Peter; Hetherington, Marion M.; Palmer, Colin N. A.			An Obesity-Associated FTO Gene Variant and Increased Energy Intake in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; ADULT OBESITY; RISK-FACTORS; HUMANS; EXPENDITURE	Background: Variation in the fat mass and obesity-associated (FTO) gene has provided the most robust associations with common obesity to date. However, the role of FTO variants in modulating specific components of energy balance is unknown. Methods: We studied 2726 Scottish children, 4 to 10 years of age, who underwent genotyping for FTO variant rs9939609 and were measured for height and weight. A subsample of 97 children was examined for possible association of the FTO variant with adiposity, energy expenditure, and food intake. Results: In the total study group and the subsample, the A allele of rs9939609 was associated with increased weight (P=0.003 and P=0.049, respectively) and body-mass index (P=0.003 and P=0.03, respectively). In the intensively phenotyped subsample, the A allele was also associated with increased fat mass (P=0.01) but not with lean mass. Although total and resting energy expenditures were increased in children with the A allele (P=0.009 and P=0.03, respectively), resting energy expenditure was identical to that predicted for the age and weight of the child, indicating that there is no defect in metabolic adaptation to obesity in persons bearing the risk-associated allele. The A allele was associated with increased energy intake (P=0.006) independently of body weight. In contrast, the weight of food ingested by children who had the allele was similar to that in children who did not have the allele (P=0.82). Conclusions: The FTO variant that confers a predisposition to obesity does not appear to be involved in the regulation of energy expenditure but may have a role in the control of food intake and food choice, suggesting a link to a hyperphagic phenotype or a preference for energy-dense foods.	[Tavendale, Roger; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Cecil, Joanne E.] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland; [Watt, Peter] Univ Brighton, Chelsea Sch, Brighton, E Sussex, England; [Hetherington, Marion M.] Glasgow Caledonian Univ, Dept Psychol, Glasgow G4 0BA, Lanark, Scotland	University of Dundee; University of St Andrews; University of Brighton; Glasgow Caledonian University	Palmer, CNA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland.	nuclear-receptor@dundee.ac.uk	Palmer, Colin NA/C-7053-2008; Hetherington, Marion/A-4397-2013; Cecil, Joanne E/A-3071-2010	Palmer, Colin NA/0000-0002-6415-6560; Hetherington, Marion/0000-0001-8677-5234; Cecil, Joanne/0000-0003-4779-6037	U.K. Biotechnology and Biological Sciences Research Council [D13460]	U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a grant from the U.K. Biotechnology and Biological Sciences Research Council (D13460). No potential conflict of interest relevant to this article was reported. We thank the children, parents, and schoolteachers for their enthusiastic participation in this study; Dr. Wendy Wrieden, Dr. Deborah Wallis, and Inez Murrie for their support; and Dr. Lydia Martinez, Dr. Andy Coward, and Antony Wright for their technical assistance and helpful discussions.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Ball EJ, 2001, AM J CLIN NUTR, V74, P524; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Burgert Tania S, 2006, Pediatr Endocrinol Rev, V3 Suppl 4, P555; Cecil JE, 2005, INT J OBESITY, V29, P1199, DOI 10.1038/sj.ijo.0803055; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Cecil JE, 2007, AM J CLIN NUTR, V86, P167, DOI 10.1093/ajcn/86.1.167; Cecil JE, 2006, PHYSIOL BEHAV, V88, P227, DOI 10.1016/j.physbeh.2006.05.028; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Ferreira AP, 2007, J PEDIAT-BRAZIL, V83, P21, DOI [10.2223/JPED.1562, 10.1590/S0021-75572007000100005]; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Freedman DS, 2002, J PEDIATR ENDOCR MET, V15, P1099; Garcia AL, 2005, OBES RES, V13, P626, DOI 10.1038/oby.2005.67; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; LOHMAN TG, 1986, EXERCISE SPORT SCI R, V14, P325; Lohman TG, 1989, PEDIATR EXERC SCI, V1, P19, DOI DOI 10.1123/PES.1.1.19; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; SCHOELLER DA, 1983, AM J CLIN NUTR, V38, P999, DOI 10.1093/ajcn/38.6.999; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; TSCHRITTER O, 2008, DIABETOLOGIA, V51, P1558; VanKreel BK, 1996, J MASS SPECTROM, V31, P108; Wiegand S, 2005, INT J OBESITY, V29, pS136, DOI 10.1038/sj.ijo.0803081; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	31	487	520	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2558	2566		10.1056/NEJMoa0803839	http://dx.doi.org/10.1056/NEJMoa0803839			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073975	Bronze			2022-12-24	WOS:000261534200007
J	Munch, E; Launey, ME; Alsem, DH; Saiz, E; Tomsia, AP; Ritchie, RO				Munch, E.; Launey, M. E.; Alsem, D. H.; Saiz, E.; Tomsia, A. P.; Ritchie, R. O.			Tough, Bio-Inspired Hybrid Materials	SCIENCE			English	Article							FRACTURE-RESISTANCE MECHANISM; HUMAN CORTICAL BONE; CRACK-PROPAGATION; LAYERED CERAMICS; POROUS CERAMICS; SILICON-CARBIDE; PORE STRUCTURE; NACRE; COMPOSITES; ALUMINA	The notion of mimicking natural structures in the synthesis of new structural materials has generated enormous interest but has yielded few practical advances. Natural composites achieve strength and toughness through complex hierarchical designs that are extremely difficult to replicate synthetically. We emulate nature's toughening mechanisms by combining two ordinary compounds, aluminum oxide and polymethyl methacrylate, into ice- templated structures whose toughness can be more than 300 times ( in energy terms) that of their constituents. The final product is a bulk hybrid ceramic- based material whose high yield strength and fracture toughness [similar to 200 megapascals (MPa) and similar to 30 MPa.m(1/2)] represent specific properties comparable to those of aluminum alloys. These model materials can be used to identify the key microstructural features that should guide the synthesis of bio- inspired ceramic- based composites with unique strength and toughness.	[Munch, E.; Launey, M. E.; Alsem, D. H.; Saiz, E.; Tomsia, A. P.; Ritchie, R. O.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Alsem, D. H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Ritchie, R. O.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ritchie, RO (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	roritchie@lbl.gov	Ritchie, Robert O/A-8066-2008	Ritchie, Robert O/0000-0002-0501-6998	Office of Science; Office of Basic Energy Sciences; Division of Materials Sciences and Engineering; U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Araki K, 2004, J AM CERAM SOC, V87, P1859; Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1; Becher PF, 1998, J AM CERAM SOC, V81, P2821, DOI 10.1111/j.1151-2916.1998.tb02702.x; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Cao JJ, 1996, J AM CERAM SOC, V79, P461, DOI 10.1111/j.1151-2916.1996.tb08145.x; Chan HM, 1997, ANNU REV MATER SCI, V27, P249, DOI 10.1146/annurev.matsci.27.1.249; COOK J, 1964, PROC R SOC LON SER-A, V282, P508, DOI 10.1098/rspa.1964.0248; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x; Fukasawa T, 2001, J MATER SCI, V36, P2523, DOI 10.1023/A:1017946518955; JOHNSON DR, 1995, INTERMETALLICS, V3, P99, DOI 10.1016/0966-9795(95)92674-O; Jones R.M., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kruzic JJ, 2005, J AM CERAM SOC, V88, P2236, DOI 10.1111/j.1551-2916.2005.00434.x; Kruzic JJ, 2004, J AM CERAM SOC, V87, P93, DOI 10.1111/j.1551-2916.2004.00093.x; LANGE FF, 1973, J AM CERAM SOC, V56, P518, DOI 10.1111/j.1151-2916.1973.tb12401.x; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; MAI YW, 1987, J AM CERAM SOC, V70, P289, DOI 10.1111/j.1151-2916.1987.tb04983.x; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; MOYA JS, 1995, ADV MATER, V7, P185, DOI 10.1002/adma.19950070219; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nalla RK, 2003, BIOMATERIALS, V24, P3955, DOI 10.1016/S0142-9612(03)00278-3; Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295; PADTURE NP, 1994, J AM CERAM SOC, V77, P2518, DOI 10.1111/j.1151-2916.1994.tb04637.x; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; RITCHIE RO, 1988, MAT SCI ENG A-STRUCT, V103, P15, DOI 10.1016/0025-5416(88)90547-2; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354; SHANG JK, 1989, METALL TRANS A, V20, P897, DOI 10.1007/BF02651656; SIGL LS, 1988, ACTA METALL MATER, V36, P945, DOI 10.1016/0001-6160(88)90149-6; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1; SWANSON PL, 1987, J AM CERAM SOC, V70, P279, DOI 10.1111/j.1151-2916.1987.tb04982.x; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Tasdemirci A, 2004, J COMPOS MATER, V38, P995, DOI 10.1177/0021998304040564; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935	41	1291	1314	76	1555	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1516	1520		10.1126/science.1164865	http://dx.doi.org/10.1126/science.1164865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056979	Green Submitted			2022-12-24	WOS:000261377400042
J	Chandran, S				Chandran, Siddharthan			What are the prospects of stem cell therapy for neurology?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; TRANSPLANTATION; NEURONS		[Chandran, Siddharthan] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Chandran, Siddharthan] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CB2 0SZ, England	University of Cambridge; University of Cambridge	Chandran, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	sc222@cam.ac.uk			Medical Research Council [G0502107] Funding Source: Medline; MRC [G0502107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Compston A, 2006, ACTA NEUROL SCAND, V113, P41, DOI 10.1111/j.1600-0404.2006.00614.x; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Rosser AE, 2007, CURR OPIN NEUROL, V20, P688, DOI 10.1097/WCO.0b013e3282f132fc; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Wasiak J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005489.pub2; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	21	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2008	337								a1934	10.1136/bmj.a1934	http://dx.doi.org/10.1136/bmj.a1934			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042937				2022-12-24	WOS:000261827800006
J	Bataille, V; de Vries, E				Bataille, Veronique; de Vries, Esther			Melanoma - Part 1: epidemiology, risk factors, and prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CUTANEOUS MELANOMA; MELANOCORTIN-1 RECEPTOR; MALIGNANT-MELANOMA; EXPOSURE; TRENDS; SITE; METAANALYSIS; AUSTRALIA; MORTALITY; SURVIVAL		[Bataille, Veronique] W Hertfordshire Hosp NHS Trust, Hemel Hempstead HP2 4AD, England; [Bataille, Veronique] Kings Coll London, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; [de Vries, Esther] Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [de Vries, Esther] Erasmus MC Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands	University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bataille, V (corresponding author), W Hertfordshire Hosp NHS Trust, Hemel Hempstead HP2 4AD, England.	bataille@doctors.org.uk	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258				*AUSTR I HLTH WELF, 2007, AUSTR CANC INC MORT; Autier P, 2005, EXPERT REV ANTICANC, V5, P821, DOI 10.1586/14737140.5.5.821; Bataille V, 2004, EUR J CANCER, V40, P429, DOI 10.1016/j.ejca.2003.09.030; Bataille W, 2005, EUR J CANCER, V41, P2141, DOI 10.1016/j.ejca.2005.04.038; Bishop JAN, 2007, SEMIN ONCOL, V34, P452, DOI 10.1053/j.seminoncol.2007.09.006; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Bulliard JL, 1997, INT J CANCER, V72, P231, DOI 10.1002/(SICI)1097-0215(19970717)72:2<231::AID-IJC5>3.0.CO;2-S; *CANC RES UK, MEL SKIN CANC; Cho EY, 2005, CANCER EPIDEM BIOMAR, V14, P1241, DOI 10.1158/1055-9965.EPI-04-0632; Coory M, 2006, CANCER CAUSE CONTROL, V17, P21, DOI 10.1007/s10552-005-3637-4; Cress RD, 1997, CANCER CAUSE CONTROL, V8, P246, DOI 10.1023/A:1018432632528; De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Giles GG, 1996, BMJ-BRIT MED J, V312, P1121; Harrison SL, 2000, J NATL CANCER I, V92, P1436, DOI 10.1093/jnci/92.17.1436; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; *MEL MOL MAP PROJ, TNM STAG; Mossner R, 2007, ARCH DERMATOL RES, V298, P371, DOI 10.1007/s00403-006-0708-7; *NCI, SURV EP END RES FAST; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; WESTERDAHL J, 1994, AM J EPIDEMIOL, V140, P691, DOI 10.1093/oxfordjournals.aje.a117317; WHITEMAN DC, 2008, J CANC PREV, V17, P243	24	67	69	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2249	10.1136/bmj.a2249	http://dx.doi.org/10.1136/bmj.a2249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HS	19022841	Green Submitted			2022-12-24	WOS:000262654100003
J	Bacaj, T; Tevlin, M; Lu, Y; Shaham, S				Bacaj, Taulant; Tevlin, Maya; Lu, Yun; Shaham, Shai			Glia Are Essential for Sensory Organ Function in C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NEURONS; CILIA; THERMOTAXIS; CHEMOTAXIS; ASTROCYTES; RESPONSES; ENCODES; PROTEIN; CELLS		[Bacaj, Taulant; Tevlin, Maya; Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu			NINDS NIH HHS [R01 NS064273, R01 NS064273-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	24	133	140	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					744	747		10.1126/science.1163074	http://dx.doi.org/10.1126/science.1163074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974354	Green Accepted			2022-12-24	WOS:000260605200050
J	De'ath, G; Lough, JM; Fabricius, KE				De'ath, Glenn; Lough, Janice M.; Fabricius, Katharina E.			Declining Coral Calcification on the Great Barrier Reef	SCIENCE			English	Article							MASSIVE PORITES; OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; GROWTH; VARIABILITY; CENTURIES; SEAWATER; CARBON	Reef- building corals are under increasing physiological stress from a changing climate and ocean absorption of increasing atmospheric carbon dioxide. We investigated 328 colonies of massive Porites corals from 69 reefs of the Great Barrier Reef ( GBR) in Australia. Their skeletal records show that throughout the GBR, calcification has declined by 14.2% since 1990, predominantly because extension ( linear growth) has declined by 13.3%. The data suggest that such a severe and sudden decline in calcification is unprecedented in at least the past 400 years. Calcification increases linearly with increasing large- scale sea surface temperature but responds nonlinearly to annual temperature anomalies. The causes of the decline remain unknown; however, this study suggests that increasing temperature stress and a declining saturation state of seawater aragonite may be diminishing the ability of GBR corals to deposit calcium carbonate.	[De'ath, Glenn; Lough, Janice M.; Fabricius, Katharina E.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	De'ath, G (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	g.death@aims.gov.au	Lough, Janice M/L-1682-2013; Fabricius, Katharina E/F-1759-2010; Gates, Audrey/AAD-2165-2019	Lough, Janice M/0000-0002-3789-1009; Fabricius, Katharina E/0000-0001-7671-4358; 	Australian Institute of Marine Science	Australian Institute of Marine Science	We thank M. Devereux, E. Matson, D. Thomson, T. Cooper, and R. Berkelmans for collecting and preparing coral samples. This study was funded by the Australian Institute of Marine Science. The long coral core growth data are lodged with the National Oceanographic and Atmospheric Administration Paleoclimatology Data Center (www.ncdc.noaa.gov/paleo/).	Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Lough JM, 2008, J ENVIRON MONITOR, V10, P21, DOI [10.1039/b714627m, 10.1039/B714627M]; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Ohde S, 2004, GEOCHEM J, V38, P613, DOI 10.2343/geochemj.38.613; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Veron J.E.N., 2008, REEF TIME GREAT BARR	28	461	467	4	534	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					116	119		10.1126/science.1165283	http://dx.doi.org/10.1126/science.1165283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119230				2022-12-24	WOS:000262104100053
J	Qato, DM; Alexander, GC; Conti, RM; Johnson, M; Schumm, P; Lindau, ST				Qato, Dima M.; Alexander, G. Caleb; Conti, Rena M.; Johnson, Michael; Schumm, Phil; Lindau, Stacy Tessler			Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; NATIONAL-HEALTH	Context Despite concerns about drug safety, current information on older adults' use of prescription and over- the- counter medications and dietary supplements is limited. Objective To estimate the prevalence and patterns of medication use among older adults ( including concurrent use), and potential major drug- drug interactions. Design, Setting, and Participants Three thousand five community- residing individuals, aged 57 through 85 years, were drawn from a cross- sectional, nationally representative probability sample of the United States. In- home interviews, including medication logs, were administered between June 2005 and March 2006. Medication use was defined as prescription, over- the- counter, and dietary supplements used "on a regular schedule, like every day or every week." Concurrent use was defined as the regular use of at least 2 medications. Main Outcome Measure Population estimates of the prevalence of medication use, concurrent use, and potential major drug- drug interactions, stratified by age group and gender. Results The unweighted survey response rate was 74.8% ( weighted response rate, 75.5%). Eighty- one percent ( 95% confidence interval [ CI], 79.4%- 83.5%) used at least 1 prescription medication, 42% ( 95% CI, 39.7%- 44.8%) used at least 1 over- the-counter medication, and 49%( 95% CI, 46.2%- 52.7%) used a dietary supplement. Twenty-nine percent ( 95% CI, 26.6%- 30.6%) used at least 5 prescription medications concurrently; this was highest among men ( 37.1%; 95% CI, 31.7%- 42.4%) and women( 36.0%; 95% CI, 30.2%- 41.9%) aged 75 to 85 years. Among prescription medication users, concurrent use of over- the- counter medications was 46%( 95% CI, 43.4%- 49.1%) and concurrent use of dietary supplements was 52% ( 95% CI, 48.8%- 55.5%). Overall, 4% of individuals were potentially at risk of having a major drug- drug interaction; half of these involved the use of nonprescription medications. These regimens were most prevalent among men in the oldest age group ( 10%; 95% CI, 6.4%- 13.7%) and nearly half involved anticoagulants. No contraindicated concurrent drug use was identified. Conclusions In this sample of community- dwelling older adults, prescription and nonprescription medications were commonly used together, with nearly 1 in 25 individuals potentially at risk for a major drug- drug interaction.	[Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Alexander, G. Caleb; Conti, Rena M.] Univ Chicago, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA; [Alexander, G. Caleb; Lindau, Stacy Tessler] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Alexander, G. Caleb; Conti, Rena M.] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Conti, Rena M.] Univ Chicago, Sect Pediat Hematol Oncol, Chicago, IL 60637 USA; [Johnson, Michael; Schumm, Phil] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lindau, Stacy Tessler] Univ Chicago, Sect Geriatr, Dept Med, Chicago, IL 60637 USA; [Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, Ctr Demog & Econ Aging, Chicago, IL 60637 USA; [Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, NORC, Chicago Core Biomarkers Populat Based Res, Chicago, IL 60637 USA; [Qato, Dima M.] Univ Illinois, Dept Hlth Policy & Adm, Sch Publ Hlth, Chicago, IL USA; [Alexander, G. Caleb] Univ Illinois, Dept Pharm Practice, Sch Pharm, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Qato, DM (corresponding author), Univ Chicago, Dept Obstet & Gynecol, 5841 S Maryland Ave,MC 2050, Chicago, IL 60637 USA.	dqato@babies.bsd.uchicago.edu		Schumm, Phil/0000-0002-3050-2429; Qato, Dima/0000-0001-5411-6998; Conti, Rena/0000-0002-4190-1839	National Institutes of Health; National Institute on Aging; Office of Research on Women's Health; Office of AIDS Research; Office of Behavioral and Social Sciences Research [5R01AG021487]; NORC; Merck Foundation; Agency for Healthcare Research and Quality [K08 HS1569901A1]; Robert Wood Johnson Physician Faculty Scholars Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032870, R01AG021487, P30AG012857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC; Merck Foundation(Merck & Company); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The National Social Life, Health and Aging Project ( NSHAP) is supported by the National Institutes of Health, including the National Institute on Aging, the Office of Research on Women's Health, the Office of AIDS Research, and the Office of Behavioral and Social Sciences Research (5R01AG021487). NSHAP is also supported by NORC, whose staff was responsible for the data collection. The National Institutes of Health, National Institute on Aging University of Chicago - NORC Center on Demography and Economics of Aging Core on Biomarkers in Population-Based Health and Aging Research ( 5 P30 AG 012857) and the University of Chicago Program in Pharmaceutical Policy ( David Meltzer, principal investigator) also supported the effort of Dr Qato and Mssrs Schumm and Johnson on this article with a pilot grant ( Dr Lindau, principal investigator). The University of Chicago Program in Pharmaceutical Policy is supported by the Merck Foundation. Dr Alexander has career development awards from the Agency for Healthcare Research and Quality (K08 HS1569901A1) and the Robert Wood Johnson Physician Faculty Scholars Program. Supplies were donated to the NSHAP study by OraSure, Sunbeam, A&D Medical/LifeSource, Wilmer Eye Institute at the Johns Hopkins Bloomberg School of Public Health, Schleicher & Schuell Bioscience, BioMerieux, Roche Diagnostics, Digene, and Richard Williams.	Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; *CERN MULT INC, LEX PLUS DAT; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; Curtis LH, 2007, JAMA-J AM MED ASSOC, V298, P1517, DOI 10.1001/jama.298.13.1517; Elmer GW, 2007, ANN PHARMACOTHER, V41, P1617, DOI 10.1345/aph.1K221; FILLENBAUM GG, 1993, AM J PUBLIC HEALTH, V83, P1577, DOI 10.2105/AJPH.83.11.1577; Gardiner P, 2006, ARCH INTERN MED, V166, P1968, DOI 10.1001/archinte.166.18.1968; Gaskin Darrell J, 2006, Am J Geriatr Pharmacother, V4, P96, DOI 10.1016/j.amjopharm.2006.06.008; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hanlon JT, 2001, DRUG AGING, V18, P123, DOI 10.2165/00002512-200118020-00005; Hensrud DD, 1999, MAYO CLIN PROC, V74, P443; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; *IMS, COMM REQ THER CLASS; *IMS, GEN MARK EXP SOAR 80; *IOM, 2006, FUT DRUG SAF PROM PR; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kris-Etherton, 2003, CIRCULATION, V107, P512, DOI 10.1161/01.CIR.0000054601.17182.B0; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; *NACDA, NAT SOC LIF HLTH AG; QATO D, NATL SOCIAL LIFE HLT; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; STAGNITTI MN, 2004, STAT BRIEF 180 TOP 5; *STATACORP, 2007, STAT COMP PROGR VERS; *THOMS REUT HEALTH, MICR HEALTHC SER; *US BUR CENS, POV THRESH 2006; *US FDA, CDER DRUG BIOL APPR; *US FDA, SENT IN NAT STRAT MO	33	630	665	4	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2867	2878						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109115	Green Accepted, Bronze			2022-12-24	WOS:000261920900020
J	Sharkey, N				Sharkey, Noel			COMPUTER SCIENCE The Ethical Frontiers of Robotics	SCIENCE			English	Editorial Material									[Sharkey, Noel] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield	Sharkey, N (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	noel@dcs.shef.ac.uk						Blum D, 2003, LOVE GOON PARK H HAR; Breazeal C, 2003, ROBOT AUTON SYST, V42, P167, DOI 10.1016/S0921-8890(02)00373-1; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Forlizzi J, 2004, HUM-COMPUT INTERACT, V19, P25, DOI 10.1207/s15327051hci1901&2_3; *IFR STAT DEP, WORLD ROB REP 2008; *NAT RES COUNC COM, 2005, AUT VEH SUPP NAV OP; Sharkey N, 2008, IEEE INTELL SYST, V23, P14, DOI 10.1109/MIS.2008.60; Sharkey N, 2006, ARTIF INTELL REV, V25, P9, DOI 10.1007/s10462-007-9048-z; Sparrow R., 2002, Ethics and Information Technology, V4, P305, DOI 10.1023/A:1021386708994; SPARROW R, 2004, MIND MACH, V16, P141; TANAKA F, 2007, P NATL ACAD SCI USA, V194, P46; *UN PRESS INT, 2008, BAE SYST TECH BOOSTS; *US DEP DEF, 2005, LSD AT L DEF SYST WA; US Department of Defense, 2007, UNM SYST ROADM 2007	15	82	84	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1800	1801		10.1126/science.1164582	http://dx.doi.org/10.1126/science.1164582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	385FF	19095930				2022-12-24	WOS:000261799400041
J	Blossom, DB; Kallen, AJ; Patel, PR; Elward, A; Robinson, L; Gao, GP; Langer, R; Perkins, KM; Jaeger, JL; Kurkjian, KM; Jones, M; Schillie, SF; Shehab, N; Ketterer, D; Venkataraman, G; Kishimoto, TK; Shriver, Z; McMahon, AW; Austen, KF; Kozlowski, S; Srinivasan, A; Turabelidze, G; Gould, CV; Arduino, MJ; Sasisekharan, R				Blossom, David B.; Kallen, Alexander J.; Patel, Priti R.; Elward, Alexis; Robinson, Luke; Gao, Ganpan; Langer, Robert; Perkins, Kiran M.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Jones, Marilyn; Schillie, Sarah F.; Shehab, Nadine; Ketterer, Daniel; Venkataraman, Ganesh; Kishimoto, Takashi Kei; Shriver, Zachary; McMahon, Ann W.; Austen, K. Frank; Kozlowski, Steven; Srinivasan, Arjun; Turabelidze, George; Gould, Carolyn V.; Arduino, Matthew J.; Sasisekharan, Ram			Outbreak of Adverse Reactions Associated with Contaminated Heparin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPHYLACTOID REACTIONS; CLINICAL EVENTS; HEMODIALYSIS	Background: In January 2008, the Centers for Disease Control and Prevention began a nationwide investigation of severe adverse reactions that were first detected in a single hemodialysis facility. Preliminary findings suggested that heparin was a possible cause of the reactions. Methods: Information on clinical manifestations and on exposure was collected for patients who had signs and symptoms that were consistent with an allergic-type reaction after November 1, 2007. Twenty-one dialysis facilities that reported reactions and 23 facilities that reported no reactions were included in a case-control study to identify facility-level risk factors. Unopened heparin vials from facilities that reported reactions were tested for contaminants. Results: A total of 152 adverse reactions associated with heparin were identified in 113 patients from 13 states from November 19, 2007, through January 31, 2008. The use of heparin manufactured by Baxter Healthcare was the factor most strongly associated with reactions (present in 100.0% of case facilities vs. 4.3% of control facilities, P<0.001). Vials of heparin manufactured by Baxter from facilities that reported reactions contained a contaminant identified as oversulfated chondroitin sulfate (OSCS). Adverse reactions to the OSCS-contaminated heparin were often characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after administration. Of 130 reactions for which information on the heparin lot was available, 128 (98.5%) occurred in a facility that had OSCS-contaminated heparin on the premises. Of 54 reactions for which the lot number of administered heparin was known, 52 (96.3%) occurred after the administration of OSCS-contaminated heparin. Conclusions: Heparin contaminated with OSCS was epidemiologically linked to adverse reactions in this nationwide outbreak. The reported clinical features of many of the cases further support the conclusion that contamination of heparin with OSCS was the cause of the outbreak.	[Blossom, David B.; Kallen, Alexander J.; Patel, Priti R.; Schillie, Sarah F.; Shehab, Nadine; Srinivasan, Arjun; Gould, Carolyn V.; Arduino, Matthew J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Blossom, David B.; Kallen, Alexander J.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Schillie, Sarah F.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA; [Blossom, David B.; Kallen, Alexander J.; Perkins, Kiran M.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Schillie, Sarah F.; Ketterer, Daniel] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Elward, Alexis] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Jones, Marilyn] BJC Healthcare, St Louis, MO USA; [Turabelidze, George] Missouri Dept Hlth & Senior Serv, St Louis, MO USA; [Robinson, Luke; Gao, Ganpan; Langer, Robert; Sasisekharan, Ram] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Robinson, Luke; Gao, Ganpan; Langer, Robert; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Venkataraman, Ganesh; Kishimoto, Takashi Kei; Shriver, Zachary] Momenta Pharmaceut, Cambridge, MA USA; [McMahon, Ann W.; Kozlowski, Steven] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Austen, K. Frank] Brigham & Womens Hosp, Boston, MA 02115 USA; [Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; St. Louis Children's Hospital; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); US Food & Drug Administration (FDA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Patel, PR (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS-A31, Atlanta, GA 30333 USA.	ppatel@cdc.gov	Arduino, Matthew/C-1461-2012; Moore, Jeff/W-5653-2019	Arduino, Matthew/0000-0001-7072-538X; Shehab, Nadine/0000-0001-8700-8539	National Institutes of Health [GM57073, HL080279]; Momenta Pharmaceuticals and Scientific Protein; Momenta Pharmaceuticals; SAGE Products; Pfizer; Lilly; Monsanto; Walgreens; General Electric; Abbott; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, R37GM057073, T32GM008334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Momenta Pharmaceuticals and Scientific Protein; Momenta Pharmaceuticals; SAGE Products(General Electric); Pfizer(Pfizer); Lilly(Eli Lilly); Monsanto; Walgreens; General Electric(General Electric); Abbott(Abbott Laboratories); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The CDC investigation had no external funding. The laboratory analysis was supported in part by grants from the National Institutes of Health (GM57073 and HL080279, to Dr. Sasisekharan).; Dr. Venkataraman reports being an employee of Momenta Pharmaceuticals and holding equity in the company, which performs the analysis and characterization of complex mixtures, including heparin, and being an inventor on patent applications for Momenta Pharmaceuticals; Dr. Kishimoto, being an employee of, holding equity in, and being an inventor on patent applications for Momenta Pharmaceuticals; Dr. Langer, receiving consulting fees from Momenta Pharmaceuticals and Scientific Protein, having equity in Momenta Pharmaceuticals, and serving on a paid board of Momenta Pharmaceuticals; Dr. Shriver, being an employee of Momenta Pharmaceuticals and holding equity in the company; Dr. Sasisekharan, holding equity in Momenta Pharmaceuticals and receiving consulting fees or serving on a paid board of Momenta Pharmaceuticals and Scientific Protein Labs; Dr. Austen, receiving consulting fees from Momenta Pharmaceuticals; Dr. Elward, receiving consulting fees or serving on a paid advisory board for Trinity and receiving grant support from SAGE Products; and Dr. Schillie, holding equity in Pfizer, Lilly, Monsanto, Walgreens, General Electric, and Abbott. No other potential conflict of interest relevant to this article was reported.; The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U. S. Department of Health and Human Services.; We thank the many health care professionals at facilities at which adverse events occurred for reporting to public health authorities and for sending heparin vials for laboratory testing; the state epidemiologists and representatives of the End Stage Renal Disease Network for their assistance in facilitating contact between facilities with adverse events and the CDC; Laura Governale ( IMS Health), Gary Warns ( Gambro), and Bill Singley ( Minntech) for the timely information they provided; and representatives of the FDA for their close collaboration, especially in the early stages of this outbreak investigation, in particular, Karen Deasy and Tarun Mallick, who served as important links between the FDA and the CDC and furthered our collective efforts.	Arduino MJ, 2000, SEMIN DIALYSIS, V13, P86, DOI 10.1046/j.1525-139x.2000.00025.x; Berkun Y, 2004, CLIN EXP ALLERGY, V34, P1916, DOI 10.1111/j.1365-2222.2004.02129.x; Bircher AJ, 2006, ALLERGY, V61, P1432, DOI 10.1111/j.1398-9995.2006.01227.x; Bishu K, 2006, CLIN J AM SOC NEPHRO, V1, P820, DOI 10.2215/CJN.00060106; Bottio T, 2003, J THORAC CARDIOV SUR, V126, P1194, DOI 10.1016/S0022-5223(03)00813-4; *CTR MED MED SERV, 2008, INF DIAL FAC COMP; Dias MBS, 2008, INFECT CONT HOSP EP, V29, P125, DOI 10.1086/526440; Ebo DG, 2006, ALLERGY, V61, P211, DOI 10.1111/j.1398-9995.2006.00982.x; *FDA, 2008, INF ADV EV REP HEP; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Leypoldt JK, 2002, KIDNEY INT, V61, P266, DOI 10.1046/j.1523-1755.2002.00099.x; Ludwig RJ, 2006, MINI-REV MED CHEM, V6, P1009, DOI 10.2174/138955706778195180; Maharaj Chris, 2004, Curr Opin Anaesthesiol, V17, P35, DOI 10.1097/00001503-200402000-00007; PEGUES DA, 1992, KIDNEY INT, V42, P1232, DOI 10.1038/ki.1992.409; Schwartz LB, 2008, NEW ENGL J MED, V358, P2505, DOI 10.1056/NEJMe0803599; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Walenga Jeanine M, 2007, Clin Adv Hematol Oncol, V5, P759; Wan S, 1999, ANN THORAC SURG, V68, P1230, DOI 10.1016/S0003-4975(99)00701-8; ZAKKAR M, 2007, CARDIOPULMONARY BYPA, P321; 2008, MMWR MORB MORTAL WKL, V57, P124; 2005, MMWR MORB MORTAL WKL, V54, P269	22	188	196	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2674	2684		10.1056/NEJMoa0806450	http://dx.doi.org/10.1056/NEJMoa0806450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19052120	Green Accepted			2022-12-24	WOS:000261757300007
J	Gormley, GJ; Dempster, M; Best, R				Gormley, Gerard J.; Dempster, Martin; Best, Rachael			Right-left discrimination among medical students: questionnaire and psychometric study	BRITISH MEDICAL JOURNAL			English	Article							SPATIAL ABILITY; MENTAL ROTATION; SEX-DIFFERENCES; HANDEDNESS; SITE	Objective To determine medical students' self awareness and ability to discriminate right from left; to identify characteristics associated with this ability; and to identify any techniques used to aid discrimination. Design Questionnaire and psychometric study. Setting Undergraduate medical school, Northern Ireland. Participants 290 first year undergraduate students. Main outcome measure Medical students' ability to discriminate right from left using the Bergen right- left discrimination test. Results Test scores ranged from 31 to 143 on a scale of 0144 ( mean 112 ( standard deviation 22.2)). Male students significantly outperformed female students ( 117.18 ( 26.96) v 110.80 ( 28.94)). Students who wanted to be surgeons performed significantly better than those who wanted to be general practitioners or medical doctors ( 119.87 ( 25.15) v 110.55 ( 27.36) v 112.50 ( 26.88)). The interaction effect for sex and career wishes was not significant ( P= 0.370). Students who used learnt techniques to help them discriminate scored significantly less than those who did not ( P< 0.001). Students had greater difficulty in discriminating right from left when looking at the forward view rather than the back view ( P< 0.001). Conclusions Male students were better than female students at distinguishing right from left, and aspiring surgeons were better than aspiring general practitioners or medical doctors. Students had more difficulty with the forward view than the back view. The ability to discriminate right from left calls on several higher functions including memory, visuospatial processing, language, integration of sensory information, and sometimes mental rotation.(1) Some people have difficulty in distinguishing right from left in themselves and in others.(23) Correctly discriminating right from left is important in the practice of medicine. Confusing a patient's right side from their left can result in surgery, procedures, and investigations being carried out on the wrong side.(4) Such mistakes may occur more frequently than is reported,(4) and prevention should start at undergraduate level.(5) Medical students perform better than psychology or law students in right- left discrimination tests, but data are limited.(6) We aimed to assess medical students' perceived and actual right- left discriminatory ability; to identify characteristics associated with this ability; and to identify any techniques used to aid discrimination.	[Gormley, Gerard J.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland; [Dempster, Martin; Best, Rachael] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Gormley, GJ (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland.	g.gormley@qub.ac.uk	Dempster, Martin/D-7188-2013	Dempster, Martin/0000-0001-9499-3186	Association for the Study of Medical Education	Association for the Study of Medical Education	Association for the Study of Medical Education (small project grant).	Auer T, 2008, LATERALITY, V13, P427, DOI 10.1080/13576500802114120; Benton AL, 1979, CLIN NEUROPSYCHOLOGY; *GEN MED COUNC, 1993, TOM DOCT REC CHANG U; Gibbs VC, 2005, SURG CLIN N AM, V85, P1307, DOI 10.1016/j.suc.2005.09.007; Gibson J B, 1973, Nature, V243, P482, DOI 10.1038/243482b0; GOLDSTEIN D, 1990, MEM COGNITION, V18, P546, DOI 10.3758/BF03198487; HANNAY HJ, 1990, PERCEPT MOTOR SKILL, V70, P451, DOI 10.2466/PMS.70.2.451-457; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; KOHN L, 2000, TO ERR IS HUMAN BUIL; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.2307/1130467; MARTINO G, 1995, BRAIN COGNITION, V29, P66, DOI 10.1006/brcg.1995.1268; MCKEEVER WF, 1986, CORTEX, V22, P521, DOI 10.1016/S0010-9452(86)80013-2; Ofte SH, 2002, J CLIN EXP NEUROPSYC, V24, P82, DOI 10.1076/jcen.24.1.82.966; Ofte SH, 2002, SCAND J PSYCHOL, V43, P213, DOI 10.1111/1467-9450.00289; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Seiden SC, 2006, ARCH SURG-CHICAGO, V141, P931, DOI 10.1001/archsurg.141.9.931; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SILVERMAN AJ, 1966, J PSYCHOSOM RES, V10, P151, DOI 10.1016/0022-3999(66)90058-4; SNYDER TJ, 1991, DEV NEUROPSYCHOL, V7, P219, DOI 10.1080/87565649109540489	19	16	16	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2826	10.1136/bmj.a2826	http://dx.doi.org/10.1136/bmj.a2826			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SV	19088140	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000262184900002
J	Blow, N				Blow, Nathan			Cell imaging: New ways to see a smaller world	NATURE			English	Editorial Material							MICROSCOPY											Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Lord SJ, 2008, J AM CHEM SOC, V130, P9204, DOI 10.1021/ja802883k; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929	6	20	22	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					825	830		10.1038/456825a	http://dx.doi.org/10.1038/456825a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079061	Bronze			2022-12-24	WOS:000261559900058
J	Thomson, G; Wilson, N; Edwards, R; Woodward, A				Thomson, George; Wilson, Nick; Edwards, Richard; Woodward, Alistair			Should smoking in outside public spaces be banned? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHOOL; HOME		[Thomson, George; Wilson, Nick; Edwards, Richard] Univ Otago, Wellington, New Zealand; [Woodward, Alistair] Univ Auckland, Auckland 1, New Zealand	University of Otago; University of Auckland	Thomson, G (corresponding author), Univ Otago, Box 7343, Wellington, New Zealand.	george.thomson@otago.ac.nz	Edwards, Richard/O-4771-2017	Edwards, Richard/0000-0003-2264-9823; Woodward, Alistair/0000-0001-5425-6018				Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; *DEP ED, 1995, DRUG PREV SCH ANN 8; Fong GT, 2004, NICOTINE TOB RES, V6, P341, DOI 10.1080/14622200412331320743; Gilpin EA, 2004, TOB CONTROL, V13, P96, DOI 10.1136/tc.2003.007054; Griffiths J, 2005, SMOKE FREE SCOTLAND; *HLTH SPONS COUNC, 2008, ACC SMOK OUTD PUBL P; Klein EG, 2007, NICOTINE TOB RES, V9, pS49, DOI 10.1080/14622200601083467; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Levy DT, 2004, TOB CONTROL, V13, P258, DOI 10.1136/tc.2003.006056; Mackay J, 2006, TOBACCO ATLAS; McCaul KD, 2006, ADDICT BEHAV, V31, P42, DOI 10.1016/j.addbeh.2005.04.004; Milton B, 2004, PUBLIC HEALTH, V118, P247, DOI 10.1016/j.puhe.2003.10.006; *NAT CHILDC ACCR C, 2006, SMOK FREE ENV POL; New Zealand Government, 2003, SMOK FREE ENV AM ACT; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; *POP, 2007, BBC DAIL POL SHOW PO; *QUIT VICT, 2007, QUIT GETS SMOK PLAYG; Repace J., 2008, W MITCHELL LAW, V34, P1621; Stewart-Knox BJ, 2005, BRIT J SOC PSYCHOL, V44, P397, DOI 10.1348/014466604X18073; Tyas SL, 1998, TOB CONTROL, V7, P409, DOI 10.1136/tc.7.4.409; United Nations Office of the High Commissioner, 1990, CONV RIGHTS CHILD; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wilson Nick, 2007, N Z Med J, V120, pU2624	23	41	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2008	337								a2806	10.1136/bmj.a2806	http://dx.doi.org/10.1136/bmj.a2806			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074220				2022-12-24	WOS:000262776900007
J	Lewis, KW; Aharonson, O; Grotzinger, JP; Kirk, RL; McEwen, AS; Suer, TA				Lewis, Kevin W.; Aharonson, Oded; Grotzinger, John P.; Kirk, Randolph L.; McEwen, Alfred S.; Suer, Terry-Ann			Quasi-Periodic Bedding in the Sedimentary Rock Record of Mars	SCIENCE			English	Article							ARABIA TERRA; ATMOSPHERE; EVOLUTION; CRATERS; CYCLES	Widespread sedimentary rocks on Mars preserve evidence of surface conditions different from the modern cold and dry environment, although it is unknown how long conditions favorable to deposition persisted. We used 1- meter stereo topographic maps to demonstrate the presence of rhythmic bedding at several outcrops in the Arabia Terra region. Repeating beds are similar to 10 meters thick, and one site contains hundreds of meters of strata bundled into larger units at a similar to 10: 1 thickness ratio. This repetition likely points to cyclicity in environmental conditions, possibly as a result of astronomical forcing. If deposition were forced by orbital variation, the rocks may have been deposited over tens of millions of years.	[Lewis, Kevin W.; Aharonson, Oded; Grotzinger, John P.; Suer, Terry-Ann] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86004 USA; [McEwen, Alfred S.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	California Institute of Technology; United States Department of the Interior; United States Geological Survey; University of Arizona	Lewis, KW (corresponding author), CALTECH, Div Geol & Planetary Sci, 150-21, Pasadena, CA 91125 USA.	klewis@gps.caltech.edu	Lewis, Kevin/E-5557-2012	Aharonson, Oded/0000-0001-9930-2495	NASA's Mars Data Analysis Program; NASA Earth and Space Science Fellowship	NASA's Mars Data Analysis Program(National Aeronautics & Space Administration (NASA)); NASA Earth and Space Science Fellowship	Supported by NASA's Mars Data Analysis Program and by the NASA Earth and Space Science Fellowship program. We thank two anonymous reviewers for helpful comments and suggestions.	Carlson J, 2001, SEDIMENTOLOGY, V48, P1331, DOI 10.1046/j.1365-3091.2001.00426.x; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Christensen, 1992, MARS, P686; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Edgett KS, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001587; Edgett KS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016515; FANALE FP, 1994, ICARUS, V111, P305, DOI 10.1006/icar.1994.1147; FISCHER AG, 1986, ANNU REV EARTH PL SC, V14, P351; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Hinnov LA, 2000, ANNU REV EARTH PL SC, V28, P419, DOI 10.1146/annurev.earth.28.1.419; HOUSE MR, 1995, GEOL SOC SP, P1, DOI 10.1144/GSL.SP.1995.085.01.01; Hynek BM, 2003, GEOLOGY, V31, P757, DOI 10.1130/G19607.1; Kahn R. A., 1992, MARS, P1017; Kieffer H. H., 1992, MARS, P1180; Kirk RL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003000; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Malamud BD, 2006, J HYDROL, V322, P168, DOI 10.1016/j.jhydrol.2005.02.032; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Milkovich SM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002349; Schwarzacher W, 2000, EARTH-SCI REV, V50, P51, DOI 10.1016/S0012-8252(99)00070-7; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WAITT RB, 1980, J GEOL, V88, P653, DOI 10.1086/628553; Ward W. R., 1992, MARS, P298; WARD WR, 1974, J GEOPHYS RES, V79, P3387, DOI 10.1029/JC079i024p03387; WEEDOM GP, 2003, TIME SERIES ANAL CYC; Wilkinson BH, 1998, GEOL SOC AM BULL, V110, P1075, DOI 10.1130/0016-7606(1998)110<1075:MHMPAR>2.3.CO;2	30	100	101	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1532	1535		10.1126/science.1161870	http://dx.doi.org/10.1126/science.1161870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056983				2022-12-24	WOS:000261377400046
J	McMahon, A; Supatto, W; Fraser, SE; Stathopoulos, A				McMahon, Amy; Supatto, Willy; Fraser, Scott E.; Stathopoulos, Angelike			Dynamic Analyses of Drosophila Gastrulation Provide Insights into Collective Cell Migration	SCIENCE			English	Article							MORPHOGENESIS; FGF; HEARTLESS; MOVEMENTS; MESODERM; INTERCALATION; ZEBRAFISH; BEHAVIOR; EMBRYOS	The concerted movement of cells from different germ layers contributes to morphogenesis during early embryonic development. Using an optimized imaging approach and quantitative methods, we analyzed the trajectories of hundreds of ectodermal cells and internalized mesodermal cells within Drosophila embryos over 2 hours during gastrulation. We found a high level of cellular organization, with mesoderm cell movements correlating with some but not all ectoderm movements. During migration, the mesoderm population underwent two ordered waves of cell division and synchronous cell intercalation, and cells at the leading edge stably maintained position. Fibroblast growth factor ( FGF) signaling guides mesodermal cell migration; however, we found some directed dorsal migration in an FGF receptor mutant, which suggests that additional signals are involved. Thus, decomposing complex cellular movements can provide detailed insights into collective cell migration.	[McMahon, Amy; Stathopoulos, Angelike] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Supatto, Willy; Fraser, Scott E.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Stathopoulos, A (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	angelike@caltech.edu	Fraser, Scott/Y-3406-2019; Supatto, Willy/B-3720-2013	Fraser, Scott/0000-0002-5377-0223; Supatto, Willy/0000-0002-4562-9166	NIH [R01 GM078542]; Searle Scholars Program; March of Dimes; Basil O'Conner Starter Scholar Award [5-FY06-12]; Caltech Beckman Institute; NIH Center for Excellence in Genomic Science [P50 HG004071]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; March of Dimes(March of Dimes); Basil O'Conner Starter Scholar Award(March of Dimes); Caltech Beckman Institute; NIH Center for Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Levine and E. Meyerowiz for comments on the manuscript, M. Liebling for advice on Imaris and Matlab, and the Caltech Biological Imaging Center for sharing equipment. This work was supported by grants to A. S. from NIH (R01 GM078542), the Searle Scholars Program, and the March of Dimes (Basil O'Conner Starter Scholar Award, 5-FY06-12), and grants to S. F. from the Caltech Beckman Institute and NIH (Center for Excellence in Genomic Science grant P50 HG004071).	Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; Murray MJ, 2007, DEVELOPMENT, V134, P3975, DOI 10.1242/dev.005389; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schumacher S, 2004, DEVELOPMENT, V131, P2631, DOI 10.1242/dev.01149; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Stern C.D., 2004, GASTRULATION CELLS E; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wilson R, 2005, DEVELOPMENT, V132, P491, DOI 10.1242/dev.01603; Wilson R, 2000, PHILOS T ROY SOC B, V355, P891, DOI 10.1098/rstb.2000.0625; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005	22	115	118	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1546	1550		10.1126/science.1167094	http://dx.doi.org/10.1126/science.1167094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056986	Green Accepted			2022-12-24	WOS:000261377400050
J	Monne, M; Han, L; Schwend, T; Burendahl, S; Jovine, L				Monne, Magnus; Han, Ling; Schwend, Thomas; Burendahl, Sofia; Jovine, Luca			Crystal structure of the ZP-N domain of ZP3 reveals the core fold of animal egg coats	NATURE			English	Article							ZONA-PELLUCIDA PROTEINS; STRUCTURE ALIGNMENT; SPERM RECEPTORS; BINDING; PREDICTION; FERTILIZATION; GLYCOPROTEIN; MODEL; TOOL; CRYSTALLOGRAPHY	Species- specific recognition between the egg extracellular matrix ( zona pellucida) and sperm is the first, crucial step of mammalian fertilization(1). Zona pellucida filament components ZP3 and ZP2 act as sperm receptors, and mice lacking either of the corresponding genes produce oocytes without a zona pellucida and are completely infertile(2). Like their counterparts in the vitelline envelope of non- mammalian eggs and many other secreted eukaryotic proteins, zona pellucida subunits polymerize using a 'zona pellucida ( ZP) domain' module(3-5), whose conserved amino- terminal part (ZP-N) was suggested to constitute a domain of its own(6). No atomic structure has been reported for ZP domain proteins, and there is no structural information on any conserved vertebrate protein that is essential for fertilization and directly involved in egg - sperm binding. Here we describe the 2.3 angstrom (angstrom) resolution structure of the ZP-N fragment of mouse primary sperm receptor ZP3. The ZP- N fold defines a new immunoglobulin superfamily subtype with a beta-sheet extension characterized by an E' strand and an invariant tyrosine residue implicated in polymerization. The structure strongly supports the presence of ZP- N repeats within the N- terminal region of ZP2 and other vertebrate zona pellucida/ vitelline envelope proteins, with implications for overall egg coat architecture, the post- fertilization block to polyspermy and speciation. Moreover, it provides an important framework for understanding human diseases caused by mutations in ZP domain proteins and developing new methods of non- hormonal contraception.	[Monne, Magnus; Han, Ling; Schwend, Thomas; Burendahl, Sofia; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14157 Huddinge, Sweden.	luca.jovine@ki.se	Monné, Magnus/D-5642-2012; Jovine, Luca/E-8170-2010; Jovine, Luca/J-3563-2019	Monné, Magnus/0000-0003-2344-3878; Jovine, Luca/0000-0002-2679-6946; Jovine, Luca/0000-0002-2679-6946	Karolinska Institutet; Swedish Research Council [2005-5102]; European Community [Marie Curie ERG 31055]; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Karolinska Institutet, the Swedish Research Council (grant 2005-5102) and European Community (Marie Curie ERG 31055). We thank P. Nordlund and G. Schneider for access to the Stockholm SGC robotic crystallization facility and beamtime; H. Belrhali, J. McCarthy, R. Ravelli and M. Walsh for assistance at ESRF; P. Afonine, R. Grosse- Kunstleve and P. Zwart for help with phenix. refine; G. Murshudov for help with REFMAC; C. Chothia, F. Cotelli, J.- A. Gustafsson, R. Herbst-Irmer, A. Kohl, R. Ladenstein, M. Letarte, E. Litscher, E. Morgunova, A. Murzin, K. Nagai, L. Nilsson, D. Rhodes, R. Toftga rd and P. Wassarman for discussions and comments.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BORK P, 2005, NUCLEIC ACIDS RES, V33, pW299; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burendahl S, 2008, BIOCHEMISTRY-US, V47, P5205, DOI 10.1021/bi7025084; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doren S, 1999, DEV GENES EVOL, V209, P330, DOI 10.1007/s004270050261; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; Familiari G, 2008, FRONT BIOSCI-LANDMRK, V13, P6730, DOI 10.2741/3185; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Galindo BE, 2003, P NATL ACAD SCI USA, V100, P4639, DOI 10.1073/pnas.0830022100; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hasegawa A, 2002, J REPROD IMMUNOL, V53, P91, DOI 10.1016/S0165-0378(01)00084-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine Luca, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091/7/11; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai S, 2008, MOL REPROD DEV, V75, P847, DOI 10.1002/mrd.20836; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P935, DOI 10.1107/S090744490703315X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Lindsay LL, 2004, BIOCHEM BIOPH RES CO, V324, P648, DOI 10.1016/j.bbrc.2004.09.099; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nixon B, 2007, CELL MOL LIFE SCI, V64, P1805, DOI 10.1007/s00018-007-6552-x; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SOMOZA JR, 1995, ACTA CRYSTALLOGR A, V51, P691, DOI 10.1107/S0108767395002315; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Sun W, 1999, BIOL REPROD, V60, P900, DOI 10.1095/biolreprod60.4.900; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tian JD, 1999, P NATL ACAD SCI USA, V96, P829, DOI 10.1073/pnas.96.3.829; Tsubamoto H, 1999, BIOL REPROD, V61, P1649, DOI 10.1095/biolreprod61.6.1649; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; WASSARMAN PM, 1991, INT REV CYTOL, V130, P85, DOI 10.1016/S0074-7696(08)61502-8; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	68	100	103	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					653	U82		10.1038/nature07599	http://dx.doi.org/10.1038/nature07599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052627				2022-12-24	WOS:000261340000044
J	Winter, J; Ilbert, M; Graf, PCF; Ozcelik, D; Jakob, U				Winter, J.; Ilbert, M.; Graf, P. C. F.; Oezcelik, D.; Jakob, U.			Bleach Activates a Redox-Regulated Chaperone by Oxidative Protein Unfolding	CELL			English	Article							HYPOCHLOROUS ACID; HEAT-SHOCK; METHIONINE SULFOXIDE; SWITCH DOMAIN; CROSS-LINKING; STRESS; DNAK; HSP33; MYELOPEROXIDASE; INACTIVATION	Hypochlorous acid (HOCl), the active ingredient in household bleach, is an effective antimicrobial produced by the mammalian host defense to kill invading microorganisms. Despite the widespread use of HOCl, surprisingly little is known about its mode of action. In this study, we demonstrate that low molar ratios of HOCl to protein cause oxidative protein unfolding in vitro and target thermolabile proteins for irreversible aggregation in vivo. As a defense mechanism, bacteria use the redox-regulated chaperone Hsp33, which responds to bleach treatment with the reversible oxidative unfolding of its C-terminal redox switch domain. HOCl-mediated unfolding turns inactive Hsp33 into a highly active chaperone holdase, which protects essential Escherichia coli proteins against HOCl-induced aggregation and increases bacterial HOCl resistance. Our results substantially improve our molecular understanding about HOCl's functional mechanism. They suggest that the antimicrobial effects of bleach are largely based on HOCl's ability to cause aggregation of essential bacterial proteins.	[Winter, J.; Ilbert, M.; Graf, P. C. F.; Oezcelik, D.; Jakob, U.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Graf, P. C. F.; Jakob, U.] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Özcelik, Dennis/M-9961-2019; Ilbert, marianne/ABG-5015-2021	Özcelik, Dennis/0000-0002-7185-4690; ilbert, marianne/0000-0002-9070-2334; Graf, Paul/0000-0002-1094-7498	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM065318, GM065318, R01 GM065318-06A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; Aliev G, 2002, BRAIN PATHOL, V12, P21; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Britigan BE, 1996, BBA-GEN SUBJECTS, V1290, P231, DOI 10.1016/0304-4165(96)00014-1; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1996, APPL ENVIRON MICROB, V62, P4003, DOI 10.1128/AEM.62.11.4003-4008.1996; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jayaraman S, 2008, BIOCHEMISTRY-US, V47, P3875, DOI 10.1021/bi7023783; Khor HK, 2004, J BIOL CHEM, V279, P19486, DOI 10.1074/jbc.M310045200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Lide D.R., 1994, CRC HDB CHEM PHYS; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	34	270	277	4	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					691	701		10.1016/j.cell.2008.09.024	http://dx.doi.org/10.1016/j.cell.2008.09.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013278	Bronze, Green Accepted			2022-12-24	WOS:000260886900019
J	Zehr, JP; Bench, SR; Carter, BJ; Hewson, I; Niazi, F; Shi, T; Tripp, HJ; Affourtit, JP				Zehr, Jonathan P.; Bench, Shellie R.; Carter, Brandon J.; Hewson, Ian; Niazi, Faheem; Shi, Tuo; Tripp, H. James; Affourtit, Jason P.			Globally Distributed Uncultivated Oceanic N-2-Fixing Cyanobacteria Lack Oxygenic Photosystem II	SCIENCE			English	Article							NITROGEN-FIXATION; UNICELLULAR CYANOBACTERIA; RHOPALODIA-GIBBA; N-2; DIAZOTROPHS; EXPRESSION; EVOLUTION; PATTERNS		[Zehr, Jonathan P.; Bench, Shellie R.; Carter, Brandon J.; Hewson, Ian; Shi, Tuo; Tripp, H. James] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Niazi, Faheem; Affourtit, Jason P.] Life Sci 454, Branford, CT 06405 USA	University of California System; University of California Santa Cruz	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	shi, tuo/E-6948-2017; Hewson, Ian/B-4871-2013; Shi, Tuo/T-7926-2017; Zehr, Jonathan P/B-3513-2014; Bench, Shellie R/E-7679-2010	shi, tuo/0000-0003-3362-8163; Shi, Tuo/0000-0003-3362-8163; Zehr, Jonathan P/0000-0002-5691-5408; 	Gordon and Betty Moore Foundation; Microbial Environmental Genomics; Modeling, Experimentation and Remote Sensing (MEGAMER) facility; NSF [OCE0425363]; NSF Center for Microbial Oceanography Research and Education [CCF424599]; 454 Life Sciences; Roche Company	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Microbial Environmental Genomics; Modeling, Experimentation and Remote Sensing (MEGAMER) facility; NSF(National Science Foundation (NSF)); NSF Center for Microbial Oceanography Research and Education(National Science Foundation (NSF)); 454 Life Sciences; Roche Company	We thank J. Montoya, D. Karl, M.J. Church, J.K. Doggett, the Hawaii Ocean Time- series crew, and the captain and crew of the R/V Kilo Moana for facilitating sample collection and analysis. We also thank E. Mondragon, P. Moisander, M. Hogan, K. Pennebaker, R. Beinart, and the Zehr laboratory for technical support. This work was partially supported by the Gordon and Betty Moore Foundation [J.P.Z. and the Microbial Environmental Genomics: Modeling, Experimentation and Remote Sensing (MEGAMER) facility], NSF (OCE0425363) (J.P.Z.), and the NSF Center for Microbial Oceanography Research and Education (CCF424599) (J.P.Z.). Support for sequencing was provided by 454 Life Sciences, a Roche Company. The GenBank accession numbers of the sequences generated from PCR in this study are EU187504 to EU187629 and FJ189800 to FJ190047. For a complete list of GenBank accessions, please see the supporting online material (21).	Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hansell DA, 2004, MAR CHEM, V84, P243, DOI 10.1016/j.marchem.2003.08.004; Kneip C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-30; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Misra HS, 2003, J PLANT PHYSIOL, V160, P33, DOI 10.1078/0176-1617-00846; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Prechtl J, 2004, MOL BIOL EVOL, V21, P1477, DOI 10.1093/molbev/msh086; Shi T, 2005, MOL BIOL EVOL, V22, P2179, DOI 10.1093/molbev/msi216; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; VENRICK EL, 1974, LIMNOL OCEANOGR, V19, P437, DOI 10.4319/lo.1974.19.3.0437; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	25	244	256	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1110	1112		10.1126/science.1165340	http://dx.doi.org/10.1126/science.1165340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008448				2022-12-24	WOS:000260867700040
J	Schwaber, MJ; Carmeli, Y				Schwaber, Mitchell J.; Carmeli, Yehuda			Carbapenem-Resistant Enterobacteriaceae A Potential Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; BETA-LACTAMASES; STAPHYLOCOCCUS-AUREUS; NEW-YORK; INFECTIONS; MORTALITY; SPREAD		[Schwaber, Mitchell J.] Minist Hlth, Natl Ctr Infect Control, IL-64239 Tel Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Med Ctr & Sch Med, Div Epidemiol & Prevent Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Schwaber, MJ (corresponding author), Minist Hlth, Natl Ctr Infect Control, 6 Weizmann St, IL-64239 Tel Aviv, Israel.	mitchells@tasmc.health.gov.il	Schwaber, Mitchell/AAI-2486-2019					Appelbaum PC, 2007, CLIN INFECT DIS, V45, pS165, DOI 10.1086/519474; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Bratu S, 2007, CLIN INFECT DIS, V44, P972, DOI 10.1086/512370; Daikos GL, 2007, INT J ANTIMICROB AG, V29, P471, DOI 10.1016/j.ijantimicag.2006.11.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rodriguez-Bano J, 2008, ARCH INTERN MED, V168, P1897, DOI 10.1001/archinte.168.17.1897; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; SCHWABER MJ, 2008, 48 ANN INT C ANT AG; Urban C, 2008, CLIN INFECT DIS, V46, pE127, DOI 10.1086/588048; Vatopoulos A, 2008, Euro Surveill, V13	14	201	210	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2911	2913						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109119	Green Accepted			2022-12-24	WOS:000261920900024
J	[Anonymous]				[Anonymous]			Cell imaging: LIGHT ACTIVATED	NATURE			English	Editorial Material																			0	2	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					826	827		10.1038/456826a	http://dx.doi.org/10.1038/456826a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079062	Bronze			2022-12-24	WOS:000261559900059
J	Garner, EC				Garner, Ethan Clark			GE PRIZE ESSAY Understanding a Minimal DNA-Segregating Machine	SCIENCE			English	Editorial Material							PROKARYOTIC ACTIN HOMOLOG; DYNAMIC INSTABILITY; PARTITION; PLASMID; GROWTH		[Garner, Ethan Clark] Univ Calif San Francisco, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Garner, EC (corresponding author), Univ Calif San Francisco, San Francisco, CA 94158 USA.	egarner@mullinslab2.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555				AUSTIN S, 1983, J MOL BIOL, V169, P353, DOI 10.1016/S0022-2836(83)80055-2; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3	9	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1486	1487		10.1126/science.1168506	http://dx.doi.org/10.1126/science.1168506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056970				2022-12-24	WOS:000261377400033
J	Vandenbroucke, JP; Psaty, BM				Vandenbroucke, Jan P.; Psaty, Bruce M.			Benefits and Risks of Drug Treatments How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMATIC REVIEWS; RANDOMIZED-TRIALS; HARMS		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Vandenbroucke, Jan P.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, U01HL080295, R01HL087652, R01HL085251, R01HL080295] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080295, HL087652, HL74745, HL085251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; BACIU A, 2006, FUTURE DRUG SAFETY P; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; JICK H, 1978, AM J EPIDEMIOL, V107, P1; Loke YK, 2008, ALIMENT PHARM THERAP, V27, P31, DOI 10.1111/j.1365-2036.2007.03541.x; Loke YK, 2004, BRIT J CLIN PHARMACO, V57, P616, DOI 10.1111/j.0306-5251.2003.02055.x; Mallett S, 2002, INT J TECHNOL ASSESS, V18, P820, DOI 10.1017/S0266462302000624; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2	15	103	104	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2417	2419		10.1001/jama.2008.723	http://dx.doi.org/10.1001/jama.2008.723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033592				2022-12-24	WOS:000261150800024
J	Bosmans, F; Martin-Eauclaire, MF; Swartz, KJ				Bosmans, Frank; Martin-Eauclaire, Marie-France; Swartz, Kenton J.			Deconstructing voltage sensor function and pharmacology in sodium channels	NATURE			English	Article							ALPHA-SCORPION TOXIN; DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; GATING MODIFIER; SKELETAL-MUSCLE; MOLECULAR DETERMINANTS; TARANTULA TOXINS; IONIC CURRENTS; RAT-BRAIN; DOMAIN IV	Voltage- activated sodium (Na-v) channels are crucial for the generation and propagation of nerve impulses, and as such are widely targeted by toxins and drugs. The four voltage sensors in Na-v channels have distinct amino acid sequences, raising fundamental questions about their relative contributions to the function and pharmacology of the channel. Here we use four- fold symmetric voltage- activated potassium ( K-v) channels as reporters to examine the contributions of individual S3b-S4 paddle motifs within Na-v channel voltage sensors to the kinetics of voltage sensor activation and to forming toxin receptors. Our results uncover binding sites for toxins from tarantula and scorpion venom on each of the four paddle motifs in Nav channels, and reveal how paddle- specific interactions can be used to reshape Na-v channel activity. One paddle motif is unique in that it slows voltage sensor activation, and toxins selectively targeting this motif impede Na-v channel inactivation. This reporter approach and the principles that emerge will be useful in developing new drugs for treating pain and Na-v channelopathies.	[Bosmans, Frank; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Bosmans, Frank] Catholic Univ Louvain, Toxicol Lab, B-3000 Louvain, Belgium; [Martin-Eauclaire, Marie-France] Univ Mediterranee, CNRS, Inst Jean Roche, UMR 6231,CRN2M, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov	Bosmans, Frank/A-9660-2013; Bosmans, Frank/T-5589-2017	Bosmans, Frank/0000-0002-6476-235X; Bosmans, Frank/0000-0002-6476-235X; Bosmans, Frank/0000-0002-0451-6050	Intramural Research Program; NINDS; NIH; NIH- FWO postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003017] Funding Source: NIH RePORTER	Intramural Research Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH- FWO postdoctoral fellowship(FWO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.W. Kyle, D.A. Hanck and A.L. Goldin for the rNa<INF>v</INF>1.2a, rNa<INF>v</INF>1.4 and beta<INF>1</INF> clones, C. Deutsch for K<INF>v</INF>1.3, M.M. Smith for GxTx-1E, K.M. Blumenthal and J.B. Herrington for ProTx-II, L.D. Possani for a sample of TsVII, the NINDS DNA sequencing facility for DNA sequencing, and the NINDS protein sequencing facility for mass spectrometry and peptide sequencing. We thank A.A. Alabi for helping with Kv and Nav channel alignments and T.-H. Chang for assistance with Nav channel mutants. We also thank A. A. Alabi, M. Holmgren, M. Mayer, M. Milescu, J. Mindell, A. Plested, S. Silberberg and members of the Swartz laboratory for discussions. This work was supported by the Intramural Research Program of the NINDS, NIH (K.J.S.) and by an NIH- FWO postdoctoral fellowship (F.B.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bendahhou S, 1999, J NEUROSCI, V19, P4762; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; CEARD B, 1992, TOXICON, V30, P105, DOI 10.1016/0041-0101(92)90506-Z; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; KOPPENHOFER E, 1968, PFLUG ARCH EUR J PHY, V303, P150, DOI 10.1007/BF00592632; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MARTIN MF, 1987, TOXICON, V25, P569, DOI 10.1016/0041-0101(87)90293-5; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sheets MF, 2000, J GEN PHYSIOL, V115, P609, DOI 10.1085/jgp.115.5.609; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TEJEDOR FJ, 1988, P NATL ACAD SCI USA, V85, P8742, DOI 10.1073/pnas.85.22.8742; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Wan XP, 2001, AM J PHYSIOL-HEART C, V280, pH354, DOI 10.1152/ajpheart.2001.280.1.H354; Wang GK, 2000, PFLUG ARCH EUR J PHY, V439, P705, DOI 10.1007/s004240050996; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	62	219	232	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					202	U28		10.1038/nature07473	http://dx.doi.org/10.1038/nature07473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005548	Green Accepted			2022-12-24	WOS:000261039300032
J	Taylor, P				Taylor, Patrick			Personal genomes: When consent gets in the way	NATURE			English	Editorial Material							PRIVACY RULE; HEALTH		[Taylor, Patrick] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Taylor, Patrick] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Taylor, P (corresponding author), Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	patrick.taylor@childrens.harvard.edu						Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, Vseventh; Breese P, 2005, JAMA-J AM MED ASSOC, V293, P1593, DOI 10.1001/jama.293.13.1593; Churchill LR, 1999, DAEDALUS, V128, P253; Gostin LO, 2002, MINN LAW REV, V86, P1439; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Huang N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-18; Ingelfinger JR, 2004, NEW ENGL J MED, V350, P1452, DOI 10.1056/NEJMe048027; JONAS H, 1969, DAEDALUS, V98, P219; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; MANOS D, HEALTHCARE IT N 1018; Ness RB, 2007, JAMA-J AM MED ASSOC, V298, P2164, DOI 10.1001/jama.298.18.2164; Westin A. E., 2008, PUBLIC VIEWS PRIVACY	13	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					32	33		10.1038/456032a	http://dx.doi.org/10.1038/456032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369DH	18987719				2022-12-24	WOS:000260674000024
J	O'Meara, WP; Bejon, P; Mwangi, TW; Okiro, EA; Peshu, N; Snow, RW; Newton, CRJC; Marsh, K				O'Meara, Wendy P.; Bejon, Phillip; Mwangi, Tabitha W.; Okiro, Emelda A.; Peshu, Norbert; Snow, Robert W.; Newton, Charles R. J. C.; Marsh, Kevin			Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya	LANCET			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INSECTICIDE-TREATED BEDNETS; PROGNOSTIC INDICATORS; CHILDHOOD MALARIA; SEVERE DISEASE; DRUG POLICY; CHILDREN; AGE; INTENSITY; EXPOSURE	Background As efforts to control malaria are expanded across the world, understanding the role of transmission intensity in determining the burden of clinical malaria is crucial to the prediction and measurement of the effectiveness of interventions to reduce transmission. Furthermore, studies comparing several endemic sites led to speculation that as transmission decreases morbidity and mortality caused by severe malaria might increase. We aimed to assess the epidemiological characteristics of malaria in Kilifi, Kenya, during a period of decreasing transmission intensity. Methods We analyse 18 years (1990-2007) of surveillance data from a paediatric ward in a malaria-endemic region of Kenya. The hospital has a catchment area of 250000 people. Clinical data and blood-film results for more than 61000 admissions are reported. Findings Hospital admissions for malaria decreased from 18-43 per 1000 children in 2003 to 3.42 in 2007. Over 18 years of surveillance, the incidence of cerebral malaria initially increased; however, malaria mortality decreased overall because of a decrease in incidence of severe malarial anaemia since 1997 (4.75 to 0.37 per 1000 children) and improved survival among children admitted with non-severe malaria. Parasite prevalence, the mean age of children admitted with malaria, and the proportion of children with cerebral malaria began to change 10 years before hospitalisation for malaria started to fall. Interpretation Sustained reduction in exposure to infection leads to changes in mean age and presentation of disease similar to those described in multisite studies. Changes in transmission might not lead to immediate reductions incidence of clinical disease. However, longitudinal data do not indicate that reductions in transmission intensity lead to transient increases in morbidity and mortality. Funding Wellcome Trust, Kenya Medical Research Institute.	[O'Meara, Wendy P.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Okiro, Emelda A.; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Program, Nairobi, Kenya; [Bejon, Phillip; Snow, Robert W.; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Newton, Charles R. J. C.] UCL, Inst Child Hlth, London, England; [O'Meara, Wendy P.; Bejon, Phillip; Mwangi, Tabitha W.; Peshu, Norbert; Newton, Charles R. J. C.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Wellcome Trust Collaborat Program, Kilifi, Kenya	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Kenya Medical Research Institute; University of Oxford; University of London; University College London; Kenya Medical Research Institute	O'Meara, WP (corresponding author), NIH, Fogarty Int Ctr, 16 Ctr Dr, Bethesda, MD 20892 USA.	prudhomw@mail.nih.gov	Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019; Snow, Robert William/AFR-1436-2022	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Snow, Robert William/0000-0003-3725-6088; Okiro, Emelda/0000-0001-9543-8360	Fogarty International Center; Wellcome Trust	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is published with the permission of the Director of Kenya Medical Research Institute. We wish to thank all the clinical, field, and laboratory staff at the Kenya Medical Research Institute-Wellcome Must Programme who made this study possible. WPO is funded by the Fogarty International Center. CRJCN is funded by the Wellcome Trust. RWS is a Wellcome Trust Principal Research Fellow (#079080).	Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; MOLYNEUX ME, 1989, Q J MED, V71, P441; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; MWANGI TW, 2003, CLIN EPIDEMIOLOGY MA; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1995, PARASITOL TODAY, V11, P188, DOI 10.1016/0169-4758(95)80156-1; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6	38	322	323	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1555	1562		10.1016/S0140-6736(08)61655-4	http://dx.doi.org/10.1016/S0140-6736(08)61655-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984188	Green Published			2022-12-24	WOS:000260590500027
J	Chou, YF; Chen, HH; Eijpe, M; Yabuuchi, A; Chenoweth, JG; Tesar, P; Lu, J; McKay, RDG; Geijsen, N				Chou, Yu-Fen; Chen, Hsu-Hsin; Eijpe, Maureen; Yabuuchi, Akiko; Chenoweth, Joshua G.; Tesar, Paul; Lu, Jun; Mckay, Ronald D. G.; Geijsen, Niels			The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells	CELL			English	Article							PRIMORDIAL GERM-CELLS; E-CADHERIN; REGULATORY CIRCUITRY; SELF-RENEWAL; FREE CULTURE; LINES; DIFFERENTIATION; GENERATION; FIBROBLASTS; DERIVATION	Pluripotent stem cell lines can be derived from blastocyst embryos, which yield embryonic stem cell lines (ES cells), as well as the postimplantation epiblast, which gives rise to epiblast stem cell lines (EpiSCs). Remarkably, ES cells and EpiSCs display profound differences in the combination of growth factors that maintain their pluripotent state. Molecular and functional differences between these two stem cell types demonstrate that the tissue of origin and/or the growth factor milieu may be important determinants of the stem cell identity. We explored how developmental stage of the tissue of origin and culture growth factor conditions affect the stem cell pluripotent state. Our findings indicate that novel stem cell lines, with unique functional and molecular properties, can be generated from murine blastocyst embryos. We demonstrate that the culture growth factor environment and cell-cell interaction play a critical role in defining several unique and stable stem cell ground states.	[Chou, Yu-Fen; Chen, Hsu-Hsin; Geijsen, Niels] Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; [Eijpe, Maureen] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Yabuuchi, Akiko] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Chenoweth, Joshua G.; Mckay, Ronald D. G.] Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Lu, Jun] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Lu, Jun] MIT, Cambridge, MA 02141 USA	Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Case Western Reserve University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Geijsen, N (corresponding author), Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, CPZN-4256,185 Cambridge St, Boston, MA 02114 USA.	ngeijsen@mgh.harvard.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155	National Institutes of Health [RO1HD048769-01A1]; Harvard Stem Cell Institute; Dutch Cancer Society (Koningin Wilhelmina Fonds); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Dutch Cancer Society (Koningin Wilhelmina Fonds)(KWF Kankerbestrijding); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. George Daley for his review of our manuscript and help with the blastocyst injections; Dr. Paul Tesar for the EpiSC image; Dr. Roger Tsien for the use of the tdTomato fluorescent reporter; Dr. Keith Orford for critical review of the manuscript; Kelly Shea for providing technical support; and Laura Prickett and Kat Folz-Donahue at the HSCI/MGH Flow Cytometry Core Facility for help with cell purifications. This work was supported by grants from the National Institutes of Health (RO1HD048769-01A1) and the Harvard Stem Cell Institute. M. E. was supported by the Dutch Cancer Society (Koningin Wilhelmina Fonds).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GIBRALTER D, 1985, DEV BIOL, V112, P292, DOI 10.1016/0012-1606(85)90400-2; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Larue L, 1996, DEVELOPMENT, V122, P3185; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rathjen J, 1999, J CELL SCI, V112, P601; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	56	171	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					449	461		10.1016/j.cell.2008.08.035	http://dx.doi.org/10.1016/j.cell.2008.08.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984157	Bronze, Green Accepted			2022-12-24	WOS:000260536300016
J	Zacho, J; Tybjaerg-Hansen, A; Jensen, JS; Grande, P; Sillesen, H; Nordestgaard, BG				Zacho, Jeppe; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Grande, Peer; Sillesen, Henrik; Nordestgaard, Borge G.			Genetically elevated C-reactive protein and ischemic vascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; CRP GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; CARDIOVASCULAR EVENTS; SERUM CRP; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; REGRESSION DILUTION; PROMOTER REGION	Background: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. Methods: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. Results: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. Conclusions: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.	[Zacho, Jeppe; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Clin Biochem,Herlev Hosp, DK-2730 Herlev, Denmark; [Zacho, Jeppe; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen Gen Populat Study,Herlev Hosp, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Clin Biochem, DK-2730 Herlev, Denmark; [Grande, Peer] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Cardiol, DK-2730 Herlev, Denmark; [Sillesen, Henrik] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Vasc Surg, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen City Heart Study,Bispebjerg Hosp, DK-2730 Herlev, Denmark; [Jensen, Jan Skov] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Cardiol,Gentofte Hosp, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Clin Biochem,Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Sillesen, Henrik/ABB-5668-2020		Danish Heart Foundation; BG Medicine; AstraZeneca; Sanofi-Aventis; Merck; Pfizer; Boehringer Ingelheim	Danish Heart Foundation; BG Medicine; AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by the Danish Heart Foundation. Dr. Nordestgaard reports receiving consulting fees from BG Medicine and AstraZeneca and lecture fees from AstraZeneca, Sanofi-Aventis, Merck, Pfizer, and Boehringer Ingelheim; Dr. Sillesen, consulting fees from Merck, Pfizer, BG Medicine, Boehringer Ingelheim, Sanofi-Aventis, and AstraZeneca; Dr. Grande, consulting fees from AstraZeneca; and Dr. Tybjaerg-Hansen, lecture fees from Pfizer and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.; We thank Hanne Damm, Dorthe Uldall Andersen, and Dorthe Kjeldgaard Hansen for their assistance with the large-scale genotyping and the staff and participants of the Copenhagen City Heart Study, the Copenhagen General Population Study, the Copenhagen Ischemic Heart Disese Study, and the Copenhagen Carotid Stroke Study for their important contributions to our study.	AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002; Balistreri CR, 2006, ANN NY ACAD SCI, V1067, P276, DOI 10.1196/annals.1354.036; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe; Frikke-Schmidt R, 2000, J AM COLL CARDIOL, V35, P1192, DOI 10.1016/S0735-1097(00)00520-9; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Klein, 2003, SURVIVAL ANAL TECHNI, P295, DOI [10.1007/b97377, DOI 10.1007/B97377]; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Reitz C, 2007, STROKE, V38, P2356, DOI 10.1161/STROKEAHA.107.482661; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2005, RHEUMATOLOGY, V44, P864, DOI 10.1093/rheumatology/keh613; Wang QW, 2006, AM J PHYSIOL-HEART C, V291, pH2752, DOI 10.1152/ajpheart.01164.2005; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	36	624	647	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1897	1908		10.1056/NEJMoa0707402	http://dx.doi.org/10.1056/NEJMoa0707402			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971492				2022-12-24	WOS:000260454500006
J	Scrima, A; Konickova, R; Czyzewski, BK; Kawasaki, Y; Jeffrey, PD; Groisman, R; Nakatani, Y; Iwai, S; Pavletich, NP; Thoma, NH				Scrima, Andrea; Konickova, Renata; Czyzewski, Bryan K.; Kawasaki, Yusuke; Jeffrey, Philip D.; Groisman, Regina; Nakatani, Yoshihiro; Iwai, Shigenori; Pavletich, Nikola P.; Thomae, Nicolas H.			Structural Basis of UV DNA-Damage Recognition by the DDB1-DDB2 Complex	CELL			English	Article							PIGMENTOSUM GROUP-E; GROUP-E CELLS; XERODERMA-PIGMENTOSUM; UBIQUITIN LIGASE; BINDING-PROTEIN; PYRIMIDINE DIMERS; DIFFRACTION DATA; REPAIR; DDB2; P48	Ultraviolet (UV) light-induced pyrimidine photodimers are repaired by the nucleotide excision repair pathway. Photolesions have biophysical parameters closely resembling undamaged DNA, impeding discovery through damage surveillance proteins. The DDB1-DDB2 complex serves in the initial detection of UV lesions in vivo. Here we present the structures of the DDB1-DDB2 complex alone and bound to DNA containing either a 6-4 pyrimidine-pyrimidone photodimer (6-4PP) lesion or an abasic site. The structure shows that the lesion is held exclusively by the WD40 domain of DDB2. A DDB2 hairpin inserts into the minor groove, extrudes the photodimer into a binding pocket, and kinks the duplex by similar to 40 degrees. The tightly localized probing of the photolesions, combined with proofreading in the photodimer pocket, enables DDB2 to detect lesions refractory to detection by other damage surveillance proteins. The structure provides insights into damage recognition in chromatin and suggests a mechanism by which the DDB1-associated CUL4 ubiquitin ligase targets proteins surrounding the site of damage.	[Czyzewski, Bryan K.; Jeffrey, Philip D.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Scrima, Andrea; Konickova, Renata; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kawasaki, Yusuke; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan; [Groisman, Regina] Univ Paris Sud, Inst Andre Lwoff, CNRS, FRE 2944, F-94801 Villejuif, France; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Friedrich Miescher Institute for Biomedical Research; Osaka University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	pavletin@mskcc.org; nicolas.thoma@fmi.ch		Groisman, Sonia/0000-0003-1153-3841; Jeffrey, Philip/0000-0002-4351-5341; Groisman, Regina/0000-0003-3990-7622	Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland; Human Frontier Science Program (HFSP); Swiss National Fond [31-120205]; Novartis Research Foundation; European Molecular Biology Organization (EMBO)	Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland; Human Frontier Science Program (HFSP)(Human Frontier Science Program); Swiss National Fond(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	We thank Norman Kairies for crystallographic support. We would like to thank Fritz Thoma, Hanspeter Naegeli, and Susan Gasser for discussions relating to DNA repair in the context of chromatin. We thank Hans Widmer for help and support. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland. Y.N. and S.I. acknowledge funding from the Human Frontier Science Program (HFSP). Funding in the laboratory of N.H.T. is provided by the Swiss National Fond (SNF;#31-120205) and the Novartis Research Foundation. A. S. gratefully acknowledges funding from the European Molecular Biology Organization (EMBO).	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELDBERG RS, 1976, BIOCHEMISTRY-US, V15, P2402, DOI 10.1021/bi00656a024; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fugmann SD, 2001, MOL CELL, V8, P899, DOI 10.1016/S1097-2765(01)00352-5; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Iwai S, 1996, J AM CHEM SOC, V118, P7642, DOI 10.1021/ja9603158; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Maillard O, 2007, TRENDS BIOCHEM SCI, V32, P494, DOI 10.1016/j.tibs.2007.08.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; O'Neil LL, 2007, J PHYS CHEM B, V111, P11843, DOI 10.1021/jp074043e; Otrin VR, 1998, MOL CELL BIOL, V18, P3182, DOI 10.1128/MCB.18.6.3182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; TAKAO M, 1993, NUCLEIC ACIDS RES, V21, P4111, DOI 10.1093/nar/21.17.4111; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wittschieben BO, 2003, DNA REPAIR, V2, P1065, DOI 10.1016/S1568-7864(03)00113-7; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yasuda G, 2007, MOL CELL BIOL, V27, P6606, DOI 10.1128/MCB.02166-06; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008	59	294	302	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1213	1223		10.1016/j.cell.2008.10.045	http://dx.doi.org/10.1016/j.cell.2008.10.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109893	Bronze, Green Accepted			2022-12-24	WOS:000261989800013
J	Heimberg, H				Heimberg, Harry			Boosting Beta-Cell Numbers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heimberg, Harry] Vrije Univ Brussels, Ctr Diabet Res, Brussels, Belgium; [Heimberg, Harry] Juvenile Diabet Res Fdn Ctr Beta Cell Therapy Dia, Brussels, Belgium	Vrije Universiteit Brussel	Heimberg, H (corresponding author), Vrije Univ Brussels, Ctr Diabet Res, Brussels, Belgium.			Heimberg, Harry/0000-0003-1954-7375				Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2723	2724		10.1056/NEJMcibr0807675	http://dx.doi.org/10.1056/NEJMcibr0807675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092158	Green Published			2022-12-24	WOS:000261757300014
J	Sarewitz, D; Nelson, R				Sarewitz, Daniel; Nelson, Richard			Three rules for technological fixes	NATURE			English	Editorial Material							CAPTURE; ENERGY		[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA; [Nelson, Richard] Columbia Univ, New York, NY 10027 USA	Arizona State University; Arizona State University-Tempe; Columbia University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu; rrn2@columbia.edu						Baciocchi R, 2006, CHEM ENG PROCESS, V45, P1047, DOI 10.1016/j.cep.2006.03.015; Foray D., 2003, LONDON REV ED, V1, P7, DOI DOI 10.1080/14748460306689; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; MURNANE R, 2004, EC INNOVATION NEW TE, V16, P307; National Research Council, 2003, STRATEGIC ED RES PAR; Prins G, 2007, NATURE, V449, P973, DOI 10.1038/449973a; Sarewitz D, 2008, CONTROVERSIES IN SCIENCE & TECHNOLOGY, VOL 2, P329; Stolaroff J.K., 2006, THESIS CARNEGIE MELL	10	62	62	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					871	872		10.1038/456871a	http://dx.doi.org/10.1038/456871a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	384TY	19092910	Bronze			2022-12-24	WOS:000261768300015
J	Anbar, AD				Anbar, Ariel D.			OCEANS Elements and Evolution	SCIENCE			English	Editorial Material							CHEMISTRY; STOICHIOMETRY; OXYGENATION; COEVOLUTION; CYCLES		[Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Anbar, AD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	anbar@asu.edu						Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Buick R, 2007, GEOBIOLOGY, V5, P97, DOI 10.1111/j.1472-4669.2007.00110.x; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Lyons TW, 2008, SCIENCE, V321, P923, DOI 10.1126/science.1162870; Morel FMM, 2008, GEOBIOLOGY, V6, P318, DOI 10.1111/j.1472-4669.2008.00144.x; PECOITS E, 2008, ASTROBIOLOGY, V8, P412; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Williams RJP, 2003, J THEOR BIOL, V220, P323, DOI 10.1006/jtbi.2003.3152; WOLFESIMON F, INT J ASTRO IN PRESS; Zerkle AL, 2005, AM J SCI, V305, P467, DOI 10.2475/ajs.305.6-8.467; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285	26	212	225	7	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1481	1483		10.1126/science.1163100	http://dx.doi.org/10.1126/science.1163100			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056967				2022-12-24	WOS:000261377400030
J	Das, P; Samarasekera, U				Das, Pam; Samarasekera, Udani			What next for UNAIDS?	LANCET			English	News Item																			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2099	2102		10.1016/S0140-6736(08)61908-X	http://dx.doi.org/10.1016/S0140-6736(08)61908-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19112650	Bronze			2022-12-24	WOS:000261894000012
J	Doria, A; Wojcik, J; Xu, R; Gervino, EV; Hauser, TH; Johnstone, MT; Nolan, D; Hu, FB; Warram, JH				Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Gervino, Ernest V.; Hauser, Thomas H.; Johnstone, Michael T.; Nolan, David; Hu, Frank B.; Warram, James H.			Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ADIPONECTIN GENE; META-ANALYSIS; INSULIN; EPIDEMIOLOGY; POLYMORPHISM; MELLITUS; SUSCEPTIBILITY	Context A common allele on chromosome 9p21 has been repeatedly associated with increased risk of coronary artery disease ( CAD) in the general population. However, the magnitude of this effect in the population with diabetes has not been well characterized. Objective To examine the association of the 9p21 variant with CAD in individuals with type 2 diabetes and evaluate its interaction with poor glycemic control. Design, Setting, and Participants ( 1) Case- control study of 734 type 2 diabetes patients ( 322 with angiographically diagnosed CAD and 412 with no evidence of CAD) who were recruited between 2001 and 2006 at the Joslin Clinic, Beth Israel Deaconess Medical Center; and ( 2) independent cohort study of 475 type 2 diabetes patients from the Joslin Clinic whose survival status was monitored from their recruitment between 1993 and 1996 until December 31, 2004. Participants for both studies were genotyped for a representative single- nucleotide polymorphism at 9p21 ( rs2383206) and characterized for their long- term glycemic control by averaging multiple hemoglobin A(1c) ( HbA(1c)) measurements taken in the years before study entry. Main Outcome Measures For the case- control study, association between single-nucleotide polymorphism rs2383206 and CAD defined as angiographically documented stenosis greater than 50% in a major coronary artery or a main branch thereof was assessed and for the cohort study, cumulative 10- year mortality was documented. Results Individuals who were homozygous for the risk allele were significantly more frequent among case than control participants ( 42.3% vs 28.9P=. 0002). This association was unaffected by adjustment for cardiovascular risk factors, but the effect of the risk genotype was significantly magnified ( adjusted P for interaction=. 048) in the presence of poor glycemic control ( worst tertile of the distribution of HbA(1c) at examination). Relative to the CAD risk for patients with neither a 9p21 risk allele nor poor glycemic control, the CAD odds for participants having 2 risk alleles but not poor glycemic control were increased 2- fold ( odds ratio [ OR], 1.99; 95% confidence interval [ CI], 1.17- 3.41), whereas the odds for study participants with the same genotype and with poor glycemic control were increased 4- fold ( OR, 4.27; 95% CI, 2.26- 8.01). The interaction was stronger ( adjusted P=. 005) when a measure of long- term glycemic control ( 7- year average rather than most recent HbA(1c)) was used with ORs of 7.83 ( 95% CI, 3.49- 17.6) for participants having 2 risk alleles and a history of poor glycemia and 1.54 ( 95% CI, 0.72- 3.30) for participants with the same genotype but without this exposure. A similar interaction between 9p21 variant and poor glycemic control was observed with respect to cumulative 10- year mortality in the cohort study ( 43.6% in patients with 2 risk alleles and poor glycemic control, 23.1% in individuals with only the 2 risk alleles, 30.0% in individuals with only poor glycemic control, and 31.6% in individuals with neither factor, P for interaction, =. 036). Conclusion In this study population, the CAD risk associated with the 9p21 variant was increased in the presence of poor glycemic control in type 2 diabetes.	[Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Nolan, David; Warram, James H.] Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, Boston, MA 02215 USA; [Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Gervino, Ernest V.; Hauser, Thomas H.; Hu, Frank B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gervino, Ernest V.; Hauser, Thomas H.] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Johnstone, Michael T.] Caritas St Elizabeth Med Ctr, Boston, MA USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Doria, Alessandro; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; St. Elizabeth's Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Doria, A (corresponding author), Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, 1 Joslin Pl, Boston, MA 02215 USA.	alessandro.doria@joslin.harvard.edu	Doria, Alessandro/H-9157-2018	Doria, Alessandro/0000-0002-3830-4304; Wojcik-Odyniec, Joanna/0000-0002-8495-4316	National Institutes of Health [HL73168, HL71981]; Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center [DK36836]; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168, R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants HL73168, HL71981, and DK36836 (Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center), and a grant from the Donald W. Reynolds Foundation. Role of the Sponsors: None of the funding agencies had any role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	ABBOTT RD, 1990, AM J MED, V88, P376, DOI 10.1016/0002-9343(90)90492-V; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; Bacci S, 2005, DIABETES, V54, P3021, DOI 10.2337/diabetes.54.10.3021; Bacci S, 2004, DIABETES CARE, V27, P2015, DOI 10.2337/diacare.27.8.2015; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DETRANO R, 1989, PROG CARDIOVASC DIS, V32, P173, DOI 10.1016/0033-0620(89)90025-X; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Freire MBS, 1998, HYPERTENSION, V31, P896, DOI 10.1161/01.HYP.31.4.896; Gavin JR, 1997, DIABETES CARE, V20, P1183; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Haffner SM, 1999, DIABETES CARE, V22, pC54; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KAMB A, 1994, SCIENCE, V264, P440; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Lacquemant C, 2004, DIABETIC MED, V21, P776, DOI 10.1111/j.1464-5491.2004.01224.x; Lange LA, 2002, STROKE, V33, P1876, DOI 10.1161/01.STR.0000019909.71547.AA; Libby P, 2002, CIRCULATION, V106, P2760, DOI 10.1161/01.CIR.0000037282.92395.AE; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qi L, 2005, DIABETES, V54, P1607, DOI 10.2337/diabetes.54.5.1607; Rask-Madsen C, 2005, ARTERIOSCL THROM VAS, V25, P487, DOI 10.1161/01.ATV.0000155325.41507.e0; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Warram JH, 1997, ENDOCRIN METAB CLIN, V26, P165, DOI 10.1016/S0889-8529(05)70239-5; Wild SH, 1999, DIABETES-METAB RES, V15, P197, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<197::AID-DMRR28>3.0.CO;2-F; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	95	97	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2389	2397		10.1001/jama.2008.649	http://dx.doi.org/10.1001/jama.2008.649			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033589	Green Accepted, Bronze			2022-12-24	WOS:000261150800021
J	Redondo, P; Prieto, J; Munoz, IG; Alibes, A; Stricher, F; Serrano, L; Cabaniols, JP; Daboussi, F; Arnould, S; Perez, C; Duchateau, P; Paques, F; Blanco, FJ; Montoya, G				Redondo, Pilar; Prieto, Jesus; Munoz, Ines G.; Alibes, Andreu; Stricher, Francois; Serrano, Luis; Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Paques, Frederic; Blanco, Francisco J.; Montoya, Guillermo			Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases	NATURE			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; HOMING ENDONUCLEASES; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; DIRECTED EVOLUTION; SITE-SPECIFICITY; CRE RECOMBINASE; GENE CORRECTION; I-CREI	Xeroderma pigmentosum is a monogenic disease characterized by hypersensitivity to ultraviolet light. The cells of xeroderma pigmentosum patients are defective in nucleotide excision repair, limiting their capacity to eliminate ultraviolet- induced DNA damage, and resulting in a strong predisposition to develop skin cancers(1). The use of rare cutting DNA endonucleases - such as homing endonucleases, also known as meganucleases - constitutes one possible strategy for repairing DNA lesions. Homing endonucleases have emerged as highly specific molecular scalpels that recognize and cleave DNA sites, promoting efficient homologous gene targeting through double- strand- break- induced homologous recombination. Here we describe two engineered heterodimeric derivatives of the homing endonuclease I- CreI, produced by a semi- rational approach. These two molecules - Amel3 - Amel4 and Ini3 - Ini4 cleave DNA from the human XPC gene ( xeroderma pigmentosum group C), in vitro and in vivo. Crystal structures of the I- CreI variants complexed with intact and cleaved XPC target DNA suggest that the mechanism of DNA recognition and cleavage by the engineered homing endonucleases is similar to that of the wild- type I- CreI. Furthermore, these derivatives induced high levels of specific gene targeting in mammalian cells while displaying no obvious genotoxicity. Thus, homing endonucleases can be designed to recognize and cleave the DNA sequences of specific genes, opening up new possibilities for genome engineering and gene therapy in xeroderma pigmentosum patients whose illness can be treated ex vivo.	[Redondo, Pilar; Munoz, Ines G.; Montoya, Guillermo] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Macromol Crystallog Grp, Madrid 28029, Spain; [Prieto, Jesus; Blanco, Francisco J.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, NMR Grp, Madrid 28029, Spain; [Alibes, Andreu; Stricher, Francois; Serrano, Luis] UPF, European Mol Biol Lab, CRG Syst Biol Unit, CRG, Barcelona 08003, Spain; [Serrano, Luis] ICREA, F-93235 Romainville, France; [Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Paques, Frederic] CELLECTIS SA, F-93235 Romainville, France	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Blanco, FJ (corresponding author), CIC bioGUNE, Parque Tecnol Vizcaya,Edificio 800, Derio 48160, Spain.	fblanco@cicbiogune.es; gmontoya@cnio.es	Stricher, François/L-2688-2015; Redondo, Pilar/L-7612-2014; Blanco, Francisco J/D-4401-2009; Alibés, Andreu/A-5790-2008; Serrano, Luis/B-3355-2013; Munoz, Ines G/M-3285-2014	Stricher, François/0000-0003-0150-0878; Redondo, Pilar/0000-0002-6723-0818; Blanco, Francisco J/0000-0003-2545-4319; Alibés, Andreu/0000-0002-0055-3014; Serrano, Luis/0000-0002-5276-1392; Munoz, Ines G/0000-0001-6732-4059; Daboussi, Fayza/0000-0001-7689-7975	EU MEGATOOL [LSHG-CT-2006-037226]; CRG-Novartis fellowship	EU MEGATOOL; CRG-Novartis fellowship	We would like to thank J. Casado and D. Megias for technical support and the beamline staff at the ESRF and SLS for advice during data collection. This project received financial support from the EU MEGATOOL project (LSHG-CT-2006-037226). A.A. is partly funded by a CRG-Novartis fellowship.	Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Rimseliene R, 2003, J MOL BIOL, V327, P383, DOI 10.1016/S0022-2836(03)00142-6; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Samuelson JC, 2002, J MOL BIOL, V319, P673, DOI 10.1016/S0022-2836(02)00343-1; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voziyanov Y, 2003, J MOL BIOL, V326, P65, DOI 10.1016/S0022-2836(02)01364-5; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	33	134	145	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					107	U8		10.1038/nature07343	http://dx.doi.org/10.1038/nature07343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987743				2022-12-24	WOS:000260674000050
J	van de Koppel, J; Gascoigne, JC; Theraulaz, G; Rietkerk, M; Mooij, WM; Herman, PMJ				van de Koppel, Johan; Gascoigne, Joanna C.; Theraulaz, Guy; Rietkerk, Max; Mooij, Wolf M.; Herman, Peter M. J.			Experimental Evidence for Spatial Self-Organization and Its Emergent Effects in Mussel Bed Ecosystems	SCIENCE			English	Article							PATTERN-FORMATION; SEMIARID VEGETATION; LOCAL INTERACTIONS; SCALE; DYNAMICS; WAVES	Spatial self- organization is the main theoretical explanation for the global occurrence of regular or otherwise coherent spatial patterns in ecosystems. Using mussel beds as a model ecosystem, we provide an experimental demonstration of spatial self- organization. Under homogeneous laboratory conditions, mussels developed regular patterns, similar to those in the field. An individual- based model derived from our experiments showed that interactions between individuals explained the observed patterns. Furthermore, a field study showed that pattern formation affected ecosystem- level processes in terms of improved growth and resistance to wave action. Our results imply that spatial self- organization is an important determinant of the structure and functioning of ecosystems, and it needs to be considered in their conservation.	[van de Koppel, Johan; Herman, Peter M. J.] Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [Gascoigne, Joanna C.] Univ Wales Bangor, Sch Ocean Sci, Menai Bridge LL59 5AB, Gwynedd, Wales; [Theraulaz, Guy] Univ Toulouse 3, CNRS, Ctr Rech Cognit Animale, UMR 5169, F-31062 Toulouse 04, France; [Rietkerk, Max] Univ Utrecht, Dept Environm Sci, Copernicus Inst, NL-3508 TC Utrecht, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol, Aquat Food Webs Dept, NL-3631 AC Nieuwersluis, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Bangor University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van de Koppel, J (corresponding author), Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, POB 140, NL-4400 AC Yerseke, Netherlands.	J.vandeKoppel@nioo.knaw.nl	Theraulaz, Guy/H-8464-2016; Herman, Peter M.J./A-9018-2011; Mooij, Wolf M/C-2677-2008; Rietkerk, Max/H-6235-2011; Van de Koppel, Johan/E-7266-2010	Theraulaz, Guy/0000-0002-3062-4215; Herman, Peter M.J./0000-0003-2188-6341; Mooij, Wolf M/0000-0001-5586-8200; Rietkerk, Max/0000-0002-2698-3848	Schure-Beijerinck-Popping; Royal Dutch Academy of Sciences; Vidi; Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW); Biotechnology and Biological Sciences Research Council [D18866]	Schure-Beijerinck-Popping; Royal Dutch Academy of Sciences; Vidi(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Koutstaal, B. Koutstaal, A. Matkin, and J. van Soelen for their assistance during the field work and lab experiments; K. Mould and J. Wilson for access to their mussel lots; and A. Altieri, M. Bertness, T. Bouma, F. Guichard, M. de Jager, A.-M. Neutel, P. de Ruiter, and B. Silliman for critical discussions and reading of the manuscript. The field work at Bangor was supported by a grant from the Schure-Beijerinck-Popping fund of the Royal Dutch Academy of Sciences to J.v.d.K. The research of M. R. is supported by a personal Vidi grant from the Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW). J.C.G. was supported by Biotechnology and Biological Sciences Research Council contract D18866. This is publication 4410 of the Netherlands Institute of Ecology (NIOO-KNAW).	Bertness MD, 1998, ECOLOGY, V79, P1382, DOI 10.2307/176750; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; Bjornstad ON, 2002, SCIENCE, V298, P1020, DOI 10.1126/science.1075182; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Gascoigne JC, 2005, OECOLOGIA, V145, P371, DOI 10.1007/s00442-005-0137-x; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; Jonsson PR, 2005, LIMNOL OCEANOGR, V50, P1989, DOI 10.4319/lo.2005.50.6.1989; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Levin S., 1999, FRAGILE DOMINION; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; Nicolis G., 1977, SELF ORG NONEQUILIBR; Rietkerk M, 2004, AM NAT, V163, P699, DOI 10.1086/383065; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; SOLE RV, 2006, SELF ORG COMPLEX ECO; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; TYSON JJ, 1989, DEVELOPMENT, V106, P421; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2006, AM NAT, V168, pE136, DOI 10.1086/508671; Wager H, 1911, PHILOS T R SOC LON B, V201; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	27	178	181	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					739	742		10.1126/science.1163952	http://dx.doi.org/10.1126/science.1163952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974353	Green Submitted			2022-12-24	WOS:000260605200048
J	Chan, FKL				Chan, Francis K. L.			Proton-pump inhibitors in peptic ulcer disease	LANCET			English	Editorial Material							INDUCED GASTROINTESTINAL TOXICITY; COST-EFFECTIVENESS; DOUBLE-BLIND; HIGH-RISK; OMEPRAZOLE; ENDOSCOPY; PREVENTION; STRATEGIES; CELECOXIB		[Chan, Francis K. L.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Chan, Francis K. L.] Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China.	fklchan@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010	Chan, Francis K. L./0000-0001-7388-2436				Al-Sabah S, 2008, CLIN GASTROENTEROL H, V6, P418, DOI 10.1016/j.cgh.2007.12.037; Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; CHAN FK, AM J GASTRO IN PRESS; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Dorward S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub2; Elliott RA, 2006, RHEUMATOLOGY, V45, P606, DOI 10.1093/rheumatology/kei241; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; ROSTOM A, 2002, COCHRANE DB SYST REV, V2002, DOI [DOI 10.1002/14651858.CD002296, 10.1002/14651858.CD002296]; Rostom A, 2007, CLIN GASTROENTEROL H, V5, P818, DOI 10.1016/j.cgh.2007.03.011; Tsoi KKF, 2008, GASTROINTEST ENDOSC, V67, P1056, DOI 10.1016/j.gie.2007.11.056	16	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1198	1200		10.1016/S0140-6736(08)61497-X	http://dx.doi.org/10.1016/S0140-6736(08)61497-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094939				2022-12-24	WOS:000259882000006
J	Ren, H; Sigman, DM; Meckler, AN; Plessen, B; Robinson, RS; Rosenthal, Y; Haug, GH				Ren, H.; Sigman, D. M.; Meckler, A. N.; Plessen, B.; Robinson, R. S.; Rosenthal, Y.; Haug, G. H.			Foraminiferal Isotope Evidence of Reduced Nitrogen Fixation in the Ice Age Atlantic Ocean	SCIENCE			English	Article							PLANKTONIC-FORAMINIFERA; SEDIMENT N-15/N-14; PARTICLE DYNAMICS; ATMOSPHERIC CO2; NORTH-ATLANTIC; ARABIAN SEA; DENITRIFICATION; PACIFIC; CARBON; FRACTIONATION	Fixed nitrogen ( N) is a limiting nutrient for algae in the low- latitude ocean, and its oceanic inventory may have been higher during ice ages, thus helping to lower atmospheric CO(2) during those intervals. In organic matter within planktonic foraminifera shells in Caribbean Sea sediments, we found that the (15)N/(14)N ratio from the last ice age is higher than that from the current interglacial, indicating a higher nitrate (15)N/(14)N ratio in the Caribbean thermocline. This change and other species- specific differences are best explained by less N fixation in the Atlantic during the last ice age. The fixation decrease was most likely a response to a known ice age reduction in ocean N loss, and it would have worked to balance the ocean N budget and to curb ice age- interglacial change in the N inventory.	[Ren, H.; Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Meckler, A. N.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Plessen, B.] Deutsch Geoforschungszentrum, Helmholtz Zentrum Potsdam, D-14473 Potsdam, Germany; [Robinson, R. S.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Rosenthal, Y.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Y.] Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; [Haug, G. H.] ETH, Dept Earth Sci, Inst Geol, CH-8092 Zurich, Switzerland; [Haug, G. H.] Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, Inst Geosci, D-14476 Potsdam, Germany	Princeton University; California Institute of Technology; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Rhode Island; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam	Ren, H (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	hren@princeton.edu	Sigman, Daniel M/A-2649-2008; Meckler, Anna Nele/AAC-2490-2020	Sigman, Daniel M/0000-0002-7923-1973; Meckler, Anna Nele/0000-0002-7225-8276; Robinson, Rebecca/0000-0002-8072-1603; REN, HAO-JIA/0000-0002-1769-4243	NSF [ANT-0453680, OCE- 9981479, OCE- 0447570, OCE-0220776, OCE-0341412, OCE-0502504, OCE-0437366, OCE-0350794]; Schlanger Ocean Drilling Fellowship; Princeton Carbon Mitigation Initiative; Deutsche Forschungsgemeinschaft	NSF(National Science Foundation (NSF)); Schlanger Ocean Drilling Fellowship; Princeton Carbon Mitigation Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Bernhard and D. McCorkle for supplying surface sediment samples; Y. Wang, M. Coray, and S. Bishop for technical assistance; B. Brunelle for advice; and two anonymous reviewers for comments. Supported by NSF grants ANT-0453680, OCE- 9981479, and OCE- 0447570 (D.M.S.), OCE-0220776, OCE-0341412, and OCE-0502504 (Y.R.), and OCE-0437366 and OCE-0350794 (J. Bernhard), a Schlanger Ocean Drilling Fellowship (H.R.), BP through the Princeton Carbon Mitigation Initiative, and Deutsche Forschungsgemeinschaft grants (G.H.H.). This research used samples provided by the ODP, which is sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions.	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; ALTABET MA, 1989, LIMNOL OCEANOGR, V34, P1185, DOI 10.4319/lo.1989.34.7.1185; Altabet MA, 1989, GLOBAL BIOGEOCHEM CY, V3, P107, DOI 10.1029/GB003i002p00107; Barford CC, 1999, APPL ENVIRON MICROB, V65, P989; Brandes JA, 1997, GEOCHIM COSMOCHIM AC, V61, P1793, DOI 10.1016/S0016-7037(97)00041-0; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHECKLEY DM, 1989, DEEP-SEA RES, V36, P1449, DOI 10.1016/0198-0149(89)90050-2; CHRISTENSEN JP, 1994, CONT SHELF RES, V14, P547, DOI 10.1016/0278-4343(94)90103-1; De Pol-Holz R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024477; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; Emmer E, 2000, PALEOCEANOGRAPHY, V15, P377, DOI 10.1029/1999PA000417; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Hastings MG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003789; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; JASPER JP, 1990, NATURE, V347, P462, DOI 10.1038/347462a0; KAO SJ, 2008, ATMOS CHEM PHYS DISC, V5, P1017; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; KING K JR, 1972, Micropaleontology (New York), V18, P285, DOI 10.2307/1485009; Knapp AN, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002320; Knapp AN, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003107; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Meckler AN, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002893; Mintenbeck K, 2007, DEEP-SEA RES PT I, V54, P1015, DOI 10.1016/j.dsr.2007.03.005; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Mora G, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001132; NAKATSUKA T, 1995, GEOPHYS RES LETT, V22, P2525, DOI 10.1029/95GL02544; Ravelo AC, 1992, PALEOCEANOGRAPHY, V7, P815, DOI 10.1029/92PA02092; REDFIELD AC, 1958, AM SCI, V46, P205; ROBBINS LL, 1990, GEOCHIM COSMOCHIM AC, V54, P2285, DOI 10.1016/0016-7037(90)90052-M; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; SWEENEY RE, 1980, MAR CHEM, V9, P145, DOI 10.1016/0304-4203(80)90064-X; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; Uhle ME, 1997, ORG GEOCHEM, V27, P103, DOI 10.1016/S0146-6380(97)00075-2; UHLE ME, 1990, LIMNOL OCEANOGR, V44, P1968; WADA E, 1976, GEOCHIM COSMOCHIM AC, V40, P249, DOI 10.1016/0016-7037(76)90183-6	41	109	112	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					244	248		10.1126/science.1165787	http://dx.doi.org/10.1126/science.1165787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19095896				2022-12-24	WOS:000262290600036
J	Kennett, DJ; Kennett, JP; West, A; Mercer, C; Hee, SSQ; Bement, L; Bunch, TE; Sellers, M; Wolbach, WS				Kennett, D. J.; Kennett, J. P.; West, A.; Mercer, C.; Hee, S. S. Que; Bement, L.; Bunch, T. E.; Sellers, M.; Wolbach, W. S.			Nanodiamonds in the Younger Dryas Boundary Sediment Layer	SCIENCE			English	Article							DIAMOND		[Kennett, D. J.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Kennett, J. P.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [West, A.] GeoSci Consulting, Dewey, AZ 86327 USA; [Mercer, C.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Hee, S. S. Que] Univ Calif Los Angeles, Dept Environm Hlth Sci, Ctr Occupat & Environm Hlth, Los Angeles, CA 90095 USA; [Bement, L.] Univ Oklahoma, Oklahoma Archeol Survey, Norman, OK 73019 USA; [Bunch, T. E.; Sellers, M.] No Arizona Univ, Dept Geol, Flagstaff, AZ 86011 USA; [Bunch, T. E.; Sellers, M.] No Arizona Univ, Dept Sci Biol, Flagstaff, AZ 86011 USA; [Wolbach, W. S.] De Paul Univ, Dept Chem, Chicago, IL 60614 USA	University of Oregon; University of California System; University of California Santa Barbara; National Institute for Materials Science; University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma - Norman; Northern Arizona University; Northern Arizona University; DePaul University	Kennett, DJ (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	dkennett@uoregon.edu	Kennett, Douglas J/I-7613-2015; MERCER, Christopher/H-2654-2011	Kennett, Douglas J/0000-0001-5133-9010; Wolbach, Wendy/0000-0003-4398-8269	NSF [ATM-0713769]	NSF(National Science Foundation (NSF))	This research was funded by the NSF (grant ATM-0713769). We thank three anonymous reviewers and V. Haynes for assistance.	Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Grady MM, 1995, EARTH PLANET SC LETT, V136, P677, DOI 10.1016/0012-821X(95)00162-6; Haynes CV, 2008, P NATL ACAD SCI USA, V105, P6520, DOI 10.1073/pnas.0800560105; Hough RM, 1997, GEOLOGY, V25, P1019, DOI 10.1130/0091-7613(1997)025<1019:DFTIRK>2.3.CO;2; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Wen B, 2007, INT MATER REV, V52, P131, DOI 10.1179/174328007X160236	7	117	123	4	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					94	94		10.1126/science.1162819	http://dx.doi.org/10.1126/science.1162819			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119227				2022-12-24	WOS:000262104100047
J	Patton, D; McIntosh, A				Patton, Declan; McIntosh, Andrew			Head and neck injury risks in heavy metal: head bangers stuck between rock and a hard bass	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To investigate the risks of mild traumatic brain injury and neck injury associated with head banging, a popular dance form accompanying heavy metal music. Design Observational studies, focus group, and biomechanical analysis. Participants Head bangers. Main outcome measures Head Injury Criterion and Neck Injury Criterion were derived for head banging styles and both popular heavy metal songs and easy listening music controls. Results An average head banging song has a tempo of about 146 beats per minute, which is predicted to cause mild head injury when the range of motion is greater than 75 degrees. At higher tempos and greater ranges of motion there is a risk of neck injury. Conclusion To minimise the risk of head and neck injury, head bangers should decrease their range of head and neck motion, head bang to slower tempo songs by replacing heavy metal with adult oriented rock, only head bang to every second beat, or use personal protective equipment.	[Patton, Declan; McIntosh, Andrew] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	McIntosh, A (corresponding author), Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia.	a.mcintosh@unsw.edu.au						BALSAMO T, 2006, EVANESCENCE GUITARIS; BASHAM D, 2001, BASSIST J NEWSTED LE; BENNETT J, 2008, SKY NEWS; BOSTROM O, 1996, INT RES COUNC BIOM I; BRANDLE L, 2003, BILLBOARD B; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; Clauser C. E., 1969, WEIGHT VOLUME CTR MA, P1; DANENBERG MA, 1987, LANG SPEECH HEAR SER, V8, P267; EGNOR M R, 1991, Pediatric Neurosurgery, V17, P135, DOI 10.1159/000120583; Ferrario VF, 2002, J ORTHOPAED RES, V20, P122, DOI 10.1016/S0736-0266(01)00079-1; FINE M, 2008, NIELSEN SOUNDSCAN; JAKOBSSON L, 1999, INT RES COUNC BIOM I; KIMPTON P, 2008, OBSERVER; Kunin M, 2007, J NEUROPHYSIOL, V98, P3095, DOI 10.1152/jn.00764.2007; LEWIS D, 1997, L ZEPPELIN CONCERT F; McConville J. T., 1980, ANTHROPOMETRIC RELAT; Neyaz Z, 2006, NEUROL INDIA, V54, P319; Panjabi MM, 2005, J BIOMECH, V38, P1694, DOI 10.1016/j.jbiomech.2004.07.015; Spheeris P., 1988, DECLINE W CIVILIZA 2; Spheeris Penelope, 1992, WAYNES WORLD; THOMPSON B, 2008, DAILY TELEGRAPH; TYRELL D, 1998, CRASHWORTHINESS PASS	22	8	8	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2825	10.1136/bmj.a2825	http://dx.doi.org/10.1136/bmj.a2825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091761	hybrid, Green Published			2022-12-24	WOS:000262185000007
J	Hori, T; Amano, M; Suzuki, A; Backer, CB; Welburn, JP; Dong, YM; McEwen, BF; Shang, WH; Suzuki, E; Okawa, K; Cheeseman, IM; Fukagawa, T				Hori, Tetsuya; Amano, Miho; Suzuki, Aussie; Backer, Chelsea B.; Welburn, Julie P.; Dong, Yimin; McEwen, Bruce F.; Shang, Wei-Hao; Suzuki, Emiko; Okawa, Katsuya; Cheeseman, Iain M.; Fukagawa, Tatsuo			CCAN Makes Multiple Contacts with Centromeric DNA to Provide Distinct Pathways to the Outer Kinetochore	CELL			English	Article							CENP-A CHROMATIN; CHROMOSOME SEGREGATION; MOLECULAR ARCHITECTURE; MITOTIC CHECKPOINT; HUMAN-CELLS; COMPLEX; COMPONENT; ORGANIZATION; INTERPHASE; PROTEINS	Kinetochore specification and assembly requires the targeted deposition of specialized nucleosomes containing the histone H3 variant CENP-A at centromeres. However, CENP-A is not sufficient to drive full-kinetochore assembly, and it is not clear how centromeric chromatin is established. Here, we identify CENP-W as a component of the DNA-proximal constitutive centromere-associated network (CCAN) of proteins. We demonstrate that CENP-W forms a DNA-binding complex together with the CCAN component CENP-T. This complex directly associates with nucleosomal DNA and with canonical histone H3, but not with CENP-A, in centromeric regions. CENP-T/CENP-W functions upstream of other CCAN components with the exception of CENP-C, an additional putative DNA-binding protein. Our analysis indicates that CENP-T/CENP-W and CENP-C provide distinct pathways to connect the centromere with outer kinetochore assembly. In total, our results suggest that the CENP-T/CENP-W complex is directly involved in establishment of centromere chromatin structure coordinately with CENP-A.	[Hori, Tetsuya; Amano, Miho; Suzuki, Aussie; Shang, Wei-Hao; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, SOKENDAI, Mishima, Shizuoka 4118540, Japan; [Backer, Chelsea B.; Welburn, Julie P.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Backer, Chelsea B.; Welburn, Julie P.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Dong, Yimin; McEwen, Bruce F.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; Wadsworth Center; Kyoto University	Fukagawa, T (corresponding author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.	tfukagaw@lab.nig.ac.jp	Suzuki, Aussie/ABF-4170-2021; Fukagawa, Tatsuo/AAK-3922-2021	Suzuki, Emiko/0000-0002-4005-0542; Welburn, Julie/0000-0002-5440-6060; Cheeseman, Iain/0000-0002-3829-5612; Suzuki, Aussie/0000-0001-7390-5116	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Smith Family Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smith Family Foundation	The authors are very grateful to K. Suzuki, M. Takahashi, and K. Kita for technical assistance. We also thank H. Kimura and V. Regnier for reagents. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T. F. and a Smith Family Foundation New Investigator Award and Thomas D. and Virginia W. Cabot Career Development Professorship to I. M. C.	Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Krasikova A, 2006, CHROMOSOME RES, V14, P777, DOI 10.1007/s10577-006-1085-y; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Yang CH, 1996, MOL CELL BIOL, V16, P3576	41	293	301	4	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1039	1052		10.1016/j.cell.2008.10.019	http://dx.doi.org/10.1016/j.cell.2008.10.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070575	Bronze			2022-12-24	WOS:000261642800020
J	Rozema, J; Flowers, T				Rozema, Jelte; Flowers, Timothy			ECOLOGY Crops for a Salinized World	SCIENCE			English	Editorial Material							SALT TOLERANCE; WATER RELATIONS; HALOPHYTES; IRRIGATION; GROWTH		[Rozema, Jelte] Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands; [Flowers, Timothy] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Flowers, Timothy] Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Crawley, WA 6009, Australia	Vrije Universiteit Amsterdam; University of Sussex; University of Western Australia	Rozema, J (corresponding author), Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands.	jelte.rozema@falw.vu.nl	Flowers, Timothy/AAI-7078-2020	Flowers, Timothy/0000-0002-2712-9504				AHMAD R, 2002, PROSPECTS SALINE AGR; Brown JJ, 1999, AQUACULTURE, V175, P255, DOI 10.1016/S0044-8486(99)00084-8; FAO, GLOB NETW INT SOIL M; FAO, TERR DAT; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; GLENN EP, 1991, SCIENCE, V251, P1065, DOI 10.1126/science.251.4997.1065; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Malash NM, 2008, IRRIGATION SCI, V26, P313, DOI 10.1007/s00271-007-0095-7; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Niazi BH, 2000, J AGRON CROP SCI, V184, P101, DOI 10.1046/j.1439-037x.2000.00353.x; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rozema J, 1996, HALOPHYTES AND BIOSALINE AGRICULTURE, P17; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; *UN POP DIV, CHART PROGR POP; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002	17	417	479	10	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1478	1480		10.1126/science.1168572	http://dx.doi.org/10.1126/science.1168572			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056965	Green Submitted			2022-12-24	WOS:000261377400028
J	Conen, D; Tedrow, UB; Cook, NR; Moorthy, MV; Buring, JE; Albert, CM				Conen, David; Tedrow, Usha B.; Cook, Nancy R.; Moorthy, M. V.; Buring, Julie E.; Albert, Christine M.			Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; ADRENERGIC ACTIVITY; PRIMARY PREVENTION; CARDIAC-RHYTHM; HEART-FAILURE; OLDER-ADULTS; FOLLOW-UP; HEALTH; MEN; DRINKING		[Conen, David] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; [Conen, David; Tedrow, Usha B.; Moorthy, M. V.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Ctr Arrhythmia Prevent, Boston, MA USA; [Conen, David; Cook, Nancy R.; Moorthy, M. V.; Buring, Julie E.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA USA; [Tedrow, Usha B.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA USA; [Cook, Nancy R.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA	University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Conen, D (corresponding author), Univ Basel Hosp, Div Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland.	conend@uhbs.ch	Tedrow, Usha/AFV-2528-2022	Albert, Christine/0000-0002-2081-1121	Swiss National Science Foundation [PASMA 118586/1]; National Heart, Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-047988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Conen was supported by grant PASMA 118586/1 from the Swiss National Science Foundation. The Women's Health Study was supported by grants HL-043851 and HL-080467 from the National Heart, Lung, and Blood Institute and CA-047988 from the National Cancer Institute.	BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; COX DR, 1972, J R STAT SOC B, V34, P187; DENISON H, 1994, BRIT HEART J, V72, P554; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Djousse L, 2007, CIRCULATION, V115, P34, DOI 10.1161/CIRCULATIONAHA.106.661868; ETTINGER PO, 1978, AM HEART J, V95, P555, DOI 10.1016/0002-8703(78)90296-X; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Gavazzi A, 2000, AM J CARDIOL, V85, P1114, DOI 10.1016/S0002-9149(00)00706-2; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; KOSKINEN P, 1987, BRIT HEART J, V57, P468, DOI 10.1136/hrt.57.5.468; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lazarevic AM, 2000, J AM COLL CARDIOL, V35, P1599, DOI 10.1016/S0735-1097(00)00565-9; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Maki T, 1998, AM J CARDIOL, V82, P317, DOI 10.1016/S0002-9149(98)00299-9; Marcus GM, 2008, PACE, V31, P266, DOI 10.1111/j.1540-8159.2008.00985.x; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Mukamal KJ, 2007, AM HEART J, V153, P260, DOI 10.1016/j.ahj.2006.10.039; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Psaty BM, 1997, CIRCULATION, V96, P2455; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; THORNTON JR, 1984, LANCET, V2, P1013; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054	32	144	143	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2489	2496		10.1001/jama.2008.755	http://dx.doi.org/10.1001/jama.2008.755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050192	Green Accepted, Bronze			2022-12-24	WOS:000261286200017
J	Keenan, HT; Hall, GC; Marshall, SW				Keenan, Heather T.; Hall, Gillian C.; Marshall, Stephen W.			Early head injury and attention-deficit/hyperactivity disorder: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT-HYPERACTIVITY DISORDER; CHILDREN; SYMPTOMS; ILLNESS	Objective To explore the hypothesis that medically attended head injury in young children may be causal in the later development of attention- deficit/ hyperactivity disorder. Design Retrospective cohort study. Setting Health improvement network database ( 1988-2003), a longitudinal UK general practice dataset. Participants All children registered in the database from birth until their 10th birthday. Main outcome measures Risk of a child with a head injury before age 2 developing attention- deficit/ hyperactivity disorder before age 10 compared with children with a burn injury before age 2 and children with neither a burn nor a head injury. Results Of the 62 088 children who comprised the cohort, 2782 ( 4.5%) had a head injury and 1116 ( 1.8%) had a burn injury. The risk of diagnosis of attention- deficit/ hyperactivity disorder before 10 years of age after adjustment for sex, prematurity, socioeconomic status, and practice identification number was similar in the head injury ( relative risk 1.9, 95% confidence interval 1.5 to 2.5) and burn injury groups ( 1.7, 1.2 to 2.5) compared with all other children. Discussion Medically attended head injury before 2 years of age does not seem to be causal in the development of attention- deficit/ hyperactivity disorder. Medically attended injury before 2 years of age may be a marker for subsequent diagnosis of attention- deficit/ hyperactivity disorder.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27699 USA	Utah System of Higher Education; University of Utah	Keenan, HT (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu		Marshall, Stephen/0000-0002-2664-9233				Bourke Alison, 2004, Inform Prim Care, V12, P171; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Huff N, 1999, J PUBLIC HEALTH MED, V21, P81, DOI 10.1093/pubmed/21.1.81; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	14	33	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2008	337								a1984	10.1136/bmj.a1984	http://dx.doi.org/10.1136/bmj.a1984			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FC	18988644	Green Published, hybrid			2022-12-24	WOS:000261236100001
J	Walsh, CA; Morrow, EM; Rubenstein, JLR				Walsh, Christopher A.; Morrow, Eric M.; Rubenstein, John L. R.			Autism and Brain Development	CELL			English	Article							MENTAL-RETARDATION; MOUSE MODEL; MUTATIONS; GENES; MECP2; TRANSCRIPTION; DISRUPTION; PLASTICITY; DISORDERS; CHILDREN	Genetic studies are refining our understanding of neurodevelopmental mechanisms in autism. Some autism-related mutations appear to disrupt genes regulated by neuronal activity, which are especially important in development of the postnatal nervous system. Gene replacement studies in mice indicate that the developmental window to ameliorate symptoms may be wider than previously anticipated.	[Walsh, Christopher A.; Morrow, Eric M.] Childrens Hosp, Dept Neurol, Div Genet, Boston, MA 02115 USA; [Walsh, Christopher A.; Morrow, Eric M.] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; [Morrow, Eric M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Childrens Hosp, Dept Neurol, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Morrow, Eric/J-2767-2013; Warfield, Simon/B-3352-2009	Morrow, Eric/0000-0003-3430-3520; Warfield, Simon/0000-0002-7659-3880	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH083565, K23 MH080954-05, R01 MH49428, K23 MH080954, R01 MH049428, 1R01 MH083565, 1K23MH080954, R01 MH083565-02] Funding Source: Medline; NINDS NIH HHS [R01 NS034661, R01 NS34661] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R01MH083565, K23MH080954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034661, R01NS035129] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamilton SP, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-52; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Turner G, 2002, AM J MED GENET, V112, P405, DOI 10.1002/ajmg.10714; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	133	140	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					396	400		10.1016/j.cell.2008.10.015	http://dx.doi.org/10.1016/j.cell.2008.10.015			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984148	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000260536300007
J	Sharma, J; Chhabra, R; Cheng, A; Brownell, J; Liu, Y; Yan, H				Sharma, Jaswinder; Chhabra, Rahul; Cheng, Anchi; Brownell, Jonathan; Liu, Yan; Yan, Hao			Control of Self-Assembly of DNA Tubules Through Integration of Gold Nanoparticles	SCIENCE			English	Article							CONDUCTIVE NANOWIRES; ARRAYS; NANOSTRUCTURES; TEMPLATES; NANOTUBES; SURFACE; CRYSTALLIZATION; ORGANIZATION; TILES	The assembly of nanoparticles into three- dimensional ( 3D) architectures could allow for greater control of the interactions between these particles or with molecules. DNA tubes are known to form through either self- association of multi- helix DNA bundle structures or closing up of 2D DNA tile lattices. By the attachment of single- stranded DNA to gold nanoparticles, nanotubes of various 3D architectures can form, ranging in shape from stacked rings to single spirals, double spirals, and nested spirals. The nanoparticles are active elements that control the preference for specific tube conformations through size- dependent steric repulsion effects. For example, we can control the tube assembly to favor stacked- ring structures using 10- nanometer gold nanoparticles. Electron tomography revealed a left- handed chirality in the spiral tubes, double- wall tube features, and conformational transitions between tubes.	[Sharma, Jaswinder; Chhabra, Rahul; Liu, Yan; Yan, Hao] Arizona State Univ, Ctr Single Mol Biophys, Biodesign Inst, Tempe, AZ 85287 USA; [Sharma, Jaswinder; Chhabra, Rahul; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Cheng, Anchi; Brownell, Jonathan] Scripps Res Inst, La Jolla, CA 92037 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Scripps Research Institute	Liu, Y (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Biodesign Inst, Tempe, AZ 85287 USA.	yan_liu@asu.edu; hao.yan@asu.edu	Liu, Yan/K-1999-2014	Liu, Yan/0000-0003-0906-2606	National Science Foundation (NSF); Army Research Office ( ARO); Air Force Office of Scientific Research; Office of Naval Research; NSF; Alfred P. Sloan Fellowship; NIH [P41 RR000592, P41 RR-01081]; Technology and Research Institute Funds funds from Arizona State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081, P41RR017573, P41RR000592] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Army Research Office ( ARO); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Technology and Research Institute Funds funds from Arizona State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank for financial support the National Science Foundation (NSF) and Army Research Office (ARO) (to Y.L.), the Air Force Office of Scientific Research, Office of Naval Research, NSF, Alfred P. Sloan Fellowship, ARO, and NIH (to H.Y.), and Technology and Research Institute Funds funds from Arizona State University (to H.Y. and Y.L.). Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by NIH though the National Center for Research Resources' P41 program (RR17573). We thank C. Potter and B. Carragher for helpful discussion and technical advice on the electron tomography work. IMOD software (Boulder Laboratory for 3D Electron Microscopy of Cells, Boulder, CO) used for tomographic reconstruction is supported by NIH grant P41 RR000592. 3D graphic images were produced using the University of California, San Francisco ( UCSF) Chimera package from the Resource for Biocomputing, Visualization, and Informatics at UCSF ( supported by NIH grant P41 RR-01081). We thank M. Palmer for technical assistance. We acknowledge the use of the EM facility in the School of Life Sciences at Arizona State University. We thank C. Lin for assistance in schematic figure drawings and Y. Ke for assistance in creating movies from the tomography reconstructions. We thank C. Flores for help proofreading the manuscript.	Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Aldaye FA, 2007, J AM CHEM SOC, V129, P4130, DOI 10.1021/ja070017i; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Deng Z., 2005, ANGEW CHEM, V117, P3648; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Fu AH, 2004, J AM CHEM SOC, V126, P10832, DOI 10.1021/ja046747x; Ke YG, 2006, J AM CHEM SOC, V128, P4414, DOI 10.1021/ja058145z; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Lee JH, 2007, ANGEW CHEM INT EDIT, V46, P9006, DOI 10.1002/anie.200702569; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Liu FR, 1999, J AM CHEM SOC, V121, P917, DOI 10.1021/ja982824a; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SH, 2005, NANO LETT, V5, P693, DOI 10.1021/nl050108i; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208; Sharma J, 2008, ANGEW CHEM INT EDIT, V47, P5157, DOI 10.1002/anie.200801485; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; SIMON U, 2004, NANOPARTICLES THEORY, P328; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	27	590	626	8	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					112	116		10.1126/science.1165831	http://dx.doi.org/10.1126/science.1165831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119229	Green Accepted			2022-12-24	WOS:000262104100052
J	Chu, G; Yang, W				Chu, Gilbert; Yang, Wei			Here Comes the Sun: Recognition of UV-Damaged DNA	CELL			English	Editorial Material							UBIQUITIN LIGASE; REPAIR; PROTEIN; LESION	The first step in the repair of DNA damage is lesion detection. In this issue, Scrima et al. (2008) report the structure of the complex of DNA Damage-Binding Protein 1 (DDB1) and DDB2 bound to a DNA photodimer, providing critical insight into the repair of DNA damage caused by ultraviolet light.	[Yang, Wei] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chu, Gilbert] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Med Ctr, Dept Biochem, Div Oncol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stanford University; Stanford University	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	Intramural NIH HHS [ZIA DK036146-08, ZIA DK075037-08] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155	9	12	12	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1172	1174		10.1016/j.cell.2008.12.015	http://dx.doi.org/10.1016/j.cell.2008.12.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109889	Green Accepted, Bronze			2022-12-24	WOS:000261989800009
J	Merkwirth, C; Langer, T				Merkwirth, Carsten; Langer, Thomas			Mitofusin 2 Builds a Bridge between ER and Mitochondria	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; DISEASE; MUTATIONS; PROTECTS	Mutations in mitofusin 2 (MFN2), a dynamin-like GTPase required for mitochondrial fusion, cause the peripheral neuropathy Charcot-Marie-Tooth type 2A. In a recent report in Nature, de Brito and Scorrano (2008) demonstrate a new function of MFN2-tethering the endoplasmic reticulum and mitochondria to control the efficiency of mitochondrial uptake of Ca(2+) ions.	[Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany; [Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Langer, T (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de	Merkwirth, Carsten/H-5992-2012	Merkwirth, Carsten/0000-0001-8895-3495; Langer, Thomas/0000-0003-1250-1462				Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	10	92	96	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2008	135	7					1165	1167		10.1016/j.cell.2008.12.005	http://dx.doi.org/10.1016/j.cell.2008.12.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109886	Bronze			2022-12-24	WOS:000261989800006
J	Pisareva, VP; Pisarev, AV; Komar, AA; Hellen, CUT; Pestova, TV				Pisareva, Vera P.; Pisarev, Andrey V.; Komar, Anton A.; Hellen, Christopher U. T.; Pestova, Tatyana V.			Translation Initiation on Mammalian mRNAs with Structured 5 ' UTRs Requires DExH-Box Protein DHX29	CELL			English	Article							INTERNAL RIBOSOMAL ENTRY; SACCHAROMYCES-CEREVISIAE; HEPATITIS-C; FACTOR EIF3; BINDING; SUBUNIT; CODON; HELICASES; ROLES; SITE	Eukaryotic protein synthesis begins with assembly of 48S initiation complexes at the initiation codon of mRNA, which requires at least seven initiation factors (eIFs). First, 43S preinitiation complexes comprising 40S ribosomal subunits, eIFs 3, 2, 1, and 1A, and tRNA(i)(Met) attach to the 5'-proximal region of mRNA and then scan along the 50 untranslated region (5'UTR) to the initiation codon. Attachment of 43S complexes is mediated by three other eIFs, 4F, 4A, and 4B, which cooperatively unwind the cap-proximal region of mRNA and later also assist 43S complexes during scanning. We now report that these seven eIFs are not sufficient for efficient 48S complex formation on mRNAs with highly structured 5'UTRs, and that this process requires the DExH-box protein DHX29. DHX29 binds 40S subunits and hydrolyzes ATP, GTP, UTP, and CTP. NTP hydrolysis by DHX29 is strongly stimulated by 43S complexes and is required for DHX29's activity in promoting 48S complex formation.	[Pisareva, Vera P.; Pisarev, Andrey V.; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University System of Ohio; Cleveland State University	Pestova, TV (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	tatyana.pestova@downstate.edu		Komar, Anton/0000-0003-4188-0633	NIH [GM059660, AI051340]; HFSP [RPG0055/2006-C]; National American Heart Association [0730120N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI051340, R01AI051340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); National American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Gauss for the NCF2 vector and A. Marintchev for helpful discussions. This work was supported by NIH grant GM059660 and HFSP grant RPG0055/2006-C to T.V.P., NIH grant AI051340 to C.U.T.H., and National American Heart Association grant 0730120N to A.A.K.	Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; De Breyne S, 2008, RNA, V14, P367, DOI 10.1261/rna.696508; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Svitkin YV, 2001, RNA, V7, P1743; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	37	167	169	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1237	1250		10.1016/j.cell.2008.10.037	http://dx.doi.org/10.1016/j.cell.2008.10.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109895	Green Accepted, Bronze			2022-12-24	WOS:000261989800015
J	Lieske, B				Lieske, B.			The left handed surgical trainee	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lieske, B.] Royal Berkshire Hosp NHS Fdn Trust, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	Lieske, B (corresponding author), Royal Berkshire Hosp NHS Fdn Trust, Reading RG1 5AN, Berks, England.	Bettina_Lieske@yahoo.co.uk						Adusumilli Prasad S, 2004, Curr Surg, V61, P587, DOI 10.1016/j.cursur.2004.05.022; McManus C, 2003, RIGHT HAND LEFT HAND; SCHOTT J, 1995, BRIT MED J, V310, P739, DOI 10.1136/bmj.310.6981.739b	3	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2883	10.1136/bmj.a2883	http://dx.doi.org/10.1136/bmj.a2883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088142				2022-12-24	WOS:000262184900005
J	Bache, S; Edenborough, F				Bache, Sarah; Edenborough, Frank			A symphony of maladies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WIND INSTRUMENT PLAYERS; EMBOUCHURE DYSTONIA; MUSICIANS DYSTONIA; BRASS MUSICIANS; FOCAL DYSTONIA; PREVALENCE; HAND; DERMATITIS; FLAUTISTS; PRESSURE		[Bache, Sarah; Edenborough, Frank] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Bache, S (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	sarahbache@doctors.org.uk						Aydin P, 2000, J GLAUCOMA, V9, P322; Bejjani FJ, 1996, ARCH PHYS MED REHAB, V77, P406, DOI 10.1016/S0003-9993(96)90093-3; BRAMLEY S, 2004, STAGE NEWS      0601; Byl NN, 2003, ARCH PHYS MED REHAB, V84, P1505, DOI 10.1016/S0003-9993(03)00276-4; Chesky KS, 2000, J OCCUP ENVIRON MED, V42, P775, DOI 10.1097/00043764-200008000-00001; COUGHLAN S, 2007, BBC NEWS        0515; CURTIS P, 1974, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.5912.226-a; DAHL MGC, 1978, BRIT MED J, V2, P1023, DOI 10.1136/bmj.2.6143.1023; David S, 1997, AM J EMERG MED, V15, P73, DOI 10.1016/S0735-6757(97)90054-1; Dawson WJ, 1997, MED PROBL PERFORM AR, V12, P107; Deniz O, 2006, ARCH MED RES, V37, P506, DOI 10.1016/j.arcmed.2005.09.015; Elghozi JL, 2008, CLIN AUTON RES, V18, P96, DOI 10.1007/s10286-008-0462-3; Evers S, 2000, NEUROLOGY, V55, P865, DOI 10.1212/WNL.55.6.865; EVERS S, 1998, NEUROLOGY, V104, P1203; Fetter D, 1993, Md Med J, V42, P289; Foxman Irina, 2006, AAOHN J, V54, P309; Frucht SJ, 2001, MOVEMENT DISORD, V16, P899, DOI 10.1002/mds.1167; Fry HJH, 1998, NEUROLOGY, V51, P512, DOI 10.1212/WNL.51.2.512; Gambichler T, 2008, CONTACT DERMATITIS, V58, P217, DOI 10.1111/j.1600-0536.2007.01310.x; Gambichler Thilo, 2004, BMC Dermatol, V4, P3, DOI 10.1186/1471-5945-4-3; Gilbert T B, 1998, Md Med J, V47, P23; HANSFORD R, 2007, BMJ CAREERS, V335, P159; Hirata Y, 2004, NEUROREPORT, V15, P815, DOI 10.1097/00001756-200404090-00015; Inesta C., 2008, J OCCUP MED TOXICOL, V3, P16, DOI [10.1186/1745-6673-3-16, DOI 10.1186/1745-6673-3-16]; Inoue A, 1998, CONTACT DERMATITIS, V39, P37, DOI 10.1111/j.1600-0536.1998.tb05816.x; Isaacson G, 2000, Ear Nose Throat J, V79, P272; Jabusch HC, 2005, MOVEMENT DISORD, V20, P1623, DOI 10.1002/mds.20631; Jabusch HC, 2006, ADV COGN PSYCHOL, P207, DOI DOI 10.2478/V10053-008-0056-6; Klotz DA, 2001, LARYNGOSCOPE, V111, P2157, DOI 10.1097/00005537-200112000-00015; Koppejan S, 2006, ERGONOMICS, V49, P316, DOI 10.1080/00140130500436213; Kumar G, 1998, BRIT J RADIOL, V71, P799, DOI 10.1259/bjr.71.847.9771394; Liu S, 2002, SOUTH MED J, V95, P727; Lombardi C, 2003, Eur Ann Allergy Clin Immunol, V35, P52; Lozano FJR, 2008, MED PROBL PERFORM AR, V23, P12; LUCIA R, 1994, J ASTHMA, V31, P375, DOI 10.3109/02770909409061317; Malick D, 2007, CLEFT PALATE-CRAN J, V44, P424, DOI 10.1597/06-176.1; MANDELL HN, 1962, NEW ENGL J MED, V266, P348, DOI 10.1056/NEJM196202152660708; MARSHMAN G, 1992, CONTACT DERMATITIS, V26, P134, DOI 10.1111/j.1600-0536.1992.tb00902.x; MENCIMER S, 2003, WASHINGTON POST 0325; Morais D, 2007, ACTA OTORRINOLAR ESP, V58, P401, DOI 10.1016/S0001-6519(07)74956-7; Moreno J C, 1997, Am J Contact Dermat, V8, P39, DOI 10.1016/S1046-199X(97)90035-X; MULCAHY D, 1990, BRIT HEART J, V64, P388; Murphy J, 1999, CONTACT DERMATITIS, V40, P334, DOI 10.1111/j.1600-0536.1999.tb06092.x; MURPHY JM, 1974, BMJ-BRIT MED J, V2, P335, DOI 10.1136/bmj.2.5914.335-a; Nakamura M, 1999, CONTACT DERMATITIS, V40, P219, DOI 10.1111/j.1600-0536.1999.tb06044.x; NIZET PM, 1976, J ELECTROCARDIOL, V9, P51, DOI 10.1016/S0022-0736(76)80010-6; Papsin BC, 1996, LARYNGOSCOPE, V106, P757, DOI 10.1097/00005537-199606000-00017; PETERS C, NOISE HEARING LOSS M; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Sakai N, 2002, MED PROBL PERFORM AR, V17, P178; SCHAFERCRANE G, 2006, PHYS MED REH CLIN N, V17, P827; Schuele S, 2005, NEUROLOGY, V64, P341, DOI 10.1212/01.WNL.0000149768.36634.92; Schuele S, 2004, MOVEMENT DISORD, V19, P43, DOI 10.1002/mds.10647; Schuman JS, 2001, OPHTHALMOLOGY, V108, P635, DOI 10.1016/S0161-6420(00)00559-5; SHARIPO P, 1991, J AM ACAD DERMATOL, V24, P665; SOLOMON JW, 2007, GUITAR REV, V133, P2; Stasney CR, 2003, MED PROBL PERFORM AR, V18, P153; Sternbach D, 1993, Md Med J, V42, P283; TADDEY JJ, 1992, CRANIO, V10, P241, DOI 10.1080/08869634.1992.11677916; Thayer JF, 2000, BIOMED SCI INSTRUM, V395, P301; Yeo DKL, 2002, AUST DENT J, V47, P2, DOI 10.1111/j.1834-7819.2002.tb00296.x; 1990, ART HAZARDS NEWS, V13	62	6	6	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2008	337								a2646	10.1136/bmj.a2646	http://dx.doi.org/10.1136/bmj.a2646			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CC	19074561				2022-12-24	WOS:000262777000001
J	von Braun, J				von Braun, Joachim			The food crisis isn't over	NATURE			English	Editorial Material									Int Food Policy Res Inst, Washington, DC 20036 USA	CGIAR; International Food Policy Research Institute (IFPRI)	von Braun, J (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	j.vonbraun@cgiar.org	von Braun, Joachim/AAA-7044-2020	von Braun, Joachim/0000-0001-6571-4838				BEINTEMA NM, 2008, MEASURING AGR RES IN; Fan SG, 2008, AGR ECON-BLACKWELL, V39, P163, DOI 10.1111/j.1574-0862.2008.00328.x; *FAO, 2008, HUNG RIS SOAR PRIC A; von Braun J., 2008, FOOD FINANCIAL CRISE; VONBRAUN J, 2008, 4 IFPRI; *WORLD BANK, 2007, WORLD DEV REP 2008 A	6	46	47	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					701	701		10.1038/456701a	http://dx.doi.org/10.1038/456701a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TX	19079033	Bronze			2022-12-24	WOS:000261559900019
J	Masip, J; Mebazaa, A; Filippatos, GS				Masip, Josep; Mebazaa, Alexandre; Filippatos, Gerasimos S.			Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							METAANALYSIS; PRESSURE		[Masip, Josep] Consorci Sanit Integral, Barcelona 08025, Spain; [Mebazaa, Alexandre] Univ Paris 07, F-75010 Paris, France; [Filippatos, Gerasimos S.] Univ Athens, Athens 12461, Greece	UDICE-French Research Universities; Universite Paris Cite; National & Kapodistrian University of Athens	Masip, J (corresponding author), Consorci Sanit Integral, Barcelona 08025, Spain.		Nicholl, Jon/B-8257-2008; Filippatos, Gerasimos/ABA-4656-2021					Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Nieminen MS, 2005, EUR HEART J, V26, P384; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Plaisance P, 2007, EUR HEART J, V28, P2895, DOI 10.1093/eurheartj/ehm502; Winck JC, 2006, CRIT CARE, V10, DOI 10.1186/cc4905	5	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2068	2069						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18990784				2022-12-24	WOS:000260632700022
J	Van Raamsdonk, CD; Bezrookove, V; Green, G; Bauer, J; Gaugler, L; O'Brien, JM; Simpson, EM; Barsh, GS; Bastian, BC				Van Raamsdonk, Catherine D.; Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; O'Brien, Joan M.; Simpson, Elizabeth M.; Barsh, Gregory S.; Bastian, Boris C.			Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi	NATURE			English	Article							KINASE-C; BRAF; MELANOCYTES; PATHWAY; CELLS	BRAF and NRAS are common targets for somatic mutations in benign and malignant neoplasms that arise from melanocytes situated in epithelial structures, and lead to constitutive activation of the mitogen- activated protein ( MAP) kinase pathway(1,2). However, BRAF and NRAS mutations are absent in a number of other melanocytic neoplasms in which the equivalent oncogenic events are currently unknown(3). Here we report frequent somatic mutations in the heterotrimeric G protein alpha-subunit, GNAQ, in blue naevi (83%) and ocular melanoma of the uvea ( 46%). The mutations occur exclusively in codon 209 in the Ras- like domain and result in constitutive activation, turning GNAQ into a dominant acting oncogene. Our results demonstrate an alternative route to MAP kinase activation in melanocytic neoplasia, providing new opportunities for therapeutic intervention.	[Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; O'Brien, Joan M.; Bastian, Boris C.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [O'Brien, Joan M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bauer, Juergen] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Simpson, Elizabeth M.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Simpson, Elizabeth M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of British Columbia; University of British Columbia; Stanford University	Bastian, BC (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	bastian@cc.ucsf.edu	Simpson, Elizabeth/H-1183-2012; Van Raamsdonk, Catherine D./B-6207-2017; Bauer, Jurgen/B-4656-2008	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Bastian, Boris/0000-0003-1836-6062; Bauer, Jurgen/0000-0001-8789-1536; Simpson, Elizabeth/0000-0002-0654-4303	National Cancer Institute [P01 CA025874 Project 2]; Melanoma Research Alliance, the Canadian Institutes of Health Research [MOP-79511]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA025874, R01CA131524] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance, the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Harbour for providing additional DNA samples from uveal melanomas and P. Viciana-Rodriguez and A. Balmain for providing advice. hTERT/CDK4<SUP>R24C</SUP>/p53<SUP>DD</SUP> melanocytes were a gift from D. Fisher, Dana Farber Cancer Institute<SUP>13</SUP>, normal human melanocytes from foreskin were a gift from M. Herlyn, and OMM1.3 and Mel202 cells were originally from B. Ksander. The melan-a cells were a gift from D. Bennett, St George's University, London23. This work was supported by grants from the National Cancer Institute (P01 CA025874 Project 2 to B.C.B.) the Melanoma Research Alliance, the Canadian Institutes of Health Research (MOP-79511 to C.D.V.R.), and the National Institutes of Health (G.S.B.).	BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; HORSMAN DE, 1993, CANCER, V71, P811, DOI 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mizushima J, 1998, BRIT J DERMATOL, V139, P349; POLLOCK PM, 2002, NAT GENET, V25, P25; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Singh AD, 1998, OPHTHALMOLOGY, V105, P195, DOI 10.1016/S0161-6420(98)92205-9; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Zembowicz A, 2004, HISTOPATHOLOGY, V45, P433, DOI 10.1111/j.1365-2559.2004.01975.x; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	23	1043	1063	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					599	U108		10.1038/nature07586	http://dx.doi.org/10.1038/nature07586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19078957	Green Accepted, Green Submitted			2022-12-24	WOS:000262852200045
J	Kawahara, A; Nishi, T; Hisano, Y; Fukui, H; Yamaguchi, A; Mochizuki, N				Kawahara, Atsuo; Nishi, Tsuyoshi; Hisano, Yu; Fukui, Hajime; Yamaguchi, Akihito; Mochizuki, Naoki			The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors	SCIENCE			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; SPHINGOSINE 1-PHOSPHATE; ENDODERM FORMATION; HEART DEVELOPMENT; SPHINGOSINE-1-PHOSPHATE; GENETICS; PROTEIN; CASANOVA; MUTATION; SLC11A3	Sphingosine-1-phosphate ( S1P) is a secreted lipid mediator that functions in vascular development; however, it remains unclear how S1P secretion is regulated during embryogenesis. We identified a zebrafish mutant, ko157, that displays cardia bifida ( two hearts) resembling that in the S1P receptor- 2 mutant. A migration defect of myocardial precursors in the ko157 mutant is due to a mutation in a multipass transmembrane protein, Spns2, and can be rescued by S1P injection. We show that the export of S1P from cells requires Spns2. spns2 is expressed in the extraembryonic tissue yolk syncytial layer ( YSL), and the introduction of spns2 mRNA in the YSL restored the cardiac defect in the ko157 mutant. Thus, Spns2 in the YSL functions as a S1P transporter in S1P secretion, thereby regulating myocardial precursor migration.	[Kawahara, Atsuo; Fukui, Hajime; Mochizuki, Naoki] Natl Cardiovasc Ctr Hosp & Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Kawahara, Atsuo] Kyoto Univ, Fac Med, HMRO, Sakyo Ku, Kyoto 6068501, Japan; [Nishi, Tsuyoshi; Hisano, Yu; Yamaguchi, Akihito] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Nishi, Tsuyoshi; Hisano, Yu; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	National Cerebral & Cardiovascular Center - Japan; Kyoto University; Osaka University; Osaka University	Kawahara, A (corresponding author), Natl Cardiovasc Ctr Hosp & Res Inst, Dept Struct Anal, Fujishirodai 5-7-1, Osaka 5658565, Japan.	atsuo@ri.ncvc.go.jp	Fukui, Hajime/AAG-2004-2020	Fukui, Hajime/0000-0002-7652-2222	Ministry of Education, Culture, Sports, Science and Technology of Japan; National BioResource Project of Japan; Japan Society for the Promotion of Science; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National BioResource Project of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank M. Sone and M. Minamimoto for technical assistance; S. Endo and R. Hanaoka for the mutagenesis screening; T. Kitaguchi for the establishment of cmlc2: mRFP; M. Masuda, Y. Igarashi, A. Kihara, S. Mitsutake, K. Shioya, I. B. Dawid, and Y. Kaziro for support and suggestions; M. Hibi, J. S. Gutkind, and M. Tsang for critical reading and valuable suggestions; D. Y. Stainier for discussions and sharing of unpublished data; and H. Okamoto, K. Kawakami, Y. Kikuchi, H. Yanagisawa, D. Yamamoto, R. Y. Tsien, and H.- J. Tsai for fish and reagents. Supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the National BioResource Project of Japan; the Japan Society for the Promotion of Science; the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; the Ministry of Health, Labor and Welfare of Japan; and the Takeda Science Foundation. The sequences of zebrafish spns2, human Spns2, and mouse Spns2 have been deposited in the DNA Data Bank of Japan [accession numbers: AB441164 (zebrafish), AB441165 (human), AB441166 (mouse)]. The authors are filing a patent based on the results reported in this paper.	Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Matsui Takaaki, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS77, DOI 10.1038/ncpcardio0764; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schoenebeck JJ, 2007, SEMIN CELL DEV BIOL, V18, P27, DOI 10.1016/j.semcdb.2006.12.010; Sekiguchi M, 2008, J IMMUNOL, V180, P1921, DOI 10.4049/jimmunol.180.3.1921; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Young RM, 2002, DEV DYNAM, V223, P298, DOI 10.1002/dvdy.10060	25	293	304	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					524	527		10.1126/science.1167449	http://dx.doi.org/10.1126/science.1167449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19074308				2022-12-24	WOS:000262587900048
J	Keller, GB; Hahnloser, RHR				Keller, Georg B.; Hahnloser, Richard H. R.			Neural processing of auditory feedback during vocal practice in a songbird	NATURE			English	Article							MALE ZEBRA FINCHES; ADULT BIRDSONG; SYSTEM; TELENCEPHALON; PERTURBATION; CONNECTIONS; BEHAVIOR; NEURONS; CORTEX; MODEL	Songbirds are capable of vocal learning and communication(1,2) and are ideally suited to the study of neural mechanisms of complex sensory and motor processing. Vocal communication in a noisy bird colony and vocal learning of a specific song template both require the ability to monitor auditory feedback(3,4) to distinguish self-generated vocalizations from external sounds and to identify mismatches between the developing song and a memorized template acquired from a tutor(5). However, neurons that respond to auditory feedback from vocal output have not been found in song-control areas despite intensive searching(6-8). Here we investigate feedback processing outside the traditional song system, in single auditory forebrain neurons of juvenile zebra finches that were in a late developmental stage of song learning. Overall, we found similarity of spike responses during singing and during playback of the bird's own song, with song responses commonly leading by a few milliseconds. However, brief time- locked acoustic perturbations of auditory feedback revealed complex sensitivity that could not be predicted from passive playback responses. Some neurons that responded to playback perturbations did not respond to song perturbations, which is reminiscent of sensory- motor mirror neurons(8,9). By contrast, some neurons were highly feedback sensitive in that they responded vigorously to song perturbations, but not to unperturbed songs or perturbed playback. These findings suggest that a computational function of forebrain auditory areas may be to detect errors between actual feedback and mirrored feedback deriving from an internal model of the bird's own song or that of its tutor. Such feedback- sensitive spikes could constitute the key signals that trigger adaptive motor responses to song disruptions(10,11) or reinforce exploratory motor gestures for vocal learning(12).	[Keller, Georg B.; Hahnloser, Richard H. R.] Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Hahnloser, RHR (corresponding author), Univ Zurich, ETH, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	rich@ini.phys.ethz.ch		Keller, Georg/0000-0002-1401-0117; Hahnloser, Richard/0000-0002-4039-7773	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a Swiss National Science Foundation Professorship Grant to R. H. R. H. We thank K. Martin, R. Mooney and R. Douglas for comments on the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Foster EF, 1998, J COMP NEUROL, V397, P118; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Immelmann K., 1969, P61; Janata P, 1999, J NEUROSCI, V19, P5108; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KARTEN H J, 1968, Brain Research, V11, P134, DOI 10.1016/0006-8993(68)90078-4; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; THORPE WH, 1975, ACTA NEUROBIOL EXP, V35, P517; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Zeng SJ, 2004, J COMP NEUROL, V470, P192, DOI 10.1002/cne.11042	30	138	139	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					187	U78		10.1038/nature07467	http://dx.doi.org/10.1038/nature07467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19005471				2022-12-24	WOS:000262360200031
J	Li, P; Tong, C; Mehrian-Shai, R; Jia, L; Wu, N; Yan, Y; Maxson, RE; Schulze, EN; Song, H; Hsieh, CL; Pera, MF; Ying, QL				Li, Ping; Tong, Chang; Mehrian-Shai, Ruty; Jia, Li; Wu, Nancy; Yan, Youzhen; Maxson, Robert E.; Schulze, Eric N.; Song, Houyan; Hsieh, Chih-Lin; Pera, Martin F.; Ying, Qi-Long			Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts	CELL			English	Article							MOUSE EMBRYOS; SELF-RENEWAL; LINE TRANSMISSION; EGG-CYLINDERS; ES CELLS; GENE; PLURIPOTENT; DIFFERENTIATION; GENOME; GROWTH	Rats have important advantages over mice as an experimental system for physiological and pharmacological investigations. The lack of rat embryonic stem (ES) cells has restricted the availability of transgenic technologies to create genetic models in this species. Here, we show that rat ES cells can be efficiently derived, propagated, and genetically manipulated in the presence of small molecules that specifically inhibit GSK3, MEK, and FGF receptor tyrosine kinases. These rat ES cells express pluripotency markers and retain the capacity to differentiate into derivatives of all three germ layers. Most importantly, they can produce high rates of chimerism when reintroduced into early stage embryos and can transmit through the germline. Establishment of authentic rat ES cells will make possible sophisticated genetic manipulation to create models for the study of human diseases.	[Li, Ping; Tong, Chang; Schulze, Eric N.; Pera, Martin F.; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Mehrian-Shai, Ruty; Maxson, Robert E.; Hsieh, Chih-Lin] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Mehrian-Shai, Ruty] Univ So Calif, Keck Sch Med, Custom Microarray Core Facil, Inst Med Genet, Los Angeles, CA 90033 USA; [Wu, Nancy; Yan, Youzhen; Maxson, Robert E.] Univ So Calif, Keck Sch Med, Knockout Core Facil, Norris Canc Ctr Transgen, Los Angeles, CA 90033 USA; [Pera, Martin F.; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Jia, Li; Hsieh, Chih-Lin] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Dept Urol, Los Angeles, CA 90033 USA; [Li, Ping; Song, Houyan] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 20032, Peoples R China	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Fudan University	Ying, QL (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	qying@keck.usc.edu	Jia, li/GPW-8015-2022; PERA, MARTIN/A-9812-2012; Mehrian-Shai, Ruty/AAF-8008-2019; li, jia/GVT-7587-2022	PERA, MARTIN/0000-0001-6239-0428; 	USC Startup fund; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) [RS1-00327-1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016320] Funding Source: NIH RePORTER	USC Startup fund; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Jing Du, Yu Su, Robin Wesselschmidt, Hongjun Zhang, and Shelley Hough for technical assistance; Gerald Chester for ordering animals; Ramiro Montano, Gloria Martinez, and colleagues for rat husbandry; and Dr. Wange Lu for sharing research materials. This work was supported by USC Startup fund (Q.-L.Y.) and in part by California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) grants RS1-00327-1 (Q.-L.Y.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; DAMJANOV I, 1977, J NATL CANCER I, V58, P1523, DOI 10.1093/jnci/58.5.1523; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P303; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; HSIEH CL, 1997, CELL BIOL LAB HDB, P391; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kuramoto T, 2001, MAMM GENOME, V12, P469, DOI 10.1007/s003350020010; Liu X, 1997, DEV DYNAM, V209, P85; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nagy A., 2003, MANIPULATING MOUSE E; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Nichols Jennifer, 2006, V329, P91; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ostertag EM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S16; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	492	570	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1299	1310		10.1016/j.cell.2008.12.006	http://dx.doi.org/10.1016/j.cell.2008.12.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109898	Green Accepted, Bronze			2022-12-24	WOS:000261989800020
J	Kennedy, S				Kennedy, Shaun			EPIDEMIOLOGY Why Can't We Test Our Way to Absolute Food Safety?	SCIENCE			English	Editorial Material									[Kennedy, Shaun] Univ Minnesota, Natl Ctr Food Protect & Def, Dept Homeland Secur, Ctr Excellence & Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Kennedy, S (corresponding author), Univ Minnesota, Natl Ctr Food Protect & Def, Dept Homeland Secur, Ctr Excellence & Vet Populat Med, St Paul, MN 55108 USA.	kenne108@umn.edu						Danzig R., 2003, CATASTROPHIC BIOTERR; Ferreira JL, 2004, J FOOD PROTECT, V67, P203, DOI 10.4315/0362-028X-67.1.203; International Commission on Microbiological Specifications for Foods, 1986, MICR FOODS, V2; International Commission on Microbiological Specifications for Foods, 2002, MICR FOODS; KENNEDY SP, 2007, FOOD MICROBIOLOGY FU, V3, pCH5	5	16	18	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1641	1643		10.1126/science.1163867	http://dx.doi.org/10.1126/science.1163867			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074334				2022-12-24	WOS:000261608300028
J	Omran, H; Kobayashi, D; Olbrich, H; Tsukahara, T; Loges, NT; Hagiwara, H; Zhang, Q; Leblond, G; O'Toole, E; Hara, C; Mizuno, H; Kawano, H; Fliegauf, M; Yagi, T; Koshida, S; Miyawaki, A; Zentgraf, H; Seithe, H; Reinhardt, R; Watanabe, Y; Kamiya, R; Mitchell, DR; Takeda, H				Omran, Heymut; Kobayashi, Daisuke; Olbrich, Heike; Tsukahara, Tatsuya; Loges, Niki T.; Hagiwara, Haruo; Zhang, Qi; Leblond, Gerard; O'Toole, Eileen; Hara, Chikako; Mizuno, Hideaki; Kawano, Hiroyuki; Fliegauf, Manfred; Yagi, Toshiki; Koshida, Sumito; Miyawaki, Atsushi; Zentgraf, Hanswalter; Seithe, Horst; Reinhardt, Richard; Watanabe, Yoshinori; Kamiya, Ritsu; Mitchell, David R.; Takeda, Hiroyuki			Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins	NATURE			English	Article							PRIMARY CILIARY DYSKINESIA; CHLAMYDOMONAS-REINHARDTII; KUPFFERS VESICLE; FLUID-FLOW; ARM DYNEIN; MUTATIONS; MEDAKA; PROTEIN; CHAIN; MUTANT	Cilia and flagella are highly conserved organelles that have diverse roles in cell motility and sensing extracellular signals. Motility defects in cilia and flagella often result in primary ciliary dyskinesia. However, the mechanisms underlying cilia formation and function, and in particular the cytoplasmic assembly of dyneins that power ciliary motility, are only poorly understood. Here we report a new gene, kintoun ( ktu), involved in this cytoplasmic process. This gene was first identified in a medaka mutant, and found to be mutated in primary ciliary dyskinesia patients from two affected families as well as in the pf13 mutant of Chlamydomonas. In the absence of Ktu/ PF13, both outer and inner dynein arms are missing or defective in the axoneme, leading to a loss of motility. Biochemical and immunohistochemical studies show that Ktu/ PF13 is one of the long- sought proteins involved in pre- assembly of dynein arm complexes in the cytoplasm before intraflagellar transport loads them for the ciliary compartment.	[Omran, Heymut; Olbrich, Heike; Loges, Niki T.; Fliegauf, Manfred] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Kobayashi, Daisuke; Yagi, Toshiki; Koshida, Sumito; Kamiya, Ritsu; Takeda, Hiroyuki] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Grad Sch Sci, Tokyo 1130033, Japan; [Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Grad Program Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan; [Hagiwara, Haruo] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Gunma 3718511, Japan; [Zhang, Qi; Leblond, Gerard; Mitchell, David R.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [O'Toole, Eileen] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Hara, Chikako; Mizuno, Hideaki; Kawano, Hiroyuki; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany; [Seithe, Horst] Klinikum Nurnberg Sud, Klin Kinder & Jugendliche, D-90471 Nurnberg, Germany; [Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Freiburg; University of Tokyo; University of Tokyo; University of Tokyo; Gunma University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Colorado System; University of Colorado Boulder; RIKEN; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Mathildenstr 1, D-79106 Freiburg, Germany.	heymut.omran@uniklinik-freiburg.de; MitchelD@upstate.edu; htakeda@biol.s.u-tokyo.ac.jp	Mizuno, Hideaki/AAH-5737-2021; Tsukahara, Tatsuya/AAO-1707-2021; TAKEDA, HIROYUKI/G-4950-2014; Kobayashi, Daisuke/AAQ-8465-2021; Miyawaki, Atsushi/K-3569-2014	Mizuno, Hideaki/0000-0002-6983-5255; Tsukahara, Tatsuya/0000-0002-6928-8562; Miyawaki, Atsushi/0000-0002-2329-3235; Omran, Heymut/0000-0003-0282-6765; Kobayashi, Daisuke/0000-0001-9755-6168; Reinhardt, Richard/0000-0001-9376-2132; Mitchell, David/0000-0003-2821-7511; Watanabe, Yoshinori/0000-0002-5488-4812; Yagi, Toshiki/0000-0002-1379-460X	NIG Cooperative Research Program; Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology ( MEXT) of Japan; Yamada Science Foundation; Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan; University of Tokyo; MEXT, Japan; ' Deutsche Forschungsgemeinschaft' [DFG Om 6/4, GRK1104]; BIOSS; NIH [GM44228]; German Ministry of Science and Education ( BMBF) [NGFN-2:01GR0414-PDN-S02T17]; 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.';  [SFB592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044228] Funding Source: NIH RePORTER	NIG Cooperative Research Program; Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology ( MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); University of Tokyo; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ' Deutsche Forschungsgemeinschaft'(German Research Foundation (DFG)); BIOSS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Science and Education ( BMBF)(Federal Ministry of Education & Research (BMBF)); 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.'; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Lo and D. Morris- Rosendahl for critical reading of this manuscript. We are grateful to M. Sugimoto, A. Ito-Igarashi, K. Nakaguchi, S. Minami, Y. H. Park, Y. Mochizuki, Y. Ozawa, K. Ohki, T. Obata, A. Heer and C. Reinhardt for excellent fish care and/or experimental assistance. We also thank A. Shimada and D. Nihei for their help in medaka experiments, J. Freshour and M. Nakatsugawa for help with Chlamydomonas, and S. King, H. Qin, W. Sale and D. Stern for antibodies. Our mutant screening was carried out mainly at the National Institute of Genetics (NIG), supported by NIG Cooperative Research Program (2002-2006). This work was supported in part by Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B), Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Yamada Science Foundation, and a Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan. D. K. was a research fellow supported by the 21th century COE program of the University of Tokyo, MEXT, Japan. This work was supported by grants to H. Omran from the ' Deutsche Forschungsgemeinschaft' DFG Om 6/4, GRK1104, BIOSS and the SFB592, and to D. R. M. from the NIH, GM44228. We would like to acknowledge the sequencing activities by K. Borzym and the Seq-Team at PI- MG, which was supported by the German Ministry of Science and Education ( BMBF) by grant NGFN-2:01GR0414-PDN-S02T17 to R. R. We are grateful for the support by the 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.'.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; CHEN XM, 1995, PLANT CELL, V7, P1295; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; HAGIWARA H, 1990, Japanese Journal of Clinical Electron Microscopy, V23, P493; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; HUANG B, 1979, J BIOL CHEM, V254, P3091; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; Mochizuki E, 2005, KIDNEY INT, V68, P23, DOI 10.1111/j.1523-1755.2005.00378.x; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; TAM LW, 1993, GENETICS, V135, P375; VANDORP DB, 1992, HUM GENET, V88, P331, DOI 10.1007/BF00197269; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yamamoto R, 2006, FEBS LETT, V580, P6357, DOI 10.1016/j.febslet.2006.10.047; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	47	262	274	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					611	U54		10.1038/nature07471	http://dx.doi.org/10.1038/nature07471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052621	Green Accepted			2022-12-24	WOS:000261340000034
J	Haine, ER; Moret, Y; Siva-Jothy, MT; Rolff, J				Haine, Eleanor R.; Moret, Yannick; Siva-Jothy, Michael T.; Rolff, Jens			Antimicrobial Defense and Persistent Infection in Insects	SCIENCE			English	Article							INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; TENEBRIO-MOLITOR; HOST-DEFENSE; RESISTANCE; PEPTIDES; SYSTEM	During 400 million years of existence, insects have rarely succumbed to the evolution of microbial resistance against their potent antimicrobial immune defenses. We found that microbial clearance after infection is extremely fast and that induced antimicrobial activity starts to increase only when most of the bacteria (99.5%) have been removed. Our experiments showed that those bacteria that survived exposure to the insect's constitutive immune response were subsequently more resistant to it. These results imply that induced antimicrobial compounds function primarily to protect the insect against the bacteria that persist within their body, rather than to clear microbial infections. These findings suggest that understanding of the management of antimicrobial peptides in natural systems might inform medical treatment strategies that avoid the risk of drug resistance.	[Haine, Eleanor R.; Siva-Jothy, Michael T.; Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Moret, Yannick] Univ Bourgogne 1, CNRS, UMR Biogeosci 5561, F-21000 Dijon, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Rolff, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	jor@sheffield.ac.uk	Moret, Yannick/I-9282-2012	Haine Bennett, Eleanor/0000-0001-8777-4532; Rolff, Jens/0000-0002-1529-5409	Leverhulme Trust; The Wellcome Trust	Leverhulme Trust(Leverhulme Trust); The Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Clare, A. Dobson, S. Webster, and A. Williams for laboratory assistance. P. Brakefield, S. Foster, and M. Osborn made valuable comments that improved the manuscript. This research was funded by The Leverhulme Trust, and E. R. H. was also supported by The Wellcome Trust.	BULET P, 1992, EUR J BIOCHEM, V209, P977, DOI 10.1111/j.1432-1033.1992.tb17371.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	23	240	248	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1257	1259		10.1126/science.1165265	http://dx.doi.org/10.1126/science.1165265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023083				2022-12-24	WOS:000261033400045
J	Yarbrough, ML; Li, Y; Kinch, LN; Grishin, NV; Ball, HL; Orth, K				Yarbrough, Melanie L.; Li, Yan; Kinch, Lisa N.; Grishin, Nick V.; Ball, Haydn L.; Orth, Kim			AMPylation of Rho GTPases by Vibrio VopS Disrupts Effector Binding and Downstream Signaling	SCIENCE			English	Article							III SECRETION SYSTEM; PARAHAEMOLYTICUS; PROTEIN; ACTIVATION	The Vibrio parahaemolyticus type III effector VopS is implicated in cell rounding and the collapse of the actin cytoskeleton by inhibiting Rho guanosine triphosphatases ( GTPases). We found that VopS could act to covalently modify a conserved threonine residue on Rho, Rac, and Cdc42 with adenosine 5 '- monophosphate ( AMP). The resulting AMPylation prevented the interaction of Rho GTPases with downstream effectors, thereby inhibiting actin assembly in the infected cell. Eukaryotic proteins were also directly modified with AMP, potentially expanding the repertoire of posttranslational modifications for molecular signaling.	[Yarbrough, Melanie L.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Li, Yan; Ball, Haydn L.] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Li, Yan; Ball, Haydn L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021; Yarbrough, Melanie/T-4078-2019	Orth, Kim/0000-0002-0678-7620; Kinch, Lisa/0000-0003-3041-2615; Yarbrough, Melanie/0000-0003-2166-7552	NIH-Allergy and Infectious Disease [R01-AI056404]; Welch Foundation [I-1561, I-1505]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER	NIH-Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Alto, R. Taussig, P. Sternweis, S. Mukherjee, M. Rosen, E. Olson, J. Goldstein, M. Brown, T. Iida, T. Honda, L. McCarter, and the Orth lab for insightful discussions, critical reading, and/or generous supply of reagents. K.O. and M.L.Y. are supported by grants from NIH-Allergy and Infectious Disease (R01-AI056404) and the Welch Foundation (I-1561). L.N.K. and N.G. are supported by the Welch Foundation (I-1505) and Howard Hughes Medical Institute. K.O. is a Beckman Young Investigator, Burroughs Wellcome Investigator, and W. W. Caruth Biomedical Scholar.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982	14	283	303	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					269	272		10.1126/science.1166382	http://dx.doi.org/10.1126/science.1166382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039103				2022-12-24	WOS:000262290600043
J	Gupta, A; Khaw, FM; Stokle, EL; George, RC; Pebody, R; Stansfield, RE; Sheppard, CL; Slack, M; Gorton, R; Spencer, DA				Gupta, Atul; Khaw, F-M; Stokle, E. L.; George, R. C.; Pebody, R.; Stansfield, R. E.; Sheppard, C. L.; Slack, M.; Gorton, R.; Spencer, D. A.			Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PNEUMOCOCCAL PNEUMONIA; PARAPNEUMONIC EMPYEMA; INVASIVE DISEASE; BURKINA-FASO; MENINGITIS; INFECTION; EPIDEMIC		[Khaw, F-M; Stokle, E. L.; Gorton, R.] Hlth Protect Agcy NE, No Off, Newcastle Upon Tyne NE1 4WH, Tyne & Wear, England; [Gupta, Atul; Spencer, D. A.] Freeman Rd Hosp, Pediat Resp Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [George, R. C.; Pebody, R.; Sheppard, C. L.; Slack, M.] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England; [Stansfield, R. E.] N Tyneside Gen Hosp, Microbiol Lab Serv, Northumbria Healthcare NHS Fdn Trust, North Shields NE29 8NH, England	Newcastle Freeman Hospital; Newcastle University - UK; Health Protection Agency	Khaw, FM (corresponding author), Hlth Protect Agcy NE, No Off, Newcastle Upon Tyne NE1 4WH, Tyne & Wear, England.	Meng.khaw@hpa.org.uk		Pebody, Richard/0000-0002-9069-2885				*BIN, NOW STREPT PNEUM TES; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Byington CL, 2002, CLIN INFECT DIS, V34, P434, DOI 10.1086/338460; Cashman P, 2007, COMMUN DIS INTELL, V31, P296; Crum NF, 2003, AM J PREV MED, V25, P107, DOI 10.1016/S0749-3797(03)00114-4; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Eltringham G, 2003, J CLIN MICROBIOL, V41, P521, DOI 10.1128/JCM.41.1.521-522.2003; GRATTEN M, 1993, MED J AUSTRALIA, V158, P340, DOI 10.5694/j.1326-5377.1993.tb121794.x; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Leeming JP, 2005, J CLIN MICROBIOL, V43, P4972, DOI 10.1128/JCM.43.10.4972-4976.2005; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Proulx J F, 2002, Can Commun Dis Rep, V28, P129; Ramphul N, 2006, PEDIATR PULM, V41, P750, DOI 10.1002/ppul.20434; RAUCH AM, 1990, AM J DIS CHILD, V144, P923, DOI 10.1001/archpedi.1990.02150320087033; SHEPPARD CL, 2006, THESIS ST MARYS COLL; SHEPPARD CL, 2006, 5 INT S PNEUM PNEUM; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	25	15	17	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2008	337								a2964	10.1136/bmj.a2964	http://dx.doi.org/10.1136/bmj.a2964			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MZ	19118084				2022-12-24	WOS:000262946300001
J	Sokol, DK				Sokol, Daniel K.			Paving the way for assisted suicide	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London, Univ London St Georges Hosp, London WC1E 7HU, England	St Georges University London; University of London	Sokol, DK (corresponding author), Univ London, Univ London St Georges Hosp, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2008	337								a3010	10.1136/bmj.a3010	http://dx.doi.org/10.1136/bmj.a3010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074231				2022-12-24	WOS:000262776900018
J	Watts, G				Watts, Geoff			Regeneration games	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Bartunek J, 2006, EUR HEART J, V27, P1338, DOI 10.1093/eurheartj/ehi793; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2008	337								a1321	10.1136/bmj.a1321	http://dx.doi.org/10.1136/bmj.a1321			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052067				2022-12-24	WOS:000261890900004
J	Ip, SCY; Rass, U; Blanco, MG; Flynn, HR; Skehel, JM; West, SC				Ip, Stephen C. Y.; Rass, Ulrich; Blanco, Miguel G.; Flynn, Helen R.; Skehel, J. Mark; West, Stephen C.			Identification of Holliday junction resolvases from humans and yeast	NATURE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MUS81/MMS4 ENDONUCLEASE; FLAP ENDONUCLEASE-1; MAMMALIAN-CELLS; GENE CONVERSION; NUCLEASE FAMILY; CROSSING-OVER; IN-VITRO; RECOMBINATION	Four-way DNA intermediates, also known as Holliday junctions, are formed during homologous recombination and DNA repair, and their resolution is necessary for proper chromosome segregation. Here we identify nucleases from Saccharomyces cerevisiae and human cells that promote Holliday junction resolution, in a manner analogous to that shown by the Escherichia coli Holliday junction resolvase RuvC. The human Holliday junction resolvase, GEN1, and its yeast orthologue, Yen1, were independently identified using two distinct experimental approaches: GEN1 was identified by mass spectrometry following extensive fractionation of HeLa cell- free extracts, whereas Yen1 was detected by screening a yeast gene fusion library for nucleases capable of Holliday junction resolution. The eukaryotic Holliday junction resolvases represent a new subclass of the Rad2/ XPG family of nucleases. Recombinant GEN1 and Yen1 resolve Holliday junctions by the introduction of symmetrically related cuts across the junction point, to produce nicked duplex products in which the nicks can be readily ligated.	[Ip, Stephen C. Y.; Rass, Ulrich; Blanco, Miguel G.; West, Stephen C.] Clare Hall Labs, London Res Inst, Canc Res UK, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Flynn, Helen R.; Skehel, J. Mark] Clare Hall Labs, London Res Inst, Canc Res UK, Prot Anal & Proteom Lab, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	West, SC (corresponding author), Clare Hall Labs, London Res Inst, Canc Res UK, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Blanco, Miguel González/J-6424-2012; Blanco, Miguel González/R-5754-2017	Blanco, Miguel González/0000-0002-2883-7326; Blanco, Miguel González/0000-0002-2883-7326; West, Stephen/0000-0001-8848-9418; Flynn, Helen/0000-0001-7002-9130; Rass, Ulrich/0000-0001-9275-9062	Cancer Research UK; Louis-Jeantet Foundation; EU DNA Repair Consortium; Croucher Foundation; Xunta de Galicia; Spanish Ministry of Education	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; EU DNA Repair Consortium; Croucher Foundation; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministry of Education(Spanish Government)	We thank M. Lichten and J. Haber for communication of unpublished work, J.-Y. Bleuyard, A. Deans and other members of our laboratory, past and present, for their input and discussions. We acknowledge the contributions of K. Elborough, H. Hyde, B. Kysela, A. Davies, A. Constantinou and Y. Liu for early studies that underpin this work, which was supported by Cancer Research UK, the Louis-Jeantet Foundation and the EU DNA Repair Consortium. S.C.Y.I. was supported by the Croucher Foundation. M. G. B. is on leave from the University of Santiago de Compostela, and supported by fellowships from the Xunta de Galicia and the Spanish Ministry of Education.	Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; de los Santos T, 2003, GENETICS, V164, P81; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Furukawa T, 2003, PLANT MOL BIOL, V51, P59, DOI 10.1023/A:1020789314722; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HYDE H, 1994, J BIOL CHEM, V269, P5202; Ishikawa G, 2004, NUCLEIC ACIDS RES, V32, P6251, DOI 10.1093/nar/gkh962; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Kanai Y, 2007, FEBS J, V274, P3914, DOI 10.1111/j.1742-4658.2007.05924.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Moritoh S, 2005, PLANT CELL PHYSIOL, V46, P699, DOI 10.1093/pcp/pci090; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Smith GR, 2003, GENETICS, V165, P2289; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	43	295	300	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					357	U39		10.1038/nature07470	http://dx.doi.org/10.1038/nature07470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020614				2022-12-24	WOS:000261039600036
J	Hauser, MD; Bever, T				Hauser, Marc D.; Bever, Thomas			BEHAVIOR A Biolinguistic Agenda	SCIENCE			English	Editorial Material							LANGUAGE; SPEECH; FOXP2		[Hauser, Marc D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bever, Thomas] Univ Arizona, Dept Linguist, Psychol & Cognit Sci Program, Tucson, AZ 85721 USA	Harvard University; University of Arizona	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh@wjh.harvard.edu						Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; BATES E, 1994, DISCUSS NEUROSCI, V10, P136; Bever T. G., 1989, NEURONS READING; Boeckx C, 2005, LINGUIST REV, V22, P447, DOI 10.1515/tlir.2005.22.2-4.447; Chan Shiao-Hui, 2007, THESIS U ARIZONA; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Chomsky N., 1957, SYNTACTIC STRUCTURES; Deacon T., 1997, SYMBOLIC SPECIES COE; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; HUTTON JT, 1977, CORTEX, V13, P195, DOI 10.1016/S0010-9452(77)80009-9; Jackendoff Ray, 2002, FDN LANGUAGE; Lennenberg E.H., 1967, BIOL FDN LANGUAGE; LURIA AR, 1969, TRAUMATIC APHASIA; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Pinker Steven., 1984, LANGUAGE LEARNABILIT; Ross DS, 2004, BRAIN LANG, V89, P115, DOI 10.1016/S0093-934X(03)00308-0; Townsend DJ, 2001, BRAIN LANG, V78, P308, DOI 10.1006/brln.2001.2469	22	18	20	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1057	1059		10.1126/science.1167437	http://dx.doi.org/10.1126/science.1167437			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371YD	19008433				2022-12-24	WOS:000260867700023
J	Friel, S; Marmot, M; McMichael, AJ; Kjellstrom, T; Vagero, D				Friel, Sharon; Marmot, Michael; McMichael, Anthony J.; Kjellstrom, Tord; Vagero, Denny			Global health equity and climate stabilisation: a common agenda	LANCET			English	Article							FOOD	Although health has improved for many people, the extent of health inequities between and within countries is growing. Meanwhile, humankind is disrupting the global climate and other life-supporting environmental systems, thereby creating serious risks for health and wellbeing, especially in vulnerable populations but ultimately for everybody. Underlying determinants of health inequity and environmental change overlap substantially; they are signs of an economic system predicated on asymmetric growth and competition, shaped by market forces that mostly disregard health and environmental consequences rather than by values of fairness and support. A shift is needed in priorities in economic development towards healthy forms of urbanisation, more efficient and renewable energy sources, and a sustainable and fairer food system. Global interconnectedness and interdependence enable the social and environmental determinants of health to be addressed in ways that will increase health equity, reduce poverty, and build societies that live within environmental limits.	[Friel, Sharon; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, Commission Social Determinants Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England; [Vagero, Denny] Stockholm Univ, Commission Social Determinants Hlth, S-10691 Stockholm, Sweden; [Vagero, Denny] Stockholm Univ, CHESS Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Vagero, Denny] Karolinska Inst, Stockholm, Sweden; [Friel, Sharon; McMichael, Anthony J.; Kjellstrom, Tord] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	University of London; University College London; Stockholm University; Stockholm University; Karolinska Institutet; Australian National University	Friel, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Commission Social Determinants Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England.	s.friel@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Vagero, Denny/0000-0002-1854-2292; Friel, Sharon/0000-0002-8345-5435	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G0100222, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alcott B, 2008, ECOL ECON, V64, P770, DOI 10.1016/j.ecolecon.2007.04.015; [Anonymous], 2006, FOOD SECURITY HUNGER; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Dixon J, 2007, J URBAN HEALTH, V84, pI118, DOI 10.1007/s11524-007-9176-4; Epstein Paul, 2005, GLOBALIZATION HLTH E, P239; Friel S, 2007, BRIT MED J, V335, P1241, DOI 10.1136/bmj.39377.622882.47; Garcia FJ, 2007, J INT ECON LAW, V10, P461, DOI 10.1093/jiel/jgm022; Gorham R., 2002, AIR POLLUTION GROUND; Hanlon P, 2008, PUBLIC HEALTH, V122, P647, DOI 10.1016/j.puhe.2008.03.020; Hastings G., 2007, EXTENT NATURE EFFECT; *INT LAB ORG, 2008, GLOB ENV TRENDS; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Kjellstrom T, 2007, J URBAN HEALTH, V84, pI86, DOI 10.1007/s11524-007-9171-9; *KNOWL NETW URB SE, 2007, OUR CIT OUR HLTH OUR; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Lobstein T, 2008, LANCET, V372, P628, DOI 10.1016/S0140-6736(08)61270-2; LUNDBERG O, 2007, NORDIC EXPERIENCE WE; McMichael AJ, 2004, LANCET, V364, P2004, DOI 10.1016/S0140-6736(04)17529-6; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; *NNC, 2001, SMART GROWTH NEIGHB; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; Pretty JN, 2005, FOOD POLICY, V30, P1, DOI 10.1016/j.foodpol.2005.02.001; Research Australia, 2007, HLTH PLAN PLAC PEOPL; Royer DL, 2008, TARGET ATMOSPHERIC C; Sachs J., 2005, END POVERTY WE CAN M; Shaffer ER, 2005, AM J PUBLIC HEALTH, V95, P23, DOI 10.2105/AJPH.2004.038091; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; Stern N. H., 2006, STERN REV EC CLIMATE; Stiglitz J, 2006, MAKING GLOBALIZATION; SWAMINATHAN M, 93 IND SCI C 2006 HY; UNDP, 2007, HUM DEV REP FIGHT CL; United Nations, 1948, UN DECL HUM RIGHTS; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; *WORLDWATCH I, 2007, STAT WORLD 2007 OUR; [No title captured]	40	115	115	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1677	1683		10.1016/S0140-6736(08)61692-X	http://dx.doi.org/10.1016/S0140-6736(08)61692-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994666				2022-12-24	WOS:000260899900030
J	Szathmary, E; Szamado, S				Szathmary, Eoers; Szamado, Szabolcs			Being Human: Language: a social history of words	NATURE			English	Editorial Material									[Szathmary, Eoers; Szamado, Szabolcs] Eotvos Lorand Univ, Inst Biol, H-1117 Budapest, Hungary; [Szathmary, Eoers] Collegium Budapest, Budapest, Hungary; [Szathmary, Eoers] Parmenides Ctr Study Thinking, Munich, Germany	Eotvos Lorand University	Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biol, 1-C Pazmany Peter Setany, H-1117 Budapest, Hungary.	szathmary@colbud.hu	Számadó, Szabolcs/A-9804-2013; Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021	Számadó, Szabolcs/0000-0003-2204-9705; Szathmary, Eors/0000-0001-5227-2997					0	10	11	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					40	41		10.1038/456040a	http://dx.doi.org/10.1038/456040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	369DH	18987725	Bronze			2022-12-24	WOS:000260674000031
J	Karkazis, K; Feder, EK				Karkazis, Katrina; Feder, Ellen K.			Naming the problem: disorders and their meanings	LANCET			English	Editorial Material									[Karkazis, Katrina] Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Feder, Ellen K.] American Univ, Dept Philosophy & Relig, Washington, DC 20016 USA	Stanford University; American University	Karkazis, K (corresponding author), Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA.	karkazis@stanford.edu	Karkazis, Katrina/AAE-7276-2019	Karkazis, Katrina/0000-0001-9103-2881; Feder, Ellen K./0000-0002-8014-2804				Aronowitz Robert, 1998, MAKING SENSE ILLNESS; Frank AW., 2013, WOUNDED STORYTELLER; KARKAZIS 9KATRINA, 2008, MEDICAL AUTHORITY LI; Kleinman A., 1988, ILLNESS NARRATIVES; Rosenberg Charles, 1992, FRAMING DIS STUDIES; Sontag Susan, 1978, ILLNESS METAPHOR	6	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2016	2017		10.1016/S0140-6736(08)61858-9	http://dx.doi.org/10.1016/S0140-6736(08)61858-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19090028				2022-12-24	WOS:000261746900012
J	Gowaty, PA; Serageldin, I; Persson, PE; Eldredge, N; Lynch, M; Nei, M; Kutschera, U; Akyol, M; Nesse, R; Greaves, M				Gowaty, Patricia Adair; Serageldin, Ismail; Persson, Per-Edvin; Eldredge, Niles; Lynch, Michael; Nei, Masatoshi; Kutschera, Ulrich; Akyol, Mustafa; Nesse, Randolph; Greaves, Mel			Darwin 200: Great expectations	NATURE			English	Editorial Material									[Gowaty, Patricia Adair] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Gowaty, Patricia Adair] Univ Calif Los Angeles, Inst Environm, Los Angeles, CA USA; [Serageldin, Ismail] New Lib Alexandria, Alexandria, Egypt; [Persson, Per-Edvin] Heureka, Finnish Sci Ctr, Vantaa, Finland; [Eldredge, Niles] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN USA; [Nei, Masatoshi] Penn State Univ, Inst Mol Evolut Genet, University Pk, PA 16802 USA; [Kutschera, Ulrich] Univ Kassel, Inst Biol, Kassel, Germany; [Nesse, Randolph] Univ Michigan, Ann Arbor, MI 48109 USA; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; American Museum of Natural History (AMNH); Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universitat Kassel; University of Michigan System; University of Michigan; University of London; Institute of Cancer Research - UK									0	1	1	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					317	318		10.1038/456317a	http://dx.doi.org/10.1038/456317a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020598	Green Submitted, Bronze			2022-12-24	WOS:000261039600020
J	Deary, I				Deary, Ian			Why do intelligent people live longer?	NATURE			English	Editorial Material							CHILDHOOD IQ; SOCIAL-CLASS; MORTALITY; RISK; LIFE		[Deary, Ian] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Deary, I (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland.	i.deary@ed.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X	Medical Research Council [G0700704B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; BATTY GD, EPIDEMIOLOG IN PRESS; Deary I. J., 2020, INTELLIGENCE VERY SH, V2nd; Deary IJ, 2008, PSYCHOL SCI, V19, P874, DOI 10.1111/j.1467-9280.2008.02171.x; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; OTOOLE BI, 1992, PERS INDIV DIFFER, V13, P699, DOI 10.1016/0191-8869(92)90241-G; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	11	102	104	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					175	176		10.1038/456175a	http://dx.doi.org/10.1038/456175a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	374JJ	19005537	Bronze			2022-12-24	WOS:000261039300019
J	Xie, YC; Yin, T; Wiegraebe, W; He, XC; Miller, D; Stark, D; Perko, K; Alexander, R; Schwartz, J; Grindley, JC; Park, J; Haug, JS; Wunderlich, JP; Li, H; Zhang, S; Johnson, T; Feldman, RA; Li, LH				Xie, Yucai; Yin, Tong; Wiegraebe, Winfried; He, Xi C.; Miller, Diana; Stark, Danny; Perko, Katherine; Alexander, Richard; Schwartz, Joel; Grindley, Justin C.; Park, Jungeun; Haug, Jeff S.; Wunderlich, Joshua P.; Li, Hua; Zhang, Simon; Johnson, Teri; Feldman, Ricardo A.; Li, Linheng			Detection of functional haematopoietic stem cell niche using real-time imaging	NATURE			English	Article							BONE-MARROW; PROGENITOR CELLS; IN-VIVO; N-CADHERIN; DIFFERENTIATION; MOBILIZATION; IDENTIFICATION; MICROSCOPY; RECEPTOR; LINEAGE	Haematopoietic stem cell (HSC) niches, although proposed decades ago(1), have only recently been identified as separate osteoblastic and vascular microenvironments(2-6). Their interrelationships and interactions with HSCs in vivo remain largely unknown. Here we report the use of a newly developed ex vivo real- time imaging technology and immunoassaying to trace the homing of purified green-fluorescent-protein- expressing (GFP(+)) HSCs. We found that transplanted HSCs tended to home to the endosteum (an inner bone surface) in irradiated mice, but were randomly distributed and unstable in non- irradiated mice. Moreover, GFP(+) HSCs were more frequently detected in the trabecular bone area compared with compact bone area, and this was validated by live imaging bioluminescence driven by the stem- cell- leukaemia ( Scl) promoter enhancer(7). HSCs home to bone marrow through the vascular system. We found that the endosteum is well vascularized and that vasculature is frequently localized near N-cadherin(+) pre-osteoblastic cells, a known niche component. By monitoring individual HSC behaviour using real- time imaging, we found that a portion of the homed HSCs underwent active division in the irradiated mice, coinciding with their expansion as measured by flow assay. Thus, in contrast to central marrow, the endosteum formed a special zone, which normally maintains HSCs but promotes their expansion in response to bone marrow damage.	[Miller, Diana; Feldman, Ricardo A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Miller, Diana; Feldman, Ricardo A.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Xie, Yucai; Yin, Tong; Wiegraebe, Winfried; He, Xi C.; Stark, Danny; Perko, Katherine; Alexander, Richard; Schwartz, Joel; Grindley, Justin C.; Park, Jungeun; Haug, Jeff S.; Wunderlich, Joshua P.; Li, Hua; Zhang, Simon; Johnson, Teri; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Xie, Yucai] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Shanghai Rui Jin Hosp, Shanghai 200025, Peoples R China; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Stowers Institute for Medical Research; Shanghai Jiao Tong University; University of Kansas; University of Kansas Medical Center	Feldman, RA (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	rfeldman@umaryland.edu; lil@stowers-institute.org		Li, Linheng/0000-0001-9963-430X; Feldman, Ricardo A./0000-0001-6090-0439	DOD [W81XWH-04-1-0801]; DRIF Award; University of Maryland; Stowers Institute for Medical Research	DOD(United States Department of Defense); DRIF Award; University of Maryland; Stowers Institute for Medical Research	We appreciate scientific support from R. Krumlauf, W. Neaves and encouragement from G. Luand W. Shen. We are grateful to D. Scadden and P. Kulesa for discussion. We thank D. Rowe for providing the Col2.3-GFP line. We thank R. Yu, L. Ma, Q. Qiu and W. Wang for technological advice, M. Hembree, A. Box, H. Marshall, E. Rendenbaugh, C. Cooper and M. Smith for technical support, S. Beckham for histology assistance, J. Perry and J. Ross for comments, and K. Tannen for proofreading. R.A.F. was supported by DOD grant W81XWH-04-1-0801 and by a DRIF Award from the University of Maryland. L.L. is supported by Stowers Institute for Medical Research.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Juopperi TA, 2007, EXP HEMATOL, V35, P335, DOI 10.1016/j.exphem.2006.09.014; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Murphy GJ, 2003, J BIOL CHEM, V278, P43556, DOI 10.1074/jbc.M302717200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osawa M, 1996, J IMMUNOL, V156, P3207; Sausville J, 2008, CLIN CANCER RES, V14, P3948, DOI 10.1158/1078-0432.CCR-07-5152; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	421	438	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					97	U102		10.1038/nature07639	http://dx.doi.org/10.1038/nature07639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19052548				2022-12-24	WOS:000262104900038
J	Petticrew, M				Petticrew, Mark			Billy Bunter and the obesogenic environment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Petticrew, Mark] Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Petticrew, M (corresponding author), Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, Keppel St, London WC1E 7HT, England.	mark.petticrew@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021					BUNTER B, 1976, VALIANT ANN, P20; BUTCHER JS, 1965, GREYFRIARS SCH PROSP, P6; Carnell S, 2008, INT J OBESITY, V32, P1468, DOI 10.1038/ijo.2008.127; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Department of Health Social Security, 1980, WORK GROUP IN HLTH I; Gustafsson U, 2002, SOC POLICY ADMIN, V36, P685, DOI 10.1111/1467-9515.00311; Halford JCG, 2007, APPETITE, V49, P263, DOI 10.1016/j.appet.2006.12.003; Hyde R, 2008, LANCET, V371, P2160, DOI 10.1016/S0140-6736(08)60936-8; Macdonald L, 2007, APPETITE, V49, P251, DOI 10.1016/j.appet.2006.11.004; Miller SA, 2008, INT J PEDIATR OBES, V3, P168, DOI 10.1080/17477160801915935; Moore L, 2008, J EPIDEMIOL COMMUN H, V62, P926, DOI 10.1136/jech.2007.070953; RICHARDS H, 1949, B BUNTER CLIFF HOUSE; School Food Trust, 2008, NEW RES REV SCAL JUN; Schwartz J, 2006, J AM DIET ASSOC, V106, P1412, DOI 10.1016/j.jada.2006.06.006; West P, 2007, TOB CONTROL, V16, P329, DOI 10.1136/tc.2006.018721; WILLIAMS C, 2008, GROCER          0112, P31; 2008, LEATHERMEAD MAT 0223	18	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2008	337								a2877	10.1136/bmj.a2877	http://dx.doi.org/10.1136/bmj.a2877			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088137	Green Accepted			2022-12-24	WOS:000262184900004
J	Lim, SS; Stein, DB; Charrow, A; Murray, CJL				Lim, Stephen S.; Stein, David B.; Charrow, Alexandra; Murray, Christopher J. L.			Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage	LANCET			English	Article							VACCINATION COVERAGE; MOTHERS REPORTS; DATA QUALITY; CHILDREN; SEROEPIDEMIOLOGY; PREVALENCE; ACCURACY; VALIDITY; ANTIBODY; MEASLES	Background Substantial resources have been invested in increasing childhood immunisation coverage through global initiatives such as the Universal Childhood Immunisation (UCI) campaign and the Global Alliance on Vaccines and Immunisations (GAVI). There are longstanding concerns that target-oriented and performance-oriented initiatives such as UCI and GAVI's immunisation services support (ISS) might encourage over-reporting. We estimated the coverage of three doses of diphtheria, tetanus, and pertussis vaccine (DTP3) based on surveys using all available data. Methods We estimated DTP3 coverage by analysing unit record data from surveys and supplemented this with reported coverage from other surveys and administrative data. We used bidirectional distance-dependent regression to estimate trends in survey-based coverage in 193 countries during 1986-2006. We used standard time-series cross-sectional analysis to investigate any association in the difference between countries' official reports and survey-based coverage as the dependent variable and the presence of GAVI ISS as the independent variable, controlling for country and time effects. Findings Crude coverage of DTP3 based on surveys increased from 59% (95% uncertainty interval 51-65) in 1986 to 65% (60-68) in 1990, 70% (65-74) in 2000, and 74% (70-77) in 2006. There were substantial differences between officially reported and survey-based coverage during VCI. GAVI ISS significantly increased the difference between officially reported coverage and survey coverage. Up to 2006, in 51 countries receiving GAVI ISS payments, 7.4 million (5.7 million to 9.2 million) additional children were immunised with DTP3 based on surveys compared with officially reported estimates of 13.9 million. On the basis of the number of additional children immunised from surveys at a rate of US$20 each, GAVI ISS payments are estimated at $150 million (115 million to 184 million) compared with actual disbursements of $290 million. Interpretation Survey-based DTP3 immunisation coverage has improved more gradually and not to the level suggested by countries' official reports or WHO and UNICEF estimates. There is an urgent need for independent and contestable monitoring of health indicators in an era of global initiatives that are target-oriented and disburse funds based on performance. Funding Bill & Melinda Gates Foundation.	[Lim, Stephen S.; Stein, David B.; Charrow, Alexandra; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu	Lim, Stephen S/B-4055-2012	Stein, David/0000-0003-3743-1595	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill & Melinda Gates Foundation. We thank Abdallah Bchir and Nina Schwalbe for helpful comments on drafts; Stanislava Nikolova for help with editing; Catherine Claiborne for help with editing and programme assistance; and Jennifer Berthiaume for assistance with data collation.	Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Brogan Donna, 1994, Annals of Epidemiology, V4, P302, DOI 10.1016/1047-2797(94)90086-8; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; Gabutti G, 2002, EPIDEMIOL INFECT, V129, P543, DOI 10.1017/S0950268802007677; GAREABALLAH ET, 1989, B WORLD HEALTH ORGAN, V67, P669; *GAVI, IMM SERV SUPP ISS; *GAVI UNICEF, 2000, VACC IMM PROD GUID C; George K, 1990, Indian J Pediatr, V57, P588, DOI 10.1007/BF02726779; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P48, DOI 10.1111/j.1467-842X.2005.tb00748.x; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; HONAKER J, 2008, WHAT DO MISSING VALU; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Jolly Richard., 2004, J HUMAN DEV, V5, P69, DOI DOI 10.1080/14649880310001660210; Katz J, 1997, INT J EPIDEMIOL, V26, P1041, DOI 10.1093/ije/26.5.1041; Katz JonathanN., 1996, POLIT ANAL, V6, DOI [10.1093/pan/6.1.1, DOI 10.1093/PAN/6.1.1]; Keele L, 2006, POLIT ANAL, V14, P186, DOI 10.1093/pan/mpj006; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; LE T, 1997, DHS ANAL REPORTS, V3; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Little R.J.A., 2002, STAT ANAL MISSING DA; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Mavimbe JC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-108; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; NIKOLETTI S, 1994, EPIDEMIOL INFECT, V112, P161, DOI 10.1017/S0950268800057526; OHUMA EO, 2008, EPIDEMIOL INFECT, V10, P1; Onta SR, 1998, HEALTH POLICY PLANN, V13, P131, DOI 10.1093/heapol/13.2.131; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Ramakrishnan R, 1999, Indian Pediatr, V36, P881; Ren R., 2006, DHS WORKING PAPERS, V30; Ringler M, 2003, EUR J EPIDEMIOL, V18, P161, DOI 10.1023/A:1023038705835; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Rubin D. B., 2004, MULTIPLE IMPUTATION; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shinall MC, 2007, PEDIATRICS, V120, pe783, DOI 10.1542/peds.2007-0052; Starling M., 2002, NEW PRODUCTS OLD SYS; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; UN, 2007, WORLD POP PROSP; *UNICEF WHO, 2007, IMM SUMM 2007; VALADEZ JJ, 1992, AM J PUBLIC HEALTH, V82, P120, DOI 10.2105/AJPH.82.1.120; Vancelik S, 2007, INDIAN J MED RES, V126, P528; *WHO UNICEF, 1980, COUNTR REP WHO UNICE; *WHO UNICEF, WHO UNICEF JOINT REP; *WHO UNICEF, 1980, WHO UNICEF REV NAT I; 2005, GLOBAL BURDEN DIS ST	60	189	191	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2008	372	9655					2031	2046		10.1016/S0140-6736(08)61869-3	http://dx.doi.org/10.1016/S0140-6736(08)61869-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384LS	19070738				2022-12-24	WOS:000261746900024
J	Faure-Andre, G; Vargas, P; Yuseff, MI; Heuze, M; Diaz, J; Lankar, D; Steri, V; Manry, J; Hugues, S; Vascotto, F; Boulanger, J; Raposo, G; Bono, MR; Rosemblatt, M; Piel, M; Lennon-Dumenil, AM				Faure-Andre, Gabrielle; Vargas, Pablo; Yuseff, Maria-Isabel; Heuze, Melina; Diaz, Jheimmy; Lankar, Danielle; Steri, Veronica; Manry, Jeremy; Hugues, Stephanie; Vascotto, Fulvia; Boulanger, Jerome; Raposo, Graca; Bono, Maria-Rosa; Rosemblatt, Mario; Piel, Matthieu; Lennon-Dumenil, Ana-Maria			Regulation of Dendritic Cell Migration by CD74, the MHC Class II-Associated Invariant Chain	SCIENCE			English	Article							CATHEPSIN-S; ANTIGEN PRESENTATION; MYOSIN-IIA; NK CELLS; STIMULATION; TRAFFICKING; DEGRADATION; COMPLEX; CD44	Dendritic cells ( DCs) sample peripheral tissues of the body in search of antigens to present to T cells. This requires two processes, antigen processing and cell motility, originally thought to occur independently. We found that the major histocompatibility complex II- associated invariant chain (li or CD74), a known regulator of antigen processing, negatively regulates DC motility in vivo. By using microfabricated channels to mimic the confined environment of peripheral tissues, we found that wild- type DCs alternate between high and low motility, whereas li-deficient cells moved in a faster and more uniform manner. The regulation of cell motility by li depended on the actin- based motor protein myosin II. Coupling antigen processing and cell motility may enable DCs to more efficiently detect and process antigens within a defined space.	[Boulanger, Jerome; Raposo, Graca; Piel, Matthieu] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Bono, Maria-Rosa; Rosemblatt, Mario] Fdn Ciencia Vida, Santiago, Chile; [Bono, Maria-Rosa; Rosemblatt, Mario] Inst Milenio Biol Fundamental & Aplicada, Santiago, Chile; [Rosemblatt, Mario] Univ Andres Bello, Fac Ciencias Salud, Santiago, Chile; [Faure-Andre, Gabrielle; Vargas, Pablo; Yuseff, Maria-Isabel; Heuze, Melina; Diaz, Jheimmy; Lankar, Danielle; Steri, Veronica; Manry, Jeremy; Hugues, Stephanie; Vascotto, Fulvia; Lennon-Dumenil, Ana-Maria] Inst Curie, INSERM, U653, F-75005 Paris, France; [Vargas, Pablo; Bono, Maria-Rosa; Rosemblatt, Mario] Univ Chile, Dept Biol, Fac Ciencias, Santiago 3425, Chile	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universidad Andres Bello; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universidad de Chile	Piel, M (corresponding author), Inst Curie, CNRS, UMR144, 12 Rue Lhomond, F-75005 Paris, France.	mpiel@curie.fr; amlennon@curie.fr	Vargas, Pablo/L-9858-2017; VARGAS, Pablo/HHM-4543-2022; Lennon-Dumenil, Ana-Maria/I-6716-2016; Diaz, Jheimmy/AAF-6886-2019; Bono, Maria/G-7461-2014	Vargas, Pablo/0000-0002-6475-494X; VARGAS, Pablo/0000-0002-6475-494X; Vascotto, Fulvia/0000-0002-9839-3484; Manry, Jeremy/0000-0001-5998-2051; hugues, stephanie/0000-0002-1031-5909; Raposo, graca/0000-0001-9590-1298; Heuze, Melina/0000-0002-4271-2706; Boulanger, Jerome/0000-0003-0237-3743	Ministere Francais de la Recherche; Association pour la Recherche contre le Cancer; ECOS-Comision Nacional de Investigacion Cientifica y Technologica; Gobierno de Chile [CO3S01]; Institut Curie and Inserm; ARC, Fondecyt (Chile) [1060834, 1060253]; Agence Nationale pour la Recherche [ANR-06-PCVI-0010]; Human Frontiers Science Program [RGY53/2007]	Ministere Francais de la Recherche(Ministry of Research, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ECOS-Comision Nacional de Investigacion Cientifica y Technologica; Gobierno de Chile; Institut Curie and Inserm; ARC, Fondecyt (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontiers Science Program(Human Frontier Science Program)	The authors thank T. Makushok for setting up the cell migration microchannel system; A. Azicune for cell micropatterning techniques; W. Faigle and D. Lowe for proteomics analysis; C. Recchi for help with gelatin-FITC degradation experiments; H. Overkleeft for synthesizing the LHVS; J. Roger for providing magnetic nanoparticles; M. Leberre, D. Baigl, and Y. Chen for help with microfabrication; and S. Amigorena, M. Sixt, P. Benaroch, V. Soumelis, C. Hivroz, and I. Fernandez for advice on the manuscript. A.-M. L.-D. thanks Y. Bellaiche for help with manuscript redaction. G.F.-A. was supported by a fellowship from the Ministere Francais de la Recherche and, together with M. H., from the Association pour la Recherche contre le Cancer (ARC). P.V. and M.- I.Y. benefited from ECOS-Comision Nacional de Investigacion Cientifica y Technologica, Gobierno de Chile fellowship (CO3S01), Institut Curie and Inserm fellowships, respectively. V.S. was part of the Leonardo Da Vinci project (Unipharma-Graduates, Sapienza University of Rome). This work was funded in part by grants from the ARC, Fondecyt (Chile) to M.- R.B. (1060834) and M. R. ( 1060253); Agence Nationale pour la Recherche (ANR-06-PCVI-0010) and Human Frontiers Science Program (RGY53/2007) to M.P.	Andzelm MM, 2007, J EXP MED, V204, P2285, DOI 10.1084/jem.20071143; Boes M, 2005, EUR J IMMUNOL, V35, P2552, DOI 10.1002/eji.200526323; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chao SH, 2007, LAB CHIP, V7, P641, DOI 10.1039/b618269k; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; FINK J, 2008, LAB CHIP, V453, P51; Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153	22	207	215	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1705	1710		10.1126/science.1159894	http://dx.doi.org/10.1126/science.1159894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074353				2022-12-24	WOS:000261608300049
J	Bouskra, D; Brezillon, C; Berard, M; Werts, C; Varona, R; Boneca, IG; Eberl, G				Bouskra, Djahida; Brezillon, Christophe; Berard, Marion; Werts, Catherine; Varona, Rosa; Boneca, Ivo Gomperts; Eberl, Gerard			Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis	NATURE			English	Article							ALTERED SCHAEDLER FLORA; BETA-DEFENSINS; FOLLICLE FORMATION; EPITHELIAL-CELLS; B-LYMPHOCYTES; RECEPTOR; GENERATION; EXPRESSION; INDUCTION; INNATE	Intestinal homeostasis is critical for efficient energy extraction from food and protection from pathogens. Its disruption can lead to an array of severe illnesses with major impacts on public health, such as inflammatory bowel disease characterized by self- destructive intestinal immunity. However, the mechanisms regulating the equilibrium between the large bacterial flora and the immune system remain unclear. Intestinal lymphoid tissues generate flora- reactive IgA- producing B cells, and include Peyer's patches and mesenteric lymph nodes, as well as numerous isolated lymphoid follicles (ILFs)(1,2). Here we show that peptidoglycan from Gram- negative bacteria is necessary and sufficient to induce the genesis of ILFs in mice through recognition by the NOD1 ( nucleotide- binding oligomerization domain containing 1) innate receptor in epithelial cells, and beta-defensin 3- and CCL20- mediated signalling through the chemokine receptor CCR6. Maturation of ILFs into large B- cell clusters requires subsequent detection of bacteria by toll- like receptors. In the absence of ILFs, the composition of the intestinal bacterial community is profoundly altered. Our results demonstrate that intestinal bacterial commensals and the immune system communicate through an innate detection system to generate adaptive lymphoid tissues and maintain intestinal homeostasis.	[Bouskra, Djahida; Eberl, Gerard] Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA1961, F-75724 Paris, France; [Brezillon, Christophe] Inst Pasteur, Lab Bacteries Pathogenes Enteriques, F-75724 Paris, France; [Berard, Marion] Inst Pasteur, Anim Centrale, F-75724 Paris, France; [Werts, Catherine; Boneca, Ivo Gomperts] Inst Pasteur, Grp Biol & Genet Bacterial Cell Wall, F-75724 Paris, France; [Varona, Rosa] CSIC, Dept Immunol & Oncol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Werts, Catherine; Boneca, Ivo Gomperts] INSERM, Grp AVENIR, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Eberl, G (corresponding author), Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA1961, 25 Rue Dr Roux, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Boneca, Ivo G/H-1677-2014; Eberl, Gerard/A-1160-2013; WERTS, Catherine/AAD-5447-2020	Boneca, Ivo G/0000-0001-8122-509X; WERTS, Catherine/0000-0003-3079-5476; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; CNRS; INSERM; ANR; Fondation de la Recherche Medicale; Mairie de Paris; Marie Curie Excellence; La Fondation de France; Ligue Nationale contre le Cancer	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Mairie de Paris(Region Ile-de-France); Marie Curie Excellence(European Commission); La Fondation de France(Fondation de France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We thank G. Milon, N. Cerf- Bensussan, P. Sansonetti, P. Cossart, A. Phalipon, D. Philpott, G. Marchal and D. Guy-Grand for discussions and critical reading of the manuscript; N. Huntington for intrahepatic injections; M. Cherrier for biochemistry; J. Perez, E. Maranghi and M. Manich for technical assistance; S. Akira, M. Chignard and V. Balloy for Myd88<SUP>-/-</SUP>, Trif<SUP>-/-</SUP>, Tlr2<SUP>-/-</SUP> or Tlr4<SUP>-/-</SUP> mice, J. P. Hugot for card15<SUP>-/-</SUP> mice, Millennium Pharmaceuticals for card4<SUP>-/-</SUP> mice and D. Philpott for card4<SUP>-/-</SUP> mice backcrossed to C57BL/ 6; J. Browning for LT beta R-Ig and Z. Ge for the 16S rDNA plasmids. This work was supported by Institut Pasteur, CNRS, INSERM, ANR, Fondation de la Recherche Medicale, Mairie de Paris, a Marie Curie Excellence grant, La Fondation de France (D.B.) and la Ligue Nationale contre le Cancer (D.B.).	Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Lugering A, 2006, ANN NY ACAD SCI, V1072, P210, DOI 10.1196/annals.1326.015; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pabst O, 2006, J IMMUNOL, V177, P6824, DOI 10.4049/jimmunol.177.10.6824; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; SCHAEDLER RUSSELL W., 1962, JOUR EXPTL MED, V115, P1149, DOI 10.1084/jem.115.6.1149; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	40	730	768	5	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					507	U34		10.1038/nature07450	http://dx.doi.org/10.1038/nature07450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18987631				2022-12-24	WOS:000261170500039
J	Roehr, B				Roehr, Bob			The invisible epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEN; SEX					BobRoehr@aol.com						amfAR, 2008, MSM HIV ROAD UN ACC; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Centers for Disease Control and Prevention, EST NEW HIV INF US; Epstein H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2638; Ottoson Daniel, 2008, STATE SPONSORED HOMO; Roehr Bob, 2008, BMJ, V337, pa1182, DOI 10.1136/bmj.a1182	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2008	337								a2566	10.1136/bmj.a2566	http://dx.doi.org/10.1136/bmj.a2566			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033333				2022-12-24	WOS:000261827500016
J	Ferlin, A; Zuccarello, D; Zuccarello, B; Chirico, MR; Zanon, GF; Foresta, C				Ferlin, Alberto; Zuccarello, Daniela; Zuccarello, Biagio; Chirico, Maria Rosaria; Zanon, Giovanni Franco; Foresta, Carlo			Genetic Alterations Associated With Cryptorchidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANDROGEN RECEPTOR GENE; MUTATIONS; PATHOGENESIS; EXPRESSION; DESCENT; TESTIS; INSL3; MICE	Context Cryptorchidism is the most frequent congenital birth defect in male children and represents an important risk factor for infertility and testicular cancer. Major regulators of testicular descent are the hormones insulin- like factor 3 ( INSL3) and testosterone, and disruption of these pathways might cause cryptorchidism. Objective To determine the frequency of genetic alterations in cryptorchidism. Design and Setting Case- control study in 2 departments of pediatric surgery in Italy between January 2003 and March 2005. Patients Six hundred male infants with cryptorchidism. Boys were followed up for 2 to 3 years ( through January 2008) and orchidopexy was performed in those who were persistently cryptorchid. We analyzed 300 noncryptorchid male children aged 1 to 4 years as controls. Main Outcome Measures Karyotype anomalies and INSL3, INSL3 receptor, and androgen receptor gene mutations. Results The frequency of genetic alterations in boys with cryptorchidism was low ( 17/ 600 [ 2.8%; 95% confidence interval {CI}, 1.7%- 4.5%]) and was significantly higher in participants with persistent cryptorchidism ( 16/ 303 [ 5.3%; 95% CI, 3.0%- 8.4%]; P=. 001) and those with bilateral cryptorchidism ( 10/ 120 [ 8.3%; 95% CI, 4.1%- 14.8%]; P=. 001) than in controls ( 1/ 300 [ 0.3%; 95% CI, 0.1%-0.8%]). Boys with persistent cryptorchidism had a 17- fold greater odds of having a genetic alteration ( odds ratio, 16.7; 95% CI, 2.2- 126.5). The most common genetic findings in those with cryptorchidism were 8 cases of Klinefelter syndrome and 5 cases of mutations in the INSL3 receptor gene. Genetic alterations were not found in boys with low birth weight or low gestational age, who had frequent spontaneous descent of the testes. Conclusion In a small percentage of the study population, there was a statistically significant association between bilateral and persistent cryptorchidism and genetic alterations, including Klinefelter syndrome and INSL3 receptor gene mutations.	[Ferlin, Alberto; Zuccarello, Daniela; Foresta, Carlo] Univ Padua, Sect Clin Pathol, I-35121 Padua, Italy; [Ferlin, Alberto; Zuccarello, Daniela; Foresta, Carlo] Univ Padua, Ctr Male Gamete Cryopreservat, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; [Zanon, Giovanni Franco] Univ Padua, Dept Pediat Surg, I-35121 Padua, Italy; [Zuccarello, Biagio; Chirico, Maria Rosaria] Univ Messina, Dept Med & Surg Pediat Sci, Unit Pediat Surg, Messina, Italy	University of Padua; University of Padua; University of Padua; University of Messina	Foresta, C (corresponding author), Univ Padua, Sect Clin Pathol, Via Gabelli 63, I-35121 Padua, Italy.	carlo.foresta@unipd.it	zuccarello, daniela/G-4822-2011; Ferlin, Alberto/AAO-3541-2020	zuccarello, daniela/0000-0001-5826-6715; Ferlin, Alberto/0000-0001-5817-8141	Italian Ministry of University [2005062572]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This study was supported by grant 2005062572 from the Italian Ministry of University to Drs Ferlin, Daniela Zuccarello, and Foresta.	Barthold JS, 2000, J UROLOGY, V164, P497, DOI 10.1016/S0022-5347(05)67411-3; Bay K, 2007, J CLIN ENDOCR METAB, V92, P4020, DOI 10.1210/jc.2007-0974; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Bojesen A, 2007, NAT CLIN PRACT UROL, V4, P192, DOI 10.1038/ncpuro0775; Cortes D, 2001, HORM RES, V55, P21, DOI 10.1159/000049959; Cortes D, 2008, J UROLOGY, V179, P314, DOI 10.1016/j.juro.2007.08.158; Ferlin A, 2006, MOL HUM REPROD, V12, P401, DOI 10.1093/molehr/gal043; Ferlin A, 2005, EUR J ENDOCRINOL, V152, P419, DOI 10.1530/eje.1.01860; Ferlin A, 2003, J CLIN ENDOCR METAB, V88, P4273, DOI 10.1210/jc.2003-030359; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI [10.1359/jbmr.080204, 10.1359/JBMR.080204]; Ferlin A, 2006, CLIN ENDOCRINOL, V65, P606, DOI 10.1111/j.1365-2265.2006.02635.x; Foresta C, 1996, FERTIL STERIL, V66, P624, DOI 10.1016/S0015-0282(16)58579-3; Foresta C, 2008, ENDOCR REV, V29, P560, DOI 10.1210/er.2007-0042; GIWERCMAN A, 1993, EUR UROL, V23, P104; Husmann DA, 2005, UROLOGY, V66, P424, DOI 10.1016/j.urology.2004.10.020; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Nielsen J, 1990, Birth Defects Orig Artic Ser, V26, P209; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x; Suzuki Y, 2001, FERTIL STERIL, V76, P834, DOI 10.1016/S0015-0282(01)02016-7; Truong A, 2003, BIOL REPROD, V69, P1658, DOI 10.1095/biolreprod.103.019166; Virtanen HE, 2008, HUM REPROD UPDATE, V14, P49, DOI 10.1093/humupd/dmm027; Walsh TJ, 2007, J UROLOGY, V178, P1440, DOI 10.1016/j.juro.2007.05.166; Wiener JS, 1998, J UROLOGY, V160, P863, DOI 10.1016/S0022-5347(01)62823-4; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	30	101	105	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2271	2276		10.1001/jama.2008.668	http://dx.doi.org/10.1001/jama.2008.668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017913	Bronze			2022-12-24	WOS:000260965500027
J	Morgan, DO				Morgan, David O.			SnapShot: Cell-Cycle Regulators I	CELL			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988	2	11	11	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					764	U15	764.e1	10.1016/j.cell.2008.10.039	http://dx.doi.org/10.1016/j.cell.2008.10.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013283	Bronze			2022-12-24	WOS:000260886900025
J	Hachinski, V				Hachinski, Vladimir			Shifts in Thinking About Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFETIME RISK; STROKE		[Hachinski, Vladimir] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Hachinski, V (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, 339 Windermere Rd, London, ON N6A 3K7, Canada.	vladimir.hachinski@lhsc.on.ca						Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Jin YP, 2008, NEUROLOGY, V70, P9, DOI 10.1212/01.wnl.0000284609.77385.03; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Silver FL, 2006, AM J PREV MED, V31, pS235, DOI 10.1016/j.amepre.2006.08.023	16	69	70	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2172	2173		10.1001/jama.2008.525	http://dx.doi.org/10.1001/jama.2008.525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001628				2022-12-24	WOS:000260793800027
J	Atwal, JK; Pinkston-Gosse, J; Syken, J; Stawicki, S; Wu, Y; Shatz, C; Tessier-Lavigne, M				Atwal, Jasvinder K.; Pinkston-Gosse, Julie; Syken, Josh; Stawicki, Scott; Wu, Yan; Shatz, Carla; Tessier-Lavigne, Marc			PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration	SCIENCE			English	Article							NOGO RECEPTOR; NEURITE OUTGROWTH; VISUAL-CORTEX; GLYCOPROTEIN; RECOVERY; GROWTH; INJURY; CELLS; PLASTICITY; LIGAND	A major barrier to regenerating axons after injury in the mammalian central nervous system is an unfavorable milieu. Three proteins found in myelin- Nogo, MAG, and OMgp- inhibit axon regeneration in vitro and bind to the glycosylphosphatidylinositol- anchored Nogo receptor ( NgR). However, genetic deletion of NgR has only a modest disinhibitory effect, suggesting that other binding receptors for these molecules probably exist. With the use of expression cloning, we have found that paired immunoglobulin- like receptor B ( PirB), which has been implicated in nervous system plasticity, is a high- affinity receptor for Nogo, MAG, and OMgp. Interfering with PirB activity, either with antibodies or genetically, partially rescues neurite inhibition by Nogo66, MAG, OMgp, and myelin in cultured neurons. Blocking both PirB and NgR activities leads to near- complete release from myelin inhibition. Our results implicate PirB in mediating regeneration block, identify PirB as a potential target for axon regeneration therapies, and provide an explanation for the similar enhancements of visual system plasticity in PirB and NgR knockout mice.	[Atwal, Jasvinder K.; Pinkston-Gosse, Julie; Tessier-Lavigne, Marc] Genentech Inc, Neurodegenerat Labs & Res Drug Discovery, San Francisco, CA 94080 USA; [Syken, Josh; Shatz, Carla] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Stawicki, Scott; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Shatz, Carla] Stanford Univ, BioX Program, James H Clark Ctr, Stanford, CA 94305 USA	Roche Holding; Genentech; Harvard University; Harvard Medical School; Roche Holding; Genentech; Stanford University	Tessier-Lavigne, M (corresponding author), Genentech Inc, Neurodegenerat Labs & Res Drug Discovery, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com			Genentech	Genentech(Roche HoldingGenentech)	We thank J. Brady and M. Yan for assistance with expression cloning and members of the Tessier-Lavigne and Shatz laboratories for helpful suggestions and discussions. This work was supported by Genentech.	Chen B, 2002, DEV BIOL, V252, P170, DOI 10.1006/dbio.2002.0847; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Pereira S, 2004, J IMMUNOL, V173, P5757, DOI 10.4049/jimmunol.173.9.5757; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	22	380	402	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					967	970		10.1126/science.1161151	http://dx.doi.org/10.1126/science.1161151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988857				2022-12-24	WOS:000260674100054
J	Cuttell, L; Vaughan, A; Silva, E; Escaron, CJ; Lavine, M; Van Goethem, E; Eid, JP; Quirin, M; Franc, NC				Cuttell, Leigh; Vaughan, Andrew; Silva, Elizabeth; Escaron, Claire J.; Lavine, Mark; Van Goethem, Emeline; Eid, Jean-Pierre; Quirin, Magali; Franc, Nathalie C.			Undertaker, a Drosophila Junctophilin, Links Draper-Mediated Phagocytosis and Calcium Homeostasis	CELL			English	Article							CELL CORPSE ENGULFMENT; APOPTOTIC CELLS; LYMPHOCYTE-ACTIVATION; RYANODINE RECEPTOR; MEMBRANE-PROTEIN; CA2+ RELEASE; REQUIREMENT; MACROPHAGES; RECOGNITION; MECHANISMS	Phagocytosis is important during development and in the immune response for the removal of apoptotic cells and pathogens, yet its molecular mechanisms are poorly understood. In Caenorhabditis elegans, the CED2/5/10/12 pathway regulates actin during phagocytosis of apoptotic cells, whereas the role of the CED1/6/7 pathway in phagocytosis is unclear. We report that Undertaker (UTA), a Drosophila Junctophilin protein, is required for Draper (CED-1 homolog)-mediated phagocytosis. Junctophilins couple Ca2+ channels at the plasma membrane to those of the endoplasmic reticulum (ER), the Ryanodine receptors. We place Draper, its adaptor drCed-6, UTA, the Ryanodine receptor Rya-r44F, the ER Ca2+ sensor dSTIM, and the Ca2+-release-activated Ca2+ channel dOrai in the same pathway that promotes calcium homeostasis and phagocytosis. Thus, our results implicatea Juncto-philin in phagocytosis and link Draper-mediated phagocytosis to Ca2+ homeostasis, highlighting a previously uncharacterized role for the CED1/6/7 pathway.	[Cuttell, Leigh; Vaughan, Andrew; Silva, Elizabeth; Escaron, Claire J.; Lavine, Mark; Van Goethem, Emeline; Eid, Jean-Pierre; Quirin, Magali; Franc, Nathalie C.] UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London	Franc, NC (corresponding author), UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, Gower St, London WC1E 6BT, England.	n.franc@ucl.ac.uk	Cuttell, Leigh/F-9281-2011; Franc, Nathalie/C-2208-2009; Silva, Elizabeth/C-1495-2008	Silva, Elizabeth/0000-0002-0684-9473; Franc, Nathalie/0000-0002-1617-385X; QUIRIN, Magali/0000-0001-7967-5622; Silva, Elizabeth/0000-0002-0524-929X	Medical Research Council; MRC Cell Biology Unit; The Genetic Society UK; Medical Research Council [MC_U122665005] Funding Source: researchfish; MRC [MC_U122665005] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Cell Biology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Genetic Society UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Bloomington and Szeged Drosophila stock centers, H. Agaisse, D. Ferrandon, M. Freeman, C. Kocks, B. Lemaitre, K. Mecklenberg, Y. Nakai, Y. Nakanishi, N. Perrimon, A. Rao, and D. Reiff for fly stocks and/or reagents and technical advice; A. V. for his help with Ca<SUP>2+</SUP> imaging, and M. Hallett for his advice on its analysis; V. Keasler and W. Yu for the qPCR; H. Agaisse and members of the DRSC for their help with the RNAi screen, and members of the core staff for their help. N. C. F. thanks S. Brown, C. Desplan, and M. Meister for their critical reading of this manuscript. This research was funded by a programme leader-track grant from the Medical Research Council to N. C. F., core support to the MRC Cell Biology Unit, and a studentship from The Genetic Society UK to M. Q.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Beppu M, 2001, ARCH BIOCHEM BIOPHYS, V390, P243, DOI 10.1006/abbi.2001.2381; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Kindzelskii AL, 2003, J IMMUNOL, V170, P64, DOI 10.4049/jimmunol.170.1.64; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mecklenburg KL, 2007, MOL GENET GENOMICS, V277, P481, DOI 10.1007/s00438-007-0211-7; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Vernon-Wilson EF, 2007, J LEUKOCYTE BIOL, V82, P1278, DOI 10.1189/jlb.0507283; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Xu XH, 2000, BIOPHYS J, V78, P1270, DOI 10.1016/S0006-3495(00)76683-5; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	47	110	112	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					524	534		10.1016/j.cell.2008.08.033	http://dx.doi.org/10.1016/j.cell.2008.08.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984163	Bronze			2022-12-24	WOS:000260536300022
J	Jin, J; Desai, BN; Navarro, B; Donovan, A; Andrews, NC; Clapham, DE				Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Donovan, Adriana; Andrews, Nancy C.; Clapham, David E.			Deletion of Trpm7 Disrupts Embryonic Development and Thymopoiesis Without Altering Mg(2+) Homeostasis	SCIENCE			English	Article							KERATINOCYTE GROWTH-FACTOR; MURINE LYMPHOCYTES-T; POTASSIUM CHANNELS; SECONDARY HYPOCALCEMIA; MIC CHANNELS; PROTEIN; CELLS; HYPOMAGNESEMIA; ACTIVATION; EXPRESSION	The gene transient receptor potential- melastatin- like 7 ( Trpm7) encodes a protein that functions as an ion channel and a kinase. TRPM7 has been proposed to be required for cellular Mg(2+) homeostasis in vertebrates. Deletion of mouse Trpm7 revealed that it is essential for embryonic development. Tissue- specific deletion of Trpm7 in the T cell lineage disrupted thymopoiesis, which led to a developmental block of thymocytes at the double- negative stage and a progressive depletion of thymic medullary cells. However, deletion of Trpm7 in T cells did not affect acute uptake of Mg(2+) or the maintenance of total cellular Mg(2+). Trpm7- deficient thymocytes exhibited dysregulated synthesis of many growth factors that are necessary for the differentiation and maintenance of thymic epithelial cells. The thymic medullary cells lost signal transducer and activator of transcription 3 activity, which accounts for their depletion when Trpm7 is disrupted in thymocytes.	[Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Jin, Jie; Donovan, Adriana; Andrews, Nancy C.] Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27702 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27702 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Duke University; Duke University	Clapham, DE (corresponding author), Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Enders Bldg 1309,300 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Andrews, Nancy/0000-0003-0243-4462; /0000-0002-3928-5854	NIH [T32HL007572-20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH and NIH postdoctoral fellowship T32HL007572-20 (B.N.D.). We thank F. Alt, H. von Boehmer, M. Fleming, G. Krapivinsky, and M. Delling for helpful discussions. Technical assistance from Y. Fujiwara (Division of Hematology Transgenic core facility), D. Campagna (identification of bacterial artificial chromosome clones), G. Losiyev (Brigham Women's Hospital Flow Cytometry core facility), R. Bronson (mouse necropsy), and Z. Chen (ICP-MS) is deeply appreciated.	CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cernkovich ER, 2007, ENDOCRINOLOGY, V148, P1598, DOI 10.1210/en.2006-1106; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P379, DOI 10.1085/jgp.89.3.379; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Erickson M, 2002, BLOOD, V100, P3269, DOI 10.1182/blood-2002-04-1036; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Huang Y, 2008, CELL CYCLE, V7, P1613, DOI 10.4161/cc.7.11.5952; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rossi S, 2002, BLOOD, V100, P682, DOI 10.1182/blood.V100.2.682; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	25	317	319	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					756	760		10.1126/science.1163493	http://dx.doi.org/10.1126/science.1163493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974357	Green Accepted			2022-12-24	WOS:000260605200053
J	Nozawa, K; O'Donoghue, P; Gundllapalli, S; Araiso, Y; Ishitani, R; Umehara, T; Soll, D; Nureki, O				Nozawa, Kayo; O'Donoghue, Patrick; Gundllapalli, Sarath; Araiso, Yuhei; Ishitani, Ryuichiro; Umehara, Takuya; Soell, Dieter; Nureki, Osamu			Pyrrolysyl-tRNA synthetase-tRNA(Pyl) structure reveals the molecular basis of orthogonality	NATURE			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; GENETIC-CODE; IN-VITRO; SYNTHETASES; RECOGNITION; TRNA(PHE); PROTEINS; ARCHAEA	Pyrrolysine (Pyl), the 22nd natural amino acid, is genetically encoded by UAG and inserted into proteins by the unique suppressor tRNA(Pyl) (ref.1). The Methanosarcinaceae produce Pyl and express Pyl-containing methyltransferases that allow growth on methylamines(2). Homologous methyltransferases and the Pyl biosynthetic and coding machinery are also found in two bacterial species(1,3). Pyl coding is maintained by pyrrolysyl-tRNA synthetase (PylRS), which catalyses the formation of Pyl-tRNA(Pyl) (refs 4, 5). Pyl is not a recent addition to the genetic code. PylRS was already present in the last universal common ancestor(6); it then persisted in organisms that utilize methylamines as energy sources. Recent protein engineering efforts added non-canonical amino acids to the genetic code(7,8). This technology relies on the directed evolution of an 'orthogonal' tRNA synthetase-tRNA pair in which an engineered aminoacyl-tRNA synthetase (aaRS) specifically and exclusively acylates the orthogonal tRNA with a non-canonical amino acid. For Pyl the natural evolutionary process developed such a system some 3 billion years ago. When transformed into Escherichia coli, Methanosarcina barkeri PylRS and tRNA(Pyl) function as an orthogonal pair in vivo(5,9). Here we show that Desulfitobacterium hafniense PylRS-tRNA(Pyl) is an orthogonal pair in vitro and in vivo, and present the crystal structure of this orthogonal pair. The ancient emergence of PylRS tRNA(Pyl) allowed the evolution of unique structural features in both the protein and the tRNA. These structural elements manifest an intricate, specialized aaRS-tRNA interaction surface that is highly distinct from those observed in any other known aaRS-tRNA complex; it is this general property that underlies the molecular basis of orthogonality.	[O'Donoghue, Patrick; Gundllapalli, Sarath; Umehara, Takuya; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Nozawa, Kayo; Araiso, Yuhei; Nureki, Osamu] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan	Yale University; Yale University; Tokyo Institute of Technology; University of Tokyo	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; nureki@ims.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014	O'Donoghue, Patrick/0000-0002-9500-8640; Nozawa, Kayo/0000-0001-6677-7195	National Science Foundation; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology; Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; National Institute of General Medical Sciences; Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NW12 of PF-AR (Tsukuba, Japan) for technical help during data collection. P.O. holds a National Science Foundation postdoctoral fellowship in Biological Informatics. This work was supported by grants from the Japan Science and Technology Agency (to O.N.), from the National Project on Protein Structural and Functional Analyses of the Ministry of Education, Culture, Sports, Science and Technology (to O.N.), from the Ministry of Education, Culture, Sports, Science and Technology (to R.I. and O.N.), from the Mitsubishi Foundation (to O.N.), from the Kurata Memorial Hitachi Science and Technology Foundation (to O.N.), from the National Institute of General Medical Sciences (to D. S.), from the Department of Energy (to D. S.), and from the National Science Foundation (to D. S.).	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Briand C, 2000, J MOL BIOL, V299, P1051, DOI 10.1006/jmbi.2000.3819; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Herring S, 2007, FEBS LETT, V581, P3197, DOI 10.1016/j.febslet.2007.06.004; Herring S, 2007, NUCLEIC ACIDS RES, V35, P1270, DOI 10.1093/nar/gkl1151; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Lee MM, 2008, BIOCHEM BIOPH RES CO, V374, P470, DOI 10.1016/j.bbrc.2008.07.074; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; MURGOLA EJ, 1985, ANNU REV GENET, V19, P57, DOI 10.1146/annurev.genet.19.1.57; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Theobald-Dietrich A, 2004, NUCLEIC ACIDS RES, V32, P1091, DOI 10.1093/nar/gkh266; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasil'eva IA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P247, DOI 10.1134/S0006297907030029; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; YANOFSKY C, 1972, J BIOL CHEM, V247, P4494; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514	35	129	139	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1163	U127		10.1038/nature07611	http://dx.doi.org/10.1038/nature07611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19118381	Green Accepted			2022-12-24	WOS:000263680100048
J	Mayo, MJ				Mayo, Merrilea J.			Video Games: A Route to Large-Scale STEM Education?	SCIENCE			English	Editorial Material									[Mayo, Merrilea J.] Ewing Marion Kauffman Fdn, Kansas City, MO 64110 USA		Mayo, MJ (corresponding author), Ewing Marion Kauffman Fdn, 4801 Rockhill Rd, Kansas City, MO 64110 USA.	mmayo@kauffman.org						Barab S, 2005, ETR&D-EDUC TECH RES, V53, P86, DOI 10.1007/BF02504859; Barab S, 2007, SCI EDUC, V91, P750, DOI 10.1002/sce.20217; Begg M., 2005, INNOVATE J ONLINE ED, V1; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; BOWER J, 2008, GRANTM ED ANN M BALT; Bransford J.D., 2000, PEOPLE LEARN BRAIN M; COLLER BD, 2006, SER GAM SUMM WASH DC; Druckman D., 1994, LEARNING REMEMBERING; Gee JP, 2003, WHAT VIDEO GAMES HAVE TO TEACH US ABOUT LEARNING AND LITERACY, P1; GRAESSER AC, 1994, AM EDUC RES J, V31, P104, DOI 10.2307/1163269; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Hays R., 2005, 2005004 NAV AIR WARF; Hewitt Nancy M., 1997, TALKING LEAVING; Hutchison D, 2007, BRIT J EDUC TECHNOL, V38, P977, DOI 10.1111/j.1467-8535.2006.00686.x; JOHNSON DW, 1981, PSYCHOL BULL, V89, P47, DOI 10.1037/0033-2909.89.1.47; Kebritchi M., 2008, THESIS U CENTRAL FLO; KEBRITCHI M, EFFECTS MODERN MATH; Ketelhut D. J., 2006, 2006 AERA ANN M SAN; Kukich K, 2000, COMPARING VALIDITY A; McClean P, 2001, SELECTED PAPERS FROM THE 12TH INTERNATIONAL CONFERENCE ON COLLEGE TEACHING AND LEARNING, P111; *NAT SCI BOARD, 2008, NSF SCI ENG IND 2008; Oblinger D. G., 2004, J INTERACTIVE MEDIA, V8; Peck AC, 2000, HUM FACTORS, V42, P379, DOI 10.1518/001872000779698150; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; Sax L.J., 2001, AM FRESHMAN NATL NOR; Squire K, 2004, ICLS2004: INTERNATIONAL CONFERENCE OF THE LEARNING SCIENCES, PROCEEDINGS, P513; Vogel J. J., 2006, Journal of Educational Computing Research, V34, P229, DOI 10.2190/FLHV-K4WA-WPVQ-H0YM; Willinsky J, 2009, SCIENCE, V323, P39, DOI 10.1126/science.1167970	28	182	187	8	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					79	82		10.1126/science.1166900	http://dx.doi.org/10.1126/science.1166900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119223				2022-12-24	WOS:000262104100043
J	Dwyer, DJ; Kohanski, MA; Collins, JJ				Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.			Networking Opportunities for Bacteria	CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; CELL-CYCLE; CIRCUIT; MOTIFS	In this post-genomic era, our capacity to explore biological networks and predict network architectures has been greatly expanded, accelerating interest in systems biology. Here, we highlight recent systems biology studies in prokaryotes, consider the challenges ahead, and suggest opportunities for future studies in bacterial models.	[Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Dept Biomed Engn, Boston, MA 02215 USA; [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Howard Hughes Medical Institute; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Ctr Adv Biotechnol, Boston, MA 02215 USA.	jcollins@engc.bu.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644, DP1 OD003644-02] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018	15	15	16	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1153	1156		10.1016/j.cell.2008.12.016	http://dx.doi.org/10.1016/j.cell.2008.12.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109881	Green Accepted, Bronze			2022-12-24	WOS:000261989800001
J	Zalts, R; Hayek, T				Zalts, Ronen; Hayek, Tony			Postpartum Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zalts, Ronen; Hayek, Tony] Rambam Med Ctr, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology	Zalts, R (corresponding author), Rambam Med Ctr, IL-31096 Haifa, Israel.	r_zalts@rambam.health.gov.il							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2706	2706		10.1056/NEJMicm065130	http://dx.doi.org/10.1056/NEJMicm065130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092155				2022-12-24	WOS:000261757300010
J	Schroder, FH; Roach, M; Scardino, P				Schroder, Fritz H.; Roach, Mack, III; Scardino, Peter			Management of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; NOMOGRAM; BRACHYTHERAPY; SURVIVAL; THERAPY; MEN		[Schroder, Fritz H.] Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands; [Roach, Mack, III] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Scardino, Peter] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center	Schroder, FH (corresponding author), Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands.							Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Arlen PM, 2008, J UROLOGY, V179, P2181, DOI 10.1016/j.juro.2008.01.099; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Karakiewicz PI, 1998, UROLOGY, V52, P1041, DOI 10.1016/S0090-4295(98)00350-1; Kattan MW, 2003, J UROLOGY, V170, P1792, DOI 10.1097/01.ju.0000091806.70171.41; Klotz L, 2007, NAT CLIN PRACT ONCOL, V4, P692, DOI 10.1038/ncponc0966; Liauw SL, 2006, INT J RADIAT ONCOL, V66, P669, DOI 10.1016/j.ijrobp.2006.05.016; Merrick GS, 2004, UROLOGY, V64, P754, DOI 10.1016/j.urology.2004.04.054; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Parker C, 2004, LANCET ONCOL, V5, P101, DOI 10.1016/S1470-2045(04)01384-1; Pickett B, 2006, INT J RADIAT ONCOL, V65, P65, DOI 10.1016/j.ijrobp.2005.11.037; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683	17	17	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2605	2609						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073981				2022-12-24	WOS:000261534200016
J	Jeziorski, A; Yan, ND; Paterson, AM; DeSellas, AM; Turner, MA; Jeffries, DS; Keller, B; Weeber, RC; McNicol, DK; Palmer, ME; McIver, K; Arseneau, K; Ginn, BK; Cumming, BF; Smol, JP				Jeziorski, Adam; Yan, Norman D.; Paterson, Andrew M.; DeSellas, Anna M.; Turner, Michael A.; Jeffries, Dean S.; Keller, Bill; Weeber, Russ C.; McNicol, Don K.; Palmer, Michelle E.; McIver, Kyle; Arseneau, Kristina; Ginn, Brian K.; Cumming, Brian F.; Smol, John P.			The Widespread Threat of Calcium Decline in Fresh Waters	SCIENCE			English	Article							SOUTH-CENTRAL ONTARIO; CRUSTACEAN ZOOPLANKTON; FORESTED CATCHMENTS; UNITED-STATES; NEW-YORK; LAKES; ACIDIFICATION; CANADA; ASSEMBLAGES; DEPOSITION	Calcium concentrations are now commonly declining in softwater boreal lakes. Although the mechanisms leading to these declines are generally well known, the consequences for the aquatic biota have not yet been reported. By examining crustacean zooplankton remains preserved in lake sediment cores, we document near extirpations of calcium- rich Daphnia species, which are keystone herbivores in pelagic food webs, concurrent with declining lake- water calcium. A large proportion ( 62%, 47 to 81% by region) of the Canadian Shield lakes we examined has a calcium concentration approaching or below the threshold at which laboratory Daphnia populations suffer reduced survival and fecundity. The ecological impacts of environmental calcium loss are likely to be both widespread and pronounced.	[Jeziorski, Adam; DeSellas, Anna M.; McIver, Kyle; Arseneau, Kristina; Ginn, Brian K.; Cumming, Brian F.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Yan, Norman D.; Palmer, Michelle E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Yan, Norman D.; Paterson, Andrew M.; DeSellas, Anna M.] Ontario Minist Environm, Dorset Environm Sci Ctr, Dorset, ON P0A 1E0, Canada; [Turner, Michael A.] Fisheries & Oceans Canada, Expt Lakes Area, Winnipeg, MB R3T 2N6, Canada; [Jeffries, Dean S.] Environm Canada, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada; [Keller, Bill] Laurentian Univ, Ontario Minist Environm, Cooperat Freshwater Ecol Unit, Sudbury, ON P3E 2C6, Canada; [Weeber, Russ C.; McNicol, Don K.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada	Queens University - Canada; York University - Canada; Fisheries & Oceans Canada; Environment & Climate Change Canada; National Water Research Institute; Laurentian University; Environment & Climate Change Canada; Canadian Wildlife Service	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Yan, Norman/H-5235-2013; Smol, John P/A-8838-2015; Jeziorski, Adam/AAJ-6982-2020; Keller, Wendel/G-1533-2012	Jeziorski, Adam/0000-0001-7701-7247; Smol, John/0000-0002-2499-6696; Yan, Norman/0000-0003-4870-6865	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of the Environment; Environment Canada; Fisheries and Oceans Canada; School of Environmental Systems Engineering; University of Western Australia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of the Environment; Environment Canada(CGIAR); Fisheries and Oceans Canada; School of Environmental Systems Engineering; University of Western Australia	This work was primarily supported by grants from the Natural Sciences and Engineering Research Council of Canada, as well as funding from the Ontario Ministry of the Environment, Environment Canada, and Fisheries and Oceans Canada. We thank the latter three agencies for the data used to develop Fig. 4. N. D. Y. thanks the School of Environmental Systems Engineering from the University of Western Australia for their support. We would also like to thank D. Schindler and S. Watmough for their valuable comments on this manuscript.	Ashforth D, 2008, LIMNOL OCEANOGR, V53, P420, DOI 10.4319/lo.2008.53.2.0420; Battarbee Richard W., 1999, P85; CHAN C, 2004, THESIS QUEENS U; CHARLES DF, 1987, BIOGEOCHEMISTRY, V3, P267, DOI 10.1007/BF02185196; Clair T.A., 2001, 16 ENV CAN; Cyr H, 1999, OECOLOGIA, V118, P306, DOI 10.1007/s004420050731; DeSellas AM, 2008, HYDROBIOLOGIA, V600, P105, DOI 10.1007/s10750-007-9180-4; Driscoll CT, 2003, ENVIRON SCI TECHNOL, V37, P2036, DOI 10.1021/es020924h; Ginn BK, 2007, CAN J FISH AQUAT SCI, V64, P1043, DOI 10.1139/F07-078; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Hall RI, 1996, CAN J FISH AQUAT SCI, V53, P1, DOI 10.1139/cjfas-53-1-1; HAVENS KE, 1993, ENVIRON SCI TECHNOL, V27, P1621, DOI 10.1021/es00045a019; Houle D, 2006, CAN J FISH AQUAT SCI, V63, P471, DOI 10.1139/f06-007; Huntington TG, 2000, SOIL SCI SOC AM J, V64, P1845, DOI 10.2136/sssaj2000.6451845x; JEFFRIES DS, 2004, 2004 CANADIAN ACID D, pCH6; Jeziorski A, 2006, CAN J FISH AQUAT SCI, V63, P1007, DOI 10.1139/F06-019; Keller W, 2001, CAN J FISH AQUAT SCI, V58, P2011, DOI 10.1139/cjfas-58-10-2011; KIRCHNER JW, 1995, ENVIRON SCI TECHNOL, V29, P1953, DOI 10.1021/es00008a012; Korhola A., 2001, TRACKING ENV CHANGE, P5, DOI DOI 10.1007/0-306-47671-1_2; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; MacRae PSD, 2001, CAN J FISH AQUAT SCI, V58, P342, DOI 10.1139/cjfas-58-2-342; Norton S.A., 2003, TREATISE GEOCHEMISTR, V9, P367, DOI [10.1016/B0-08-043751-6/09052-6, DOI 10.1016/B0-08-043751-6/09052-6]; Skjelkvale BL, 2005, ENVIRON POLLUT, V137, P165, DOI 10.1016/j.envpol.2004.12.023; Smol J.P., 2009, POLLUTION LAKES RIVE; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Watmough SA, 2005, ENVIRON MONIT ASSESS, V109, P1, DOI 10.1007/s10661-005-4336-z; Watmough SA, 2003, CAN J FISH AQUAT SCI, V60, P1095, DOI [10.1139/f03-093, 10.1139/F03-093]; Watmough SA, 2008, CAN J FISH AQUAT SCI, V65, P821, DOI 10.1139/F07-196; YARI ND, 2008, CAN J FISH AQUAT SCI, V65, P862	30	235	246	6	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1374	1377		10.1126/science.1164949	http://dx.doi.org/10.1126/science.1164949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039134				2022-12-24	WOS:000261170600037
J	Hovhannisyan, Z; Weiss, A; Martin, A; Wiesner, M; Tollefsen, S; Yoshida, K; Ciszewski, C; Curran, SA; Murray, JA; David, CS; Sollid, LM; Koning, F; Teyton, L; Jabri, B				Hovhannisyan, Zaruhi; Weiss, Angela; Martin, Alexandra; Wiesner, Martina; Tollefsen, Stig; Yoshida, Kenji; Ciszewski, Cezary; Curran, Shane A.; Murray, Joseph A.; David, Chella S.; Sollid, Ludvig M.; Koning, Frits; Teyton, Luc; Jabri, Bana			The role of HLA-DQ8 beta 57 polymorphism in the anti-gluten T-cell response in coeliac disease	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II MOLECULES; SMALL-INTESTINAL MUCOSA; GLIADIN; SUSCEPTIBILITY; RECOGNITION; REPERTOIRE; PEPTIDES; MOUSE; GENE	Major histocompatibility complex ( MHC) class II alleles HLA-DQ8 and the mouse homologue I-A(g7) lacking a canonical aspartic acid residue at position beta 57 are associated with coeliac disease(1,2) and type I diabetes(3,4). However, the role of this single polymorphism in disease initiation and progression remains poorly understood. The lack of Asp 57 creates a positively charged P9 pocket, which confers a preference for negatively charged peptides. Gluten lacks such peptides, but tissue transglutaminase ( TG2) introduces negatively charged residues at defined positions into gluten T- cell epitopes by deamidating specific glutamine residues(5,6) on the basis of their spacing to proline residues(7). The commonly accepted model, proposing that HLA-DQ8 simply favours binding of negatively charged peptides, does not take into account the fact that TG2 requires inflammation for activation(8) and that T- cell responses against native gluten peptides are found(9,10), particularly in children(11). Here we show that beta 57 polymorphism promotes the recruitment of T- cell receptors bearing a negative signature charge in the complementary determining region 3 beta (CDR3 beta) during the response against native gluten peptides presented by HLA-DQ8 in coeliac disease. These T cells showed a crossreactive and heteroclitic ( stronger) response to deamidated gluten peptides. Furthermore, gluten peptide deamidation extended the T- cell- receptor repertoire by relieving the requirement for a charged residue in CDR3 beta. Thus, the lack of a negative charge at position beta 57 in MHC class II was met by negatively charged residues in the T- cell receptor or in the peptide, the combination of which might explain the role of HLA-DQ8 in amplifying the T- cell response against dietary gluten.	[Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Weiss, Angela] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Wiesner, Martina; Koning, Frits] Leiden Univ, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Tollefsen, Stig; Sollid, Ludvig M.] Natl Hosp Norway, Ctr Immune Regulat, Inst Immunol, N-0027 Oslo, Norway; [Yoshida, Kenji; Teyton, Luc] Scripps Res Inst, La Jolla, CA 92037 USA; [Murray, Joseph A.; David, Chella S.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Inst Immunol, N-0027 Oslo, Norway	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Princeton University; Leiden University; Leiden University - Excl LUMC; University of Oslo; National Hospital Norway; Scripps Research Institute; Mayo Clinic; University of Oslo	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Koning, Frits/0000-0002-4007-5715; murray, joseph/0000-0003-1941-9090	Digestive Disease Research Core Center of the University of Chicago [DK42086]; NIH [DK67180, DK55037]; Celiac Disease Consortium; EU MC-RTN [512385]; Research Council of Norway; University of Oslo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R01DK055037, R01DK067180] Funding Source: NIH RePORTER	Digestive Disease Research Core Center of the University of Chicago(University of Chicago); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celiac Disease Consortium; EU MC-RTN; Research Council of Norway(Research Council of Norway); University of Oslo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Sadegh-Nasseri for advice and discussion, and A. Bendelac and M. Mush for critical reading of the manuscript. This work was supported by the Digestive Disease Research Core Center of the University of Chicago (DK42086), NIH DK67180, DK55037, the Celiac Disease Consortium (F.K.), EU MC-RTN 512385 (M.W.), the Research Council of Norway (L.S.) and the University of Oslo (S.T.).	ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Arden Bernhard, 1995, Immunogenetics, V42, P501; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Bankovich AJ, 2004, MOL IMMUNOL, V40, P1033, DOI 10.1016/j.molimm.2003.11.016; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Quinn A, 2006, INT IMMUNOL, V18, P967, DOI 10.1093/intimm/dxl033; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; SPURKLAND A, 1992, HUM IMMUNOL, V35, P188, DOI 10.1016/0198-8859(92)90104-U; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J	30	69	78	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					534	538		10.1038/nature07524	http://dx.doi.org/10.1038/nature07524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037317	Green Accepted			2022-12-24	WOS:000261170500045
J	Costa-Mattioli, M				Costa-Mattioli, Mauro			EPPENDORF WINNER Switching Memories ON and OFF	SCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; NEUROSCIENCE; TERM; MECHANISMS; STORAGE		[Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu						BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borges JL., 1962, FUNES MEMORIOUS BORG, V2, P107; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014	21	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					874	875		10.1126/science.1167228	http://dx.doi.org/10.1126/science.1167228			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988834				2022-12-24	WOS:000260674100029
J	Lameire, N; Van Biesen, W; Vanholder, R				Lameire, Norbert; Van Biesen, Wim; Vanholder, Raymond			Acute kidney injury	LANCET			English	Editorial Material							RENAL REPLACEMENT THERAPY; INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; SODIUM-BICARBONATE; SEPTIC SHOCK; PREVENTION; MANAGEMENT; SEPSIS; AKI		[Lameire, Norbert; Van Biesen, Wim; Vanholder, Raymond] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital	Lameire, N (corresponding author), Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium.	norbert.lameire@ugent.be						Adolph E, 2008, CORONARY ARTERY DIS, V19, P413, DOI 10.1097/MCA.0b013e3283021ac6; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Bouchard J, 2008, ADV CHRONIC KIDNEY D, V15, P235, DOI 10.1053/j.ackd.2008.04.004; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Kellum JA, 2008, NEPHROL DIAL TRANSPL, V23, P1471, DOI 10.1093/ndt/gfn012; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026; Murray PT, 2008, CLIN J AM SOC NEPHRO, V3, P864, DOI 10.2215/CJN.04851107; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Preiser JC, 2007, INTENS CARE MED, V33, P570, DOI 10.1007/s00134-006-0485-y; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thomas G, 2007, NEPHROL DIAL TRANSPL, V22, P2849, DOI 10.1093/ndt/gfm401; Tolwani AJ, 2008, J AM SOC NEPHROL, V19, P1233, DOI 10.1681/ASN.2007111173; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Tumlin J, 2008, J AM SOC NEPHROL, V19, P1034, DOI 10.1681/ASN.2007080895; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615	22	85	88	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1863	1865		10.1016/S0140-6736(08)61794-8	http://dx.doi.org/10.1016/S0140-6736(08)61794-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041789				2022-12-24	WOS:000261388700007
J	Hamdan, SM; Loparo, JJ; Takahashi, M; Richardson, CC; van Oijen, AM				Hamdan, Samir M.; Loparo, Joseph J.; Takahashi, Masateru; Richardson, Charles C.; van Oijen, Antoine M.			Dynamics of DNA replication loops reveal temporal control of lagging-strand synthesis	NATURE			English	Article							OKAZAKI FRAGMENT SYNTHESIS; BACTERIOPHAGE T7; SINGLE-MOLECULE; POLYMERASE; FORK; PRIMASE; PROCESSIVITY; PROTEINS; DISSOCIATION; EXTENSION	In all organisms, the protein machinery responsible for the replication of DNA, the replisome, is faced with a directionality problem. The antiparallel nature of duplex DNA permits the leading- strand polymerase to advance in a continuous fashion, but forces the lagging- strand polymerase to synthesize in the opposite direction. By extending RNA primers, the lagging- strand polymerase restarts at short intervals and produces Okazaki fragments(1,2).At least in prokaryotic systems, this directionality problem is solved by the formation of a loop in the lagging strand of the replication fork to reorient the lagging- strand DNA polymerase so that it advances in parallel with the leading- strand polymerase. The replication loop grows and shrinks during each cycle of Okazaki fragment synthesis(3). Here we use single- molecule techniques to visualize, in real time, the formation and release of replication loops by individual replisomes of bacteriophage T7 supporting coordinated DNA replication. Analysis of the distributions of loop sizes and lag times between loops reveals that initiation of primer synthesis and the completion of an Okazaki fragment each serve as a trigger for loop release. The presence of two triggers may represent a fail-safe mechanism ensuring the timely reset of the replisome after the synthesis of every Okazaki fragment.	[Hamdan, Samir M.; Loparo, Joseph J.; Takahashi, Masateru; Richardson, Charles C.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	van Oijen, AM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM-077248, GM-54397]; National Science Foundation [CAREER 0543784]; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077248, R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-B. Lee for technical advice and S. Moskowitz for illustrations. This work was supported by the National Institutes of Health (grants GM-077248 to A.M.v.O. and GM-54397 to C.C.R.) and the National Science Foundation (CAREER grant 0543784 to A.M.v.O.). J.J.L. acknowledges the Jane Coffin Childs Memorial Fund for a postdoctoral fellowship.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hyland EM, 2003, J BIOL CHEM, V278, P7247, DOI 10.1074/jbc.M210605200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; WU CA, 1992, J BIOL CHEM, V267, P4074; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029	27	116	116	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					336	U9		10.1038/nature07512	http://dx.doi.org/10.1038/nature07512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19029884	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000262440900044
J	Falit, BP; Gross, CP				Falit, Benjamin P.; Gross, Cary P.			Access to Experimental Drugs for Terminally Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Falit, Benjamin P.; Gross, Cary P.] Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu						DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; Krohmal BJ, 2007, ARCH INTERN MED, V167, P433, DOI 10.1001/archinte.167.5.433; STGEORGE D, 2004, WASH POST       0118, pW10; 2006, FED REG, V71, P75147	5	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2793	2795		10.1001/jama.2008.828	http://dx.doi.org/10.1001/jama.2008.828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088356				2022-12-24	WOS:000261730400025
J	Raoult, D				Raoult, Didier			Creationism-remember the principle of falsifiability	LANCET			English	Editorial Material									[Raoult, Didier] Univ Aix Marseille 2, Fac Med, Marseille 05, France	UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), Univ Aix Marseille 2, Fac Med, Marseille 05, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Darwin C., 1877, DIFFERENT FORMS FLOW; Dawkins R, 1976, SELFISH GENE; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Kuhn, 1962, STRUCTURE SCI REVOLU, P148; Popper K., 2002, LOGIC SCI DISCOVERY; Trivers R. L., 2006, GENES CONFLICT	6	3	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2095	2096		10.1016/S0140-6736(08)61904-2	http://dx.doi.org/10.1016/S0140-6736(08)61904-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19101368				2022-12-24	WOS:000261894000008
J	Hernandez, AF; Shea, AM; Milano, CA; Rogers, JG; Hammill, BG; O'Connor, CM; Schulman, KA; Peterson, ED; Curtis, LH				Hernandez, Adrian F.; Shea, Alisa M.; Milano, Carmelo A.; Rogers, Joseph G.; Hammill, Bradley G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.			Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL CIRCULATORY SUPPORT; CHRONIC HEART-FAILURE; TRANSPLANTATION; IMPLANTATION; UPDATE; DESTINATION; MANAGEMENT; COMMITTEE; ACCURACY; ICD-9-CM	Context In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end- stage heart failure. Little is known about the long- term outcomes and costs associated with these devices. Objective To examine the acute and long- term outcomes of Medicare beneficiaries receiving ventricular assist devices alone or after open- heart surgery. Design, Setting, and Patients Analysis of inpatient claims from the Centers for Medicare & Medicaid Services for the period 2000 through 2006. Patients were Medicare fee- for- service beneficiaries who received a ventricular assist device between February 2000 and June 2006 alone as primary therapy ( primary device group; n= 1476) or after cardiotomy in the previous 30 days ( postcardiotomy group; n= 1467). Main Outcome Measures Cumulative incidence of device replacement, device removal, heart transplantation, readmission, and death, accounting for censoring and competing risks. Patients were followed up for at least 6 months and factors independently associated with long- term survival were identified. Medicare payments were used to calculate total inpatient costs and costs per day outside the hospital. Results Overall 1- year survival was 51.6% ( n= 669) in the primary device group and 30.8% ( n= 424) in the postcardiotomy group. Among primary device patients, 815 ( 55.2%) were discharged alive with a device. Of those, 450 (55.6%) were readmitted within 6 months and 504 (73.2%) were alive at 1 year. Of the 493 (33.6%) postcardiotomy patients discharged alive with a device, 237 (48.3%) were readmitted within 6 months and 355 (76.6%) were alive at 1 year. Mean 1- year Medicare payments for inpatient care for patients in the 2000- 2005 cohorts were $178714 (SD, $142549) in the primary device group and $ 111769 ( SD, $ 95413) in the postcardiotomy group. Conclusions Among Medicare beneficiaries receiving a ventricular assist device, early mortality, morbidity, and costs remain high. Improving patient selection and reducing perioperative mortality are critical for improving overall outcomes.	[Hernandez, Adrian F.; Shea, Alisa M.; Rogers, Joseph G.; Hammill, Bradley G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Rogers, Joseph G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Milano, Carmelo A.] Duke Univ, Sch Med, Dept Surg, Durham, NC 27715 USA	Duke University; Duke University; Duke University	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021	Hernandez, Adrian F/0000-0003-3387-9616; 	National Institute on Aging [1R01AG026038-01A1]; Agency for Healthcare Research and Quality [1U18HS016964-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026038] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by grants 1R01AG026038-01A1 from the National Institute on Aging and 1U18HS016964-01 from the Agency for Healthcare Research and Quality.	Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; *CTR MED MED SERV, DEC MEM VENTR ASS DE; CURTIS LH, IN PRESS ARCH INTERN; Esmore D, 2007, EUR J CARDIO-THORAC, V32, P735, DOI 10.1016/j.ejcts.2007.07.028; Felker GM, 2008, J CARD FAIL, V14, P368, DOI 10.1016/j.cardfail.2008.01.009; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Goldstein DJ, 2003, CIRCULATION, V108, P272, DOI 10.1161/01.cir.0000087387.02218.7e; Helman DN, 1999, ANN THORAC SURG, V68, P1187, DOI 10.1016/S0003-4975(99)00911-X; Hernandez AF, 2007, CIRCULATION, V116, P606, DOI 10.1161/CIRCULATIONAHA.106.666289; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kherani AR, 2003, J THORAC CARDIOV SUR, V126, P1634, DOI 10.1016/S0022-5223(03)00727-X; Kirklin JK, 2008, CIRC-HEART FAIL, V1, P200, DOI 10.1161/CIRCHEARTFAILURE.108.782599; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Long James W, 2005, Congest Heart Fail, V11, P133, DOI 10.1111/j.1527-5299.2005.04540.x; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; *NAT HEART LUNG BL, CLIN US VENTR ASS DE; *NAT HEART LUNG BL, NEXT GEN VENTR ASS D; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rogers JG, 2007, J AM COLL CARDIOL, V50, P741, DOI 10.1016/j.jacc.2007.03.063; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Russo MJ, 2008, J CARD FAIL, V14, P651, DOI 10.1016/j.cardfail.2008.06.005; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Stevenson LW, 2005, CIRCULATION, V112, pE111, DOI 10.1161/CIRCULATIONAHA.104.506451; Stevenson LW, 2004, CIRCULATION, V110, P975, DOI 10.1161/01.CIR.0000139862.48167.23; Tunis SR, 2004, NEW ENGL J MED, V350, P2196, DOI 10.1056/NEJMe048091	30	67	67	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2398	2406		10.1001/jama.2008.716	http://dx.doi.org/10.1001/jama.2008.716			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033590	Green Accepted, Bronze			2022-12-24	WOS:000261150800022
J	Epstein, H				Epstein, Helen			AIDS and the irrational	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONCURRENT SEXUAL PARTNERSHIPS; HIV-INFECTION; TRANSMITTED INFECTIONS; AFRICAN-AMERICANS; YOUNG MEN; BEHAVIOR; RISK; PREVENTION; SPREAD; COMMUNITIES					helenepstein@yahoo.com						Adimora AA, 2004, ANN EPIDEMIOL, V14, P155, DOI 10.1016/S1047-2797(03)00129-7; Adimora AA, 2003, JAIDS-J ACQ IMM DEF, V34, P423, DOI 10.1097/00126334-200312010-00010; ANKRAH M, 1993, AIDS UGANDA ANAL SOC; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; BARTON T, 1997, EPIDEMICS BEHA UNPUB; BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BOGART L, 2005, J ACQ IMMUN DEF SYND, V38, P2; CARAEL M, 2001, AFRICAN J REPROD HLT, V5, P83, DOI DOI 10.2307/3583201; Carael M., 1995, SEXUAL BEHAV AIDS DE; Carter MW, 2007, AIDS BEHAV, V11, P822, DOI 10.1007/s10461-006-9203-6; Christakis NA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1675; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Colvin M, 1998, INT J STD AIDS, V9, P548, DOI 10.1258/0956462981922683; Drumright LN, 2004, SEX TRANSM DIS, V31, P437, DOI 10.1097/01.olq.0000129949.30114.37; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; EPSTEIN H, 2004, DISCOVER         FEB; EPSTEIN H, 2005, AIDSLINK         SEP, P93; Epstein Helen, 2008, INVISIBLE CURE AFRIC; *FAM HLTH INT, 2002, SWAZ BEH SURV SURV; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GILGEN D, 2000, NATURAL HIST HIV AID; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2007, S AFR J HIV MED, P19; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; HEATON L, 2006, 16 INT AIDS C 13 18; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; HUDSON CP, 1994, AIDS, V8, P1739, DOI 10.1097/00002030-199412000-00021; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; HUDSON CP, 1993, AIDS, V7, P286, DOI 10.1097/00002030-199302000-00024; Human Rights Watch, 2007, HIDD MEAL MEAL GEND; KALEEBA N, 2002, WE MISS YOU ALL AIDS; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; MAH T, 2008, 225 CTR SOC SCI RES; MAH T, 2008, AIDS BEHAV      0722; MAJIRIOGHENE B, 2008, NIGERIANS AM    1013; Matovu JKB, 2007, AIDS BEHAV, V11, P71, DOI 10.1007/s10461-006-9170-y; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; MEYERSON B, TCM EXPOSURE HIV REL; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; MORRIS M, 2007, SEXUALLY TRANSMITTED; Moszynski P, 2007, BRIT MED J, V334, P712, DOI 10.1136/bmj.39171.431736.DB; MUSINGUZI J, 1996, RESULTS POPULATION B; MUSSA A, 2001, THESIS U WASHINGTON; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; OBBO C, 1993, SOC SCI MED, V36, P949, DOI 10.1016/0277-9536(93)90086-J; Parker W, 2007, CONCURRENT SEXUAL PA; PARKER W, 2007, NAMIBIA MIDTERM HOUS; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; PIOT P, 1994, HIV EPIDEMIOLOGY, P77; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; *POP COUNC, 2006, AD GIRLS SOC SUPP LI; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Roehr B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2566; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; *SO AFR DEV COMM, 2006, REP EXP THINK TANK M; STANDING H, 1989, SEXUAL BEHAV AIDS SU; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; SULLIVAN J, 2006, AIDS; TALLE A, 1995, YOUNG PEOPLE RISK FI; Tuffs A, 2007, BRIT MED J, V334, P712, DOI 10.1136/bmj.39170.736412.DB; *UG MIN HLTH, 1995, UG DEM HLTH SURV 199; UNAIDS, 2001, HIV PREV NEEDS SUCC; *UNAIDS, 2006, REP GLOB AIDS EP 200, P127; *UNAIDS, 2008, REP GLOB AIDS EP 200, P36; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; *WORLD BANK, 2003, ED HIV AIDS SOUR HIV	73	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2008	337								a2638	10.1136/bmj.a2638	http://dx.doi.org/10.1136/bmj.a2638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033334				2022-12-24	WOS:000261827500017
J	Campbell, JE; Carmichael, GR; Chai, T; Mena-Carrasco, M; Tang, Y; Blake, DR; Blake, NJ; Vay, SA; Collatz, GJ; Baker, I; Berry, JA; Montzka, SA; Sweeney, C; Schnoor, JL; Stanier, CO				Campbell, J. E.; Carmichael, G. R.; Chai, T.; Mena-Carrasco, M.; Tang, Y.; Blake, D. R.; Blake, N. J.; Vay, S. A.; Collatz, G. J.; Baker, I.; Berry, J. A.; Montzka, S. A.; Sweeney, C.; Schnoor, J. L.; Stanier, C. O.			Photosynthetic Control of Atmospheric Carbonyl Sulfide During the Growing Season	SCIENCE			English	Article							CHEMICAL-TRANSPORT MODEL; GROSS PRIMARY PRODUCTION; ECOSYSTEM RESPIRATION; COS; EXCHANGE; FLUXES; CONSUMPTION; VEGETATION; FEEDBACKS	Climate models incorporate photosynthesis- climate feedbacks, yet we lack robust tools for large- scale assessments of these processes. Recent work suggests that carbonyl sulfide ( COS), a trace gas consumed by plants, could provide a valuable constraint on photosynthesis. Here we analyze airborne observations of COS and carbon dioxide concentrations during the growing season over North America with a three- dimensional atmospheric transport model. We successfully modeled the persistent vertical drawdown of atmospheric COS using the quantitative relation between COS and photosynthesis that has been measured in plant chamber experiments. Furthermore, this drawdown is driven by plant uptake rather than other continental and oceanic fluxes in the model. These results provide quantitative evidence that COS gradients in the continental growing season may have broad use as a measurement- based photosynthesis tracer.	[Campbell, J. E.; Schnoor, J. L.] Univ Iowa, Dept Civil & Environm Engn, Iowa City, IA 52242 USA; [Carmichael, G. R.; Tang, Y.; Stanier, C. O.] Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; [Chai, T.] Sci & Technol Corp, Hampton, VA 23666 USA; [Mena-Carrasco, M.] Univ Andres Bello, Dept Environm Engn, Santiago, Chile; [Mena-Carrasco, M.] MIT, Molina Ctr Energy & Environm, Cambridge, MA 02139 USA; [Blake, D. R.; Blake, N. J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Vay, S. A.] NASA, Langley Res Ctr, Hampton, VA 23681 USA; [Collatz, G. J.] NASA, Goddard Space Flight Ctr, Biospher Sci Branch, Greenbelt, MD 20771 USA; [Baker, I.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Berry, J. A.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Montzka, S. A.] NOAA, Earth Syst Res Lab, Global Monitoring Div, Boulder, CO 80305 USA; [Sweeney, C.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80304 USA	University of Iowa; University of Iowa; Universidad Andres Bello; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Colorado State University; Carnegie Institution for Science; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Campbell, JE (corresponding author), Univ Calif Merced, Coll Engn, Merced, CA 95344 USA.	ecampbell3@ucmerced.edu	Berry, Joseph/ABA-8496-2020; Sweeney, Colm/AAE-9291-2019; Chai, Tianfeng/E-5577-2010; collatz, george j/D-5381-2012; Tang, Youhua/D-5205-2016; Mena-Carrasco, Marcelo/B-8483-2012; montzka, stephen/V-6162-2019; Schnoor, Jerald L/B-1951-2008; Mena-Carrasco, Marcelo/L-9730-2016; Stanier, Charles O/D-4307-2016; Chai, TF/I-5893-2019	Berry, Joseph/0000-0002-5849-6438; Chai, Tianfeng/0000-0003-3520-2641; Tang, Youhua/0000-0001-7089-7915; montzka, stephen/0000-0002-9396-0400; Stanier, Charles O/0000-0001-9924-0853; Chai, TF/0000-0003-3520-2641; Mena, Marcelo/0000-0002-8847-7588; Blake, Donald/0000-0002-8283-5014; Sweeney, Colm/0000-0002-4517-0797	NASA Earth System Science Graduate Fellowship; Center for Global and Regional Environmental Research; NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program; NASA INTEX; NSF Information Technology Research; NATIONAL CANCER INSTITUTE [U54CA151662] Funding Source: NIH RePORTER	NASA Earth System Science Graduate Fellowship; Center for Global and Regional Environmental Research; NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program(National Oceanic Atmospheric Admin (NOAA) - USA); NASA INTEX; NSF Information Technology Research(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Kettle for COS flux data and C. Tebaldi, J. Dungan, T. Campbell, and D. Campbell for critical comments on the manuscript. This research was supported by a NASA Earth System Science Graduate Fellowship, Center for Global and Regional Environmental Research, NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program, NASA INTEX, and NSF Information Technology Research grants. NOAA observations of COS and CO<INF>2</INF> were made possible by the assistance of P. Tans, C. Sweeney, L. Miller, T. Conway, P. Lang, C. Siso, and B. Hall.	Blake NJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009163; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Campbell JE, 2007, TELLUS B, V59, P199, DOI 10.1111/j.1600-0889.2006.00239.x; Carmichael GR, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003117; CHIN M, 1995, J GEOPHYS RES-ATMOS, V100, P8993, DOI 10.1029/95JD00275; Choi YH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008899; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; CRUTZEN PJ, 1976, GEOPHYS RES LETT, V3, P73, DOI 10.1029/GL003i002p00073; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerbig C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003770; Kettle AJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002187; Kettle AJ, 2002, ATMOS CHEM PHYS, V2, P343, DOI 10.5194/acp-2-343-2002; Kjellstrom E, 1998, J ATMOS CHEM, V29, P151, DOI 10.1023/A:1005976511096; Matross DM, 2006, TELLUS B, V58, P344, DOI 10.1111/j.1600-0889.2006.00206.x; Montzka SA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007665; Notholt J, 2003, SCIENCE, V300, P307, DOI 10.1126/science.1080320; NOTHOLT J, 2006, SPARC ASSESSMENT STR, P29; Olsen SC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003968; PROTOSCHILL-KREBS G, 1992, BOT ACTA, V105, P206, DOI 10.1111/j.1438-8677.1992.tb00288.x; ProtoschillKrebs G, 1996, ATMOS ENVIRON, V30, P3151, DOI 10.1016/1352-2310(96)00026-X; Rodgers C.D., 2000, INVERSE METHODS ATMO, P238, DOI [10.5194/amt-7-3233-2014, DOI 10.5194/AMT-7-3233-2014]; Sandoval-Soto L, 2005, BIOGEOSCIENCES, V2, P125, DOI 10.5194/bg-2-125-2005; Singh HB, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007905; Steinbacher M, 2004, ATMOS ENVIRON, V38, P6043, DOI 10.1016/j.atmosenv.2004.06.022; Suyker AE, 2005, AGR FOREST METEOROL, V131, P180, DOI 10.1016/j.agrformet.2005.05.007	30	138	142	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1085	1088		10.1126/science.1164015	http://dx.doi.org/10.1126/science.1164015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008442	Green Submitted			2022-12-24	WOS:000260867700033
J	Lampard, GR; MacAlister, CA; Bergmann, DC				Lampard, Gregory R.; MacAlister, Cora A.; Bergmann, Dominique C.			Arabidopsis Stomatal Initiation Is Controlled by MAPK-Mediated Regulation of the bHLH SPEECHLESS	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAY; DIFFERENTIATION; UNCOVERS	Stomata, epidermal structures that modulate gas exchange between plants and the atmosphere, play critical roles in primary productivity and the global climate. Positively acting transcription factors and negatively acting mitogen- activated protein kinase ( MAPK) signaling control stomatal development in Arabidopsis; however, it is not known how the opposing activities of these regulators are integrated. We found that a unique domain in a basic helix- loop- helix ( bHLH) stomatal initiating factor, SPEECHLESS, renders it a MAPK phosphorylation target in vitro and modulates its function in vivo. MAPK cascades modulate a diverse set of activities including development, cell proliferation, and response to external stresses. The coupling of MAPK signaling to SPEECHLESS activity provides cell type specificity for MAPK output while allowing the integration of multiple developmental and environmental signals into the production and spacing of stomata.	[Lampard, Gregory R.; MacAlister, Cora A.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dbergmann@stanford.edu		Bergmann, Dominique/0000-0003-0873-3543; MacAlister, Cora/0000-0003-1470-0596	NSF [IOS-0544895]; U. S. Department of Energy [DE-FG02-06ER15810]; Terman award; Stanford Genome Training Program (National Human Genome Research Institute)	NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); Terman award; Stanford Genome Training Program (National Human Genome Research Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank lab members for discussion and comments on the manuscript, The Carnegie Department of Plant Biology for use of microscopes, and L. Smith for identification of maize homologs. Supported by NSF grant IOS- 0544895, U. S. Department of Energy grant DE-FG02-06ER15810, a Terman award, and the Stanford Genome Training Program (National Human Genome Research Institute).	Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Joo S, 2008, PLANT J, V54, P129, DOI 10.1111/j.1365-313X.2008.03404.x; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	24	310	325	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1113	1116		10.1126/science.1162263	http://dx.doi.org/10.1126/science.1162263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008449	Green Published			2022-12-24	WOS:000260867700041
J	Cormie, PJ; Nairn, M; Welsh, J				Cormie, P. J.; Nairn, M.; Welsh, J.		Guideline Dev Grp	Control of pain in adults with cancer: summary of SIGN guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VALIDATION; RELIEF; SCALE		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Cormie, P. J.] Stow Hlth Ctr, Stow TD1 2SQ, Galashiels, Scotland; [Welsh, J.] Univ Glasgow, Fac Med, Div Canc Sci, Glasgow, Lanark, Scotland; [Welsh, J.] Beatson W Scotland Canc Ctr, Glasgow G12 0YN, Lanark, Scotland	University of Glasgow; Beatson Oncology Centre	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410; Colvin, Lesley/0000-0002-1563-8600; Mair, Jane/0000-0001-6617-0203				Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; DUAT R, 1983, PAIN, V17, P197; LARUE F, 1995, BRIT MED J, V310, P1034, DOI 10.1136/bmj.310.6986.1034; Launay-Vacher V, 2005, J PAIN, V6, P137, DOI 10.1016/j.jpain.2004.11.009; Mercadante S, 2004, J PAIN, V5, P2, DOI 10.1016/j.jpain.2003.09.007; Pautex S, 2005, J GERONTOL A-BIOL, V60, P524, DOI 10.1093/gerona/60.4.524; PORTENOY RK, 1989, CANCER, V63, P2298, DOI 10.1002/1097-0142(19890601)63:11<2298::AID-CNCR2820631140>3.0.CO;2-A; Scottish Intercollegiate Guidelines Network (SIGN), 2008, 106 SIGN; VENTAFRIDDA V, 1987, CANCER, V59, P850, DOI 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1; Walker J, 2007, J PSYCHOSOM RES, V63, P83, DOI 10.1016/j.jpsychores.2007.01.009; World Health Organization, 1996, CANC PAIN REL; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	13	23	23	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2008	337								a2154	10.1136/bmj.a2154	http://dx.doi.org/10.1136/bmj.a2154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FB	18987038				2022-12-24	WOS:000261236000002
J	White, MA; Eykelenboom, JK; Lopez-Vernaza, MA; Wilson, E; Leach, DRF				White, Martin A.; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; Wilson, Emily; Leach, David R. F.			Non-random segregation of sister chromosomes in Escherichia coli	NATURE			English	Article							SEPARATE CELL HALVES; IMMORTAL STRAND HYPOTHESIS; BACTERIAL CHROMOSOME; DNA-POLYMERASE; STEM-CELLS; REPLICATION; ORGANIZATION; REGION; ARMS; MREB	It has long been known that the 59 to 39 polarity of DNA synthesis results in both a leading and lagging strand at all replication forks(1). Until now, however, there has been no evidence that leading or lagging strands are spatially organized in any way within a cell. Here we show that chromosome segregation in Escherichia coli is not random but is driven in a manner that results in the leading and lagging strands being addressed to particular cellular destinations. These destinations are consistent with the known patterns of chromosome segregation(2,3). Our work demonstrates a new level of organization relating to the replication and segregation of the E. coli chromosome.	[White, Martin A.; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; Wilson, Emily; Leach, David R. F.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Leach, DRF (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913; Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Eykelenboom, John/0000-0003-4115-9686; White, Martin/0000-0001-6482-8462	Medical Research Council; MRC [G0401313] Funding Source: UKRI; Medical Research Council [G0401313] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Sherratt for the gifts of plasmids pWX6, pLau43 and pLau44. We also thank E. Darmon and J. Blackwood for reading the manuscript. This work was supported by the Medical Research Council.	CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Darmon E, 2007, J BACTERIOL, V189, P6686, DOI 10.1128/JB.00489-07; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Karczmarek A, 2007, MOL MICROBIOL, V65, P51, DOI 10.1111/j.1365-2958.2007.05777.x; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lew DJ, 2008, CELL, V133, P21, DOI 10.1016/j.cell.2008.03.016; MASON DJ, 1956, J BACTERIOL, V71, P474, DOI 10.1128/JB.71.4.474-479.1956; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; Pinder DJ, 1998, MOL MICROBIOL, V28, P719, DOI 10.1046/j.1365-2958.1998.00831.x; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Rocha EPC, 2003, MOL MICROBIOL, V49, P895, DOI 10.1046/j.1365-2958.2003.03606.x; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SKARSTAD K, 1993, J BACTERIOL, V175, P5505, DOI 10.1128/JB.175.17.5505-5509.1993; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Woldringh CL, 2006, J STRUCT BIOL, V156, P273, DOI 10.1016/j.jsb.2006.04.013; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	30	58	58	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1248	1250		10.1038/nature07282	http://dx.doi.org/10.1038/nature07282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972020				2022-12-24	WOS:000260462100046
J	He, YP; Vogelstein, B; Velculescu, VE; Papadopoulos, N; Kinzler, KW				He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.			The Antisense Transcriptomes of Human Cells	SCIENCE			English	Article							GENOME; RNA	Transcription in mammalian cells can be assessed at a genome- wide level, but it has been difficult to reliably determine whether individual transcripts are derived from the plus or minus strands of chromosomes. This distinction can be critical for understanding the relationship between known transcripts ( sense) and the complementary antisense transcripts that may regulate them. Here, we describe a technique that can be used to (i) identify the DNA strand of origin for any particular RNA transcript, and (ii) quantify the number of sense and antisense transcripts from expressed genes at a global level. We examined five different human cell types and in each case found evidence for antisense transcripts in 2900 to 6400 human genes. The distribution of antisense transcripts was distinct from that of sense transcripts, was nonrandom across the genome, and differed among cell types. Antisense transcripts thus appear to be a pervasive feature of human cells, which suggests that they are a fundamental component of gene regulation.	[He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Papadopoulos, N (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	npapado1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; 	Virginia and D. K. Ludwig Fund for Cancer Research; NIH [CA57345, CA43460, CA62924, CA121113]; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA057345, R37CA043460, R01CA121113, P50CA062924, R01CA043460] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Yu for assistance with microarrays. Supported by the Virginia and D. K. Ludwig Fund for Cancer Research and NIH grants CA57345, CA43460, CA62924, and CA121113. Under a licensing agreement between Johns Hopkins University and Genzyme, technologies related to SAGE were licensed to Genzyme for commercial purposes, and B.V., V.E.V., and K.W.K. are entitled to a share of the royalties received by the university from the sales of the licensed technologies. The university and researchers (B.V. and K.W.K.) own Genzyme stock, which is subject to certain restrictions under university policy. The terms of these arrangements are being managed by the university in accordance with its conflict-of-interest policies. There are existing patents for SAGE that have been licensed as disclosed above, and similar patents are likely to be filed for ASSAGE.	Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carmichael GG, 2003, NAT BIOTECHNOL, V21, P371, DOI 10.1038/nbt0403-371; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Fahey ME, 2002, COMP FUNCT GENOM, V3, P244, DOI 10.1002/cfg.173; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Peters BA, 2007, GENOME RES, V17, P287, DOI 10.1101/gr.5486607; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Shendure J, 2002, GENOME BIOL, V3; Simpson AJG, 2001, COMP FUNCT GENOM, V2, P169, DOI 10.1002/cfg.81; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Timmons JA, 2006, BIOCHEM SOC T, V34, P1148, DOI 10.1042/BST0341148; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Yazgan O, 2007, BIOCHEM CELL BIOL, V85, P484, DOI 10.1139/O07-061; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	25	394	432	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1855	1857		10.1126/science.1163853	http://dx.doi.org/10.1126/science.1163853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056939	Green Accepted			2022-12-24	WOS:000261799400058
J	Greenberg, JI; Shields, DJ; Barillas, SG; Acevedo, LM; Murphy, E; Huang, JH; Scheppke, L; Stockmann, C; Johnson, RS; Angle, N; Cheresh, DA				Greenberg, Joshua I.; Shields, David J.; Barillas, Samuel G.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Stockmann, Christian; Johnson, Randall S.; Angle, Niren; Cheresh, David A.			A role for VEGF as a negative regulator of pericyte function and vessel maturation	NATURE			English	Article							GROWTH-FACTOR PDGF; INDUCED ANGIOGENESIS; ENDOTHELIAL-CELLS; IN-SITU; BETA; BB; DIFFERENTIATION; RECRUITMENT; INHIBITION; PROMOTES	Angiogenesis does not only depend on endothelial cell invasion and proliferation: it alsorequires pericyte coverage of vascular sprouts for vessel stabilization(1,2). These processes are coordinated by vascular endothelial growth factor ( VEGF) and platelet- derived growth factor ( PDGF) through their cognate receptors on endothelial cells and vascular smooth muscle cells ( VSMCs), respectively(3,4). PDGF induces neovascularization by priming VSMCs/pericytes to release proangiogenic mediators(5-7). Although VEGF directly stimulates endothelial cell proliferation and migration, its role in pericyte biology is less clear. Here we define a role for VEGF as an inhibitor of neovascularization on the basis of its capacity to disrupt VSMC function. Specifically, under conditions of PDGF- mediated angiogenesis, VEGF ablates pericyte coverage of nascent vascular sprouts, leading to vessel destabilization. At the molecular level, VEGF- mediated activation of VEGF- R2 suppresses PDGF- R beta signalling in VSMCs through the assembly of a previously undescribed receptor complex consisting of PDGF- Rb and VEGF- R2. Inhibition of VEGF- R2 not only prevents assembly of this receptor complex but also restores angiogenesis in tissues exposed to both VEGF and PDGF. Finally, genetic deletion of tumour cell VEGF disrupts PDGF-R beta/VEGF-R2 complex formation and increases tumour vessel maturation. These findings underscore the importance of VSMCs/ pericytes in neovascularization(8,9) and reveal a dichotomous role forVEGF and VEGF-R2 signalling as both a promoter of endothelial cell function and a negative regulator of VSMCs and vessel maturation.	[Shields, David J.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Greenberg, Joshua I.; Barillas, Samuel G.; Angle, Niren] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Shields, David J.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Cheresh, David A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Stockmann, Christian; Johnson, Randall S.] Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	Johnson, Randall/AAM-1189-2021; Stockmann, Christian/L-6956-2017; Stockmann, Christian/Q-1615-2017	Johnson, Randall/0000-0002-4084-6639; Stockmann, Christian/0000-0002-9726-6838	National Institutes of Health [R37-CA50286, CA082515, GM 68524]; University of California Academic Senate Grant; Deutsche Forschungsgemeinschaft [DFG STO 787/1-1]; Institutional Research and Academic Career Development Award; NATIONAL CANCER INSTITUTE [R01CA118165, R37CA050286, R01CA095262, P01CA078045, R01CA082515, R21CA129660] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Academic Senate Grant(University of California System); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institutional Research and Academic Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Stupack and D. Schlaepfer for advice and review of the manuscript. We also thank A. Tomar for assistance with the PLA imaging; C. Heldin for the PDGF-Rb complementary DNA; and J. Desgrosellier for processing pancreatic tumour samples. This work was supported by National Institutes of Health grants R37-CA50286 (D.A.C.) and CA082515 (R.S.J.), and by a University of California Academic Senate Grant (N.A.). C.S. was funded by the Deutsche Forschungsgemeinschaft (DFG STO 787/1-1), and L.M.A. received an Institutional Research and Academic Career Development Award postdoctoral fellowship (National Institutes of Health grant GM 68524).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Alavi AS, 2007, CANCER RES, V67, P2766, DOI 10.1158/0008-5472.CAN-06-3648; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fong TAT, 1999, CANCER RES, V59, P99; GRUNSTEIN J, 2004, CANCER RES, V23, P2800; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; INUI H, 1994, J BIOL CHEM, V269, P30546; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LUO J, 2007, NATURE PROTOC, V2, P1536; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	27	472	502	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					809	U101		10.1038/nature07424	http://dx.doi.org/10.1038/nature07424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18997771	Green Submitted, Green Accepted			2022-12-24	WOS:000261559900053
J	Oberdoerffer, P; Michan, S; Mcvay, M; Mostoslavsky, R; Vann, J; Park, SK; Hartlerode, A; Stegmuller, J; Hafner, A; Loerch, P; Wright, SM; Mills, KD; Bonni, A; Yankner, BA; Scully, R; Prolla, TA; Alt, FW; Sinclair, DA				Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Mostoslavsky, Raul; Vann, James; Park, Sang-Kyu; Hartlerode, Andrea; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Wright, Sarah M.; Mills, Kevin D.; Bonni, Azad; Yankner, Bruce A.; Scully, Ralph; Prolla, Tomas A.; Alt, Frederick W.; Sinclair, David A.			SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging	CELL			English	Article							DOUBLE-STRAND BREAKS; EMBRYONIC STEM-CELLS; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; DNA-DAMAGE; HISTONE H2AX; HETEROCHROMATIN FORMATION; CELLULAR SENESCENCE; GENOTOXIC STRESS; MATING-TYPE	Genomic instability and alterations in gene expression are hallmarks of eukaryotic aging. The yeast histone deacetylase Sir2 silences transcription and stabilizes repetitive DNA, but during aging or in response to a DNA break, the Sir complex relocalizes to sites of genomic instability, resulting in the desilencing of genes that cause sterility, a characteristic of yeast aging. Using embryonic stem cells, we show that mammalian Sir2, SIRT1, represses repetitive DNA and a functionally diverse set of genes across the mouse genome. In response to DNA damage, SIRT1 dissociates from these loci and relocalizes to DNA breaks to promote repair, resulting in transcriptional changes that parallel those in the aging mouse brain. Increased SIRT1 expression promotes survival in a mouse model of genomic instability and suppresses age-dependent transcriptional changes. Thus, DNA damage-induced redistribution of SIRT1 and other chromatin-modifying proteins may be a conserved mechanism of aging in eukaryotes.	[Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Bonni, Azad; Yankner, Bruce A.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Bonni, Azad; Yankner, Bruce A.; Sinclair, David A.] Harvard Univ, Sch Med, Glenn Labs Aging Res, Boston, MA 02115 USA; [Mostoslavsky, Raul] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Vann, James; Park, Sang-Kyu; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [Hartlerode, Andrea; Scully, Ralph] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hartlerode, Andrea; Scully, Ralph] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wright, Sarah M.; Mills, Kevin D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Jackson Laboratory; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Scully, Ralph/F-5008-2013	Sinclair, David/0000-0002-9936-436X	National Space Biomedical Research Institute [PF00903]; National Institutes of Health [NIH] [RO1GM068072, R01AG19719, NS047188, GM 073894, R01AG 020681]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072, R01GM073894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019719, R01AG020681, R01AG028730, P01AG027916] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D. A. S. wishes to thank B. Stillman and C. Westphal for advice and scientific discussions. We are also grateful to K. Rajewsky, D. Reinberg, D. Lamming, L. Guarente, A. Vaquero, and M. Jasin for advice and reagents. We thank E. Vollmann, J. Campbell, and D. Zimmerman for technical assistance and R. Bronson for mouse necropsy. We are especially grateful to P. Glenn, M. Collins, and L. Ellison for their support of aging research. P. O. was supported by a fellowship from the National Space Biomedical Research Institute (grant PF00903), the Sinclair Lab by grants RO1GM068072 and R01AG19719 (National Institutes of Health [NIH]), and the Glenn Foundation for Medical Research. D. A. S. and F. W. A. are Ellison Medical Foundation Senior Scholars. R. M. is a V and Kimmel Foundation Scholar. A. B. supported by NIH grant NS047188; R. S. by GM 073894; and J. V., S. P., and T. A. P. by R01AG 020681. F. W. A. is an Investigator of the Howard Hughes Medical Institute. D. A. S. is a consultant to Shaklee, Genocea, and Sirtris (a GSK company developing sirtuin-based drugs) and an inventor on Harvard patents licensed to GSK.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; CUTLER RG, 1995, MCBU, P15; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Imai S, 1998, EXP GERONTOL, V33, P555; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KLAR AJS, 1979, GENETICS, V93, P37; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; NICHOLS NR, 1995, NEUROBIOL AGING, V16, P105, DOI 10.1016/0197-4580(95)80013-H; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Park PU, 1999, MOL CELL BIOL, V19, P3848; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; RINE J, 1979, GENETICS, V93, P877; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vijg J, 2004, MECH AGEING DEV, V125, P747, DOI 10.1016/j.mad.2004.07.004; Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Wu JF, 2008, J MOL NEUROSCI, V34, P1, DOI 10.1007/s12031-007-0009-4; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhu P, 2004, CELL CYCLE, V3, P1240, DOI 10.4161/cc.3.10.1195	70	584	610	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					907	918		10.1016/j.cell.2008.10.025	http://dx.doi.org/10.1016/j.cell.2008.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041753	Bronze, Green Accepted			2022-12-24	WOS:000261183900021
J	Whooley, MA; de Jonge, P; Vittinghoff, E; Otte, C; Moos, R; Carney, RM; Ali, S; Dowray, S; Na, B; Feldman, MD; Schiller, NB; Browner, WS				Whooley, Mary A.; de Jonge, Peter; Vittinghoff, Eric; Otte, Christian; Moos, Rudolf; Carney, Robert M.; Ali, Sadia; Dowray, Sunaina; Na, Beeya; Feldman, Mitchell D.; Schiller, Nelson B.; Browner, Warren S.			Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTED PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; MEDICATION ADHERENCE; ENHANCING RECOVERY; CONSTRUCT-VALIDITY; EXERCISE TREATMENT; RATE-VARIABILITY; NATIONAL-HEART; OLDER PERSONS	Context Depressive symptoms predict adverse cardiovascular outcomes in patients with coronary heart disease, but the mechanisms responsible for this association are unknown. Objective To determine why depressive symptoms are associated with an increased risk of cardiovascular events. Design and Participants The Heart and Soul Study is a prospective cohort study of 1017 outpatients with stable coronary heart disease followed up for a mean ( SD) of 4.8 ( 1.4) years. Setting Participants were recruited between September 11, 2000, and December 20, 2002, from 12 outpatient clinics in the San Francisco Bay Area and were followed up to January 12, 2008. Main Outcome Measures Baseline depressive symptoms were assessed using the Patient Health Questionnaire ( PHQ). We used proportional hazards models to evaluate the extent to which the association of depressive symptoms with subsequent cardiovascular events ( heart failure, myocardial infarction, stroke, transient ischemic attack, or death) was explained by baseline disease severity and potential biological or behavioral mediators. Results A total of 341 cardiovascular events occurred during 4876 person- years of follow-up. The age- adjusted annual rate of cardiovascular events was 10.0% among the 199 participants with depressive symptoms ( PHQ score >= 10) and 6.7% among the 818 participants without depressive symptoms ( hazard ratio [ HR], 1.50; 95% confidence interval, [ CI], 1.16- 1.95; P=. 002). After adjustment for comorbid conditions and disease severity, depressive symptoms were associated with a 31% higher rate of cardiovascular events ( HR, 1.31; 95% CI, 1.00- 1.71; P=. 04). Additional adjustment for potential biological mediators attenuated this association ( HR, 1.24; 95% CI, 0.94- 1.63; P=. 12). After further adjustment for potential behavioral mediators, including physical inactivity, there was no significant association ( HR, 1.05; 95% CI, 0.79- 1.40; P=. 75). Conclusion In this sample of outpatients with coronary heart disease, the association between depressive symptoms and adverse cardiovascular events was largely explained by behavioral factors, particularly physical inactivity.	[Whooley, Mary A.; Ali, Sadia; Dowray, Sunaina; Na, Beeya; Schiller, Nelson B.] VA Med Ctr, San Francisco, CA USA; [Whooley, Mary A.; Vittinghoff, Eric; Feldman, Mitchell D.; Schiller, Nelson B.; Browner, Warren S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [de Jonge, Peter] Univ Groningen, Groningen, Netherlands; [de Jonge, Peter] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Otte, Christian] Univ Hosp Hamburg Eppendorf, Hamburg, Germany; [Moos, Rudolf] Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Moos, Rudolf] Stanford Univ, Palo Alto, CA 94304 USA; [Carney, Robert M.] Washington Univ, St Louis, MO USA; [Browner, Warren S.] Calif Pacific Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of Groningen; Tilburg University; University of Hamburg; University Medical Center Hamburg-Eppendorf; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Washington University (WUSTL); California Pacific Medical Center	Whooley, MA (corresponding author), 4150 Clement St 111A1, San Francisco, CA 94121 USA.	mary.whooley@ucsf.edu	de Jonge, peter/L-6395-2013	de Jonge, peter/0000-0002-0866-6929; Otte, Christian/0000-0002-4051-997X	VA Epidemiology (Merit Review) Program; VA Health Research and Development Service Career Development Program; National Heart, Lung, and Blood Institute [R01 HL079235]; American Federation for Aging Research (Paul Beeson Scholars Program); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program); Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	VA Epidemiology (Merit Review) Program(US Department of Veterans Affairs); VA Health Research and Development Service Career Development Program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Federation for Aging Research (Paul Beeson Scholars Program); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program)(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the VA Epidemiology (Merit Review) Program; the VA Health Research and Development Service Career Development Program; the National Heart, Lung, and Blood Institute (R01 HL079235); the American Federation for Aging Research (Paul Beeson Scholars Program); the Robert Wood Johnson Foundation ( Generalist Physician Faculty Scholars Program); the Ischemia Research and Education Foundation; and the Nancy Kirwan Heart Research Fund.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Abramson J, 2001, ARCH INTERN MED, V161, P1725, DOI 10.1001/archinte.161.14.1725; Ades PA, 2002, AM HEART J, V143, P151, DOI 10.1067/mhj.2002.119379; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALI S, IN PRESS PSYCHOTHER; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; BLOUIN AG, 1988, PSYCHIAT RES, V23, P335, DOI 10.1016/0165-1781(88)90024-8; Blumberg EJ, 2005, J CLIN EPIDEMIOL, V58, P645, DOI 10.1016/j.jclinepi.2004.11.022; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, CLIN TRIALS, V4, P548, DOI 10.1177/1740774507083388; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464; Bowles HR, 2004, AM J EPIDEMIOL, V160, P279, DOI 10.1093/aje/kwh209; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Carney RM, 2004, PSYCHOSOM MED, V66, P466, DOI 10.1097/01.psy.0000133362.75075.a6; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Craft LL, 1998, J SPORT EXERCISE PSY, V20, P339, DOI 10.1123/jsep.20.4.339; de Jonge P, 2007, AM J PSYCHIAT, V164, P1371, DOI 10.1176/appi.ajp.2007.06091492; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GREIST JH, 1987, HOSP COMMUNITY PSYCH, V38, P1304; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackson AW, 2007, RES Q EXERCISE SPORT, V78, P24; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kaleta Dorota, 2004, Int J Occup Med Environ Health, V17, P457; KNAPIK J, 1993, AM J PREV MED, V9, P203, DOI 10.1016/S0749-3797(18)30716-5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lett H, 2008, PSYCHOSOM MED, V70, P444, DOI 10.1097/PSY.0b013e31816c3c5c; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MATSUI D, 1994, J CLIN PHARMACOL, V34, P944, DOI 10.1002/j.1552-4604.1994.tb04009.x; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Otte C, 2005, AM J PSYCHIAT, V162, P2139, DOI 10.1176/appi.ajp.162.11.2139; Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biopsych.2004.06.003; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Ren XS, 2007, AM J CARDIOL, V99, P1643, DOI 10.1016/j.amjcard.2007.01.041; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Ruo B, 2004, AM J CARDIOL, V94, P96, DOI 10.1016/j.amjcard.2004.03.035; Schins A, 2004, LIFE SCI, V76, P637, DOI 10.1016/j.lfs.2004.04.060; Schmoor C, 2000, STAT MED, V19, P441, DOI 10.1002/(SICI)1097-0258(20000229)19:4<441::AID-SIM349>3.0.CO;2-N; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Vaccarino V, 2001, J AM COLL CARDIOL, V38, P199, DOI 10.1016/S0735-1097(01)01334-1; Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wellenius GA, 2008, CIRCULATION, V117, P2313, DOI 10.1161/CIRCULATIONAHA.107.741058; WHO, 2007, WORLD HLTH STAT; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	80	569	584	5	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2379	2388		10.1001/jama.2008.711	http://dx.doi.org/10.1001/jama.2008.711			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375YX	19033588	Green Accepted			2022-12-24	WOS:000261150800020
J	Goodarzi, MO; Psaty, BM				Goodarzi, Mark O.; Psaty, Bruce M.			Glucose Lowering to Control Macrovascular Disease in Type 2 Diabetes Treating the Wrong Surrogate End Point?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BLOOD-GLUCOSE; INSULIN; HYPERINSULINEMIA; EVENTS; TRIAL; RISK		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Inst Med Genet, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu	Goodarzi, Mark/AAH-7106-2021	Goodarzi, Mark/0000-0001-6364-5103	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL085251, R01HL080295, U01HL080295, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL085251, HL080295, HL74745, HL087652] Funding Source: Medline; NIDDK NIH HHS [DK079888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Dandona P, 2004, METAB SYNDR RELAT D, V2, P137, DOI 10.1089/met.2004.2.137; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goalstone ML, 1998, ENDOCRINOLOGY, V139, P4067, DOI 10.1210/en.139.10.4067; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; HOLMAN RR, 10 YEAR FOLLOW UP IN; Kronmal RA, 2004, J CLIN ENDOCR METAB, V89, P2852, DOI 10.1210/jc.2003-031822; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Port SC, 2006, AM J EPIDEMIOL, V163, P342, DOI 10.1093/aje/kwj027; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	15	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2051	2053		10.1001/jama.2008.510	http://dx.doi.org/10.1001/jama.2008.510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984894				2022-12-24	WOS:000260605400028
J	Kelleher, RJ; Bear, MF				Kelleher, Raymond J., III; Bear, Mark F.			The Autistic Neuron: Troubled Translation?	CELL			English	Article							LONG-TERM DEPRESSION; FRAGILE-X-SYNDROME; OCULAR DOMINANCE PLASTICITY; DENDRITIC PROTEIN-SYNTHESIS; MAMMALIAN-CELL SIZE; SYNAPTIC PLASTICITY; MOUSE MODEL; TUBEROUS-SCLEROSIS; MENTAL-RETARDATION; SPECTRUM DISORDERS	Autism is a complex genetic disorder, but single-gene disorders with a high prevalence of autism offer insight into its pathogenesis. Recent evidence suggests that some molecular defects in autism may interfere with the mechanisms of synaptic protein synthesis. We propose that aberrant synaptic protein synthesis may represent one possible pathway leading to autistic phenotypes, including cognitive impairment and savant abilities.	[Kelleher, Raymond J., III] Harvard Univ, Sch Med, Harvard Partners Ctr, Ctr Human Genet Res, Boston, MA 02115 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Program Neurosci,Autism Consortium, Boston, MA 02115 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Bear, Mark F.] Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Bear, Mark F.] MIT, Autism Consortium, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Northwell Health; Massachusetts Institute of Technology (MIT)	Kelleher, RJ (corresponding author), Harvard Univ, Sch Med, Harvard Partners Ctr, Ctr Human Genet Res, Boston, MA 02115 USA.	kelleher@helix.mgh.harvard.edu; mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dasgupta B, 2003, CURR OPIN GENET DEV, V13, P20, DOI 10.1016/S0959-437X(02)00015-1; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Heaton P, 2004, J CHILD PSYCHOL PSYC, V45, P899, DOI 10.1111/j.1469-7610.2004.t01-1-00284.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kanner L, 1943, NERV CHILD, V2, P217; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Maffei L, 2002, NEURON, V34, P328, DOI 10.1016/S0896-6273(02)00688-8; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zho WM, 2002, J NEUROSCI, V22, P8838; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	60	419	433	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					401	406		10.1016/j.cell.2008.10.017	http://dx.doi.org/10.1016/j.cell.2008.10.017			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984149	Bronze			2022-12-24	WOS:000260536300008
J	Hyder, AA; Peden, M; Krug, E				Hyder, Adnan A.; Peden, Margie; Krug, Etienne			Child health must include injury prevention	LANCET			English	Editorial Material									[Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Dept Int Hlth, Baltimore, MD 21205 USA; [Peden, Margie; Krug, Etienne] WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Hyder, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Dept Int Hlth, Baltimore, MD 21205 USA.	ahyder@jhsph.edu	Hyder, Adnan/AAT-9503-2021	Mary, Margaret/0000-0003-0872-9851; Hyder, Adnan/0000-0002-7292-577X				[Anonymous], WORLD HLTH REP 2002; Branche C., 2008, WORLD REPORT CHILD I; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; Lopez A, 2008, LANCET, V372, P1525, DOI 10.1016/S0140-6736(08)61632-3; Peden M., 2004, WORLD REPORT ROAD TR; Peden M, 2002, INJURY CHART BOOK GR; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; [No title captured]	8	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					102	103		10.1016/S0140-6736(08)61736-5	http://dx.doi.org/10.1016/S0140-6736(08)61736-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19081617				2022-12-24	WOS:000262340900007
J	Macchiarini, P; Jungebluth, P; Go, T; Asnaghi, MA; Rees, LE; Cogan, TA; Dodson, A; Martorell, J; Bellini, S; Parnigotto, PP; Dickinson, SC; Hollander, AP; Mantero, S; Conconi, MT; Birchall, MA				Macchiarini, Paolo; Jungebluth, Philipp; Go, Tetsuhiko; Asnaghi, M. Adelaide; Rees, Louisa E.; Cogan, Tristan A.; Dodson, Amanda; Martorell, Jaume; Bellini, Silvia; Parnigotto, Pier Paolo; Dickinson, Sally C.; Hollander, Anthony P.; Mantero, Sara; Conconi, Maria Teresa; Birchall, Martin A.			Clinical transplantation of a tissue-engineered airway	LANCET			English	Article							ACELLULAR MATRIX; IN-VITRO; PROSPECTIVE TRIAL; EPITHELIAL-CELLS; HLA ANTIBODIES; CHONDROCYTES; REPLACEMENT; IMPLANTS; ADHESION; IMPROVES	Background The loss of a normal airway is devastating. Attempts to replace large airways have met with serious problems. Prerequisites for a tissue-engineered replacement are a suitable matrix, cells, ideal-mechanical properties, and the absence of antigenicity. We aimed to bicengineer tubular tracheal matrices, using a tissue-engineering protocol, and to assess the application of this technology in a patient with-end-stage airway disease. Methods We removed cells and MHC antigens from a human donor trachea, which was then readily colonised by epithelia] cells and mesenchymal stem-cell.derived chondrocytes that had been cultured from cells taken from the recipient (a 30-year old woman with end-stage bronchomalacia). This graft was then used to replace the recipient's left main bronchus. Findings The graft immediately provided the recipient with a functional airway, improved her quality of life, and had a normal appearance and mechanical properties at 4 months. The patient had no anti-donor antibodies and was not on immunosuppressive drugs. Interpretation The results show that we can produce a cellular, tissue-engineered airway with mechanical properties that allow normal functioning, and which is free from the risks of rejection. The findings suggest that autologous cells combined with appropriate biomaterials might provide successful treatment for patients with serious clinical disorders. Funding Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Spain; Charles Courtenay-Cowlin Fund, University of Bristol; UK Arthritis Research Campaign; and the James Tudor Foundation.	[Macchiarini, Paolo; Jungebluth, Philipp; Go, Tetsuhiko; Martorell, Jaume] Univ Barcelona, Hosp Clin Barcelona, Dept Gen Thorac Surg, E-08036 Barcelona, Spain; [Macchiarini, Paolo] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fdn Clin, Barcelona, Spain; [Macchiarini, Paolo] Univ Barcelona, CIBER Enfermedades Resp, Barcelona, Spain; [Asnaghi, M. Adelaide; Mantero, Sara] Politecn Milan, I-20133 Milan, Italy; [Bellini, Silvia; Parnigotto, Pier Paolo; Conconi, Maria Teresa] Univ Padua, Padua, Italy; [Cogan, Tristan A.; Dickinson, Sally C.; Hollander, Anthony P.] Univ Bristol, Dept Cellular & Mol Med, Bristol, Avon, England; [Rees, Louisa E.; Dodson, Amanda; Birchall, Martin A.] Univ Bristol, Fac Clin Med & Dent, Bristol, Avon, England	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Polytechnic University of Milan; University of Padua; University of Bristol; University of Bristol	Macchiarini, P (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Dept Gen Thorac Surg, C Villarroel 170, E-08036 Barcelona, Spain.	pmacchiarini@ub.edu	Mantero, Sara/F-6587-2013; Macchiarini, Paolo/E-6878-2013	MANTERO, SARA/0000-0002-1264-0465; Asnaghi, Maria Adelaide/0000-0002-4261-3767	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (PI050987), Spain; Charles Courtenay-Cowlin Fund; University of Bristol, UK; UK Arthritis Research Campaign; James Tudor Foundation	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (PI050987), Spain(Instituto de Salud Carlos III); Charles Courtenay-Cowlin Fund; University of Bristol, UK; UK Arthritis Research Campaign(Versus Arthritis); James Tudor Foundation	This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (PI050987), Spain, and the Charles Courtenay-Cowlin Fund, University of Bristol, UK. APH is funded in part by an endowed chair from the UK Arthritis Research Campaign. SCD is funded by a Research Fellowship from the James Tudor Foundation. We thank Laura Morte for her excellent organisation and trouble-shooting; Victor Peinado, and others in his team, for their superb assistance, to whom we are indebted; John Armitage of the Human Tissue Working Group and the Research Enterprise Development team, including Christine Nileshwar, Sean Jauss, Ginny Hope, and Birgit Whitman at the University of Bristol for providing exceptional support and advice on this project; and all the medical and nurse staff at the Institute Clinic of Thorax and Transplant Foundation Services of the Hospital Clinic of Barcelona, without whom accomplishment of this success would have been impossible. None of the authors have any financial interest in the present work.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Birchall M, 2008, TRANSPLANTATION, V85, P1075, DOI 10.1097/TP.0b013e31816a10e4; Burra P, 2004, INT J MOL MED, V14, P511; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Conconi MT, 2009, J BIOMED MATER RES A, V89A, P304, DOI 10.1002/jbm.a.31982; Conconi MT, 2005, TRANSPLANT INT, V18, P727, DOI 10.1111/j.1432-2277.2005.00082.x; Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035; Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; JUNGEBLUTH P, J THORAC CA IN PRESS; Kafienah W, 2007, STEM CELLS, V25, P2460, DOI 10.1634/stemcells.2007-0059; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P638, DOI 10.1016/j.jtcvs.2004.02.042; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P14, DOI 10.1016/j.jtcvs.2003.11.069; Macchiarini P, 2006, ANN THORAC SURG, V82, P1989, DOI 10.1016/j.athoracsur.2006.07.016; Marzaro M, 2002, INT J MOL MED, V10, P177; Marzaro M, 2006, J BIOMED MATER RES A, V77A, P795, DOI 10.1002/jbm.a.30666; Parnigotto PP, 2000, J PEDIATR SURG, V35, P1304, DOI 10.1053/jpsu.2000.9309; Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020; Rees LE, 2003, CLIN EXP IMMUNOL, V134, P497, DOI 10.1111/j.1365-2249.2003.02301.x; Rees LEN, 2006, MOL IMMUNOL, V43, P725, DOI 10.1016/j.molimm.2005.03.017; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Sato T, 2008, ANN THORAC SURG, V86, P422, DOI 10.1016/j.athoracsur.2008.04.015; Shaari CM, 1998, HEAD NECK-J SCI SPEC, V20, P522, DOI 10.1002/(SICI)1097-0347(199809)20:6<522::AID-HED6>3.0.CO;2-O; Terasaki PI, 2005, TRANSPLANTATION, V80, P1194, DOI 10.1097/01.tp.0000174338.97313.5a; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Zani BG, 2008, P NATL ACAD SCI USA, V105, P7046, DOI 10.1073/pnas.0802463105	27	1059	1158	3	241	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2023	2030		10.1016/S0140-6736(08)61598-6	http://dx.doi.org/10.1016/S0140-6736(08)61598-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19022496				2022-12-24	WOS:000261746900023
J	Zender, L; Xue, W; Zuber, J; Semighini, CP; Krasnitz, A; Ma, B; Zender, P; Kubicka, S; Luk, JM; Schirmacher, P; McCombie, WR; Wigler, M; Hicks, J; Hannon, GJ; Powers, S; Lowe, SW				Zender, Lars; Xue, Wen; Zuber, Johannes; Semighini, Camile P.; Krasnitz, Alexander; Ma, Beicong; Zender, Peggy; Kubicka, Stefan; Luk, John M.; Schirmacher, Peter; McCombie, W. Richard; Wigler, Michael; Hicks, James; Hannon, Gregory J.; Powers, Scott; Lowe, Scott W.			An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer	CELL			English	Article							HEPATOCELLULAR-CARCINOMA; NUCLEAR EXPORT; OVARIAN-CANCER; BREAST-CANCER; GENOME; MECHANISM; PATHWAY; CELLS; EXPRESSION; INHIBITORS	Cancers are highly heterogeneous and contain many passenger and driver mutations. To functionally identify tumor suppressor genes relevant to human cancer, we compiled pools of short hairpin RNAs (shRNAs) targeting the mouse orthologs of genes recurrently deleted in a series of human hepatocellular carcinomas and tested their ability to promote tumorigenesis in a mosaic mouse model. In contrast to randomly selected shRNA pools, many deletion-specific pools accelerated hepatocarcinogenesis in mice. Through further analysis, we identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encodes a nuclear export protein whose substrate, EIF5A2, is amplified in human tumors, is required for proliferation of XPO4-deficient tumor cells, and promotes hepatocellular carcinoma in mice. Our results establish the feasibility of in vivo RNAi screens and illustrate how combining cancer genomics, RNA interference, and mosaic mouse models can facilitate the functional annotation of the cancer genome.	[Zender, Lars; Xue, Wen; Zuber, Johannes; Semighini, Camile P.; Krasnitz, Alexander; Ma, Beicong; Zender, Peggy; McCombie, W. Richard; Wigler, Michael; Hicks, James; Hannon, Gregory J.; Powers, Scott; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Kubicka, Stefan] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany; [Luk, John M.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Hannover Medical School; University of Hong Kong; Ruprecht Karls University Heidelberg	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Zuber, Johannes/E-7517-2011; Luk, John/A-4085-2008	Zuber, Johannes/0000-0001-8810-6835; Luk, John/0000-0002-6323-7940; Wigler, Michael/0000-0003-4396-1971; Powers, Scott/0000-0003-2769-1932; McCombie, W. Richard/0000-0003-1899-0682	Don Monti Memorial Research Foundations; Rebirth Excellence Cluster; Leukemia and Lymphoma Society; National Institutes of Health [CA13106, CA87497, CA105388]; NATIONAL CANCER INSTITUTE [U01CA105388, P01CA087497, P01CA013106, P30CA008748] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundations; Rebirth Excellence Cluster; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ken Nguyen, Stephanie Muller, Kristin Diggins-Lehet, and Lisa Bianco and her team for excellent technical assistance and Ravi Sachidanandam for assistance with computational analyses. We acknowledge members of the Lowe lab for constructive criticism and discussions throughout the course of this work. This work was supported by gifts from the Alan and Edith Seligson and the Don Monti Memorial Research Foundations, grants from the German Research foundation (Emmy Noether Program), the Rebirth Excellence Cluster, the Leukemia and Lymphoma Society (C. P. S.), and grants CA13106, CA87497, and CA105388 from the National Institutes of Health. W. X. is in the Molecular and Cellular Biology graduate program at Stony Brook University. G. J. H. and S. W. L. are Howard Hughes Medical Institute investigators.	BENNE R, 1978, J BIOL CHEM, V253, P3078; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Clement PMJ, 2006, FEBS J, V273, P1102, DOI 10.1111/j.1742-4658.2006.05135.x; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Guan XY, 2001, CANCER RES, V61, P3806; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Lee JS, 2006, ONCOGENE, V25, P3801, DOI 10.1038/sj.onc.1209561; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; PARK MH, 1994, J BIOL CHEM, V269, P27827; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; VONLINDERN M, 1992, BAILLIERE CLIN HAEM, V5, P857, DOI 10.1016/S0950-3536(11)80049-1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	41	357	365	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					852	864		10.1016/j.cell.2008.09.061	http://dx.doi.org/10.1016/j.cell.2008.09.061			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19012953	Green Accepted, Bronze			2022-12-24	WOS:000261183900017
J	Boys, C; Cunningham, C; McKenna, D; Robertson, P; Weeks, DJ; Wishart, J				Boys, Carol; Cunningham, Cliff; McKenna, Down; Robertson, Penny; Weeks, Daniel J.; Wishart, Jennifer			Prenatal screening for Down's syndrome: editorial responsibilities	LANCET			English	Editorial Material							AMNIOCENTESIS		[Wishart, Jennifer] Univ Edinburgh, Moray House Sch Educ, Edinburgh EH8 8AQ, Midlothian, Scotland; [Boys, Carol] Downs Syndrome Assoc, Teddington, Middx, England; [Cunningham, Cliff] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [McKenna, Down] Down Syndrome Res Fdn, Vancouver, BC, Canada; [Robertson, Penny] Down Syndrome Int, Jakarta, Indonesia; [Weeks, Daniel J.] Simon Fraser Univ, Dept Psychol, Vancouver, BC, Canada	University of Edinburgh; Liverpool John Moores University; Simon Fraser University	Wishart, J (corresponding author), Univ Edinburgh, Moray House Sch Educ, Edinburgh EH8 8AQ, Midlothian, Scotland.	J.Wishart@ed.ac.uk						[Anonymous], 2007, OBSTET GYNECOL, V110, P1459; BUCKLEY F, 2008, DSRP SCREENING EDITO; Buckley Frank, 2008, Downs Syndr Res Pract, V12, P79, DOI 10.3104/editorials.2087; BUCKLEY S, 2008, PRENATAL SCREENING C; CANADY RL, 1989, FOCUS CHANGE, V1, P1; Caughey AB, 2006, OBSTET GYNECOL, V108, P612, DOI 10.1097/01.AOG.0000232512.46869.fc; *DOWN SYNDR ED INT, 2008, MOR PEOPL DOWN SYNDR; Evans MI, 2008, CURR OPIN OBSTET GYN, V20, P164, DOI 10.1097/GCO.0b013e3282f7321f; FAN HC, 2008, P NATL ACAD SCI 1016; Morris K, 2008, LANCET, V372, P791, DOI 10.1016/S0140-6736(08)61321-5; *NAT DOWN SYNDR CY, 2008, NAT DOWN SYNDR CYT R; Odibo AO, 2008, OBSTET GYNECOL, V111, P589, DOI 10.1097/AOG.0b013e318162eb53; Smith-Bindman R, 2003, AM J OBSTET GYNECOL, V189, P980, DOI 10.1067/S0002-9378(03)00721-X; TABOR A, 1986, LANCET, V1, P1287	14	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1789	1791		10.1016/S0140-6736(08)61742-0	http://dx.doi.org/10.1016/S0140-6736(08)61742-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027473	Green Submitted			2022-12-24	WOS:000261112000007
J	Ro, KEI; Gude, T; Tyssen, R; Aasland, OG				Ro, Karin E. Isaksson; Gude, Tore; Tyssen, Reidar; Aasland, Olaf G.			Counselling for burnout in Norwegian doctors: one year cohort study	BRITISH MEDICAL JOURNAL			English	Article							MENTAL-HEALTH PROBLEMS; JUNIOR HOUSE OFFICERS; JOB STRESS; EMOTIONAL DISTRESS; NATIONWIDE SAMPLE; YOUNG PHYSICIANS; MEDICAL-STUDENTS; SUICIDE RATES; PATIENT-CARE; RESIDENTS	Objective To investigate levels and predictors of change in dimensions of burnout after an intervention for stressed doctors. Design Cohort study followed by self reported assessment at one year. Setting Norwegian resource centre. Participants 227 doctors participating in counselling intervention, 2003- 5. Interventions Counselling ( lasting one day ( individual) or one week ( group based)) aimed at motivating reflection on and acknowledgement of the doctors' situation and personal needs. Main outcome measures Levels of burnout ( Maslach burnout inventory) and predictors of reduction in emotional exhaustion investigated by linear regression. Results 185 doctors ( 81%, 88 men, 97 women) completed one year follow- up. The mean level of emotional exhaustion ( scale 1- 5) was significantly reduced from 3.00 ( SD 0.94) to 2.53 ( SD 0.76) ( t= 6.76, P< 0.001), similar to the level found in a representative sample of 390 Norwegian doctors. Participants had reduced their working hours by 1.6 hours/ week ( SD 11.4). There was a considerable reduction in the proportion of doctors on full time sick leave, from 35% ( 63/ 182) at baseline to 6% ( 10/ 182) at follow- up and a parallel increase in the proportion who had undergone psychotherapy, from 20% ( 36/ 182) to 53% ( 97/ 182). In the whole cohort, reduction in emotional exhaustion was independently associated with reduced number of work hours/ week ( beta= 0.17, P= 0.03), adjusted for sex, age, and personality dimensions. Among men "satisfaction with the intervention" ( beta= 0.25, P= 0.04) independently predicted reduction in emotional exhaustion. Conclusions A short term counselling intervention could contribute to reduction in emotional exhaustion in doctors. This was associated with reduced working hours for the whole cohort and, in men, was predicted by satisfaction with the intervention.	[Ro, Karin E. Isaksson; Gude, Tore] Res Inst, NO-3370 Vikersund, Norway; [Ro, Karin E. Isaksson; Gude, Tore; Tyssen, Reidar] Univ Oslo, Dept Behav Sci Med, Inst Basic Med Sci, Fac Med, NO-0317 Oslo, Norway; [Aasland, Olaf G.] Norwegian Med Assoc, Res Inst, NO-0107 Oslo, Norway; [Aasland, Olaf G.] Univ Oslo, Inst Hlth Management & Hlth Econ, Oslo, Norway	University of Oslo; University of Oslo	Ro, KEI (corresponding author), Res Inst, NO-3370 Vikersund, Norway.	karin.roe@modum-bad.no						Aasland O G, 1994, Tidsskr Nor Laegeforen, V114, P3052; Barnett R C, 1999, J Occup Health Psychol, V4, P307, DOI 10.1037/1076-8998.4.4.307; Barnett R. C., 1999, J APPL BIOBEHAVIORAL, V4, P65, DOI DOI 10.1111/JABR.1999.4.ISSUE-2; Barrack RL, 2006, CLIN ORTHOP RELAT R, P134, DOI 10.1097/01.blo.0000224030.78108.58; Cohen D, 2005, MED EDUC, V39, P476, DOI 10.1111/j.1365-2929.2005.02122.x; COOPER CL, 1989, BRIT MED J, V298, P366, DOI 10.1136/bmj.298.6670.366; DEPUE RA, 1986, PSYCHOL BULL, V99, P36, DOI 10.1037/0033-2909.99.1.36; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; ELLIS JJ, 1988, AM J PSYCHOTHER, V42, P380, DOI 10.1176/appi.psychotherapy.1988.42.3.380; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Falkum E, 2000, Tidsskr Nor Laegeforen, V120, P1122; FALKUM E, 2001, EVALUERING VIRKSOMHE; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; FIRTHCOZENS J, 1997, DEPRESSION PHYSICAL, P95; FRANCIS LJ, 1992, PERS INDIV DIFFER, V13, P443, DOI 10.1016/0191-8869(92)90073-X; Garelick AI, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-26; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; HALL JA, 1988, SOC SCI MED, V27, P935, DOI 10.1016/0277-9536(88)90284-5; Hargreave Marie, 2007, Ugeskr Laeger, V169, P2418; Hem E, 2005, PSYCHOL MED, V35, P873, DOI 10.1017/S0033291704003344; Hem E, 2000, EUR PSYCHIAT, V15, P183, DOI 10.1016/S0924-9338(00)00227-3; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Holt J, 2006, HEALTH EDUC RES, V21, P501, DOI 10.1093/her/cyh076; HSU K, 1987, AM J PSYCHIAT, V144, P1561; KING MB, 1992, J ROY SOC MED, V85, P605; Kivimaki M, 2001, OCCUP ENVIRON MED, V58, P361, DOI 10.1136/oem.58.6.361; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; MCCRANIE EW, 1988, BEHAV MED, V14, P30, DOI 10.1080/08964289.1988.9935120; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Pitt E, 2004, ACAD MED, V79, P840, DOI 10.1097/00001888-200409000-00005; Ro KEI, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-36; Rosvold EO, 2002, SCAND J PUBLIC HEALT, V30, P125, DOI 10.1080/14034940210133744; Rovik JO, 2007, IND HEALTH, V45, P662, DOI 10.2486/indhealth.45.662; Schattner P, 2004, MED J AUSTRALIA, V181, P348, DOI 10.5694/j.1326-5377.2004.tb06321.x; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Silvester S, 1994, PROVISION MED SERVIC; SIVERTZ K, 1998, B C MED J, V40, P156; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Taub S, 2006, OCCUP MED-OXFORD, V56, P77, DOI 10.1093/occmed/kqj025; Tyssen R, 2004, SOC PSYCH PSYCH EPID, V39, P989, DOI 10.1007/s00127-004-0831-8; Tyssen R, 2000, MED EDUC, V34, P374, DOI 10.1046/j.1365-2923.2000.00540.x; Tyssen R, 1998, ADDICTION, V93, P1341, DOI 10.1046/j.1360-0443.1998.93913415.x; Tyssen R, 2007, IND HEALTH, V45, P599, DOI 10.2486/indhealth.45.599; Tyssen R, 2007, MED EDUC, V41, P781, DOI 10.1111/j.1365-2923.2007.02802.x; Vaglum P, 1999, J AFFECT DISORDERS, V52, P153, DOI 10.1016/S0165-0327(98)00081-0; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071	52	68	67	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2008	337								a2004	10.1136/bmj.a2004	http://dx.doi.org/10.1136/bmj.a2004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	385AA	19001492	hybrid, Green Published			2022-12-24	WOS:000261784100001
J	Yen, HCS; Elledge, SJ				Yen, Hsueh-Chi Sherry; Elledge, Stephen J.			Identification of SCF Ubiquitin Ligase Substrates by Global Protein Stability Profiling	SCIENCE			English	Article							F-BOX PROTEINS; HISTONE MESSENGER-RNA; KAPPA-B-ALPHA; BETA-CATENIN; CYCLIN-E; S-PHASE; DEGRADATION; PATHWAY; COMPLEX; REVEALS	Ubiquitin- mediated proteolysis regulates all aspects of cellular function, and defects in this process are associated with human diseases. The limited number of identified ubiquitin ligase- substrate pairs is a major bottleneck in the ubiquitin field. We established and applied genetic technologies that combine global protein stability ( GPS) profiling and genetic perturbation of E3 activity to screen for substrates of the Skp1- cullin- F- box ( SCF) ubiquitin ligase in mammalian cells. Among the > 350 potential substrates identified, we found most known SCF targets and many previously unknown substrates involved in cell cycle, apoptosis, and signaling pathways. Exploring cell cycle- stage stability, we found that several substrates used the SCF and other E3s in different cell cycle stages. Our results demonstrate the potential of these technologies as general platforms for the global discovery of E3- substrate regulatory networks.	[Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	Jane Coffin Childs Memorial Fund; NIH [AG 11085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Vidal, J. W. Harper. J. Jin, and G. Hu for the hORFeome v1.1 library; J. W. Harper for the DNCul1/pcDNA3 construct; D. M. Chou for experimental assistance and discussion; Q. Xu for bioinformatics analysis; M. Schlabach for microarray assistance; J. Daly and S. Lazo-Kallanian for their help with cytometry; and K. Hurov for suggestions. H.-C.S.Y. is a fellow of Jane Coffin Childs Memorial Fund. This work was funded by an NIH grant AG 11085 to J.W. Harper and S.J.E. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2003, CANCER TREAT REV, V29, P49, DOI 10.1016/S0305-7372(03)00083-5; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Pfleger CM, 2000, GENE DEV, V14, P655; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Schwartz AL, 1999, ANNU REV MED, V50, P57; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tago K, 2000, GENE DEV, V14, P1741; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	37	148	149	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					923	929		10.1126/science.1160462	http://dx.doi.org/10.1126/science.1160462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988848				2022-12-24	WOS:000260674100041
J	Ceesay, SJ; Casals-Pascual, C; Erskine, J; Anya, SE; Duah, NO; Fulford, AJC; Sesay, SSS; Abubakar, I; Dunyo, S; Sey, O; Palmer, A; Fofana, M; Corrah, T; Bojang, KA; Whittle, HC; Greenwood, BM; Conway, DJ				Ceesay, Serign J.; Casals-Pascual, Climent; Erskine, Jamie; Anya, Samuel E.; Duah, Nancy O.; Fulford, Anthony J. C.; Sesay, Sanie S. S.; Abubakar, Ismaela; Dunyo, Samuel; Sey, Omar; Palmer, Ayo; Fofana, Malang; Corrah, Tumani; Bojang, Kalifa A.; Whittle, Hilton C.; Greenwood, Brian M.; Conway, David J.			Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis	LANCET			English	Article							TREATED BED NETS; MOSQUITO NETS; RURAL AREA; FOLLOW-UP; MORTALITY; CHILDREN; MORBIDITY; AFRICA; TRIAL; RISK	Background Malaria is a major cause of morbidity and mortality in Africa. International effort and funding for control has been stepped up, with substantial increases from 2003 in the delivery of malaria interventions to pregnant women and children younger than 5 years in The Gambia. We investigated the changes in malaria indices in this country, and the causes and public-health significance of these changes. Methods We undertook a retrospective analysis of original records to establish numbers and proportions of malaria inpatients, deaths, and blood-slide examinations at one hospital over 9 years (January, 1999-December, 2007), and at four health facilities in three different administrative regions over 7 years (January, 2001-December, 2007). We obtained additional data from single sites for haernoglobin concentrations in paediatric admissions and for age distribution of malaria admissions. Findings From 2003 to 2007, at four sites with complete slide examination records, the proportions of malaria-positive slides decreased by 82% (3397/10861 in 2003 to 337/6142 in 2007), 85% (137/1259 to 6/368), 73% (3664/16932 to 666/11333), and 50% (1206/3304 to 336/1853). At three sites with complete admission records, the proportions of malaria admissions fell by 74% (435/2530 to 69/1531), 69% (797/2824 to 89/1032), and 27% (2204/4056 to 496/1251.). Proportions of deaths attributed to malaria in two hospitals decreased by 100% (seven of 115 in 2003 to none of 117 in 2007) and 90% (22/122 in 2003 to one of 58 in 2007). Since 2004, mean haemoglobin concentrations for all-cause admissions increased by 12 g/L (85 g/L in 2000-04 to 97 g/L in 2005-07), and mean age of paediatric malaria admissions increased from 3.9 years (95% CI 3.7-4 . 0) to 5.6 years (5.0-6.2). Interpretation A large proportion of the malaria burden has been alleviated in The Gambia. Our results encourage consideration of a policy to eliminate malaria as a public-health problem, while emphasising the importance of accurate and continuous surveillance. Funding UK Medical Research Council,	[Ceesay, Serign J.; Casals-Pascual, Climent; Duah, Nancy O.; Fulford, Anthony J. C.; Sesay, Sanie S. S.; Abubakar, Ismaela; Dunyo, Samuel; Corrah, Tumani; Bojang, Kalifa A.; Whittle, Hilton C.; Conway, David J.] MRC Labs, Banjul, Gambia; [Erskine, Jamie] WEC Mission Hosp, Sibanor, Western Region, Gambia; [Anya, Samuel E.] Univ Gambia, Sch Med & Allied Hlth Sci, Kanifing, Gambia; [Anya, Samuel E.; Palmer, Ayo] CIAM Publ Hlth Res & Dev Ctr, Kanifing, Gambia; [Fulford, Anthony J. C.; Greenwood, Brian M.; Conway, David J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Sey, Omar] AFPRC Farafenni Hosp, N Bank Region, Gambia; [Fofana, Malang] NMCP, Banjul, Gambia	MRC Laboratory Molecular Biology; University of the Gambia; University of London; London School of Hygiene & Tropical Medicine	Conway, DJ (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	dconway@mrc.gm	Casals-Pascual, Climent/N-7692-2018; Sesay, Sanie Samuel Sogoyan/M-2982-2014	Casals-Pascual, Climent/0000-0002-0867-8954; Sesay, Sanie Samuel Sogoyan/0000-0001-6233-7854; Bojang, Kalifa/0000-0001-7506-0938; Conway, David/0000-0002-8711-3037; Duah-Quashie, Nancy/0000-0001-8819-1793	UK Medical Research Council; Medical Research Council [MC_U190074193] Funding Source: researchfish; MRC [MC_U190074193] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support for the research was provided by the UK Medical Research Council (MRC). We thank Jula Jaiteh. and Lamin Sanyang (Senior Nursing Officers at Government health facilities) for providing hospital records and helping to extract data; Gibril Bah, Lamin Manneh, Bernard Ndaye, Lamin Gibba. Fabakary Sanyang, Hawa Manneh. Demba B T Sainbou, and Yorro Bah (MRC staff) for data extraction of the haematology laboratory) and ward records: Aja Abbie Khan (Head of Regional Health Team for Western Division) for support in implementing the project at the Government health facilities: Andrew Prentice (Head of MRC Nutrition Research Programme) for supporting the Keneba laboratory record database management: Pamela Collier Njie and Muminatou Jallow for help with the provision of clinical data front the MRC ward in Fajara; and many other colleagues and partner organisations who have encouraged this work.	ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; [Anonymous], 2007, LANCET, V370, P1459; Anya SE, 2004, AM J TROP MED HYG, V70, P510, DOI 10.4269/ajtmh.2004.70.510; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Butler D, 2007, NATURE, V450, P144, DOI 10.1038/450144b; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Chambers RG, 2008, LANCET, V371, P1399, DOI 10.1016/S0140-6736(08)60609-1; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; GREENWOOD BM, 1988, LANCET, V1, P1121; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; MARSDEN P. D., 1964, TRANS ROY SOC TROP MED HYG, V58, P455, DOI 10.1016/0035-9203(64)90101-4; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; MENON A, 1990, T ROY SOC TROP MED H, V84, P638, DOI 10.1016/0035-9203(90)90130-7; *MICS, 2002, GAMB MULT IND CLUST, P1; *MICS, 2007, GAMB MULT IND CLUST, P1; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Shanks GD, 2008, LANCET INFECT DIS, V8, P564, DOI 10.1016/S1473-3099(08)70130-0; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P838, DOI 10.1016/0035-9203(88)90011-9; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *UNICEF, 2007, MAL CHILDR PROGR INT, P1; *WHO, 2008, IMP LONG LAST INS NE; Williams Christopher J, 2007, Travel Med Infect Dis, V5, P295, DOI 10.1016/j.tmaid.2007.05.001	41	307	311	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1545	1554		10.1016/S0140-6736(08)61654-2	http://dx.doi.org/10.1016/S0140-6736(08)61654-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984187	Green Published, Green Accepted			2022-12-24	WOS:000260590500026
J	Shank, SS; Margoliash, D				Shank, Sylvan S.; Margoliash, Daniel			Sleep and sensorimotor integration during early vocal learning in a songbird	NATURE			English	Article							SLOW-WAVE SLEEP; ZEBRA FINCHES; HUMAN HIPPOCAMPUS; MEMORY; SPARROWS; REPLAY; CONSOLIDATION; SEQUENCES; BIRDSONG; BEHAVIOR	Behavioural studies widely implicate sleep in memory consolidation in the learning of a broad range of behaviours(1-4). During sleep, brain regions are reactivated(5,6), and specific patterns of neural activity are replayed(7-10), consistent with patterns observed in previous waking behaviour. Birdsong learning is a paradigmatic model system for skill learning(11-14). Song development in juvenile zebra finches (Taeniopygia guttata) is characterized by sleep-dependent circadian fluctuations in singing behaviour, with immediate post-sleep deterioration in song structure followed by recovery later in the day(15). In sleeping adult birds, spontaneous bursting activity of forebrain premotor neurons in the robust nucleus of the arcopallium (RA) carries information about daytime singing(16). Here we show that, in juvenile zebra finches, playback during the day of an adult 'tutor' song induced profound and tutor-song-specific changes in bursting activity of RA neurons during the following night of sleep. The night-time neuronal changes preceded tutor-song-induced changes in singing, first observed the following day. Interruption of auditory feedback greatly reduced sleep bursting and prevented the tutor-song-specific neuronal remodelling. Thus, night-time neuronal activity is shaped by the interaction of the song model (sensory template) and auditory feedback, with changes in night-time activity preceding the onset of practice associated with vocal learning. We hypothesize that night-time bursting induces adaptive changes in premotor networks during sleep as part of vocal learning. By this hypothesis, adaptive changes driven by replay of sensory information at night and by evaluation of sensory feedback during the day interact to produce the complex circadian patterns seen early in vocal development.	[Shank, Sylvan S.; Margoliash, Daniel] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Margoliash, D (corresponding author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu			NIMH NIH HHS [R01 MH059831, R01 MH059831-09] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; Crandall SR, 2007, J NEUROPHYSIOL, V98, P232, DOI 10.1152/jn.00128.2007; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; EVARTS EV, 1962, SCIENCE, V135, P727, DOI 10.1126/science.135.3505.726; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; HULTSCH H, 1989, J COMP PHYSIOL A, V165, P197, DOI 10.1007/BF00619194; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M., 1978, PERCEPTION EXPERIENC, P105; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Pytte CL, 1999, NEUROREPORT, V10, P1773, DOI 10.1097/00001756-199906030-00027; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; ZEIGLER HP, 2004, BEHAV NEUROBIOLOGY B	34	122	123	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					73	U4		10.1038/nature07615	http://dx.doi.org/10.1038/nature07615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19079238	Green Accepted			2022-12-24	WOS:000263836000035
J	Salje, J; Zuber, B; Lowe, J				Salje, Jeanne; Zuber, Benoit; Lowe, Jan			Electron Cryomicroscopy of E-coli Reveals Filament Bundles Involved in Plasmid DNA Segregation	SCIENCE			English	Article							PROKARYOTIC ACTIN HOMOLOG; DYNAMIC INSTABILITY; PARM; R1; INCOMPATIBILITY; MECHANISM; MICROSCOPY; DRIVEN	Bipolar elongation of filaments of the bacterial actin homolog ParM drives movement of newly replicated plasmid DNA to opposite poles of a bacterial cell. We used a combination of vitreous sectioning and electron cryotomography to study this DNA partitioning system directly in native, frozen cells. The diffraction patterns from overexpressed ParM bundles in electron cryotomographic reconstructions were used to unambiguously identify ParM filaments in Escherichia coli cells. Using a low- copy number plasmid encoding components required for partitioning, we observed small bundles of three to five intracellular ParM filaments that were situated close to the edge of the nucleoid. We propose that this may indicate the capture of plasmid DNA within the periphery of this loosely defined, chromosome- containing region.	[Salje, Jeanne; Zuber, Benoit; Lowe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Salje, J (corresponding author), Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	jsalje@mrc-lmb.cam.ac.uk	Zuber, Benoît/U-1952-2019; Löwe, Jan/X-6998-2019; Löwe, Jan/B-3882-2011	Zuber, Benoît/0000-0001-7725-5579; Lowe, Jan/0000-0002-5218-6615	European Molecular Biology Organization; MRC [MC_U105184294, MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184294, MC_U105184326] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Gerdes (Newcastle, UK) and J. Moller-Jensen (Odense, Denmark) for kindly supplying plasmids and strains and W. Kuhlbrandt and D. Mills (Frankfurt, Germany) for generously allowing us the use of their microscope. J.S. is supported by MRC and Leverhulme Trust studentships, and B.Z. is supported by a European Molecular Biology Organization long-term fellowship. J.S. performed all experiments and their analysis except the initial cryo-sectioning that was done with B.Z.	Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Ebersbach G, 2005, MOL MICROBIOL, V56, P1430, DOI 10.1111/j.1365-2958.2005.04643.x; Eltsov M, 2006, J STRUCT BIOL, V156, P246, DOI 10.1016/j.jsb.2006.07.007; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; NORDSTROM K, 1980, PLASMID, V4, P332, DOI 10.1016/0147-619X(80)90071-2; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Tao WT, 2000, MOL MICROBIOL, V38, P392, DOI 10.1046/j.1365-2958.2000.02138.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	19	79	79	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					509	512		10.1126/science.1164346	http://dx.doi.org/10.1126/science.1164346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19095899				2022-12-24	WOS:000262587900044
J	Kim, JV; Kang, SS; Dustin, ML; McGavern, DB				Kim, Jiyun V.; Kang, Silvia S.; Dustin, Michael L.; McGavern, Dorian B.			Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis	NATURE			English	Article							BLOOD-BRAIN-BARRIER; MURINE LYMPHOCYTIC CHORIOMENINGITIS; CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; T-CELLS; ANTICONVULSANT PROLONGATION; CHEMOKINE RECEPTOR; HOST-DEFENSE; MICE; PERMEABILITY	Lymphocytic choriomeningitis virus(1) infection of the mouse central nervous system (CNS) elicits fatal immunopathology through blood - brain barrier breakdown(2) and convulsive seizures(3). Although lymphocytic- choriomeningitis- virus- specific cytotoxic T lymphocytes ( CTLs) are essential for disease(4), their mechanism of action is not known. To gain insights into disease pathogenesis, we observed the dynamics of immune cells in the meninges by two-photon microscopy. Here we report visualization of motile CTLs and massive secondary recruitment of pathogenic monocytes and neutrophils that were required for vascular leakage and acute lethality. CTLs expressed multiple chemoattractants capable of recruiting myelomonocytic cells. We conclude that a CD8(+) T- cell- dependent disorder can proceed in the absence of direct T- cell effector mechanisms and rely instead on CTL- recruited myelomonocytic cells.	[Kim, Jiyun V.; Dustin, Michael L.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Program Mol Pathogenesis, New York, NY 10016 USA; [Kang, Silvia S.; McGavern, Dorian B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	New York University; Scripps Research Institute	Dustin, ML (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Program Mol Pathogenesis, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu; mcgad@scripps.edu	Dustin, Michael/AAM-4611-2020; McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health [AI070967-01, AI055037, NS041219-06]; The Burroughs Wellcome Fund; Dana Foundation; National Research Service [NS061447-01]; Multiple Sclerosis Society Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055037, R21AI055037, R01AI070967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112, T32NS041219, F32NS061447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Burroughs Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; National Research Service; Multiple Sclerosis Society Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants AI070967-01 (D.B.M.), AI055037 (M.L.D.), a grant from The Burroughs Wellcome Fund (D.B.M.) and the Dana Foundation (M.L.D.). S.S.K. was supported by a National Institutes of Health training grant NS041219-06 and is presently supported by a National Research Service Award (NS061447-01), and J.V.K. is supported by a Multiple Sclerosis Society Center Grant. We thank C. Yau for technical support and the Scripps DNA Array core for their assistance with the gene array experiment.	Ancuta P, 2004, IMMUNOBIOLOGY, V209, P11, DOI 10.1016/j.imbio.2004.04.001; ANDERSEN IH, 1991, J NEUROIMMUNOL, V31, P155, DOI 10.1016/0165-5728(91)90021-X; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Bjork J, 1982, Agents Actions Suppl, V11, P63; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; CAMENGA DL, 1977, J NEUROPATH EXP NEUR, V36, P9, DOI 10.1097/00005072-197701000-00003; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; DOHERTY PC, 1990, IMMUNOL TODAY, V11, P55; Faust N, 2000, BLOOD, V96, P719; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; JOHNSON ED, 1978, CELL IMMUNOL, V36, P143, DOI 10.1016/0008-8749(78)90257-5; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kang SS, 2008, FRONT BIOSCI-LANDMRK, V13, P4529, DOI 10.2741/3021; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lauterbach H, 2006, J EXP MED, V203, P1963, DOI 10.1084/jem.20060039; LEIST TP, 1987, J IMMUNOL, V138, P2278; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; MARKER O, 1984, ACTA NEUROPATHOL, V63, P229, DOI 10.1007/BF00685249; Maus U, 2002, AM J RESP CRIT CARE, V166, P268, DOI 10.1164/rccm.2112012; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; ROSENGREN S, 1989, MICROVASC RES, V38, P243, DOI 10.1016/0026-2862(89)90003-4; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Storm P, 2006, J VIROL, V80, P1222, DOI 10.1128/JVI.80.3.1222-1230.2006; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; WALKER DH, 1977, J NEUROPATH EXP NEUR, V36, P21, DOI 10.1097/00005072-197701000-00004; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	36	248	250	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					191	U85		10.1038/nature07591	http://dx.doi.org/10.1038/nature07591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19011611	Green Accepted			2022-12-24	WOS:000262360200032
J	Noor, AM; Mutheu, JJ; Tatem, AJ; Hay, SI; Snow, RW				Noor, Abdisalan M.; Mutheu, Juliette J.; Tatem, Andrew J.; Hay, Simon I.; Snow, Robert W.			Insecticide-treated net coverage in Africa: mapping progress in 2000-07	LANCET			English	Article							MALARIA CONTROL; PLASMODIUM-FALCIPARUM; TRANSMISSION	Background Insecticide-treated bednets (ITNs) provide a means to improve child survival across Africa. Sales figures of these nets and survey coverage data presented nationally mask inequities in populations at biological and economic risk, and do not allow for precision in the estimation of unmet commodity needs. We gathered subnational ITN coverage sample survey data from 40 malaria-endemic countries in Africa between 2000 and 2007. Methods We computed the projected ITN coverage among children aged less than 5 years for age-adjusted population data that were stratified according to malaria transmission risks, proximate determinants of poverty, and methods of ITN delivery. Findings In 2000, only 1.7 million (1.8%) African children living in stable malaria-endemic conditions were protected by an ITN and the number increased to 20.3 million (18. 5%) by 2007 leaving 89.6 million children unprotected. Of these, 30 million were living in some of the poorest areas of Africa: 54% were living in only seven countries and 25% in Nigeria alone. Overall, 33 (83%) countries were estimated to have ITN coverage of less than 40% in 2007. On average, we noted a greater increase in ITN coverage in areas where free distribution had operated between survey periods. Interpretation By mapping the distribution of populations in relation to malaria risk and intervention coverage, we provide a means to track the future requirements for scaling up essential disease- prevention strategies. The present coverage of ITN in Africa remains inadequate and a focused effort to improve distribution in selected areas would have a substantial effect on the continent's malaria burden. Funding Wellcome Trust.	[Noor, Abdisalan M.; Mutheu, Juliette J.; Tatem, Andrew J.; Hay, Simon I.; Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford, England; [Tatem, Andrew J.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England	University of Oxford; University of Oxford	Noor, AM (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, POB 43640-00100, Nairobi, Kenya.	anoor@nairobi.kemri-wellcome.org	Hay, Simon Iain/F-8967-2015; Snow, Robert William/AFR-1436-2022	Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	AMN (Research Training Fellowship, 081829), SIH (Senior Research Fellowship, 079091), and RWS (Principal Researcli Fellowship, 079081) are supported by the Wellcome Trust. This work forms part of die output of the Malaria Atlas Project, mainly funded by the Wellcome Trust, UK. We thank Priscilla Gikandi and Victor Alegana for their assistance during data abstraction and digitisation ofadministrative boundaries; Alfredo Fort of Opinion Research Corporation-Macro International for his assistance in connecting the authors with national survey teams; Pete Gething and Emelda Okiro for comments on earlier versions of this report. This report is published with the permission of the Director of KEMRI.	[Anonymous], GLOB MAL ACT PLAN; [Anonymous], MAL CHILDR PROGR INT; [Anonymous], DEM HLTH SURV; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2000, GLOB PARTN ROLL BACK; *CIESIN COL U IFPR, 2007, GLOB RUR URB MAPP PR; *DMSP, NIGHTT LIGHTS WORLD; *FED MIN HLTH, 2007, SUD HOUS HLTH SURV; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; HANSON K, 2007, MONITORING EVALUATIO; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; KULKARNI M, 2008, EVALUATION APPROPRAT; Lengeler C, 2007, AM J TROP MED HYG, V77, P222, DOI 10.4269/ajtmh.2007.77.222; *MIN HLTH ANG, 2007, ANG NAT MAL IND SURV; *MIN HLTH ETH, 2008, ETH NAT MAL IND SURV; *MIN HLTH KEN, 2008, KEN NAT MAL IND SURV; *MIN HLTH MOZ, 2007, MOZ NAT MAL IND SURV; *MIN HLTH SOC WELF, 2008, ZANZ NAT MAL IND SUR; *MIN SANT, 2007, ENQ NAT PAL SEN 2006; Ministry of Health [Zambia], 2006, ZAMB NAT MAL IND SUR; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; *POP SERV INT, 2007, DET UT MOUST IMPR BU; RBM, 2005, GLOB STRAT PLAN ROLL; *RBM, 2000, WHOCDSRBM200017 RBM; *RBM MERG, COR HOUS QUEST; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 2004, NATURE, V430, P934, DOI 10.1038/430934a; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; *UNGIWG SALB, 2 ADM LEV BOUND; *UNICEF, BEDN SUPPL UPD; *UNICEF, MULT CLUST IND SURV; United Nation, 2001, ROAD MAP IMPL UN MIL; *UNPD, WORLD POP PROSP 2006; *WHO UN CHILDR FUN, 2008, WORLD MAL REP	39	147	149	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					58	67		10.1016/S0140-6736(08)61596-2	http://dx.doi.org/10.1016/S0140-6736(08)61596-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19019422	Green Accepted, Green Submitted			2022-12-24	WOS:000262183800032
J	Ballestar, E; Esteller, M				Ballestar, Esteban; Esteller, Manel			SnapShot: The Human DNA Methylome in Health and Disease	CELL			English	Editorial Material							METHYLATION; CANCER; EPIGENOMICS; CELLS		[Ballestar, Esteban; Esteller, Manel] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Ballestar, E (corresponding author), Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid 28029, Spain.		Esteller, Manel/L-5956-2014; Ballestar, Esteban/ABG-8561-2020	Esteller, Manel/0000-0003-4490-6093; Ballestar, Esteban/0000-0002-1400-2440				Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	10	6	8	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1144	U25	1144.e1	10.1016/j.cell.2008.11.040	http://dx.doi.org/10.1016/j.cell.2008.11.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070582	Bronze			2022-12-24	WOS:000261642800029
J	Hameed, S				Hameed, Salman			Science and religion Bracing for Islamic Creationism	SCIENCE			English	Editorial Material									[Hameed, Salman] Hampshire Coll, Sch Cognit Sci, Amherst, MA 01002 USA; [Hameed, Salman] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA		Hameed, S (corresponding author), Hampshire Coll, Sch Cognit Sci, Amherst, MA 01002 USA.	shameed@hampshire.edu						Asghar A., 2007, P NAT ASS RES SCI TE; Bucaille Maurice, 1989, WHAT IS ORIGIN MAN; Edis Taner, 2007, ILLUSION HARMONY SCI; Hassan R, 2007, MUSLIM WORLD, V97, P437, DOI 10.1111/j.1478-1913.2007.00190.x; IAP, 2006, IAP STAT TEACH EV; Iqbal Mohammad., 1930, RECONSTRUCTION RELIG; Iqbal Muzaffar, 2006, ISLAM SCI, V4, P89; Koning D., 2006, ISIM NEWSLETTER, V18, P48; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Nasr SeyyedHossein., 2006, ISLAM SCI, V4, P181; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; Numbers RL, 2006, CREATIONISTS SCI CRE; *PUNJ TXB BOARD, 2003, BIOLOGY, V12, P222	13	58	59	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1637	1638		10.1126/science.1163672	http://dx.doi.org/10.1126/science.1163672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	382LU	19074331				2022-12-24	WOS:000261608300025
J	Bhutta, MF				Bhutta, Mahmood F.			Fair and ethical trade in health procurement	LANCET			English	Editorial Material									[Bhutta, Mahmood F.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Bhutta, Mahmood F.] Int Grp, Med Fair & Eth Trade Grp, London WC1H 9JP, England	University of Oxford	Bhutta, MF (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.	fairtrade@bma.org.uk		Bhutta, Mahmood/0000-0002-4688-1670				Bhutta MF, 2006, BMJ-BRIT MED J, V333, P297, DOI 10.1136/bmj.38901.619074.55; BJURLING K, 2007, DARK SIDE HEALTHCARE; Fairtrade Foundation, 2008, ANN REV 2007 2008; KJELLSTROM T, 2007, SCAND J PUBLIC HEALT, V35, P2; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-6; *NHS PURCH SUPPL A, 2008, FRAM ETH PROC STRAT; *NHS SUPPL CHAIN, 2008, SUPPL COD COND; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; *STOCKH COUNT COUN, 2008, SUST PROC; [No title captured]	10	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1935	1937		10.1016/S0140-6736(08)61826-7	http://dx.doi.org/10.1016/S0140-6736(08)61826-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19059038				2022-12-24	WOS:000261471600008
J	Mathieson, PW				Mathieson, Peter W.			Proteinuria and Immunity - An Overstated Relationship?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PODOCYTES; CYTOSKELETON		[Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Mathieson, Peter W.] Southmead Hosp, Bristol, Avon, England	University of Bristol; Southmead Hospital	Mathieson, PW (corresponding author), Univ Bristol, Acad Renal Unit, Bristol, Avon, England.							Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Grimbert P, 2003, J EXP MED, V198, P797, DOI 10.1084/jem.20030566; Guigonis V, 2008, PEDIATR NEPHROL, V23, P1269, DOI 10.1007/s00467-008-0814-1; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655	5	53	60	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2492	2494		10.1056/NEJMcibr0806881	http://dx.doi.org/10.1056/NEJMcibr0806881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052132				2022-12-24	WOS:000261325900014
J	Chopra, AR; Louet, JF; Saha, P; An, J; DeMayo, F; Xu, JM; York, B; Karpen, S; Finegold, M; Moore, D; Chan, L; Newgard, CB; O'Malley, BW				Chopra, Atul R.; Louet, Jean-Francois; Saha, Pradip; An, Jie; DeMayo, Franco; Xu, Jianming; York, Brian; Karpen, Saul; Finegold, Milton; Moore, David; Chan, Lawrence; Newgard, Christopher B.; O'Malley, Bert W.			Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease	SCIENCE			English	Article							STEROID-RECEPTOR COACTIVATOR-2; STORAGE-DISEASE; LIVER-REGENERATION; MOUSE; GLUCOSE-6-PHOSPHATASE; GENE; SUPPRESSION; DELETION; GLUCOSE; PGC-1	Hepatic glucose production is critical for basal brain function and survival when dietary glucose is unavailable. Glucose- 6- phosphatase (G6Pase) is an essential, rate- limiting enzyme that serves as a terminal gatekeeper for hepatic glucose release into the plasma. Mutations in G6Pase result in Von Gierke's disease ( glycogen storage disease-1a), a potentially fatal genetic disorder. We have identified the transcriptional coactivator SRC-2 as a regulator of fasting hepatic glucose release, a function that SRC- 2 performs by controlling the expression of hepatic G6Pase. SRC- 2 modulates G6Pase expression directly by acting as a coactivator with the orphan nuclear receptor ROR alpha. In addition, SRC- 2 ablation, in both a whole- body and liver- specific manner, resulted in a Von Gierke's disease phenotype in mice. Our results position SRC- 2 as a critical regulator of mammalian glucose production.	[Chopra, Atul R.; Louet, Jean-Francois; Saha, Pradip; DeMayo, Franco; Xu, Jianming; York, Brian; Karpen, Saul; Moore, David; Chan, Lawrence; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Karpen, Saul] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Finegold, Milton] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [An, Jie; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Duke University	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Chopra, Atul/0000-0002-1304-3777; Louet, Jean-Francois/0000-0002-1626-7098	National Institute of Diabetes and Digestive and Kidney Diseases [PO1 DK59820]; NIH [HL51586, DK58242, PO1 DK58398]; Nuclear Receptor Signaling Atlas ( NURSA) [U19 DK062434]; Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056239, P01DK059820, R01DK058242, P01DK058398, U19DK062434] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Receptor Signaling Atlas ( NURSA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank O. McGuinness for help with assessment of liver glycogen and triglyceride content; D. White for help with primary hepatocyte isolation; S. Zhou and J. Song for help with animal breeding; J. Barish for performing the electron microscopy; J. Lin for the RORa adenovirus; J. Lydon for the SRC- 2 F/ F mice and M. Stallcup for the SRC- 2 activation domain mutants; R. Lanz for help with QPCR setup and analysis; M. Muehlbauer for help with plasma analysis of various metabolites; H. Klein and S. Greene for help with figure and model construction; and J. Sagen and C. Foulds for helpful discussion and critical reading of the manuscript. F. D. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grant PO1 DK59820). L.C. is supported by the NIH (grant HL51586). J.X. is supported by the NIH (DK58242). C.B.N. is supported by the NIH (grant PO1 DK58398). B.W.O. is supported by the NIDDK (grant PO1 DK59820), Nuclear Receptor Signaling Atlas (NURSA) (U19 DK062434), and a grant from the Welch Foundation.	Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gogus S, 2002, PEDIATR DEVEL PATHOL, V5, P299, DOI 10.1007/s10024-001-0139-6; Jeong JW, 2007, ENDOCRINOLOGY, V148, P4238, DOI 10.1210/en.2007-0122; Koeberl DD, 2007, MOL THER, V15, P1253, DOI 10.1038/sj.mt.6300188; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Liedtke AJ, 1997, J MOL CELL CARDIOL, V29, P1073, DOI 10.1006/jmcc.1996.0341; Mukherjee Atish, 2007, Nucl Recept Signal, V5, pe011, DOI 10.1621/nrs.05011; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; Nordlie R C, 1974, Curr Top Cell Regul, V8, P33; NORDLIE RC, 1979, LIFE SCI, V24, P2397, DOI 10.1016/0024-3205(79)90447-8; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Phaneuf D, 2004, DNA CELL BIOL, V23, P592, DOI 10.1089/dna.2004.23.592; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	20	127	131	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1395	1399		10.1126/science.1164847	http://dx.doi.org/10.1126/science.1164847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039140	Green Accepted			2022-12-24	WOS:000261170600043
J	Fragoso, G; Spencer, T				Fragoso, Gerardo; Spencer, Tom			Physiographic Control on the Development of Spartina Marshes	SCIENCE			English	Article							SALT-MARSH; ALTERNIFLORA		[Fragoso, Gerardo] UNEP WCMC, Cambridge CB3 0DL, England; [Spencer, Tom] Univ Cambridge, Dept Geog, Cambridge Coastal Res Unit, Cambridge CB2 3EN, England	United Nations Environment Programme; University of Cambridge	Fragoso, G (corresponding author), UNEP WCMC, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	gerardo.fragoso@unep-wcmc.org						GOODMAN PJ, 1961, J ECOL, V49, P391, DOI 10.2307/2257271; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; MCKEE KL, 1988, ESTUARIES, V11, P143, DOI 10.2307/1351966; Mendelssohn IA, 2003, ECOL ENG, V21, P115, DOI 10.1016/j.ecoleng.2003.09.006; Morris JT, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P87; MORRIS JT, 1984, AM J BOT, V71, P979, DOI 10.2307/2443668; REDFIELD AC, 1965, SCIENCE, V147, P50, DOI 10.1126/science.147.3653.50; Tukey JW, 1977, EXPLORATORY DATA ANA	8	13	14	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1064	1064		10.1126/science.1159973	http://dx.doi.org/10.1126/science.1159973			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008437				2022-12-24	WOS:000260867700027
J	Takehara-Nishiuchi, K; McNaughton, BL				Takehara-Nishiuchi, Kaori; McNaughton, Bruce L.			Spontaneous Changes of Neocortical Code for Associative Memory During Consolidation	SCIENCE			English	Article							TIME-DEPENDENT REORGANIZATION; MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL; TRACE; AMNESIA; LESIONS; SLEEP; JUDGMENTS; MONKEYS; SYSTEMS	After learning, the medial prefrontal cortex (mPFC) gradually comes to modulate the expression of memories that initially depended on the hippocampus. We show that during this consolidation period, neural firing in the mPFC becomes selective for the acquired memories. After acquisition of memory associations, neuron populations in the mPFC of rats developed sustained activity during the interval between two paired stimuli, but reduced activity during the corresponding interval between two unpaired stimuli. These new patterns developed over a period of several weeks after learning, with and without continued conditioning trials. Thus, in agreement with a central tenet of consolidation theory, acquired associations initiate subsequent, gradual processes that result in lasting changes of the mPFC's code, without continued training.	[Takehara-Nishiuchi, Kaori; McNaughton, Bruce L.] Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	University of Arizona	McNaughton, BL (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA.	bruce@nsma.arizona.edu	Takehara-Nishiuchi, Kaori/Q-9053-2019; Takehara, Kaori/ABD-2977-2020	Takehara-Nishiuchi, Kaori/0000-0002-7282-7838; Takehara, Kaori/0000-0002-7282-7838	NIH [NS020331, MH046823]; Human Frontier Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046823, R37MH046823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020331, R37NS020331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS020331 and MH046823 (B.L.M.) and the Human Frontier Science Program (K.T.-N.). We thank M. Tatsuno and S. Cowen for helping with construction of the experimental apparatus and programming of the code for data analysis; J. Meltzer, J. Wang, H. DeFour, and A. Mosley for help with data collection and analysis; K. Bohne for constructing hyperdrives; and N. Insel for critical reading of the manuscript.	Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freeman JH, 1999, NEUROBIOL LEARN MEM, V72, P259, DOI 10.1006/nlme.1998.3896; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; MOSS M, 1981, J NEUROSCI, V1, P227; Paller KA, 1997, MEMORY, V5, P73, DOI 10.1080/741941150; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	27	166	166	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					960	963		10.1126/science.1161299	http://dx.doi.org/10.1126/science.1161299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988855				2022-12-24	WOS:000260674100052
J	Prainsack, B; Reardon, J; Hindmarsh, R; Gottweis, H; Naue, U; Lunshof, JE				Prainsack, Barbara; Reardon, Jenny; Hindmarsh, Richard; Gottweis, Herbert; Naue, Ursula; Lunshof, Jeantine E.			Personal genomes: Misdirected precaution	NATURE			English	Editorial Material							CONSUMER		[Prainsack, Barbara] Kings Coll London, Ctr Biomed & Soc, London WC2R 2LS, England; [Prainsack, Barbara] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Reardon, Jenny] Univ Calif Santa Cruz, Dept Sociol, Santa Cruz, CA 95064 USA; [Hindmarsh, Richard] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Hindmarsh, Richard] Griffith Univ, Ctr Governance & Publ Policy, Nathan, Qld 4111, Australia; [Gottweis, Herbert; Naue, Ursula] Univ Vienna, Dept Polit Sci, Life Sci Governance Res Platform, A-1010 Vienna, Austria; [Lunshof, Jeantine E.] Maastricht Univ, Dept Social Med, NL-6211 LK Maastricht, Netherlands; [Lunshof, Jeantine E.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands	University of London; King's College London; University of London; King's College London; University of California System; University of California Santa Cruz; Griffith University; Griffith University; University of Vienna; Maastricht University; Vrije Universiteit Amsterdam	Prainsack, B (corresponding author), Kings Coll London, Ctr Biomed & Soc, London WC2R 2LS, England.	barbara.prainsack@kcl.ac.uk	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532; Naue, Ursula/0000-0003-2678-9962; Hindmarsh, Richard/0000-0001-5560-2904				Borry P, 2008, NAT BIOTECHNOL, V26, P736, DOI 10.1038/nbt0708-736; Gniady J, 2008, FORDHAM LAW REV, V76, P2429; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Reardon Jenny, 2007, BIOSOCIETIES, V2, P239, DOI DOI 10.1017/S174585520700573X; Rose Nikolas S., 2007, POLITICS LIFE ITSELF; van Ommen GB, 2008, EUR J HUM GENET, V16, P403, DOI 10.1038/ejhg.2008.32; 2008, NATURE BIOTECHNOL, V26, P716	8	83	87	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					34	35		10.1038/456034a	http://dx.doi.org/10.1038/456034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987720				2022-12-24	WOS:000260674000025
J	Coll, AP; Yeo, GSH; Farooqi, IS; O'Rahilly, S				Coll, Anthony P.; Yeo, Giles S. H.; Farooqi, I. Sadaf; O'Rahilly, Stephen			SnapShot: The Hormonal Control of Food Intake	CELL			English	Editorial Material							OBESITY; NEURONS		[Coll, Anthony P.; Yeo, Giles S. H.; Farooqi, I. Sadaf; O'Rahilly, Stephen] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England	University of Cambridge	Coll, AP (corresponding author), Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England.		O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Coll, Anthony Patrick/0000-0003-2594-7463; Farooqi, Sadaf/0000-0001-7609-3504; Yeo, Giles See How/0000-0001-8823-3615	MRC [G9824984, G108/617] Funding Source: UKRI; Medical Research Council [G9824984, G108/617] Funding Source: Medline; Wellcome Trust [082390] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007	10	8	9	2	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3							572.e1	10.1016/j.cell.2008.10.014	http://dx.doi.org/10.1016/j.cell.2008.10.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984167	Bronze			2022-12-24	WOS:000260536300026
J	Colantonio, JR; Vermot, J; Wu, D; Langenbacher, AD; Fraser, S; Chen, JN; Hill, KL				Colantonio, Jessica R.; Vermot, Julien; Wu, David; Langenbacher, Adam D.; Fraser, Scott; Chen, Jau-Nian; Hill, Kent L.			The dynein regulatory complex is required for ciliary motility and otolith biogenesis in the inner ear	NATURE			English	Article							TRYPANOSOMA-BRUCEI; ZEBRAFISH; CHLAMYDOMONAS; PROTEIN; MUTATIONS; GAS11; COMPONENTS; MECHANISM; HOMOLOG; ARMS	In teleosts, proper balance and hearing depend on mechanical sensors in the inner ear. These sensors include actin- based microvilli and microtubule- based cilia that extend from the surface of sensory hair cells and attach to biomineralized 'ear stones' ( or otoliths)(1). Otolith number, size and placement are under strict developmental control, but the mechanisms that ensure otolith assembly atop specific cells of the sensory epithelium are unclear. Here we demonstrate that cilia motility is required for normal otolith assembly and localization. Using in vivo video microscopy, we show that motile tether cilia at opposite poles of the otic vesicle create fluid vortices that attract otolith precursor particles, thereby biasing an otherwise random distribution to direct localized otolith seeding on tether cilia. Independent knockdown of subunits for the dynein regulatory complex and outer- arm dynein disrupt cilia motility, leading to defective otolith biogenesis. These results demonstrate a requirement for the dynein regulatory complex in vertebrates and show that cilia- driven flow is a key epigenetic factor in controlling otolith biomineralization.	[Colantonio, Jessica R.; Hill, Kent L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Langenbacher, Adam D.; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Chen, Jau-Nian; Hill, Kent L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vermot, Julien; Wu, David; Fraser, Scott] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology	Hill, KL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	kenthill@mednet.ucla.edu	Chen, Jau-Nian/AAM-7808-2020; Vermot, Julien/I-6568-2016; Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; , Julien/0000-0002-8924-732X; Wu, David/0000-0003-3162-3238; Chen, Jau-Nian/0000-0001-8807-3607	Human Frontier Science Program; NIH Medical Scientist Training Program at UCLA/Caltech; NIH RSDA [M07185]; Warsaw Fellowship; NSF; NIH [R01 HL081799, R01AI52348]; Beckman Young Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052348] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); NIH Medical Scientist Training Program at UCLA/Caltech(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH RSDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warsaw Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to R. Crosbie for discussions and encouragement throughout the course of the project. We thank I. Drummond and C. Nguyen for discussions and comments on the work. We are grateful to L. Trinh, O. Bricaud and A. Collazo for sharing reagents and for providing probes, as well as to all the members of the Fraser laboratory for discussions, in particular M. Liebling and W. Supatto for sharing Matlab scripts and comments. We are grateful to Z.P. Kabututu for performing the lrrc50 reverse transcriptase PCR experiments. J.V. was supported by a fellowship from the Human Frontier Science Program, D.W. was supported by the NIH Medical Scientist Training Program at UCLA/ Caltech. J. R. C. was supported by NIH RSDA training grant no. M07185 and a Warsaw Fellowship from the MIMG Department at UCLA. A. D. L is supported by an NSF fellowship. This work was supported by NIH grant R01 HL081799 ( J. C.), NIH grant R01AI52348 and Beckman Young Investigator Award ( K. L. H.).	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bok J, 2007, DEV BIOL, V311, P69, DOI 10.1016/j.ydbio.2007.08.013; Chen JN, 1996, DEVELOPMENT, V122, P3809; Colantonio JR, 2006, TRAFFIC, V7, P538, DOI 10.1111/j.1600-0854.2006.00411.x; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Shastry Barkur S., 2000, Microbial and Comparative Genomics, V5, P61, DOI 10.1089/10906590050179747; Sollner C., 2004, BIOMINERALIZATION PR, P229; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200	34	93	95	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					205	U102		10.1038/nature07520	http://dx.doi.org/10.1038/nature07520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19043402	Green Accepted			2022-12-24	WOS:000262360200035
J	Baxter, NN; Goldwasser, MA; Paszat, LF; Saskin, R; Urbach, DR; Rabeneck, L				Baxter, Nancy N.; Goldwasser, Meredith A.; Paszat, Lawrence F.; Saskin, Refik; Urbach, David R.; Rabeneck, Linda			Association of Colonoscopy and Death From Colorectal Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							NEGATIVE SCREENING COLONOSCOPY; POPULATION-BASED ANALYSIS; COLON-CANCER; UNITED-STATES; RISK; ENDOSCOPY; PATTERNS; SIGMOIDOSCOPY; SURVEILLANCE; PROTECTION	Background: Colonoscopy is advocated for screening and prevention of colorectal cancer (CRC), but randomized trials supporting the benefit of this practice are not available. Objective: To evaluate the association between colonoscopy and CRC deaths. Design: Population-based, case -control study. Setting: Ontario, Canada. Patients: Persons age 52 to 90 years who received a CRC diagnosis from January 1996 to December 2001 and died of CRC by December 2003. Five controls matched by age, sex, geographic location, and socioeconomic status were randomly selected for each case patient. Measurements: Administrative claims data were used to detect exposure to any colonoscopy and complete colonoscopy (to the cecum) from January 1992 to an index date 6 months before diagnosis in each case patient and the same assigned date in matched controls. Exposures in case patients and controls were compared by using conditional logistic regression to control for comorbid conditions. Secondary analyses were done to see whether associations differed by site of primary CRC, age, or sex. Results: 10 292 case patients and 51 460 controls were identified; 719 case patients (7.0%) and 5031 controls (9.8%) had undergone colonoscopy. Compared with controls, case patients were less likely to have undergone any attempted colonoscopy (adjusted conditional odds ratio [OR], 0.69 [95% CI, 0.63 to 0.74; P < 0.001]) or complete colonoscopy (adjusted conditional OR, 0.63 [CI, 0.57 to 0.69; P < 0.001]). Complete colonoscopy was strongly associated with fewer deaths from left-sided CRC (adjusted conditional OR, 0.33 [CI, 0.28 to 0.39]) but not from right-sided CRC (adjusted conditional OR, 0.99 [CI, 0.86 to 1.14]). Limitation: Screening could not be differentiated from diagnostic procedures. Conclusion: In usual practice, colonoscopy is associated with fewer deaths from CRC. This association is primarily limited to deaths from cancer developing in the left side of the colon.	[Baxter, Nancy N.] Univ Toronto, St Michaels Hosp, Div Gen Surg, Toronto, ON M5B 1W8, Canada; [Goldwasser, Meredith A.; Paszat, Lawrence F.; Saskin, Refik] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Urbach, David R.] Univ Toronto, Toronto, ON M5G 2C4, Canada; [Rabeneck, Linda] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Baxter, NN (corresponding author), Univ Toronto, St Michaels Hosp, Div Gen Surg, 30 Bond St 16CC-40, Toronto, ON M5B 1W8, Canada.	baxtern@smh.toronto.on.ca	Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620	Canadian Institutes of Health Research; American Society of Clinical Oncology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Society of Clinical Oncology	Canadian Institutes of Health Research and American Society of Clinical Oncology.	*AM COLL GASTR, COL CANC YOU CAN PRE; American Cancer Society, 2008, CANC FACTS FIG 2008; Azzoni C, 2007, INT J COLORECTAL DIS, V22, P115, DOI 10.1007/s00384-006-0093-x; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *COL CANC PREV PRO, 2006, COL CANC SCREEN TIP; Cremers MI, 2006, DIGEST LIVER DIS, V38, P912, DOI 10.1016/j.dld.2006.04.011; Dafnis G, 2000, SCAND J GASTROENTERO, V35, P765, DOI 10.1080/003655200750023462; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Fasoli R, 2002, DIGEST LIVER DIS, V34, P833, DOI 10.1016/S1590-8658(02)80252-3; Gervaz P, 2004, J SURG ONCOL, V88, P261, DOI 10.1002/jso.20156; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hodgson DC, 2001, JNCI-J NATL CANCER I, V93, P501, DOI 10.1093/jnci/93.7.501; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; MORRISON AS, 1982, AM J EPIDEMIOL, V115, P6; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; *NEW YORK CIT DEP, 2005, GET CHECK; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Rabeneck L, 2004, AM J GASTROENTEROL, V99, P1141, DOI 10.1111/j.1572-0241.2004.30623.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh G, 2007, GASTROENTEROLOGY, V132, pA81; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh SM, 2004, CAN MED ASSOC J, V171, P461, DOI 10.1503/cmaj.1031921; Sonnenberg A, 2008, GASTROINTEST ENDOSC, V67, P489, DOI 10.1016/j.gie.2007.08.041; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Taylor C, 2007, CAN J GASTROENTEROL, V21, P805, DOI 10.1155/2007/230420; Vinden CM., 2004, ICES RES ATLAS USE L; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163	46	988	1006	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					1	W1		10.7326/0003-4819-150-1-200901060-00306	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19075198				2022-12-24	WOS:000262655100001
J	Sun, S; Kondabagil, K; Draper, B; Alam, TI; Bowman, VD; Zhang, Z; Hegde, S; Fokine, A; Rossmann, MG; Rao, VB				Sun, Siyang; Kondabagil, Kiran; Draper, Bonnie; Alam, Tanfis I.; Bowman, Valorie D.; Zhang, Zhihong; Hegde, Shylaja; Fokine, Andrei; Rossmann, Michael G.; Rao, Venigalla B.			The Structure of the Phage T4 DNA Packaging Motor Suggests a Mechanism Dependent on Electrostatic Forces	CELL			English	Article							ATPASE ACTIVITY; PORTAL PROTEIN; REVEALS; RECONSTRUCTION; VISUALIZATION; ORGANIZATION; GENERATION; MICROSCOPY; RESOLUTION; EVOLUTION	Viral genomes are packaged into "procapsids'' by powerful molecular motors. We report the crystal structure of the DNA packaging motor protein, gene product 17 (gp17), in bacteriophage T4. The structure consists of an N-terminal ATPase domain, which provides energy for compacting DNA, and a C-terminal nuclease domain, which terminates packaging. We show that another function of the C-terminal domain is to translocate the genome into the procapsid. The two domains are in close contact in the crystal structure, representing a "tensed state.'' A cryo-electron microscopy reconstruction of the T4 procapsid complexed with gp17 shows that the packaging motor is a pentamer and that the domains within each monomer are spatially separated, representing a "relaxed state.'' These structures suggest a mechanism, supported by mutational and other data, in which electrostatic forces drive the DNA packaging by alternating between tensed and relaxed states. Similar mechanisms may occur in other molecular motors.	[Sun, Siyang; Bowman, Valorie D.; Fokine, Andrei; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kondabagil, Kiran; Draper, Bonnie; Alam, Tanfis I.; Zhang, Zhihong; Hegde, Shylaja; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Catholic University of America	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu; rao@cua.edu	Fokine, Andrei/A-1330-2013	Rao, Venigalla/0000-0002-0777-6587	U. S. Department of Energy; National Institutes of Health; National Science Foundation [MCB-443899, MCB-423528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Petr Leiman, Ping Zhang, Ye Xiang, Paul Chipman, and especially Victor Kostyuchenko for helpful advice on cryo-EM reconstruction. We also thank Anastasia Aksyuk, Petr Leiman, and William Cramer for discussions on the mechanisms of ATP-driven motors. We are grateful to David Stuart, Marc Morais, Petr Leiman, and Bentley Fane for reading and commenting on the manuscript. We thank Sheryl Kelly and Cheryl Towell for help in the preparation of the manuscript. We also thank the staff of the Advanced Photon Source, The General Medicine and Cancer Institutes sector for their help in X-ray diffraction data collection, whose facilities are supported by the U. S. Department of Energy and the National Institutes of Health. This work was supported by National Science Foundation grants to M. G. R (MCB-443899) and V. B. R (MCB-423528).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RAO VB, 1985, J MOL BIOL, V185, P565, DOI 10.1016/0022-2836(85)90072-5; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510	52	181	188	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1251	1262		10.1016/j.cell.2008.11.015	http://dx.doi.org/10.1016/j.cell.2008.11.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109896	Bronze			2022-12-24	WOS:000261989800016
J	Trivedi, AN; Swaminathan, S; Mor, V				Trivedi, Amal N.; Swaminathan, Shailender; Mor, Vincent			Insurance Parity and the Use of Outpatient Mental Health Care Following a Psychiatric Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE; FEDERAL-EMPLOYEES; SUBSTANCE-ABUSE; SERVICES; QUALITY; LEGISLATION; COVERAGE; BENEFITS; TRENDS; READMISSION	Context Mental health services are typically subject to higher cost sharing than other health services. In 2008, the US Congress enacted legislation requiring parity in insurance coverage for mental health services in group health plans and Medicare Part B. Objective To determine the relationship between mental health insurance parity and the use of timely follow- up care after a psychiatric hospitalization. Design, Setting, and Population We reviewed cost- sharing requirements for outpatient mental health and general medical services for 302 Medicare health plans from 2001 to 2006. Among 43 892 enrollees in 173 health plans who were hospitalized for a mental illness, we determined the relation between parity in cost sharing and receipt of timely outpatient mental health care after discharge using cross- sectional analyses of all Medicare plans and longitudinal analyses of 10 plans that discontinued parity compared with 10 matched control plans that maintained parity. Main Outcome Measures Outpatient mental health visits within 7 and 30 days following a discharge for a psychiatric hospitalization. Results More than three- quarters of Medicare plans, representing 79% of Medicare enrollees, required greater cost sharing for mental health care compared with primary or specialty care. The adjusted rate of follow- up within 30 days after a psychiatric hospitalization was 10.9 percentage points greater ( 95% confidence interval [CI], 4.6- 17.3; P <. 001) in plans with equivalent cost sharing for mental health and primary care compared with plans with mental health cost sharing greater than primary and specialty care cost sharing. The association of parity with follow- up care was increased for enrollees from areas of low income and less education. Rates of follow- up visits within 30 days decreased by 7.7 percentage points ( 95% CI, - 12.9 to - 2.4; P=. 004) in plans that discontinued parity and increased by 7.5 percentage points ( 95% CI, 2.012.9; P=. 008) among control plans that maintained parity ( adjusted difference in difference, 14.2 percentage points; 95% CI, 4.5- 23.9; P=. 007). Conclusion Medicare enrollees in health plans with insurance parity for mental health and primary care have markedly higher use of clinically appropriate mental health services following a psychiatric hospitalization.	[Trivedi, Amal N.; Swaminathan, Shailender; Mor, Vincent] Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence VA Med Ctr, Res Enhancement Award Program, Providence, RI USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Box G-S121, Providence, RI 02912 USA.	amal_trivedi@brown.edu			Health Policy Scholars Award; Agency for Healthcare Research and Quality [T32 HS000011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000011] Funding Source: NIH RePORTER	Health Policy Scholars Award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by a Health Policy Scholars Award to Dr Trivedi from the Pfizer Foundation. Dr Swaminathan was supported by a postdoctoral training grant (T32 HS000011) from the Agency for Healthcare Research and Quality, of which Dr Mor is principal investigator.	*AG HEALTHC RES QU, 2004, 2004 NAT HEALTHC QUA; [Anonymous], 2001, INTERSTUDY COMPETITI; Bao YH, 2004, HEALTH SERV RES, V39, P1361, DOI 10.1111/j.1475-6773.2004.00294.x; Barry CL, 2003, HEALTH AFFAIR, V22, P127, DOI 10.1377/hlthaff.22.5.127; Buchmueller TC, 2007, HEALTH AFFAIR, V26, pW483, DOI 10.1377/hlthaff.26.4.w483; Busch AB, 2006, MED CARE, V44, P506, DOI 10.1097/01.mlr.0000215890.30756.b2; DORWART RA, 1994, AM J PUBLIC HEALTH, V84, P1229, DOI 10.2105/AJPH.84.8.1229; Druss BG, 2002, AM J PSYCHIAT, V159, P860, DOI 10.1176/appi.ajp.159.5.860; FRANK R, 1999, 7052 NAT BUR EC RES; Frank RG, 2001, NEW ENGL J MED, V345, P1701, DOI 10.1056/NEJM200112063452311; Glied SA, 2006, BETTER BUT NOT WELL; Glied SA, 2008, NEW ENGL J MED, V359, P113, DOI 10.1056/NEJMp0804447; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Harman JS, 2003, J BEHAV HEALTH SER R, V30, P332, DOI 10.1007/BF02287321; Harris KM, 2006, MED CARE, V44, P499, DOI 10.1097/01.mlr.0000215813.16211.00; *HLTH CAR FIN ADM, 301998 HEDIS HLTH CA; Hodgkin D, 2003, MED CARE RES REV, V60, P101, DOI 10.1177/1077558702250248; KEELER E B, 1985, Journal of the American Medical Association, V254, P1926, DOI 10.1001/jama.254.14.1926; KEELER EB, 1988, J HEALTH ECON, V7, P369, DOI 10.1016/0167-6296(88)90021-5; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Klinkenberg WD, 1996, PSYCHIATR SERV, V47, P487; LURIE N, 1989, AM J PUBLIC HEALTH, V79, P640, DOI 10.2105/AJPH.79.5.640; MANNING WG, 1986, J HUM RESOUR, V21, P293, DOI 10.2307/145965; MECHANIC D, 1993, MILBANK Q, V71, P349, DOI 10.2307/3350406; Mechanic D, 2003, PSYCHIAT SERV, V54, P1227, DOI 10.1176/appi.ps.54.9.1227; MECHANIC D, 1995, MILBANK Q, V73, P19, DOI 10.2307/3350312; Nelson EA, 2000, PSYCHIAT SERV, V51, P885, DOI 10.1176/appi.ps.51.7.885; Pacula RL, 2000, HEALTH SERV RES, V35, P263; Patel KK, 2006, HEALTH AFFAIR, V25, P681, DOI 10.1377/hlthaff.25.3.681; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Regier DA, 2008, HEALTH AFFAIR, V27, pW70, DOI 10.1377/hlthaff.27.1.w70; ROSENFIELD S, 1986, J APPL BEHAV SCI, V22, P411, DOI 10.1177/002188638602200405; Sakauye K, 2005, PSYCHIAT SERV, V56, P795; SCHOENBAUM SC, 1995, PSYCHIATR SERV, V46, P943; SOLOMON P, 1986, HOSP COMMUNITY PSYCH, V37, P708; Sturm R, 1997, JAMA-J AM MED ASSOC, V278, P1533, DOI 10.1001/jama.278.18.1533; Sturm R, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.5.182; Sturm Roland, 2000, J Ment Health Policy Econ, V3, P209; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; WINSTON A, 1977, HOSP COMMUNITY PSYCH, V28, P118; Zuvekas Samuel H., 1998, J Ment Health Policy Econ, V1, P135, DOI 10.1002/(SICI)1099-176X(1998100)1:3<135::AID-MHP17>3.0.CO;2-S	43	31	31	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2879	2885						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386ZG	19109116	Green Accepted, Bronze			2022-12-24	WOS:000261920900021
J	Griffith, EM; Paytan, A; Caldeira, K; Bullen, TD; Thomas, E				Griffith, Elizabeth M.; Paytan, Adina; Caldeira, Ken; Bullen, Thomas D.; Thomas, Ellen			A Dynamic Marine Calcium Cycle During the Past 28 Million Years	SCIENCE			English	Article							SEAWATER CHEMISTRY; CHEMICAL EVOLUTION; ISOTOPE RECORD; FRACTIONATION; MONITOR	Multiple lines of evidence have shown that the isotopic composition and concentration of calcium in seawater have changed over the past 28 million years. A high- resolution, continuous seawater calcium isotope ratio curve from marine ( pelagic) barite reveals distinct features in the evolution of the seawater calcium isotopic ratio suggesting changes in seawater calcium concentrations. The most pronounced increase in the delta Ca-44/40 value of seawater (of 0.3 per mil) occurred over roughly 4 million years following a period of low values around 13 million years ago. The major change in marine calcium corresponds to a climatic transition and global change in the carbon cycle and suggests a reorganization of the global biogeochemical system.	[Griffith, Elizabeth M.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Griffith, Elizabeth M.; Paytan, Adina] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Bullen, Thomas D.] US Geol Survey, Div Water Resources, Branch Reg Res, Menlo Pk, CA 94025 USA; [Thomas, Ellen] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Thomas, Ellen] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA	Stanford University; University of California System; University of California Santa Cruz; Carnegie Institution for Science; United States Department of the Interior; United States Geological Survey; Yale University; Wesleyan University	Griffith, EM (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Bldg 320,Room 118, Stanford, CA 94305 USA.	egriffith@ucsc.edu	Caldeira, Ken/E-7914-2011; Thomas, Ellen/E-5573-2011	Caldeira, Ken/0000-0002-4591-643X; Griffith, Elizabeth/0000-0002-7919-4551; Thomas, Ellen/0000-0002-7141-9904	NSF CAREER [OCE-0449732]; National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF))	Samples provided by the Integrated Ocean Drilling Program. We thank A. Eisenhauer, J. Fitzpatrick, W. A. Griffith, R. Jones, and G. Li for analytical assistance. Supported by NSF CAREER Grant OCE-0449732 (A.P.) and by a National Defense Science and Engineering Graduate Fellowship and an NSF Graduate Research Fellowship (E.M.G.).	Amini M, 2008, GEOCHIM COSMOCHIM AC, V72, P4107, DOI 10.1016/j.gca.2008.05.055; Budyko MI, 1987, HIST EARTHS ATMOSPHE; Conrad CP, 2007, GEOLOGY, V35, P29, DOI 10.1130/G22759A.1; De La Rocha CL, 2000, SCIENCE, V289, P1176, DOI 10.1126/science.289.5482.1176; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Fantle MS, 2005, EARTH PLANET SC LETT, V237, P102, DOI 10.1016/j.epsl.2005.06.024; Farkas J, 2007, GEOCHIM COSMOCHIM AC, V71, P5117, DOI 10.1016/j.gca.2007.09.004; Griffith EM, 2008, GEOCHIM COSMOCHIM AC, V72, P5641, DOI 10.1016/j.gca.2008.08.010; Gussone N, 2005, GEOCHIM COSMOCHIM AC, V69, P4485, DOI 10.1016/j.gca.2005.06.003; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hathorne EC, 2006, EARTH PLANET SC LETT, V246, P393, DOI 10.1016/j.epsl.2006.04.020; HEUSER A, 2005, PALEOCEANOGRAPHY, V20, DOI DOI 10.1029/2004PA01048; HODELL DA, 1989, EARTH PLANET SC LETT, V92, P165, DOI 10.1016/0012-821X(89)90044-7; Holbourn A, 2005, NATURE, V438, P483, DOI 10.1038/nature04123; Holland HD, 2005, AM J SCI, V305, P220, DOI 10.2475/ajs.305.3.220; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Lyle M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000777; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; PAYTAN A, 1993, NATURE, V366, P445, DOI 10.1038/366445a0; Ridgwell AJ, 2003, SCIENCE, V302, P859, DOI 10.1126/science.1088342; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Schmitt AD, 2003, EARTH PLANET SC LETT, V213, P503, DOI 10.1016/S0012-821X(03)00341-8; Sime NG, 2007, GEOCHIM COSMOCHIM AC, V71, P3979, DOI 10.1016/j.gca.2007.06.009; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu P, 1998, GEOCHIM COSMOCHIM AC, V62, P1691, DOI 10.1016/S0016-7037(98)00110-0	30	70	74	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1671	1674		10.1126/science.1163614	http://dx.doi.org/10.1126/science.1163614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074345				2022-12-24	WOS:000261608300039
J	Steinbrook, R				Steinbrook, Robert			Physician-Assisted Death - From Oregon to Washington State.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						GANZINI L, 2008, BMJ-BRIT MED J, V337, P973; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Quill TE, 2007, NEW ENGL J MED, V356, P1911, DOI 10.1056/NEJMp078061; *TASK FORC IMPR CA, OR DEATH DIGN ACT GU	4	21	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2513	2515		10.1056/NEJMp0809394	http://dx.doi.org/10.1056/NEJMp0809394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	381KG	19073972				2022-12-24	WOS:000261534200001
J	Christakis, NA				Christakis, Nicholas A.			This allergies hysteria is just nuts	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	14	14	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2008	337								a2880	10.1136/bmj.a2880	http://dx.doi.org/10.1136/bmj.a2880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CA	19073662				2022-12-24	WOS:000262776800007
J	Avierinos, JF; Inamo, J; Grigioni, F; Gersh, B; Shub, C; Enriquez-Sarano, M				Avierinos, Jean-Francois; Inamo, Jocelyn; Grigioni, Francesco; Gersh, Bernard; Shub, Clarence; Enriquez-Sarano, Maurice			Sex Differences in Morphology and Outcomes of Mitral Valve Prolapse	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION-BASED SAMPLE; TERM-FOLLOW-UP; DOPPLER-ECHOCARDIOGRAPHY; AORTIC REGURGITATION; NATURAL-HISTORY; REFERRAL BIAS; PREVALENCE; DIAGNOSIS; DISEASE; EPIDEMIOLOGY	Background: Mitral valve prolapse is more common in women than in men, but men more often have surgery for severe regurgitation. Objective: To compare morphology and outcomes of mitral valve prolapse in men and women. Design: Retrospective cohort study. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: 4461 women and 3768 men who received a diagnosis of mitral valve prolapse by echocardiography from 1989 to 1998 ( 896 Olmsted County residents and 7333 referred patients). Measurements: Mitral prolapse characteristics ( localization, leaflet thickening or flail, regurgitation), ventricular and atrial characteristics, cardiac surgery, and mortality. Results: Compared with men, women had less posterior prolapse (22% vs. 31%), less flail (2% vs. 8%), more leaflet thickening (32% vs. 28%), and less frequent severe regurgitation (10% vs. 23%) ( P < 0.001 for all comparisons). Regardless of the severity of regurgitation, left ventricular and atrial diameters were smaller in women than in men but were larger in women after normalization to body surface area. Among patients with severe regurgitation, women were less likely than men to undergo cardiac valve surgery (52% vs. 60%; adjusted risk ratio, 0.79 [95% CI, 0.74 to 0.84]). At 15 years, women with no or mild mitral regurgitation had better odds of survival than men (87% vs. 77%; adjusted risk ratio, 0.82 [CI, 0.76 to 0.89]), but those with severe regurgitation had worse survival than men ( 60% vs. 68%; adjusted risk ratio, 1.13 [CI, 1.01 to 1.26]). The survival rate 10 years after surgery was similar in women and men (77% vs. 79%; P = 0.14). Observations in Olmsted County patients and referred patients were similar. Limitation: Diagnoses were based on echocardiography, and clinical data at initial diagnosis, reason for index echocardiography, and cause of all deaths were lacking. Conclusion: Morphology and severity of mitral valve prolapse differ according to sex. Among patients with severe regurgitation, women have higher mortality and lower surgery rates than men.	[Enriquez-Sarano, Maurice] Mayo Clin, Rochester, MN 55905 USA; Hop Enfants La Timone, Marseille, France; Osped Univ Bologna, Bologna, Italy	Mayo Clinic; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Bologna	Enriquez-Sarano, M (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu	Grigioni, Francesco/AAL-3603-2020; INAMO, Jocelyn/AGZ-1674-2022	GRIGIONI, FRANCESCO/0000-0002-4767-7073; Avierinos, Jean Francois/0000-0002-3775-8371	NIAMS NIH HHS [R01 AR030582, R01 AR030582-43] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Devereux R B, 1989, Cardiovasc Clin, V19, P243; Devereux RB, 2001, AM J MED, V111, P679, DOI 10.1016/S0002-9343(01)00981-0; Dujardin KS, 1999, CIRCULATION, V99, P1851, DOI 10.1161/01.CIR.99.14.1851; DUREN DR, 1988, J AM COLL CARDIOL, V11, P42; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; Flack JM, 1999, AM HEART J, V138, P486, DOI 10.1016/S0002-8703(99)70151-1; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; GUTMAN J, 1983, AM J CARDIOL, V51, P336, DOI 10.1016/S0002-9149(83)80061-7; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Kokmen E, 1996, J CLIN EPIDEMIOL, V49, P79, DOI 10.1016/0895-4356(95)00031-3; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; LEVINE RA, 1987, CIRCULATION, V75, P756, DOI 10.1161/01.CIR.75.4.756; LEVY D, 1987, AM HEART J, V113, P1281, DOI 10.1016/0002-8703(87)90956-2; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; MACMAHON SW, 1987, AM J CARDIOL, V59, P105, DOI 10.1016/S0002-9149(87)80080-2; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MELTON LJ, 1985, MAYO CLIN PROC, V60, P880, DOI 10.1016/S0025-6196(12)64794-6; MINTZ GS, 1980, AM J CARDIOL, V45, P253, DOI 10.1016/0002-9149(80)90643-8; Mitts WR, 2004, AM HEART J, V148, P144, DOI 10.1016/j.ahj.2004.01.021; Mohty D, 2001, CIRCULATION, V104, pI1; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; SALIVE ME, 1994, MAYO CLIN PROC, V69, P808, DOI 10.1016/S0025-6196(12)61105-7; Singh RG, 2000, AM J CARDIOL, V85, P193, DOI 10.1016/S0002-9149(99)00645-1; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; Trochu JN, 2000, J AM COLL CARDIOL, V35, P1890, DOI 10.1016/S0735-1097(00)00617-3; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	97	100	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					787	W164		10.7326/0003-4819-149-11-200812020-00003	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047025	Green Accepted			2022-12-24	WOS:000261645300002
J	Imai, J; Katagiri, H; Yamada, T; Ishigaki, Y; Suzuki, T; Kudo, H; Uno, K; Hasegawa, Y; Gao, JH; Kaneko, K; Ishihara, H; Niijima, A; Nakazato, M; Asano, T; Minokoshi, Y; Oka, Y				Imai, Junta; Katagiri, Hideki; Yamada, Tetsuya; Ishigaki, Yasushi; Suzuki, Toshinobu; Kudo, Hirohito; Uno, Kenji; Hasegawa, Yutaka; Gao, Junhong; Kaneko, Keizo; Ishihara, Hisamitsu; Niijima, Akira; Nakazato, Masamitsu; Asano, Tomoichiro; Minokoshi, Yasuhiko; Oka, Yoshitomo			Regulation of Pancreatic beta Cell Mass by Neuronal Signals from the Liver	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; INSULIN; GENE; PROLIFERATION; SENSITIVITY; DYSFUNCTION; DISRUPTION; OBESITY	Metabolic regulation in mammals requires communication between multiple organs and tissues. The rise in the incidence of obesity and associated metabolic disorders, including type 2 diabetes, has renewed interest in interorgan communication. We used mouse models to explore the mechanism whereby obesity enhances pancreatic beta cell mass, pathophysiological compensation for insulin resistance. We found that hepatic activation of extracellular regulated kinase (ERK) signaling induced pancreatic b cell proliferation through a neuronal- mediated relay of metabolic signals. This metabolic relay from the liver to the pancreas is involved in obesity- induced islet expansion. In mouse models of insulin- deficient diabetes, liver- selective activation of ERK signaling increased b cell mass and normalized serum glucose levels. Thus, interorgan metabolic relay systems may serve as valuable targets in regenerative treatments for diabetes.	[Katagiri, Hideki; Suzuki, Toshinobu; Kudo, Hirohito; Uno, Kenji; Gao, Junhong; Kaneko, Keizo] Tohoku Univ, Grad Sch Med, Div Adv Therapeut Metab Dis, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan; [Imai, Junta; Yamada, Tetsuya; Ishigaki, Yasushi; Suzuki, Toshinobu; Kudo, Hirohito; Hasegawa, Yutaka; Kaneko, Keizo; Ishihara, Hisamitsu; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808575, Japan; [Niijima, Akira] Niigata Univ, Sch Med, Niigata 9518150, Japan; [Nakazato, Masamitsu] Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Hiroshima, Japan; [Minokoshi, Yasuhiko] Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Tohoku University; Tohoku University; Niigata University; University of Miyazaki; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Katagiri, H (corresponding author), Tohoku Univ, Grad Sch Med, Div Adv Therapeut Metab Dis, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan.	katagiri@mail.tains.tohoku.ac.jp		Minokoshi, Yasuhiko/0000-0002-7119-4805	21st Center of Excellence (COE); Global-COE; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	21st Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global-COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank M. Yokoyama for the generous gift of recombinant adenoviruses. This work was supported by Grants-in Aid (H.K., Y.O., and J.I.); the 21st Center of Excellence (COE) (H.K.) and Global-COE (Y.O.) programs from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant-in Aid (Y.O.) from the Ministry of Health, Labor and Welfare of Japan. Tohoku University, J.I., H.K., and Y.O have applied for patents related to this work in the United States and Japan.	Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiba T, 1996, GASTROENTEROLOGY, V110, P885, DOI 10.1053/gast.1996.v110.pm8608899; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yang J, 2001, CANCER RES, V61, P4010	24	158	162	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1250	1254		10.1126/science.1163971	http://dx.doi.org/10.1126/science.1163971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023081				2022-12-24	WOS:000261033400043
J	Vincent, C; Aylin, P; Franklin, BD; Holmes, A; Iskander, S; Jacklin, A; Moorthy, K				Vincent, Charles; Aylin, Paul; Franklin, Bryony Dean; Holmes, Alison; Iskander, Sandra; Jacklin, Ann; Moorthy, Krishna			Is health care getting safer?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; PATIENT SAFETY; ERRORS		[Vincent, Charles; Iskander, Sandra] St Marys Hosp, Imperial Ctr Patient Safety & Serv Qual, Dept Biosurg & Technol, London W2 1NY, England; [Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol & Publ Hlth, London, England; [Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London, England; [Franklin, Bryony Dean; Holmes, Alison; Jacklin, Ann; Moorthy, Krishna] Imperial Coll Healthcare NHS Trust, Ctr Med Safety & Serv Qual, London, England; [Franklin, Bryony Dean; Jacklin, Ann] Univ London, Sch Pharm, London WC1N 1AX, England; [Moorthy, Krishna] Univ London Imperial Coll Sci Technol & Med, Clin Safety Res Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; University College London; University of London School of Pharmacy; Imperial College London	Vincent, C (corresponding author), St Marys Hosp, Imperial Ctr Patient Safety & Serv Qual, Dept Biosurg & Technol, Praed St, London W2 1NY, England.	c.vincent@imperial.ac.uk	Vincent, Charles A/D-1134-2010; Aylin, Paul/A-1073-2014	Vincent, Charles A/0000-0003-0270-0222; Aylin, Paul/0000-0003-4589-1743; Moorthy, Krishna/0000-0001-8960-465X; Franklin, Bryony/0000-0002-2892-1245				Agency for Healthcare Research and Quality, 2008, QUAL IND; [Anonymous], 2003, 2003 REP NAT CONF EN; Audit Commission, 2004, INF DAT QUAL NHS KEY; Barber N, 2006, SAFER FASTER BETTER; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Bottle A., 2008, HLTH CARE RISK R MAY, P12; BOTTLE A, QUAL SAFETY IN PRESS; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Department of Health National Audit Office, 2005, SAF PLAC PAT LEARN I; Franklin BD, 2005, DRUG SAFETY, V28, P891, DOI 10.2165/00002018-200528100-00005; Hansell A, 2001, J PUBLIC HEALTH MED, V23, P51, DOI 10.1093/pubmed/23.1.51; Health Protection Agency, 2006, MAND SURV HEALTHC AS; Healthcare Commission, 2007, HEALTHC ASS INF WHAT; *HLTH PROT AG, 2008, Q REP RES CLOS DIFF; Holmes AH, 2007, J HOSP INFECT, V65, P191, DOI 10.1016/S0195-6701(07)60042-5; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Neale G, 2001, J ROY SOC MED, V94, P322, DOI 10.1177/014107680109400702; O'Neill, 2008, SAFE BIRTHS EVERYBOD; *OFF NAT STAT, 2008, HLTH STAT Q, V37, P7; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; *SCOTT AUD SURG MO, 2008, PERC CAS ADV EV MAN; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Vincent C., 2006, PATIENT SAFETY	23	116	116	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 13	2008	337								a2426	10.1136/bmj.a2426	http://dx.doi.org/10.1136/bmj.a2426			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008272	Green Submitted			2022-12-24	WOS:000261784500010
J	Denny, CC; Emanuel, EJ				Denny, Colleen C.; Emanuel, Ezekiel J.			US Health Aid Beyond PEPFAR The Mother & Child Campaign	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS ANALYSIS; DEVELOPING-COUNTRIES; INTERVENTIONS; STRATEGIES; HIV/AIDS		[Denny, Colleen C.; Emanuel, Ezekiel J.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov		Denny, Colleen/0000-0001-5671-6540				Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; JAMISON DT, 2006, DIS CONTROL PRIORITI, pCH10; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *OFF US GLOB AIDS, US PRES EM PLAN AIDS; SINGER P, 1972, PHILOS PUBLIC AFF, V1, P229; *UN AIDS, GLOB SUMM AIDS EP; *UNICEF, MILL DEV GOALS RED C; Varley RCG, 1998, B WORLD HEALTH ORGAN, V76, P617; WHO, WHY DO SO MAN WOM ST; *WHO, 2007, 310 WHO; *WHO, 2007, 104 WHO; WHO, WAT REL DIS; World Health Organization, CHOOS INT AR COST EF	15	36	37	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2048	2051		10.1001/jama.2008.556	http://dx.doi.org/10.1001/jama.2008.556			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984893				2022-12-24	WOS:000260605400027
J	McElrath, MJ; De Rosa, SC; Moodie, Z; Dubey, S; Kierstead, L; Janes, H; Defawe, OD; Carter, DK; Hural, J; Akondy, R; Buchbinder, SP; Robertson, MN; Mehrotra, DV; Self, SG; Corey, L; Shiver, JW; Casimiro, DR				McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Dubey, Sheri; Kierstead, Lisa; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Akondy, Rama; Buchbinder, Susan P.; Robertson, Michael N.; Mehrotra, Devan V.; Self, Steven G.; Corey, Lawrence; Shiver, John W.; Casimiro, Danilo R.		Step Study Protocol Team	HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis	LANCET			English	Article; Proceedings Paper	15th Conference on Retroviruses and Opportunistic Infections	FEB 03-06, 2008	Boston, MA				T-CELL RESPONSES; VIRAL LOAD; INFECTION; REPLICATION; DIVERSITY; SELECTION; TRIAL; IMMUNOGENICITY; PROLIFERATION; PROTECTION	Background In the Step Study, the MRKAd5 HIV-1 gag/pol/nef vaccine did not reduce plasma viraemia after infection, and HIV-1 incidence was higher in vaccine-treated than in placebo-treated men with pre-existing adenovirus serotype 5 (ALIS) immunity. We assessed vaccine-induced immunity and its potential contributions to infection risk. Methods To assess immunogenicity, we characterised HIV-specific T cells ex vivo with validated interferon-Y ELISPOT and intracelluilar cytokine staining assays, using a case-cohort design. To establish effects of vaccine and pre-existing Ad5 immunity on infection risk, we undertook flow cytometric studies to measure Ad5-specific T cells and circulating activated (Ki-67+/BcL-2(lo)) CD4+ T cells expressing CCR5. Findings We detected interferon-V-secreting HIV-specific T cells (range 1.63/106 to 686/106 peripheral blood mononuclear cells) ex vivo by ELISPOT in 77% (258/354) of people receiving vaccine; 218 of 354 (62%) recognised two to three HIV proteins. We identified HIV-specific CD4+ T cells by intracellular cytokine staining in 58 of 142 (41%) people. In those with reactive CD4+ T cells, the median percentage of CD4+ T cells expressing interleukin 2 was 88%, and the median co-expression of interferon y or tumor necrosis factor a (TNFa), or both, was 72%. We noted HIV-specific CD8+ T cells (range 0.4-1.0%) in 117 of 160 (73%) participants, expressing predominantly either interferon V alone or with TNFa. Vaccine-induced HIV-specific immunity, including response rate, magnitude, and cytokine profile, did not differ between vaccinated male cases (before infection) and non-cases. Ad5-specific T cells were lower in cases than in non-cases in several subgroup analyses. The percentage of circ it la ti jig Ki-67+BcL-2(lo)/CCR5+ CD4+ T cells did not differ between cases and non-cases. Interpretation Consistent with previous trials, the MRKAd5 HIV-1 gag/pol/nef vaccine was highly immunogenic for inducing HIV-specific CD8+ T cells. Our findings suggest that future candidate vaccines have to elicit responses that either exceed in magnitude or differ in breadth or function from those recorded in this trial. Funding National Institute of Allergy and Infectious Diseases, US National Institutes of Health; and Merck Research Laboratories.	[McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Self, Steven G.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Self, Steven G.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA; [McElrath, M. Juliana; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [McElrath, M. Juliana; De Rosa, Stephen C.; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Self, Steven G.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Akondy, Rama] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA USA; [Dubey, Sheri; Kierstead, Lisa; Robertson, Michael N.; Mehrotra, Devan V.; Shiver, John W.; Casimiro, Danilo R.] Merck Res Labs, West Point, PA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; San Francisco Department of Public Health; Merck & Company	McElrath, MJ (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, 1100 Fairview Ave N,D3-100, Seattle, WA 98109 USA.	jmcelrat@fhcrc.org	Emery, Sean/J-3825-2017; Frew, Paula M./B-4774-2012; Akondy, Rama/AAC-4656-2020; Corey, Lawrence/AAE-1796-2020; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Frew, Paula M./0000-0002-3078-9124; Corey, Lawrence/0000-0002-2179-2436; Emery, Sean/0000-0001-6072-8309; Akondy, Rama/0000-0003-4737-5240	NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NIAID NIH HHS [U01 AI068618, U01 AI068614, U01 AI068618-02, U01 AI068614-03, U01 AI068618-01, U01 AI068618-03, P30 AI027757, U01 AI068614-01, U01 AI068614-02] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068614, U01AI068618, P30AI027757] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BUCHBINDER SP, 2008, LANCET          1113, DOI DOI 10.1016/S0140-6736(08)61591-3; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Li FS, 2007, CURR HIV RES, V5, P97, DOI 10.2174/157016207779316260; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; ROSENBLUM MG, 1989, CRIT REV IMMUNOL, V9, P21; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Shulman N, 2008, CYTOM PART A, V73A, P847, DOI 10.1002/cyto.a.20600; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Trinvuthipong C, 2004, SCIENCE, V303, P954; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	40	572	598	2	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1894	1905		10.1016/S0140-6736(08)61592-5	http://dx.doi.org/10.1016/S0140-6736(08)61592-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	379IA	19012957	Green Accepted			2022-12-24	WOS:000261388700024
J	Roy, K; Hilliard, GM; Hamilton, DJ; Luo, JW; Ostmann, MM; Fleckenstein, JM				Roy, Koushik; Hilliard, George M.; Hamilton, David J.; Luo, Jiwen; Ostmann, Marguerite M.; Fleckenstein, James M.			Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells	NATURE			English	Article							HEAT-LABILE ENTEROTOXIN; TOLL-LIKE RECEPTOR-5; 2-PARTNER SECRETION; EPITHELIAL-CELLS; COLONIZATION; VIRULENCE; PROTEINS; IDENTIFICATION; ADHERENCE; FILAMENT	Adhesion to epithelial cells(1) and flagella- mediated motility are critical virulence traits for many Gram- negative pathogens, including enterotoxigenic Escherichia coli (ETEC)(2), a major cause of diarrhoea in travellers and children in developing countries(3,4). Many flagellated pathogens export putative adhesins belonging to the two- partner secretion ( TPS) family(5). However, the actual function of these adhesins remains largely undefined. Here we demonstrate that EtpA, a TPS exoprotein adhesin of enterotoxigenic E. coli(6), mimics and interacts with highly conserved regions of flagellin, the major subunit of flagella, and that these interactions are critical for adherence and intestinal colonization. Although conserved regions of flagellin are mostly buried in the flagellar shaft(7), our results suggest that they are at least transiently exposed at the tips of flagella where they capture EtpA adhesin molecules for presentation to eukaryotic receptors. Similarity of EtpA to molecules encoded by other motile pathogens suggests a potential common pattern for bacterial adhesion, whereas participation of conserved regions of flagellin in adherence has implications for development of vaccines for Gram- negative pathogens.	[Roy, Koushik; Luo, Jiwen; Fleckenstein, James M.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Hilliard, George M.; Fleckenstein, James M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Hamilton, David J.] Univ Tennessee, Ctr Hlth Sci, Dept Comparat Med, Memphis, TN 38163 USA; [Ostmann, Marguerite M.] Vet Adm Med Ctr, Res Serv, Memphis, TN 38104 USA; [Fleckenstein, James M.] Vet Adm Med Ctr, Med Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Fleckenstein, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, 956 Court Ave, Memphis, TN 38163 USA.	jflecke1@tennessee.edu	Fleckenstein, James M./P-6242-2019	Fleckenstein, James M./0000-0002-1148-697X	National Institutes of Health (National Center for Research Resources) [RR16190-05]; Department of Veterans Affairs; University of Tennessee Microbial Pathogenesis Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016190] Funding Source: NIH RePORTER	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Veterans Affairs(US Department of Veterans Affairs); University of Tennessee Microbial Pathogenesis Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank B. Westerlund-Wikstrom for supplying anti- flagellar antisera, K. Troughton of the Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, for her assistance with transmission electron microscopy, and L. Boykins of the Integrated Microscopy Center at the University of Memphis for her assistance with scanning electron microscopy. We thank G. Byrne, H. Courtney, J. Dale, S. Dagogo-Jack and T. Strom for reading the manuscript. This research was supported by grants from the National Institutes of Health ( National Center for Research Resources) RR16190-05, the Department of Veterans Affairs and funds from the University of Tennessee Microbial Pathogenesis Research Center.	Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Cummings ED, 2007, J PROTEOME RES, V6, P1603, DOI 10.1021/pr060472y; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GOFF SP, 1991, METHOD ENZYMOL, V208, P586; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Maki-Yonekura S, 2003, P NATL ACAD SCI USA, V100, P15528, DOI 10.1073/pnas.2534343100; Mu XQ, 2008, J MOL BIOL, V376, P614, DOI 10.1016/j.jmb.2007.10.067; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Roy K, 2008, INFECT IMMUN, V76, P2106, DOI 10.1128/IAI.01304-07; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SUDAKIN V, 2005, PROTEIN PROTEIN INTE, V1, P337; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Torres AG, 2005, INFECT IMMUN, V73, P18, DOI 10.1128/IAI.73.1.18-29.2005; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	29	141	153	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					594	U103		10.1038/nature07568	http://dx.doi.org/10.1038/nature07568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19060885	Green Accepted			2022-12-24	WOS:000262852200044
J	West, JB				West, John B.			A New Approach to Very-High-Altitude Land Travel: The Train to Lhasa, Tibet	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OXYGEN ENRICHMENT; ROOM AIR	The train from Golmud in Qinghai Province, China, to Lhasa, Tibet, travels for more than 14 hours at an average altitude of 4500 m, the highest point being 5072 m (16 600 ft). Therefore, passengers are potentially exposed to very severe sustained hypoxia. The enterprising solution is to increase the oxygen concentration of the air in the train from 21% to between 24% and 25% by the use of oxygen generators in each passenger car. By increasing the oxygen concentration to 25%, the equivalent altitude is reduced by about 1200 m. The engineering challenge of oxygenating the whole train is immense but has been successfully accomplished. This is an extraordinary innovation in high-altitude transportation.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	West, JB (corresponding author), Univ Calif San Diego, Dept Med, 0623A,9500 Gilman Dr, La Jolla, CA 92093 USA.	jwest@ucsd.edu			National Heart, Lung, and Blood Institute [R01 HL 060968]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060968] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	From the National Heart, Lung, and Blood Institute, R01 HL 060968.	Barash IA, 2001, HIGH ALT MED BIOL, V2, P525, DOI 10.1089/152702901753397090; Forster P., 1986, ASPECTS HYPOXIA, P217; Gerard A B, 2000, High Alt Med Biol, V1, P51, DOI 10.1089/152702900320685; Murdoch, 1995, J Travel Med, V2, P255, DOI 10.1111/j.1708-8305.1995.tb00671.x; RAHN H, 1949, AM J PHYSIOL, V157, P445, DOI 10.1152/ajplegacy.1949.157.3.445; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; West JB, 2004, OBSERVATORY, V124, P1; WEST JB, 1995, RESP PHYSIOL, V99, P225, DOI 10.1016/0034-5687(94)00094-G; Wu TY, 2007, HIGH ALT MED BIOL, V8, P88, DOI 10.1089/ham.2007.1015; Wu TY, 2006, HIGH ALT MED BIOL, V7, P275, DOI 10.1089/ham.2006.7.275	10	11	13	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					898	900		10.7326/0003-4819-149-12-200812160-00009	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075209				2022-12-24	WOS:000261771900007
J	Shum, WWC; Da Silva, N; Mckee, M; Smith, PJS; Brown, D; Breton, S				Shum, Winnie Wai Chi; Da Silva, Nicolas; McKee, Mary; Smith, Peter J. S.; Brown, Dennis; Breton, Sylvie			Transepithelial Projections from Basal Cells Are Luminal Sensors in Pseudostratified Epithelia	CELL			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MALE REPRODUCTIVE-TRACT; ENDOTHELIAL NITRIC-OXIDE; TIGHT JUNCTIONS; H+-ATPASE; EPIDIDYMAL EPITHELIUM; INTERCALATED CELLS; BLOOD-PRESSURE; CLEAR CELLS; STEM-CELLS	Basal cells are by definition located on the basolateral side of several epithelia, and they have never been observed reaching the lumen. Using high-resolution 3D confocal imaging, we report that basal cells extend long and slender cytoplasmic projections that not only reach toward the lumen but can cross the tight junction barrier in some epithelia of the male reproductive and respiratory tracts. In this way, the basal cell plasma membrane is exposed to the luminal environment. In the epididymis, in which luminal acidification is crucial for sperm maturation and storage, these projections contain the angiotensin II type 2 receptor (AGTR2). Activation of AGTR2 by luminal angiotensin II, increases proton secretion by adjacent clear cells, which are devoid of AGTR2. We propose a paradigm in which basal cells scan and sense the luminal environment of pseudostratified epithelia and modulate epithelial function by a mechanism involving crosstalk with other epithelial cells.	[Shum, Winnie Wai Chi; Da Silva, Nicolas; McKee, Mary; Brown, Dennis; Breton, Sylvie] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; [Shum, Winnie Wai Chi; Da Silva, Nicolas; Brown, Dennis; Breton, Sylvie] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Smith, Peter J. S.] Marine Biol Lab, Mol Physiol Program, BioCurrents Res Ctr, Woods Hole, MA 02543 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Marine Biological Laboratory - Woods Hole	Breton, S (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA.	sbreton@partners.org	Da Silva, Nicolas/T-3528-2019	Smith, Peter/0000-0003-4400-6853	National Institute of Health [HD40793, DK38452, DK42956]; NCRR [P41 RR001395]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Center for the Study of Inflammatory Bowel Disease [DK43341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040793] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043341, R01DK085715, P01DK038452, P30DK057521, R37DK042956, R56DK042956, R01DK042956] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants HD40793 (S. B.), DK38452 (S. B. and D. B.), DK42956 (D. B.), and NCRR P41 RR001395 grant (P.J.S. Smith). The Microscopy Core facility of the MGH Program in Membrane Biology receives support from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Center for the Study of Inflammatory Bowel Disease (DK43341).	Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; BROWN D, 1992, AM J PHYSIOL, V263, pC913, DOI 10.1152/ajpcell.1992.263.4.C913; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Burns AR, 2000, J CELL SCI, V113, P45; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Cheung KH, 2005, J GEN PHYSIOL, V125, P443, DOI 10.1085/jgp.200409205; Clermont Y, 1970, Biology Reprod., V3, P283; Da Silva N, 2007, AM J PHYSIOL-CELL PH, V293, pC199, DOI 10.1152/ajpcell.00596.2006; Esther CR, 1996, LAB INVEST, V74, P953; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; FORD JR, 1992, EXP CELL RES, V198, P69, DOI 10.1016/0014-4827(92)90150-7; Gatti JL, 1999, BIOL REPROD, V60, P937, DOI 10.1095/biolreprod60.4.937; Gregory M, 2006, MOL REPROD DEV, V73, P580, DOI 10.1002/mrd.20467; Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Hermo L., 2002, EPIDIDYMIS MOL CLIN, P81, DOI [10.1007/978-1-4615-0679-9_5, DOI 10.1007/978-1-4615-0679-9_5]; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; Ihrler S, 2002, VIRCHOWS ARCH, V440, P519, DOI 10.1007/s004280100537; Isnard-Bagnis C, 2003, AM J PHYSIOL-CELL PH, V284, pC220, DOI 10.1152/ajpcell.00374.2001; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Leung GPH, 2004, MOL CELL ENDOCRINOL, V216, P5, DOI 10.1016/j.mce.2003.10.077; Leung PS, 2003, J MOL ENDOCRINOL, V30, P263, DOI 10.1677/jme.0.0300263; Leung PS, 1997, BBA-MOL CELL RES, V1357, P65, DOI 10.1016/S0167-4889(97)00015-3; Mewe M, 2006, ENDOCRINOLOGY, V147, P2051, DOI 10.1210/en.2005-1324; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Pech V, 2008, J AM SOC NEPHROL, V19, P84, DOI 10.1681/ASN.2007030277; PRICE DOROTHY, 1963, NATL CANCER INST MONOGR, V12, P1; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rizzo S, 2005, CELL PROLIFERAT, V38, P363, DOI 10.1111/j.1365-2184.2005.00356.x; ROBAIRE B, 1995, BIOL REPROD, V52, P226, DOI 10.1095/biolreprod52.2.226; Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Saez F, 2004, J ANDROL, V25, P784; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Skrabanek L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-177; SMITH PJS, 2007, METHODS NEW FRONTIER, P373; STEIN B, 1997, ENDOTHELIUM CLIN PRA, P147; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/jhc.4A6539.2005; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; van Leenders GJLH, 2003, CRIT REV ONCOL HEMAT, V46, pS3, DOI 10.1016/S1040-8428(03)00059-3; VERI JP, 1993, J ANDROL, V14, P23; Wei CW, 1997, P NATL ACAD SCI USA, V94, P6369, DOI 10.1073/pnas.94.12.6369; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174; YEUNG CH, 1994, BIOL REPROD, V50, P917, DOI 10.1095/biolreprod50.4.917; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	57	121	128	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1108	1117		10.1016/j.cell.2008.10.020	http://dx.doi.org/10.1016/j.cell.2008.10.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070580	Green Accepted, Bronze			2022-12-24	WOS:000261642800026
J	Barry, MJ				Barry, Michael J.			Screening for Prostate Cancer among Men 75 Years of Age or Older.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Barry, Michael J.] Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA; [Barry, Michael J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Barry, MJ (corresponding author), Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA.							Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; WOLOSHIN S, 2008, JNCI-J NATL CANCER I, V100, P1133; Woloshin S, 2008, J NATL CANCER I, V100, P845, DOI 10.1093/jnci/djn124	6	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2515	2516		10.1056/NEJMp0807209	http://dx.doi.org/10.1056/NEJMp0807209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	381KG	19073973				2022-12-24	WOS:000261534200002
J	Hall, AJ; Logan, JE; Toblin, RL; Kaplan, JA; Kraner, JC; Bixler, D; Crosby, AE; Paulozzi, LJ				Hall, Aron J.; Logan, Joseph E.; Toblin, Robin L.; Kaplan, James A.; Kraner, James C.; Bixler, Danae; Crosby, Alex E.; Paulozzi, Leonard J.			Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; OPIOID ANALGESICS; CHRONIC PAIN; DEATHS	Context Use and abuse of prescription narcotic analgesics have increased dramatically in the United States since 1990. The effect of this pharmacoepidemic has been most pronounced in rural states, including West Virginia, which experienced the nation's largest increase in drug overdose mortality rates during 1999- 2004. Objective To evaluate the risk characteristics of persons dying of unintentional pharmaceutical overdose in West Virginia, the types of drugs involved, and the role of drug abuse in the deaths. Design, Setting, and Participants Population- based, observational study using data from medical examiner, prescription drug monitoring program, and opiate treatment program records. The study population was all state residents who died of unintentional pharmaceutical overdoses in West Virginia in 2006. Main Outcome Measures Rates and rate ratios for selected demographic variables. Prevalence of specific drugs among decedents and proportion that had been prescribed to decedents. Associations between demographics and substance abuse indicators and evidence of pharmaceutical diversion, defined as a death involving a prescription drug without a documented prescription and having received prescriptions for controlled substances from 5 or more clinicians during the year prior to death ( ie, doctor shopping). Results Of 295 decedents, 198 ( 67.1%) were men and 271 ( 91.9%) were aged 18 through 54 years. Pharmaceutical diversion was associated with 186 ( 63.1%) deaths, while 63 ( 21.4%) were accompanied by evidence of doctor shopping. Prevalence of diversion was greatest among decedents aged 18 through 24 years and decreased across each successive age group. Having prescriptions for a controlled substance from 5 or more clinicians in the year prior to death was more common among women (30 [ 30.9%]) and decedents aged 35 through 44 years ( 23 [ 30.7%]) compared with men ( 33 [ 16.7%]) and other age groups ( 40 [ 18.2%]). Substance abuse indicators were identified in 279 decedents ( 94.6%), with nonmedical routes of exposure and illicit contributory drugs particularly prevalent among drug diverters. Multiple contributory substances were implicated in 234 deaths ( 79.3%). Opioid analgesics were taken by 275 decedents (93.2%), of whom only 122 ( 44.4%) had ever been prescribed these drugs. Conclusion The majority of overdose deaths in West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primarily opioid analgesics.	[Hall, Aron J.; Logan, Joseph E.; Toblin, Robin L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Logan, Joseph E.; Toblin, Robin L.; Crosby, Alex E.; Paulozzi, Leonard J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Hall, Aron J.; Bixler, Danae] W Virginia Dept Hlth & Human Resources, Div Surveillance & Dis Control, Charleston, WV USA; [Kaplan, James A.; Kraner, James C.] W Virginia Dept Hlth & Human Resources, Off Chief Med Examiner, Charleston, WV USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hall, AJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	ajhall@cdc.gov						[Anonymous], MOD POL US CONTR SUB; BISHAW A, EVALUATION POVERTY E; *CDCP, 2007, CDC WONDER; *CDCP, HLTH US 2006 CHARTB; Drug Abuse Warning Network, 2005, NAT EST DRUG REL EM; *DRUG ENF ADM, 2007, DEA APP REP W VIRG 2; Drug Enforcement Administration Diversion Control Division, STAT PRESCR DRUG MON; Foley K, 2000, JAMA-J AM MED ASSOC, V283, P115, DOI 10.1001/jama.283.1.115; Gilson AM, 2007, CA-CANCER J CLIN, V57, P341, DOI 10.3322/CA.57.6.341; Haddox JD, 1997, CLIN J PAIN, V13, P6; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; *NAT DRUG INT CTR, 2008, 2008R0813001 US DEP; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Substance Abuse and Mental Health Services Administration, DRUG AB WARN NETW DA; Substance Abuse and Mental Health Services Administration, RES 2005 NAT SURV DR; Substance Abuse and Mental Health Services Administration Office of Applied Studies, NSDUH REP PATT TREND; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Toombs JD, 2005, AM FAM PHYSICIAN, V71, P1353; Trescot Andrea M, 2006, Pain Physician, V9, P1; TURLEY E, DRUG VIOLENT CRIME C; *US BUR CENS, POP AR HOUS UN DENS; *US BUR CENS, 2006 AM COMM SURV; *US BUR CENS, SMALL AR INC POV EST; *US BUR CENS, 2006 ANN STAT POP ES; *US DEP JUST DRUG, ARCOS AUT REP CONS O; Washington State Agency Medical Directors' Group, 2010, INT GUID OP DOS CHRO; Wilson PR, 1997, ANESTHESIOLOGY, V86, P995	29	615	621	1	44	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2613	2620		10.1001/jama.2008.802	http://dx.doi.org/10.1001/jama.2008.802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066381	Bronze			2022-12-24	WOS:000261503000020
J	Hurtado, A; Holmes, KA; Geistlinger, TR; Hutcheson, IR; Nicholson, RI; Brown, M; Jiang, J; Howat, WJ; Ali, S; Carroll, JS				Hurtado, Antoni; Holmes, Kelly A.; Geistlinger, Timothy R.; Hutcheson, Iain R.; Nicholson, Robert I.; Brown, Myles; Jiang, Jie; Howat, William J.; Ali, Simak; Carroll, Jason S.			Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen	NATURE			English	Article							BREAST-CANCER CELLS; MCF-7 CELLS; RESISTANCE; COACTIVATOR; EXPRESSION; ACTIVATION; AIB1; TRANSCRIPTION; SURVIVAL; THERAPY	Crosstalk between the oestrogen receptor (ER) and ERBB2/HER-2 pathways has long been implicated in breast cancer aetiology and drug eresponse(1), yet no direct connection at a transcriptional level has been shown. Here we show that oestrogen-ER and tamoxifen ER complexes directly repress ERBB2 transcription by means of a cis- regulatory element within the ERBB2 gene in human cell lines. We implicate the paired box 2 gene product ( PAX2), in a previously unrecognized role, as a crucial mediator of ER repression of ERBB2 by the anti- cancer drug tamoxifen. Weshow that PAX2 and the ER co-activator AIB-1/SRC-3 compete for binding and regulation of ERBB2 transcription, the outcome of which determines tamoxifen response in breast cancer cells. The repression of ERBB2 by ER-PAX2 links these two breast cancer subtypes and suggests that aggressive ERBB2- positive tumours can originate from ER- positive luminal tumours by circumventing this repressive mechanism. These data provide mechanistic insight into the molecular basis of endocrine resistance in breast cancer.	[Hurtado, Antoni; Holmes, Kelly A.; Howat, William J.; Carroll, Jason S.] Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Geistlinger, Timothy R.; Brown, Myles] Dana Farber Canc Inst, Boston, MA 02115 USA; [Geistlinger, Timothy R.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hutcheson, Iain R.; Nicholson, Robert I.] Cardiff Univ, Tenovus Ctr Canc Res, Welsh Sch Pharm, Cardiff CF10 3XF, Wales; [Jiang, Jie; Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cardiff University; Imperial College London	Carroll, JS (corresponding author), Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	jason.carroll@cancer.org.uk	Ali, Simak/N-4740-2019; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	Ali, Simak/0000-0002-1320-0816; Brown, Myles/0000-0002-8213-1658; Coombes, Raoul Charles/0000-0002-4811-1100; Hurtado, Antoni/0000-0002-0145-4763; Carroll, Jason/0000-0003-3643-0080	National Institute of Diabetes and Digestive and Kidney Disease [R01DK074967]; National Cancer Institute [P01CA8011105]; DF/HCC Breast Cancer SPORE; University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; NATIONAL CANCER INSTITUTE [P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074967] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DF/HCC Breast Cancer SPORE; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Carroll, S.-F. Chin, I. Mills, C. Massie and P. Edwards for discussions; J. Mitchell for histology work; M. Eldridge, S. Vowler and B. Adryan for bioinformatic help; S. Buttiglieri for the p-TARGET-PAX2 construct; J. Eeckhoute for the pcDNA- AIB- 1 construct; and M. Iddawela for the gift of Herceptin. This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Disease (R01DK074967 to M. B.) and the National Cancer Institute (P01CA8011105, and the DF/HCC Breast Cancer SPORE Grant to M. B.). We acknowledge support from the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bates NP, 1997, ONCOGENE, V15, P473, DOI 10.1038/sj.onc.1201368; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Clark J, 2002, GENE CHROMOSOME CANC, V34, P104, DOI 10.1002/gcc.10039; Clarke R, 2001, PHARMACOL REV, V53, P25; Dowsett M, 2001, ENDOCR-RELAT CANCER, V8, P191, DOI 10.1677/erc.0.0080191; Dowsett M, 2001, CANCER RES, V61, P8452; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhou ZC, 2005, J CENT SOUTH UNIV T, V12, P1, DOI 10.1007/s11771-005-0190-y	30	245	254	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					663	U93		10.1038/nature07483	http://dx.doi.org/10.1038/nature07483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19005469	Bronze, Green Accepted			2022-12-24	WOS:000261340000046
J	Zhu, LQ; Gibson, P; Currle, DS; Tong, Y; Richardson, RJ; Bayazitov, IT; Poppleton, H; Zakharenko, S; Ellison, DW; Gilbertson, RJ				Zhu, Liqin; Gibson, Paul; Currle, D. Spencer; Tong, Yiai; Richardson, Robert J.; Bayazitov, Ildar T.; Poppleton, Helen; Zakharenko, Stanislav; Ellison, David W.; Gilbertson, Richard J.			Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation	NATURE			English	Article							HEMATOPOIETIC STEM; PERIVASCULAR NICHE; COLORECTAL-CANCER; TUMOR-GROWTH; MOUSE; IDENTIFICATION; MUTATION; GENE; TUMORIGENESIS; POLYPOSIS	Cancer stem cells are remarkably similar to normal stem cells: both self- renew, are multipotent and express common surface markers, for example, prominin 1 ( PROM1, also called CD133)(1). What remains unclear is whether cancer stem cells are the direct progeny of mutated stem cells or more mature cells that reacquire stem cell properties during tumour formation. Answering this question will require knowledge of whether normal stem cells are susceptible to cancer- causing mutations; however, this has proved difficult to test because the identity of most adult tissue stem cells is not known. Here, using an inducible Cre, nuclear LacZ reporter allele knocked into the Prom1 locus (Prom1(C-L)), we show that Prom1 is expressed in a variety of developing and adult tissues. Lineage- tracing studies of adult Prom1(+/C-L) mice containing the Rosa26-YFP reporter allele showed that Prom1(+) cells are located at the base of crypts in the small intestine, co- express Lgr5 ( ref. 2), generate the entire intestinal epithelium, and are therefore the small intestinal stem cell. Prom1 was reported recently to mark cancer stem cells of human intestinal tumours that arise frequently as a consequence of aberrant wingless ( Wnt) signalling(3-5). Activation of endogenous Wnt signalling in Prom1(+/C-L) mice containing a Cre- dependent mutant allele of beta-catenin (Ctnnb1(lox(ex3))) resulted in a gross disruption of crypt architecture and a disproportionate expansion of Prom1(+) cells at the crypt base. Lineage tracing demonstrated that the progeny of these cells replaced the mucosa of the entire small intestine with neoplastic tissue that was characterized by focal high- grade intraepithelial neoplasia and crypt adenoma formation. Although all neoplastic cells arose from Prom1(+) cells in these mice, only 7% of tumour cells retained Prom1 expression. Our data indicate that Prom1 marks stem cells in the adult small intestine that are susceptible to transformation into tumours retaining a fraction of mutant Prom1(+) tumour cells.	[Zhu, Liqin; Gibson, Paul; Currle, D. Spencer; Tong, Yiai; Richardson, Robert J.; Bayazitov, Ildar T.; Poppleton, Helen; Zakharenko, Stanislav; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Zakharenko, Stanislav/D-3287-2013; Ellison, David/N-4806-2018	Gilbertson, Richard James/0000-0001-7539-9472; Zakharenko, Stanislav/0000-0001-8115-202X; 	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA129541, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	R.J.G. holds the Sydney Schlobohm Leadership Chair of Research from the Brain Tumor Society and the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network (CERN) and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to the staff of the ARC for technical assistance.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SHMELKOV SV, 2008, J CLIN INVEST, V22, P22; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sparks AB, 1998, CANCER RES, V58, P1130; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318	30	493	518	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					603	U114		10.1038/nature07589	http://dx.doi.org/10.1038/nature07589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19092805	Green Accepted			2022-12-24	WOS:000262852200046
J	Zhao, R; Follows, GA; Beer, PA; Scott, LM; Huntly, BJP; Green, AR; Alexander, DR				Zhao, Rui; Follows, George A.; Beer, Philip A.; Scott, Linda M.; Huntly, Brian J. P.; Green, Anthony R.; Alexander, Denis R.			Inhibition of the Bcl-x(L) Deamidation Pathway in Myeloproliferative Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; X-L DEAMIDATION; TYROSINE KINASE JAK2; BCL-X; POLYCYTHEMIA-VERA; V617F MUTATION; DNA-DAMAGE; STEM-CELLS; RESISTANCE; APOPTOSIS	Background: The myeloproliferative disorders are clonal disorders with frequent somatic gain-of-function alterations affecting tyrosine kinases. In these diseases, there is an increase in DNA damage and a risk of progression to acute leukemia. The molecular mechanisms in myeloproliferative disorders that prevent apoptosis induced by damaged DNA are obscure. Methods: We searched for abnormalities of the proapoptotic Bcl-x(L) deamidation pathway in primary cells from patients with chronic myeloid leukemia (CML) or polycythemia vera, myeloproliferative disorders associated with the BCR-ABL fusion kinase and the Janus tyrosine kinase 2 (JAK2) V617F mutation, respectively. Results: The Bcl-x(L) deamidation pathway was inhibited in myeloid cells, but not T cells, in patients with CML or polycythemia vera. DNA damage did not increase levels of the amiloride-sensitive sodium-hydrogen exchanger isoform 1 (NHE-1), intracellular pH, Bcl-x(L) deamidation, and apoptosis. Inhibition of the pathway was reversed by enforced alkalinization or overexpression of NHE-1, leading to a restoration of apoptosis. In patients with CML, the pathway was blocked in CD34+ progenitor cells and mature myeloid cells. Imatinib or JAK2 inhibitors reversed inhibition of the pathway in cells from patients with CML and polycythemia vera, respectively, but not in cells from a patient with resistance to imatinib because of a mutation in the BCR-ABL kinase domain. Conclusions: BCR-ABL and mutant JAK2 inhibit the Bcl-x(L) deamidation pathway and the apoptotic response to DNA damage in primary cells from patients with CML or polycythemia vera.	[Zhao, Rui; Alexander, Denis R.] Univ Cambridge, Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; [Follows, George A.; Beer, Philip A.; Scott, Linda M.; Huntly, Brian J. P.; Green, Anthony R.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Zhao, R (corresponding author), Univ Cambridge, Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England.	rui.zhao@bbsrc.ac.uk; arg1000@cam.ac.uk	Scott, Linda/D-9777-2012; huntly, brian JP/E-6725-2014	Scott, Linda/0000-0003-0334-1479; huntly, brian JP/0000-0003-0312-161X; Beer, Philip/0000-0003-3056-5419; Green, Anthony/0000-0002-9795-0218	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council; U.K. Leukaemia Research Fund; Wellcome Trust; U.K. Medical Research Council; Cancer Research UK; National Institute for Health Research Cambridge Biomedical Research Center; U.S. Leukemia and Lymphoma Society; MRC [G116/187] Funding Source: UKRI; Cancer Research UK [8961] Funding Source: researchfish; Medical Research Council [G116/187, G0300723B] Funding Source: researchfish	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.K. Leukaemia Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); U.S. Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Association for International Cancer Research, the Biotechnology and Biological Sciences Research Council, the U.K. Leukaemia Research Fund, the Wellcome Trust, the U.K. Medical Research Council, Cancer Research UK, the National Institute for Health Research Cambridge Biomedical Research Center, and the U.S. Leukemia and Lymphoma Society.	Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Amarante-Mendes GP, 1998, BLOOD, V91, P1700, DOI 10.1182/blood.V91.5.1700.1700_1700_1705; Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Amundson SA, 2000, CANCER RES, V60, P6101; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chang CY, 2006, ONCOGENE, V25, P2656, DOI 10.1038/sj.onc.1209294; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kano Y, 2001, BLOOD, V97, P1999, DOI 10.1182/blood.V97.7.1999; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kuroda J, 2007, CELL DEATH DIFFER, V14, P1667, DOI 10.1038/sj.cdd.4402168; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Nishii K, 1996, ONCOGENE, V13, P2225; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Robinson N. E., 2004, MOL CLOCKS DEAMIDATI; Schiffer CA, 2007, NEW ENGL J MED, V357, P258, DOI 10.1056/NEJMct071828; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Topaly J, 2001, LEUKEMIA, V15, P342, DOI 10.1038/sj.leu.2402041; Zhao R, 2004, CANCER CELL, V5, P37, DOI 10.1016/S1535-6108(03)00333-7; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001	44	71	74	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2778	2789		10.1056/NEJMoa0804953	http://dx.doi.org/10.1056/NEJMoa0804953			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109573	Bronze			2022-12-24	WOS:000261950800005
J	Wang, YL; Juranek, S; Li, HT; Sheng, G; Tuschl, T; Patel, DJ				Wang, Yanli; Juranek, Stefan; Li, Haitao; Sheng, Gang; Tuschl, Thomas; Patel, Dinshaw J.			Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex	NATURE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; RISC; SIRNAS; SLICER; INTERFERENCE; CLEAVAGE; INSIGHTS; DISEASE	Here we report on a 3.0 angstrom crystal structure of a ternary complex of wild- type Thermus thermophilus argonaute bound to a 5 '- phosphorylated 21- nucleotide guide DNA and a 20- nucleotide target RNA containing cleavage- preventing mismatches at the 10 - 11 step. The seed segment ( positions 2 to 8) adopts an A- helical- like Watson - Crick paired duplex, with both ends of the guide strand anchored in the complex. An arginine, inserted between guide- strand bases 10 and 11 in the binary complex, locking it in an inactive conformation, is released on ternary complex formation. The nucleic- acid- binding channel between the PAZ- and PIWI- containing lobes of argonaute widens on formation of a more open ternary complex. The relationship of structure to function was established by determining cleavage activity of ternary complexes containing position- dependent base mismatch, bulge and 2 '- O- methyl modifications. Consistent with the geometry of the ternary complex, bulges residing in the seed segments of the target, but not the guide strand, were better accommodated and their complexes were catalytically active.	[Wang, Yanli; Li, Haitao; Sheng, Gang; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Juranek, Stefan; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Li, Haitao/B-2668-2012; wang, yanli/G-3306-2010	Li, Haitao/0000-0001-6741-293X; Wang, Yanli/0000-0002-5969-1745	National Institutes of Health; Starr Foundation; US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by funds from the National Institutes of Health and the Starr Foundation to D.J.P. and T.T. We would like to thank the staff of NE-CAT beam line at the Advanced Photon Source, Argonne National Laboratory, supported by the US Department of Energy, for assistance with data collection.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	41	411	440	8	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					921	U72		10.1038/nature07666	http://dx.doi.org/10.1038/nature07666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092929	Green Accepted			2022-12-24	WOS:000261768300038
J	Anderson, DJ				Anderson, Deborah J.			Coca-Cola douches and contraception	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPERMATOZOA; INFECTION		[Anderson, Deborah J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Anderson, Deborah J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Harvard University; Harvard Medical School	Anderson, DJ (corresponding author), Boston Univ, Sch Med, 670 Albany St,Suite 516, Boston, MA 02118 USA.	Deborah.Anderson@BMC.org		Anderson, Deborah/0000-0002-2848-7290	NIAID NIH HHS [R56 AI071909] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1966, FUGS; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Cooper TG, 2006, FERTIL STERIL, V85, P220, DOI 10.1016/j.fertnstert.2005.07.1286; Douglas RJ, 2007, BMJ-BRIT MED J, V335, P1281, DOI 10.1136/bmj.39419.449942.AD; HONG CY, 1987, HUM TOXICOL, V6, P395, DOI 10.1177/096032718700600508; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Ness RB, 2005, AM J EPIDEMIOL, V161, P186, DOI 10.1093/aje/kwi025; NWOHA PU, 1992, CONTRACEPTION, V46, P537, DOI 10.1016/0010-7824(92)90118-D; Tanne JH, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1992; TIETZE C, 1959, AM J OBSTET GYNECOL, V78, P650, DOI 10.1016/0002-9378(59)90541-1; Trussell J, 1999, FAM PLANN PERSPECT, V31, P64, DOI 10.2307/2991641; UMPIERRE SA, 1985, NEW ENGL J MED, V313, P1351; Zhang J, 1997, AM J PUBLIC HEALTH, V87, P1207, DOI 10.2105/AJPH.87.7.1207	13	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2008	337								a2873	10.1136/bmj.a2873	http://dx.doi.org/10.1136/bmj.a2873			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091763				2022-12-24	WOS:000262185000009
J	Hanna, RA; Campbell, RL; Davies, PL				Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.			Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin	NATURE			English	Article							CRYSTAL-STRUCTURES; ACTIVE-SITE; MU-CALPAIN; ACTIVATION; PEPTIDE; BINDING; MODEL; COMPLEXES	Calpains are non-lysosomal calcium-dependent cysteine proteinases that selectively cleave proteins in response to calcium signals(1) and thereby control cellular functions such as cytoskeletal remodelling, cell cycle progression, gene expression and apoptotic cell death(2-4). In mammals, the two best-characterized members of the calpain family, calpain 1 and calpain 2 ( mu-calpain and m-calpain, respectively), are ubiquitously expressed. The activity of calpains is tightly controlled by the endogenous inhibitor calpastatin, which is an intrinsically unstructured protein capable of reversibly binding and inhibiting four molecules of calpain, but only in the presence of calcium(5,6). To date, the mechanism of inhibition by calpastatin and the basis for its absolute specificity have remained speculative(7-9). It was not clear how this unstructured protein inhibits calpains without being cleaved itself, nor was it known how calcium induced changes that facilitated the binding of calpastatin to calpain. Here we report the 2.4-angstrom-resolution crystal structure of the calcium-bound calpain 2 heterodimer bound by one of the four inhibitory domains of calpastatin. Calpastatin is seen to inhibit calpain by occupying both sides of the active site cleft. Although the inhibitor passes through the active site cleft it escapes cleavage in a novel manner by looping out and around the active site cysteine. The inhibitory domain of calpastatin recognizes multiple lower affinity sites present only in the calcium-bound form of the enzyme, resulting in an interaction that is tight, specific and calcium dependent. This crystal structure, and that of a related complex(10), also reveal the conformational changes that calpain undergoes on binding calcium, which include opening of the active site cleft and movement of the domains relative to each other to produce a more compact enzyme.	[Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca		Campbell, Robert/0000-0002-5473-5876	Canadian Institutes for Health Research; Bauman Fellowship; R. J. Wilson Fellowship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Bauman Fellowship; R. J. Wilson Fellowship	This work was funded by the Canadian Institutes for Health Research. R. A. H. is the recipient of a Bauman Fellowship and an R. J. Wilson Fellowship. P. L. D. holds a Canada Research Chair in Protein Engineering. We are grateful to S. Gauthier for technical assistance, to M. Kuiper for the simulation of the conformational change in calpain on binding Ca<SUP>2+</SUP>, to the Queen's University Protein Function Discovery (PFD) Facility and D. McLeod for mass spectrometry, Z. Jia for access to data collection on a home source and to M. Allaire at Brookhaven National Laboratory for assistance with data collection on beam line X6A.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; ISHIMA R, 1991, FEBS LETT, V294, P64, DOI 10.1016/0014-5793(91)81344-8; Li M, 2000, NAT STRUCT BIOL, V7, P113, DOI 10.1038/72378; Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4; MAKI M, 1989, J BIOL CHEM, V264, P18866; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Neffe AT, 2005, CURR OPIN DRUG DISC, V8, P684; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Pfizer J, 2008, BIOL CHEM, V389, P83, DOI 10.1515/BC.2008.004; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	32	221	240	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					409	U78		10.1038/nature07451	http://dx.doi.org/10.1038/nature07451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020623				2022-12-24	WOS:000261039600048
J	Gunnell, D; Hawton, K; Ho, D; Evans, J; O'Connor, S; Potokar, J; Donovan, J; Kapur, N				Gunnell, David; Hawton, Keith; Ho, Davidson; Evans, Jonathan; O'Connor, Susan; Potokar, John; Donovan, Jenny; Kapur, Nav			Hospital admissions for self harm after discharge from psychiatric inpatient care: cohort study	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE-PREVENTION; RISK; ADOLESCENTS; MANAGEMENT	Objective To determine the risk of non- fatal self harm in the 12 months after discharge from psychiatric inpatient care. Design Cohort study based on national hospital episode statistics. Setting England. Population Patients aged 16- 64 years discharged from psychiatric inpatient care between 1 April 2004 and 31 March 2005 and followed up for one year. Results 75 401 people were discharged from psychiatric inpatient care over the study period, 4935 ( 6.5%) of whom were admitted at least once for self harm in the following 12 months. Risk of self harm was greatest in the four weeks after discharge; one third ( 32%, n= 1578) of admissions for self harm occurred in this period. The strongest risk factor for self harm after discharge was admission for self harm in the previous 12 months ( hazard ratio 4.9, 95% confidence interval 4.6 to 5.2). The risk of self harm was also higher in females, younger people, those with diagnoses of depression, personality disorders, and substance misuse, and those with short lengths of stay. Conclusion More than 6% of patients discharged from psychiatric inpatient care are readmitted for an episode of self harm within 12 months, with one third of these episodes occurring in the month after discharge. Self harm after discharge from hospital shares many of the features of suicide after discharge. Interventions should be developed to reduce risk in this period.	[Gunnell, David; Ho, Davidson; Donovan, Jenny] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Hawton, Keith] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Ho, Davidson] SW Publ Hlth Observ, Bristol, Avon, England; [Evans, Jonathan; Potokar, John] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; [O'Connor, Susan] Avon & Wiltshire Partnership NHS Trust, Chippenham, Wilts, England; [Kapur, Nav] Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England	University of Bristol; University of Oxford; University of Bristol; University of Manchester	Gunnell, D (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.j.gunnell@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Evans, Jonathan/0000-0003-3171-640X; Kapur, Nav/0000-0002-3100-3234	National Institute of Health Research	National Institute of Health Research(National Institute for Health Research (NIHR))	This work was funded by a National Institute of Health Research programme grant for applied research.	Department of Health, 2002, NAT SUIC PREV STRAT; GEDDES JR, 1995, BRIT MED J, V311, P357, DOI 10.1136/bmj.311.7001.357; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Goldston DB, 1999, J AM ACAD CHILD PSY, V38, P660, DOI 10.1097/00004583-199906000-00012; Gunnell D, 2005, J PUBLIC HEALTH-UK, V27, P67, DOI 10.1093/pubmed/fdh192; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; King EA, 2001, BRIT J PSYCHIAT, V178, P531, DOI 10.1192/bjp.178.6.531; Meehan J, 2006, BRIT J PSYCHIAT, V188, P129, DOI 10.1192/bjp.188.2.129; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; MOTTO JA, 1976, SUICIDE LIFE-THREAT, V6, P223; National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester, 2006, MAKING MENTAL HLTH C; Prinstein MJ, 2008, J CONSULT CLIN PSYCH, V76, P92, DOI 10.1037/0022-006X.76.1.92; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; SELLAR C, 1990, J EPIDEMIOL COMMUN H, V44, P313, DOI 10.1136/jech.44.4.313; Skeem JL, 2006, BEHAV SCI LAW, V24, P731, DOI 10.1002/bsl.726; Taylor SJ, 1997, ACTA PSYCHIAT SCAND, V95, P457, DOI 10.1111/j.1600-0447.1997.tb10132.x	16	62	62	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2278	10.1136/bmj.a2278	http://dx.doi.org/10.1136/bmj.a2278			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19018041	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000262653900003
J	Hawkes, N				Hawkes, Nigel			National obesity strategy: what's the big idea?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2548	10.1136/bmj.a2548	http://dx.doi.org/10.1136/bmj.a2548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19017715				2022-12-24	WOS:000262653900006
J	McColl, K				McColl, Karen			The fattening truth about restaurant food	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFORMATION					karen@karenmccoll.co.uk						BARRON J, 2008, NY TIMES        0422; Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020; Berman M, 2008, JAMA-J AM MED ASSOC, V300, P433, DOI 10.1001/jama.300.4.433; BRUNI F, 2008, NY TIMES        0422; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; *CTR SCI PUBL INT, 2003, AN GUESS NEED NUTR L; DIGREGORIA A, VILLAGE VOICE; *FOOD COMM, 2008, FOOD MAGAZINE    AUG, P82; Food Standards Agency, 2008, CONS GIV THEIR VIEWS; *NEW YORK CIT DEP, 2008, CAL POST LEG TIM; US Centers for Disease control and Prevention, 2008, OV OB	11	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2229	10.1136/bmj.a2229	http://dx.doi.org/10.1136/bmj.a2229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19017714				2022-12-24	WOS:000262653900002
J	Chadwick, DW; Baker, GA; Jacoby, A; Marson, AG; Smith, PE				Chadwick, David W.; Baker, Gus A.; Jacoby, Ann; Marson, Anthony G.; Smith, Phil E.			What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DRUG; LAMOTRIGINE; TOPIRAMATE; SEIZURES; OUTCOMES; SANAD		[Chadwick, David W.; Baker, Gus A.; Jacoby, Ann; Marson, Anthony G.] Univ Liverpool, Walton Ctr, Liverpool L9 7LJ, Merseyside, England; [Smith, Phil E.] Univ Wales Hosp, Cardiff CF14 4XW, Wales	University of Liverpool; Walton Centre; Cardiff University	Chadwick, DW (corresponding author), Univ Liverpool, Walton Ctr, Liverpool L9 7LJ, Merseyside, England.	d.w.chadwick@liverpool.ac.uk	Marson, Anthony/AAW-9776-2020	Marson, Anthony/0000-0002-6861-8806				ANNEGERS JF, 1979, EPILEPSIA, V20, P729, DOI 10.1111/j.1528-1157.1979.tb04857.x; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Deckers CLP, 2000, EPILEPSIA, V41, P1364, DOI 10.1111/j.1528-1157.2000.tb00111.x; Gilliam Frank, 2003, Curr Neurol Neurosci Rep, V3, P357, DOI 10.1007/s11910-003-0014-0; Jacoby A, 2007, NEUROLOGY, V68, P1188, DOI 10.1212/01.wnl.0000259411.78423.50; JACOBY A, 1992, EPILEPSIA, V33, P1123, DOI 10.1111/j.1528-1157.1992.tb01769.x; Jacoby A, 1996, EPILEPSIA, V37, P148, DOI 10.1111/j.1528-1157.1996.tb00006.x; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; *NAT I HLTH CLIN E, 2004, EP AD NEW DRUGS GUID; *NAT I HLTH CLIN E, 2004, EP AD CHILDR NICE GU	12	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 14	2008	337								a2199	10.1136/bmj.a2199	http://dx.doi.org/10.1136/bmj.a2199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AF	19010969				2022-12-24	WOS:000261784600001
J	Schenck, S				Schenck, Sarah			A Lesson Learned by Accident	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sschenck@christianacare.org							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2101	2101		10.1001/jama.2008.630	http://dx.doi.org/10.1001/jama.2008.630			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001611				2022-12-24	WOS:000260793800001
J	Djukanovic, R; Gadola, SD				Djukanovic, Ratko; Gadola, Stephan D.			Virus Infection, Asthma, and Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KILLER T-CELLS		[Djukanovic, Ratko; Gadola, Stephan D.] Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO9 4XY, Hants, England	University of Southampton	Djukanovic, R (corresponding author), Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO9 4XY, Hants, England.			Djukanovic, Ratko/0000-0001-6039-5612	GlaxoSmithKline; Synairgen; Boehringer Ingelheim; Cellestis; Medigene	GlaxoSmithKline(GlaxoSmithKline); Synairgen; Boehringer Ingelheim(Boehringer Ingelheim); Cellestis; Medigene	Dr. Djukanovic reports receiving consulting and lecture fees and grant support from GlaxoSmithKline, receiving consulting fees and having an equity interest in Synairgen, and receiving consulting fees from Boehringer Ingelheim; and Dr. Gadola, receiving lecture fees from Cellestis and Medigene. No other potential conflict of interest relevant to this article was reported.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691	5	10	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2062	2064		10.1056/NEJMcibr0806978	http://dx.doi.org/10.1056/NEJMcibr0806978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987374				2022-12-24	WOS:000260632700015
J	Myong, S; Cui, S; Cornish, PV; Kirchhofer, A; Gack, MU; Jung, JU; Hopfner, KP; Ha, T				Myong, Sua; Cui, Sheng; Cornish, Peter V.; Kirchhofer, Axel; Gack, Michaela U.; Jung, Jae U.; Hopfner, Karl-Peter; Ha, Taekjip			Cytosolic Viral Sensor RIG-I Is a 5 '-Triphosphate-Dependent Translocase on Double-Stranded RNA	SCIENCE			English	Article							HEPATITIS-C VIRUS; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; DNA; MECHANISM; HELICASE; RECOGNITION; DOMAIN; ROLES	Retinoic acid inducible- gene I ( RIG- I) is a cytosolic multidomain protein that detects viral RNA and elicits an antiviral immune response. Two N- terminal caspase activation and recruitment domains ( CARDs) transmit the signal, and the regulatory domain prevents signaling in the absence of viral RNA. 5 '- triphosphate and double- stranded RNA ( dsRNA) are two molecular patterns that enable RIG- I to discriminate pathogenic from self- RNA. However, the function of the DExH box helicase domain that is also required for activity is less clear. Using single- molecule protein- induced fluorescence enhancement, we discovered a robust adenosine 5 ' - triphosphate- powered dsRNA translocation activity of RIG- I. The CARDs dramatically suppress translocation in the absence of 5 '- triphosphate, and the activation by 5 '- triphosphate triggers RIG- I to translocate preferentially on dsRNA in cis. This functional integration of two RNA molecular patterns may provide a means to specifically sense and counteract replicating viruses.	[Myong, Sua; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cui, Sheng; Kirchhofer, Axel; Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Cui, Sheng; Kirchhofer, Axel; Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, Gene Ctr, D-81377 Munich, Germany; [Cornish, Peter V.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Cornish, Peter V.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Cornish, Peter V.; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA; [Gack, Michaela U.; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Gack, Michaela U.; Jung, Jae U.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gack, Michaela U.; Jung, Jae U.] Harvard Univ, Sch Med, Div Tumor Virol, New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gack, Michaela U.] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of Illinois System; University of Illinois Urbana-Champaign; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Southern California; Harvard University; Harvard University; University of Erlangen Nuremberg	Myong, S (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	smyong@uiuc.edu; hopfner@lmb.uni-muenchen.de; tjha@uiuc.edu	Sheng, CUI/M-6405-2013; Hopfner, Karl-Peter/B-6864-2014; Ha, Taekjip/B-9506-2009; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; Hopfner, Karl-Peter/0000-0002-4528-8357; Ha, Taekjip/0000-0003-2195-6258; 	NIH [R01-GM065367, CA82057]; NSF Physics Frontiers Center [0822613]; Human Frontiers of Science; German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) program project 455; DFG graduate school 1202; Institute for Genomic Biology; NATIONAL CANCER INSTITUTE [R01CA082057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Physics Frontiers Center(National Science Foundation (NSF)); Human Frontiers of Science; German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) program project 455(German Research Foundation (DFG)); DFG graduate school 1202(German Research Foundation (DFG)); Institute for Genomic Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo and K. Ragunathan for careful review of the manuscript. This work was supported by NIH grant R01-GM065367 and NSF Physics Frontiers Center grant 0822613 to T.H., NIH grant CA82057 to J. U. J., and a Human Frontiers of Science grant to T.H. and K.-P. H.K.-P.H. acknowledges support from the German Excellence Initiative. S. C. is supported by Deutsche Forschungsgemeinschaft (DFG) program project 455 to K.- P. H. A. K. acknowledges support from the DFG graduate school 1202. T. H. is an investigator with Howard Hughes Medical Institute. S. M. is a fellow at the Institute for Genomic Biology.	Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	29	284	288	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1070	1074		10.1126/science.1168352	http://dx.doi.org/10.1126/science.1168352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19119185	Green Accepted			2022-12-24	WOS:000263478400045
J	McDonald-Madden, E; Gordon, A; Wintle, BA; Walker, S; Grantham, H; Carvalho, S; Bottrill, M; Joseph, L; Ponce, R; Stewart, R; Possingham, HP				McDonald-Madden, Eve; Gordon, Ascelin; Wintle, Brendan A.; Walker, Susan; Grantham, Hedley; Carvalho, Silvia; Bottrill, Madeleine; Joseph, Liana; Ponce, Rocio; Stewart, Romola; Possingham, Hugh P.			ENVIRONMENT "True" Conservation Progress	SCIENCE			English	Editorial Material							PROTECTED AREAS; BIODIVERSITY; TRENDS		[McDonald-Madden, Eve; Grantham, Hedley; Carvalho, Silvia; Bottrill, Madeleine; Joseph, Liana; Ponce, Rocio; Stewart, Romola; Possingham, Hugh P.] Univ Queensland, Ctr Appl Environm Decis Anal, Sch Integrat Biol, St Lucia, Qld 4075, Australia; [Gordon, Ascelin] RMIT Univ, Melbourne, Vic 3001, Australia; [Wintle, Brendan A.] Univ Melbourne, Ctr Appl Environm Decis Anal, Sch Bot, Melbourne, Vic 3010, Australia; [Walker, Susan] Landcare Res, Dunedin, New Zealand; [Carvalho, Silvia] Univ Lisbon, Dept Anim Biol, Fac Ciencias, P-1749016 Lisbon, Portugal; [Carvalho, Silvia] Univ Porto, Inst Ciencias Agr Vairao, CIBIO, Ctr Invest Biodivers & Recursos Genet, P-4485661 Vairao, Portugal; Univ Nacl Autonoma Mexico, Colecc Nacl Anfibios & Reptiles Inst Biol, Mexico City 04510, DF, Mexico	University of Queensland; Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Landcare Research - New Zealand; Universidade de Lisboa; Universidade do Porto; Universidad Nacional Autonoma de Mexico	McDonald-Madden, E (corresponding author), Univ Queensland, Ctr Appl Environm Decis Anal, Sch Integrat Biol, St Lucia, Qld 4075, Australia.	e.mcdonaldmadden@uq.edu.au	Ponce-Reyes, Rocio/K-1553-2013; Ponce-Reyes, Rocio/V-5178-2019; Carvalho, Silvia B/J-3343-2013; Carvalho, Silvia/AAE-9566-2020; Gordon, Ascelin/I-9184-2012; Bottrill, Madeleine/A-4687-2011; McDonald-Madden, Eve/A-5186-2012; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019	Ponce-Reyes, Rocio/0000-0002-3680-8736; Ponce-Reyes, Rocio/0000-0002-3680-8736; Carvalho, Silvia B/0000-0003-4368-4708; Carvalho, Silvia/0000-0003-4368-4708; Gordon, Ascelin/0000-0002-0648-0346; McDonald-Madden, Eve/0000-0001-7755-2338; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; STEWART, Romola/0000-0002-4280-8951; wintle, brendan/0000-0002-4234-5950				ACCAD A, 2006, REMNANT VEGETATION Q; BALLANCE A, 1999, STATE ENV S AFRICA O; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; *COMM ENV COOP, 2001, N AM MOS STAT ENV RE; *DETR, 2000, CAS STUD BUS BIOD; Economic and Social Commission for Asia and the Pacific, 2005, STAT ENV AS PAC; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; HIGGINS J, 2007, ECOREGIONAL STATUS M; *HJ HEINZ III CTR, 2002, STAT NAT EC MEAS LAN, P1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; POSSINGHAM HP, 2001, TELA, V9, P1; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; State of the Environment Advisory Council, 1996, AUSTR STAT ENV 1996; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Truscott M, 2006, AUSTR STAT ENV COMM; UNEP, 2007, GLOB ENV OUTL 4 ENV; Walker S, 2008, CONSERV BIOL, V22, P48, DOI 10.1111/j.1523-1739.2007.00844.x	18	30	32	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					43	44		10.1126/science.1164342	http://dx.doi.org/10.1126/science.1164342			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119202				2022-12-24	WOS:000262104100026
J	Petrovic, M; Hummel, T				Petrovic, Milan; Hummel, Thomas			Temporal identity in axonal target layer recognition	NATURE			English	Article							ZINC-FINGER PROTEIN; LAMINA-SPECIFIC CONNECTIVITY; N-CADHERIN; TRANSCRIPTION FACTORS; GENE-FUNCTION; DROSOPHILA; RECEPTOR; EXPRESSION; SYSTEM; REGULATOR	The segregation of axon and dendrite projections into distinct synaptic layers is a fundamental principle of nervous system organization and the structural basis for information processing in the brain(1). Layer- specific recognition molecules that allow projecting neurons to stabilize transient contacts and initiate synaptogenesis(2,3) have been identified. However, most of the neuronal cell- surface molecules critical for layer organization are expressed broadly in the developing nervous system(4,5), raising the question of how these so- called permissive adhesion molecules support synaptic specificity. Here we show that the temporal expression dynamics of the zinc- finger protein sequoia is the major determinant of Drosophila photoreceptor connectivity into distinct synaptic layers. Neighbouring R8 and R7 photoreceptors show consecutive peaks of elevated sequoia expression, which correspond to their sequential target- layer innervation. Loss of sequoia in R7 leads to a projection switch into the R8 recipient layer, whereas a prolonged expression in R8 induces a redirection of their axons into the R7 layer. The sequoia- induced axon targeting is mediated through the ubiquitously expressed Cadherin- N cell adhesion molecule. Our data support a model in which recognition specificity during synaptic layer formation is generated through a temporally restricted axonal competence to respond to broadly expressed adhesion molecules. Because developing neurons innervating the same target area often project in a distinct, birth- order- dependent sequence, temporal identity seems to contain crucial information in generating not only cell type diversity during neuronal division(6) but also connection diversity of projecting neurons.	[Petrovic, Milan; Hummel, Thomas] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Hummel, T (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	hummel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB629]; EMBO Young Investigator Programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO))	We thank H. Bellen, J. Brenman, I. Salecker and R. Schuh for fly stocks and antibodies; D. Hawellek for the identification and analysis of seq<SUP>6</SUP>; and H. Aberle, S. Bogdan, C. Klambt, A. Puschel and members of the Hummel laboratory for critical comments on the manuscript. T. H. is supported by the Deutsche Forschungsgemeinschaft (SFB629) and the EMBO Young Investigator Programme.	BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; DESAI CJ, 1994, J NEUROSCI, V14, P7272; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gil OD, 2002, J COMP NEUROL, V453, P372, DOI 10.1002/cne.10424; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MCGUIRE SE, 2004, SCI STKE, pPL6; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Sun Q, 2000, DEVELOPMENT, V127, P801; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	42	60	60	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					800	U87		10.1038/nature07407	http://dx.doi.org/10.1038/nature07407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18978776				2022-12-24	WOS:000261559900051
J	Puthanveettil, SV; Monje, FJ; Miniaci, MC; Choi, YB; Karl, KA; Khandros, E; Gawinowicz, MA; Sheetz, MP; Kandel, ER				Puthanveettil, Sathyanarayanan V.; Monje, Francisco J.; Miniaci, Maria Concetta; Choi, Yun-Beom; Karl, Kevin A.; Khandros, Eugene; Gawinowicz, Mary Ann; Sheetz, Michael P.; Kandel, Eric R.			A New Component in Synaptic Plasticity: Upregulation of Kinesin in the Neurons of the Gill-Withdrawal Reflex	CELL			English	Article							LONG-TERM FACILITATION; LOCAL PROTEIN-SYNTHESIS; APLYSIA SENSORY NEURONS; AXONAL-TRANSPORT; HETEROSYNAPTIC FACILITATION; NERVOUS-SYSTEM; MEMORY STORAGE; MOTOR; EXPRESSION; SYNAPSES	To explore how gene products, required for the initiation of synaptic growth, move from the cell body of the sensory neuron to its presynaptic terminals, and from the cell body of the motor neuron to its postsynaptic dendritic spines, we have investigated the anterograde transport machinery in both the sensory and motor neurons of the gill-withdrawal reflex of Aplysia. We found that the induction of long-term facilitation (LTF) by repeated applications of serotonin, a modulatory transmitter released during learning in Aplysia, requires upregulation of kinesin heavy chain (KHC) in both pre- and postsynaptic neurons. Indeed, upregulation of KHC in the presynaptic neurons alone is sufficient for the induction of LTF. However, KHC is not required for the persistence of LTF. Thus, in addition to transcriptional activation in the nucleus and local protein synthesis at the synapse, our studies have identified a third component critical for long-term learning-related plasticity: the coordinated upregulation of kinesin-mediated transport.	[Puthanveettil, Sathyanarayanan V.; Monje, Francisco J.; Miniaci, Maria Concetta; Choi, Yun-Beom; Khandros, Eugene; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Karl, Kevin A.; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Gawinowicz, Mary Ann] Columbia Univ Coll Phys & Surg, Prot Chem Core Facil, New York, NY 10032 USA; [Sheetz, Michael P.] Columbia Univ Coll Phys & Surg, Dept Biol Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Kavli Inst Brain Sci, New York, NY 10032 USA; [Choi, Yun-Beom] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Miniaci, Maria Concetta] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of Naples Federico II	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu		Miniaci, Maria/0000-0003-3844-0581	HHMI; NIH [P50 HG002806, R01 MH075026]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	members Joseph Rayman and Ilias Pavlopoulos for their critical comments on an earlier version of this manuscript. We are grateful to Peter Schieffele for the gift of anti-neurexin antibody. We thank Joun-Hun Kim for help with Piccolo antisense microinjection experiments, Aviva Olsavsky for help with the RTPCR experiments, and John Edwards of Columbia's Genome Center for help with kinesin ESTs. Special thanks to Vivian Zhu for help with cell cultures, Hannah Cho for technical help, and Charles Lam for help with graphics. This work is supported by HHMI, and NIH grants P50 HG002806 and R01 MH075026.	BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Grigoriev I S, 1999, Membr Cell Biol, V13, P23; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026	44	67	67	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					960	973		10.1016/j.cell.2008.11.003	http://dx.doi.org/10.1016/j.cell.2008.11.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041756	Bronze, Green Accepted			2022-12-24	WOS:000261183900025
J	Onwude, JL				Onwude, Joseph L.			What is the most effective treatment of interstitial cystitis?	BRITISH MEDICAL JOURNAL			English	Editorial Material							BACILLUS-CALMETTE-GUERIN; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PENTOSAN POLYSULFATE; DIMETHYL-SULFOXIDE; L-ARGININE; EFFICACY		[Onwude, Joseph L.] Community Gynaecol Ltd, Chelmsford CM1 3RW, Essex, England		Onwude, JL (corresponding author), Community Gynaecol Ltd, Chelmsford CM1 3RW, Essex, England.	jlonwude@btconnect.com	ONWUDE, JOSEPH LOZE/ABA-4929-2021; ONWUDE, JOSEPH Loze/AFM-0527-2022; ONWUDE, JOSEPH Loze/AAH-2903-2022; ONWUDE, JOSEPH LOZE/ABF-7876-2021					Bade JJ, 1997, BRIT J UROL, V79, P168, DOI 10.1046/j.1464-410X.1997.03384.x; Cartledge JJ, 2000, BJU INT, V85, P421, DOI 10.1046/j.1464-410x.2000.00490.x; Hwang P, 1997, UROLOGY, V50, P39, DOI 10.1016/S0090-4295(97)00110-6; *INT CYST CLIN RES, 2007, EFF AM PAINF BLADD S; Korting GE, 1999, J UROLOGY, V161, P558, DOI 10.1016/S0022-5347(01)61950-5; Mayer R, 2005, J UROLOGY, V173, P1186, DOI 10.1097/01.ju.0000152337.82806.e8; Payne CK, 2005, J UROLOGY, V173, P1590, DOI 10.1097/01.ju.0000154631.92150.ef; Peeker R, 2000, J UROLOGY, V164, P1912, DOI 10.1016/S0022-5347(05)66916-9; PEREZMARRERO R, 1988, J UROLOGY, V140, P36, DOI 10.1016/S0022-5347(17)41478-9; Peters K, 1997, J UROLOGY, V157, P2090, DOI 10.1016/S0022-5347(01)64682-2; Sairanen J, 2005, J UROLOGY, V174, P2235, DOI 10.1097/01.ju.0000181808.45786.84; Sant GR, 2003, J UROLOGY, V170, P810, DOI 10.1097/01.ju.0000083020.06212.3d; Thilagarajah R, 2001, BJU INT, V87, P207, DOI 10.1046/j.1464-410x.2001.02031.x; van Ophoven A, 2004, J UROLOGY, V172, P533, DOI 10.1097/01.ju.0000132388.54703.4d; Warren JW, 2000, J UROLOGY, V163, P1685, DOI 10.1016/S0022-5347(05)67520-9	15	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 27	2008	337								a2325	10.1136/bmj.a2325	http://dx.doi.org/10.1136/bmj.a2325			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039011				2022-12-24	WOS:000261827700003
J	Liu, SX; Abbondanzieri, EA; Rausch, JW; Le Grice, SFJ; Zhuang, XW				Liu, Shixin; Abbondanzieri, Elio A.; Rausch, Jason W.; Le Grice, Stuart F. J.; Zhuang, Xiaowei			Slide into Action: Dynamic Shuttling of HIV Reverse Transcriptase on Nucleic Acid Substrates	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRAND DISPLACEMENT SYNTHESIS; DEPENDENT DNA-POLYMERASE; RNASE-H; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SINGLE MOLECULES; ENERGY-TRANSFER	The reverse transcriptase ( RT) of human immunodeficiency virus ( HIV) catalyzes a series of reactions to convert single- stranded viral RNA into double- stranded DNA for host cell integration. This process requires a variety of enzymatic activities, including DNA polymerization, RNA cleavage, strand transfer, and strand displacement synthesis. We used single- molecule fluorescence resonance energy transfer to probe the interactions between RT and nucleic acid substrates in real time. RT was observed to slide on nucleic acid duplexes, rapidly shuttling between opposite termini of the duplex. Upon reaching the DNA 3' terminus, RT can spontaneously flip into a polymerization orientation. Sliding kinetics were regulated by cognate nucleotides and anti- HIV drugs, which stabilized and destabilized the polymerization mode, respectively. These long- range translocation activities facilitate multiple stages of the reverse transcription pathway, including normal DNA polymerization and strand displacement synthesis.	[Liu, Shixin; Abbondanzieri, Elio A.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Liu, Shixin/A-4560-2012		NIH [GM 068518]; Intramural Research Program of the Center for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by NIH (GM 068518 to X. Z.) and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (to S.F.J.L.G.). X.Z. is a Howard Hughes Medical Institute investigator. E.A.A. is a Jane Coffin Childs postdoctoral fellow. Nevirapine was provided through the AIDS Research and Reference Reagent Program of NIH.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Fuentes GM, 1996, NUCLEIC ACIDS RES, V24, P1719, DOI 10.1093/nar/24.9.1719; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HOSTOMSKY Z, 1992, J VIROL, V66, P3179, DOI 10.1128/JVI.66.5.3179-3182.1992; HOTTIGER M, 1994, J BIOL CHEM, V269, P986; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1989, J BIOL CHEM, V264, P4669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kelleher CD, 1998, J BIOL CHEM, V273, P9976, DOI 10.1074/jbc.273.16.9976; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanciault C, 2004, J BIOL CHEM, V279, P32252, DOI 10.1074/jbc.M404117200; LEIS JP, 1973, P NATL ACAD SCI USA, V70, P466, DOI 10.1073/pnas.70.2.466; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SMITH JK, 1984, J VIROL, V49, P200, DOI 10.1128/JVI.49.1.200-204.1984; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Telesnitsky A., 1997, P121; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WHITING SH, 1994, J VIROL, V68, P4747, DOI 10.1128/JVI.68.8.4747-4758.1994; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682; Winshell J, 2004, J BIOL CHEM, V279, P52924, DOI 10.1074/jbc.M409134200; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200	44	128	130	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1092	1097		10.1126/science.1163108	http://dx.doi.org/10.1126/science.1163108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008444	Green Accepted			2022-12-24	WOS:000260867700035
J	Yusufzai, T; Kadonaga, JT				Yusufzai, Timur; Kadonaga, James T.			HARP Is an ATP-Driven Annealing Helicase	SCIENCE			English	Article							REPLICATION PROTEIN-A; CHROMATIN REMODELING PROTEIN; IMMUNO-OSSEOUS DYSPLASIA; DNA; SUBFAMILIES; REGRESSION; CLONING; FAMILY; ENZYME; REPAIR	DNA- dependent adenosine triphosphatases ( ATPases) participate in a broad range of biological processes including transcription, DNA repair, and chromatin dynamics. Mutations in the HepA- related protein ( HARP) ATPase are responsible for Schimke immuno- osseous dysplasia ( SIOD), but the function of the protein is unknown. We found that HARP is an ATP- dependent annealing helicase that rewinds single- stranded DNA bubbles that are stably bound by replication protein A. Other related ATPases, including the DNA translocase Rad54, did not exhibit annealing helicase activity. Analysis of mutant HARP proteins suggests that SIOD is caused by a deficiency in annealing helicase activity. Moreover, the pleiotropy of HARP mutations is consistent with the function of HARP as an annealing helicase that acts throughout the genome to oppose the action of DNA- unwinding activities in the nucleus.	[Yusufzai, Timur; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu			NIH [GM058272]; NIH National Research Service Award fellowship [F32 GM76936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076936, R01GM058272] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Rattner, J.-Y. A. Hsu, T. Juven-Gershon, D. Urwin, and J. Theisen for critical reading of the manuscript; M. Coleman for the gift of HARP cDNAs in the early stages of this study; M. Wold for the human RPA expression vector; B. Cairns for the triple- helix plasmid; R. Kingston for the BRG1 expression vector; and M. Gellert for a helpful discussion on this work prior to publication. Supported by NIH grant GM058272 (J.T.K.) and by NIH National Research Service Award fellowship F32 GM76936 (T.Y.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Elizondo LI, 2006, AM J MED GENET A, V140A, P340, DOI 10.1002/ajmg.a.31089; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; HOCKENSMITH JW, 1986, BIOCHEMISTRY-US, V25, P7812, DOI 10.1021/bi00372a005; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Muthuswami R, 2000, J BIOL CHEM, V275, P7648, DOI 10.1074/jbc.275.11.7648; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636	19	136	141	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					748	750		10.1126/science.1161233	http://dx.doi.org/10.1126/science.1161233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974355	Green Accepted			2022-12-24	WOS:000260605200051
J	Honjoh, S; Yamamoto, T; Uno, M; Nishida, E				Honjoh, Sakiko; Yamamoto, Takuya; Uno, Masaharu; Nishida, Eisuke			Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C-elegans	NATURE			English	Article							LIFE-SPAN EXTENSION; RESTRICTION-INDUCED LONGEVITY; MESSENGER-RNA TRANSLATION; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; TOR; DAF-16; DEPRIVATION; INHIBITION; RESISTANCE	Dietary restriction is the most effective and reproducible intervention to extend lifespan in divergent species(1). In mammals, two regimens of dietary restriction, intermittent fasting ( IF) and chronic caloric restriction, have proven to extend lifespan and reduce the incidence of age- related disorders(2). An important characteristic of IF is that it can increase lifespan even when there is little or no overall decrease in calorie intake(2). The molecular mechanisms underlying IF- induced longevity, however, remain largely unknown. Here we establish an IF regimen that effectively extends the lifespan of Caenorhabditis elegans, and show that the low molecular weight GTPase RHEB- 1 has a dual role in lifespan regulation; RHEB- 1 is required for the IF- induced longevity, whereas inhibition of RHEB- 1 mimics the caloric- restriction effects. RHEB- 1 exerts its effects in part by the insulin/ insulin growth factor ( IGF)- like signalling effector DAF- 16 in IF. Our analyses demonstrate that most fasting- induced upregulated genes require RHEB- 1 function for their induction, and that RHEB- 1 and TOR signalling are required for the fasting- induced downregulation of an insulin- like peptide, INS- 7. These findings identify the essential role of signalling by RHEB- 1 in IF- induced longevity and gene expression changes, and suggest a molecular link between the IF- induced longevity and the insulin/ IGF- like signalling pathway.	[Honjoh, Sakiko; Yamamoto, Takuya; Uno, Masaharu; Nishida, Eisuke] Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	L50174@sakura.kudpc.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Uno, Masaharu/0000-0001-7770-3941	Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH National Center for Research Resources	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank members of our laboratory for technical comments and helpful discussion. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E.N.). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRENNER S, 1974, GENETICS, V77, P71; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Malone EA, 1996, GENETICS, V143, P1193; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1	33	171	179	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					726	U6		10.1038/nature07583	http://dx.doi.org/10.1038/nature07583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079239				2022-12-24	WOS:000263064700042
J	Gillum, MP; Zhang, D; Zhang, XM; Erion, DM; Jamison, RA; Choi, C; Dong, J; Shanabrough, M; Duenas, HR; Frederick, DW; Hsiao, JJ; Horvath, TL; Lo, CM; Tso, P; Cline, GW; Shulman, GI				Gillum, Matthew P.; Zhang, Dongyan; Zhang, Xian-Man; Erion, Derek M.; Jamison, Rachel A.; Choi, Cheolsoo; Dong, Jianying; Shanabrough, Marya; Duenas, Hillary R.; Frederick, David W.; Hsiao, Jennifer J.; Horvath, Tamas L.; Lo, Chun Min; Tso, Pat; Cline, Gary W.; Shulman, Gerald I.			N-acylphosphatidylethanolamine, a Gut-Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake	CELL			English	Article							NERVOUS-SYSTEM CONTROL; ENERGY-INTAKE; DIETARY-FAT; BODY-WEIGHT; RECEPTOR; OLEOYLETHANOLAMIDE; BRAIN; ACTIVATION; GLUCOSE	N-acylphosphatidylethanolamines (NAPEs) are a relatively abundant group of plasma lipids of unknown physiological significance. Here, we show that NAPEs are secreted into circulation from the small intestine in response to ingested fat and that systemic administration of the most abundant circulating NAPE, at physiologic doses, decreases food intake in rats without causing conditioned taste aversion. Furthermore, C-14-radiolabeled NAPE enters the brain and is particularly concentrated in the hypothalamus, and intracerebroventricular infusions of nanomolar amounts of NAPE reduce food intake, collectively suggesting that its effects may be mediated through direct interactions with the central nervous system. Finally, chronic NAPE infusion results in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.	[Gillum, Matthew P.; Zhang, Dongyan; Erion, Derek M.; Jamison, Rachel A.; Dong, Jianying; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Gillum, Matthew P.; Zhang, Xian-Man; Erion, Derek M.; Jamison, Rachel A.; Choi, Cheolsoo; Frederick, David W.; Hsiao, Jennifer J.; Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Gillum, Matthew P.; Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shanabrough, Marya; Duenas, Hillary R.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [Lo, Chun Min; Tso, Pat] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45627 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; University System of Ohio; University of Cincinnati	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064; Gillum, Matthew/0000-0003-4893-012X	United States Public Health Service [R01 DK-40936, P30 DK-45735, U24 DK-76169]; Endocrine Society Research; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, P30DK045735, U24DK059635, R01DK040936, R01DK049230, R24DK085638] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Endocrine Society Research; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Drs. James Pickel and George Kunos for kindly providing us with the CB1<SUP>-/-</SUP> mice and Maya Kotas for incisive commentary. This work was supported by grants from the United States Public Health Service (R01 DK-40936, P30 DK-45735, and U24 DK-76169), an Endocrine Society Research Fellowship (M. P. G.), and a Distinguished Clinical ScientistAward (G. I. S.) from the American Diabetes Association.	Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Carter RJ, 1999, J NEUROSCI, V19, P3248; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Donahoo W, 2008, OBESITY, V16, P64, DOI 10.1038/oby.2007.31; Emond M, 2001, PHYSIOL BEHAV, V72, P123, DOI 10.1016/S0031-9384(00)00393-0; Fry M, 2007, PHYSIOL BEHAV, V91, P413, DOI 10.1016/j.physbeh.2007.04.003; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Holder JL, 2000, HUM MOL GENET, V9, P101; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kobelt P, 2005, AM J PHYSIOL-REG I, V288, pR751, DOI 10.1152/ajpregu.00094.2004; Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MISELIS RR, 1975, AM J PHYSIOL, V229, P1438, DOI 10.1152/ajplegacy.1975.229.5.1438; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Riley Anthony L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0806es29; Rowland NE, 1997, REGUL PEPTIDES, V71, P171, DOI 10.1016/S0167-0115(97)01034-3; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104	33	114	118	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					813	824		10.1016/j.cell.2008.10.043	http://dx.doi.org/10.1016/j.cell.2008.10.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041747	Green Accepted, Bronze			2022-12-24	WOS:000261183900014
J	Wierzbicki, AT; Haag, JR; Pikaard, CS				Wierzbicki, Andrzej T.; Haag, Jeremy R.; Pikaard, Craig S.			Noncoding Transcription by RNA Polymerase Pol IVb/Pol V Mediates Transcriptional Silencing of Overlapping and Adjacent Genes	CELL			English	Article							DIRECTED DNA-METHYLATION; IV; HETEROCHROMATIN; ELEMENTS; SIRNA; ORGANIZATION; THALIANA; REQUIRES; PATHWAY; CORE	Nuclear transcription is not restricted to genes but occurs throughout the intergenic and noncoding space of eukaryotic genomes. The functional significance of this widespread noncoding transcription is mostly unknown. We show that Arabidopsis RNA polymerase IVb/Pol V, a multisubunit nuclear enzyme required for siRNA-mediated gene silencing of transposons and other repeats, transcribes intergenic and noncoding sequences, thereby facilitating heterochromatin formation and silencing of overlapping and adjacent genes. Pol IVb/Pol V transcription requires the chromatin-remodeling protein DRD1 but is independent of siRNA biogenesis. However, Pol IVb/Pol V transcription and siRNA production are both required to silence transposons, suggesting that Pol IVb/Pol V generates RNAs or chromatin structures that serve as scaffolds for siRNA-mediated heterochromatin-forming complexes. Pol IVb/Pol V function provides a solution to a paradox of epigenetic control: the need for transcription in order to transcriptionally silence the same region.	[Wierzbicki, Andrzej T.; Haag, Jeremy R.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	NIGMS NIH HHS [R01 GM077590, R01 GM077590-03, GM077590] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Baulcombe DC, 2006, COLD SPRING HARB SYM, V71, P13, DOI 10.1101/sqb.2006.71.052; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Gilbert C., 2006, CURRENT PROTOCOLS MO; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2005, NAT METHODS, V2, P219, DOI 10.1038/nmeth0305-219; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke SM, 2006, COLD SPRING HARB SYM, V71, P497, DOI 10.1101/sqb.2006.71.062; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Myouga F, 2001, GENES GENET SYST, V76, P169, DOI 10.1266/ggs.76.169; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; Willingham AT, 2006, COLD SPRING HARB SYM, V71, P101, DOI 10.1101/sqb.2006.71.068; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	52	492	522	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					635	648		10.1016/j.cell.2008.09.035	http://dx.doi.org/10.1016/j.cell.2008.09.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013275	Green Accepted, Bronze			2022-12-24	WOS:000260886900015
J	Kivimaki, M; Shipley, MJ; Ferrie, JE; Singh-Manoux, A; Batty, GD; Chandola, T; Marmot, MG; Smith, GD				Kivimaki, Mika; Shipley, Martin J.; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Chandola, Tarani; Marmot, Michael G.; Smith, George Davey			Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study	LANCET			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; SOCIAL INEQUALITIES; YANOMAMO INDIANS; CIVIL-SERVANTS; ABSOLUTE; HEALTH; METAANALYSIS; HYPERTENSION; EFFICACY	Background How much the successful implementation of the most effective (ie, best-practice) interventions could reduce socioeconomic inequalities of coronary heart disease mortality is not known. We assessed this issue in an occupational cohort study comparing low with high socioeconomic groups. Methods We undertook a prospective cohort study on 17 186 male civil servants aged 40-69 years between 1967 and 1970 in the UK (the Whitehall study). Socioeconomic position was based on employment grade. We compared the potential reduction in excess coronary heart disease mortality in men of low with those of high socioeconomic position with either best-practice interventions (reduction of systolic blood pressure by 10 mm Hg, of total cholesterol by 2 mmol/L, and of blood glucose by 1 mmol/L in pre-diabetic people; halving the prevalence of non-insulin-dependent diabetes; and complete cessation of cigarette smoking) or primordial prevention. Findings 15-year absolute risk of death due to coronary heart disease per 100 men, standardised to age 55 years, was 11.0 for men in the low employment grade group and 7.5 for those in the high grade group. Population-wide best-practice interventions would reduce coronary heart disease mortality by 57%, and the difference in mortality between socioeconomic groups by 69%. For primordial prevention, the corresponding reductions would be 73% and 86%, respectively. Interpretation Our results suggest that current best-practice interventions to reduce classic coronary risk factors, if successfully implemented in both high and low socioeconomic groups, could eliminate most of the differences in coronary heart disease mortality. Modest further benefits would result if the classic coronary risk factors could be reduced to primordial levels for the whole population.	[Kivimaki, Mika; Shipley, Martin J.; Ferrie, Jane E.; Singh-Manoux, Archana; Chandola, Tarani; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Singh-Manoux, Archana] Hop Paul Brousse, INSERM, Villejuif, France; [Batty, G. David] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Smith, George Davey] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Bristol	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018; Singh-Manoux, Archana/F-6804-2013; Ferrie, Jane/AAZ-2009-2020; Marmot, M G/Y-3920-2019; Davey Smith, George/A-7407-2013; Chandola, Tarani/I-3192-2013	Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Singh-Manoux, Archana/0000-0002-1244-5037; Marmot, M G/0000-0002-2431-6419; Davey Smith, George/0000-0002-1407-8314; Chandola, Tarani/0000-0002-1864-3413; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Department of Health and Social Security (UK); Tobacco Research Council (UK); British Heart Foundation (UK); Medical Research Council (UK); European Science Foundation (EU); Wellcome Trust (UK); Academy of Finland (Finland); British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_U130059821, G8802774, G0700704B, G19/35, G0100222] Funding Source: researchfish; MRC [MC_U130059821] Funding Source: UKRI	Department of Health and Social Security (UK); Tobacco Research Council (UK); British Heart Foundation (UK)(British Heart Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Science Foundation (EU)(European Science Foundation (ESF)European Commission); Wellcome Trust (UK)(Wellcome Trust); Academy of Finland (Finland)(Academy of Finland); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Department of Health and Social Security (UK), Tobacco Research Council (UK), British Heart Foundation (UK), Medical Research Council (UK), European Science Foundation (EU), Wellcome Trust (UK), and Academy of Finland (Finland). The original screening of the Whitehall study was funded by the Department of Health and Social Security, and the Tobacco Research Council (UK). MK was supported by the Academy of Finland (Finland); MJS by the British Heart Foundation (UK); JEF by the Medical Research Council (UK); and ASM by the European Science Foundation (EU). GDB is a Wellcome Trust fellow. MGM is a Medical Research Council professor and, at the time of this work, was supported by the WHO Commission on Determinants of Socioeconomic inequalities in Health, which he chaired.	Acheson D., 1998, INDEPENDENT INQUIRY; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Black D, 1980, INEQUALITIES HLTH RE; Brunner EJ, 2006, DIABETES CARE, V29, P26; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; CSDH, 2008, CLOS GAP GEN HLTH EQ; *DEP HLTH, 2003, NAT STAT RISK FACT C; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Edwards Jayne E, 2003, BMC Fam Pract, V4, P18, DOI 10.1186/1471-2296-4-18; EYER J, 1975, INT J HEALTH SERV, V5, P539, DOI 10.2190/UT72-3RTX-V0KN-64AF; FAHEY T, 2006, COCHRANE DB SYST REV, V4, P5182; Fuchs FD, 2004, LANCET, V363, P332, DOI 10.1016/S0140-6736(03)15405-0; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Khang YH, 2008, HEART, V94, P75, DOI 10.1136/hrt.2007.117747; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MANCILHACARVALHO JJ, 1989, J HUM HYPERTENS, V3, P309; MANCILHACARVALHO JJ, 1990, PREV MED, V19, P66, DOI 10.1016/0091-7435(90)90009-9; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; ODEA K, 1992, J INTERN MED, V232, P103, DOI 10.1111/j.1365-2796.1992.tb00559.x; REID DD, 1974, LANCET, V1, P469; ROSE G, 1990, LANCET, V335, P275, DOI 10.1016/0140-6736(90)90082-G; ROSE GA, 1964, LANCET, V1, P296; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P599, DOI 10.1097/EDE.0b013e3181761cdc; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZIMMET P, 1978, AUST NZ J MED, V8, P141, DOI 10.1111/j.1445-5994.1978.tb04500.x	41	90	90	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1648	1654		10.1016/S0140-6736(08)61688-8	http://dx.doi.org/10.1016/S0140-6736(08)61688-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994662	Bronze, Green Submitted			2022-12-24	WOS:000260899900026
J	Melhuish, E; Belsky, J; Leyland, AH; Barnes, J				Melhuish, Edward; Belsky, Jay; Leyland, Alastair H.; Barnes, Jacqueline		Natl Evaluation Sure Start Res Tea	Effects of fully-established Sure Start Local Programmes on 3-year-old children and their families living in England: a quasi-experimental observational study	LANCET			English	Article							INTERVENTION	Background Sure Start Local Programmes (SSLPs) are area-based interventions to improve services for young children and their families in deprived communities, promote health and development, and reduce inequalities. We therefore investigated whether SSLPs affect the wellbeing of 3-year-old children and their families. Methods In a quasi-experimental observational study, we compared 5883 3-year-old children and their families from 93 disadvantaged SSLP areas with 1879 3-year-old children and their families from 72 similarly deprived areas in England who took part in the Millennium Cohort Study. We studied 14 outcomes--children's immunisations, accidents, language development, positive and negative social behaviours, and independence; parenting risk; home-learning environment; father's involvement; maternal smoking, body-mass index,and life satisfaction; family's service use; and mother's rating of area. Findings After we controlled for background factors, we noted beneficial effects associated with the programmes for five of 14 outcomes. Children in the SSLP areas showed better social development than those in the non-SSLP areas, with more positive social behaviour (mean difference 0.45, 95% CI 0.09 to 0.80, p=0.01) and greater independence (0.32, 0.18 to 0.47, p<0.0001). Families in SSLP areas showed less negative parenting (-0.90, -1.11 to -0.69, p<0.0001) and provided a better home-learning environment (1.30, 0.75 to 1. 86, p<0.0001). These families used more services for supporting child and family development than those not living in SSLP areas (0.98, 0.86 to 1.09, p<0.0001). Effects of SSLPs seemed to apply to all subpopulations and SSLP areas. Interpretation Children and their families benefited from living in SSLP areas. The contrast between these and previous findings on the effect of SSLPs might indicate increased exposure to programmes that have become more effective. Early interventions can improve the life chances of young children living in deprived areas.	[Melhuish, Edward; Belsky, Jay; Barnes, Jacqueline] Univ London Birkbeck Coll, Inst Study Children Families & Social Issues, London WC1B 3RA, England; [Leyland, Alastair H.] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of London; Birkbeck University London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT	Melhuish, E (corresponding author), Univ London Birkbeck Coll, Inst Study Children Families & Social Issues, 7 Bedford Sq, London WC1B 3RA, England.	e.melhuish@bbk.ac.uk	Leyland, Alastair/C-6069-2011	Belsky, Jay/0000-0003-2191-2503; Ram, Bina/0000-0003-0023-1573; Leyland, Alastair/0000-0003-3741-7099	Department for Children, Schools and Families (DCSF); Medical Research Council; Chief Scientist Office of the Scottish Government Health Directorates [wbs U.1300.00.001]; Medical Research Council [MC_U130059823] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059823] Funding Source: UKRI	Department for Children, Schools and Families (DCSF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Department for Children, Schools and Families (DCSF) after competitive tender. The Medical Research Council Social and Public Health Sciences Unit is jointly funded by the Medical Research Council and the Chief Scientist Office of the Scottish Government Health Directorates (wbs U.1300.00.001).	[Anonymous], 2006, SAS MIXED MODELS; Belsky J., 2007, NATL EVALUATION SURE; Belsky J, 2006, BMJ-BRIT MED J, V332, P1476, DOI 10.1136/bmj.38853.451748.2F; Caldwell BM, 1984, HOME OBSERVATION MEA; Elliot C. D., 1996, BRIT ABILITY SCALES; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; HANSEN K, 2006, MILLENNIUM COHORT ST; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Love JM, 2005, DEV PSYCHOL, V41, P885, DOI 10.1037/0012-1649.41.6.885; MATHENY AP, 1995, J APPL DEV PSYCHOL, V16, P429, DOI 10.1016/0193-3973(95)90028-4; MEADOWS P, 2007, NATL EVALUATION SURE; MELHUISH E, 2007, NATL EVALUATION SURE; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; *ODPM, 2004, ENGL IND DEPR REV; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; Pianta, 2001, STUDENT TEACHER RELA; Raghunathan TE., 2007, IVEWARE IMPUTATION V; RAMEY CT, 2000, APPL DEV SCI, V0004; Roberts C, 2006, J CLIN CHILD ADOLESC, V35, P180, DOI 10.1207/s15374424jccp3502_2; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; SAMMONS P, 2003, 8B DFES; Schafer J., 1999, ANAL INCOMPLETE MULT; STPIERRE RG, 1997, NATL IMPACT EVALUATI; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9	26	134	135	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1641	1647		10.1016/S0140-6736(08)61687-6	http://dx.doi.org/10.1016/S0140-6736(08)61687-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994661	Bronze, Green Submitted			2022-12-24	WOS:000260899900025
J	Eggeling, C; Ringemann, C; Medda, R; Schwarzmann, G; Sandhoff, K; Polyakova, S; Belov, VN; Hein, B; von Middendorff, C; Schonle, A; Hell, SW				Eggeling, Christian; Ringemann, Christian; Medda, Rebecca; Schwarzmann, Guenter; Sandhoff, Konrad; Polyakova, Svetlana; Belov, Vladimir N.; Hein, Birka; von Middendorff, Claas; Schoenle, Andreas; Hell, Stefan W.			Direct observation of the nanoscale dynamics of membrane lipids in a living cell	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CULTURED-CELLS; RAFTS; MICROSCOPY; DIFFUSION; ORGANIZATION; RESOLUTION; GLUCOSYLCERAMIDE; MICRODOMAINS; DEPLETION	Cholesterol-mediated lipid interactions are thought to have a functional role in many membrane-associated processes such as signalling events(1-5). Although several experiments indicate their existence, lipid nanodomains ('rafts') remain controversial owing to the lack of suitable detection techniques in living cells(4,6-9). The controversy is reflected in their putative size of 5-200 nm, spanning the range between the extent of a protein complex and the resolution limit of optical microscopy. Here we demonstrate the ability of stimulated emission depletion (STED) far-field fluorescence nanoscopy(10) to detect single diffusing (lipid) molecules in nanosized areas in the plasma membrane of living cells. Tuning of the probed area to spot sizes similar to 70-fold below the diffraction barrier reveals that unlike phosphoglycerolipids, sphingolipids and glycosylphosphatidylinositol-anchored proteins are transiently (similar to 10-20 ms) trapped in cholesterol-mediated molecular complexes dwelling within <20-nm diameter areas. The non-invasive optical recording of molecular time traces and fluctuation data in tunable nanoscale domains is a powerful new approach to study the dynamics of biomolecules in living cells.	[Eggeling, Christian; Ringemann, Christian; Medda, Rebecca; Polyakova, Svetlana; Belov, Vladimir N.; Hein, Birka; von Middendorff, Claas; Schoenle, Andreas; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Schwarzmann, Guenter; Sandhoff, Konrad] Univ Bonn, LIMES Membrane Biol & Lipid Biochem Unit, D-53121 Bonn, Germany	Max Planck Society; University of Bonn	Eggeling, C (corresponding author), Max Planck Inst Biophys Chem, Dept Nanobiophoton, Fassberg 11, D-37077 Gottingen, Germany.	ceggeli@gwdg.de; shell@gwdg.de	Polyakova, Svetlana M./U-4325-2018	Polyakova, Svetlana M./0000-0002-2971-5267; Belov, Vladimir N/0000-0002-7741-4653				BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; FAHEY PF, 1977, SCIENCE, V195, P305, DOI 10.1126/science.831279; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fielding C. J, 2006, LIPID RAFTS CAVEOLAE; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Lommerse PHM, 2004, BBA-BIOMEMBRANES, V1664, P119, DOI 10.1016/j.bbamem.2004.05.005; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OSBORN M, 1977, P NATL ACAD SCI USA, V74, P2490, DOI 10.1073/pnas.74.6.2490; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; SCHWARZMANN G, 1995, J BIOL CHEM, V270, P21271, DOI 10.1074/jbc.270.36.21271; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Wenger J, 2007, BIOPHYS J, V92, P913, DOI 10.1529/biophysj.106.096586; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	32	1103	1118	17	746	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1159	U121		10.1038/nature07596	http://dx.doi.org/10.1038/nature07596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19098897	Green Published			2022-12-24	WOS:000263680100047
J	Ma, DK; Jang, MH; Guo, JU; Kitabatake, Y; Chang, ML; Pow-Anpongkul, N; Flavell, RA; Lu, B; Ming, GL; Song, H				Ma, Dengke K.; Jang, Mi-Hyeon; Guo, Junjie U.; Kitabatake, Yasuji; Chang, Min-lin; Pow-Anpongkul, Nattapol; Flavell, Richard A.; Lu, Binfeng; Ming, Guo-li; Song, Hongjun			Neuronal Activity-Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis	SCIENCE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MOUSE; TRANSCRIPTION; METHYLATION; MECHANISMS; PLASTICITY; SIGNALS; PROTEIN; CORTEX	The mammalian brain exhibits diverse types of neural plasticity, including activity- dependent neurogenesis in the adult hippocampus. How transient activation of mature neurons leads to long-lasting modulation of adult neurogenesis is unknown. Here we identify Gadd45b as a neural activity- induced immediate early gene in mature hippocampal neurons. Mice with Gadd45b deletion exhibit specific deficits in neural activity- induced proliferation of neural progenitors and dendritic growth of newborn neurons in the adult hippocampus. Mechanistically, Gadd45b is required for activity- induced DNA demethylation of specific promoters and expression of corresponding genes critical for adult neurogenesis, including brain- derived neurotrophic factor and fibroblast growth factor. Thus, Gadd45b links neuronal circuit activity to epigenetic DNA modification and expression of secreted factors in mature neurons for extrinsic modulation of neurogenesis in the adult brain.	[Ma, Dengke K.; Jang, Mi-Hyeon; Guo, Junjie U.; Kitabatake, Yasuji; Chang, Min-lin; Pow-Anpongkul, Nattapol; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Kitabatake, Yasuji; Chang, Min-lin; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ma, DK (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	dma2@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075	NIH; McKnight; NARSAD; March of Dimes; Johns Hopkins Brain Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight; NARSAD(NARSAD); March of Dimes(March of Dimes); Johns Hopkins Brain Science Institute(Johns Hopkins University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty, S. Synder, and members of Ming and Song laboratories for help and critical comments and L. Liu and Y. Cai for technical support. This work was supported by NIH, McKnight, and NARSAD (to H.S.) and by NIH, March of Dimes, and Johns Hopkins Brain Science Institute (to G-L.M.). R.A.F. is an investigator with the Howard Hughes Medical Institute.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kempermann G, 2000, Prog Brain Res, V127, P35; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MING GL, 2005, BIOL PSYCHIAT, V47, P223; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zhang YX, 2001, BBA-GENE STRUCT EXPR, V1521, P45, DOI 10.1016/S0167-4781(01)00282-2	28	699	722	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1074	1077		10.1126/science.1166859	http://dx.doi.org/10.1126/science.1166859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19119186	Green Accepted			2022-12-24	WOS:000263478400046
J	Narbonne, P; Roy, R				Narbonne, Patrick; Roy, Richard			Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival	NATURE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; C-ELEGANS; LIFE-SPAN; SIGNALING PATHWAY; GENE-EXPRESSION; TISSUE; RESTRICTION; METABOLISM; HYPODERMIS; LONGEVITY	Many organisms can enter a dormant state or diapause to survive harsh environmental conditions for extended durations. When Caenorhabditis elegans larvae enter dauer they arrest feeding but remain active and motile, yet become stress- resistant, extremely long- lived and non- ageing(1). Entry into dauer is associated with a reduction in insulin- like signalling, the accumulation of nutritive resources and a concomitant global change in metabolism(2-5), yet the precise molecular and physiological processes that enable long- term survival in the absence of caloric intake remain largely unknown. We show here that C. elegans larvae that lack LKB1/ AMPK (AMP-activated protein kinase) signalling enter dauer normally, but then rapidly consume their stored energy and prematurely expire following vital organ failure. We found that this signalling pathway acts in adipose- like tissues to downregulate triglyceride hydrolysis so that these lipid reserves are rationed to last the entire duration of the arrest. Indeed, the downregulation of adipose triglyceride lipase (ATGL-1) activity suppresses both the rapid depletion of stored lipids and reduced life span of AMPK mutant dauers, while AMPK directly phosphorylates ATGL-1. Finally, we show that the slow release of energy during dauer is critical for appropriate long- term osmoregulation, which fails as triglyceride resources become depleted. These mechanisms may be essential for survival through diapause, hibernation, or long- term fasting in diverse organisms and may also underlie AMPK- dependent life span extension.	[Narbonne, Patrick; Roy, Richard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Roy, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	richard.roy@mcgill.ca			Canadian Cancer Society; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank A. Fire, O. Hobert, I. Greenwald, D. Baillie, K. Nehrke, J. McGhee, M. Han, S. Li, E. Colella, M. Hebeisen, J. Ouellet, A. Shingina, M. Maduro, F. Solari, E. Greer, J. Lapointe, W. Yang and S. Hekimi for reagents, strains, constructs, help, advice and support. Some of the strains that were used in this analysis came from the Caenorhabditis Genetic Center (CGC), the C. elegans Gene Knockout Consortium, the Japan National Bioresource Project, and the Genome BC C. elegans Gene Expression Consortium. This work was supported by research grants from the Canadian Cancer Society and the Canadian Institutes of Health Research (CIHR) to R.R. P.N. is a recipient of an NSERC studentship. R. R. is a CIHR New Investigator.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; MADURO M, 1995, GENETICS, V141, P977; Masse I, 2005, DEV BIOL, V286, P91, DOI 10.1016/j.ydbio.2005.07.010; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; OKKEMA PG, 1993, GENETICS, V135, P385; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	231	247	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					210	U108		10.1038/nature07536	http://dx.doi.org/10.1038/nature07536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19052547				2022-12-24	WOS:000262360200036
J	Gebauer, D; Volkel, A; Colfen, H				Gebauer, Denis; Voelkel, Antje; Coelfen, Helmut			Stable Prenucleation Calcium Carbonate Clusters	SCIENCE			English	Article							BIOMINERALIZATION; NUCLEATION	Calcium carbonate forms scales, geological deposits, biominerals, and ocean sediments. Huge amounts of carbon dioxide are retained as carbonate ions, and calcium ions represent a major contribution to water hardness. Despite its relevance, little is known about the precipitation mechanism of calcium carbonate, and specified complex crystal structures challenge the classical view on nucleation considering the formation of metastable ion clusters. We demonstrate that dissolved calcium carbonate in fact contains stable prenucleation ion clusters forming even in undersaturated solution. The cluster formation can be characterized by means of equilibrium thermodynamics, applying a multiple- binding model, which allows for structural preformation. Stable clusters are the relevant species in calcium carbonate nucleation. Such mechanisms may also be important for the crystallization of other minerals.	[Gebauer, Denis; Voelkel, Antje; Coelfen, Helmut] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Max Planck Society	Colfen, H (corresponding author), Max Planck Inst Colloids & Interfaces, Res Campus Golm,Muhlenberg 1, D-14424 Potsdam, Germany.	coelfen@mpikg.mpg.de	Gebauer, Denis/H-2408-2011	Gebauer, Denis/0000-0003-1612-051X	German Science Foundation [1117]; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	Financial support by the German Science Foundation priority program 1117 "Principles of Biomineralization" and the Max Planck Society are gratefully acknowledged. We thank M. Antonietti (MPI) and P. Bowen (Ecole Polytechnique Federale de Lausanne, Switzerland) for valuable discussions on the manuscript, A. Verch (MPI) for experimental assistance, and O. Paris and I. Zenke (both MPI) for SAXS analysis. D. G. thanks T. Ketterer and J. Thomas of Deutsche Metrohm for technical assistance.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Becker R, 1935, ANN PHYS-BERLIN, V24, P719; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Casey WH, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000118; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Faatz M, 2004, ADV MATER, V16, P996, DOI 10.1002/adma.200306565; Furrer G, 2002, SCIENCE, V297, P2245, DOI 10.1126/science.1076505; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Hasse B, 2000, CHEM-EUR J, V6, P3679, DOI 10.1002/1521-3765(20001016)6:20<3679::AID-CHEM3679>3.0.CO;2-#; Horn D, 2001, ANGEW CHEM INT EDIT, V40, P4331; Izmailov AF, 1999, J CRYST GROWTH, V196, P234, DOI 10.1016/S0022-0248(98)00830-6; Knezic D, 2004, J PHYS CHEM B, V108, P10672, DOI 10.1021/jp049586s; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; LARSON MA, 1991, ADVANCES IN INDUSTRIAL CRYSTALLIZATION, P20; LARSON MA, 1986, CHEM ENG SCI, V41, P1285, DOI 10.1016/0009-2509(86)87101-9; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Quigley D., 2008, J CHEM PHYS, V128, P4; Rieger J, 2007, FARADAY DISCUSS, V136, P265, DOI 10.1039/b701450c; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sinn CG, 2004, MACROMOLECULES, V37, P3444, DOI 10.1021/ma030550s; Volmer M, 1939, KINETIK PHASENBILDUN; Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	27	1107	1124	41	717	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1819	1822		10.1126/science.1164271	http://dx.doi.org/10.1126/science.1164271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095936	Green Submitted			2022-12-24	WOS:000261799400047
J	Seila, AC; Calabrese, JM; Levine, SS; Yeo, GW; Rahl, PB; Flynn, RA; Young, RA; Sharp, PA				Seila, Amy C.; Calabrese, J. Mauro; Levine, Stuart S.; Yeo, Gene W.; Rahl, Peter B.; Flynn, Ryan A.; Young, Richard A.; Sharp, Phillip A.			Divergent Transcription from Active Promoters	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; GENOME; POLYCOMB	Transcription initiation by RNA polymerase II ( RNAPII) is thought to occur unidirectionally from most genes. Here, we present evidence of widespread divergent transcription at protein- encoding gene promoters. Transcription start site- associated RNAs ( TSSa- RNAs) nonrandomly flank active promoters, with peaks of antisense and sense short RNAs at 250 nucleotides upstream and 50 nucleotides downstream of TSSs, respectively. Northern analysis shows that TSSa- RNAs are subsets of an RNA population 20 to 90 nucleotides in length. Promoter- associated RNAPII and H3K4- trimethylated histones, transcription initiation hallmarks, colocalize at sense and antisense TSSa- RNA positions; however, H3K79- dimethylated histones, characteristic of elongating RNAPII, are only present downstream of TSSs. These results suggest that divergent transcription over short distances is common for active promoters and may help promoter regions maintain a state poised for subsequent regulation.	[Seila, Amy C.; Calabrese, J. Mauro; Flynn, Ryan A.; Sharp, Phillip A.] MIT, Robert Koch Inst, Cambridge, MA 02139 USA; [Calabrese, J. Mauro; Young, Richard A.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Levine, Stuart S.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Yeo, Gene W.] Crick Jacobs Ctr Theoret & Computat Biol, Salk Inst, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Salk Institute	Sharp, PA (corresponding author), MIT, Robert Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Young, Richard A/F-6495-2012; Yeo, Gene/AAE-7676-2019	Young, Richard A/0000-0001-8855-8647; Yeo, Gene/0000-0002-0799-6037; Levine, Stuart/0000-0001-7363-562X; Flynn, Ryan/0000-0001-5013-0442	NIH [5-F32-HD051190, RO1-GM34277, HG002668]; Crick-Jacobs Center for Computational Biology; NCI Cancer Center Support (core) [PO1- CA42063, P30- CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD051190] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crick-Jacobs Center for Computational Biology; NCI Cancer Center Support (core)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Zheng, C. Whittaker, S. Hoersch, and A.F. Seila. A.C.S. was supported by NIH postdoctoral fellowship 5-F32-HD051190 and G.W.Y. by the Crick-Jacobs Center for Computational Biology. This work was supported by NIH grants RO1-GM34277 and HG002668, NCI grant PO1- CA42063, and the NCI Cancer Center Support (core) grant P30- CA14051. The data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession numbers GSE13483 and GSE12680.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Kays AR, 2000, CHEM BIOL, V7, P601, DOI 10.1016/S1074-5521(00)00009-0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; XIAO H, 1994, NUCLEIC ACIDS RES, V22, P1966, DOI 10.1093/nar/22.11.1966	16	658	684	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1849	1851		10.1126/science.1162253	http://dx.doi.org/10.1126/science.1162253			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056940	Green Accepted			2022-12-24	WOS:000261799400056
J	Box, JA; Bunch, JT; Tang, W; Baumann, P				Box, Jessica A.; Bunch, Jeremy T.; Tang, Wen; Baumann, Peter			Spliceosomal cleavage generates the 3 ' end of telomerase RNA	NATURE			English	Article							PRE-MESSENGER-RNA; FISSION YEAST TELOMERASE; SMALL NUCLEOLAR RNAS; SCHIZOSACCHAROMYCES-POMBE; DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; MUTATIONAL ANALYSIS; CATALYTIC SUBUNIT; APLASTIC-ANEMIA; U1 SNRNA	Telomeres cap the ends of chromosomes and provide a means to complete replication. The DNA portion of telomeres is synthesized by the enzyme telomerase using part of an RNA subunit as a template for reverse transcription. How the mature 39 end of telomerase RNA is generated has so far remained elusive. Here we show that in Schizosaccharomyces pombe telomerase RNA transcripts must be processed to generate functional telomerase. Characterization of the maturation pathway uncovered an unexpected role for the spliceosome, which normally catalyses splicing of pre- messenger RNA. The first spliceosomal cleavage reaction generates the mature 39 end of telomerase RNA ( TER1, the functional RNA encoded by the ter1(+) gene), releasing the active form of the RNA without exon ligation. Blocking the first step or permitting completion of splicing generates inactive forms of TER1 and causes progressive telomere shortening. We establish that 39 end processing of TER1 is critical for telomerase function and describe a previously unknown mechanism for RNA maturation that uses the ability of the spliceosome to mediate site- specific cleavage.	[Box, Jessica A.; Bunch, Jeremy T.; Tang, Wen; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Tang, Wen; Baumann, Peter] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	peb@stowers-institute.org		Baumann, Peter/0000-0003-4892-1485	Stowers Institute for Medical Research; Pew Scholars; Biomedical Sciences Award	Stowers Institute for Medical Research; Pew Scholars; Biomedical Sciences Award	The authors thank H. Yang and the other members of the Baumann laboratory for help and discussions, Y. Tzfati and L. Tomaska for sharing results before publication, and A. Berglund, M. Blanchette, R. Conaway and T. Cech for discussions and comments on the manuscript. We also thank the Molecular Biology Core Facility for site- directed mutagenesis and sequencing, M. Gogol and R. Voelker for computational analysis, and D. Baumann and R. Helston for proofreading of the manuscript. This work was funded by the Stowers Institute for Medical Research and a Pew Scholars in the Biomedical Sciences Award to P. B.	Alvarez CJ, 1996, RNA, V2, P404; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Box JA, 2008, J BIOL CHEM, V283, P24224, DOI 10.1074/jbc.M802043200; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Burge CB, 1999, RNA WORLD, P525; Chapon C, 1997, RNA, V3, P1337; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DOMDEY H, 1984, CELL, V39, P611, DOI 10.1016/0092-8674(84)90468-9; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Li SG, 2005, J BIOL CHEM, V280, P16446, DOI 10.1074/jbc.M500326200; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Romfo CM, 1997, NUCLEIC ACIDS RES, V25, P4658, DOI 10.1093/nar/25.22.4658; SERAPHIN B, 1989, GENE, V82, P145, DOI 10.1016/0378-1119(89)90039-5; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; ZHANG MQ, 1994, NUCLEIC ACIDS RES, V22, P1750, DOI 10.1093/nar/22.9.1750; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	34	76	78	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					910	U71		10.1038/nature07584	http://dx.doi.org/10.1038/nature07584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19052544				2022-12-24	WOS:000261768300036
J	Wilson, A; Laurenti, E; Oser, G; van der Wath, RC; Blanco-Bose, W; Jaworski, M; Offner, S; Dunant, CF; Eshkind, L; Bockamp, E; Lio, P; MacDonald, HR; Trumpp, A				Wilson, Anne; Laurenti, Elisa; Oser, Gabriela; van der Wath, Richard C.; Blanco-Bose, William; Jaworski, Maike; Offner, Sandra; Dunant, Cyrille F.; Eshkind, Leonid; Bockamp, Ernesto; Lio, Pietro; MacDonald, H. Robson; Trumpp, Andreas			Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair	CELL			English	Article							OSTEOBLASTIC NICHE; PROGENITOR CELLS; MOUSE MODEL; IN-VITRO; MARROW; CYCLE; LONG; CANCER; PROLIFERATION; QUIESCENCE	Bone marrow hematopoietic stem cells (HSCs) are crucial to maintain lifelong production of all blood cells. Although HSCs divide infrequently, it is thought that the entire HSC pool turns over every few weeks, suggesting that HSCs regularly enter and exit cell cycle. Here, we combine flow cytometry with label-retaining assays (BrdU and histone H2B-GFP) to identify a population of dormant mouse HSCs (d-HSCs) within the lin(-)Sca1(+)cKit(+)CD150(+)CD48(-)CD34(-) population. Computational modeling suggests that d-HSCs divide about every 145 days, or five times per lifetime. d-HSCs harbor the vast majority of multilineage long-term self-renewal activity. While they form a silent reservoir of the most potent HSCs during homeostasis, they are efficiently activated to self-renew in response to bone marrow injury or G-CSF stimulation. After re-establishment of homeostasis, activated HSCs return to dormancy, suggesting that HSCs are not stochastically entering the cell cycle but reversibly switch from dormancy to self-renewal under conditions of hematopoietic stress.	[Laurenti, Elisa; Oser, Gabriela; Blanco-Bose, William; Jaworski, Maike; Offner, Sandra; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Trumpp, Andreas] Deutsch Krebsforschungszentrum, Div Cell Biol, ZMBH Alliance, D-69120 Heidelberg, Germany; [Wilson, Anne; MacDonald, H. Robson] Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [van der Wath, Richard C.; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England; [Eshkind, Leonid; Bockamp, Ernesto] Johannes Gutenberg Univ Mainz, Lab Mol Mouse Genet, Inst Toxicol, D-55113 Mainz, Germany; [Dunant, Cyrille F.] LMC IMX, CH-1015 Lausanne, Switzerland; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ludwig Institute for Cancer Research; University of Lausanne; University of Cambridge; Johannes Gutenberg University of Mainz	Trumpp, A (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland.	a.trumpp@dkfz.de	P. Lió, Pietro Lio/AAV-3358-2021; Wilson, Anne/A-7131-2011; Trumpp, Andreas/Z-2141-2019	P. Lió, Pietro Lio/0000-0002-0540-5053; Trumpp, Andreas/0000-0002-6212-3466; Bockamp, Ernesto/0000-0002-6181-1734; Laurenti, Elisa/0000-0002-9917-9092; Dunant, Cyrille/0000-0001-5176-4439	Swiss National Science Foundation; Swiss Cancer League; EU-FP6 program "INTACT"; EU-FP7 progam "Eurosystem."; Bradlow Foundation; St. Johns College Cambridge	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU-FP6 program "INTACT"(European Commission); EU-FP7 progam "Eurosystem."(European Commission); Bradlow Foundation; St. Johns College Cambridge	We thank Dr. Christelle Adolphe for the initial breeding of the Scl-tTA; H2B-GFP mice; Christelle Dubey and Catherine Fumey for animal husbandry and genetic screening; Armin Ehninger for help with RT-PCR analysis; Joanna Roberts and Steven Merlin for FACS sorting; and the MIM facility for help with histology. This work was supported in part by grants to A. T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU-FP6 program "INTACT" and the EU-FP7 progam "Eurosystem." R.C.v.d.W. would like to thank the Bradlow Foundation and St. Johns College Cambridge for financial support. The authors declare no financial conflict of interest.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Furness SGB, 2006, IMMUNOL RES, V34, P13, DOI 10.1385/IR:34:1:13; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bockamp E, 2006, BLOOD, V108, P1533, DOI 10.1182/blood-2005-12-012104; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Bradford GB, 1997, EXP HEMATOL, V25, P445; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Caldwell MA, 2005, EUR J NEUROSCI, V22, P2965, DOI 10.1111/j.1460-9568.2005.04504.x; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Colucci F, 1999, J IMMUNOL, V162, P2761; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; GRAF T, 2007, NATURE REV IMMUNOLOG; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jorgensen HG, 2006, CLIN CANCER RES, V12, P626, DOI 10.1158/1078-0432.CCR-05-0429; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; LERNER C, 1990, EXP HEMATOL, V18, P114; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; MITCHELL JB, 1983, INT J RADIAT ONCOL, V9, P457, DOI 10.1016/0360-3016(83)90061-5; MORSTYN G, 1985, EXP HEMATOL, V13, P289; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Punzel M, 2001, ANN NY ACAD SCI, V938, P72; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Quesenberry PJ, 2006, CURR OPIN HEMATOL, V13, P216, DOI 10.1097/01.moh.0000231417.08031.ac; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Siegl-Cachedenier I, 2007, GENE DEV, V21, P2234, DOI 10.1101/gad.430107; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Suda T, 2005, CORNEA, V24, pS12, DOI 10.1097/01.ico.0000178742.98716.65; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Wath RC, 2008, LECT N BIOINFORMAT, V5307, P387, DOI 10.1007/978-3-540-88562-7_26; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	67	1304	1345	2	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1118	1129		10.1016/j.cell.2008.10.048	http://dx.doi.org/10.1016/j.cell.2008.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19062086	Bronze			2022-12-24	WOS:000261642800027
J	Morey, M; Yee, SK; Herman, T; Nern, A; Blanco, E; Zipursky, SL				Morey, Marta; Yee, Susan K.; Herman, Tory; Nern, Aljoscha; Blanco, Enrique; Zipursky, S. Lawrence			Coordinate control of synaptic-layer specificity and rhodopsins in photoreceptor neurons	NATURE			English	Article							DROSOPHILA VISUAL-SYSTEM; AXON-TARGET INTERACTIONS; TRANSCRIPTION FACTOR; CELL FATES; NF-Y; R7; SENSELESS; DIFFERENTIATION; SELECTION; PROSPERO	How neurons make specific synaptic connections is a central question in neurobiology. The targeting of the Drosophila R7 and R8 photoreceptor axons to different synaptic layers in the brain provides a model with which to explore the genetic programs regulating target specificity. In principle this can be accomplished by cell- type- specific molecules mediating the recognition between synaptic partners(1). Alternatively, specificity could also be achieved through cell- type- specific repression of particular targeting molecules. Here we show that a key step in the targeting of the R7 neuron is the active repression of the R8 targeting program. Repression is dependent on NF-YC, a subunit of the NF-Y ( nuclear factor Y) transcription factor(2). In the absence of NF-YC, R7 axons terminate in the same layer as R8 axons. Genetic experiments indicate that this is due solely to the derepression of the R8specific transcription factor Senseless(3) ( Sens) late in R7 differentiation. Sens is sufficient to control R8 targeting specificity and we demonstrate that Sens directly binds to an evolutionarily conserved DNA sequence upstream of the start of transcription of an R8- specific cell- surface protein, Capricious ( Caps) that regulates R8 target specificity. We show that R7 targeting requires the R7- specific transcription factor Prospero(4,5) ( Pros) in parallel to repression of the R8 targeting pathway by NF-YC. Previous studies demonstrated that Sens(6,7) and Pros(8) directly regulate the expression of specific rhodopsins in R8 and R7. We propose that the use of the same transcription factors to promote the cell- type- specific expression of sensory receptors and cell- surface proteins regulating synaptic target specificity provides a simple and general mechanism for ensuring that transmission of sensory information is processed by the appropriate specialized neural circuits.	[Morey, Marta; Yee, Susan K.; Herman, Tory; Nern, Aljoscha; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Blanco, Enrique] Univ Barcelona, Dept Genet, E-08028 Barcelona, Catalunya, Spain; [Blanco, Enrique] Univ Barcelona, IBUB, E-08028 Barcelona, Catalunya, Spain	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Barcelona; University of Barcelona	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Blanco, Enrique/I-5902-2015; Ramonell, Marta Morey/F-8864-2015; Ramonell, Marta Morey/AAS-1160-2020	Blanco, Enrique/0000-0001-6261-7370; Ramonell, Marta Morey/0000-0001-9732-1983; Ramonell, Marta Morey/0000-0001-9732-1983; Zipursky, Stephen/0000-0001-5630-7181	Ruth L. Kirschstein National Research Service Award [GM7185]; Burroughs Wellcome Fund for Biomedical Research; European Molecular Biology Organization; Human Frontiers Science Program; Juan de la Cierva postdoctoral contract; Ministerio de Educacion y Ciencia [BMC2006- 07334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund for Biomedical Research(Burroughs Wellcome Fund); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Juan de la Cierva postdoctoral contract; Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. N. Jan, H. J. Bellen, A. Nose, S. Britt, C. Desplan, T. Cook, U. Banerjee, the Developmental Studies Hybridoma Bank and Bloomington Stock Center for reagents; H. Schjerven, S. T. Smale and M. Carey for advice and assistance with gel-shift assays; and members of the Zipursky laboratory for comments on the manuscript. S.L.Z. is an investigator of the Howard Hughes Medical Institute. M.M. was supported by the Howard Hughes Medical Institute. S.K.Y. was supported by the Ruth L. Kirschstein National Research Service Award GM7185. T.H. was supported by the Burroughs Wellcome Fund for Biomedical Research. A.N. was supported by the European Molecular Biology Organization and the Human Frontiers Science Program. E. B. was supported by Juan de la Cierva postdoctoral contract and the grant BMC2006- 07334 from the Ministerio de Educacion y Ciencia (MEC), Spain.	Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Miller AC, 2008, DEVELOPMENT, V135, P707, DOI 10.1242/dev.016386; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260	29	64	64	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					795	U82		10.1038/nature07419	http://dx.doi.org/10.1038/nature07419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18978774	Green Accepted			2022-12-24	WOS:000261559900050
J	Granick, S; Bae, SC				Granick, Steve; Bae, Sung Chul			CHEMISTRY A Curious Antipathy for Water	SCIENCE			English	Editorial Material							HYDROPHOBICITY; TRANSPORT		[Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Granick, S (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	sgranick@uiuc.edu	Bae, Sung C/A-3423-2008	Bae, Sung C/0000-0002-9765-6801				Ben-Amotz D, 2006, J PHYS CHEM B, V110, P19839, DOI 10.1021/jp061824r; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Janecek J, 2007, LANGMUIR, V23, P8417, DOI 10.1021/la700561q; Kalra A, 2004, J PHYS CHEM B, V108, P544, DOI 10.1021/jp035828x; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Kashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076102; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Maibaum L, 2003, J PHYS CHEM B, V107, P1189, DOI 10.1021/jp0267196; Mezger M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2931574; Poynor A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.039602; Poynor A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266101; Sovago M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173901; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; Wang HJ, 2008, SCIENCE, V322, P80, DOI 10.1126/science.1162412; Zhang XY, 2002, SCIENCE, V295, P663, DOI 10.1126/science.1066854	16	93	93	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1477	1478		10.1126/science.1167219	http://dx.doi.org/10.1126/science.1167219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056964				2022-12-24	WOS:000261377400027
J	Mercier, R; Petit, MA; Schbath, S; Robin, S; El Karoui, M; Boccard, F; Espeli, O				Mercier, Romain; Petit, Marie-Agnes; Schbath, Sophie; Robin, Stephane; El Karoui, Meriem; Boccard, Frederic; Espeli, Olivier			The MatP/matS Site-Specific System Organizes the Terminus Region of the E-coli Chromosome into a Macrodomain	CELL			English	Article							SEPARATE CELL HALVES; BACILLUS-SUBTILIS; DNA-REPLICATION; BINDING-SITES; SEGREGATION; PROTEIN; IDENTIFICATION; MOVEMENT; ARMS; MAINTENANCE	The organization of the Escherichia coli chromosome into insulated macrodomains influences the segregation of sister chromatids and the mobility of chromosomal DNA. Here, we report that organization of the Terminus region (Ter) into a macrodomain relies on the presence of a 13 bp motif called matS repeated 23 times in the 800-kb-long domain. matS sites are the main targets in the E. coli chromosome of a newly identified protein designated MatP. MatP accumulates in the cell as a discrete focus that colocalizes with the Ter macrodomain. The effects of MatP inactivation reveal its role as main organizer of the Ter macrodomain: in the absence of MatP, DNA is less compacted, the mobility of markers is increased, and segregation of Ter macrodomain occurs early in the cell cycle. Our results indicate that a specific organizational system is required in the Terminus region for bacterial chromosome management during the cell cycle.	[Mercier, Romain; Boccard, Frederic; Espeli, Olivier] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Petit, Marie-Agnes; El Karoui, Meriem] INRA, Unite Bacteries Lact & Pathogenes Opportuniste, UR888, F-78350 Jouy En Josas, France; [Schbath, Sophie] INRA, UR Math Informat & Genome 1077, F-78350 Jouy En Josas, France; [Robin, Stephane] AgroParisTech INRA, Unite Math & Informat Appl, UMR518, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Boccard, F (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	boccard@cgm.cnrs-gif.fr; espeli@cgm.cnrs-gif.fr	Mercier, Romain/E-3642-2012; espeli, olivier/A-6337-2009	Petit, Marie-Agnes/0000-0003-2242-2768; SCHBATH, Sophie/0000-0003-3574-8222; Boccard, Frederic/0000-0002-1866-2489; espeli, olivier/0000-0003-2804-2192; El Karoui, Meriem/0000-0003-2522-613X	Agence Nationale de la Recherche; Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire; ACI Biologie Cellulaire, Moleculaire, Structurale; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire; ACI Biologie Cellulaire, Moleculaire, Structurale; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank Kenneth Marians, Benedicte Michel, and Linda Sperling for critical reading of the manuscript, Stuart Austin, Flemming Hansen, Takashi Horiuchi, Christophe Possoz, and David Sherratt for the kind gift of FROS systems and the Ssb-YFP strain, and Francois-Xavier Barre, Philippe Bouloc, Nelly Dubarry, Alexandra Gruss, Christelle Hennequet-Antier, Sandrine Imbault, Christian Lesterlin, and Michele Valens for helpful discussions. The Migale bioinformatics platform (Institut National de la Recherche Agronomique) provided computational resources. Macroarrays were obtained in the framework of Program "Puces a ADN'' from Centre National de la Recherche Scientifique and the program "Microbiologie, Maladies Infectieuses et parasitaires'' of the French Ministere de l'Education Nationale, de la Recherche et de la Technologie. This study was supported by the Agence Nationale de la Recherche (F.B.), the Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire (S. S., F. B., and M. E.), the ACI Biologie Cellulaire, Moleculaire, Structurale (F. B.), and the Association pour la Recherche sur le Cancer (F. B.).	Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; BLAKELY G, 1991, NEW BIOL, V3, P789; Brezellec P, 2006, BIOINFORMATICS, V22, P1935, DOI 10.1093/bioinformatics/btl336; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Guarne A, 2005, EMBO J, V24, P1502, DOI 10.1038/sj.emboj.7600634; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; HILDEBRANDT ER, 1995, CELL, V81, P331, DOI 10.1016/0092-8674(95)90386-0; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mearini G, 2006, CELL CYCLE, V5, P1989, DOI 10.4161/cc.5.17.3186; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Murtin C, 1998, J MOL BIOL, V284, P949, DOI 10.1006/jmbi.1998.2256; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Niki H, 2000, GENE DEV, V14, P212; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Robin S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-84; Sunako Y, 2001, MOL MICROBIOL, V42, P1233, DOI 10.1046/j.1365-2958.2001.02680.x; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	33	187	189	3	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					475	485		10.1016/j.cell.2008.08.031	http://dx.doi.org/10.1016/j.cell.2008.08.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984159	Green Submitted, Bronze			2022-12-24	WOS:000260536300018
J	Mega, JL; Close, SL; Wiviott, SD; Shen, L; Hockett, RD; Brandt, JT; Walker, JR; Antman, EM; Macias, W; Braunwald, E; Sabatine, MS				Mega, Jessica L.; Close, Sandra L.; Wiviott, Stephen D.; Shen, Lei; Hockett, Richard D.; Brandt, John T.; Walker, Joseph R.; Antman, Elliott M.; Macias, William; Braunwald, Eugene; Sabatine, Marc S.			Cytochrome P-450 Polymorphisms and Response to Clopidogrel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PLATELET INHIBITION; INDIVIDUAL RESPONSIVENESS; ATHEROTHROMBOTIC EVENTS; STENT THROMBOSIS; INCREASED RISK; PRASUGREL; PHARMACOKINETICS; PHARMACODYNAMICS; VARIABILITY	Background: Clopidogrel requires transformation into an active metabolite by cytochrome P-450 (CYP) enzymes for its antiplatelet effect. The genes encoding CYP enzymes are polymorphic, with common alleles conferring reduced function. Methods: We tested the association between functional genetic variants in CYP genes, plasma concentrations of active drug metabolite, and platelet inhibition in response to clopidogrel in 162 healthy subjects. We then examined the association between these genetic variants and cardiovascular outcomes in a separate cohort of 1477 subjects with acute coronary syndromes who were treated with clopidogrel in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI) 38. Results: In healthy subjects who were treated with clopidogrel, carriers of at least one CYP2C19 reduced-function allele (approximately 30% of the study population) had a relative reduction of 32.4% in plasma exposure to the active metabolite of clopidogrel, as compared with noncarriers (P<0.001). Carriers also had an absolute reduction in maximal platelet aggregation in response to clopidogrel that was 9 percentage points less than that seen in noncarriers (P<0.001). Among clopidogrel-treated subjects in TRITON-TIMI 38, carriers had a relative increase of 53% in the composite primary efficacy outcome of the risk of death from cardiovascular causes, myocardial infarction, or stroke, as compared with noncarriers (12.1% vs. 8.0%; hazard ratio for carriers, 1.53; 95% confidence interval [CI], 1.07 to 2.19; P=0.01) and an increase by a factor of 3 in the risk of stent thrombosis (2.6% vs. 0.8%; hazard ratio, 3.09; 95% CI, 1.19 to 8.00; P=0.02). Conclusions: Among persons treated with clopidogrel, carriers of a reduced-function CYP2C19 allele had significantly lower levels of the active metabolite of clopidogrel, diminished platelet inhibition, and a higher rate of major adverse cardiovascular events, including stent thrombosis, than did noncarriers. N Engl J Med 2009;360:354-62.	[Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Dept Med, Boston, MA 02115 USA; [Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Close, Sandra L.; Shen, Lei; Hockett, Richard D.; Brandt, John T.; Macias, William] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Walker, Joseph R.] Daiichi Sankyo Pharma Dev, Edison, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eli Lilly; Daiichi Sankyo Company Limited	Mega, JL (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Dept Med, 350 Longwood Ave, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Wiviott, Stephen/HIK-2534-2022; Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359	Daiichi Sankyo; Eli Lilly; Sanofi-Aventis; Schering-Plough; AstraZeneca; Bristol-Myers Squibb	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb)	Supported by research grants from Daiichi Sankyo and Eli Lilly.; The TIMI Study Group reports receiving grant support from Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, and Schering-Plough. In addition, Dr. Mega reports receiving grant support from Schering-Plough; Dr. Wiviott, grant support from Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis, consulting fees from AstraZeneca and Sanofi-Aventis, and lecture fees from Daiichi-Sankyo, Eli Lilly, and AstraZeneca; Dr. Antman, grant support from Daiichi Sankyo and Eli Lilly, consulting fees from Sanofi- Aventis, and lecture fees from Eli Lilly and Sanofi-Aventis; Dr. Braunwald, grant support from Daiichi Sankyo, Eli Lilly, SanofiAventis, and Schering- Plough, consulting fees from Daiichi Sankyo, Eli Lilly, and Schering- Plough, and lecture fees from Eli Lilly and Schering-Plough; and Dr. Sabatine, grant support from Sanofi- Aventis and Schering-Plough, consulting fees from AstraZeneca, Bristol-Myers Squibb, and Sanofi- Aventis, and lecture fees from Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis. Dr. Walker reports being an employee of Daiichi Sankyo and having an equity interest or stock options in the company; and Drs. Close, Shen, Hockett, Brandt, and Macias, being employees of Eli Lilly and having an equity interest or stock options in the company. No other potential conflict of interest relevant to this article was reported.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; *BLUE CROSS BLUE S, 2004, SPEC REP GEN CYT P45; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Daly TM, 2007, CLIN CHEM, V53, P1222, DOI 10.1373/clinchem.2007.086348; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Dumaual C, 2007, PHARMACOGENOMICS, V8, P293, DOI 10.2217/14622416.8.3.293; Farid NA, 2007, CLIN PHARMACOL THER, V81, P735, DOI 10.1038/sj.clpt.6100139; Farid NA, 2007, RAPID COMMUN MASS SP, V21, P169, DOI 10.1002/rcm.2813; Farid NA, 2008, PHARMACOTHERAPY, V28, P1483, DOI 10.1592/phco.28.12.1483; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; *KAR I, HUM CYT P450 CYP ALL; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kurihara A., 2005, DRUG METAB REV S2, V37, P99; LI YG, 2008, AM J CARDIOL S, V102, P76; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; O'Donoghue M, 2006, CIRCULATION, V114, pE600, DOI 10.1161/CIRCULATIONAHA.106.643171; Payne CD, 2008, PLATELETS, V19, P275, DOI 10.1080/09537100801891640; Payne CD, 2007, J CARDIOVASC PHARM, V50, P555, DOI 10.1097/FJC.0b013e3181492209; Rehmel JLF, 2006, DRUG METAB DISPOS, V34, P600, DOI 10.1124/dmd.105.007989; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Small DS, 2008, CURR MED RES OPIN, V24, P2251, DOI 10.1185/03007990802205985; SMALL DS, 2008, CLIN PHARM THER S1, V83, pS56; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Suh JW, 2006, CAN MED ASSOC J, V175, P64, DOI 10.1503/cmaj.060701; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2001, N ENGL J MED, V345, P1506; 2001, N ENGL J MED, V345, P1716	38	1817	1958	6	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					354	362		10.1056/NEJMoa0809171	http://dx.doi.org/10.1056/NEJMoa0809171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19106084				2022-12-24	WOS:000262519900007
J	Barna, M; Pusic, A; Zollo, O; Costa, M; Kondrashov, N; Rego, E; Rao, PH; Ruggero, D				Barna, Maria; Pusic, Aya; Zollo, Ornella; Costa, Maria; Kondrashov, Nadya; Rego, Eduardo; Rao, Pulivarthi H.; Ruggero, Davide			Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency	NATURE			English	Article							KINASE GENE-COMPLEX; C-MYC; CELL-CYCLE; MEDIATED TRANSLATION; ENTRY SITE; CANCER; 1P36; TUMORIGENESIS; CYTOKINESIS; CONTRIBUTES	The Myc oncogene regulates the expression of several components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, RNA polymerase III and ribosomal DNA(1,2). Whether and how increasing the cellular protein synthesis capacity affects the multistep process leading to cancer remains to be addressed. Here we use ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in E mu-Myc/+ transgenic mice to normal levels, and show that the oncogenic potential of Myc in this context is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc- overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a new mechanism that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation used to regulate the expression of selective messenger RNAs. We show that an aberrant increase in cap- dependent translation downstream of Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site ( IRES)- dependent translation that is required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic- specific expression of the endogenous IRES- dependent form of Cdk11 ( also known as Cdc21 and PITSLRE)(3-5), which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in E mu-Myc/+ mice. When accurate translational control is re- established in E mu-Myc/+ mice, genome instability is suppressed. Our findings demonstrate how perturbations in translational control provide a highly specific outcome for gene expression, genome stability and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post- genomic level.	[Barna, Maria; Kondrashov, Nadya] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Pusic, Aya; Zollo, Ornella; Costa, Maria; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Pusic, Aya; Zollo, Ornella; Costa, Maria; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Rego, Eduardo] Univ Sao Paulo, Ctr Cell Based Therapy, Fdn Hemoctr Ribeirao Preto, BR-14048900 Sao Paulo, Brazil; [Rao, Pulivarthi H.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universidade de Sao Paulo; Baylor College of Medicine	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Rock Hall Room 384C,1550 4th St, San Francisco, CA 94158 USA.	maria.barna@ucsf.edu; Davide.Ruggero@ucsf.edu	Rego, Eduardo M/A-1058-2012; Rego, Eduardo M./Y-5572-2019; Rego, Eduardo/AFS-7973-2022; Costa, Maria Jose/I-7754-2013	Rego, Eduardo M/0000-0003-1567-4086; Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086; Costa, Maria Jose/0000-0001-6111-7614	NIH; Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. McCormick, G. Evan and P. O'Farrell for critically reading the manuscript; J. Testa for support and critical discussion during early stages of this work; W. Xu and R. Adamo for technical assistance; J. Copley for editing the manuscript, S. Cornelis for the Cdk11 IRES bicistronic vector. This work was supported by the NIH (D.R.) and the Sandler Foundation (M.B.).	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chandramouli A, 2007, CARCINOGENESIS, V28, P2028, DOI 10.1093/carcin/bgm066; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dave BJ, 1999, CANCER GENET CYTOGEN, V108, P120, DOI 10.1016/S0165-4608(98)00138-1; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; Lenahan MK, 1996, ONCOGENE, V12, P1847; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Nelson MA, 1999, CANCER GENET CYTOGEN, V108, P91, DOI 10.1016/S0165-4608(98)00122-8; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	35	298	307	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					971	U79		10.1038/nature07449	http://dx.doi.org/10.1038/nature07449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011615	Green Accepted, Green Submitted			2022-12-24	WOS:000261768300050
J	Mold, JE; Michaelsson, J; Burt, TD; Muench, MO; Beckerman, KP; Busch, MP; Lee, TH; Nixon, DF; McCune, JM				Mold, Jeff E.; Michaelsson, Jakob; Burt, Trevor D.; Muench, Marcus O.; Beckerman, Karen P.; Busch, Michael P.; Lee, Tzong-Hae; Nixon, Douglas F.; McCune, Joseph M.			Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero	SCIENCE			English	Article							MEDIATED LYMPHOLYSIS; HLA ANTIGENS; MICROCHIMERISM; LYMPHOCYTES; RESPONSES; TOLERANCE; ONTOGENY; BLOOD; TIME	As the immune system develops, T cells are selected or regulated to become tolerant of self antigens and reactive against foreign antigens. In mice, the induction of such tolerance is thought to be attributable to the deletion of self- reactive cells. Here, we show that the human fetal immune system takes advantage of an additional mechanism: the generation of regulatory T cells ( T-regs) that suppress fetal immune responses. We find that substantial numbers of maternal cells cross the placenta to reside in fetal lymph nodes, inducing the development of CD4+CD25(high)FoxP3+ T-regs that suppress fetal antimaternal immunity and persist at least until early adulthood. These findings reveal a form of antigen- specific tolerance in humans, induced in utero and probably active in regulating immune responses after birth.	[Mold, Jeff E.; Burt, Trevor D.; Nixon, Douglas F.; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA; [Mold, Jeff E.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Michaelsson, Jakob] Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med, S-14186 Huddinge, Sweden; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; [Muench, Marcus O.; Busch, Michael P.; Lee, Tzong-Hae] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94118 USA; [Muench, Marcus O.; Busch, Michael P.; Lee, Tzong-Hae] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94118 USA; [Beckerman, Karen P.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	mike.mccune@ucsf.edu	Nixon, Douglas/AAU-5734-2020; Muench, Marcus O./C-5025-2009	Nixon, Douglas/0000-0002-2801-1786; Muench, Marcus O./0000-0001-8946-6605; Burt, Trevor/0000-0001-7933-529X; Mold, Jeffrey/0000-0003-2195-2978	NIH [OD000329, AI40312, AI68498]; AIDS Biology Program of the AIDS Research Institute at UCSF; Swedish Research Council; National Institute of Child Health and Development [HD00850]; American Academy of Pediatrics; American Pediatric Society; Broad Medical Research Program of The Eli and Edythe L. Broad Foundation; National Blood Foundation; Blood Systems, Inc; UCSF Clinical and Translational Institute Clinical Research Center [RR024131]; Elizabeth Glaser Pediatric AIDS Foundation [PG-50804]; National Heart Lung and Blood Institute [HL083388]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068498, R01AI040312, R37AI040312] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Biology Program of the AIDS Research Institute at UCSF; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Academy of Pediatrics; American Pediatric Society; Broad Medical Research Program of The Eli and Edythe L. Broad Foundation; National Blood Foundation; Blood Systems, Inc; UCSF Clinical and Translational Institute Clinical Research Center; Elizabeth Glaser Pediatric AIDS Foundation; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the families who donated blood for the studies shown in Fig. 3. We also thank B. Kanwar, D. Favre, E. Trachtenberg, R. Derynck, and S. Fisher for technical assistance and valuable discussions. Support for this work was provided by grants from NIH to J. M. M (OD000329 and AI40312) and D. F. N. (AI68498) and from the AIDS Biology Program of the AIDS Research Institute at UCSF. J. M. is supported by the Swedish Research Council. T. D. B. is a National Institute of Child Health and Development fellow (HD00850) and was also funded by the American Academy of Pediatrics and the American Pediatric Society. M.O.M. was supported by grants from the Broad Medical Research Program of The Eli and Edythe L. Broad Foundation, National Blood Foundation, and Blood Systems, Inc. K.P.B. was supported by grants from the UCSF Clinical and Translational Institute Clinical Research Center (RR024131) and the Elizabeth Glaser Pediatric AIDS Foundation (PG-50804). M.P.B. and T.-H.L. were both supported by grants from the National Heart Lung and Blood Institute (HL083388). J. M. M. is a recipient of the NIH Director's Pioneer Award Program.	Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; FRIEDBER.SH, 1974, J IMMUNOL, V113, P1477; GITLIN D, 1964, J CLIN INVEST, V43, P1938, DOI 10.1172/JCI105068; GRANBERG C, 1980, CELL IMMUNOL, V51, P13, DOI 10.1016/0008-8749(80)90233-6; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Lee TH, 2006, TRANSFUSION, V46, P1870, DOI 10.1111/j.1537-2995.2006.00992.x; Loubiere LS, 2006, LAB INVEST, V86, P1185, DOI 10.1038/labinvest.3700471; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Rastogi D, 2007, J CLIN INVEST, V117, P1637, DOI 10.1172/JCI29466; RAYFIELD LS, 1980, CLIN EXP IMMUNOL, V42, P561; REMINGTON JS, 2006, INFECT DIS FETUS NEW, P11; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; West LJ, 2002, HUM EXP TOXICOL, V21, P499, DOI 10.1191/0960327102ht288oa	24	551	561	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1562	1565		10.1126/science.1164511	http://dx.doi.org/10.1126/science.1164511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056990	Green Accepted			2022-12-24	WOS:000261377400054
J	de Brito, OM; Scorrano, L				de Brito, Olga Martins; Scorrano, Luca			Mitofusin 2 tethers endoplasmic reticulum to mitochondria	NATURE			English	Article							MAMMALIAN-CELLS; CA2+; APOPTOSIS; FUSION; DETERMINANTS; OSCILLATIONS; MICRODOMAINS; MUSCLE; BAX; ER	Juxtaposition between endoplasmic reticulum ( ER) and mitochondria is a common structural feature, providing the physical basis for intercommunication during Ca(2+) signalling; yet, the molecular mechanisms controlling this interaction are unknown. Here we show that mitofusin 2, a mitochondrial dynamin- related protein mutated in the inherited motor neuropathy Charcot - Marie - Tooth type IIa, is enriched at the ER - mitochondria interface. Ablation or silencing of mitofusin 2 in mouse embryonic fibroblasts and HeLa cells disrupts ER morphology and loosens ER - mitochondria interactions, thereby reducing the efficiency of mitochondrial Ca(2+) uptake in response to stimuli that generate inositol-1,4,5-trisphosphate. An in vitro assay as well as genetic and biochemical evidences support a model in which mitofusin 2 on the ER bridges the two organelles by engaging in homotypic and heterotypic complexes with mitofusin 1 or 2 on the surface of mitochondria. Thus, mitofusin 2 tethers ER to mitochondria, a juxtaposition required for efficient mitochondrial Ca(2+) uptake.	[de Brito, Olga Martins; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Geneva	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Via Orus 2, I-35129 Padua, Italy.	lscorrano@dti.telethon.it	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	Telethon Italy; Compagnia di San Paolo Italy; United Mitochondrial Disease Foundation USA; Muscular Distrophy Association USA; Swiss National Science Foundation [3100A0-118171]	Telethon Italy(Fondazione Telethon); Compagnia di San Paolo Italy(Compagnia di San Paolo); United Mitochondrial Disease Foundation USA; Muscular Distrophy Association USA(Muscular Dystrophy Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	O.M.d.B. received a 'Bolsa de Doutoramento' of FCT Portugal. L. S. is senior scientist of the Dulbecco-Telethon Institute and EMBO YIP. This work was supported by Telethon Italy, Compagnia di San Paolo Italy, United Mitochondrial Disease Foundation USA, Muscular Distrophy Association USA and Swiss National Science Foundation 3100A0-118171.	Annis MG, 2001, ONCOGENE, V20, P1939, DOI 10.1038/sj.onc.1204288; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rojo M, 2002, J CELL SCI, V115, P1663; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; SOLTYS BJ, 1992, BIOCHEM CELL BIOL, V70, P1174, DOI 10.1139/o92-163; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	35	1655	1670	6	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					605	U47		10.1038/nature07534	http://dx.doi.org/10.1038/nature07534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052620				2022-12-24	WOS:000261340000033
J	Varambally, S; Cao, Q; Mani, RS; Shankar, S; Wang, XS; Ateeq, B; Laxman, B; Cao, XH; Jing, XJ; Ramnarayanan, K; Brenner, JC; Yu, JD; Kim, JH; Han, B; Tan, P; Kumar-Sinha, C; Lonigro, RJ; Palanisamy, N; Maher, CA; Chinnaiyan, AM				Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Cao, Xuhong; Jing, Xiaojun; Ramnarayanan, Kalpana; Brenner, J. Chad; Yu, Jindan; Kim, Jung H.; Han, Bo; Tan, Patrick; Kumar-Sinha, Chandan; Lonigro, Robert J.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.			Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; H3 LYSINE-27 METHYLATION; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; ZESTE HOMOLOG-2; IN-VIVO; POLYCOMB; ENHANCER; EXPRESSION; TARGETS	Enhancer of zeste homolog 2 ( EZH2) is a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes and regulates the survival and metastasis of cancer cells. EZH2 is overexpressed in aggressive solid tumors by mechanisms that remain unclear. Here we show that the expression and function of EZH2 in cancer cell lines are inhibited by microRNA- 101 ( miR- 101). Analysis of human prostate tumors revealed that miR- 101 expression decreases during cancer progression, paralleling an increase in EZH2 expression. One or both of the two genomic loci encoding miR- 101 were somatically lost in 37.5% of clinically localized prostate cancer cells ( 6 of 16) and 66.7% of metastatic disease cells ( 22 of 33). We propose that the genomic loss of miR- 101 in cancer leads to overexpression of EZH2 and concomitant dysregulation of epigenetic pathways, resulting in cancer progression.	[Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Cao, Xuhong; Jing, Xiaojun; Brenner, J. Chad; Yu, Jindan; Kim, Jung H.; Han, Bo; Kumar-Sinha, Chandan; Lonigro, Robert J.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Jing, Xiaojun; Brenner, J. Chad; Yu, Jindan; Han, Bo; Kumar-Sinha, Chandan; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Kim, Jung H.; Lonigro, Robert J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ramnarayanan, Kalpana; Tan, Patrick; Palanisamy, Nallasivam] Genome Inst Singapore, Singapore 138672, Singapore; [Brenner, J. Chad; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Tan, Patrick] Natl Canc Ctr, Singapore 169610, Singapore; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Michigan System; University of Michigan; National Cancer Centre Singapore (NCCS); University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020	Cao, Qi/0000-0002-5140-3681; Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Mani, Ram/0000-0003-3552-7905; Kumar, Chandan/0000-0002-8696-3400; Varambally, Sooryanarayana/0000-0002-2277-1127	NIH (Prostate Specialized Program of Reasearch Excellence [P50CA69568]; Early Detection Research Network [UO1 111275]; U.S. Department of Defense Era of Hope Scholar [BC075023, PC051081, BC083217]; NIH postdoctoral training; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research; Canary Foundation; American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [U01CA111275, K99CA129565, P50CA069568] Funding Source: NIH RePORTER	NIH (Prostate Specialized Program of Reasearch Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; U.S. Department of Defense Era of Hope Scholar(United States Department of Defense); NIH postdoctoral training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research(Amgen); Canary Foundation; American Cancer Society Early Detection Postdoctoral Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. M. Dhanasekaran, S. Tomlins, and J. Yu for helpful discussions; J. Siddiqui and M. Pandhi for technical assistance; and J. Granger and K. Giles for critically reading the manuscript. A. M. C. is supported by a Burroughs Welcome Foundation Award in Clinical Translational Research. This work was supported in part by NIH (Prostate Specialized Program of Reasearch Excellence grant P50CA69568 to A.M.C. and Early Detection Research Network grant UO1 111275 to A.M.C.) and the U.S. Department of Defense (Era of Hope Scholar grant BC075023 to A.M.C., PC051081 to A.M.C. and S.V., and BC083217 to J.C.B.). C.A.M. was supported by an NIH postdoctoral training grant and currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research and the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship. The microarray data used in this study have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus with the accession number GSE13286.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Weikert S, 2005, INT J MOL MED, V16, P349; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	27	817	904	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1695	1699		10.1126/science.1165395	http://dx.doi.org/10.1126/science.1165395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19008416	Green Accepted			2022-12-24	WOS:000261608300046
J	Thompson, RJ; Jackson, MF; Olah, ME; Rungta, RL; Hines, DJ; Beazely, MA; MacDonald, JF; MacVicar, BA				Thompson, Roger J.; Jackson, Michael F.; Olah, Michelle E.; Rungta, Ravi L.; Hines, Dustin J.; Beazely, Michael A.; MacDonald, John F.; MacVicar, Brian A.			Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus	SCIENCE			English	Article							EPILEPTIFORM ACTIVITY; ENTORHINAL CORTEX; P2X(7) RECEPTOR; IN-VIVO; NEURONS; GAP; SLICES; ATP	Pannexin- 1 ( Px1) is expressed at postsynaptic sites in pyramidal neurons, suggesting that these hemichannels contribute to dendritic signals associated with synaptic function. We found that, in pyramidal neurons, N- methyl- D- aspartate receptor ( NMDAR) activation induced a secondary prolonged current and dye flux that were blocked with a specific inhibitory peptide against Px1 hemichannels; knockdown of Px1 by RNA interference blocked the current in cultured neurons. Enhancing endogenous NMDAR activation in brain slices by removing external magnesium ions (Mg2+) triggered epileptiform activity, which had decreased spike amplitude and prolonged interburst interval during application of the Px1 hemichannel blocking peptide. We conclude that Px1 hemichannel opening is triggered by NMDAR stimulation and can contribute to epileptiform seizure activity.	[Thompson, Roger J.; Rungta, Ravi L.; Hines, Dustin J.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Thompson, Roger J.; Rungta, Ravi L.; Hines, Dustin J.; MacVicar, Brian A.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Jackson, Michael F.; Olah, Michelle E.; Beazely, Michael A.; MacDonald, John F.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada	University of British Columbia; University of British Columbia; Western University (University of Western Ontario)	Thompson, RJ (corresponding author), Univ Calgary, Dept Cell Biol & Anat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rj.thompson@ucalgary.ca; bmacvicar@brain.ubc.ca	Thompson, Roger/A-3029-2012; Hines, Dustin/AAC-6394-2021; Thompson, Roger/L-3930-2016; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015; Jackson, Mike/H-5573-2012	Thompson, Roger/0000-0002-7019-7246; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Jackson, Mike/0000-0002-4730-201X; Beazely, Michael/0000-0002-8722-460X; Rungta, Ravi/0000-0003-3505-2743	Heart and Stroke Foundation of British Columbia; Canadian Institutes of Health Research; Canadian Stroke Network	Heart and Stroke Foundation of British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network	This work was supported by grants to B. A. M. from the Heart and Stroke Foundation of British Columbia, to B.A.M. or J.F.M. (15514) from the Canadian Institutes of Health Research, and by a grant from the Canadian Stroke Network to B.A.M., J.F.M., and R.J.T. B.A.M. holds a Canada Research Chair (Tier 1) in Neuroscience. The authors kindly acknowledge Y.T. Wang for critical reading of the manuscript and S. Panuela and D. Laird for generously providing the anti-Px1 antibody.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bennett MVL, 2006, BRAIN CELL BIOL, V35, P5, DOI 10.1007/s11068-006-9004-x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chen QX, 1997, J NEUROSCI, V17, P4032; Connor JA, 2000, J NEUROPHYSIOL, V83, P90, DOI 10.1152/jn.2000.83.1.90; DREIER JP, 1990, NEUROSCI LETT, V119, P68, DOI 10.1016/0304-3940(90)90757-Z; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Jagt TAV, 2008, J NEUROSCI, V28, P5029, DOI 10.1523/JNEUROSCI.5069-07.2008; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	18	263	266	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1555	1559		10.1126/science.1165209	http://dx.doi.org/10.1126/science.1165209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056988				2022-12-24	WOS:000261377400052
J	Kohyama, M; Ise, W; Edelson, BT; Wilker, PR; Hildner, K; Mejia, C; Frazier, WA; Murphy, TL; Murphy, KM				Kohyama, Masako; Ise, Wataru; Edelson, Brian T.; Wilker, Peter R.; Hildner, Kai; Mejia, Carlo; Frazier, William A.; Murphy, Theresa L.; Murphy, Kenneth M.			Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis	NATURE			English	Article							ETS PROTEIN; IN-VIVO; B-CELLS; EXPRESSION; GENE; HEMOCHROMATOSIS; MICE; HETEROGENEITY; RECOGNITION; RECEPTORS	Tissue macrophages comprise a heterogeneous group of cell types differing in location, surface markers and function(1). Red pulp macrophages are a distinct splenic subset involved in removing senescent red blood cells(2). Transcription factors such as PU.1 ( also known as Sfpi1) and C/EBPa (Cebpa) have general roles in myelomonocytic development(3,4), but the transcriptional basis for producing tissue macrophage subsets remains unknown. Here we show that Spi-C ( encoded by Spic), a PU.1- related transcription factor, selectively controls the development of red pulp macrophages. Spi-C is highly expressed in red pulp macrophages, but not monocytes, dendritic cells or other tissue macrophages. Spic(-/-) mice have a cell- autonomous defect in the development of red pulp macrophages that is corrected by retroviral Spi- C expression in bone marrow cells, but have normal monocyte and other macrophage subsets. Red pulp macrophages highly express genes involved in capturing circulating haemoglobin and in iron regulation. Spic(-/-) mice show ormal trapping of red blood cells in the spleen, but fail to phagocytose these red blood cells efficiently, and develop an iron overload localized selectively to splenic red pulp. Thus, Spi- C controls development of red pulp macrophages required for red blood cell recycling and iron homeostasis.	[Kohyama, Masako; Ise, Wataru; Edelson, Brian T.; Wilker, Peter R.; Hildner, Kai; Mejia, Carlo; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kohyama, Masako; Ise, Wataru; Hildner, Kai; Mejia, Carlo; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@wustl.edu		Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; Burroughs Wellcome Fund Career Award for Medical Scientists	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	This work was supported by the Howard Hughes Medical Institute (K.M.M.), and the Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.).	Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Carlsson R, 2002, GENE, V299, P271, DOI 10.1016/S0378-1119(02)01078-8; Carlsson R, 2006, BIOCHEM BIOPH RES CO, V344, P1155, DOI 10.1016/j.bbrc.2006.04.026; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hashimoto S, 1999, INT IMMUNOL, V11, P1423, DOI 10.1093/intimm/11.9.1423; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schweitzer BL, 2006, J IMMUNOL, V177, P2195, DOI 10.4049/jimmunol.177.4.2195; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Zhou XY, 1998, GASTROENTEROLOGY, V114, pA1372, DOI 10.1016/S0016-5085(98)85570-4	30	289	298	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					318	321		10.1038/nature07472	http://dx.doi.org/10.1038/nature07472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19037245	Green Accepted			2022-12-24	WOS:000262440900040
J	Ni, ZF; Kim, ED; Ha, MS; Lackey, E; Liu, JX; Zhang, YR; Sun, QX; Chen, ZJ				Ni, Zhongfu; Kim, Eun-Deok; Ha, Misook; Lackey, Erika; Liu, Jianxin; Zhang, Yirong; Sun, Qixin; Chen, Z. Jeffrey			Altered circadian rhythms regulate growth vigour in hybrids and allopolyploids	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS ALLOTETRAPLOIDS; STARCH DEGRADATION; FLOWERING-TIME; CLOCK; THALIANA; MUTANT; PLANTS; CCA1; TRANSCRIPTION	Segregating hybrids and stable allopolyploids display morphological vigour(1-3), and Arabidopsis allotetraploids are larger than the parents Arabidopsis thaliana and Arabidopsis arenosa(1,4)- the mechanisms for this are unknown. Circadian clocks mediate metabolic pathways and increase fitness in animals and plants(5-8). Here we report that epigenetic modifications of the circadian clock genes CIRCADIAN CLOCK ASSOCIATED 1 (CCA1) and LATE ELONGATED HYPOCOTYL (LHY)(9-11) and their reciprocal regulators TIMING OF CAB EXPRESSION 1 ( TOC1) and GIGANTEA (GI)(10,12,13) mediate expression changes in downstream genes and pathways. During the day, epigenetic repression of CCA1 and LHY induced the expression of TOC1, GI and downstream genes containing evening elements(14) in chlorophyll and starch metabolic pathways in allotetraploids and F-1 hybrids, which produced more chlorophyll and starch than the parents in the same environment. Mutations in cca1 and cca1 lhy and the daily repression of cca1 by RNA interference (RNAi) in TOC1:: cca1(RNAi) transgenic plants increased the expression of downstream genes and increased chlorophyll and starch content, whereas constitutively expressing CCA1 or ectopically expressing TOC1:: CCA1 had the opposite effect. The causal effects of CCA1 on output traits suggest that hybrids and allopolyploids gain advantages from the control of circadian- mediated physiological and metabolic pathways, leading to growth vigour and increased biomass.	[Ni, Zhongfu; Kim, Eun-Deok; Ha, Misook; Lackey, Erika; Liu, Jianxin; Zhang, Yirong; Chen, Z. Jeffrey] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Ha, Misook; Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ha, Misook; Chen, Z. Jeffrey] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Sun, Qixin] China Agr Univ, Dept Genet & Plant Breeding, Beijing 100094, Peoples R China	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; China Agricultural University	Chen, ZJ (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, 1 University Stn,A-4800, Austin, TX 78712 USA.	zjchen@mail.utexas.edu		KIM, EUN-DEOK/0000-0002-0593-4553	National Science Foundation Plant Genome Research Program [DBI0733857, DBI0624077]; National Institutes of Health [GM067015]; National Basic Research Program of China [2007CB109000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067015] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to E. Tobin for her gifts of the CCA1-overexpression (CCA1-OX) line and antibodies against CCA1. We thank H.Y. Chen for advice on recombinant CCA1 production, D. W. Ng for western blot analysis, T. Juenger for insightful discussions on life history traits in Arabidopsis, and D.Y. Chen and E. Huq for careful readings of the manuscript. The work was supported by the grants from the National Science Foundation Plant Genome Research Program (DBI0733857 and DBI0624077) and the National Institutes of Health (GM067015; Z.J.C.) and National Basic Research Program of China (2007CB109000; Q.S.).	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Wang JL, 2006, GENETICS, V173, P965, DOI 10.1534/genetics.106.056580; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907	42	469	520	9	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					327	U7		10.1038/nature07523	http://dx.doi.org/10.1038/nature07523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19029881	Green Accepted			2022-12-24	WOS:000262440900042
J	Gertz, J; Siggia, ED; Cohen, BA				Gertz, Jason; Siggia, Eric D.; Cohen, Barak A.			Analysis of combinatorial cis-regulation in synthetic and genomic promoters	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PATTERNS; ASSOCIATIONS; SEQUENCE; NETWORK; MODELS	Transcription factor binding sites are being discovered at a rapid pace(1,2). It is now necessary to turn attention towards understanding how these sites work in combination to influence gene expression. Quantitative models that accurately predict gene expression from promoter sequence(3-5) will be a crucial part of solving this problem. Here we present such a model, based on the analysis of synthetic promoter libraries in yeast ( Saccharomyces cerevisiae). Thermodynamic models based only on the equilibrium binding of transcription factors to DNA and to each other captured a large fraction of the variation in expression in every library. Thermodynamic analysis of these libraries uncovered several phenomena in our system, including cooperativity and the effects of weak binding sites. When applied to the S. cerevisiae genome, a model of repression by Mig1 ( which was trained on synthetic promoters) predicts a number of Mig1- regulated genes that lack significant Mig1- binding sites in their promoters. The success of the thermodynamic approach suggests that the information encoded by combinations of cis- regulatory sites is interpreted primarily through simple protein - DNA and protein - protein interactions, with complicated biochemical reactions - such as nucleosome modifications - being downstream events. Quantitative analyses of synthetic promoter libraries will be an important tool in unravelling the rules underlying combinatorial cis- regulation.	[Gertz, Jason; Cohen, Barak A.] Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, St Louis, MO 63108 USA; [Siggia, Eric D.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Washington University (WUSTL); Rockefeller University	Cohen, BA (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, 4444 Forest Park Ave, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu		Gertz, Jason/0000-0001-7568-6789	NIH [R01 GM078222]; NSF [DMR0129848, DGE-0202737]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Mitra, G. Stormo, M. Johnston, K. Varley, S. Doniger and members of the Cohen laboratory for discussions and suggestions, and J. Sabina for technical help with LacZ experiments. B.A.C. and J.G. were supported by the NIH (R01 GM078222) and E.D.S. was supported by the NSF (DMR0129848). J.G. was also supported by an NSF Graduate Research Fellowship (DGE-0202737).	Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brachmann CB, 1998, YEAST, V14, P115; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; GISH W, 1995, WU BLAST; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Ligr M, 2006, GENETICS, V172, P2113, DOI 10.1534/genetics.105.052688; Lutfiyya LL, 1998, GENETICS, V150, P1377; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; PTASHNE M, 2002, GENES SIGNALS; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	26	215	219	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					215	U113		10.1038/nature07521	http://dx.doi.org/10.1038/nature07521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19029883	Green Accepted			2022-12-24	WOS:000262360200037
J	Freudiger, CW; Min, W; Saar, BG; Lu, S; Holtom, GR; He, CW; Tsai, JC; Kang, JX; Xie, XS				Freudiger, Christian W.; Min, Wei; Saar, Brian G.; Lu, Sijia; Holtom, Gary R.; He, Chengwei; Tsai, Jason C.; Kang, Jing X.; Xie, X. Sunney			Label-Free Biomedical Imaging with High Sensitivity by Stimulated Raman Scattering Microscopy	SCIENCE			English	Article							IN-VIVO; CARS-MICROSCOPY; SPECTROSCOPY	Label- free chemical contrast is highly desirable in biomedical imaging. Spontaneous Raman microscopy provides specific vibrational signatures of chemical bonds, but is often hindered by low sensitivity. Here we report a three- dimensional multiphoton vibrational imaging technique based on stimulated Raman scattering ( SRS). The sensitivity of SRS imaging is significantly greater than that of spontaneous Raman microscopy, which is achieved by implementing high- frequency ( megahertz) phase- sensitive detection. SRS microscopy has a major advantage over previous coherent Raman techniques in that it offers background- free and readily interpretable chemical contrast. We show a variety of biomedical applications, such as differentiating distributions of omega- 3 fatty acids and saturated lipids in living cells, imaging of brain and skin tissues based on intrinsic lipid contrast, and monitoring drug delivery through the epidermis.	[Freudiger, Christian W.; Min, Wei; Saar, Brian G.; Lu, Sijia; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Freudiger, Christian W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [He, Chengwei; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [He, Chengwei; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Tsai, Jason C.] Pfizer Global Med, New York, NY 10017 USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pfizer	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Wei, Min/GSI-8510-2022	He, Chengwei/0000-0003-4701-2984	Boehringer Ingelheim Fonds for a Ph.D. Fellowship; Army Research Office for a National Defense Science and Engineering Graduate Fellowship; NIH [CA113605]; U. S. Department of Energy's Basic Energy Sciences [DE-FG02-07ER15875]; NSF [DBI-0649892]; NIH Director's Pioneer Award; Melinda Gates Foundation Gates Foundation; Pfizer Global Medical; NATIONAL CANCER INSTITUTE [R01CA113605] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds for a Ph.D. Fellowship(Boehringer Ingelheim); Army Research Office for a National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy's Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melinda Gates Foundation Gates Foundation(Bill & Melinda Gates Foundation); Pfizer Global Medical; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Ackermann and S. Zhang for advice on skin imaging; S. Kesari, X. Xu and the MCB Harvard Mouse Facilities for providing mouse tissue; J. Grice and M. Roberts for the loan of a sonicator; and G. Young, X. Xu, M. Ruckel, and P. Sims for helpful discussions. C.W.F. and B.G.S. thank Boehringer Ingelheim Fonds for a Ph.D. Fellowship and the Army Research Office for a National Defense Science and Engineering Graduate Fellowship, respectively. J.X.K. acknowledges support from the NIH (grant CA113605). The Xie Group is grateful to the U. S. Department of Energy's Basic Energy Sciences program (DE-FG02-07ER15875) for supporting high-sensitivity Raman detection. The instrumentation development was supported by NSF (grant DBI-0649892), NIH Director's Pioneer Award (to X.S.X.), the Bill & Melinda Gates Foundation Gates Foundation, and Pfizer Global Medical. Harvard University has filed a patent application based on this work.	BLOEMBERGEN N, 1967, AM J PHYS, V35, P989, DOI 10.1119/1.1973774; Boyd RW., 2003, NONLINEAR OPTICS, V2nd edn; Caspers PJ, 2002, PHARMACEUT RES, V19, P1577, DOI 10.1023/A:1020481305420; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Einstein A, 1917, PHYS Z, V18, P121; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P27; Fu D, 2007, OPT LETT, V32, P2641, DOI 10.1364/OL.32.002641; Fu Y, 2006, OPT EXPRESS, V14, P3942, DOI 10.1364/OE.14.003942; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Heinrich C, 2008, OPT EXPRESS, V16, P2699, DOI 10.1364/OE.16.002699; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kukura P, 2004, J PHYS CHEM A, V108, P5921, DOI 10.1021/jp0482971; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Levenson M. D., 1988, INTRO NONLINEAR LASE; LEVINE BF, 1979, IEEE J QUANTUM ELECT, V15, P1418, DOI 10.1109/JQE.1979.1069939; OWYOUNG A, 1977, OPT COMMUN, V22, P323, DOI 10.1016/S0030-4018(97)90020-1; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Potma EO, 2000, J OPT SOC AM B, V17, P1678, DOI 10.1364/JOSAB.17.001678; Raman CV, 1928, NATURE, V121, P711, DOI 10.1038/121711a0; Shen Y. R, 2003, PRINCIPLE NONLINEAR; Turrell G., 1996, RAMAN MICROSCOPY DEV; Van De Kerkhof PCM, 2006, J DERMATOL TREAT, V17, P198, DOI 10.1080/09546630600830596; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WOODBURY EJ, 1962, P IRE, V50, P2367; Ye J, 1998, J OPT SOC AM B, V15, P6, DOI 10.1364/JOSAB.15.000006; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	27	1488	1534	34	703	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1857	1861		10.1126/science.1165758	http://dx.doi.org/10.1126/science.1165758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095943	Green Accepted, Green Submitted			2022-12-24	WOS:000261799400059
J	Carter, AP; Garbarino, JE; Wilson-Kubalek, EM; Shipley, WE; Cho, C; Milligan, RA; Vale, RD; Gibbons, IR				Carter, Andrew P.; Garbarino, Joan E.; Wilson-Kubalek, Elizabeth M.; Shipley, Wesley E.; Cho, Carol; Milligan, Ronald A.; Vale, Ronald D.; Gibbons, I. R.			Structure and Functional Role of Dynein's Microtubule-Binding Domain	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; MOTOR PROTEINS; TRANSPORT; RESOLUTION; MUTATIONS; MOTIONS; SITE	Dynein motors move various cargos along microtubules within the cytoplasm and power the beating of cilia and flagella. An unusual feature of dynein is that its microtubule- binding domain ( MTBD) is separated from its ring- shaped AAA+ adenosine triphosphatase ( ATPase) domain by a 15- nanometer coiled- coil stalk. We report the crystal structure of the mouse cytoplasmic dynein MTBD and a portion of the coiled coil, which supports a mechanism by which the ATPase domain and MTBD may communicate through a shift in the heptad registry of the coiled coil. Surprisingly, functional data suggest that the MTBD, and not the ATPase domain, is the main determinant of the direction of dynein motility.	[Carter, Andrew P.; Cho, Carol; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Carter, Andrew P.; Cho, Carol; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Garbarino, Joan E.; Shipley, Wesley E.; Gibbons, I. R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wilson-Kubalek, Elizabeth M.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Scripps Research Institute	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Cho, Carol/0000-0003-4070-6561; Carter, Andrew/0000-0001-7292-5430	Jane Coffin Childs Foundation; NIH [GM52468-14, P01-AR42895, GM30401-29]; Agouron Institute; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052468, R37GM030401, R01GM052468, R01GM030401, R01GM097312] Funding Source: NIH RePORTER	Jane Coffin Childs Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agouron Institute(Pfizer); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Welburn and E. Nogales for advice and equipment; M. Kikkawa for sending his group's electron density map; and N. Bradshaw, J. Kardon, K. Aathavan, A. Dose, A. Gennerich, A. Roll- Mecak, and S. Reck- Peterson for critically reading the manuscript. Supported by the Jane Coffin Childs Foundation (A.P.C.); NIH grants GM52468-14 (R.A.M.), P01-AR42895 (R.D.V.) and GM30401-29 (I.R.G.)]; the Agouron Institute (A.P.C.); the Leukemia and Lymphoma Society (A.P.C.); and the Howard Hughes Medical Institute. Crystallography data were collected at beamline 8.3.1 of the Advanced Light Source at Lawrence Berkeley National Laboratory. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (code 3ERR). Cryo-EM data were collected in part at the National Resource for Automated Molecular Microscopy at the Scripps Research Institute (NIH P41 RR-17573). Maps were deposited at the EMDataBank (EMD-1581).	Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	24	181	183	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1691	1695		10.1126/science.1164424	http://dx.doi.org/10.1126/science.1164424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074350	Green Accepted			2022-12-24	WOS:000261608300045
J	Gsponer, J; Futschik, ME; Teichmann, SA; Babu, MM				Gsponer, Jorg; Futschik, Matthias E.; Teichmann, Sarah A.; Babu, M. Madan			Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation	SCIENCE			English	Article							INTRINSIC DISORDER; ALPHA-SYNUCLEIN; METABOLISM; P27(KIP1); BINDING; CANCER; P27	Altered abundance of several intrinsically unstructured proteins ( IUPs) has been associated with perturbed cellular signaling that may lead to pathological conditions such as cancer. Therefore, it is important to understand how cells precisely regulate the availability of IUPs. We observed that regulation of transcript clearance, proteolytic degradation, and translational rate contribute to controlling the abundance of IUPs, some of which are present in low amounts and for short periods of time. Abundant phosphorylation and low stochasticity in transcription and translation indicate that the availability of IUPs can be finely tuned. Fidelity in signaling may require that most IUPs be available in appropriate amounts and not present longer than needed.	[Gsponer, Jorg; Futschik, Matthias E.; Teichmann, Sarah A.; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Futschik, Matthias E.] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Futschik, Matthias E.] Univ Algarve, Inst Biotechnol & Bioengn, Ctr Mol & Struct Biomed, P-8005139 Faro, Portugal	MRC Laboratory Molecular Biology; Humboldt University of Berlin; Universidade do Algarve	Gsponer, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	jgsponer@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019; Futschik, Matthias/AAK-8837-2020	Futschik, Matthias/0000-0002-6245-8071; Teichmann, Sarah/0000-0002-6294-6366	Royal Society; MRC Special Training Fellowship; Medical Research Council [G0600158, MC_U105185859, MC_U105161047] Funding Source: researchfish; MRC [MC_U105185859, G0600158, MC_U105161047] Funding Source: UKRI	Royal Society(Royal Society of London); MRC Special Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge MRC for funding and thank the two anonymous referees, the editor, A. Bertolotti, A. Tzakos, A. Wuster, C. Brockmann, C. Chothia, D. Finley, D. Rubinsztein, E. Levy, H. McMahon, I. Schafer, J. Bui, K. Weber, M. Goedert, R. Janky, S. Michnick, and S. Sarkar for providing helpful comments. We apologize for, because of lack of space, not citing the work that describes the datasets and other references. Many can be found in the SOM. M.M.B. acknowledges Darwin College and Schlumberger Ltd, and M.M.B. and M.E.F. acknowledge the Royal Society for support. J.G. is funded by an MRC Special Training Fellowship in computational biology.	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mathes E, 2008, EMBO J, V27, P1421, DOI 10.1038/emboj.2008.91; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Tambyrajah WS, 2007, ARCH BIOCHEM BIOPHYS, V466, P186, DOI 10.1016/j.abb.2007.07.019; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	29	347	350	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1365	1368		10.1126/science.1163581	http://dx.doi.org/10.1126/science.1163581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039133	Green Submitted, Green Accepted			2022-12-24	WOS:000261170600035
J	Yen, HCS; Xu, QK; Chou, DM; Zhao, ZM; Elledge, SJ				Yen, Hsueh-Chi Sherry; Xu, Qikai; Chou, Danny M.; Zhao, Zhenming; Elledge, Stephen J.			Global Protein Stability Profiling in Mammalian Cells	SCIENCE			English	Article							PROTEASOME-MEDIATED DEGRADATION; SCFFBW7 UBIQUITIN LIGASE; CYCLIN-E; SACCHAROMYCES-CEREVISIAE; HUMAN-DISEASES; PHOSPHORYLATION; PROTEOMICS; SYSTEM; PATHOGENESIS; DESTRUCTION	The abundance of cellular proteins is determined largely by the rate of transcription and translation coupled with the stability of individual proteins. Although we know a great deal about global transcript abundance, little is known about global protein stability. We present a highly parallel multiplexing strategy to monitor protein turnover on a global scale by coupling flow cytometry with microarray technology to track the stability of individual proteins within a complex mixture. We demonstrated the feasibility of this approach by measuring the stability of similar to 8000 human proteins and identifying proteasome substrates. The technology provides a general platform for proteome- scale analysis of protein turnover under various physiological and disease conditions.	[Yen, Hsueh-Chi Sherry; Xu, Qikai; Chou, Danny M.; Zhao, Zhenming; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	Jane Coffin Childs Memorial Fund fellow; National Science Foundation; NIH [AG11085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund fellow; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Vidal, J. W. Harper, G. Hu, and J. Jin for the hORFome v1.1 library; J. Daly and S. Lazo-Kallanian for FACS assistance; and J. Love, S. Gupta, and K. Hurov for helpful discussions. H.-C.S.Y. is a Jane Coffin Childs Memorial Fund fellow. D.M.C. is supported by the National Science Foundation. This work is supported by an NIH grant AG11085 to J.W.H. and S.J.E. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Sun Y, 2003, CANCER BIOL THER, V2, P623; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462	33	320	334	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					918	923		10.1126/science.1160489	http://dx.doi.org/10.1126/science.1160489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988847				2022-12-24	WOS:000260674100040
J	Singh, SK; Piscitelli, CL; Yamashita, A; Gouaux, E				Singh, Satinder K.; Piscitelli, Chayne L.; Yamashita, Atsuko; Gouaux, Eric			A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation	SCIENCE			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; HUMAN SEROTONIN TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; GABA TRANSPORTER; BINDING-SITE; MECHANISM; ANTIDEPRESSANTS; DEFICIENCY	Secondary transporters are workhorses of cellular membranes, catalyzing the movement of small molecules and ions across the bilayer and coupling substrate passage to ion gradients. However, the conformational changes that accompany substrate transport, the mechanism by which a substrate moves through the transporter, and principles of competitive inhibition remain unclear. We used crystallographic and functional studies on the leucine transporter ( LeuT), a model for neurotransmitter sodium symporters, to show that various amino acid substrates induce the same occluded conformational state and that a competitive inhibitor, tryptophan ( Trp), traps LeuT in an open- to- out conformation. In the Trp complex, the extracellular gate residues arginine 30 and aspartic acid 404 define a second weak binding site for substrates or inhibitors as they permeate from the extracellular solution to the primary substrate site, which demonstrates how residues that participate in gating also mediate permeation.	[Singh, Satinder K.; Piscitelli, Chayne L.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Yamashita, Atsuko] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Columbia University	Singh, SK (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.		Yamashita, Atsuko/H-5566-2017; Gouaux, Eric/Y-4370-2019	Yamashita, Atsuko/0000-0002-8001-4642; Gouaux, Eric/0000-0002-8549-2360	NIH/National Institute of Neurological Disorders and Stroke National Research Service Award; NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award; NIH Multidisciplinary Training in Neuroendocrinology; NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083050, R01MH070039] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Multidisciplinary Training in Neuroendocrinology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the staff of National Synchrotron Light Source beamline X29A and Advanced Light Source beamlines 8.2.1 and 8.2.2 for assistance with data collection. S. K. S. was supported by an individual NIH/National Institute of Neurological Disorders and Stroke National Research Service Award postdoctoral fellowship and a NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award. C. L. P. was supported by an institutional NIH Multidisciplinary Training in Neuroendocrinology grant. A. Y. was on leave from the Laboratory for Structural Biochemistry, RIKEN Harima Institute at SPring-8, Japan. This work was supported by NIH (E.G.). E.G. is an investigator with the Howard Hughes Medical Institute. Coordinates and structure factors of the LeuT complexes have been deposited in the Protein Data Bank with the following accession codes: glycine (3F4J), alanine (3F48), 30 mM Leu (3F3E), methionine (3F3D), selenomethionine (3F4I), 4-fluorophenylalanine (3F3C) and Trp (3F3A).	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; BARKER EL, 2000, PSYCHOPHARMACOLOGY 4, P321; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; KIMELBERG HK, 1983, J NEUROCHEM, V40, P1265, DOI 10.1111/j.1471-4159.1983.tb13565.x; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Masson J, 1999, PHARMACOL REV, V51, P439; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	36	338	340	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1655	1661		10.1126/science.1166777	http://dx.doi.org/10.1126/science.1166777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074341	Green Accepted			2022-12-24	WOS:000261608300035
J	Gostin, LO; Hankins, CA				Gostin, Lawrence O.; Hankins, Catherine A.			Male Circumcision as an HIV Prevention Strategy in Sub-Saharan Africa Sociolegal Barriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION; PARTNERS; HEALTH; RISK		[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS UNAIDS, Dept Evidence Monitoring & Policy, Geneva, Switzerland	Georgetown University; UNAIDS	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Hankins, Catherine/0000-0002-1642-8592				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2046, DOI 10.1001/jama.2008.588; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; SERWADDA D, 2008, 15 C RETR OPP INF FE; *UN EC SOC COUNC, 2000, 122004 UN EC UN COMM; UNAIDS, 2007, MAL CIRC GLOB TRENDS; *UNAIDS, 2007, SAF VOL INF MAL CIRC; *UNAIDS, 2008, LEG REG SELF ASS TOO; World Health Organization, 2007, NEW DAT MAL CIRC HIV	15	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2539	2541		10.1001/jama.2008.752	http://dx.doi.org/10.1001/jama.2008.752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050196				2022-12-24	WOS:000261286200022
J	Meng, W; Mushika, Y; Ichii, T; Takeichi, M				Meng, Wenxiang; Mushika, Yoshimi; Ichii, Tetsuo; Takeichi, Masatoshi			Anchorage of Microtubule Minus Ends to Adherens Junctions Regulates Epithelial Cell-Cell Contacts	CELL			English	Article							TRACKING PROTEINS; CADHERIN FUNCTION; N-CADHERIN; CATENIN; COMPLEX; DYNAMICS; KINESIN; BINDING; LOCALIZATION; P120-CATENIN	Epithelial cells contain noncentrosomal microtubules (MTs), whose minus ends are oriented apically. In contrast with the well-known interactions of the minus ends with the centrosome, little is known about the termination site of the noncentrosomal minus ends. Here we show that a population of MT minus ends is anchored at the zonula adherens (ZA), the apical-most part of the cadherin-based adherens junction, via a protein that we have termed Nezha. We initially identified PLEKHA7 as a ZA component and subsequently detected Nezha as a partner for PLEKHA7. Nezha bound MTs at their minus ends and tethered them to the ZA. Furthermore, we found that a minus end-directed motor, KIFC3, was concentrated at the ZA in a PLEKHA7/Nezha/MT-dependent manner; and depletion of any of these proteins resulted in disorganization of the ZA. We propose that the PLEKHA7/Nezha/MT complex regulates the ZA integrity by recruiting KIFC3 to this junctional site.	[Meng, Wenxiang; Mushika, Yoshimi; Ichii, Tetsuo; Takeichi, Masatoshi] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Mushika, Yoshimi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Takeichi, M (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Meng, Wenxiang/0000-0003-0060-0535	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Mimori-Kiyosue for advice, N. Hirokawa for KIFC3 antibody and cDNA, and K. Shinmyozu for mass spectrometric analysis. We are also grateful to C. Yoshii, H. Abe-Ishigami, and M. Nomura-Harata for their technical support, as well as other members of our laboratory for discussion. This work was supported by a grant from the program Grants-in-Aid for Specially Promoted Research of the Ministry of Education, Science, Sports, and Culture of Japan.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ichii T, 2007, GENES CELLS, V12, P827, DOI 10.1111/j.1365-2443.2007.01095.x; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kaufmann U, 1999, J CELL SCI, V112, P55; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Maekawa S, 2001, J BIOCHEM-TOKYO, V129, P691, DOI 10.1093/oxfordjournals.jbchem.a002908; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mogensen MM, 2000, J CELL SCI, V113, P3013; MOGENSEN MM, 1987, J CELL SCI, V88, P95; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SU LK, 1995, CANCER RES, V55, P2972; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yang ZH, 1997, GENOMICS, V45, P123, DOI 10.1006/geno.1997.4901; Yvon AMC, 1997, J CELL SCI, V110, P2391	40	298	313	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					948	959		10.1016/j.cell.2008.09.040	http://dx.doi.org/10.1016/j.cell.2008.09.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041755	Bronze			2022-12-24	WOS:000261183900024
J	Merksamer, PI; Trusina, A; Papa, FR				Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.			Real-Time Redox Measurements during Endoplasmic Reticulum Stress Reveal Interlinked Protein Folding Functions	CELL			English	Article							ER-ASSOCIATED DEGRADATION; UNFOLDED-PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; DISULFIDE-ISOMERASE; MISFOLDED PROTEINS; LUMINAL DOMAIN; MEMBRANE; PATHWAY; KINASE	Disruption of protein folding in the endoplasmic reticulum (ER) causes unfolded proteins to accumulate, triggering the unfolded protein response (UPR). UPR outputs in turn decrease ER unfolded proteins to close a negative feedback loop. However, because it is infeasible to directly measure the concentration of unfolded proteins in vivo, cells are generically described as experiencing "ER stress'' whenever the UPR is active. Because ER redox potential is optimized for oxidative protein folding, we reasoned that measureable redox changes should accompany unfolded protein accumulation. To test this concept, we employed fluorescent protein reporters to dynamically measure ER redox status and UPR activity in single cells. Using these tools, we show that diverse stressors, both experimental and physiological, compromise ER protein oxidation when UPR-imposed homeostatic control is lost. Using genetic analysis we uncovered redox heterogeneities in isogenic cell populations, and revealed functional interlinks between ER protein folding, modification, and quality control systems.	[Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu	trusina, ala/H-7312-2012; Trusina, Ala/L-6069-2013; Trusina, Ala/N-5030-2019	Trusina, Ala/0000-0003-1945-454X; Trusina, Ala/0000-0003-1945-454X; Papa, Feroz/0000-0002-3684-9108	NIH Director's New Innovator [DP2OD001925]; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Culpeper Scholarship from the Partnership for Cures; Sandler Foundation; Hillblom Foundation; National Science Foundation Predoctoral; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	NIH Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Culpeper Scholarship from the Partnership for Cures; Sandler Foundation; Hillblom Foundation; National Science Foundation Predoctoral(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. James Remington for providing the roGFP2 construct; Victor Chubukov for assistance with automated flow cytometry and for data analysis software; Maya Schuldiner, Martin Jonikas, Erin Quan, Davis Ng, Chao Zhang, and Antony Cooper for reagents; and Kurt Thorn for imaging assistance. We thank Mark Hochstrasser, Scott Oakes, Chris Patil, Jonathan Weissman, and members of the Papa lab for comments on the manuscript. Microscopy images were collected at the Nikon Imaging Center at UCSF/QB3. F. R. P. is funded through an NIH Director's New Innovator Award (DP2OD001925), a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Culpeper Scholarship from the Partnership for Cures, and startup awards from the Sandler Foundation and the Hillblom Foundation. P. I. M. is supported through a National Science Foundation Predoctoral Fellowship.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	41	224	228	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					933	947		10.1016/j.cell.2008.10.011	http://dx.doi.org/10.1016/j.cell.2008.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19026441	Green Accepted, Bronze			2022-12-24	WOS:000261183900023
J	Lin, CH; MacGum, JA; Chu, T; Stefan, CJ; Emr, SD				Lin, Charles H.; MacGum, Jason A.; Chu, Tony; Stefan, Christopher J.; Emr, Scott D.			Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface	CELL			English	Article							PLASMA-MEMBRANE ATPASE; QUALITY-CONTROL; NEUROMUSCULAR SYNAPTOGENESIS; SACCHAROMYCES-CEREVISIAE; BETA-ARRESTINS; PY MOTIFS; YEAST; RETROMER; RECEPTOR; BINDING	The diversity of plasma membrane (PM) proteins presents a challenge for the achievement of cargo-specific regulation of endocytosis. Here, we describe a family of proteins in yeast (ARTs, for arrestin-related trafficking adaptors) that function by targeting specific PM proteins to the endocytic system. Two members (Art1 and Art2) of the family were discovered in chemical-genetic screens, and they direct downregulation of distinct amino acid transporters triggered by specific stimuli. Sequence analysis revealed a total of nine ART family members in yeast. In addition to similarity to arrestins, the ARTs each contain multiple PY motifs. These motifs are required for recruitment of the Rsp5/Nedd4-like ubiquitin ligase, which modifies the cargoes as well as the ARTs. As a result, ubiquitinated cargoes are internalized and targeted to the vacuole (lysosome) for degradation. We propose that ARTs provide a cargo-specific quality-control pathway that mediates endocytic downregulation by coupling Rsp5/Nedd4 to diverse plasma membrane proteins.	[Lin, Charles H.; Chu, Tony; Stefan, Christopher J.; Emr, Scott D.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Emr, SD (corresponding author), Cornell Univ, Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	sde26@cornell.edu		Stefan, Christopher/0000-0002-4118-5721	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li Y, 1999, MOL CELL BIOL, V19, P3588; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Wolf B, 1998, DEVELOPMENT, V125, P3853	36	362	377	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					714	725		10.1016/j.cell.2008.09.025	http://dx.doi.org/10.1016/j.cell.2008.09.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	18976803	Bronze			2022-12-24	WOS:000260886900021
J	Rai, K; Huggins, IJ; James, SR; Karpf, AR; Jones, DA; Cairns, BR				Rai, Kunal; Huggins, Ian J.; James, Smitha R.; Karpf, Adam R.; Jones, David A.; Cairns, Bradley R.			DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45	CELL			English	Article							PATERNAL GENOME; METHYLATION; 5-METHYLCYTOSINE; ARABIDOPSIS; MBD4; ACTIVATION; PROMOTER; DEMETER	Evidence for active DNA demethylation in vertebrates is accumulating, but the mechanisms and enzymes remain unclear. Using zebrafish embryos we provide evidence for 5-methylcytosine (5-meC) removal in vivo via the coupling of a 5-meC deaminase (AID, which converts 5-meC to thymine) and a G: T mismatch-specific thymine glycosylase (Mbd4). The injection of methylated DNA into embryos induced a potent DNA demethylation activity, which was attenuated by depletion of AID or the non enzymatic factor Gadd45. Remarkably, overexpression of the deaminase/glycosylase pair AID/Mbd4 in vivo caused demethylation of the bulk genome and injected methylated DNA fragments, likely involving a G: T intermediate. Furthermore, AID or Mbd4 knockdown caused the remethylation of a set of common genes. Finally, Gadd45 promoted demethylation and enhanced functional interactions between deaminase/glycosylase pairs. Our results provide evidence for a coupled mechanism of 5-meC demethylation, whereby AID deaminates 5-meC, followed by thymine base excision by Mbd4, promoted by Gadd45.	[Rai, Kunal; Jones, David A.; Cairns, Bradley R.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rai, Kunal; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Huggins, Ian J.; Jones, David A.; Cairns, Bradley R.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [James, Smitha R.; Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Roswell Park Cancer Institute	Jones, DA (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	david.jones@hci.utah.edu; brad.cairns@hci.utah.edu		Karpf, Adam/0000-0002-0866-0666; Rai, Kunal/0000-0003-2321-6894	Huntsman Cancer Institute; National Cancer Institute [CA24014, CA16056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA116468, R01CA116674, P30CA016056] Funding Source: NIH RePORTER	Huntsman Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jacqui Wittmeyer for generating antibodies for Apobec2a/b, Richard Dorsky for probes, Sung Wan Kim for plasmids, M. Ben Major for Gadd45 morpholino efficacy determinations, Bob Schackmann for oligos and Helaman Escobar for sequencing. We thank Brenda Bass, Don Ayer, and Barbara Graves for comments on the manuscript. Support has been received from: Huntsman Cancer Institute (supplies, genomics and support of K.R., I.H., and D.A.J.), the National Cancer Institute (for D.A.J, S.R.J., and A.R.K.), CA24014 and CA16056 (for core facilities), and the Howard Hughes Medical Institute (supplies, genomics, and support of B.R.C.).	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collas P, 1998, NUCLEIC ACIDS RES, V26, P4454, DOI 10.1093/nar/26.19.4454; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157	33	517	538	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1201	1212		10.1016/j.cell.2008.11.042	http://dx.doi.org/10.1016/j.cell.2008.11.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109892	Bronze, Green Accepted			2022-12-24	WOS:000261989800012
J	Lin, YF; Gill, ME; Koubova, J; Page, DC				Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.			Germ Cell-Intrinsic and -Extrinsic Factors Govern Meiotic Initiation in Mouse Embryos	SCIENCE			English	Article							MEIOSIS; PROTEIN; FEMALE; GENE; EXPRESSION; HOMOLOG; PATHWAY; GONADS; ARREST	Retinoic acid ( RA) is an essential extrinsic inducer of meiotic initiation in mammalian germ cells. However, RA acts too widely in mammalian development to account, by itself, for the cell- type and temporal specificity of meiotic initiation. We considered parallels to yeast, in which extrinsic and intrinsic factors combine to restrict meiotic initiation. We demonstrate that, in mouse embryos, extrinsic and intrinsic factors together regulate meiotic initiation. The mouse RNA- binding protein DAZL, which is expressed by postmigratory germ cells, is a key intrinsic factor, enabling those cells to initiate meiosis in response to RA. Within a brief developmental window, Dazl- expressing germ cells in both XX and XY embryos actively acquire the ability to interpret RA as a meiosis- inducing signal.	[Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lin, YF (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA.			Gill, Mark/0000-0002-2069-958X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank H. Cooke for mice carrying the Dazl<SUP>Tm1Hgu</SUP> allele; C. Heyting for SYCP3 antisera; T. Noce for MVH antisera; and A. Amon, E. Anderson, A. Baltus, A. Bortvin, M. Carmell, G. Fink, A. Hochwagen, Y. Hu, J. Lange, J. Mueller, L. Okumura, and T. Orr-Weaver for advice and comments on the manuscript. Microscopy and image capture were conducted at the W. M. Keck Foundation Biological Imaging Facility at the Whitehead Institute. This work was supported by the Howard Hughes Medical Institute.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bannister LA, 2004, CYTOGENET GENOME RES, V107, P191, DOI 10.1159/000080597; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; BYSKOV AGS, 1974, NATURE, V252, P396, DOI 10.1038/252396a0; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; HOPPER AK, 1975, GENETICS, V80, P41; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MCLAREN A, 1983, J EXP ZOOL, V228, P167, DOI 10.1002/jez.1402280203; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Scherthan H, 2003, CYTOGENET GENOME RES, V103, P235, DOI 10.1159/000076809; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584	25	186	193	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1685	1687		10.1126/science.1166340	http://dx.doi.org/10.1126/science.1166340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074348				2022-12-24	WOS:000261608300043
J	Gordon, GRJ; Choi, HB; Rungta, RL; Ellis-Davies, GCR; MacVicar, BA				Gordon, Grant R. J.; Choi, Hyun B.; Rungta, Ravi L.; Ellis-Davies, Graham C. R.; MacVicar, Brian A.			Brain metabolism dictates the polarity of astrocyte control over arterioles	NATURE			English	Article							CEREBRAL-BLOOD-FLOW; PROSTAGLANDIN TRANSPORTER PGT; RAT HIPPOCAMPAL SLICES; ACTIVATED HUMAN BRAIN; NEURONAL-ACTIVITY; OXIDATIVE-METABOLISM; IN-VIVO; EXTRACELLULAR LACTATE; SENSORY STIMULATION; CORTICAL ASTROCYTES	Calcium signalling in astrocytes couples changes in neural activity to alterations in cerebral blood flow by eliciting vasoconstriction or vasodilation of arterioles. However, the mechanism for how these opposite astrocyte influences provide appropriate changes in vessel tone within an environment that has dynamic metabolic requirements remains unclear. Here we show that the ability of astrocytes to induce vasodilations over vasoconstrictions relies on the metabolic state of the rat brain tissue. When oxygen availability is lowered and astrocyte calcium concentration is elevated, astrocyte glycolysis and lactate release are maximized. External lactate attenuates transporter- mediated uptake from the extracellular space of prostaglandin E(2), leading to accumulation and subsequent vasodilation. In conditions of low oxygen concentration extracellular adenosine also increases, which blocks astrocyte- mediated constriction, facilitating dilation. These data reveal the role of metabolic substrates in regulating brain blood flow and provide a mechanism for differential astrocyte control over cerebrovascular diameter during different states of brain activation.	[Gordon, Grant R. J.; Choi, Hyun B.; Rungta, Ravi L.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC T2N 2B5, Canada; [Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	University of British Columbia; Drexel University	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC T2N 2B5, Canada.	bmacvicar@brain.ubc.ca	MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Rungta, Ravi/0000-0003-3505-2743	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Natural Science and Engineering Council of Canada; Wilms Foundation; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wilms Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Murphy, T. Phillips and Y. Tian Wang for reading an earlier version of the manuscript. T34 was a gift from V.L. Schuster and Y. Chi. This work was supported by an operating grant from the Canadian Institutes of Health Research. B.A.M. is a Canada Research Chair and a Michael Smith Foundation for Health Research (MSFHR) Distinguished Scholar. G.R.J.G. is supported by fellowships from the Alberta Heritage Foundation for Medical Research, MSFHR and the Natural Science and Engineering Council of Canada. H. B. C. is supported by postdoctoral fellowships from Wilms Foundation and the Heart and Stroke Foundation of Canada.	Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brust TB, 2006, J NEUROSCI, V26, P12427, DOI 10.1523/JNEUROSCI.4052-06.2006; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Chan BS, 1998, J BIOL CHEM, V273, P6689, DOI 10.1074/jbc.273.12.6689; Chan BS, 2002, AM J PHYSIOL-RENAL, V282, pF1097, DOI 10.1152/ajprenal.00151.2001; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chi YL, 2006, J PHARMACOL EXP THER, V316, P1346, DOI 10.1124/jpet.105.091975; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Frenguelli BG, 2003, J NEUROCHEM, V86, P1506, DOI 10.1046/j.1471-4159.2003.01957.x; Hein TW, 2006, INVEST OPHTH VIS SCI, V47, P693, DOI 10.1167/iovs.05-1224; Hu YB, 1997, J NEUROCHEM, V69, P1484; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murphy K, 2003, MOL PHARMACOL, V64, P640, DOI 10.1124/mol.64.3.640; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Ryu JK, 2003, NEUROBIOL DIS, V12, P121, DOI 10.1016/S0969-9961(03)00002-0; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Simard M, 2003, J NEUROSCI, V23, P9254; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	49	510	521	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					745	U45		10.1038/nature07525	http://dx.doi.org/10.1038/nature07525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18971930	Green Accepted			2022-12-24	WOS:000261559900039
J	Byres, E; Paton, AW; Paton, JC; Lofling, JC; Smith, DF; Wilce, MCJ; Talbot, UM; Chong, DC; Yu, H; Huang, SS; Chen, X; Varki, NM; Varki, A; Rossjohn, J; Beddoe, T				Byres, Emma; Paton, Adrienne W.; Paton, James C.; Lofling, Jonas C.; Smith, David F.; Wilce, Matthew C. J.; Talbot, Ursula M.; Chong, Damien C.; Yu, Hai; Huang, Shengshu; Chen, Xi; Varki, Nissi M.; Varki, Ajit; Rossjohn, Jamie; Beddoe, Travis			Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin	NATURE			English	Article							SUBTILASE CYTOTOXIN; CHOLERA-TOXIN; AB(5) TOXIN; MODEL; MICE; TARGETS; BINDING; POTENT; SITE	AB(5) toxins comprise an A subunit that corrupts essential eukaryotic cell functions, and pentameric B subunits that direct targetcell uptake after binding surface glycans. Subtilase cytotoxin (SubAB) is an AB5 toxin secreted by Shiga toxigenic Escherichia coli (STEC)(1), which causes serious gastrointestinal disease in humans(2). SubAB causes haemolytic uraemic syndrome- like pathology in mice(3) through SubA- mediated cleavage of BiP/GRP78, an essential endoplasmic reticulum chaperone(4). Here we show that SubB has a strong preference for glycans terminating in the sialic acid N- glycolylneuraminic acid (Neu5Gc), a monosaccharide not synthesized in humans. Structures of SubB - Neu5Gc complexes revealed the basis for this specificity, and mutagenesis of key SubB residues abrogated in vitro glycan recognition, cell binding and cytotoxicity. SubAB specificity for Neu5Gc was confirmed using mouse tissues with a human- like deficiency of Neu5Gc and human cell lines fed with Neu5Gc. Despite lack of Neu5Gc biosynthesis in humans, assimilation of dietary Neu5Gc creates high- affinity receptors on human gut epithelia and kidney vasculature. This, and the lack of Neu5Gc- containing body fluid competitors in humans, confers susceptibility to the gastrointestinal and systemic toxicities of SubAB. Ironically, foods rich in Neu5Gc are the most common source of STEC contamination. Thus a bacterial toxin's receptor is generated by metabolic incorporation of an exogenous factor derived from food.	[Lofling, Jonas C.; Varki, Nissi M.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Byres, Emma; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Prot Crystallog Unit, Clayton, Vic 3800, Australia; [Byres, Emma; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Paton, Adrienne W.; Paton, James C.; Talbot, Ursula M.; Chong, Damien C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Smith, David F.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Yu, Hai; Huang, Shengshu; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; Monash University; Monash University; University of Adelaide; Emory University; University of California System; University of California Davis	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu; jamie.rossjohn@med.monash.edu.au; travis.beddoe@med.monash.edu.au	Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013; Chen, Xi/H-1811-2018; Paton, James C/A-9920-2008	Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Chen, Xi/0000-0002-3160-614X; 	Program Grant from the National Health; Medical Research Council of Australia; NHMRC Project Grant; National Institute of General Medical Sciences to the Consortium for Functional Glycomics; National Institutes of Health [RO1]; ARC Centre of Excellence in Structural and Functional Microbial Genomics; Australian Research Council Federation Fellowship; NHMRC Career Development Award; NHMRC Australia Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068715] Funding Source: NIH RePORTER	Program Grant from the National Health; Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); National Institute of General Medical Sciences to the Consortium for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); Australian Research Council Federation Fellowship(Australian Research Council); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff at the General Medicine and Cancer Institutes Collaborative Access Team Advanced Photon Source, Chicago, for assistance with data collection. This research was supported by a Program Grant from the National Health and Medical Research Council of Australia (NHMRC; to A.W.P. and J.C.P.), an NHMRC Project Grant (to T.B. and A.W.P.), a grant from the National Institute of General Medical Sciences to the Consortium for Functional Glycomics, RO1 grants from the National Institutes of Health (to A.W.P., J.C.P., J.R., X.C. and A.V.) and from the ARC Centre of Excellence in Structural and Functional Microbial Genomics (to J.R.). J.R. is supported by an Australian Research Council Federation Fellowship; T.B. by an NHMRC Career Development Award; J. C. P. by an NHMRC Australia Fellowship. We also thank C.J. Gregg for assistance with in vivo experiments and with collection of data, and L. Wiggleton for technical assistance with tissue sectioning and staining.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, P CCP4 STUD WEEK REC, P97; Gagneux P, 2001, AM J PHYS ANTHROPOL, V115, P99, DOI 10.1002/ajpa.1061; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; PERRAKIS A, 1997, ACTA CRYSTALLOGR D, V30, P551; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x	30	170	174	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					648	U75		10.1038/nature07428	http://dx.doi.org/10.1038/nature07428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18971931	Green Accepted			2022-12-24	WOS:000261340000043
J	Creyghton, MP; Markoulaki, S; Levine, SS; Hanna, J; Lodato, MA; Sha, K; Young, RA; Jaenisch, R; Boyer, LA				Creyghton, Menno P.; Markoulaki, Styliani; Levine, Stuart S.; Hanna, Jacob; Lodato, Michael A.; Sha, Ky; Young, Richard A.; Jaenisch, Rudolf; Boyer, Laurie A.			H2AZ Is Enriched at Polycomb Complex Target Genes in ES Cells and Is Necessary for Lineage Commitment	CELL			English	Article							HISTONE VARIANT H2A.Z; EMBRYONIC STEM-CELLS; EARLY MAMMALIAN DEVELOPMENT; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; NUCLEOSOME SURFACE; CHROMATIN STATE; X-INACTIVATION; HUMAN GENOME; PROMOTERS	Elucidating how chromatin influences gene expression patterns and ultimately cell fate is fundamental to understanding development and disease. The histone variant H2AZ has emerged as a key regulator of chromatin function and plays an essential but unknown role during mammalian development. Here, genome-wide analysis reveals that H2AZ occupies the promoters of developmentally important genes in a manner that is remarkably similar to that of the Polycomb group (PcG) protein Suz12. By using RNAi, we demonstrate a role for H2AZ in regulating target gene expression, find that H2AZ and PcG protein occupancy is interdependent at promoters, and further show that H2AZ is necessary for ES cell differentiation. Notably, H2AZ occupies a different subset of genes in lineage-committed cells, suggesting that its dynamic redistribution is necessary for cell fate transitions. Thus, H2AZ, together with PcG proteins, may establish specialized chromatin states in ES cells necessary for the proper execution of developmental gene expression programs.	[Lodato, Michael A.; Sha, Ky; Young, Richard A.; Jaenisch, Rudolf; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Creyghton, Menno P.; Markoulaki, Styliani; Levine, Stuart S.; Hanna, Jacob; Lodato, Michael A.; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu	Hanna, Jacob/K-1339-2012; Lodato, Michael/AAX-9211-2021; Young, Richard A/F-6495-2012	Hanna, Jacob/0000-0003-2042-9974; Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X; Lodato, Michael/0000-0003-4175-1073	NCI NIH HHS [R37 CA084198-09, R37 CA084198-08, R37 CA084198, 5 R37CA084198] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, R01 HG002668-05, R01HG002668] Funding Source: Medline; NICHD NIH HHS [R01 HD045022, R01 HD045022-06] Funding Source: Medline; PHS HHS [5-RO1-HDO45022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Glaser T, 2005, TRENDS NEUROSCI, V28, P397, DOI 10.1016/j.tins.2005.05.008; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; ZILBERMAN D, 2008, NATURE IN PRESS	68	248	252	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					649	661		10.1016/j.cell.2008.09.056	http://dx.doi.org/10.1016/j.cell.2008.09.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	18992931	Bronze, Green Accepted			2022-12-24	WOS:000260886900016
J	Pischon, T; Boeing, H; Hoffmann, K; Bergmann, M; Schulze, MB; Overvad, K; van der Schouw, YT; Spencer, E; Moons, KGM; Tjonneland, A; Halkjaer, J; Jensen, MK; Stegger, J; Clavel-Chapelon, F; Boutron-Ruault, MC; Chajes, V; Linseisen, J; Kaaks, R; Trichopoulou, A; Trichopoulos, D; Bamia, C; Sieri, S; Palli, D; Tumino, R; Vineis, P; Panico, S; Peeters, PHM; May, AM; Bueno-De-Mesquita, HB; van Duijnhoven, FJB; Hallmans, G; Weinehall, L; Manjer, J; Hedblad, B; Lund, E; Agudo, A; Arriola, L; Barricarte, A; Navarro, C; Martinez, C; Quiros, JR; Key, T; Bingham, S; Khaw, KT; Boffetta, P; Jenab, M; Ferrari, P; Riboli, E				Pischon, T.; Boeing, H.; Hoffmann, K.; Bergmann, M.; Schulze, M. B.; Overvad, K.; van der Schouw, Y. T.; Spencer, E.; Moons, K. G. M.; Tjonneland, A.; Halkjaer, J.; Jensen, M. K.; Stegger, J.; Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.; Linseisen, J.; Kaaks, R.; Trichopoulou, A.; Trichopoulos, D.; Bamia, C.; Sieri, S.; Palli, D.; Tumino, R.; Vineis, P.; Panico, S.; Peeters, P. H. M.; May, A. M.; Bueno-de-Mesquita, H. B.; van Duijnhoven, F. J. B.; Hallmans, G.; Weinehall, L.; Manjer, J.; Hedblad, B.; Lund, E.; Agudo, A.; Arriola, L.; Barricarte, A.; Navarro, C.; Martinez, C.; Quiros, J. R.; Key, T.; Bingham, S.; Khaw, K. T.; Boffetta, P.; Jenab, M.; Ferrari, P.; Riboli, E.			General and Abdominal Adiposity and Risk of Death in Europe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; PREDICTING MORTALITY; WAIST CIRCUMFERENCE; TISSUE DISTRIBUTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; ROC CURVE; FOLLOW-UP; OBESITY	BACKGROUND Previous studies have relied predominantly on the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) to assess the association of adiposity with the risk of death, but few have examined whether the distribution of body fat contributes to the prediction of death. METHODS We examined the association of BMI, waist circumference, and waist-to-hip ratio with the risk of death among 359,387 participants from nine countries in the European Prospective Investigation into Cancer and Nutrition (EPIC). We used a Cox regression analysis, with age as the time variable, and stratified the models according to study center and age at recruitment, with further adjustment for educational level, smoking status, alcohol consumption, physical activity, and height. RESULTS During a mean follow-up of 9.7 years, 14,723 participants died. The lowest risks of death related to BMI were observed at a BMI of 25.3 for men and 24.3 for women. After adjustment for BMI, waist circumference and waist-to-hip ratio were strongly associated with the risk of death. Relative risks among men and women in the highest quintile of waist circumference were 2.05 (95% confidence interval [CI], 1.80 to 2.33) and 1.78 (95% CI, 1.56 to 2.04), respectively, and in the highest quintile of waist-to-hip ratio, the relative risks were 1.68 (95% CI, 1.53 to 1.84) and 1.51 (95% CI, 1.37 to 1.66), respectively. BMI remained significantly associated with the risk of death in models that included waist circumference or waist-to-hip ratio (P<0.001). CONCLUSIONS These data suggest that both general adiposity and abdominal adiposity are associated with the risk of death and support the use of waist circumference or waist-tohip ratio in addition to BMI in assessing the risk of death.	[Pischon, T.; Boeing, H.; Hoffmann, K.; Bergmann, M.; Schulze, M. B.] German Inst Human Nutr, Dept Epidemiol, D-14558 Potsdam, Germany; [Overvad, K.; Jensen, M. K.] Aalborg Hosp, Aarhus Univ Hosp Syst, Dept Clin Epidemiol, Aalborg, Denmark; [Overvad, K.; Stegger, J.] Aalborg Hosp, Aarhus Univ Hosp Syst, Dept Cardiol, Aalborg, Denmark; [van der Schouw, Y. T.; Moons, K. G. M.; Peeters, P. H. M.; May, A. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spencer, E.; Key, T.] Univ Oxford, Canc Res UK Epidemiol Unit, Oxford, England; [Tjonneland, A.; Halkjaer, J.] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.] INSERM, ERI 20, EA 4045, Villejuif, France; [Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.] Inst Gustave Roussy, Villejuif, France; [Linseisen, J.; Kaaks, R.] German Canc Res Ctr, Div Clin Epidemiol, D-6900 Heidelberg, Germany; [Trichopoulou, A.; Bamia, C.] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; [Trichopoulos, D.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, D.] Hellen Hlth Fdn, Athens, Greece; [Sieri, S.] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Palli, D.] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Tumino, R.] Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy; [Vineis, P.; Riboli, E.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Vineis, P.] Univ Turin, Turin, Italy; [Panico, S.] Univ Naples Federico 2, Naples, Italy; [Bueno-de-Mesquita, H. B.; van Duijnhoven, F. J. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands; [Hallmans, G.; Weinehall, L.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Manjer, J.] Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [Hedblad, B.] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Lund, E.] Univ Tromso, Inst Community Med, Tromso, Norway; [Agudo, A.] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Arriola, L.] Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Barricarte, A.] Publ Hlth Inst Navarra, Pamplona, Spain; [Navarro, C.] Murcia Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, C.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Martinez, C.] Escuela Andaluza Salud Publ, Granada, Spain; [Quiros, J. R.] Publ Hlth & Hlth Planning Directorate, Hlth Informat Unit, Asturias, Spain; [Bingham, S.] Univ Cambridge, Ctr Nutr & Canc, Cambridge, England; [Khaw, K. T.] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Boffetta, P.; Jenab, M.; Ferrari, P.] WHO, Int Agcy Res Canc, Lyon, France	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Utrecht University; Utrecht University Medical Center; Cancer Research UK; University of Oxford; Danish Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Imperial College London; University of Turin; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Umea University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; UiT The Arctic University of Tromso; Catalan Institute of Oncology; Public Health Institute of Navarra; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Escuela Andaluza de Salud Publica; University of Cambridge; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC)	Pischon, T (corresponding author), German Inst Human Nutr, Dept Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	pischon@dife.de	Clavel-Chapelon, Francoise/G-6733-2014; Khaw, Kay-Tee/AAZ-3209-2021; Pischon, Tobias/HGE-8577-2022; Linseisen, Jakob/B-5353-2014; Panico, Salvatore/K-6506-2016; Agudo, Antonio/J-1805-2016; van der Schouw, Yvonne T./F-8327-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Boutron-Ruault, Marie-Christine/H-3936-2014; van Duijnhoven, Fränzel/GWC-0059-2022; Schulze, Matthias B/AAH-6906-2021; Sieri, Sabina/K-4667-2016; Boffetta, Paolo/AAI-7767-2021; May, Anne M/G-9183-2011	Pischon, Tobias/0000-0003-1568-767X; Linseisen, Jakob/0000-0002-9386-382X; Panico, Salvatore/0000-0002-5498-8312; Agudo, Antonio/0000-0001-9900-5677; van der Schouw, Yvonne T./0000-0002-4605-435X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Schulze, Matthias B/0000-0002-0830-5277; Sieri, Sabina/0000-0001-5201-172X; Boffetta, Paolo/0000-0002-3811-2791; Jensen, Majken Karoline/0000-0003-4729-7545; Spencer, Elizabeth/0000-0002-9079-8006; Navarro, Carmen/0000-0001-8896-7483; Overvad, Kim/0000-0001-6429-7921; Chajes, Veronique/0000-0003-1297-3064; Lund, Eiliv/0000-0002-8071-8711; tumino, rosario/0000-0003-2666-414X; Jenab, Mazda/0000-0002-0573-1852; PALLI, Domenico/0000-0002-5558-2437; Tjonneland, Anne/0000-0003-4385-2097; Riboli, Elio/0000-0001-6795-6080; Weinehall, Lars/0000-0003-3025-2690; Arriola, Larraitz/0000-0001-8487-7181	European Commission: Public Health and Consumer Protection Directorate; Research Directorate-General; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09); Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East; Maastricht of the Netherlands; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; 3M Company; Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; Institut National de la Sante et de la Recherche Medicale, France.	European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); Research Directorate-General; Deutsche Krebshilfe; German Cancer Research Center(Deutsche Krebshilfe); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09)(Instituto de Salud Carlos III); Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association, United Kingdom; British Heart Foundation(British Heart Foundation); Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom(Wellcome Trust); Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education(Greek Ministry of Development-GSRT); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East; Maastricht of the Netherlands; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; 3M Company(3M); Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; Institut National de la Sante et de la Recherche Medicale, France.(Institut National de la Sante et de la Recherche Medicale (Inserm))	Supported by grants from the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005-present; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09); the Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK; Medical Research Council, United Kingdom; the Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; the Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East, and Maastricht of the Netherlands; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; the 3M Company; Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; and Institut National de la Sante et de la Recherche Medicale, France.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P1254; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu FB, 2007, ARCH INTERN MED, V167, P875, DOI 10.1001/archinte.167.9.875; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kalmijn S, 1999, INT J OBESITY, V23, P395, DOI 10.1038/sj.ijo.0800832; Katzmarzyk PT, 2002, INT J OBESITY, V26, P1054, DOI 10.1038/sj.ijo.0802057; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Poulain M, 2006, CAN MED ASSOC J, V174, P1293, DOI 10.1503/cmaj.051299; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; WORLD H, 2000, WHO TECH REP SER, V894, P1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	40	1395	1435	2	142	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2105	2120		10.1056/NEJMoa0801891	http://dx.doi.org/10.1056/NEJMoa0801891			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005195	Green Published			2022-12-24	WOS:000260823900009
J	Blehert, DS; Hicks, AC; Behr, M; Meteyer, CU; Berlowski-Zier, BM; Buckles, EL; Coleman, JTH; Darling, SR; Gargas, A; Niver, R; Okoniewski, JC; Rudd, RJ; Stone, WB				Blehert, David S.; Hicks, Alan C.; Behr, Melissa; Meteyer, Carol U.; Berlowski-Zier, Brenda M.; Buckles, Elizabeth L.; Coleman, Jeremy T. H.; Darling, Scott R.; Gargas, Andrea; Niver, Robyn; Okoniewski, Joseph C.; Rudd, Robert J.; Stone, Ward B.			Bat White-Nose Syndrome: An Emerging Fungal Pathogen?	SCIENCE			English	Article									[Blehert, David S.; Meteyer, Carol U.; Berlowski-Zier, Brenda M.] US Geol Survey, Natl Wildlife Hlth Res Ctr, Madison, WI 53711 USA; [Hicks, Alan C.; Okoniewski, Joseph C.; Stone, Ward B.] New York Dept Environm Conservat, Albany, NY 12233 USA; [Behr, Melissa; Rudd, Robert J.] New York State Dept Hlth, Albany, NY 12201 USA; [Buckles, Elizabeth L.] Cornell Univ, Ithaca, NY 14853 USA; [Coleman, Jeremy T. H.; Niver, Robyn] US Fish & Wildlife Serv, Cortland, NY 13045 USA; [Darling, Scott R.] Vermont Fish & Wildlife Dept, Rutland, VT 05701 USA; [Gargas, Andrea] Symbiol Ltd Liabil Corp, Middleton, WI 53562 USA	United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; Cornell University; United States Department of the Interior; US Fish & Wildlife Service	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Res Ctr, 6006 Schroeder Rd, Madison, WI 53711 USA.	dblehert@usgs.gov	Gargas, Andrea/T-1028-2016	Gargas, Andrea/0000-0002-6586-047X; Blehert, David/0000-0002-1065-9760; Berlowski-Zier, Brenda/0000-0002-7922-8352; Coleman, Jeremy/0000-0002-2762-947X				[Anonymous], [No title captured]; Duncan SM, 2008, ANTARCT SCI, V20, P463, DOI 10.1017/S0954102008001314; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; SIGLER L, 1976, Mycotaxon, V4, P349; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5	6	632	666	6	520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					227	227		10.1126/science.1163874	http://dx.doi.org/10.1126/science.1163874			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	18974316				2022-12-24	WOS:000262290600030
J	Granich, RM; Gilks, CF; Dye, C; De Cock, KM; Williams, BG				Granich, Reuben M.; Gilks, Charles F.; Dye, Christopher; De Cock, Kevin M.; Williams, Brian G.			Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model	LANCET			English	Article							PREVENTION INTERVENTIONS; MALE CIRCUMCISION; PUBLIC-HEALTH; INFECTION; IMPACT; RISK; MORTALITY; COUNTRIES; EPIDEMIC; BEHAVIOR	Background Roughly 3 million people worldwide were receiving antiretroviral therapy (ART) at the end of 2007, but an estimated 6.7 million were still in need of treatment and a further 2.7 million became infected with HIV in 2007. Prevention efforts might reduce HIV incidence but are unlikely to eliminate this disease. We investigated a theoretical strategy of universal voluntary HIV testing and immediate treatment with ART, and examined the conditions under which the HIV epidemic could be driven towards elimination. Methods We used mathematical models to explore the effect on the case reproduction number (stochastic model) and long-term dynamics of the HIV epidemic (deterministic transmission model) of testing all people in our test-case community (aged 15 years and older) for HIV every year and starting people on ART immediately after they are diagnosed HIV positive. We used data from South Africa as the test case for a generalised epidemic, and assumed that all HIV transmission was heterosexual. Findings The studied strategy could greatly accelerate the transition from the present endemic phase, in which most adults living with HIV are not receiving ART, to an elimination phase, in which most are on ART, within 5 years. it could reduce HIV incidence and mortality to less than one case per 1000 people per year by 2016, or within 10 years of full implementation of the strategy, and reduce the prevalence of HIV to less than 1% within 50 years. We estimate that in 2032, the yearly cost of the present strategy and the theoretical strategy would both be US$1.7 billion; however, after this time, the cost of the present strategy would continue to increase whereas that of the theoretical strategy would decrease. Interpretation Universal voluntary HIV testing and immediate ART, combined with present prevention approaches, could have a major effect on severe genralised HIV/AIDS epidemics. This approach merits further mathematical modelling, research, and broad consultation. Funding None.	[Granich, Reuben M.; Gilks, Charles F.; De Cock, Kevin M.] WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland; [Dye, Christopher; Williams, Brian G.] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland	World Health Organization; World Health Organization	Granich, RM (corresponding author), WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	granichr@who.int	Dye, Christopher/AIC-4659-2022; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; Dye, Christopher/0000-0002-2957-1793; Williams, Brian/0000-0002-3174-4876				Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bennett DE, 2008, ANTIVIR THER, V13, P25; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; *CLINT FDN, 2008, ANT ARV PRIC LIST; Cohen J, 2008, SCIENCE, V321, P512, DOI 10.1126/science.321.5888.512; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; DESROSIERS R, 2008, 15 C RETR OPP INF CR; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Hirsch MS, 2008, J INFECT DIS, V197, pS252, DOI 10.1086/533416; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Horton R, 2008, LANCET, V372, P421, DOI 10.1016/S0140-6736(08)60882-X; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Kilby JM, 2008, AIDS, V22, P957, DOI 10.1097/QAD.0b013e3282fbd1da; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; *MED SANS FRONT, 2007, UNT WEB ARV PRIC RED; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; NASH D, 2008, 15 C RETR OPP INF CR; *PEPFAR, 2007, POW PARTN PRES EM PL; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SHISANA O, 2005, S AFRICAN NATL HIV P; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2008, EX SUMM 2008 REP GLO; UNAIDS, 2007, FIN RES REQ ACH UN A; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; WHO / UNAIDS, 2008, UN ACC SCAL UP PRIOR; Williams BG, 2000, S AFR J SCI, V96, P305; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2007, ESSENTIAL PREVENTION; Wright RJ, 2004, AM J PREV MED, V27, P42, DOI 10.1016/j.amepre.2004.03.004; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; 2008, NATL HIV SYPHILIS AN; 2008, S AFR J HIV MED, V29, P18	55	1418	1447	2	161	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					48	57		10.1016/S0140-6736(08)61697-9	http://dx.doi.org/10.1016/S0140-6736(08)61697-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19038438				2022-12-24	WOS:000262183800031
J	Chan, CE; Odde, DJ				Chan, Clarence E.; Odde, David J.			Traction Dynamics of Filopodia on Compliant Substrates	SCIENCE			English	Article							FOCAL ADHESIONS; GROWTH; ACTIN; FORCE; CELLS	Cells sense the environment's mechanical stiffness to control their own shape, migration, and fate. To better understand stiffness sensing, we constructed a stochastic model of the "motor-clutch" force transmission system, where molecular clutches link F-actin to the substrate and mechanically resist myosin- driven F- actin retrograde flow. The model predicts two distinct regimes: ( i) "frictional slippage," with fast retrograde flow and low traction forces on stiff substrates and ( ii) oscillatory "load-and-fail" dynamics, with slower retrograde flow and higher traction forces on soft substrates. We experimentally confirmed these model predictions in embryonic chick forebrain neurons by measuring the nanoscale dynamics of single- growth- cone filopodia. Furthermore, we experimentally observed a model- predicted switch in F- actin dynamics around an elastic modulus of 1 kilopascal. Thus, a motor- clutch system inherently senses and responds to the mechanical stiffness of the local environment.	[Chan, Clarence E.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020; Odde, David/H-4925-2011; Ladoux, Benoit/A-9879-2013	Odde, David/0000-0001-7731-2799; 	Institute for Engineering in Medicine at the University of Minnesota; NSF [MCB-0615568]; National Institute of General Medical Sciences [R01-GM-76177]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177] Funding Source: NIH RePORTER	Institute for Engineering in Medicine at the University of Minnesota(University of Minnesota System); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Institute for Engineering in Medicine at the University of Minnesota, NSF (grant MCB-0615568), and the National Institute of General Medical Sciences (grant R01-GM-76177). We thank P. Letourneau, D. Bray, and E. Tuzel for stimulating discussions; N. Simha for helpful discussions on gel mechanics; N. Koyano for assistance with in ovo electroporation; and members of the Odde Lab, D. Seetapun, A. Bicek, M. Gardner, and T. Dahl for technical assistance.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Howard J., 2002, APPL MECH REV, V55, pB39; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	19	549	568	11	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1687	1691		10.1126/science.1163595	http://dx.doi.org/10.1126/science.1163595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074349				2022-12-24	WOS:000261608300044
J	Samson, RY; Obita, T; Freund, SM; Williams, RL; Bell, SD				Samson, Rachel Y.; Obita, Takayuki; Freund, Stefan M.; Williams, Roger L.; Bell, Stephen D.			A Role for the ESCRT System in Cell Division in Archaea	SCIENCE			English	Article							III RECOGNITION; SULFOLOBUS; ALIX	Archaea are prokaryotic organisms that lack endomembrane structures. However, a number of hyperthermophilic members of the Kingdom Crenarchaea, including members of the Sulfolobus genus, encode homologs of the eukaryotic endosomal sorting system components Vps4 and ESCRT- III ( endosomal sorting complex required for transport- III). We found that Sulfolobus ESCRT- III and Vps4 homologs underwent regulation of their expression during the cell cycle. The proteins interacted and we established the structural basis of this interaction. Furthermore, these proteins specifically localized to the mid- cell during cell division. Overexpression of a catalytically inactive mutant Vps4 in Sulfolobus resulted in the accumulation of enlarged cells, indicative of failed cell division. Thus, the archaeal ESCRT system plays a key role in cell division.	[Samson, Rachel Y.; Bell, Stephen D.] MRC, Canc Cell Unit, Cambridge CB2 0XZ, England; [Obita, Takayuki; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Freund, Stefan M.] MRC, Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Bell, SD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	stephen.bell@path.ox.ac.uk		Bell, Stephen/0000-0002-8474-6592; Williams, Roger/0000-0001-7754-4207	Wellcome Trust [083639/Z/07/Z]; Edward Penley Abraham Trust; MRC; MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Edward Penley Abraham Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank O. Perisic and I. Duggin for advice and helpful discussions, C. Mueller-Dieckmann for help with European Synchrotron Radiation Facility beamline ID29, and S. McCallum for flow cytometry. The work was supported by Wellcome Trust (grant 083639/Z/07/Z to R. L. W.), the Edward Penley Abraham Trust (S.D.B.). and the MRC (R.L.W. and S.D.B.). The coordinates for the structure reported in this work have been deposited in the Protein Data Bank (accession number 2w2u).	Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Dye NA, 2007, TRENDS CELL BIOL, V17, P239, DOI 10.1016/j.tcb.2007.03.005; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Hobel CFV, 2008, BIOCHEM SOC T, V36, P94, DOI 10.1042/BST0360094; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Lubelska JM, 2006, EXTREMOPHILES, V10, P383, DOI 10.1007/s00792-006-0510-7; Maaty WSA, 2006, J VIROL, V80, P7625, DOI 10.1128/JVI.00522-06; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pogliano J, 2008, CURR OPIN CELL BIOL, V20, P19, DOI 10.1016/j.ceb.2007.12.006; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	21	243	254	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1710	1713		10.1126/science.1165322	http://dx.doi.org/10.1126/science.1165322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19008417	Green Accepted			2022-12-24	WOS:000261608300050
J	Sabio, G; Das, M; Mora, A; Zhang, ZY; Jun, JY; Ko, HJ; Barrett, T; Kim, JK; Davis, RJ				Sabio, Guadalupe; Das, Madhumita; Mora, Alfonso; Zhang, Zhiyou; Jun, John Y.; Ko, Hwi Jin; Barrett, Tamera; Kim, Jason K.; Davis, Roger J.			A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; IN-VIVO; INTERLEUKIN-6 DOES/DOES; GLUCOSE-HOMEOSTASIS; BENEFICIAL ROLE; OBESITY; SOCS-3; MICE; INFLAMMATION; HEPATOCYTES	A high-fat diet causes activation of the regulatory protein c-Jun NH(2)-terminal kinase 1 (JNK1) and triggers development of insulin resistance. JNK1 is therefore a potential target for therapeutic treatment of metabolic syndrome. We explored the mechanism of JNK1 signaling by engineering mice in which the Jnk1 gene was ablated selectively in adipose tissue. JNK1 deficiency in adipose tissue suppressed high- fat diet- induced insulin resistance in the liver. JNK1- dependent secretion of the inflammatory cytokine interleukin- 6 by adipose tissue caused increased expression of liver SOCS3, a protein that induces hepatic insulin resistance. Thus, JNK1 activation in adipose tissue can cause insulin resistance in the liver.	[Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Sabio, Guadalupe; Das, Madhumita; Mora, Alfonso; Barrett, Tamera; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Jun, John Y.] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Sabio, Guadalupe/H-9733-2015; Mora, Alfonso/D-2759-2017	Sabio, Guadalupe/0000-0002-2822-0625; Mora, Alfonso/0000-0002-6397-4836; Davis, Roger/0000-0002-0130-1652; Kim, Jason/0000-0002-7185-042X	NIH; American Diabetes Association [1-04-RA-47]; Pennsylvania State Department of Health; Core facilities at the University of Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases; Diabetes and Endocrinology Research Center [DK52530]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530, R01DK080756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Pennsylvania State Department of Health; Core facilities at the University of Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes and Endocrinology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Benoit, J. Cavanagh- Kyros, K. Gemme, N. Kennedy, J. Liu, and J. Reilly for expert assistance. These studies were supported by grants from NIH (to R.J.D.), the American Diabetes Association (1-04-RA-47 to J.K.K.), and the Pennsylvania State Department of Health (to J.K.K.). Core facilities at the University of Massachusetts used by these studies were supported by the National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes and Endocrinology Research Center (DK52530). R.J.D. is an Investigator of the Howard Hughes Medical Institute.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Mauvais-Jarvis F, 2002, CLIN ENDOCRINOL, V57, P1, DOI 10.1046/j.1365-2265.2002.01563.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2001, CURR OPIN HEMATOL, V8, P137, DOI 10.1097/00062752-200105000-00002; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	26	433	450	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1539	1543		10.1126/science.1160794	http://dx.doi.org/10.1126/science.1160794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056984	Green Accepted			2022-12-24	WOS:000261377400048
J	Core, LJ; Waterfall, JJ; Lis, JT				Core, Leighton J.; Waterfall, Joshua J.; Lis, John T.			Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters	SCIENCE			English	Article							HUMAN GENOME; POLYMERASE-II; HUMAN-CELLS; TRANSCRIPTION; ARCHITECTURE; BINDING; GENES; MAPS	RNA polymerases are highly regulated molecular machines. We present a method ( global run-on sequencing, GRO-seq) that maps the position, amount, and orientation of transcriptionally engaged RNA polymerases genome- wide. In this method, nuclear run- on RNA molecules are subjected to large- scale parallel sequencing and mapped to the genome. We show that peaks of promoter- proximal polymerase reside on similar to 30% of human genes, transcription extends beyond pre-messenger RNA 3 ' cleavage, and antisense transcription is prevalent. Additionally, most promoters have an engaged polymerase upstream and in an orientation opposite to the annotated gene. This divergent polymerase is associated with active genes but does not elongate effectively beyond the promoter. These results imply that the interplay between polymerases and regulators over broad promoter regions dictates the orientation and efficiency of productive transcription.	[Core, Leighton J.; Waterfall, Joshua J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu		Waterfall, Joshua/0000-0002-3762-5050	NIH [GM25232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully thank C. Haudenschild for advice on construction of our libraries and for performing the initial alignments, Q. Sun and L. Ponnala for aligning the trimmed reads, A. Siepel for computational and statistical discussion, and the members of the Lis lab for suggestions regarding this work. The work was funded by NIH grant GM25232 to J.T.L. The data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession number GSE13518. The authors are filing a patent based on the work in this paper.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	22	1356	1391	8	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1845	1848		10.1126/science.1162228	http://dx.doi.org/10.1126/science.1162228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056941	Green Accepted			2022-12-24	WOS:000261799400055
J	Pomerantz, RT; O'Donnell, M				Pomerantz, Richard T.; O'Donnell, Mike			The replisome uses mRNA as a primer after colliding with RNA polymerase	NATURE			English	Article							STALLED REPLICATION FORKS; DISCONTINUOUS DNA-REPLICATION; ESCHERICHIA-COLI; LAGGING-STRAND; LEADING-STRAND; CHAIN GROWTH; TRANSCRIPTION; REPAIR; ORGANIZATION; ELONGATION	Replication forks are impeded by DNA damage and protein - nucleic acid complexes such as transcribing RNA polymerase. For example, head- on collision of the replisome with RNA polymerase results in replication fork arrest. However, co- directional collision of the replisome with RNA polymerase has little or no effect on fork progression. Here we examine co- directional collisions between a replisome and RNA polymerase in vitro. We show that the Escherichia coli replisome uses the RNAtranscript as a primer to continue leading- strand synthesis after the collision with RNA polymerase that is displaced from the DNA. This action results in a discontinuity in the leading strand, yet the replisome remains intact and bound to DNA during the entire process. These findings underscore the notable plasticity by which the replisome operates to circumvent obstacles in its path and may explain why the leading strand is synthesized discontinuously in vivo.	[Pomerantz, Richard T.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnell@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health; Marie-Josee and Henry Kravis Fellowship at the Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R37GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie-Josee and Henry Kravis Fellowship at the Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to W. T. McAllister and R. Castagna for providing T7 RNAP, and to S. Darst and L. Westblade for providing E. coli RNAP proteins and plasmids. This work was supported by a grant from the National Institutes of Health (M.O.D.) and by a Marie-Josee and Henry Kravis Fellowship at the Rockefeller University (R.T.P.).	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOTTESMAN MM, 1973, J MOL BIOL, V77, P531, DOI 10.1016/0022-2836(73)90221-0; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; KONRAD EB, 1973, J MOL BIOL, V77, P519, DOI 10.1016/0022-2836(73)90220-9; KORNBERG A, 1992, DNA REPLICATION, P246; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OLIVERA BM, 1974, NATURE, V250, P513, DOI 10.1038/250513a0; PAULING C, 1969, P NATL ACAD SCI USA, V64, P1195, DOI 10.1073/pnas.64.4.1195; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; STERNGLANZ R, 1976, BIOCHEMISTRY-US, V15, P1838, DOI 10.1021/bi00654a008; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; WANG TCV, 1994, BIOCHEM BIOPH RES CO, V198, P844, DOI 10.1006/bbrc.1994.1120; Wang TCV, 2005, BIOESSAYS, V27, P633, DOI 10.1002/bies.20233; WANG TCV, 1989, BIOCHEM BIOPH RES CO, V165, P685, DOI 10.1016/S0006-291X(89)80020-8	50	142	145	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					762	U51		10.1038/nature07527	http://dx.doi.org/10.1038/nature07527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19020502	Green Accepted			2022-12-24	WOS:000261559900042
J	Fishman, L; Saunders, A				Fishman, Lila; Saunders, Arpiar			Centromere-Associated Female Meiotic Drive Entails Male Fitness Costs in Monkeyflowers	SCIENCE			English	Article							TRANSMISSION RATIO DISTORTION; SEGREGATION; SELECTION; MEIOSIS; LOCUS	Female meiotic drive, in which paired chromosomes compete for access to the egg, is a potentially powerful but rarely documented evolutionary force. In interspecific monkeyflower ( Mimulus) hybrids, a driving M. guttatus allele ( D) exhibits a 98: 2 transmission advantage via female meiosis. We show that extreme interspecific drive is most likely caused by divergence in centromere- associated repeat domains and document cytogenetic and functional polymorphism for drive within a population of M. guttatus. In conspecific crosses, D had a 58: 42 transmission advantage over nondriving alternative alleles. However, individuals homozygous for the driving allele suffered reduced pollen viability. These fitness effects and molecular population genetic data suggest that balancing selection prevents the fixation or loss of D and that selfish chromosomal transmission may affect both individual fitness and population genetic load.	[Fishman, Lila; Saunders, Arpiar] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Fishman, L (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	lila.fishman@mso.umt.edu			NSF [DEB-0316786, BIO-0328326]	NSF(National Science Foundation (NSF))	We thank J. H. Willis, J. K. Kelly, J. Birchler, D. Charlesworth, H. Malik, C. Barr, V. Ezenwa, D. Emlen, and S. Miller for critical comments; J. H. Willis, C. Wu, T. J. Vision, E. Ganko, L. Bridges, and J. K. Kelly for materials and communicatingunpublished results; and D. Pedersen, D. Carvey, T. Huggins, E. Peters, and B. Utgaard for lab, greenhouse, and field assistance. D. Rokhsar and J. Schmutz of DOE Joint Genome Institute provided the M. guttatus draft whole-genome sequence. Supported by NSF grants DEB-0316786 (L.F.) and BIO-0328326 (J.H. Willis, L.F., et al.). Sequences have been deposited in GenBank, with the accession numbers FJ147360 to FJ147465.	Ardlie KG, 1998, TRENDS GENET, V14, P189, DOI 10.1016/S0168-9525(98)01455-3; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Birchler JA, 2003, GENETICS, V164, P835; Buckler ES, 1999, GENETICS, V153, P415; Charlesworth B, 2007, GENET RES, V89, P85, DOI 10.1017/S001667230700866X; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Dawe RK, 2004, CHROMOSOME RES, V12, P655, DOI 10.1023/B:CHRO.0000036607.74671.db; de Villena FPM, 2001, GENETICS, V159, P1179; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Fishman L, 2001, GENETICS, V159, P1701; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Kelly JK, 2003, GENETICS, V164, P1071; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lamb JC, 2007, CURR OPIN PLANT BIOL, V10, P116, DOI 10.1016/j.pbi.2007.01.008; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Malik HS, 2005, TRENDS ECOL EVOL, V20, P151, DOI 10.1016/j.tree.2005.01.014; Mroczek RJ, 2006, GENETICS, V174, P145, DOI 10.1534/genetics.105.048322; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Zwick ME, 1999, GENETICS, V152, P1605	24	183	183	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1559	1562		10.1126/science.1161406	http://dx.doi.org/10.1126/science.1161406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056989				2022-12-24	WOS:000261377400053
J	Singh, R; Manjunatha, U; Boshoff, HIM; Ha, YH; Niyomrattanakit, P; Ledwidge, R; Dowd, CS; Lee, IY; Kim, P; Zhang, L; Kang, SH; Keller, TH; Jiricek, J; Barry, CE				Singh, Ramandeep; Manjunatha, Ujjini; Boshoff, Helena I. M.; Ha, Young Hwan; Niyomrattanakit, Pornwaratt; Ledwidge, Richard; Dowd, Cynthia S.; Lee, Ill Young; Kim, Pilho; Zhang, Liang; Kang, Sunhee; Keller, Thomas H.; Jiricek, Jan; Barry, Clifton E., III			PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release	SCIENCE			English	Article							NITRIC-OXIDE; COENZYME F-420; BOVIS BCG; METABOLISM; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE	Bicyclic nitroimidazoles, including PA- 824, are exciting candidates for the treatment of tuberculosis. These prodrugs require intracellular activation for their biological function. We found that Rv3547 is a deazaflavin- dependent nitroreductase ( Ddn) that converts PA- 824 into three primary metabolites; the major one is the corresponding des- nitroimidazole ( des- nitro). When derivatives of PA- 824 were used, the amount of des- nitro metabolite formed was highly correlated with anaerobic killing of Mycobacterium tuberculosis ( Mtb). Des- nitro metabolite formation generated reactive nitrogen species, including nitric oxide ( NO), which are the major effectors of the anaerobic activity of these compounds. Furthermore, NO scavengers protected the bacilli from the lethal effects of the drug. Thus, these compounds may act as intracellular NO donors and could augment a killing mechanism intrinsic to the innate immune system.	[Singh, Ramandeep; Manjunatha, Ujjini; Boshoff, Helena I. M.; Ha, Young Hwan; Ledwidge, Richard; Dowd, Cynthia S.; Lee, Ill Young; Kim, Pilho; Zhang, Liang; Kang, Sunhee; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Manjunatha, Ujjini; Niyomrattanakit, Pornwaratt; Keller, Thomas H.; Jiricek, Jan] Novartis Inst Trop Dis, Singapore 138670, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis	Barry, CE (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@mail.nih.gov	Barry, III, Clifton/H-3839-2012; kang, sunhee/AAM-9148-2020; Jiricek, Jan/AAA-4701-2021; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Keller, Thomas/0000-0002-7553-6235	National Institute of Allergy and Infectious Diseases; NIH; Bill and Melinda Gates Foundation; Wellcome Trust; Grand Challenges in Global Health Initiative; Korea Foundation for International Cooperation of Science and Technology; Korean Ministry of Education, Science and Technology ( MEST) [No. K20501000001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); Grand Challenges in Global Health Initiative; Korea Foundation for International Cooperation of Science and Technology; Korean Ministry of Education, Science and Technology ( MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nathan ( Cornell University) and T. P. Begley ( Cornell University) for insightful comments, S. Ehrt ( Cornell University) for proteosome mutants, L. Daniels ( Texas A& M University) for F420 and M. Goodwin ( Tuberculosis Research Section) for analytical support. This work was funded ( in part) by the intramural research program of National Institute of Allergy and Infectious Diseases, NIH, and ( in part) by a grant from the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative. This work was also supported by the Korea Foundation for International Cooperation of Science and Technology ( KICOS) through a grant provided by the Korean Ministry of Education, Science and Technology ( MEST) ( No. K20501000001).	Anderson RF, 2008, ORG BIOMOL CHEM, V6, P1973, DOI 10.1039/b801859f; Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; Barry CE, 2004, CURR PHARM DESIGN, V10, P3239, DOI 10.2174/1381612043383214; BEAULIEU BB, 1981, ANTIMICROB AGENTS CH, V20, P410, DOI 10.1128/AAC.20.3.410; Boshoff H.I., 2006, DRUG DISCOV TOD DIS, V3, P237, DOI 10.1016/j.ddmec.2006.06.002; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Fitzpatrick PF, 2005, ARCH BIOCHEM BIOPHYS, V433, P157, DOI 10.1016/j.abb.2004.08.021; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hofmann KW, 2004, APPL ENVIRON MICROB, V70, P2854, DOI 10.1128/AEM.70.5.2854-2860.2004; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Rigas B, 2008, NITRIC OXIDE-BIOL CH, V19, P199, DOI 10.1016/j.niox.2008.04.022; Smets BF, 2007, APPL MICROBIOL BIOT, V76, P267, DOI 10.1007/s00253-007-1008-7; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004	23	449	482	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1392	1395		10.1126/science.1164571	http://dx.doi.org/10.1126/science.1164571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039139	Green Accepted			2022-12-24	WOS:000261170600042
J	Kim, M; Cui, ML; Cubas, P; Gillies, A; Lee, K; Chapman, MA; Abbott, RJ; Coen, E				Kim, Minsung; Cui, Min-Long; Cubas, Pilar; Gillies, Amanda; Lee, Karen; Chapman, Mark A.; Abbott, Richard J.; Coen, Enrico			Regulatory Genes Control a Key Morphological and Ecological Trait Transferred Between Species	SCIENCE			English	Article							SENECIO-VULGARIS; RADIATE GROUNDSEL; MATING SYSTEMS; CYCLOIDEA GENE; TCP DOMAIN; MADS-BOX; ORIGIN; HIBERNICUS; EVOLUTION	Hybridization between species can lead to introgression of genes from one species to another, providing a potential mechanism for preserving and recombining key traits during evolution. To determine the molecular basis of such transfers, we analyzed a natural polymorphism for flowerhead development in Senecio. We show that the polymorphism arose by introgression of a cluster of regulatory genes, the RAY locus, from the diploid species S. squalidus into the tetraploid S. vulgaris. The RAY genes are expressed in the peripheral regions of the inflorescence meristem, where they promote flower asymmetry and lead to an increase in the rate of outcrossing. Our results highlight how key morphological and ecological traits controlled by regulatory genes may be gained, lost, and regained during evolution.	[Kim, Minsung; Cui, Min-Long; Cubas, Pilar; Lee, Karen; Coen, Enrico] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Gillies, Amanda; Chapman, Mark A.; Abbott, Richard J.] Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; [Kim, Minsung] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Cubas, Pilar] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Chapman, Mark A.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of St Andrews; University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University System of Georgia; University of Georgia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Cubas, Pilar/M-2268-2015; Cubas, Pilar/ABE-8670-2020; Chapman, Mark/E-5260-2011; cui, min/HGD-8340-2022; Lee, Karen/GVT-9602-2022	Cubas, Pilar/0000-0003-4679-2173; Cubas, Pilar/0000-0003-4679-2173; Chapman, Mark/0000-0002-7151-723X; Lee, Karen/0000-0003-4544-5217	EMBO; HFSP long-term fellowship; BBSRC [BB-D017742, G10929]; NERC/S/A/2000/03636; NERC [NE/D014166/1] Funding Source: UKRI; Natural Environment Research Council [NE/D014166/1] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); HFSP long-term fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC/S/A/2000/03636(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Walton for critical discussion. Supported by EMBO and HFSP long-term fellowship (M.K.), BBSRC grant BB-D017742 (M.C.), BBSRC grant G10929 (R.J.A.) and NERC/S/A/2000/03636 studentship (M.A.C.). GenBank accession numbers for RAY1 and RAY2 are FJ356698 to FJ356704.	ABBOTT RJ, 1992, HEREDITY, V68, P425, DOI 10.1038/hdy.1992.62; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Clark JI, 2002, PLANT J, V30, P639, DOI 10.1046/j.1365-313X.2002.01310.x; COEN ES, 1995, PHILOS T R SOC B, V350, P35, DOI 10.1098/rstb.1995.0134; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Harris S. A., 2002, Watsonia, V24, P31; HOLSINGER KE, 1991, AM NAT, V138, P606, DOI 10.1086/285237; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; INGRAM R, 1980, NEW PHYTOL, V84, P543, DOI 10.1111/j.1469-8137.1980.tb04561.x; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kramer EM, 1999, NATURE, V399, P144, DOI 10.1038/20172; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Lowe AJ, 2000, AM J BOT, V87, P1159, DOI 10.2307/2656652; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; MARSHALL DF, 1980, HEREDITY, V45, P133, DOI 10.1038/hdy.1980.57; STACE CA, 1977, HEREDITY, V39, P383, DOI 10.1038/hdy.1977.80; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; TAJIMA F, 1989, GENETICS, V123, P585; Trow AH, 1912, J GENET, V2, P239, DOI 10.1007/BF02981542	28	194	202	1	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1116	1119		10.1126/science.1164371	http://dx.doi.org/10.1126/science.1164371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008450				2022-12-24	WOS:000260867700042
J	Mott, ML; Erzberger, JP; Coons, MM; Berger, JM				Mott, Melissa L.; Erzberger, Jan P.; Coons, Mary M.; Berger, James M.			Structural Synergy and Molecular Crosstalk between Bacterial Helicase Loaders and Replication Initiators	CELL			English	Article							ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; N-TERMINAL DOMAIN; AAA PLUS ATPASES; ORIGIN RECOGNITION; CRYSTAL-STRUCTURE; ATP-HYDROLYSIS; PROTEIN COMPLEX; POLYMERASE-III; BINDING	The loading of oligomeric helicases onto replication origins marks an essential step in replisome assembly. In cells, dedicated AAA+ ATPases regulate loading, however, the mechanism by which these factors recruit and deposit helicases has remained unclear. To better understand this process, we determined the structure of the ATPase region of the bacterial helicase loader DnaC from Aquifex aeolicus to 2.7 angstrom resolution. The structure shows that DnaC is a close paralog of the bacterial replication initiator, DnaA, and unexpectedly shares an ability to form a helical assembly similar to that of ATP-bound DnaA. Complementation and ssDNA-binding assays validate the importance of homomeric DnaC interactions, while pull-down experiments show that the DnaC and DnaA AAA+ domains interact in a nucleotide-dependent manner. These findings implicate DnaC as a molecular adaptor that uses ATP-activated DnaA as a docking site for regulating the recruitment and correct spatial deposition of the DnaB helicase onto origins.	[Mott, Melissa L.; Coons, Mary M.; Berger, James M.] Univ Calif Berkeley, Quantitat Biosci Inst, Mol & Cell Biol Dept, Berkeley, CA 94720 USA; [Erzberger, Jan P.] ETH, Inst Mol Biol Biophys, CH-8093 Zurich, Switzerland	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich	Berger, JM (corresponding author), Univ Calif Berkeley, Quantitat Biosci Inst, Mol & Cell Biol Dept, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NIGMS NIH HHS [R01 GM071747-04, R01 GM071747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN GC, 1991, J BIOL CHEM, V266, P22096; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2000, BIOCHEMISTRY-US, V39, P12959, DOI 10.1021/bi0012484; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ioannou C, 2006, NUCLEIC ACIDS RES, V34, P5247, DOI 10.1093/nar/gkl690; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Marszalek J, 1996, J BIOL CHEM, V271, P18535, DOI 10.1074/jbc.271.31.18535; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; SALUJA D, 1995, J BACTERIOL, V177, P1104, DOI 10.1128/jb.177.4.1104-1111.1995; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shin JH, 2008, J BACTERIOL, V190, P4091, DOI 10.1128/JB.00233-08; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998	64	90	90	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					623	634		10.1016/j.cell.2008.09.058	http://dx.doi.org/10.1016/j.cell.2008.09.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013274	Green Accepted, Bronze			2022-12-24	WOS:000260886900014
J	Gros, J; Serralbo, O; Marcelle, C				Gros, Jerome; Serralbo, Olivier; Marcelle, Christophe			WNT11 acts as a directional cue to organize the elongation of early muscle fibres	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; CELL POLARITY; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAYS; PLANAR POLARITY; NEURAL-TUBE; GASTRULATION; PRICKLE; MEDIATE; CHICK	The early vertebrate skeletal muscle is a well- organized tissue in which the primitive muscle fibres, the myocytes, are all parallel and aligned along the antero- posterior axis of the embryo. How myofibres acquire their orientation during development is unknown. Here we show that during early chick myogenesis WNT11 has an essential role in the oriented elongation of the myocytes. We find that the neural tube, known to drive WNT11 expression in the medial border of somites(1), is necessary and sufficient to orient myocyte elongation. We then show that the specific inhibition of WNT11 function in somites leads to the disorganization of myocytes. We establish that WNT11 mediates this effect through the evolutionary conserved planar cell polarity ( PCP) pathway, downstream of the WNT/beta-catenin-dependent pathway, required to initiate the myogenic program of myocytes and WNT11 expression. Finally, we demonstrate that a localized ectopic source of WNT11 can markedly change the orientation of myocytes, indicating that WNT11 acts as a directional cue in this process. All together, these data show that the sequential action of the WNT/ PCP and the WNT/beta-catenin pathways is necessary for the formation of fully functional embryonic muscle fibres. This study also provides evidence that WNTs can act as instructive cues to regulate the PCP pathway in vertebrates.	[Gros, Jerome; Serralbo, Olivier; Marcelle, Christophe] Univ Aix Marseille 2, CNRS, Dev Biol Inst Marseille Luminy IBDML, UMR 6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marcelle, C (corresponding author), Univ Aix Marseille 2, CNRS, Dev Biol Inst Marseille Luminy IBDML, UMR 6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	marcelle@ibdm.univ-mrs.fr		Gros, Jerome/0000-0002-2264-2851; Serralbo, Olivier/0000-0003-0808-3464	Actions Concertees Incitatives; Agence Nationale de la Recherche; Association Francaise contre les Myopathies; EU 6th Framework Programme Network of Excellence MYORES	Actions Concertees Incitatives; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); EU 6th Framework Programme Network of Excellence MYORES(European Commission)	We thank C. Tabin for critical reading of the manuscript. The help of P. Weber for the two- photon imaging, and of the Zeiss team, are acknowledged. We are grateful to M. Manceau for Supplementary Fig. 1d, and to R. Kanadia for his help. This study was funded by grants from the Actions Concertees Incitatives (ACI), the Agence Nationale de la Recherche (ANR), the Association Francaise contre les Myopathies (AFM) and by the EU 6th Framework Programme Network of Excellence MYORES. J. G. was a Fellow of the AFM.	Anakwe K, 2002, J Anat, V201, P421; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cooper O, 2008, DEV DYNAM, V237, P1442, DOI 10.1002/dvdy.21490; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Jiang D, 2005, CURR BIOL, V15, P79; Kahane N, 2007, DEV BIOL, V305, P439, DOI 10.1016/j.ydbio.2007.02.030; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Linker C, 2003, DEVELOPMENT, V130, P4797, DOI 10.1242/dev.00688; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montross WT, 2000, J CELL SCI, V113, P1759; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Tada M, 2000, DEVELOPMENT, V127, P2227; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	35	142	149	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					589	U97		10.1038/nature07564	http://dx.doi.org/10.1038/nature07564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	18987628				2022-12-24	WOS:000262852200043
J	Hilf, RJC; Dutzler, R				Hilf, Ricarda J. C.; Dutzler, Raimund			Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHARGED AMINO-ACIDS; CYS-LOOP; GATING MECHANISM; MONO-VALENT; BINDING; SELECTIVITY; DOMAIN; SOFTWARE; REVEALS	The X- ray structure of a pentameric ligand- gated ion channel from Erwinia chrysanthemi ( ELIC) has recently provided structural insight into this family of ion channels at high resolution(1). The structure shows a homo- pentameric protein with a barrel- stave architecture that defines an ion- conduction pore located on the fivefold axis of symmetry. In this structure, the wide aqueous vestibule that is encircled by the extracellular ligand- binding domains of the five subunits narrows to a discontinuous pore that spans the lipid bilayer. The pore is constricted by bulky hydrophobic residues towards the extracellular side, which probably serve as barriers that prevent the diffusion of ions. This interrupted pore architecture in ELIC thus depicts a non- conducting conformation of a pentameric ligand- gated ion channel, the thermodynamically stable state in the absence of bound ligand. As ligand binding promotes pore opening in these ion channels and the specific ligand for ELIC has not yet been identified, we have turned our attention towards a homologous protein from the cyanobacterium Gloebacter violaceus ( GLIC). GLIC was shown to form proton- gated channels that are activated by a pH decrease on the extracellular side and that do not desensitize after activation(2). Both prokaryotic proteins, ELIC and GLIC form ion channels that are selective for cations over anions with poor discrimination among monovalent cations(1,2), characteristics that resemble the conduction properties of the cation- selective branch of the family that includes acetylcholine and serotonin receptors(3,4). Here we present the X- ray structure of GLIC at 3.1 angstrom resolution. The structure reveals a conformation of the channel that is distinct from ELIC and that probably resembles the open state. In combination, both structures suggest a novel gating mechanism for pentameric ligand- gated ion channels where channel opening proceeds by a change in the tilt of the pore- forming helices.	[Hilf, Ricarda J. C.; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch			National Center for Competence in Research; EC FP7	National Center for Competence in Research; EC FP7(European Commission)	We thank B. Blattmann and C. Stutz-Duocommun for assistance with crystal screening, C. Schulze-Briese and the staff of the XO6SA beamline for support during data collection, the protein analysis group at the functional genomics centre of the University of Zurich for help with mass spectrometry, R. MacKinnon for comments on the manuscript and members of the Dutzler laboratory for help in all stages of the project. Data collection was performed at the Swiss Light Source of the Paul Scherrer Institute. The research leading to these results was supported by a grant from the National Center for Competence in Research ( NCCR) in Structural Biology and by an EC FP7 grant for the EDICT consortium (HEALTH-201924). R.J.C.H. is affiliated with the Molecular Life Sciences Ph.D. programme of the University/ETH Zurich.	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; COWTAN K, 1994, AUTOMATED PROCEDURE, P34; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leslie AGW, 1992, RECENT CHANGES MOSFL; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	42	465	469	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					115	U122		10.1038/nature07461	http://dx.doi.org/10.1038/nature07461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18987630				2022-12-24	WOS:000262104900042
J	Marraffini, LA; Sontheimer, EJ				Marraffini, Luciano A.; Sontheimer, Erik J.			CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA	SCIENCE			English	Article							PROVIDES ACQUIRED-RESISTANCE; EPIDERMIDIS STRAIN; PLASMID; AUREUS; GENOME; IDENTIFICATION; PROKARYOTES; INFECTIONS; RNAS; REPLICATION	Horizontal gene transfer (HGT) in bacteria and archaea occurs through phage transduction, transformation, or conjugation, and the latter is particularly important for the spread of antibiotic resistance. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci confer sequence- directed immunity against phages. A clinical isolate of Staphylococcus epidermidis harbors a CRISPR spacer that matches the nickase gene present in nearly all staphylococcal conjugative plasmids. Here we show that CRISPR interference prevents conjugation and plasmid transformation in S. epidermidis. Insertion of a self- splicing intron into nickase blocks interference despite the reconstitution of the target sequence in the spliced mRNA, which indicates that the interference machinery targets DNA directly. We conclude that CRISPR loci counteract multiple routes of HGT and can limit the spread of antibiotic resistance in pathogenic bacteria.	[Marraffini, Luciano A.; Sontheimer, Erik J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	The Jane Coffin Childs Memorial Fund for Medical Research; NIH [GM072830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072830] Funding Source: NIH RePORTER	The Jane Coffin Childs Memorial Fund for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to O. Schneewind (University of Chicago) for reagents and experimental assistance, B. Golden (Purdue University) for orf142-2 intron constructs and advice, and members of our laboratory for discussions and comments on the manuscript. Results described here are being used in support of a patent filing by Northwestern University. L.A.M. is a fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by a grant (GM072830) from NIH to E. J. S.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Climo MW, 1996, J BACTERIOL, V178, P4975, DOI 10.1128/jb.178.16.4975-4983.1996; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GROS MF, 1987, EMBO J, V6, P3863, DOI 10.1002/j.1460-2075.1987.tb02724.x; GROS MF, 1989, EMBO J, V8, P2711, DOI 10.1002/j.1460-2075.1989.tb08412.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005; Lim SM, 2005, ANAESTHESIA, V60, P887, DOI 10.1111/j.1365-2044.2005.04220.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; MORTON TM, 1995, ANTIMICROB AGENTS CH, V39, P1272, DOI 10.1128/AAC.39.6.1272; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	28	1092	1286	20	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1843	1845		10.1126/science.1165771	http://dx.doi.org/10.1126/science.1165771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095942	Green Accepted			2022-12-24	WOS:000261799400054
J	Mastepanov, M; Sigsgaard, C; Dlugokencky, EJ; Houweling, S; Strom, L; Tamstorf, MP; Christensen, TR				Mastepanov, Mikhail; Sigsgaard, Charlotte; Dlugokencky, Edward J.; Houweling, Sander; Strom, Lena; Tamstorf, Mikkel P.; Christensen, Torben R.			Large tundra methane burst during onset of freezing	NATURE			English	Article							TRACE GAS-EXCHANGE; ATMOSPHERIC METHANE; NORTHEAST GREENLAND; ARCTIC TUNDRA; CH4; EMISSION; CLIMATE; THAW; CO2	Terrestrial wetland emissions are the largest single source of the greenhouse gas methane(1). Northern high- latitude wetlands contribute significantly to the overall methane emissions from wetlands, but the relative source distribution between tropical and high- latitude wetlands remains uncertain(2,3). As a result, not all the observed spatial and seasonal patterns of atmospheric methane concentrations can be satisfactorily explained, particularly for high northern latitudes. For example, a late- autumn shoulder is consistently observed in the seasonal cycles of atmospheric methane at high- latitude sites(4), but the sources responsible for these increased methane concentrations remain uncertain. Here we report a data set that extends hourly methane flux measurements from a high Arctic setting into the late autumn and early winter, during the onset of soil freezing. We find that emissions fall to a low steady level after the growing season but then increase significantly during the freeze- in period. The integral of emissions during the freeze- in period is approximately equal to the amount of methane emitted during the entire summer season. Three- dimensional atmospheric chemistry and transport model simulations of global atmospheric methane concentrations indicate that the observed early winter emission burst improves the agreement between the simulated seasonal cycle and atmospheric data from latitudes north of 60 degrees N. Our findings suggest that permafrost- associated freeze- in bursts of methane emissions from tundra regions could be an important and so far unrecognized component of the seasonal distribution of methane emissions from high latitudes.	[Mastepanov, Mikhail; Strom, Lena; Christensen, Torben R.] Lund Univ, Geobiosphere Sci Ctr, S-22362 Lund, Sweden; [Sigsgaard, Charlotte] Univ Copenhagen, Inst Geog & Geol, DK-1350 Copenhagen, Denmark; [Dlugokencky, Edward J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Houweling, Sander] SRON, Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Houweling, Sander] Univ Utrecht, Inst Marine & Atmospher Res Utrecht IMAU, NL-3584 CC Utrecht, Netherlands; [Tamstorf, Mikkel P.] Univ Aarhus, Natl Environm Res Inst, DK-4000 Roskilde, Denmark	Lund University; University of Copenhagen; National Oceanic Atmospheric Admin (NOAA) - USA; Utrecht University; Aarhus University	Christensen, TR (corresponding author), Lund Univ, Geobiosphere Sci Ctr, Solvegatan 12, S-22362 Lund, Sweden.	Torben.Christensen@nateko.lu.se	Tamstorf, Mikkel/I-7101-2013; Tamstorf, Mikkel/ACU-7592-2022; Tamstorf, Mikkel/AAB-6627-2020; Dlugokencky, Edward/AAN-8746-2020; Mastepanov, Mikhail/G-1235-2016	Tamstorf, Mikkel/0000-0002-2811-331X; Tamstorf, Mikkel/0000-0002-2811-331X; Dlugokencky, Edward/0000-0003-0612-6985; Mastepanov, Mikhail/0000-0002-5543-0302	Danish Ministry of the Environment; Commission for Scientific Research in Greenland (KVUG); Swedish Research Councils VR; FORMAS	Danish Ministry of the Environment; Commission for Scientific Research in Greenland (KVUG); Swedish Research Councils VR(Swedish Research Council); FORMAS(Swedish Research Council Formas)	This work was carried out under the auspices of the GeoBasis programme and part of the Zackenberg Ecological Research Operations funded by the Danish Ministry of the Environment and the ISICaB project funded by the Commission for Scientific Research in Greenland (KVUG). ASIAQ-Greenland Survey provided climate data. The work was also supported by the Swedish Research Councils VR and FORMAS. We thank P. Bergamachi (JRC) and J.-F. Meirink (KNMI) for providing the TM5 model setup. T. Tagesson helped with the field work in Zackenberg. We are grateful for comments on earlier versions of this manuscript from A. Lindroth and B. Christensen.	Bergamaschi P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007268; Bliss L.C., 1992, ARCTIC ECOSYSTEMS CH, V59, P89; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Christensen TR, 2000, GLOBAL BIOGEOCHEM CY, V14, P701, DOI 10.1029/1999GB001134; CHRISTENSEN TR, 1993, BIOGEOCHEMISTRY, V21, P117, DOI 10.1007/BF00000874; Christiansen HH, 2002, J QUATERNARY SCI, V17, P145, DOI 10.1002/jqs.665; Corradi C, 2005, GLOBAL CHANGE BIOL, V11, P1910, DOI 10.1111/j.1365-2486.2005.01023.x; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; FAN SM, 1992, J GEOPHYS RES-ATMOS, V97, P16627, DOI 10.1029/91JD02531; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; Friborg T, 2000, GLOBAL BIOGEOCHEM CY, V14, P715, DOI 10.1029/1999GB001136; Gedney N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020919; Hargreaves KJ, 2001, THEOR APPL CLIMATOL, V70, P203, DOI 10.1007/s007040170015; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Meltofte H, 2008, ADV ECOL RES, V40, P1, DOI 10.1016/S0065-2504(07)00001-3; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; Reeburgh WS, 1998, J GEOPHYS RES-ATMOS, V103, P29005, DOI 10.1029/98JD00993; Tokida T, 2007, CHEMOSPHERE, V70, P165, DOI 10.1016/j.chemosphere.2007.06.042; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Whalen SC, 1988, GLOBAL BIOGEOCHEM CY, V2, P399, DOI 10.1029/GB002i004p00399	22	219	247	4	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					628	U58		10.1038/nature07464	http://dx.doi.org/10.1038/nature07464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052625	Green Published			2022-12-24	WOS:000261340000038
J	Zhan, LX; Rosenberg, A; Bergami, KC; Yu, M; Xuan, ZY; Jaffe, AB; Allred, C; Muthuswamy, SK				Zhan, Lixing; Rosenberg, Avi; Bergami, Kenneth C.; Yu, Min; Xuan, Zhenyu; Jaffe, Aron B.; Allred, Craig; Muthuswamy, Senthil K.			Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma	CELL			English	Article							PAPILLOMAVIRUS E6 PROTEINS; TUMOR-SUPPRESSOR SCRIBBLE; MYC-INDUCED TUMORIGENESIS; GROWTH-FACTOR-ALPHA; C-MYC; TRANSGENIC MICE; MOUSE MAMMARY; EPITHELIAL-CELLS; BREAST-CANCER; PROLIFERATION CONTROL	Loss of cell polarity proteins such as Scribble induces neoplasia in Drosophila by promoting uncontrolled proliferation. In mammals, the role that polarity proteins play during tumorigenesis is not well understood. Here, we demonstrate that depletion of Scribble in mammary epithelia disrupts cell polarity, blocks three-dimensional morphogenesis, inhibits apoptosis, and induces dysplasia in vivo that progress to tumors after long latency. Loss of Scribble cooperates with oncogenes such as c-myc to transform epithelial cells and induce tumors in vivo by blocking activation of an apoptosis pathway. Like depletion, mislocalization of Scribble from cell-cell junction was sufficient to promote cell transformation. Interestingly, spontaneous mammary tumors in mice and humans possess both downregulated and mislocalized Scribble. Thus, we demonstrate that scribble inhibits breast cancer formation and that deregulation of polarity pathways promotes dysplastic and neoplastic growth in mammals by disrupting morphogenesis and inhibiting cell death.	[Zhan, Lixing; Rosenberg, Avi; Bergami, Kenneth C.; Yu, Min; Xuan, Zhenyu; Muthuswamy, Senthil K.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Rosenberg, Avi] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Jaffe, Aron B.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Allred, Craig] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Washington University (WUSTL)	Muthuswamy, SK (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	muthuswa@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Zhan, Lixing/0000-0003-4949-4358; Yu, Min/0000-0002-3969-8720; Jaffe, Aron/0000-0002-6220-0476; Rosenberg, Avi/0000-0003-2356-950X; Xuan, Zhenyu/0000-0001-9344-8493	NCI [CA098830, DOD BC075024, CA105388]; Rita Allen Foundation; FACT foundation; Glen Cove Cares; Long Islanders Against Breast Cancer; NATIONAL CANCER INSTITUTE [R01CA098830, U01CA105388, R56CA098830] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rita Allen Foundation; FACT foundation; Glen Cove Cares; Long Islanders Against Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dan Medina (Baylor College of Medicine) for the COMMA-1D cells and for his continued support and guidance during the course of the experiments. We thank Lewis Chodosh for providing tumor samples from MMTV-Myc transgenics and Patrick Humbert for the Scribble cDNA. We also wish to thank Alan Hall and members of the Muthuswamy laboratory for their critical discussions and comments regarding the manuscript, Jim Duffy for his assistance with art work, and Bill Tansey for the reagents and helpful discussions. This work was supported by CA098830, DOD BC075024, and CA105388 grants from NCI, Rita Allen Foundation, FACT foundation, Glen Cove Cares, and Long Islanders Against Breast Cancer.	AGUILARCORDOVA E, 1991, ONCOGENE, V6, P1601; ALLRED CA, 2004, DIS BREAST, P507; Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737; Amundadottir LT, 1996, ONCOGENE, V13, P757; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Edwards P A, 1996, Cancer Treat Res, V83, P23; EHMANN UK, 1987, JNCI-J NATL CANCER I, V78, P751; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Jager R, 1997, ONCOGENE, V15, P1787, DOI 10.1038/sj.onc.1201353; Jamerson MH, 2004, BRIT J CANCER, V91, P1372, DOI 10.1038/sj.bjc.6602137; JERRY DJ, 1994, IN VITRO CELL DEV-AN, V30A, P87; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lane MA, 1999, ONCOL REP, V6, P507; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; LORENZO C, 1999, CANC METASTASIS REV, V18, P295; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Murtagh J, 2004, J CELL BIOL, V166, P133, DOI 10.1083/jcb.200403020; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Ramljak D, 2003, EXP CELL RES, V287, P397, DOI 10.1016/S0014-4827(03)00135-6; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SANDGREN EP, 1995, CANCER RES, V55, P3915; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SPANDIDOS DA, 1987, ANTICANCER RES, V7, P1299; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tilli Maddalena T, 2003, Breast Cancer Res, V5, P202, DOI 10.1186/bcr614; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yu K, 1997, CELL GROWTH DIFFER, V8, P731; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	64	308	322	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					865	878		10.1016/j.cell.2008.09.045	http://dx.doi.org/10.1016/j.cell.2008.09.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041750	Bronze, Green Accepted			2022-12-24	WOS:000261183900018
J	Weixlbaumer, A; Jin, H; Neubauer, C; Voorhees, RM; Petry, S; Kelley, AC; Ramakrishnan, V				Weixlbaumer, Albert; Jin, Hong; Neubauer, Cajetan; Voorhees, Rebecca M.; Petry, Sabine; Kelley, Ann C.; Ramakrishnan, Venki			Insights into Translational Termination from the Structure of RF2 Bound to the Ribosome	SCIENCE			English	Article							PEPTIDYL-TRANSFER-RNA; POLYPEPTIDE RELEASE FACTORS; STOP CODON RECOGNITION; GGQ MOTIF; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BOND FORMATION; MESSENGER-RNA; 70S RIBOSOME; HYDROLYSIS	The termination of protein synthesis occurs through the specific recognition of a stop codon in the A site of the ribosome by a release factor ( RF), which then catalyzes the hydrolysis of the nascent protein chain from the P- site transfer RNA. Here we present, at a resolution of 3.5 angstroms, the crystal structure of RF2 in complex with its cognate UGA stop codon in the 70S ribosome. The structure provides insight into how RF2 specifically recognizes the stop codon; it also suggests a model for the role of a universally conserved GGQ motif in the catalysis of peptide release.	[Weixlbaumer, Albert; Jin, Hong; Neubauer, Cajetan; Voorhees, Rebecca M.; Petry, Sabine; Kelley, Ann C.; Ramakrishnan, Venki] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Weixlbaumer, Albert/AAI-8474-2021; Neubauer, Cajetan/B-8935-2016; Weixlbaumer, Albert/P-3587-2016	Weixlbaumer, Albert/0000-0001-9635-3844; Neubauer, Cajetan/0000-0002-5348-5609; Weixlbaumer, Albert/0000-0001-9635-3844; VOORHEES, REBECCA/0000-0003-1640-2293; Ramakrishnan, V/0000-0002-4699-2194; Jin, Hong/0000-0003-2027-9435	MRC UK; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Boehringer-Ingelheim fellowship; Gates-Cambridge fellowship; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Boehringer-Ingelheim fellowship(Boehringer Ingelheim); Gates-Cambridge fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Schmeing for his useful comments and M. Fuchs and C. Schulze-Briese for their help and advice with data collection at the Swiss Light Source. This work was supported by MRC UK, a program grant from the Wellcome Trust, and awards from the Agouron Institute and Louis- Jeantet Foundation. C.N. is supported by a Boehringer-Ingelheim fellowship and R.M.V. is supported by a Gates-Cambridge fellowship. Coordinates for the structure have been deposited in the Protein Data Bank with accession codes 2jl5 to 2jl8. V.R. holds stock options in Rib-X Pharmaceuticals, a company that develops antibacterial drugs that target the ribosome.	Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Ejby M, 2007, P NATL ACAD SCI USA, V104, P19410, DOI 10.1073/pnas.0706558104; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zoldak G, 2007, NUCLEIC ACIDS RES, V35, P1343, DOI 10.1093/nar/gkl696	30	232	282	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					953	956		10.1126/science.1164840	http://dx.doi.org/10.1126/science.1164840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988853	Green Accepted			2022-12-24	WOS:000260674100050
J	Chari, A; Golas, MM; Klingenhager, M; Neuenkirchen, N; Sander, B; Englbrecht, C; Sickmann, A; Stark, H; Fischer, U				Chari, Ashwin; Golas, Monika M.; Klingenhaeger, Michael; Neuenkirchen, Nils; Sander, Bjoern; Englbrecht, Clemens; Sickmann, Albert; Stark, Holger; Fischer, Utz			An Assembly Chaperone Collaborates with the SMN Complex to Generate Spliceosomal SnRNPs	CELL			English	Article							NUCLEAR RIBONUCLEOPROTEIN PARTICLE; ELECTRON-MICROSCOPY; CORE STRUCTURE; PROTEINS; RNA; BIOGENESIS; PATHWAY; PICLN; CLAMP; DNA	Spliceosomal small nuclear ribonucleoproteins (snRNPs) are essential components of the nuclear pre-mRNA processing machinery. A hallmark of these particles is a ring-shaped core domain generated by the binding of Sm proteins onto snRNA. PRMT5 and SMN complexes mediate the formation of the core domain in vivo. Here, we have elucidated the mechanism of this reaction by both biochemical and structural studies. We show that pICln, a component of the PRMT5 complex, induces the formation of an otherwise unstable higher-order Sm protein unit. In this state, the Sm proteins are kinetically trapped, preventing their association with snRNA. The SMN complex subsequently binds to these Sm protein units, dissociates pICln, and catalyzes ring closure on snRNA. Our data identify pICln as an assembly chaperone and the SMN complex as a catalyst of spliceosomal snRNP formation. The mode of action of this combined chaperone/catalyst system is reminiscent of the mechanism employed by DNA clamp loaders.	[Chari, Ashwin; Klingenhaeger, Michael; Neuenkirchen, Nils; Englbrecht, Clemens; Fischer, Utz] Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany; [Golas, Monika M.; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, Res Grp Electron Cryomicroscopy 3D, D-37070 Gottingen, Germany; [Sickmann, Albert] Rudolf Virchow Ctr Expt Med, D-97078 Wurzburg, Germany	University of Wurzburg; Max Planck Society	Fischer, U (corresponding author), Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de	Sander, Bjoern/AAO-9021-2021; Fischer, Utz/AAT-8422-2020; Chari, Ashwin/ABC-5304-2020; Fischer, Utz/A-4090-2016; Sickmann, Albert/A-1010-2011	Sander, Bjoern/0000-0001-8495-2321; Fischer, Utz/0000-0002-1465-6591; Chari, Ashwin/0000-0001-6220-9828; Fischer, Utz/0000-0002-1465-6591; Sickmann, Albert/0000-0002-2388-5265; Holger, Stark/0000-0002-6161-1118	DFG [SFB581, TP B18]; AFM [ID11730]; BMBF; European "3D Repertoire''	DFG(German Research Foundation (DFG)); AFM(Association Francaise contre les Myopathies); BMBF(Federal Ministry of Education & Research (BMBF)); European "3D Repertoire''	We thank T. Muller, P. Stayton, C. Kambach, J. Steitz, and I. Mattaj for reagents; J. Ohmer for technical assistance; and B. Laggerbauer, M. Kroiss, G. Matera, S. Jentsch, S. Rospert, F. U. Hartl, and R. Luhrmann for comments. This work was supported by grants of the DFG (SFB581, TP B18) and AFM (ID11730) to U. F. and grants of the BMBF and European "3D Repertoire'' to H.S.	Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FISHER DE, 1985, CELL, V42, P751, DOI 10.1016/0092-8674(85)90271-5; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI 10.1016/j.jsb,2005.04.004; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	43	154	174	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					497	509		10.1016/j.cell.2008.09.020	http://dx.doi.org/10.1016/j.cell.2008.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984161	Bronze, Green Submitted			2022-12-24	WOS:000260536300020
J	Hedges, LM; Brownlie, JC; O'Neill, SL; Johnson, KN				Hedges, Lauren M.; Brownlie, Jeremy C.; O'Neill, Scott L.; Johnson, Karyn N.			Wolbachia and Virus Protection in Insects	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER		[Hedges, Lauren M.; Brownlie, Jeremy C.; O'Neill, Scott L.; Johnson, Karyn N.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Queensland	Johnson, KN (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	karynj@uq.edu.au	O'Neill, Scott/R-9560-2019; Johnson, Karyn N/B-7980-2008; O'Neill, Scott L/B-3568-2009	O'Neill, Scott/0000-0002-4131-3615; Johnson, Karyn N/0000-0001-8647-8985; O'Neill, Scott L/0000-0002-4131-3615; Brownlie, Jeremy/0000-0003-0161-2204	University of Queensland; Australian Research Council; Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative	University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative	We thank M. Riegler for advice and E. McGraw and F. Pringle for critical reading of the manuscript. This work was supported by funding from The University of Queensland, Australian Research Council, and the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative.	Brun G., 1980, Genetics and Biology of Drosophila, V2d, P625; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Hoffmann AA, 1998, GENETICS, V148, P221; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; ONeill SL, 1997, INFLUENTIAL PASSENGE; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	7	792	839	4	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					702	702		10.1126/science.1162418	http://dx.doi.org/10.1126/science.1162418			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974344				2022-12-24	WOS:000260605200037
J	Wang, ZP; Edwards, JG; Riley, N; Provance, DW; Karcher, R; Li, XD; Davison, IG; Ikebe, M; Mercer, JA; Kauer, JA; Ehlers, MD				Wang, Zhiping; Edwards, Jeffrey G.; Riley, Nathan; Provance, D. William, Jr.; Karcher, Ryan; Li, Xiang-dong; Davison, Ian G.; Ikebe, Mitsuo; Mercer, John A.; Kauer, Julie A.; Ehlers, Michael D.			Myosin Vb Mobilizes Recycling Endosomes and AMPA Receptors for Postsynaptic Plasticity	CELL			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC TRANSMISSION; FAMILY INTERACTING PROTEIN-2; GLOBULAR TAIL DOMAIN; DENDRITIC SPINES; ENDOCYTIC ZONES; TRAFFICKING; VA; MEMBRANE; CALCIUM	Learning-related plasticity at excitatory synapses in the mammalian brain requires the trafficking of AMPA receptors and the growth of dendritic spines. However, the mechanisms that couple plasticity stimuli to the trafficking of postsynaptic cargo are poorly understood. Here we demonstrate that myosin Vb (MyoVb), a Ca2+-sensitive motor, conducts spine trafficking during long-term potentiation (LTP) of synaptic strength. Upon activation of NMDA receptors and corresponding Ca2+ influx, MyoVb associates with recycling endosomes (REs), triggering rapid spine recruitment of endosomes and local exocytosis in spines. Disruption of MyoVb or its interaction with the RE adaptor Rab11-FIP2 abolishes LTP-induced exocytosis from REs and prevents both AMPA receptor insertion and spine growth. Furthermore, induction of tight binding of MyoVb to actin using an acute chemical genetic strategy eradicates LTP in hippocampal slices. Thus, Ca2+-activated MyoVb captures and mobilizes REs for AMPA receptor insertion and spine growth, providing a mechanistic link between the induction and expression of postsynaptic plasticity.	[Wang, Zhiping; Davison, Ian G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wang, Zhiping; Davison, Ian G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Edwards, Jeffrey G.; Riley, Nathan; Kauer, Julie A.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Provance, D. William, Jr.; Karcher, Ryan; Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA; [Li, Xiang-dong; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA	Duke University; Duke University; Howard Hughes Medical Institute; Brown University; McLaughlin Research Institute for Biomedical Sciences, Inc.; University of Massachusetts System; University of Massachusetts Worcester	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Provance, David W/D-5294-2013	Provance, David W/0000-0002-9824-0672; Mercer, John/0000-0003-0307-4438; Kauer, Julie/0000-0002-3362-1642	NIH; American Heart Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402, R01NS047574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kavita Shah for supplying PE-ADP. We thank Rytis Prekeris for providing Rab11-FIP2 reagents. We thank Marguerita Klein, Irina Lebedeva, and Haiwei Zhang for excellent technical assistance. We thank Benjamin Arenkiel, Kathryn Condon, Ian Davison, Xing Guo, Cyril Hanus, Tom Helton, Juliet Hernandez, Hyun-Soo Je, Matthew Kennedy, Ming-Chia Lee, Jiuyi Lu, Angela Mabb, Thomas Newpher, Mikyoung Park, Ben Philpot, Sridhar Raghavachari, Tingting Wang, Ryohei Yasuda, and Jason Yi for critical discussions of the data and review of the manuscript. This work was supported by grants from the NIH (to M.D.E, J.A.K., J.A.M., and M. I.) and a grant from American Heart Association (to X.d.L.). M. D. E. is an Investigator of the Howard Hughes Medical Institute.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Provance DW, 2004, P NATL ACAD SCI USA, V101, P1868, DOI 10.1073/pnas.0305895101; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	48	353	361	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					535	548		10.1016/j.cell.2008.09.057	http://dx.doi.org/10.1016/j.cell.2008.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984164	Green Accepted, Bronze			2022-12-24	WOS:000260536300023
J	Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M				Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Bonhoeffer, Tobias; Huebener, Mark			Experience leaves a lasting structural trace in cortical circuits	NATURE			English	Article							OCULAR DOMINANCE PLASTICITY; MOUSE VISUAL-CORTEX; LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; DENDRITIC SPINES; ADULT CORTEX; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; RESPONSES; STABILITY	Sensory experiences exert a powerful influence on the function and future performance of neuronal circuits in the mammalian neocortex(1-3). Restructuring of synaptic connections is believed to be one mechanism by which cortical circuits store information about the sensory world(4,5). Excitatory synaptic structures, such as dendritic spines, are dynamic entities(6-8) that remain sensitive to alteration of sensory input throughout life(6,9). It remains unclear, however, whether structural changes at the level of dendritic spines can outlast the original experience and thereby provide a morphological basis for long- term information storage. Here we follow spine dynamics on apical dendrites of pyramidal neurons in functionally defined regions of adult mouse visual cortex during plasticity of eye- specific responses induced by repeated closure of one eye ( monocular deprivation). The first monocular deprivation episode doubled the rate of spine formation, thereby increasing spine density. This effect was specific to layer-5 cells located in binocular cortex, where most neurons increase their responsiveness to the non-deprived eye(3,10). Restoring binocular vision returned spine dynamics to baseline levels, but absolute spine density remained elevated and many monocular deprivation-induced spines persisted during this period of functional recovery. However, spine addition did not increase again when the same eye was closed for a second time. This absence of structural plasticity stands out against the robust changes of eye- specific responses that occur even faster after repeated deprivation(3). Thus, spines added during the first monocular deprivation experience may provide a structural basis for subsequent functional shifts. These results provide a strong link between functional plasticity and specific synaptic rearrangements, revealing a mechanism of how prior experiences could be stored in cortical circuits.	[Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Bonhoeffer, Tobias; Huebener, Mark] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Max Planck Society; Wellcome Trust; Humboldt Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome TrustEuropean Commission); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank T. Keck for contributing control data for Supplementary Fig. 7a, and M. Sperling and B. Pichler for programming help. This work was supported by the Max Planck Society, the Wellcome Trust and the Humboldt Foundation.	BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	30	359	366	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					313	U4		10.1038/nature07487	http://dx.doi.org/10.1038/nature07487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19005470	Green Accepted			2022-12-24	WOS:000262440900039
J	James, AB; Monreal, JA; Nimmo, GA; Kelly, CL; Herzyk, P; Jenkins, GI; Nimmo, HG				James, Allan B.; Monreal, Jose A.; Nimmo, Gillian A.; Kelly, Ciaran L.; Herzyk, Pawel; Jenkins, Gareth I.; Nimmo, Hugh G.			The Circadian Clock in Arabidopsis Roots Is a Simplified Slave Version of the Clock in Shoots	SCIENCE			English	Article							GENE-EXPRESSION; MOLECULAR-BASES; FEEDBACK LOOP; RHYTHMS; PATHWAYS; LIVER; PRR7; CCA1; LHY	The circadian oscillator in eukaryotes consists of several interlocking feedback loops through which the expression of clock genes is controlled. It is generally assumed that all plant cells contain essentially identical and cell- autonomous multiloop clocks. Here, we show that the circadian clock in the roots of mature Arabidopsis plants differs markedly from that in the shoots and that the root clock is synchronized by a photosynthesis- related signal from the shoot. Two of the feedback loops of the plant circadian clock are disengaged in roots, because two key clock components, the transcription factors CCA1 and LHY, are able to inhibit gene expression in shoots but not in roots. Thus, the plant clock is organ- specific but not organ- autonomous.	[James, Allan B.; Monreal, Jose A.; Nimmo, Gillian A.; Kelly, Ciaran L.; Jenkins, Gareth I.; Nimmo, Hugh G.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel] Univ Glasgow, Fac Biomed & Life Sci, Div Integrated Biol, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel] Univ Glasgow, Fac Biomed & Life Sci, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Nimmo, HG (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland.	h.g.nimmo@bio.gla.ac.uk	Jenkins, Gareth I/B-4785-2010; Monreal, Jose Antonio/K-2210-2014; Kelly, Ciarán/AAR-2404-2021	Monreal, Jose Antonio/0000-0002-0186-5634; Kelly, Ciarán/0000-0002-2263-5176; Nimmo, Hugh/0000-0003-1389-7147; James, Allan/0000-0003-4472-7095	Leverhulme Trust; Spanish Ministry of Education and Science	Leverhulme Trust(Leverhulme Trust); Spanish Ministry of Education and Science(Spanish Government)	We thank A. Millar (Edinburgh), S.A. Kay (San Diego), and C.R. McClung (Dartmouth) for Arabidopsis lines; I. Carr, (Warwick) and E. M. Tobin (Los Angeles) for the LHY- and CCA1-specific antisera, respectively; K. Edwards (Advanced Technologies, Cambridge) for advice on COSOPT; and J. Galbraith (Faculty of Biomedical and Life Sciences, University of Glasgow) for microarray experiments. The work was supported by the Leverhulme Trust. J.A.M. holds a fellowship from the Spanish Ministry of Education and Science.	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Straume M, 2004, METHOD ENZYMOL, V383, P149; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; Thain SC, 2000, CURR BIOL, V10, P951, DOI 10.1016/S0960-9822(00)00630-8; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	28	177	193	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1832	1835		10.1126/science.1161403	http://dx.doi.org/10.1126/science.1161403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095940				2022-12-24	WOS:000261799400051
J	Bornholdt, ZA; Prasad, BVV				Bornholdt, Zachary A.; Prasad, B. V. Venkataram			X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus	NATURE			English	Article							ANTIVIRAL CYTOKINE RESPONSES; DOUBLE-STRANDED-RNA; PRE-MESSENGER-RNAS; A VIRUS; EFFECTOR DOMAIN; PROTEIN; BINDING; INTERFERON; ACTIVATION; INFECTION	The recent emergence of highly pathogenic avian (H5N1) influenza viruses, their epizootic and panzootic nature, and their association with lethal human infections have raised significant global health concerns(1,2). Several studies have underlined the importance of non-structural protein NS1 in the increased pathogenicity and virulence of these strains(3,4). NS1, which consists of two domains a double-stranded RNA (dsRNA) binding domain(5,6) and the effector domain(7), separated through a linker - is an antagonist of antiviral type-I interferon response in the host(8,9). Here we report the X-ray structure of the full- length NS1 from an H5N1 strain (A/Vietnam/1203/2004) that was associated with 60% of human deaths in an outbreak in Vietnam(1,2). Compared to the individually determined structures of the RNA binding domain and the effector domain from non- H5N1 strains, the RNA binding domain within H5N1 NS1 exhibits modest structural changes, while the H5N1 effector domain shows significant alteration, particularly in the dimeric interface. Although both domains in the full- length NS1 individually participate in dimeric interactions, an unexpected finding is that these interactions result in the formation of a chain of NS1 molecules instead of distinct dimeric units. Three such chains in the crystal interact with one another extensively to form a tubular organization of similar dimensions to that observed in the cryo- electron microscopy images of NS1 in the presence of dsRNA. The tubular oligomeric organization of NS1, in which residues implicated in dsRNA binding face a 20-angstrom-wide central tunnel, provides a plausible mechanism for how NS1 sequesters varying lengths of dsRNA, to counter cellular antiviral dsRNA response pathways, while simultaneously interacting with other cellular ligands during an infection.	[Bornholdt, Zachary A.; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Prasad, B. V. Venkataram] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Prasad, BVV (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	vprasad@bcm.tmc.edu		Bornholdt, Zachary/0000-0002-7557-9219; Prasad, B.V.Venkataram/0000-0002-1172-2071	NIH [AI36040, AI07471, RR002250]; Robert Welch Foundation; US Department of Energy,; Basic Energy Sciences; Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036040, T32AI007471, R37AI036040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); US Department of Energy,(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Palese for providing us clones of A/Vietnam/1203/2004 H5N1 and A/PR8/34 (H1N1) NS1. This work was supported by the NIH (AI36040) and the Robert Welch Foundation (to B.V.V.P.). Z.A.B. acknowledges support from an NIH virology training grant (AI07471). We thank P. Palese, A. Rice, M. Schmid and B. Carrillo for discussions and comments on the manuscript and H. Chen for technical assistance with cryo-EM. We acknowledge the use of cryo-EM facilities at the National Center for Macromolecular Imaging ( Baylor College of Medicine) supported by the National Institutes of Health (RR002250 to W. Chiu); we also acknowledge the Center for Advanced Microstructures & Devices (CAMD), Baton Rouge, Los Angeles, and H. Bellamy, and the SBC- CAT 19ID beam line at the Advanced Photon Source (supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38) and its staff for their help during data collection.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000	33	116	126	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					985	U85		10.1038/nature07444	http://dx.doi.org/10.1038/nature07444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18987632	Green Accepted			2022-12-24	WOS:000261768300053
J	Wang, ET; Sandberg, R; Luo, SJ; Khrebtukova, I; Zhang, L; Mayr, C; Kingsmore, SF; Schroth, GP; Burge, CB				Wang, Eric T.; Sandberg, Rickard; Luo, Shujun; Khrebtukova, Irina; Zhang, Lu; Mayr, Christine; Kingsmore, Stephen F.; Schroth, Gary P.; Burge, Christopher B.			Alternative isoform regulation in human tissue transcriptomes	NATURE			English	Article							MESSENGER-RNA; SPLICING REGULATION; MICRORNA TARGETS; PROTEIN; GENOME; EXPRESSION; BINDING; FOX-1; MICROARRAYS; HOMOLOGS	Through alternative processing of pre- messenger RNAs, individual mammalian genes often produce multiple mRNA and protein isoforms that may have related, distinct or even opposing functions. Here we report an in- depth analysis of 15 diverse human tissue and cell line transcriptomes on the basis of deep sequencing of complementary DNA fragments, yielding a digital inventory of gene and mRNA isoform expression. Analyses in which sequence reads are mapped to exon - exon junctions indicated that 92 - 94% of human genes undergo alternative splicing,, 86% with a minor isoform frequency of 15% or more. Differences in isoform- specific read densities indicated that most alternative splicing and alternative cleavage and polyadenylation events vary between tissues, whereas variation between individuals was approximately twofold to threefold less common. Extreme or 'switch-like' regulation of splicing between tissues was associated with increased sequence conservation in regulatory regions and with generation of full- length open reading frames. Patterns of alternative splicing and alternative cleavage and polyadenylation were strongly correlated across tissues, suggesting coordinated regulation of these processes, and sequence conservation of a subset of known regulatory motifs in both alternative introns and 39 untranslated regions suggested common involvement of specific factors in tissue- level regulation of both splicing and polyadenylation.	[Wang, Eric T.; Sandberg, Rickard; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Eric T.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Luo, Shujun; Khrebtukova, Irina; Zhang, Lu; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Mayr, Christine] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA	Massachusetts Institute of Technology (MIT); Harvard University; Karolinska Institutet; Illumina; Massachusetts Institute of Technology (MIT); Whitehead Institute; National Center for Genome Resources (NCGR)	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020	kingsmore, stephen/0000-0002-3758-4631; Sandberg, Rickard/0000-0001-6473-1740; Kingsmore, Stephen/0000-0001-7180-2527	NIH; Knut & Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Anderson, D. Black, B. Friedman, and members of the Burge laboratory for comments on the manuscript, N. Spies for analyses, J. Mudge, G. D. May, N. A. Miller, E. Vermaas, T. Kerelska, J. Yan and V. Quijano for assistance in generating the mRNA- Seq data, and R. C. Roberts and N. Perrone- Bizzozero for supplying cerebellar cortex RNA samples. This research was supported by an NIH training grant ( E. T. W.), and by grants from the Knut & Alice Wallenberg Foundation and the Swedish Foundation for Strategic Research ( R. S.) and from the NIH ( C. B. B.).	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; *ILL INC, 2008, TRANSCR AN MRNA SEQ; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kim HH, 2008, MOL CELL, V29, P151, DOI 10.1016/j.molcel.2008.01.005; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; PAN Q, NATURE GENE IN PRESS; Paz RD, 2006, AM J PSYCHIAT, V163, P1829, DOI 10.1176/appi.ajp.163.10.1829; SCHROTH GP, METHODS MOL IN PRESS; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xing Y, 2005, PLOS GENET, V1, P323, DOI 10.1371/journal.pgen.0010034; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200	41	3371	3546	8	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					470	476		10.1038/nature07509	http://dx.doi.org/10.1038/nature07509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18978772	Green Accepted			2022-12-24	WOS:000261170500031
J	Hagerman, RJ; Hagerman, PJ				Hagerman, Randi J.; Hagerman, Paul J.			Testing for Fragile X Gene Mutations Throughout the Life Span	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TREMOR/ATAXIA-SYNDROME; PREMUTATION; FXTAS		[Hagerman, Randi J.] Univ Calif Davis, Sch Med, MIND Inst, Davis, CA 95616 USA; [Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Hagerman, Paul J.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hagerman, RJ (corresponding author), Univ Calif Davis Hlth Syst, 2825 50th St, Sacramento, CA 95817 USA.	randi.hagerman@ucdmc.ucdavis.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RL1AG032119, RL1AG032115] Funding Source: NIH RePORTER; NIA NIH HHS [RL1 AG032119-01, RL1 AG032115, RL1 AG032115-01, AG032115, AG032119, RL1 AG032119] Funding Source: Medline; NICHD NIH HHS [HD02274, R01 HD036071, P30 HD002274-36S1, HD036071, R01 HD036071-10, P30 HD002274] Funding Source: Medline; NIDCR NIH HHS [DE19583, UL1 DE019583, UL1 DE019583-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bailey DB, 2003, PEDIATRICS, V111, P407, DOI 10.1542/peds.111.2.407; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Coffey SM, 2008, AM J MED GENET A, V146A, P1009, DOI 10.1002/ajmg.a.32060; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Greco CM, 2007, J UROLOGY, V177, P1434, DOI 10.1016/j.juro.2006.11.097; Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794; HAGERMAN RJ, IN PRESS PEDIATRICS; Hall DA, 2005, NEUROLOGY, V65, P299, DOI 10.1212/01.wnl.0000168900.86323.9c; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; ROBERTS JE, AM J MED GENET B, DOI DOI 10.1002/AIMG.B.30786; Song FJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073	15	27	27	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2419	2421		10.1001/jama.2008.684	http://dx.doi.org/10.1001/jama.2008.684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033593	Green Accepted			2022-12-24	WOS:000261150800025
J	Hongoh, Y; Sharma, VK; Prakash, T; Noda, S; Toh, H; Taylor, TD; Kudo, T; Sakaki, Y; Toyoda, A; Hattori, M; Ohkuma, M				Hongoh, Yuichi; Sharma, Vineet K.; Prakash, Tulika; Noda, Satoko; Toh, Hidehiro; Taylor, Todd D.; Kudo, Toshiaki; Sakaki, Yoshiyuki; Toyoda, Atsushi; Hattori, Masahira; Ohkuma, Moriya			Genome of an Endosymbiont Coupling N-2 Fixation to Cellulolysis Within Protist Cells in Termite Gut	SCIENCE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; COPTOTERMES-FORMOSANUS; NITROGEN-FIXATION; PHYLOGENETIC DIVERSITY; BACTERIA; RHINOTERMITIDAE; COMMUNITY; ISOPTERA	Termites harbor diverse symbiotic gut microorganisms, the majority of which are as yet uncultivable and their interrelationships unclear. Here, we present the complete genome sequence of the uncultured Bacteroidales endosymbiont of the cellulolytic protist Pseudotrichonympha grassii, which accounts for 70% of the bacterial cells in the gut of the termite Coptotermes formosanus. Functional annotation of the chromosome ( 1,114,206 base pairs) unveiled its ability to fix dinitrogen and recycle putative host nitrogen wastes for biosynthesis of diverse amino acids and cofactors, and import glucose and xylose as energy and carbon sources. Thus, nitrogen fixation and cellulolysis are coupled within the protist's cells. This highly evolved symbiotic system probably underlies the ability of the worldwide pest termites Coptotermes to use wood as their sole food.	[Hongoh, Yuichi; Noda, Satoko; Kudo, Toshiaki; Ohkuma, Moriya] RIKEN, Adv Sci Inst, Ecomol Biorecycling Sci Res Team, Wako, Saitama 3510198, Japan; [Sharma, Vineet K.; Prakash, Tulika; Toh, Hidehiro; Taylor, Todd D.; Sakaki, Yoshiyuki; Toyoda, Atsushi; Hattori, Masahira] RIKEN, Genom Sci Ctr, Kanagawa 2300045, Japan; [Sharma, Vineet K.; Prakash, Tulika; Toh, Hidehiro; Taylor, Todd D.] RIKEN, MetaSyst Res Team, Adv Sci Inst, Kanagawa 2300045, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Hattori, Masahira] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Chiba 2778561, Japan	RIKEN; RIKEN; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Hongoh, Y (corresponding author), RIKEN, Adv Sci Inst, Ecomol Biorecycling Sci Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yhongo@riken.jp; atoyoda@lab.nig.ac.jp	Hongoh, Yuichi/A-2303-2014; Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; Srivastava, Tulika/A-7207-2009; Ohkuma, Moriya/A-8100-2011; sharma, vineet/A-7199-2009; Hattori, Masahira/AAD-3785-2019	Hongoh, Yuichi/0000-0002-5901-9625; Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; K. Sharma, Vineet/0000-0002-2958-6215	President's Discretionary Fund of RIKEN; RIKEN GSC; Bioarchitect Research Program; Eco Molecular Science Research Program; Discovery Research Institute Research Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	President's Discretionary Fund of RIKEN; RIKEN GSC; Bioarchitect Research Program; Eco Molecular Science Research Program; Discovery Research Institute Research Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to all the technical staff of the Sequence Technology Team at RIKEN Genomic Sciences Center (GSC) and the Ecomolecular Biorecycling Science Research Team for their assistance. This work was supported in part by a grant for the President's Discretionary Fund of RIKEN; a Special Fund for RIKEN GSC; grants for the Bioarchitect Research Program and the Eco Molecular Science Research Program from RIKEN; a Discovery Research Institute Research Grant to Y. H. from RIKEN; a Grant- in- Aid for Scientific Research on Priority Areas " Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to M. H.; and a Grant- inAid for Scientific Research from Japan Society for the Promotion of Science to Y. H. and M. O. The authors declare no competing financial interests. The sequence data have been deposited in GenBank/DDBJ/EMBL under accession numbers AP010656-60.	BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Inoue JI, 2007, EUKARYOT CELL, V6, P1925, DOI 10.1128/EC.00251-07; Lax AR, 2003, PEST MANAG SCI, V59, P788, DOI 10.1002/ps.721; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Noda S, 2005, APPL ENVIRON MICROB, V71, P8811, DOI 10.1128/AEM.71.12.8811-8817.2005; Noda Satoko, 2002, Microbes and Environments, V17, P139, DOI 10.1264/jsme2.17.139; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Shinzato N, 2005, BIOSCI BIOTECH BIOCH, V69, P1145, DOI 10.1271/bbb.69.1145; Su NY, 2003, SOCIOBIOLOGY, V41, P7; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; Tsunoda K, 2003, SOCIOBIOLOGY, V41, P27; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yoshimura Tsuyoshi, 1995, Wood Research, V82, P68	18	148	293	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1108	1109		10.1126/science.1165578	http://dx.doi.org/10.1126/science.1165578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008447				2022-12-24	WOS:000260867700039
J	Tomas-Loba, A; Flores, I; Fernandez-Marcos, PJ; Cayuela, ML; Maraver, A; Tejera, A; Borras, C; Matheu, A; Klatt, P; Flores, JM; Vina, J; Serrano, M; Blasco, MA				Tomas-Loba, Antonia; Flores, Ignacio; Fernandez-Marcos, Pablo J.; Cayuela, Maria L.; Maraver, Antonio; Tejera, Agueda; Borras, Consuelo; Matheu, Ander; Klatt, Peter; Flores, Juana M.; Vina, Jose; Serrano, Manuel; Blasco, Maria A.			Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice	CELL			English	Article							STEM-CELLS; DYSKERATOSIS-CONGENITA; CELLULAR SENESCENCE; PULMONARY-FIBROSIS; TUMOR-SUPPRESSOR; RNA COMPONENT; HUMAN-DISEASE; DNA-DAMAGE; LIFE-SPAN; IN-VIVO	Telomerase confers limitless proliferative potential to most human cells through its ability to elongate telomeres, the natural ends of chromosomes, which otherwise would undergo progressive attrition and eventually compromise cell viability. However, the role of telomerase in organismal aging has remained unaddressed, in part because of the cancer-promoting activity of telomerase. To circumvent this problem, we have constitutively expressed telomerase reverse transcriptase (TERT), one of the components of telomerase, in mice engineered to be cancer resistant by means of enhanced expression of the tumor suppressors p53, p16, and p19ARF. In this context, TERT over-expression improves the fitness of epithelial barriers, particularly the skin and the intestine, and produces a systemic delay in aging accompanied by extension of the median life span. These results demonstrate that constitutive expression of Tert provides antiaging activity in the context of a mammalian organism.	[Tomas-Loba, Antonia; Flores, Ignacio; Cayuela, Maria L.; Tejera, Agueda; Klatt, Peter; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain; [Fernandez-Marcos, Pablo J.; Maraver, Antonio; Matheu, Ander; Klatt, Peter; Serrano, Manuel] Spanish Natl Canc Ctr CNIO, Tumor Suppress Grp, Mol Oncol Program, Madrid 28029, Spain; [Borras, Consuelo; Vina, Jose] Univ Valencia, Dept Physiol, Valencia 46010, Spain; [Tomas-Loba, Antonia; Flores, Ignacio] Univ Complutense Madrid, Dept Anim Surg & Med, E-28040 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia; Complutense University of Madrid	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	matheu, ander/G-9906-2014; Blasco, Maria A./M-1694-2014; Serrano, Manuel/H-2634-2015; Vina, Jose/AAB-3069-2021; Loba, Antonia Tomas/AAB-6814-2019; Tejera, Agueda/L-1946-2015; Maraver, Antonio/G-2666-2015; Tejera, Agueda M./AAU-2000-2021; Flores, Ignacio/E-8304-2016; Tomas-Loba, Antonia/N-6828-2016; Tejera, Agueda/Z-1938-2019; Fernandez, Pablo J/F-1840-2016; borras, consuelo/Y-3407-2019	matheu, ander/0000-0002-1848-0781; Blasco, Maria A./0000-0002-4211-233X; Serrano, Manuel/0000-0001-7177-9312; Vina, Jose/0000-0001-9709-0089; Flores, Ignacio/0000-0001-8789-6396; Tomas-Loba, Antonia/0000-0002-6440-3373; Fernandez, Pablo J/0000-0003-3515-4125; borras, consuelo/0000-0003-4606-1792; Flores, Juana M/0000-0002-7995-4426; Maraver, Antonio/0000-0002-5527-5680; Tejera, Agueda M/0000-0002-6703-9466				Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004; Cayuela ML, 2005, EMBO REP, V6, P268, DOI 10.1038/sj.embor.7400359; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2006, MOL CELL BIOL, V26, P6130, DOI 10.1128/MCB.00543-06; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAMMERMAN MR, 1987, ENDOCRIN METAB CLIN, V16, P995, DOI 10.1016/S0889-8529(18)30455-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; INGRAM DK, 1986, EXP AGING RES, V12, P155; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yuen KCJ, 2007, DIABETES OBES METAB, V9, P11, DOI 10.1111/j.1463-1326.2006.00591.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	61	310	331	0	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					609	622		10.1016/j.cell.2008.09.034	http://dx.doi.org/10.1016/j.cell.2008.09.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013273	Bronze			2022-12-24	WOS:000260886900013
J	Portner, HO; Farrell, AP				Poertner, Hans O.; Farrell, Anthony P.			ECOLOGY Physiology and Climate Change	SCIENCE			English	Editorial Material							THERMAL TOLERANCE; TEMPERATURE; SALMON; OCEAN; SHIFTS; HEAT; COD		[Poertner, Hans O.] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of British Columbia; University of British Columbia	Portner, HO (corresponding author), Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany.	hans.poertner@awi.de	Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575				Brander K, 2003, ICES MARINE SCI S, V219, P261; BRETT JR, 1971, AM ZOOL, V11, P99; Dahle R, 2003, COMP BIOCHEM PHYS A, V136, P641, DOI 10.1016/S1095-6433(03)00215-0; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinkhaus O, 2007, FRESHWATER BIOL, V52, P1537, DOI 10.1111/j.1365-2427.2007.01786.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Takasuka A, 2008, MAR ECOL PROG SER, V360, P211, DOI 10.3354/meps07407; Takasuka A, 2007, CAN J FISH AQUAT SCI, V64, P768, DOI 10.1139/F07-052; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	23	6395	6508	67	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					690	692		10.1126/science.1163156	http://dx.doi.org/10.1126/science.1163156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974339				2022-12-24	WOS:000260605200032
J	Shah, IM; Laaberki, MH; Popham, DL; Dworkin, J				Shah, Ishita M.; Laaberki, Maria-Halima; Popham, David L.; Dworkin, Jonathan			A Eukaryotic-like Ser/Thr Kinase Signals Bacteria to Exit Dormancy in Response to Peptidoglycan Fragments	CELL			English	Article							BACILLUS-SUBTILIS SPORE; MYCOBACTERIUM-TUBERCULOSIS; CELL-WALL; PROTEIN-KINASES; CLOSTRIDIUM-DIFFICILE; RECOGNITION PROTEINS; VEGETATIVE CELLS; BINDING DOMAIN; BETA-LACTAM; GERMINATION	Bacteria can respond to adverse environmental conditions by drastically reducing or even ceasing metabolic activity. They must then determine that conditions have improved before exiting dormancy, and one indication of such a change is the growth of other bacteria in the local environment. Growing bacteria release muropeptide fragments of the cell wall into the extracellular milieu, and we report here that these muropeptides are potent germinants of dormant Bacillus subtilis spores. The ability of a muropeptide to act as a germinant is determined by the identity of a single amino acid. A well-conserved, eukaryotic-like Ser/Thr membrane kinase containing an extracellular domain capable of binding peptidoglycan is necessary for this response, and a small molecule that stimulates related eukaryotic kinases is sufficient to induce germination. Another small molecule, staurosporine, that inhibits related eukaryotic kinases blocks muropeptide-dependent germination. Thus, in contrast to traditional antimicrobials that inhibit metabolically active cells, staurosporine acts by blocking germination of dormant spores.	[Shah, Ishita M.; Laaberki, Maria-Halima; Dworkin, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; [Popham, David L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Columbia University; Virginia Polytechnic Institute & State University	Dworkin, J (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA.	jonathan.dworkin@columbia.edu	Popham, David L/F-8066-2015; Laaberki, Maria-Halima/M-6369-2014	Popham, David L/0000-0002-2614-143X; Laaberki, Maria-Halima/0000-0001-5796-5995	Department of Microbiology, Columbia University; NIH [GM56695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056695, R01GM081368] Funding Source: NIH RePORTER	Department of Microbiology, Columbia University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Aaron Mitchell and Howard Shuman for helpful discussions and Adriano Henriques, Marjorie Russel, Howard Shuman, and Leslie Vosshall for critically reading the manuscript. We thank C. Price and P. Setlow for B. subtilis strains and D. Garsin, F. Lowy, D. Portnoy, and A. Ratner for additional bacterial strains. This work was supported by startup funds from the Department of Microbiology, Columbia University to J.D. and by NIH grant GM56695 to D. L. P. J.D. is an Irma T. Hirschl Trust Scholar.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hecht DW, 2007, ANTIMICROB AGENTS CH, V51, P2716, DOI 10.1128/AAC.01623-06; Hudson KD, 2001, J BACTERIOL, V183, P4317, DOI 10.1128/JB.183.14.4317-4322.2001; HUNGERER KD, 1969, BIOCHEMISTRY-US, V8, P3577, DOI 10.1021/bi00837a013; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Keep NH, 2006, TRENDS MICROBIOL, V14, P271, DOI 10.1016/j.tim.2006.04.003; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MAUCK J, 1971, J BIOL CHEM, V246, P1820; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1970, J BIOL CHEM, V245, P3645; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	358	381	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					486	496		10.1016/j.cell.2008.08.039	http://dx.doi.org/10.1016/j.cell.2008.08.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984160	Bronze, Green Accepted			2022-12-24	WOS:000260536300019
J	Rohr, JR; Schotthoefer, AM; Raffel, TR; Carrick, HJ; Halstead, N; Hoverman, JT; Johnson, CM; Johnson, LB; Lieske, C; Piwoni, MD; Schoff, PK; Beasley, VR				Rohr, Jason R.; Schotthoefer, Anna M.; Raffel, Thomas R.; Carrick, Hunter J.; Halstead, Neal; Hoverman, Jason T.; Johnson, Catherine M.; Johnson, Lucinda B.; Lieske, Camilla; Piwoni, Marvin D.; Schoff, Patrick K.; Beasley, Val R.			Agrochemicals increase trematode infections in a declining amphibian species	NATURE			English	Article							FROGS RANA-PIPIENS; LIMB DEVELOPMENT; ATRAZINE; EXPOSURE; SURVIVAL; SURVIVORSHIP; DEFORMITIES; HERBICIDE; DISEASE; STAGE	Global amphibian declines have often been attributed to disease(1,2), but ignorance of the relative importance and mode of action of potential drivers of infection has made it difficult to develop effective remediation. In a field study, here we show that the widely used herbicide, atrazine, was the best predictor ( out of more than 240 plausible candidates) of the abundance of larval trematodes ( parasitic flatworms) in the declining northern leopard frog Rana pipiens. The effects of atrazine were consistent across trematode taxa. The combination of atrazine and phosphate - principal agrochemicals in global corn and sorghum production - accounted for 74% of the variation in the abundance of these often debilitating larval trematodes ( atrazine alone accounted for 51%). Analysis of field data supported a causal mechanism whereby both agrochemicals increase exposure and susceptibility to larval trematodes by augmenting snail intermediate hosts and suppressing amphibian immunity. A mesocosm experiment demonstrated that, relative to control tanks, atrazine tanks had immunosuppressed tadpoles, had significantly more attached algae and snails, and had tadpoles with elevated trematode loads, further supporting a causal relationship between atrazine and elevated trematode infections in amphibians. These results raise concerns about the role of atrazine and phosphate in amphibian declines, and illustrate the value of quantifying the relative importance of several possible drivers of disease risk while determining the mechanisms by which they facilitate disease emergence.	[Rohr, Jason R.; Raffel, Thomas R.; Halstead, Neal] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Rohr, Jason R.; Raffel, Thomas R.] Penn State Univ, Penn State Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Schotthoefer, Anna M.; Lieske, Camilla; Beasley, Val R.] Univ Illinois, Coll Vet Med, Urbana, IL 61802 USA; [Carrick, Hunter J.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Hoverman, Jason T.] Univ Tennessee, Dept Forest Wildlife & Fisheries, Knoxville, TN 37996 USA; [Johnson, Catherine M.; Johnson, Lucinda B.; Schoff, Patrick K.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA; [Piwoni, Marvin D.] Illinois Waste Management & Res Ctr, Champaign, IL 61820 USA	State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Tennessee System; University of Tennessee Knoxville; University of Minnesota System; University of Minnesota Duluth	Rohr, JR (corresponding author), Univ S Florida, Dept Biol, Tampa, FL 33620 USA.	jasonrohr@gmail.com	Hoverman, Jason T/D-1756-2013; Rohr, Jason R./AAJ-5856-2021; Hoverman, Jason/AGR-0056-2022	Hoverman, Jason T/0000-0002-4002-2728; Hoverman, Jason/0000-0002-4002-2728; Johnson, Catherine/0000-0003-3241-9394; Johnson, Catherine/0000-0003-3133-9616	National Science Foundation [DEB-0809487]; US Department of Agriculture [NRI 2008-00622, NRI 2008-01785]; US Environmental Protection Agency STAR [R825867, R833835]	National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); US Environmental Protection Agency STAR(United States Environmental Protection Agency)	We thank J. Murphy, A. Antolin, K. Beckman, R. Cole, A. Koehler, C. Hall, T. Hollenhorst and J. Romansic for collection and compilation of field, parasitological or land cover data; R. Cole, M. Martin, M. Mescher, J. Romansic, J. Runyon and the O. Bjornstad, C. De Moraes, E. Holmes, P. Hudson, B. Grenfell and M. Poss laboratories for comments and suggestions on this work; and J. Grace for reviewing sections of the paper on structural equation modelling. We also thank the USGS National Wildlife Health Center for laboratory space and support. Funds came from National Science Foundation (DEB-0809487) and US Department of Agriculture (NRI 2008-00622 and 2008-01785) grants to J.R.R., and US Environmental Protection Agency STAR grants to V. R. B. (R825867) and J.R.R. and T.R.R (R833835). This work does not necessarily reflect the views of these agencies.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; [Anonymous], 2004, PESTICIDE IND SALES; BEASLEY VR, 2003, STATUS CONSERVATION, P153; BROCK TCM, 2000, 088 ALT GREEN WORLD; Brodkin MA, 2007, ENVIRON TOXICOL CHEM, V26, P80, DOI 10.1897/05-469.1; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dezfuli BS, 2007, J PARASITOL, V93, P1416, DOI 10.1645/GE-1214.1; Forson D, 2006, ENVIRON TOXICOL CHEM, V25, P168, DOI 10.1897/05-260R.1; Gammon DW., 2001, ATRAZINE RISK CHARAC; Grace J.B., 2006, STRUCT EQ MOD NAT; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2003, TRENDS PARASITOL, V19, P332, DOI 10.1016/S1471-4922(03)00148-X; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Rohr JR, 2006, ENVIRON HEALTH PERSP, V114, P46, DOI 10.1289/ehp.8405; Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353; ROHR JR, ECOL APPL IN PRESS; Rorabaugh JC, 2005, AMPHIBIAN DECLINES C; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; Skelly David K., 2006, P153; Storrs SI, 2004, ENVIRON HEALTH PERSP, V112, P1054, DOI 10.1289/ehp.6821; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538	30	324	333	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1235	U50		10.1038/nature07281	http://dx.doi.org/10.1038/nature07281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972018				2022-12-24	WOS:000260462100043
J	Jovanovic-Talisman, T; Tetenbaum-Novatt, J; McKenney, AS; Zilman, A; Peters, R; Rout, MP; Chait, BT				Jovanovic-Talisman, Tijana; Tetenbaum-Novatt, Jaclyn; McKenney, Anna Sophia; Zilman, Anton; Peters, Reiner; Rout, Michael P.; Chait, Brian T.			Artificial nanopores that mimic the transport selectivity of the nuclear pore complex	NATURE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; IMPORTIN-BETA; NUCLEOPORINS; PERMEABILITY; ARCHITECTURE; MECHANISM; MEMBRANES; REVEALS; REGIONS; SITES	Nuclear pore complexes ( NPCs) act as effective and robust gateways between the nucleus and the cytoplasm, selecting for the passage of particular macromolecules across the nuclear envelope. NPCs comprise an elaborate scaffold that defines a similar to 30 nm diameter passageway connecting the nucleus and the cytoplasm. This scaffold anchors proteins termed 'phenylalanine- glycine' ( FG)- nucleoporins, the natively disordered domains of which line the passageway and extend into its lumen(1). Passive diffusion through this lined passageway is hindered in a size- dependent manner. However, transport factors and their cargo- bound complexes overcome this restriction by transient binding to the FG-nucleoporins(2-10). To test whether a simple passageway and a lining of transport- factor- binding FG- nucleoporins are sufficient for selective transport, we designed a functionalized membrane that incorporates just these two elements. Here we demonstrate that this membrane functions as a nanoselective filter, efficiently passing transport factors and transport- factor - cargo complexes that specifically bind FG- nucleoporins, while significantly inhibiting the passage of proteins that do not. This inhibition is greatly enhanced when transport factor is present. Determinants of selectivity include the passageway diameter, the length of the nanopore region coated with FG- nucleoporins, the binding strength to FG-nucleoporins, and the antagonistic effect of transport factors on the passage of proteins that do not specifically bind FG- nucleoporins. We show that this artificial system faithfully reproduces key features of trafficking through the NPC, including transport-factor-mediated cargo import.	[Jovanovic-Talisman, Tijana; Chait, Brian T.] Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, New York, NY 10065 USA; [Tetenbaum-Novatt, Jaclyn; McKenney, Anna Sophia; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Zilman, Anton] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Zilman, Anton] Los Alamos Natl Lab, Div Theoret, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Peters, Reiner] Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; [Peters, Reiner] Univ Munster, Ctr Nanotechnol CeNTech, D-48149 Munster, Germany	Rockefeller University; Rockefeller University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Munster; University of Munster	Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, 1230 York Ave, New York, NY 10065 USA.	chait@rockefeller.edu	Novatt, Jaclyn/H-3459-2013	Novatt, Jaclyn/0000-0002-3906-3469; Rout, Michael/0000-0003-2010-706X; McKenney, Anna Sophia/0000-0003-4464-6869; Jovanovic-Talisman, Tijana/0000-0003-1928-4763	NIH; DoE; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071329, T32GM007739, R01GM062427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Coutavas, S. Darst, G. Belfort and C. Martin for suggestions and comments, G. Blobel for use of his confocal microscope, D. Phillips for use of his sputtering device, P. Nahirney and A. Labissiere for electron microscopy work, J. M. Crawford for amino acid analysis, D. Gadsby and A. Gulyas Kovacs for providing Xenopus oocytes, J. Aitchison for Kap95-GST and Kap121-GST plasmids, K. Zerf and M. Kahms for providing RanGDP, K. Zerf for NTF2-YFP cloning assistance, R. Mironska for help in preparing measuring chambers, and other members of the Peters, Rout and Chait laboratories for their assistance. We gratefully acknowledge support from the NIH and DoE. J.T.-N. is a HHMI pre-doctoral fellow.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dutta AK, 2007, LANGMUIR, V23, P3088, DOI 10.1021/la0624743; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Jirage KB, 1999, ANAL CHEM, V71, P4913, DOI 10.1021/ac990615i; Koerner C, 2003, J BIOL CHEM, V278, P16216, DOI 10.1074/jbc.M301137200; Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2003, ANNU REV BIOPH BIOM, V32, P47, DOI 10.1146/annurev.biophys.32.110601.142429; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	29	219	220	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1023	1027		10.1038/nature07600	http://dx.doi.org/10.1038/nature07600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19098896	Green Accepted			2022-12-24	WOS:000263425400045
J	Mihola, O; Trachtulec, Z; Vlcek, C; Schimenti, JC; Forejt, J				Mihola, Ondrej; Trachtulec, Zdenek; Vlcek, Cestmir; Schimenti, John C.; Forejt, Jiri			A Mouse Speciation Gene Encodes a Meiotic Histone H3 Methyltransferase	SCIENCE			English	Article							HYBRID STERILITY; CHROMOSOME 17; WILD MOUSE; DROSOPHILA; MUSCULUS; STRAINS; REGION; MICE	Speciation genes restrict gene flow between the incipient species and related taxa. Three decades ago, we mapped a mammalian speciation gene, hybrid sterility 1 (Hst1), in the intersubspecific hybrids of house mouse. Here, we identify this gene as Prdm9, encoding a histone H3 lysine 4 trimethyltransferase. We rescued infertility in male hybrids with bacterial artificial chromosomes carrying Prdm9 from a strain with the "fertility" Hst1(f) allele. Sterile hybrids display down-regulated microrchidia 2B (Morc2b) and fail to compartmentalize gamma H2AX into the pachynema sex (XY) body. These defects, seen also in Prdm9-null mutants, are rescued by the Prdm9 transgene. Identification of a vertebrate hybrid sterility gene reveals a role for epigenetics in speciation and opens a window to a hybrid sterility gene network.	[Mihola, Ondrej; Trachtulec, Zdenek; Vlcek, Cestmir; Forejt, Jiri] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Schimenti, John C.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ctr Vertebrate Genom, Ithaca, NY 14853 USA	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Cornell University	Forejt, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	jforejt@img.cas.cz	Forejt, Jiri/G-7719-2012; Mihola, Ondrej/AAM-7009-2020; Forejt, Jiri/AAF-5276-2019; Trachtulec, Zdenek/G-3449-2014; Vlcek, Cestmir/I-8820-2014; Mihola, Ondrej/G-6362-2014	Forejt, Jiri/0000-0002-2793-3623; Forejt, Jiri/0000-0002-2793-3623; Trachtulec, Zdenek/0000-0001-5772-9394; Mihola, Ondrej/0000-0003-3243-0825	Czech Science Foundation; Grant Agency of the Academy of Sciences of the Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic; NIH	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Nachman (University of Arizona), K. Paigen (The Jackson Laboratory), and D. Barbash (Cornell University) for valuable comments. We are grateful to P. Jansa for advice with the immunofluorescence and P. Flachs for assistance. This work was funded by the Czech Science Foundation, the Grant Agency of the Academy of Sciences of the Czech Republic and the Ministry of Education, Youth and Sports of the Czech Republic (J. F. and Z. T.), and a grant from NIH (J. C. S.). J. F. was an International Fellow of the Howard Hughes Medical Institute.	Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Dobzhansky T., 1951, COPEIA; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; FOREJT J, 1981, CURRENT TRENDS HISTO, V1, P103; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Gregorova S, 1996, MAMM GENOME, V7, P107, DOI 10.1007/s003359900029; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-20; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; Osoegawa K, 2000, GENOME RES, V10, P116; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Trachtulec Z, 2005, BIOL J LINN SOC, V84, P637, DOI 10.1111/j.1095-8312.2005.00460.x; Trachtulec Z, 1997, MAMM GENOME, V8, P312, DOI 10.1007/s003359900430; Trachtulec Z, 2008, GENETICS, V178, P1777, DOI 10.1534/genetics.107.082404; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; YOSHIKI A, 1993, DEV GROWTH DIFFER, V35, P271, DOI 10.1111/j.1440-169X.1993.00271.x	25	309	317	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					373	375		10.1126/science.1163601	http://dx.doi.org/10.1126/science.1163601			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074312				2022-12-24	WOS:000262481400036
J	Hamant, O; Heisler, MG; Jonsson, H; Krupinski, P; Uyttewaal, M; Bokov, P; Corson, F; Sahlin, P; Boudaoud, A; Meyerowitz, EM; Couder, Y; Traas, J				Hamant, Olivier; Heisler, Marcus G.; Jonsson, Henrik; Krupinski, Pawel; Uyttewaal, Magalie; Bokov, Plamen; Corson, Francis; Sahlin, Patrik; Boudaoud, Arezki; Meyerowitz, Elliot M.; Couder, Yves; Traas, Jan			Developmental Patterning by Mechanical Signals in Arabidopsis	SCIENCE			English	Article							SHOOT APICAL MERISTEM; CORTICAL MICROTUBULES; EPIDERMAL-CELLS; AUXIN TRANSPORT; GROWTH; MORPHOGENESIS; APEX; WALL; PHYLLOTAXIS; MODEL	A central question in developmental biology is whether and how mechanical forces serve as cues for cellular behavior and thereby regulate morphogenesis. We found that morphogenesis at the Arabidopsis shoot apex depends on the microtubule cytoskeleton, which in turn is regulated by mechanical stress. A combination of experiments and modeling shows that a feedback loop encompassing tissue morphology, stress patterns, and microtubule- mediated cellular properties is sufficient to account for the coordinated patterns of microtubule arrays observed in epidermal cells, as well as for patterns of apical morphogenesis.	[Heisler, Marcus G.; Meyerowitz, Elliot M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jonsson, Henrik; Krupinski, Pawel; Sahlin, Patrik] Lund Univ, Computat Biol & Biol Phys Grp, Dept Theoret Phys, S-22100 Lund, Sweden; [Bokov, Plamen; Corson, Francis; Boudaoud, Arezki] Ecole Normale Super, Phys Stat Lab, F-75231 Paris 05, France; [Bokov, Plamen; Couder, Yves] Univ Paris Diderot, F-75025 Paris 13, France; [Hamant, Olivier; Uyttewaal, Magalie; Traas, Jan] INRA, Lab Reprod & Dev Plantes, F-69364 Lyon 07, France; [Hamant, Olivier; Uyttewaal, Magalie; Traas, Jan] Univ Lyon 1, CNRS, ENS, F-69364 Lyon 07, France	California Institute of Technology; Lund University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Meyerowitz, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	meyerow@caltech.edu; couder@lps.ens.fr; jan.traas@ens-lyon.fr	Meyerowitz, Elliot M/A-7118-2009; heisler, marcus G/B-9738-2015; Boudaoud, Arezki/Q-7436-2016; Traas, Jan/AAZ-7004-2020	heisler, marcus G/0000-0001-5644-8398; Boudaoud, Arezki/0000-0002-2780-4717; Traas, Jan/0000-0001-5107-1472; Hamant, Olivier/0000-0001-6906-6620	International Human Frontier Science Program Organization; U. S. Department of Energy [FG02-88ER13873]; Balzan Foundation; Swedish Research Council	International Human Frontier Science Program Organization(Human Frontier Science Program); U. S. Department of Energy(United States Department of Energy (DOE)); Balzan Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank A. Roeder for critical reading of the manuscript, and P. Barbier de Reuille and IFR128 Platim for help with imaging. Supported by the International Human Frontier Science Program Organization, by U. S. Department of Energy grant FG02-88ER13873 (E.M.M.), by the Balzan Foundation (E.M.M.), and by the Swedish Research Council (H.J.).	BEENAKKER CWJ, 1986, PHYS REV LETT, V57, P2454, DOI 10.1103/PhysRevLett.57.2454; Castle ES, 1937, J CELL COMPAR PHYSL, V10, P113, DOI 10.1002/jcp.1030100110; Chan J, 2007, NAT CELL BIOL, V9, P171, DOI 10.1038/ncb1533; CLEARY AL, 1993, PLANT CELL PHYSIOL, V34, P1003; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; CYR RJ, 1994, ANNU REV CELL BIOL, V10, P153, DOI 10.1146/annurev.cb.10.110194.001101; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7, DOI 10.1007/s003440000003; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Flugge W., 1973, STRESS IN SHELLS, Vsecond, DOI [10.1007/978-3-642-88291-3, DOI 10.1007/978-3-642-88291-3]; GLAZIER JA, 1987, PHYS REV A, V36, P306, DOI 10.1103/PhysRevA.36.306; GOODBODY KC, 1990, PROTOPLASMA, V157, P92, DOI 10.1007/BF01322641; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; GREEN PB, 1966, AUST J BIOL SCI, V19, P421, DOI 10.1071/BI9660421; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hejnowicz Z, 2005, PROTOPLASMA, V225, P243, DOI 10.1007/s00709-005-0091-9; Hejnowicz Z, 2000, PATTERN FORMATION BI, P240; HERNANDEZ LF, 1993, PLANT CELL, V5, P1725, DOI 10.1105/tpc.5.12.1725; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; HUSH JM, 1991, CELL BIOL INT REP, V15, P551, DOI 10.1016/0309-1651(91)90002-Z; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lintilhac P. M., 1984, Positional controls in plant development, P83; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peters WS, 1996, ANN BOT-LONDON, V77, P657, DOI 10.1006/anbo.1996.0082; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; SAKAGUCHI S, 1988, BOT MAG TOKYO, V101, P497, DOI 10.1007/BF02488091; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; SELKER JML, 1992, DEV BIOL, V153, P29, DOI 10.1016/0012-1606(92)90089-Y; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Traas J, 2001, INT REV CYTOL, V208, P161; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wei CF, 2001, PLANT PHYSIOL, V126, P1129, DOI 10.1104/pp.126.3.1129; WILLIAMSON RE, 1990, AUST J PLANT PHYSIOL, V17, P601, DOI 10.1071/PP9900601; WILLIAMSON RE, 1991, INT REV CYTOL, V129, P135; Wymer CL, 1996, PLANT PHYSIOL, V110, P425, DOI 10.1104/pp.110.2.425	40	608	622	5	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1650	1655		10.1126/science.1165594	http://dx.doi.org/10.1126/science.1165594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074340				2022-12-24	WOS:000261608300034
J	Pollin, TI; Damcott, CM; Shen, HQ; Ott, SH; Shelton, J; Horenstein, RB; Post, W; McLenithan, JC; Bielak, LF; Peyser, PA; Mitchell, BD; Miller, M; O'Connell, JR; Shuldiner, AR				Pollin, Toni I.; Damcott, Coleen M.; Shen, Haiqing; Ott, Sandra H.; Shelton, John; Horenstein, Richard B.; Post, Wendy; McLenithan, John C.; Bielak, Lawrence F.; Peyser, Patricia A.; Mitchell, Braxton D.; Miller, Michael; O'Connell, Jeffrey R.; Shuldiner, Alan R.			A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection	SCIENCE			English	Article							APOLIPOPROTEIN-C-III; CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; A-I; NONFASTING TRIGLYCERIDES; RISK; ARTERY; GENE; CIII; ATHEROSCLEROSIS	Apolipoprotein C-III ( apoC-III) inhibits triglyceride hydrolysis and has been implicated in coronary artery disease. Through a genome- wide association study, we have found that about 5% of the Lancaster Amish are heterozygous carriers of a null mutation ( R19X) in the gene encoding apoC- III ( APOC3) and, as a result, express half the amount of apoC- III present in noncarriers. Mutation carriers compared with noncarriers had lower fasting and postprandial serum triglycerides, higher levels of HDL- cholesterol and lower levels of LDL- cholesterol. Subclinical atherosclerosis, as measured by coronary artery calcification, was less common in carriers than noncarriers, which suggests that lifelong deficiency of apoC- III has a cardioprotective effect.	[Pollin, Toni I.; Damcott, Coleen M.; Shen, Haiqing; Ott, Sandra H.; Shelton, John; Horenstein, Richard B.; McLenithan, John C.; Mitchell, Braxton D.; Miller, Michael; O'Connell, Jeffrey R.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Post, Wendy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [McLenithan, John C.; Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Bielak, Lawrence F.; Peyser, Patricia A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Pollin, TI (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	tpollin@medicine.umaryland.edu	Talmud, Philippa J/C-4402-2008; Humphries, Stephen E/C-5075-2008; Mitchell, Braxton/CAF-0876-2022; Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095; Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	NIH [R01 HL088119, R01 AR046838, U01 HL72515, R01 AG18728, U01 HL084756]; General Clinical Research Centers Program; National Center for Research Resources; University of Maryland General Clinical Research Center [M01 RR 16500]; University of Maryland Clinical Nutrition Research Unit [P30 DK072488]; Johns Hopkins University General Clinical Research Center [M01 RR 000052]; Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Paul Beeson Faculty Scholars in Aging Program; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500, M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088119, U01HL084756, U01HL072515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Maryland Clinical Nutrition Research Unit; Johns Hopkins University General Clinical Research Center(Johns Hopkins UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Paul Beeson Faculty Scholars in Aging Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge our Amish liaisons, field workers, and clinic staff and the extraordinary cooperation and support of the Amish community, without which these studies would not have been possible. We thank R. Agarwala and A. Schaffer for assistance in pedigree construction and K. Ryan for data management. This work was supported by NIH grants R01 HL088119, R01 AR046838, U01 HL72515, R01 AG18728, and U01 HL084756; General Clinical Research Centers Program, National Center for Research Resources (NCRR), NIH; the University of Maryland General Clinical Research Center, grant M01 RR 16500; University of Maryland Clinical Nutrition Research Unit grant P30 DK072488; the Johns Hopkins University General Clinical Research Center, grant M01 RR 000052; the Baltimore Veterans Administration Geriatric Research and Education Clinical Center (GRECC); and the Paul Beeson Faculty Scholars in Aging Program.	Auwerx J, 1996, ATHEROSCLEROSIS, V124, pS29, DOI 10.1016/0021-9150(96)05854-6; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Chan DC, 2008, J CLIN ENDOCR METAB, V93, P557, DOI 10.1210/jc.2006-2676; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; HOSPATTANKAR AV, 1986, FEBS LETT, V197, P67, DOI 10.1016/0014-5793(86)80300-3; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; KANE JP, 2001, ONLINE METABOLIC MOL, pCH114; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; Kawakami A, 2006, CIRCULATION, V113, P691, DOI 10.1161/CIRCULATIONAHA.105.591743; Libby P, 2007, CIRC RES, V100, P299, DOI 10.1161/01.RES.0000259393.89870.58; Liu HQ, 2000, J LIPID RES, V41, P1760; MAEDA N, 1994, J BIOL CHEM, V269, P23610; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; ORDOVAS JM, 1989, J BIOL CHEM, V264, P16339; Post W, 2007, CIRCULATION, V115, P717, DOI 10.1161/CIRCULATIONAHA.106.637512; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	32	503	562	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1702	1705		10.1126/science.1161524	http://dx.doi.org/10.1126/science.1161524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074352	Green Accepted			2022-12-24	WOS:000261608300048
J	Velu, V; Titanji, K; Zhu, BG; Husain, S; Pladevega, A; Lai, LL; Vanderford, TH; Chennareddi, L; Silvestri, G; Freeman, GJ; Ahmed, R; Amara, RR				Velu, Vijayakumar; Titanji, Kehmia; Zhu, Baogong; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Vanderford, Thomas H.; Chennareddi, Lakshmi; Silvestri, Guido; Freeman, Gordon J.; Ahmed, Rafi; Amara, Rama Rao			Enhancing SIV-specific immunity in vivo by PD-1 blockade	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD8 T-CELLS; CHRONIC VIRAL-INFECTION; PROGRAMMED DEATH-1; EFFECTOR FUNCTION; EXPRESSION; LYMPHOCYTES; PERSISTENCE; EXHAUSTION; MECHANISMS	Chronic immunodeficiency virus infections are characterized by dysfunctional cellular and humoral antiviral immune responses(1-3). As such, immune modulatory therapies that enhance and/or restore the function of virus-specific immunity may protect from disease progression. Here we investigate the safety and immune restoration potential of blockade of the co-inhibitory receptor programmed death 1 (PD-1) 4,5 during chronic simian immunodeficiency virus (SIV) infection in macaques. We demonstrate that PD-1 blockade using an antibody to PD-1 is well tolerated and results in rapid expansion of virus-specific CD8 T cells with improved functional quality. This enhanced T-cell immunity was seen in the blood and also in the gut, a major reservoir of SIV infection. PD-1 blockade also resulted in proliferation of memory B cells and increases in SIV envelope-specific antibody. These improved immune responses were associated with significant reductions in plasma viral load and also prolonged the survival of SIV-infected macaques. Blockade was effective during the early (week 10) as well as late (similar to week 90) phases of chronic infection even under conditions of severe lymphopenia. These results demonstrate enhancement of both cellular and humoral immune responses during a pathogenic immunodeficiency virus infection by blocking a single inhibitory pathway and identify a novel therapeutic approach for control of human immunodeficiency virus infections.	[Velu, Vijayakumar; Titanji, Kehmia; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Chennareddi, Lakshmi; Ahmed, Rafi; Amara, Rama Rao] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Velu, Vijayakumar; Titanji, Kehmia; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Chennareddi, Lakshmi; Amara, Rama Rao] Emory Univ, Div Microbiol & Immunol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Zhu, Baogong; Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhu, Baogong; Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Vanderford, Thomas H.; Silvestri, Guido] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Emory University; Emory University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Pennsylvania	Amara, RR (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ramara@emory.edu	Amara, Rama/AAO-8136-2021; Velu, Vijayakumar/I-7585-2019; Freeman, Gordon/AAC-5380-2019	Velu, Vijayakumar/0000-0003-4238-1924; Freeman, Gordon/0000-0002-7210-5616; Lai, Lilin/0000-0002-9528-6990	NCRR NIH HHS [R24 RR016038, P51 RR000165, R24 RR16038, P51 RR00165] Funding Source: Medline; NIAID NIH HHS [R01 AI057029-01, R01 AI057029-04, R01 AI057029-02, R01 AI057029, R01 AI057029-05, R01 AI071852, R01 AI074417-02, P30 AI050409, R01 AI074417, R01 AI057029-03, R01 AI074417-01A1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038, P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071852, P30AI050409, R01AI057029, R01AI074417] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Malley R, 1998, J INFECT DIS, V178, P1555, DOI 10.1086/314523; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	576	618	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					206	U5		10.1038/nature07662	http://dx.doi.org/10.1038/nature07662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19078956	Green Accepted			2022-12-24	WOS:000264059700044
J	van Mameren, J; Modesti, M; Kanaar, R; Wyman, C; Peterman, EJG; Wuite, GJL				van Mameren, Joost; Modesti, Mauro; Kanaar, Roland; Wyman, Claire; Peterman, Erwin J. G.; Wuite, Gijs J. L.			Counting RAD51 proteins disassembling from nucleoprotein filaments under tension	NATURE			English	Article							DNA STRAND-EXCHANGE; ATP HYDROLYSIS; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; RAD51-DSDNA FILAMENT; RECA FILAMENTS; MOLECULES; DYNAMICS; BINDING; RESOLUTION	The central catalyst in eukaryotic ATP- dependent homologous recombination consists of RAD51 proteins, polymerized around single- stranded DNA. This nucleoprotein filament recognizes and invades a homologous duplex DNA segment(1,2). After strand exchange, the nucleoprotein filament should disassemble so that the recombination process can be completed(3). The molecular mechanism of RAD51 filament disassembly is poorly understood. Here we show, by combining optical tweezers with single- molecule fluorescence microscopy and microfluidics(4,5), that disassembly of human RAD51 nucleoprotein filaments results from the interplay between ATP hydrolysis and the release of the tension stored in the filament. By applying external tension to the DNA, we found that disassembly slows down and can even be stalled. We quantified the fluorescence of RAD51 patches and found that disassembly occurs in bursts interspersed by long pauses. After relaxation of a stalled complex, pauses were suppressed resulting in a large burst. These results indicate that tension- dependent disassembly takes place only from filament ends, after tension- independent ATP hydrolysis. This integrative single-molecule approach allowed us to dissect the mechanism of this principal homologous recombination reaction step, which in turn clarifies how disassembly can be influenced by accessory proteins.	[van Mameren, Joost; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands; [van Mameren, Joost; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Modesti, Mauro; Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Modesti, Mauro] Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France; [Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Ctr Laser, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	erwinp@few.vu.nl; gwuite@few.vu.nl	Modesti, Mauro/D-6258-2017; Classen, Scott/AAY-8176-2020; Peterman, Erwin/G-5529-2010	Modesti, Mauro/0000-0002-4964-331X; Peterman, Erwin/0000-0003-1058-249X; van Mameren, Joost/0000-0002-0582-6173; wuite, gijs/0000-0002-5706-043X	Biomolecular Physics; Dutch organization for Fundamental Research of Matter (FOM); Dutch Cancer Society; Netherlands Organization for Scientific Research; Netherlands Genomics Initiative/NWO; Association for International Cancer Research; European Commission Integrated Projects Molecular Imaging; DNA Repair; National Cancer Institute-National Institutes of Health USA; NWO Vidi; NWO Vici; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	Biomolecular Physics; Dutch organization for Fundamental Research of Matter (FOM)(FOM (The Netherlands)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO)); Association for International Cancer Research; European Commission Integrated Projects Molecular Imaging(European CommissionEuropean Commission Joint Research Centre); DNA Repair; National Cancer Institute-National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NWO Vidi(Netherlands Organization for Scientific Research (NWO)); NWO Vici(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. van den Broek and R. T. Dame for discussions and a critical reading of the manuscript and J. Kerssemakers for kindly providing his step fitting algorithm. This work was supported by the Biomolecular Physics program of the Dutch organization for Fundamental Research of Matter (FOM) ( to R.K., C.W., E.J. G.P. and G.J.L.W.), and grants from the Dutch Cancer Society (KWF), the Netherlands Organization for Scientific Research (NWO), the Netherlands Genomics Initiative/NWO, the Association for International Cancer Research and the European Commission Integrated Projects Molecular Imaging and DNA Repair and a National Cancer Institute-National Institutes of Health USA program project (to C.W. and R.K.). E.J.G.P. and G.J.L.W. are recipients of NWO Vidi grants; C.W. of an NWO Vici grant.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P R, 1998, Front Biosci, V3, pD570; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Shim KS, 2006, DNA REPAIR, V5, P704, DOI 10.1016/j.dnarep.2006.03.004; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Tombline G, 2002, J BIOL CHEM, V277, P14426, DOI 10.1074/jbc.M109916200; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; van Mameren J, 2006, BIOPHYS J, V91, pL78, DOI 10.1529/biophysj.106.089466; Wyman C, 2006, STRUCTURE, V14, P949, DOI 10.1016/j.str.2006.05.008; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	30	127	128	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					745	748		10.1038/nature07581	http://dx.doi.org/10.1038/nature07581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19060884	Green Accepted			2022-12-24	WOS:000263064700046
J	Yu, Y; Maroney, PA; Denker, JA; Zhang, XHF; Dybkov, O; Luhrmann, R; Jankowsky, E; Chasin, LA; Nilsen, TW				Yu, Yang; Maroney, Patricia A.; Denker, John A.; Zhang, Xiang H. -F.; Dybkov, Olexandr; Luehrmann, Reinhard; Jankowsky, Eckhard; Chasin, Lawrence A.; Nilsen, Timothy W.			Dynamic Regulation of Alternative Splicing by Silencers that Modulate 5 ' Splice Site Competition	CELL			English	Article							PRE-MESSENGER-RNA; SEX-LETHAL; U1 SNRNP; PREMESSENGER RNA; EXON RECOGNITION; GENE-EXPRESSION; SR PROTEINS; HNRNP A1; IN-VIVO; COMPLEX	Alternative splicing makes a major contribution to proteomic diversity in higher eukaryotes with similar to 70% of genes encoding two or more isoforms. In most cases, the molecular mechanisms responsible for splice site choice remain poorly understood. Here, we used a randomization-selection approach in vitro to identify sequence elements that could silence a proximal strong 5' splice site located downstream of a weakened 5' splice site. We recovered two exonic and four intronic motifs that effectively silenced the proximal 5' splice site both in vitro and in vivo. Surprisingly, silencing was only observed in the presence of the competing upstream 5' splice site. Biochemical evidence strongly suggests that the silencing motifs function by altering the U1 snRNP/5' splice site complex in a manner that impairs commitment to specific splice site pairing. The data indicate that perturbations of non-ratelimiting step(s) in splicing can lead to dramatic shifts in splice site choice.	[Yu, Yang; Maroney, Patricia A.; Denker, John A.; Jankowsky, Eckhard; Nilsen, Timothy W.] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Yu, Yang; Jankowsky, Eckhard; Nilsen, Timothy W.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Zhang, Xiang H. -F.; Chasin, Lawrence A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Dybkov, Olexandr; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Abt Zellulare Biochem, D-37077 Gottingen, Germany	Case Western Reserve University; Case Western Reserve University; Columbia University; Max Planck Society	Nilsen, TW (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	twn@case.edu	Yu, Yang/E-8245-2010	Zhang, Xiang/0000-0002-5674-8670; Jankowsky, Eckhard/0000-0001-7677-7412; Yu, Yang/0000-0003-0536-2783	Sixth Framework Program of the European Union; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM031528] Funding Source: NIH RePORTER	Sixth Framework Program of the European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bruzik, B. Chabot, and P. Grabowski for providing constructs, and S. Gunderson and I. Mattai for anti-U1A antiserum. We also thank D. Black, C. Burge, M. Caprara, X.D. Fu, B. Graveley, K. Hertel, B. Konforti, A. Krainer, K. Lynch, J. Manley, D. Rio, and J. Steitz as well as the anonymous reviewers for constructive comments, and A. M. Micenmacher for preparing the manuscript. The research was supported by a grant from the Sixth Framework Program of the European Union via The Network of Excellence "EURASNET'' to R.L. and NIH grants to E.J., L.A.C., and T.W.N.	AGRIS CH, 1989, MOL CELL BIOL, V9, P259, DOI 10.1128/MCB.9.1.259; BARABINO SML, 1990, CELL, V63, P293, DOI 10.1016/0092-8674(90)90162-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-317; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chen CD, 1999, RNA, V5, P290, DOI 10.1017/S1355838299980743; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donmez G, 2007, MOL CELL, V25, P399, DOI 10.1016/j.molcel.2006.12.019; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Giles KE, 2005, MOL CELL BIOL, V25, P4397, DOI 10.1128/MCB.25.11.4397-4405.2005; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hochleitner EO, 2005, J BIOL CHEM, V280, P2536, DOI 10.1074/jbc.M409587200; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kheli AH, 2008, FEBS J, V275, P1150, DOI 10.1111/j.1742-4658.2008.06276.x; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Manabe T, 2007, GENES CELLS, V12, P1179, DOI 10.1111/j.1365-2443.2007.01123.x; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maroney PA, 2000, RNA, V6, P1905, DOI 10.1017/S1355838200001308; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1988, MOL CELL BIOL, V8, P4484, DOI 10.1128/MCB.8.10.4484; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; NELSON KK, 1988, GENE DEV, V2, P319, DOI 10.1101/gad.2.3.319; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; RUSKIN B, 1985, CELL, V43, P131, DOI 10.1016/0092-8674(85)90018-2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; TAKACS AM, 1988, P NATL ACAD SCI USA, V85, P7932, DOI 10.1073/pnas.85.21.7932; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang XHF, 2003, GENOME RES, V13, P2637, DOI 10.1101/gr.1679003; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	70	102	104	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1224	1236		10.1016/j.cell.2008.10.046	http://dx.doi.org/10.1016/j.cell.2008.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109894	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000261989800014
J	Agogue, H; Brink, M; Dinasquet, J; Herndl, GJ				Agogue, Helene; Brink, Maaike; Dinasquet, Julie; Herndl, Gerhard J.			Major gradients in putatively nitrifying and non-nitrifying Archaea in the deep North Atlantic	NATURE			English	Article							AMMONIA-OXIDIZING BACTERIA; WATER MASSES; PLANKTONIC ARCHAEA; AMINO-ACIDS; OCEAN; SEA; NITRIFICATION; CRENARCHAEOTA; OXIDATION; ABUNDANCE	Aerobic nitrification of ammonia to nitrite and nitrate is a key process in the oceanic nitrogen cycling mediated by prokaryotes(1). Apart from Bacteria belonging to the beta- and gamma-Proteobacteria involved in the first nitrification step, Crenarchaeota have recently been recognized as main drivers of the oxidation of ammonia to nitrite in soil as well as in the ocean, as indicated by the dominance of archaeal ammonia monooxygenase (amoA) genes over bacterial amoA(2,3). Evidence is accumulating that archaeal amoA genes are common in a wide range of marine systems(3-6). Essentially, all these reports focused on surface and mesopelagic (200-1,000 m depth) waters, where ammonia concentrations are higher than in waters below 1,000 m depth. However, Crenarchaeota are also abundant in the water column below 1,000 m, where ammonia concentrations are extremely low. Here we show that, throughout the NorthAtlantic Ocean, the abundance of archaeal amoA genes decreases markedly from subsurface waters to 4,000 m depth, and from subpolar to equatorial deep waters, leading to pronounced vertical and latitudinal gradients in the ratio of archaeal amoA to crenarchaeal 16S ribosomal RNA ( rRNA) genes. The lack of significant copy numbers of amoA genes and the very low fixation rates of dark carbon dioxide in the bathypelagic North Atlantic suggest that most bathypelagic Crenarchaeota are not autotrophic ammonia oxidizers: most likely, they utilize organic matter and hence live heterotrophically.	[Agogue, Helene; Brink, Maaike; Dinasquet, Julie; Herndl, Gerhard J.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, NL-1790 AB Den Burg, Texel, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Herndl, GJ (corresponding author), Univ Vienna, Vienna Ecol Ctr, Dept Marine Biol, Waehringer Guertel 18, A-1090 Vienna, Austria.	herndl@nioz.nl	Herndl, Gerhard J./S-3011-2019; Herndl, Gerhard J./B-1513-2013; Agogué, Hélène/O-4122-2014; chen, qi/C-8585-2011	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Agogué, Hélène/0000-0002-1078-0130; 	Marie Curie Fellowship of the European Community; Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects); 6th Framework Program of the European Union	Marie Curie Fellowship of the European Community(European Commission); Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects)(Netherlands Organization for Scientific Research (NWO)); 6th Framework Program of the European Union(European Commission)	We thank the captain and crew of the RV Pelagia for their help during work at sea. We thank H. M. van Aken for the characterization of the water masses, J.M. Arrieta for collecting the samples during the TRANSAT-1 cruise, B. Abbas, J. van Bleijswijk and H. Witte for technical discussions about the qPCR and phylogenetic analyses, and T. Reinthaler for discussions. We also thank A. Hunting, A. M. Schmitz and W. D. Lienhart for help with data processing. This research was supported by a Marie Curie Fellowship of the European Community to H. A. Shiptimewas provided through grants of the Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects) to G. J. H. The work was performed within the frame of the 'Networks of Excellence' MarBef and EurOceans supported by the 6th Framework Program of the European Union.	Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hollibaugh JT, 2002, APPL ENVIRON MICROB, V68, P1478, DOI 10.1128/AEM.68.3.1478-1484.2002; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Nakagawa T, 2007, MICROBES ENVIRON, V22, P365, DOI 10.1264/jsme2.22.365; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Rhein M, 2002, J PHYS OCEANOGR, V32, P648, DOI 10.1175/1520-0485(2002)032<0648:LSWPCI>2.0.CO;2; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Smethie WM, 2001, DEEP-SEA RES PT I, V48, P189, DOI 10.1016/S0967-0637(00)00048-0; Teira E, 2006, LIMNOL OCEANOGR, V51, P60, DOI 10.4319/lo.2006.51.1.0060; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; van Aken HM, 2000, DEEP-SEA RES PT I, V47, P757, DOI 10.1016/S0967-0637(99)00092-8; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward BB, 2007, OCEANOGRAPHY, V20, P101, DOI 10.5670/oceanog.2007.53; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	29	205	217	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					788	U72		10.1038/nature07535	http://dx.doi.org/10.1038/nature07535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19037244	Green Submitted			2022-12-24	WOS:000261559900048
J	Ginsberg, J; Mohebbi, MH; Patel, RS; Brammer, L; Smolinski, MS; Brilliant, L				Ginsberg, Jeremy; Mohebbi, Matthew H.; Patel, Rajan S.; Brammer, Lynnette; Smolinski, Mark S.; Brilliant, Larry			Detecting influenza epidemics using search engine query data	NATURE			English	Article								Seasonal influenza epidemics are a major public health concern, causing tens of millions of respiratory illnesses and 250,000 to 500,000 deaths worldwide each year(1). In addition to seasonal influenza, a new strain of influenza virus against which no previous immunity exists and that demonstrates human- to- human transmission could result in a pandemic with millions of fatalities(2). Early detection of disease activity, when followed by a rapid response, can reduce the impact of both seasonal and pandemic influenza(3,4). One way to improve early detection is to monitor health- seeking behaviour in the form of queries to online search engines, which are submitted by millions of users around the world each day. Here we present a method of analysing large numbers of Google search queries to track influenza- like illness in a population. Because the relative frequency of certain queries is highly correlated with the percentage of physician visits in which a patient presents with influenza- like symptoms, we can accurately estimate the current level of weekly influenza activity in each region of the United States, with a reporting lag of about one day. This approach may make it possible to use search queries to detect influenza epidemics in areas with a large population of web search users.	[Ginsberg, Jeremy; Mohebbi, Matthew H.; Patel, Rajan S.; Smolinski, Mark S.; Brilliant, Larry] Google Inc, Mountain View, CA 94043 USA; [Brammer, Lynnette] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Google Incorporated; Centers for Disease Control & Prevention - USA	Ginsberg, J (corresponding author), Google Inc, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA.	flutrends-support@google.com		Ginsberg, Jeremy/0000-0001-9527-0510				DAVID FN, 1949, BIOMETRIKA, V36, P394, DOI 10.1093/biomet/36.3-4.394; DEAN J, 2004, 6 S OP SYST DES IMP; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FOX S, 2006, PEW INTERNET AM LIFE; Johnson HA, 2004, STUD HEALTH TECHNOL, V107, P1202; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; World Health Organization, 2003, INFL FACT SHEET; World Health Organization, 2004, WHO CONS PRIOR PUBL	12	2311	2433	22	64	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1012	U4		10.1038/nature07634	http://dx.doi.org/10.1038/nature07634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19020500				2022-12-24	WOS:000263425400042
J	Kafsack, BFC; Pena, JDO; Coppens, I; Ravindran, S; Boothroyd, JC; Carruthers, VB				Kafsack, Bjorn F. C.; Pena, Janethe D. O.; Coppens, Isabelle; Ravindran, Sandeep; Boothroyd, John C.; Carruthers, Vern B.			Rapid Membrane Disruption by a Perforin-Like Protein Facilitates Parasite Exit from Host Cells	SCIENCE			English	Article							PORE-FORMING TOXINS; TOXOPLASMA-GONDII; ATTACK; MECHANISM; DOMAIN; FAMILY; SPOROZOITES; INFECTION; DEFENSE; DEATH	Perforin-like proteins are expressed by many bacterial and protozoan pathogens, yet little is known about their function or mode of action. Here, we describe Toxoplasma perforin- like protein 1 ( TgPLP1), a secreted perforin- like protein of the intracellular protozoan pathogen Toxoplasma gondii that displays structural features necessary for pore formation. After intracellular growth, TgPLP1- deficient parasites failed to exit normally, resulting in entrapment within host cells. We show that this defect is due to an inability to rapidly permeabilize the parasitophorous vacuole membrane and host plasma membrane during exit. TgPLP1 ablation had little effect on growth in culture but resulted in a reduction greater than five orders of magnitude of acute virulence in mice. Perforin- like proteins from other intracellular pathogens may play a similar role in microbial egress and virulence.	[Kafsack, Bjorn F. C.; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kafsack, Bjorn F. C.; Coppens, Isabelle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Pena, Janethe D. O.] Univ Fed Uberlandia, Dept Immunol, BR-38400 Uberlandia, MG, Brazil; [Ravindran, Sandeep; Boothroyd, John C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Uberlandia; Stanford University	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895; Kafsack, Bjorn F.C./0000-0003-0089-1096; Boothroyd, John C./0000-0001-9719-745X	NIH [RO1 AI46675]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R01AI021423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Schultz, S. Meshinchi, A. Silva, E. Mastrantonio, and C. Pereira for technical assistance; D. Roos and F. Dzierszinski for reagents; G. Zeiner for help with the HA-tagging; and M.-H. Huynh, L.D. Sibley, J. Swanson, and M. O'Riordan for valuable discussion and input. This work was supported by NIH grant RO1 AI46675 and a predoctoral fellowship by the American Heart Association. TgPLP1 GenBank accession number is EF102772.	Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983	20	207	215	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					530	533		10.1126/science.1165740	http://dx.doi.org/10.1126/science.1165740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19095897	Green Accepted			2022-12-24	WOS:000262587900050
J	Zaher, HS; Green, R				Zaher, Hani S.; Green, Rachel			Quality control by the ribosome following peptide bond formation	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; CODON RECOGNITION; RELEASE FACTORS; E-SITE; TRANSLATION; ACCURACY; DISCRIMINATION; TERMINATION; ERRORS	The overall fidelity of protein synthesis has been thought to rely on the combined accuracy of two basic processes: the aminoacylation of transfer RNAs with their cognate amino acid by the aminoacyl- tRNA synthetases, and the selection of cognate aminoacyl- tRNAs by the ribosome in cooperation with the GTPase elongation factor EF- Tu. These two processes, which together ensure the specific acceptance of a correctly charged cognate tRNA into the aminoacyl ( A) site, operate before peptide bond formation. Here we report the identification of an additional mechanism that contributes to high fidelity protein synthesis after peptidyl transfer, using a well- defined in vitro bacterial translation system. In this retrospective quality control step, the incorporation of an amino acid from a non- cognate tRNA into the growing polypeptide chain leads to a general loss of specificity in the A site of the ribosome, and thus to a propagation of errors that results in abortive termination of protein synthesis.	[Zaher, Hani S.; Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			National Institutes of Health; Howard Hughes Medical Institute.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute.(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Cormack, A. Nahvi, A. Buskirk and R. Reed for helpful comments on the manuscript and members of the laboratory for useful discussions. This work was supported by the National Institutes of Health with salary support from Howard Hughes Medical Institute.	Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; BARTETZKO A, 1988, METHOD ENZYMOL, V164, P650; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; MANLEY JL, 1978, J MOL BIOL, V125, P407, DOI 10.1016/0022-2836(78)90308-X; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PRECUP J, 1987, J BIOL CHEM, V262, P11351; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SOLL D, 1990, EXPERIENTIA, V46, P1089; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300	39	155	162	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					161	U51		10.1038/nature07582	http://dx.doi.org/10.1038/nature07582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19092806	Green Accepted			2022-12-24	WOS:000262360200025
J	Freiberg, JJ; Tybjaerg-Hansen, A; Jensen, JS; Nordestgaard, BG				Freiberg, Jacob J.; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.			Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETICALLY HYPERLIPIDEMIC RABBITS; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FOLLOW-UP; SELECTIVE RETENTION; ARTERIAL INTIMA; IN-VIVO; PLASMA; MUTATIONS	Context The role of triglycerides in the risk of ischemic stroke remains controversial. Recently, a strong association was found between elevated levels of nonfasting triglycerides, which indicate the presence of remnant lipoproteins, and increased risk of ischemic heart disease. Objective To test the hypothesis that increased levels of nonfasting triglycerides are associated with ischemic stroke in the general population. Design, Setting, and Participants The Copenhagen City Heart Study, a prospective, Danish population - based cohort study initiated in 1976, with follow- up through July 2007. Participants were 13 956 men and women aged 20 through 93 years. A cross- sectional study included 9637 individuals attending the 1991- 1994 examination of the prospective study. Main Outcome Measures Prospective study: baseline levels of nonfasting triglycerides, other risk factors at baseline and at follow- up examinations, and incidence of ischemic stroke. Cross- sectional study: levels of nonfasting triglycerides, levels of remnant cholesterol, and prevalence of ischemic stroke. Results Of the 13 956 participants in the prospective study, 1529 developed ischemic stroke. Cumulative incidence of ischemic stroke increased with increasing levels of nonfasting triglycerides ( log- rank trend, P <. 001). Men with elevated nonfasting triglyceride levels of 89 through 176 mg/ dL had multivariate- adjusted hazard ratios ( HRs) for ischemic stroke of 1.3 ( 95% CI, 0.8- 1.9; 351 events); for 177 through 265 mg/ dL, 1.6 ( 95% CI, 1.0- 2.5; 189 events); for 266 through 353 mg/ dL, 1.5 ( 95% CI, 0.9- 2.7; 73 events); for 354 through 442 mg/ dL, 2.2 ( 95% CI, 1.1- 4.2; 40 events); and for 443 mg/ dL or greater, 2.5 ( 95% CI, 1.3- 4.8; 41 events) vs men with nonfasting levels less than 89 mg/ dL ( HR, 1.0; 85 events) ( P <. 001 for trend). Corresponding values for women were 1.3 ( 95% CI, 0.9- 1.7; 407 events), 2.0 ( 95% CI, 1.3- 2.9; 135 events), 1.4 ( 95% CI, 0.7- 2.9; 26 events), 2.5 ( 95% CI, 1.0- 6.4; 13 events), and 3.8 ( 95% CI, 1.3- 11; 10 events) vs women with nonfasting triglyceride levels less than 89 mg/ dL ( HR, 1.0; 159 events) ( P <. 001 for trend). Absolute 10- year risk of ischemic stroke ranged from 2.6% in men younger than 55 years with nonfasting triglyceride levels of less than 89 mg/ dL to 16.7% in men aged 55 years or older with levels of 443 mg/ dL or greater. Corresponding values in women were 1.9% and 12.2%. In the cross- sectional study, men with a previous ischemic stroke vs controls had nonfasting triglyceride levels of 191 ( IQR, 131- 259) mg/ dL vs 148 ( IQR, 104- 214) mg/ dL ( P <. 01); corresponding values for women were 167 ( IQR, 121- 229) mg/ dL vs 127 ( IQR, 91- 181) mg/ dL ( P <. 05). For remnant cholesterol, corresponding values were 38 ( IQR, 26- 51) mg/ dL vs 29 ( IQR, 20- 42) mg/ dL in men ( P <. 01) and 33 ( IQR, 2445) mg/ dL vs 25 ( IQR, 18- 35) mg/ dL in women ( P <. 05). Conclusion In this study population, nonfasting triglyceride levels were associated with risk of ischemic stroke.	[Freiberg, Jacob J.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen Hosp, Bispebjerg Hosp, Copenhagen City Heart Study, DK-2100 Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Jensen, Jan Skov] Univ Copenhagen Hosp, Gentofte Hosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Adiels, Martin/C-9278-2011		University of Copenhagen; Danish Heart Foundation; Danish Medical Research Council; Research Fund at Rigshospitalet; Copenhagen University Hospital; European Union	University of Copenhagen; Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Fund at Rigshospitalet; Copenhagen University Hospital; European Union(European Commission)	This study was supported by the University of Copenhagen, the Danish Heart Foundation, the Danish Medical Research Council, the Research Fund at Rigshospitalet, Copenhagen University Hospital, and the European Union, Sixth Framework Programme Priority (FP-2005-LIFESCIHEALTH-6), contract 037631.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; Bowman TS, 2003, STROKE, V34, P2930, DOI 10.1161/01.STR.0000102171.91292.DC; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COHN JS, 1988, J LIPID RES, V29, P925; Friberg J, 2003, AM J CARDIOL, V92, P1419, DOI 10.1016/j.amjcard.2003.08.050; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024; HAHEIM LL, 1993, STROKE, V24, P1484, DOI 10.1161/01.STR.24.10.1484; Hokanson JE, 1999, CURR OPIN LIPIDOL, V10, P393, DOI 10.1097/00041433-199910000-00003; Kolovou GD, 2005, CURR MED CHEM, V12, P1931, DOI 10.2174/0929867054546609; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; Mahley RW., 2001, METABOLIC MOL BASES, V8th ed, P2835; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; NORDESTGAARD BG, 1992, ARTERIOSCLER THROMB, V12, P6, DOI 10.1161/01.ATV.12.1.6; NORDESTGAARD BG, 1988, J LIPID RES, V29, P1491; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; NORDESTGAARD BG, 1988, ARTERIOSCLEROSIS, V8, P421, DOI 10.1161/01.ATV.8.4.421; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Proctor SD, 2002, CURR OPIN LIPIDOL, V13, P461, DOI 10.1097/00041433-200210000-00001; RIFAI N, 2006, TIETZ TXB CLIN CHEM, P903; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rutledge JC, 2000, CIRC RES, V86, P768, DOI 10.1161/01.RES.86.7.768; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Shahar E, 2003, STROKE, V34, P623, DOI 10.1161/01.STR.0000057812.51734.FF; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Truelsen T, 2002, NEUROEPIDEMIOLOGY, V21, P22, DOI 10.1159/000048610; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	40	373	390	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2142	2152		10.1001/jama.2008.621	http://dx.doi.org/10.1001/jama.2008.621			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001625	Bronze			2022-12-24	WOS:000260793800024
J	Wang, MC; O'Rourke, EJ; Ruvkun, G				Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary			Fat Metabolism Links Germline Stem Cells and Longevity in C. elegans	SCIENCE			English	Article							LIFE-SPAN; SEX-DETERMINATION; DAF-16; GLP-1; REPRODUCTION; DROSOPHILA; RECEPTOR; PATHWAY; DFOXO	Fat metabolism, reproduction, and aging are intertwined regulatory axes; however, the mechanism by which they are coupled remains poorly understood. We found that germline stem cells (GSCs) actively modulate lipid hydrolysis in Caenorhabditis elegans, which in turn regulates longevity. GSC arrest promotes systemic lipolysis via induction of a specific fat lipase. Subsequently, fat mobilization is promoted and life span is prolonged. Constitutive expression of this lipase in fat storage tissue generates lean and long- lived animals. This lipase is a key factor in the lipid hydrolysis and increased longevity that are induced by decreased insulin signaling. These results suggest a link between C. elegans fat metabolism and longevity.	[Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Wang, Meng/F-2951-2019; O'Rourke, Eyleen Jorgelina/AAG-2009-2021	Wang, Meng/0000-0002-5898-6007; O'Rourke, Eyleen Jorgelina/0000-0003-0503-4181	Life Sciences Research Foundation; Ellison Medical Foundation; Human Frontier Science Program; NIH [5R01AG016636, 5R37AG14161]; NATIONAL INSTITUTE ON AGING [R37AG014161, R01AG016636] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Mak, J. Dittman, and J. Avruch for critical reading of the manuscript; N. Ringstad for laser ablation techniques; V. Rottiers, A. Antebi, and the Caenorhabditis Genetics Center for providing strains; A. Fire for GFP vectors; and members of the Ruvkun lab for discussions. Supported by Life Sciences Research Foundation and Ellison Medical Foundation fellowships (M.C.W.), a Human Frontier Science Program fellowship (E.J.O.), and NIH grants 5R01AG016636 and 5R37AG14161 (G.R.).	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; FRANCIS R, 1995, GENETICS, V139, P607; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HODGKIN J, 1986, GENETICS, V114, P15; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pepper ASR, 2003, GENETICS, V163, P115; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Tissenbaum HA, 1998, GENETICS, V148, P703; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c	24	274	293	9	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					957	960		10.1126/science.1162011	http://dx.doi.org/10.1126/science.1162011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988854	Green Accepted			2022-12-24	WOS:000260674100051
J	Geschwind, DH				Geschwind, Daniel H.			Autism: Many Genes, Common Pathways?	CELL			English	Article							SPECTRUM DISORDERS; CHROMOSOMAL REARRANGEMENTS; PATERNAL AGE; LINKAGE; CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2; TRANSCRIPTION; ASSOCIATION; CNTNAP2; VARIANT; RISK	Autism is a heterogeneous neurodevelopmental syndrome with a complex genetic etiology. It is still not clear whether autism comprises a vast collection of different disorders akin to intellectual disability or a few disorders sharing common aberrant pathways. Unifying principles among cases of autism are likely to be at the level of brain circuitry in addition to molecular pathways.	Univ Calif Los Angeles, David Geffen Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA.	dhg@ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH068172, R37MH060233, R01MH064547] Funding Source: NIH RePORTER; NICHD NIH HHS [P50 HD055784] Funding Source: Medline; NIMH NIH HHS [R37 MH060233, R37 MH060233-08, U54 MH68172, R37 MH60233, R01 MH64547, U54 MH068172, R01 MH064547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; ABRAHAMS BS, 2008, NAT REV GENET, V9, P493; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	26	225	233	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					391	395		10.1016/j.cell.2008.10.016	http://dx.doi.org/10.1016/j.cell.2008.10.016			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984147	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000260536300006
J	Liu, HT; Yu, XH; Li, KW; Klejnot, J; Yang, HY; Lisiero, D; Lin, CT				Liu, Hongtao; Yu, Xuhong; Li, Kunwu; Klejnot, John; Yang, Hongyun; Lisiero, Dominique; Lin, Chentao			Photoexcited CRY2 Interacts with CIB1 to Regulate Transcription and Floral Initiation in Arabidopsis	SCIENCE			English	Article							BLUE-LIGHT PHOTORECEPTORS; SIGNAL-TRANSDUCTION; DNA PHOTOLYASE; CIRCADIAN CLOCK; FLOWERING TIME; CRYPTOCHROMES; THALIANA; PROTEIN; FAMILY; COP1	Cryptochromes (CRY) are photolyase- like blue- light receptors that mediate light responses in plants and animals. How plant cryptochromes act in response to blue light is not well understood. We report here the identification and characterization of the Arabidopsis CIB1 ( cryptochrome- interacting basic- helix- loop- helix) protein. CIB1 interacts with CRY2 ( cryptochrome 2) in a blue light- specific manner in yeast and Arabidopsis cells, and it acts together with additional CIB1- related proteins to promote CRY2- dependent floral initiation. CIB1 binds to G box ( CACGTG) in vitro with a higher affinity than its interaction with other E- box elements ( CANNTG). However, CIB1 stimulates FT messenger RNA expression, and it interacts with chromatin DNA of the FT gene that possesses various E- box elements except G box. We propose that the blue light- dependent interaction of cryptochrome( s) with CIB1 and CIB1- related proteins represents an early photoreceptor signaling mechanism in plants.	[Liu, Hongtao; Yu, Xuhong; Li, Kunwu; Klejnot, John; Yang, Hongyun; Lisiero, Dominique; Lin, Chentao] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lin, CT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clin@mcdb.ucla.edu	Liu, Hongtao/A-7556-2010		NIH [GM56265]; University of California-Los Angeles; Sol Leshin UCLA-BGU Academic Cooperation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056265, R01GM056265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Los Angeles(University of California System); Sol Leshin UCLA-BGU Academic Cooperation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Ecker, Z. Wang, W. Laing, S. Poethig, G. Chen, L. Johnson, S. Jacobsen, S. Knowles, E. Tobin, and R. Goldberg for materials and technical assistance. This work is supported in part by NIH (GM56265 to C.L.), University of California-Los Angeles faculty research, and Sol Leshin UCLA-BGU Academic Cooperation programs.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yu X, 2007, PLANT CELL, V19, P3146, DOI 10.1105/tpc.107.053017; Yu XH, 2007, P NATL ACAD SCI USA, V104, P7289, DOI 10.1073/pnas.0701912104	30	474	522	11	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1535	1539		10.1126/science.1163927	http://dx.doi.org/10.1126/science.1163927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	18988809				2022-12-24	WOS:000261377400047
J	Jekely, G; Colombelli, J; Hausen, H; Guy, K; Stelzer, E; Nedelec, F; Arendt, D				Jekely, Gaspar; Colombelli, Julien; Hausen, Harald; Guy, Keren; Stelzer, Ernst; Nedelec, Francois; Arendt, Detlev			Mechanism of phototaxis in marine zooplankton	NATURE			English	Article							PLATYNEREIS-DUMERILII; CHLAMYDOMONAS-REINHARDTII; SPONGE LARVA; BEHAVIOR; ANNELIDA; EYE; NANOSURGERY; POLYCHAETA; ORGANISMS; EVOLUTION	The simplest animal eyes are eyespots composed of two cells only: a photoreceptor and a shading pigment cell. They resemble Darwin's 'proto-eyes', considered to be the first eyes to appear in animal evolution(1-4). Eyespots cannot form images but enable the animal to sense the direction of light. They are characteristic for the zooplankton larvae of marine invertebrates and are thought to mediate larval swimming towards the light. Phototaxis of invertebrate larvae contributes to the vertical migration of marine plankton(5), which is thought to represent the biggest biomass transport on Earth(6,7). Yet, despite its ecological and evolutionary importance, the mechanism by which eyespots regulate phototaxis is poorly understood. Here we show how simple eyespots in marine zooplankton mediate phototactic swimming, using the marine annelid Platynereis dumerilii as a model(8). We find that the selective illumination of one eyespot changes the beating of adjacent cilia by direct cholinergic innervation resulting in locally reduced water flow. Computer simulations of larval swimming show that these local effects are sufficient to direct the helical swimming trajectories towards the light. The computer model also shows that axial rotation of the larval body is essential for phototaxis and that helical swimming increases the precision of navigation. These results provide, to our knowledge, the first mechanistic understanding of phototaxis in a marine zooplankton larva and show how simple eyespots regulate it. We propose that the underlying direct coupling of light sensing and ciliary locomotor control was a principal feature of the proto- eye and an important landmark in the evolution of animal eyes.	[Jekely, Gaspar; Guy, Keren; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Colombelli, Julien; Stelzer, Ernst; Nedelec, Francois] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Hausen, Harald] Free Univ Berlin, Inst Biol Systemat & Evolut Tiere, D-14195 Berlin, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Free University of Berlin	Jekely, G (corresponding author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	gaspar.jekely@tuebingen.mpg.de; arendt@embl.de	Stelzer, Ernst H K/A-7648-2011; Jékely, Gáspár/I-8708-2012; Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019	Stelzer, Ernst H K/0000-0003-1545-0736; Jékely, Gáspár/0000-0001-8496-9836; Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Colombelli, Julien/0000-0002-2784-4276	Center for Modelling and Simulation in the Biosciences; Deutsche Forschungsgemeinschaft [HA 4443/1-1, DA Ar387/1-1]; FEBS Long Term Fellowship	Center for Modelling and Simulation in the Biosciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FEBS Long Term Fellowship	We thank K. Miura for advice on behavioural assays and digital image processing, K. Tessmar- Raible for identifying FVRI- amide in our expressed- sequence- tag collection, G. Plickert for advice on antibody production, D. Nilsson for advice on action spectra, and H. Snyman for technical assistance. This work was supported by Center for Modelling and Simulation in the Biosciences and by grants from Deutsche Forschungsgemeinschaft (HA 4443/1-1 and DA Ar387/1-1). G. J. was supported by a FEBS Long Term Fellowship during the initial phase of the project	Angel MV, 2000, HYDROBIOLOGIA, V440, P161, DOI 10.1023/A:1004115010030; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; BRANDENBURGER JL, 1973, Z ZELLFORSCH MIK ANA, V142, P89, DOI 10.1007/BF00306706; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Colombelli J, 2007, METHOD CELL BIOL, V82, P267, DOI 10.1016/S0091-679X(06)82008-X; Darwin C., 1859, ORIGIN SPECIES MEANS; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Denny M. W., 1993, AIR WATER BIOL PHYS; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P260, DOI 10.1007/BF00363215; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Jennings HS, 1901, AM NAT, V35, P369, DOI 10.1086/277922; Josef K, 2005, CELL MOTIL CYTOSKEL, V61, P97, DOI 10.1002/cm.20069; Josef K, 2006, CELL MOTIL CYTOSKEL, V63, P758, DOI 10.1002/cm.20158; LACALLI TC, 1988, CAN J ZOOL, V66, P1004, DOI 10.1139/z88-148; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; MARSDEN JR, 1984, MAR BIOL, V83, P13, DOI 10.1007/BF00393081; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; RHODE B, 1992, J MORPHOL, V212, P71, DOI 10.1002/jmor.1052120108; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; THORSON G, 1964, OPHELIA, V1, P167, DOI DOI 10.1080/00785326.1964.10416277; Witman George B., 1993, Trends in Cell Biology, V3, P403, DOI 10.1016/0962-8924(93)90091-E	29	190	191	10	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					395	U62		10.1038/nature07590	http://dx.doi.org/10.1038/nature07590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020621	Bronze			2022-12-24	WOS:000261039600045
J	Korennykh, AV; Egea, PF; Korostelev, AA; Finer-Moore, J; Zhang, C; Shokat, KM; Stroud, RM; Walter, P				Korennykh, Alexei V.; Egea, Pascal F.; Korostelev, Andrei A.; Finer-Moore, Janet; Zhang, Chao; Shokat, Kevan M.; Stroud, Robert M.; Walter, Peter			The unfolded protein response signals through high-order assembly of Ire1	NATURE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER-STRESS; KINASE; MECHANISM; AUTOPHOSPHORYLATION; ACTIVATION; SOFTWARE	Aberrant folding of proteins in the endoplasmic reticulum activates the bifunctional transmembrane kinase/ endoribonuclease Ire1. Ire1 excises an intron from HAC1 messenger RNA in yeasts and Xbp1 messenger RNA in metozoans encoding homologous transcription factors. This non- conventional mRNA splicing event initiates the unfolded protein response, a transcriptional program that relieves the endoplasmic reticulum stress. Here we show that oligomerization is central to Ire1 function and is an intrinsic attribute of its cytosolic domains. We obtained the 3.2- A crystal structure of the oligomer of the Ire1 cytosolic domains in complex with a kinase inhibitor that acts as a potent activator of the Ire1 RNase. The structure reveals a rod- shaped assembly that has no known precedence among kinases. This assembly positions the kinase domain for trans- autophosphorylation, orders the RNase domain, and creates an interaction surface for binding of the mRNA substrate. Activation of Ire1 through oligomerization expands the mechanistic repertoire of kinase- based signalling receptors.	[Korennykh, Alexei V.; Egea, Pascal F.; Finer-Moore, Janet; Stroud, Robert M.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Korennykh, Alexei V.; Zhang, Chao; Shokat, Kevan M.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Korostelev, Andrei A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Korennykh, AV (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	alexei.korennykh@ucsf.edu	Egea, Pascal Francois/AAI-2759-2020; egea, pascal/V-7662-2019; Longo, Kenneth A/A-5631-2010	egea, pascal/0000-0003-4432-8625; Korostelev, Andrei/0000-0003-1588-717X	Jane Coffin Childs; National Parkinson Foundation; NIH [RO1 GM60641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641] Funding Source: NIH RePORTER	Jane Coffin Childs; National Parkinson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Krutchinsky for the help with MALDI instruments and for the tryptic digest analysis of Ire1KR32, F. Gruswitz for useful discussions, C. Waddling for managing the protein crystallization facility of the molecular structure group (MSG) at UCSF, and to the staff of the beamline 8.3.1 at the Advanced Light Source (Berkeley). We thank members of the Walter laboratory for critical review of the manuscript. A.V.K. is a recipient of Jane Coffin Childs fellowship. C.Z. was supported by a grant from the National Parkinson Foundation. R.M.S., J.F.-M. and P.F.E. were supported by an NIH grant RO1 GM60641. P. W. and K.M.S. are Investigators of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Goffin L, 2006, MOL BIOL CELL, V17, P5309, DOI 10.1091/mbc.E06-04-0292; Gonzalez TN, 2000, METH MOL B, V160, P25; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Nock S, 2001, METHOD ENZYMOL, V342, P3, DOI 10.1016/S0076-6879(01)42530-4; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Yonemoto W, 1997, PROTEIN ENG, V10, P915, DOI 10.1093/protein/10.8.915; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zheng Y, 2005, J MICROBIOL, V43, P529	35	445	464	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					687	U2		10.1038/nature07661	http://dx.doi.org/10.1038/nature07661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079236	Green Accepted			2022-12-24	WOS:000263064700033
J	Eid, J; Fehr, A; Gray, J; Luong, K; Lyle, J; Otto, G; Peluso, P; Rank, D; Baybayan, P; Bettman, B; Bibillo, A; Bjornson, K; Chaudhuri, B; Christians, F; Cicero, R; Clark, S; Dalal, R; Dewinter, A; Dixon, J; Foquet, M; Gaertner, A; Hardenbol, P; Heiner, C; Hester, K; Holden, D; Kearns, G; Kong, XX; Kuse, R; Lacroix, Y; Lin, S; Lundquist, P; Ma, CC; Marks, P; Maxham, M; Murphy, D; Park, I; Pham, T; Phillips, M; Roy, J; Sebra, R; Shen, G; Sorenson, J; Tomaney, A; Travers, K; Trulson, M; Vieceli, J; Wegener, J; Wu, D; Yang, A; Zaccarin, D; Zhao, P; Zhong, F; Korlach, J; Turner, S				Eid, John; Fehr, Adrian; Gray, Jeremy; Luong, Khai; Lyle, John; Otto, Geoff; Peluso, Paul; Rank, David; Baybayan, Primo; Bettman, Brad; Bibillo, Arkadiusz; Bjornson, Keith; Chaudhuri, Bidhan; Christians, Frederick; Cicero, Ronald; Clark, Sonya; Dalal, Ravindra; deWinter, Alex; Dixon, John; Foquet, Mathieu; Gaertner, Alfred; Hardenbol, Paul; Heiner, Cheryl; Hester, Kevin; Holden, David; Kearns, Gregory; Kong, Xiangxu; Kuse, Ronald; Lacroix, Yves; Lin, Steven; Lundquist, Paul; Ma, Congcong; Marks, Patrick; Maxham, Mark; Murphy, Devon; Park, Insil; Pham, Thang; Phillips, Michael; Roy, Joy; Sebra, Robert; Shen, Gene; Sorenson, Jon; Tomaney, Austin; Travers, Kevin; Trulson, Mark; Vieceli, John; Wegener, Jeffrey; Wu, Dawn; Yang, Alicia; Zaccarin, Denis; Zhao, Peter; Zhong, Frank; Korlach, Jonas; Turner, Stephen			Real-Time DNA Sequencing from Single Polymerase Molecules	SCIENCE			English	Article							PHOSPHATE-LABELED NUCLEOTIDES; HUMAN GENOME; MODE; FLUORESCENCE; SPECTROSCOPY; RESOLUTION; ALGORITHM; SUBSTRATE	We present single- molecule, real- time sequencing data obtained from a DNA polymerase performing uninterrupted template- directed synthesis using four distinguishable fluorescently labeled deoxyribonucleoside triphosphates (dNTPs). We detected the temporal order of their enzymatic incorporation into a growing DNA strand with zero- mode waveguide nanostructure arrays, which provide optical observation volume confinement and enable parallel, simultaneous detection of thousands of single- molecule sequencing reactions. Conjugation of fluorophores to the terminal phosphate moiety of the dNTPs allows continuous observation of DNA synthesis over thousands of bases without steric hindrance. The data report directly on polymerase dynamics, revealing distinct polymerization states and pause sites corresponding to DNA secondary structure. Sequence data were aligned with the known reference sequence to assay biophysical parameters of polymerization for each template position. Consensus sequences were generated from the single- molecule reads at 15- fold coverage, showing a median accuracy of 99.3%, with no systematic error beyond fluorophore- dependent error rates.	[Eid, John; Fehr, Adrian; Gray, Jeremy; Luong, Khai; Lyle, John; Otto, Geoff; Peluso, Paul; Rank, David; Baybayan, Primo; Bettman, Brad; Bibillo, Arkadiusz; Bjornson, Keith; Chaudhuri, Bidhan; Christians, Frederick; Cicero, Ronald; Clark, Sonya; Dalal, Ravindra; deWinter, Alex; Dixon, John; Foquet, Mathieu; Gaertner, Alfred; Hardenbol, Paul; Heiner, Cheryl; Hester, Kevin; Holden, David; Kearns, Gregory; Kong, Xiangxu; Kuse, Ronald; Lacroix, Yves; Lin, Steven; Lundquist, Paul; Ma, Congcong; Marks, Patrick; Maxham, Mark; Murphy, Devon; Park, Insil; Pham, Thang; Phillips, Michael; Roy, Joy; Sebra, Robert; Shen, Gene; Sorenson, Jon; Tomaney, Austin; Travers, Kevin; Trulson, Mark; Vieceli, John; Wegener, Jeffrey; Wu, Dawn; Yang, Alicia; Zaccarin, Denis; Zhao, Peter; Zhong, Frank; Korlach, Jonas; Turner, Stephen] Pacific Biosci, Menlo Pk, CA 94025 USA		Korlach, J (corresponding author), Pacific Biosci, 1505 Adams Dr, Menlo Pk, CA 94025 USA.	jkorlach@pacificbiosciences.com; sturner@pacificbiosciences.com	chen, qi/C-8585-2011; Turner, Stephen/GXM-4654-2022	Marks, Patrick/0000-0002-3231-7163; Eid, John/0000-0002-2099-8344; Sorenson, Jon/0000-0002-5301-8306; Rank, David/0000-0001-9213-6965	National Human Genome Research Institute [R01HG003710]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003710] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the entire staff at Pacific Biosciences, and J. Puglisi, M. Hunkapiller, R. Kornberg, K. Johnson, D. Haussler, W. Webb, and H. Craighead for many helpful discussions. Supported by National Human Genome Research Institute grant R01HG003710.	BALASUBRAMANIAN S, 2001, Patent No. 01057248; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bosiers JT, 2008, PROC SPIE, V6996, DOI 10.1117/12.785847; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; CHAN EY, 2001, Patent No. 6210896; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Foquet M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831366; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gusfield D., 1997, ALGORITHMS STRINGS T; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Ju JY, 2006, P NATL ACAD SCI USA, V103, P19635, DOI 10.1073/pnas.0609513103; KAO CC, 2002, Patent No. 6399335; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Kornberg A., 1992, DNA REPLICATION; KORTACH J, 2008, NUCLEOS NUCLEOT, V27, P1072; Kumar S, 2005, NUCLEOS NUCLEOT NUCL, V24, P401, DOI 10.1081/NCN-200059823; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lieto AM, 2003, BIOPHYS J, V85, P3294, DOI 10.1016/S0006-3495(03)74748-1; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mulder BA, 2005, NUCLEIC ACIDS RES, V33, P4865, DOI 10.1093/nar/gki779; Reynolds B, 2008, NUCLEOS NUCLEOT NUCL, V27, P18, DOI 10.1080/15257770701571768; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sood A, 2005, J AM CHEM SOC, V127, P2394, DOI 10.1021/ja043595x; TABOR S, 1987, J BIOL CHEM, V262, P16212; Themissen AJP, 2008, SOLID STATE ELECTRON, V52, P1401, DOI 10.1016/j.sse.2008.04.012; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108	40	2284	2732	31	700	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					133	138		10.1126/science.1162986	http://dx.doi.org/10.1126/science.1162986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19023044				2022-12-24	WOS:000262104100059
J	Lo Celso, C; Fleming, HE; Wu, JWW; Zhao, CX; Miake-Lye, S; Fujisaki, J; Cote, D; Rowe, DW; Lin, CP; Scadden, DT				Lo Celso, Cristina; Fleming, Heather E.; Wu, Juwell W.; Zhao, Cher X.; Miake-Lye, Sam; Fujisaki, Joji; Cote, Daniel; Rowe, David W.; Lin, Charles P.; Scadden, David T.			Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche	NATURE			English	Article							STEM-CELL; IDENTIFICATION; OSTEOPONTIN; EXPRESSION; COMPONENT	Stem cells reside in a specialized, regulatory environment termed the niche that dictates how they generate, maintain and repair tissues(1,2). We have previously documented that transplanted haematopoietic stem and progenitor cell populations localize to subdomains of bone- marrow microvessels where the chemokine CXCL12 is particularly abundant(3). Using a combination of high-resolution confocal microscopy and two- photon video imaging of individual haematopoietic cells in the calvarium bone marrow of living mice over time, we examine the relationship of haematopoietic stem and progenitor cells to blood vessels, osteoblasts and endosteal surface as they home and engraft in irradiated and c-Kit-receptor-deficient recipient mice. Osteoblasts were enmeshed in microvessels and relative positioning of stem/ progenitor cells within this complex tissue was nonrandom and dynamic. Both cell autonomous and non- autonomous factors influenced primitive cell localization. Different haematopoietic cell subsets localized to distinct locations according to the stage of differentiation. When physiological challenges drove either engraftment or expansion, bone- marrow stem/ progenitor cells assumed positions in close proximity to bone and osteoblasts. Our analysis permits observing in real time, at a single cell level, processes that previously have been studied only by their long- term outcome at the organismal level.	[Lo Celso, Cristina; Fleming, Heather E.; Zhao, Cher X.; Miake-Lye, Sam; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Wu, Juwell W.; Fujisaki, Joji; Cote, Daniel; Lin, Charles P.] Massachusetts Gen Hosp, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02114 USA; [Wu, Juwell W.; Fujisaki, Joji; Cote, Daniel; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Lo Celso, Cristina; Fleming, Heather E.; Wu, Juwell W.; Zhao, Cher X.; Fujisaki, Joji; Lin, Charles P.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rowe, David W.] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Connecticut; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	lin@helix.mgh.harvard.edu; dscadden@mgh.harvard.edu	Côté, Daniel/D-5185-2011; Fang, Zhijun/L-9620-2013	Lo Celso, Cristina/0000-0002-1163-4207	EMBO; HFSP; National Institutes of Health; Harvard Stem Cell Institute; NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Schipani for providing the PPR mice. We are grateful for help and advice from A. Catic, L. Purton, V. Janzen, G. Adams, J. Spencer, J. Runnels and P. O'Donovan. We thank Y. Tang for the mice husbandry care; D. Dombkowski, L. Prickett and K. Folz-Donahue for cell sorting expertise; R. Klein and K. Chomsky-Higgins for technical assistance; and C. Pasker, V. Shannon, M. Indico Miklosik and D. Machon for administrative assistance. C. L. C. was funded by EMBO and HFSP. The project was funded by the National Institutes of Health (to D.T.S. and C.P.L.), the Harvard Stem Cell Institute (to C.P.L.) and philanthropic sources (to D.T.S. and C.L.C.).	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CROCK HW, 1967, BLOOD SUPPLY LOWER L; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; LORD BI, 1975, BLOOD, V46, P65; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Migliaccio AR, 1999, EXP HEMATOL, V27, P1655, DOI 10.1016/S0301-472X(99)00110-1; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 1997, BLOOD, V90, P4646; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Taichman RUSSELL S., 2000, Hematology, V4, P421; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	33	659	667	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					92	U96		10.1038/nature07434	http://dx.doi.org/10.1038/nature07434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19052546	Green Accepted			2022-12-24	WOS:000262104900037
J	Shubeita, GT; Tran, SL; Xu, J; Vershinin, M; Cermelli, S; Cotton, SL; Welte, MA; Gross, SP				Shubeita, George T.; Tran, Susan L.; Xu, Jing; Vershinin, Michael; Cermelli, Silvia; Cotton, Sean L.; Welte, Michael A.; Gross, Steven P.			Consequences of Motor Copy Number on the Intracellular Transport of Kinesin-1-Driven Lipid Droplets	CELL			English	Article							KINESIN-HEAVY-CHAIN; TUG-OF-WAR; CARGO TRANSPORT; IN-VIVO; ORGANELLE TRANSPORT; DROSOPHILA EMBRYOS; CYTOPLASMIC DYNEIN; VESICLE TRANSPORT; MOLECULAR MOTORS; PROTEIN	The microtubule motor kinesin-1 plays central roles in intracellular transport. It has been widely assumed that many cellular cargos are moved by multiple kinesins and that cargos with more motors move faster and for longer distances; concrete evidence, however, is sparse. Here we rigorously test these notions using lipid droplets in Drosophila embryos. We first employ antibody inhibition, genetics, biochemistry, and particle tracking to demonstrate that kinesin-1 mediates plus-end droplet motion. We then measure how variation in kinesin-1 expression affects the forces driving individual droplets and estimate the number of kinesins actively engaged per droplet. Unlike in vitro, increased motor number results in neither longer travel distances nor higher velocities. Our data suggest that cargos in vivo can simultaneously engage multiple kinesins and that transport properties are largely unaffected by variation in motor number. Apparently, higher-order regulatory mechanisms rather than motor number per se dominate cargo transport in vivo.	[Shubeita, George T.; Xu, Jing; Vershinin, Michael; Cermelli, Silvia; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Tran, Susan L.; Welte, Michael A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Tran, Susan L.; Cotton, Sean L.; Welte, Michael A.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Tran, Susan L.; Cotton, Sean L.; Welte, Michael A.] Brandeis Univ, Rosenstiel Med Res Ctr, Waltham, MA 02454 USA	University of California System; University of California Irvine; University of Rochester; Brandeis University; Brandeis University	Welte, MA (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.	michael.welte@rochester.edu; sgross@uci.edu	Welte, Michael/AAH-5589-2019	Welte, Michael/0000-0001-5741-4720; Shubeita, George/0000-0003-4889-7542; Vershinin, Michael/0000-0002-8207-1376	NIGMS [GM64624, GM64687]; University of Rochester; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064687, R01GM064624, T32GM007122] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Rochester; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Stock Center, B. Saxton, and I. Palacios for fly stocks, B. Theurkauf and B. Cha for advice on antibody microinjections, N. Rizzo for help with western analysis, and A. Mu r ller and D. Lambert for comments on the manuscript. This work was supported by NIGMS grantGM64624 ( to S. P. G.) and NIGMS grant GM64687 and start- up support from the University of Rochester ( to M. A. W). G. T. S. was a Paul Sigler/Agouron Fellow of the Helen Hay Whitney Foundation.	Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Foe Victoria E., 1993, P149; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo Y, 2005, MOL BIOL CELL, V16, P1406, DOI 10.1091/mbc.E04-10-0920; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Snider J, 2004, P NATL ACAD SCI USA, V101, P13204, DOI 10.1073/pnas.0403092101; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	33	270	272	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1098	1107		10.1016/j.cell.2008.10.021	http://dx.doi.org/10.1016/j.cell.2008.10.021			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070579	Bronze, Green Accepted			2022-12-24	WOS:000261642800025
J	Greely, H; Sahakian, B; Harris, J; Kessler, RC; Gazzaniga, M; Campbell, P; Farah, MJ				Greely, Henry; Sahakian, Barbara; Harris, John; Kessler, Ronald C.; Gazzaniga, Michael; Campbell, Philip; Farah, Martha J.			Towards responsible use of cognitive-enhancing drugs by the healthy	NATURE			English	Editorial Material							BRAIN; MODAFINIL; SLEEP		[Greely, Henry] Stanford Univ, Sch Law, Stanford, CA 94305 USA; [Sahakian, Barbara] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sahakian, Barbara] MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Harris, John] Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England; [Harris, John] Univ Manchester, Wellcome Strateg Programme Human Body Its Scope L, Manchester M13 9PL, Lancs, England; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Gazzaniga, Michael] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA; [Campbell, Philip] Nature, London N1 9XW, England; [Farah, Martha J.] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	Stanford University; University of Cambridge; University of Cambridge; University of Manchester; University of Manchester; Harvard University; Harvard Medical School; University of California System; University of California Santa Barbara; University of Pennsylvania; Pennsylvania Medicine	Greely, H (corresponding author), Stanford Univ, Sch Law, Crown Quadrangle,559 Nathan Abbott Way, Stanford, CA 94305 USA.	hgreely@stanford.edu; jenny.hall@cpft.nhs.uk; john.harris@manchester.ac.uk; kessler@hcp.med.harvard.edu; m.gazzaniga@psych.ucsb.edu; nature@nature.com; mfarah@psych.upenn.edu	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0001354] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Almeida SS, 2002, NUTR NEUROSCI, V5, P311, DOI 10.1080/1028415021000033776; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Chatterjee A, 2004, NEUROLOGY, V63, P968, DOI 10.1212/01.WNL.0000138438.88589.7C; Diller LD, 1996, HASTINGS CENT REP, V26, P12, DOI 10.2307/3528571; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Fukuyama Francis, 2002, OUR POSTHUMAN FUTURE; Gron G, 2005, PSYCHOPHARMACOLOGY, V182, P170, DOI 10.1007/s00213-005-0043-2; Harris J., 2007, ENHANCING EVOLUTION; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Kass L, 2003, THER BIOT PURS HAPP; Lynch G, 2006, TRENDS NEUROSCI, V29, P554, DOI 10.1016/j.tins.2006.07.007; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Moreno J. D., 2006, MIND WARS BRAIN RES; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schacter D., 2002, 7 SINS MEMORY; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P167, DOI 10.1001/jama.291.2.167; Weyandt Lisa L, 2006, J Atten Disord, V10, P9	23	472	485	1	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					702	705		10.1038/456702a	http://dx.doi.org/10.1038/456702a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19060880	Green Submitted			2022-12-24	WOS:000261559900020
J	Stockmann, C; Doedens, A; Weidemann, A; Zhang, N; Takeda, N; Greenberg, JI; Cheresh, DA; Johnson, RS				Stockmann, Christian; Doedens, Andrew; Weidemann, Alexander; Zhang, Na; Takeda, Norihiko; Greenberg, Joshua I.; Cheresh, David A.; Johnson, Randall S.			Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis	NATURE			English	Article							BREAST-CANCER; MOUSE MODEL; MACROPHAGES; EXPRESSION; ANGIOGENESIS; VEGF; MICE	Angiogenesis and the development of a vascular network are required for tumour progression, and they involve the release of angiogenic factors, including vascular endothelial growth factor ( VEGF-A), from both malignant and stromal cell types(1). Infiltration by cells of the myeloid lineage is a hallmark of many tumours, and in many cases the macrophages in these infiltrates express VEGF-A(2). Here we show that the deletion of inflammatory-cell-derived VEGF- A attenuates the formation of a typical high-density vessel network, thus blocking the angiogenic switch in solid tumours in mice. Vasculature in tumours lacking myeloid- cell-derived VEGF-A was less tortuous, with increased pericyte coverage and decreased vessel length, indicating vascular normalization. In addition, loss of myeloid-derived VEGF- A decreases the phosphorylation of VEGF receptor 2 (VEGFR2) in tumours, even though overall VEGF- A levels in the tumours are unaffected. However, deletion of myeloid- cell VEGF- A resulted in an accelerated tumour progression in multiple subcutaneous isograft models and an autochthonous transgenic model of mammary tumorigenesis, with less overall tumour cell death and decreased tumour hypoxia. Furthermore, loss of myeloid- cell VEGF- A increased the susceptibility of tumours to chemotherapeutic cytotoxicity. This shows that myeloid- derived VEGF- A is essential for the tumorigenic alteration of vasculature and signalling to VEGFR2, and that these changes act to retard, not promote, tumour progression.	[Stockmann, Christian; Doedens, Andrew; Weidemann, Alexander; Zhang, Na; Takeda, Norihiko; Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Greenberg, Joshua I.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Johnson, RS (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	rsjohnson@ucsd.edu	Stockmann, Christian/L-6956-2017; Johnson, Randall/AAM-1189-2021; Stockmann, Christian/Q-1615-2017	Johnson, Randall/0000-0002-4084-6639; Doedens, Andrew/0000-0003-2461-3496; Stockmann, Christian/0000-0002-9726-6838	Deutsche Forschungsgemeinschaft [STO 787/1-1, WE 4275/1-1]; Susan G. Komen Dissertation Research Award [DISS0402406]; National Institutes of Health [CA82515, CA118165, AI060840]; NATIONAL CANCER INSTITUTE [R01CA082515, R01CA118165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060840] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Susan G. Komen Dissertation Research Award(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. DuRose, N. Ferrara, L. Iruela- Arispe, L. Coussens, M. Karin, V. Nizet and H.- P. Gerber for helpful conversations. Financial support was provided by the Deutsche Forschungsgemeinschaft to C. S. (STO 787/1-1) and A. W. (WE 4275/ 1- 1), a Susan G. Komen Dissertation Research Award ( DISS0402406) to A. D., and National Institutes of Health grants CA82515, CA118165 and AI060840 to R. S. J.	Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Grunstein J, 1999, CANCER RES, V59, P1592; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hurwitz HI, 2006, CLIN COLORECTAL CANC, V6, P66, DOI 10.3816/CCC.2006.n.023; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mayer Erica L, 2007, J Natl Compr Canc Netw, V5, P314	12	344	359	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					814	U107		10.1038/nature07445	http://dx.doi.org/10.1038/nature07445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18997773	Green Submitted, Green Accepted			2022-12-24	WOS:000261559900054
J	Quintana, E; Shackleton, M; Sabel, MS; Fullen, DR; Johnson, TM; Morrison, SJ				Quintana, Elsa; Shackleton, Mark; Sabel, Michael S.; Fullen, Douglas R.; Johnson, Timothy M.; Morrison, Sean J.			Efficient tumour formation by single human melanoma cells	NATURE			English	Article							CANCER STEM-CELLS; ACUTE MYELOID-LEUKEMIA; NOD/SCID MICE; LYMPHOBLASTIC-LEUKEMIA; MALIGNANT-MELANOMA; BASEMENT-MEMBRANE; INITIATING CELLS; LIVER METASTASIS; PROGENITOR CELLS; CD122(+) CELLS	A fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells ( 0.1 - 0.0001%) form tumours when transplanted into non- obese diabetic/ severe combined immunodeficiency ( NOD/ SCID) mice. However, the extent to which NOD/ SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/ SCID interleukin- 2 receptor gamma chain null (Il2rg(-/-)) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single- cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.	[Quintana, Elsa; Shackleton, Mark; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; [Quintana, Elsa; Shackleton, Mark; Morrison, Sean J.] Univ Michigan, Ctr Cell Biol, Ann Arbor, MI 48109 USA; [Sabel, Michael S.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Fullen, Douglas R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Johnson, Timothy M.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Sabel, Michael S/A-7521-2009	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; Allen H. Blondy Research Fellowship; Lewis and Lillian Becker; University of Michigan Comprehensive Cancer Center; National Institutes of Health [CA46592]; University of Michigan Flow Cytometry Core Facility; N. McAnsh and the University of Michigan Cancer Centre Histology Core; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60- DK20572]; Michigan Diabetes Research and Training Center; Spanish Ministry of Education; Marie Curie Outgoing International Fellowship from the European Commission; Australian National Health and Medical Research Council; Human Frontiers Science Program and Australia Post; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Allen H. Blondy Research Fellowship; Lewis and Lillian Becker; University of Michigan Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Flow Cytometry Core Facility(University of Michigan System); N. McAnsh and the University of Michigan Cancer Centre Histology Core; National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center; Spanish Ministry of Education(Spanish Government); Marie Curie Outgoing International Fellowship from the European Commission(European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program and Australia Post(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute and by the Allen H. Blondy Research Fellowship. The University of Michigan Melanoma Bank was supported by a gift from Lewis and Lillian Becker. Flow cytometry was partly supported by the University of Michigan Comprehensive Cancer Center grant from the National Institutes of Health CA46592. We thank: D. Adams, M. White and the University of Michigan Flow Cytometry Core Facility for support; N. McAnsh and the University of Michigan Cancer Centre Histology Core for histological studies; G. K. Smyth for assistance with statistics; and Z. Azizan for support with tissue collection. Antibody production was supported in part by the National Institute of Diabetes, Digestive, and Kidney Diseases, grant NIH5P60- DK20572 to the Michigan Diabetes Research and Training Center. Some antibodies were provided by Caltag or by eBioscience to screen for cancer stem- cell markers. Human primary melanocyte cultures were provided by M. Soengas. Human mesenchymal stem cells were provided by Z. Wang and P. Krebsbach. E. Q. was supported by the Spanish Ministry of Education and the Marie Curie Outgoing International Fellowship from the European Commission. M. S. was supported by the Australian National Health and Medical Research Council, the Human Frontiers Science Program and Australia Post.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bancroft JD, 1990, THEORY PRACTICE HIST; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Cox CV, 2004, BLOOD, V104, P2919, DOI 10.1182/blood-2004-03-0901; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; FRIDMAN R, 1991, JNCI-J NATL CANCER I, V83, P769, DOI 10.1093/jnci/83.11.769; Hamada K, 2008, INT J ONCOL, V32, P153; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; NAKAJIMA T, 1982, CANCER, V50, P912, DOI 10.1002/1097-0142(19820901)50:5<912::AID-CNCR2820500519>3.0.CO;2-U; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; PRETLOW TG, 1991, CANCER RES, V51, P3814; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2003, EXP HEMATOL, V31, P551, DOI 10.1016/S0301-472X(03)00076-6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Suemizu H, 2007, INT J ONCOL, V31, P741; SWEENEY TM, 1991, CANCER METAST REV, V10, P245, DOI 10.1007/BF00050795; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wang Z, 2006, STEM CELLS, V24, P1573, DOI 10.1634/stemcells.2005-0399; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	43	1347	1401	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					593	U33		10.1038/nature07567	http://dx.doi.org/10.1038/nature07567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052619	Green Published, Green Accepted			2022-12-24	WOS:000261340000031
J	Venkatachalam, K; Long, AA; Elsaesser, R; Nikolaeva, D; Broadie, K; Montell, C				Venkatachalam, Kartik; Long, A. Ashleigh; Elsaesser, Rebecca; Nikolaeva, Daria; Broadie, Kendal; Montell, Craig			Motor Deficit in a Drosophila Model of Mucolipidosis Type IV due to Defective Clearance of Apoptotic Cells	CELL			English	Article							RETINAL DEGENERATION; MEMBRANE-PROTEIN; DEATH; NEURODEGENERATION; MUTATIONS; AUTOPHAGY; IDENTIFICATION; SUPPRESSION; ENDOCYTOSIS; CROQUEMORT	Disruption of the Transient Receptor Potential (TRP) mucolipin 1 (TRPML1) channel results in the neurodegenerative disorder mucolipidosis type IV (MLIV), a lysosomal storage disease with severe motor impairments. The mechanisms underlying MLIV are poorly understood and there is no treatment. Here, we report a Drosophila MLIV model, which recapitulates the key disease features, including abnormal intracellular accumulation of macromolecules, motor defects, and neurodegeneration. The basis for the buildup of macromolecules was defective autophagy, which resulted in oxidative stress and impaired synaptic transmission. Late-apoptotic cells accumulated in trpml mutant brains, suggesting diminished cell clearance. The accumulation of late-apoptotic cells and motor deficits were suppressed by expression of trpml(+) in neurons, glia, or hematopoietic cells. We conclude that the neurodegeneration and motor defects result primarily from decreased clearance of apoptotic cells. Since hematopoietic cells in humans are involved in clearance of apoptotic cells, our results raise the possibility that bone marrow transplantation may limit the progression of MLIV.	[Venkatachalam, Kartik; Elsaesser, Rebecca; Nikolaeva, Daria; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Venkatachalam, Kartik; Elsaesser, Rebecca; Nikolaeva, Daria; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA; [Long, A. Ashleigh; Broadie, Kendal] Vanderbilt Univ, Vanderbilt Brain Inst, Kennedy Ctr Res Human Dev, Dept Biol Sci, Nashville, TN 37232 USA	Johns Hopkins University; Johns Hopkins University; Vanderbilt University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Long, Ashleigh/AAE-7365-2022; Montell, Craig/AAH-3357-2021	Long, Ashleigh/0000-0002-0190-6707; Montell, Craig/0000-0001-5637-1482	MLIV Foundation; National Institute of Neurological Disorders and Stroke [NS41740]; March of Dimes; National Eye Institute [EY08117]; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041740] Funding Source: NIH RePORTER	MLIV Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes(March of Dimes); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Bloomington Stock Center for fly stocks, T. Neufeld for the hsGFP-ATG8 flies, N. Franc for the UAS-crq flies, J. Corden, J. Lorsch, R. Rao, and S. Muend for use of equipment, and M. Sepanski for preparing sections of fly heads. We thank S. J. Moon, Y. Jiao, and X. Wang for technical advice, and M. Kottgen, Y. Kwon, and D. Wasserman for helpful discussions. We also thank the Microscopy Facility at the Cell Biology Department, the Johns Hopkins University School of Medicine, for use of their equipment. K. V. was supported in part by an MLIV Foundation postdoctoral fellowship. The work in the K. B. laboratory was supported by the National Institute of Neurological Disorders and Stroke (NS41740), and that in the C. M. laboratory was supported by grants from the March of Dimes and the National Eye Institute (EY08117). The authors declare no conflicts of interest.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Brunell AB, 2007, J SOC CLIN PSYCHOL, V26, P92, DOI 10.1521/jscp.2007.26.1.92; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Fergestad T, 2001, J NEUROSCI, V21, P1218; FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Lee CY, 2001, DEVELOPMENT, V128, P1443; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Menoret A, 2002, INT J HYPERTHER, V18, P490, DOI 10.1080/02656730210146926; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Pang Z, 1997, J NEUROSCI, V17, P3064; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112	52	169	171	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					838	851		10.1016/j.cell.2008.09.041	http://dx.doi.org/10.1016/j.cell.2008.09.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041749	Green Accepted, Bronze			2022-12-24	WOS:000261183900016
J	Park, KK; Liu, K; Hu, Y; Smith, PD; Wang, C; Cai, B; Xu, BG; Connolly, L; Kramvis, I; Sahin, M; He, ZG				Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang			Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway	SCIENCE			English	Article							TUBEROUS SCLEROSIS; GROWTH; INJURY; MTOR; HYPOXIA; CELLS; TSC1	The failure of axons to regenerate is a major obstacle for functional recovery after central nervous system (CNS) injury. Removing extracellular inhibitory molecules results in limited axon regeneration in vivo. To test for the role of intrinsic impediments to axon regrowth, we analyzed cell growth control genes using a virus- assisted in vivo conditional knockout approach. Deletion of PTEN ( phosphatase and tensin homolog), a negative regulator of the mammalian target of rapamycin ( mTOR) pathway, in adult retinal ganglion cells ( RGCs) promotes robust axon regeneration after optic nerve injury. In wild- type adult mice, the mTOR activity was suppressed and new protein synthesis was impaired in axotomized RGCs, which may contribute to the regeneration failure. Reactivating this pathway by conditional knockout of tuberous sclerosis complex 1, another negative regulator of the mTOR pathway, also leads to axon regeneration. Thus, our results suggest the manipulation of intrinsic growth control pathways as a therapeutic approach to promote axon regeneration after CNS injury.	[Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	He, ZG (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Hu, Yang/0000-0002-7980-1649; Liu, Kai/0000-0001-9351-1640; Smith, Patrice/0000-0002-0731-2803	Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke; Wings for Life, and Adelson Foundation; Ruth L. Kirschstein National Research Service Award; Canadian Institute of Health Research; NINDS; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058956, R01NS051788] Funding Source: NIH RePORTER	Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wings for Life, and Adelson Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Hasegawa and F. Wang for providing Rosa-stop-PLAP mice, D. Kwiatkowski for proving TSC1<SUP>f/f</SUP> mice, C. Deng for Smad4<SUP>f/f</SUP> mice, M. Ericsson and L. Bu for microscopic analysis, and L. Benowitz, M. Greenberg, T. Hensch and J. Kanter for reading the manuscript. This study was supported by grants from Craig H. Neilson Foundation (to K. K. P.); National Institute of Neurological Disorders and Stroke ( NINDS), Wings for Life, and Adelson Foundation (to Z.H.); Ruth L. Kirschstein National Research Service Award (NRSA) (to Y.H.); Canadian Institute of Health Research (to P.D.S.); and NINDS and Tuberous Sclerosis Alliance (to M.S.).	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marino S, 2000, GENE DEV, V14, P994; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Namikawa K, 2000, J NEUROSCI, V20, P2875; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Weinberg RA, 2007, BIOL CANC, P209; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	27	1085	1139	3	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					963	966		10.1126/science.1161566	http://dx.doi.org/10.1126/science.1161566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988856	Green Accepted			2022-12-24	WOS:000260674100053
J	Aragon, T; van Anken, E; Pincus, D; Serafimova, IM; Korennykh, AV; Rubio, CA; Walter, P				Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter			Messenger RNA targeting to endoplasmic reticulum stress signalling sites	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSLATION; YEAST; KINASE; LOCALIZATION; DEGRADATION; EXPRESSION; MECHANISM; TRANSPORT	Deficiencies in the protein- folding capacity of the endoplasmic reticulum (ER) in all eukaryotic cells lead to ER stress and trigger the unfolded protein response (UPR)(1-3). ER stress is sensed by Ire1, a transmembrane kinase/ endoribonuclease, which initiates the non- conventional splicing of the messenger RNA encoding a key transcription activator, Hac1 in yeast or XBP1 in metazoans. In the absence of ER stress, ribosomes are stalled on unspliced HAC1 mRNA. The translational control is imposed by a base- pairing interaction between the HAC1 intron and the HAC1 5' untranslated region(4). After excision of the intron, transfer RNA ligase joins the severed exons(5,6), lifting the translational block and allowing synthesis of Hac1 from the spliced HAC1 mRNA to ensue(4). Hac1 in turn drives the UPR gene expression program comprising 7-8% of the yeast genome(7) to counteract ER stress. Here we show that, on activation, Ire1 molecules cluster in the ER membrane into discrete foci of higher- order oligomers, to which unspliced HAC1 mRNA is recruited by means of a conserved bipartite targeting element contained in the 3' untranslated region. Disruption of either Ire1 clustering or HAC1 mRNA recruitment impairs UPR signalling. The HAC1 3' untranslated region element is sufficient to target other mRNAs to Ire1 foci, as long as their translation is repressed. Translational repression afforded by the intron fulfils this requirement for HAC1 mRNA. Recruitment of mRNA to signalling centres provides a new paradigm for the control of eukaryotic gene expression.	[Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Aragon, T (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	Tomas.Aragon@ucsf.edu	Aragon, Tomas/ABH-4616-2020; van Anken, Eelco/AAN-9015-2020; Longo, Kenneth A/A-5631-2010	Aragon, Tomas/0000-0002-1700-2729; van Anken, Eelco/0000-0001-9529-2701	Basque Foundation for Science; Howard Hughes Medical Institute; Netherlands Organization for Scientific Research (NWO); National Science Foundation; President's Dissertation Year Fellowship; Jane Childs Memorial Fund for Medical Research	Basque Foundation for Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); President's Dissertation Year Fellowship; Jane Childs Memorial Fund for Medical Research	We thank M. Jonikas and B. Kornmann for their help with the MatLab scripts; R. Parker for the pPS2037 and pRP1187 plasmids; K. Thorn for the pKT127 plasmid and for his assistance with microscopy at the Nikon Imaging Center at UCSF; and C. Guthrie, R. Andino, J. Gross and members of the Walter laboratory for discussion and comments on the manuscript. T. A. was supported by the Basque Foundation for Science and the Howard Hughes Medical Institute; E. v. A. by the Netherlands Organization for Scientific Research (NWO); D. P. and C. A. R. by the National Science Foundation; C.A.R. by the President's Dissertation Year Fellowship; and A.V.K. by the Jane Childs Memorial Fund for Medical Research. P. W. is an Investigator of the Howard Hughes Medical Institute.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Guthrie C., 2002, GUIDE YEAST GENETICS; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MADDOCK JR, 1993, SCIENCE, V259, P1717; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pollock R, 1999, METHOD ENZYMOL, V306, P263; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352	33	229	249	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					736	U9		10.1038/nature07641	http://dx.doi.org/10.1038/nature07641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079237	Green Accepted, Green Submitted			2022-12-24	WOS:000263064700044
J	Preker, P; Nielsen, J; Kammler, S; Lykke-Andersen, S; Christensen, MS; Mapendano, CK; Schierup, MH; Jensen, TH				Preker, Pascal; Nielsen, Jesper; Kammler, Susanne; Lykke-Andersen, Soren; Christensen, Marianne S.; Mapendano, Christophe K.; Schierup, Mikkel H.; Jensen, Torben Heick			RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters	SCIENCE			English	Article							HUMAN GENOME; DNA DEMETHYLATION; POLYMERASE; CHROMATIN; HISTORY; ENCODE; WIDE	Studies have shown that the bulk of eukaryotic genomes is transcribed. Transcriptome maps are frequently updated, but low- abundant transcripts have probably gone unnoticed. To eliminate RNA degradation, we depleted the exonucleolytic RNA exosome from human cells and then subjected the RNA to tiling microarray analysis. This revealed a class of short, polyadenylated and highly unstable RNAs. These promoter upstream transcripts ( PROMPTs) are produced similar to 0.5 to 2.5 kilobases upstream of active transcription start sites. PROMPT transcription occurs in both sense and antisense directions with respect to the downstream gene. In addition, it requires the presence of the gene promoter and is positively correlated with gene activity. We propose that PROMPT transcription is a common characteristic of RNA polymerase II ( RNAPII) transcribed genes with a possible regulatory potential.	[Preker, Pascal; Kammler, Susanne; Lykke-Andersen, Soren; Christensen, Marianne S.; Mapendano, Christophe K.; Jensen, Torben Heick] Univ Aarhus, Ctr mRNP Biogenesis & Metab, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Nielsen, Jesper; Schierup, Mikkel H.] Univ Aarhus, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Jensen, TH (corresponding author), Univ Aarhus, Ctr mRNP Biogenesis & Metab, Dept Mol Biol, CF Mollers Alle,Bldg 1130, DK-8000 Aarhus C, Denmark.	thj@mb.au.dk	Lykke-Andersen, Søren/B-1553-2013; Jensen, Torben H/G-2954-2017; Schierup, Mikkel H/F-1675-2010; Schierup, Mikkel Heide/AAM-4997-2020	Schierup, Mikkel H/0000-0002-5028-1790; Schierup, Mikkel Heide/0000-0002-5028-1790; Lykke-Andersen, Soren/0000-0001-9357-2910; Jensen, Torben Heick/0000-0001-5127-1239	Danish National Research Foundation; Danish Natural Science Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council(Danish Natural Science Research Council)	We thank G. Pruijn for antibodies, D. Libri, A. Sandelin, and D. Schubeler for comments on the manuscript, and D. Riishoj and K. Jorgensen for technical assistance. This work was supported by the Danish National Research Foundation and the Danish Natural Science Research Council. Microarray data have been submitted to gene expression omnibus (GEO) at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/) under accession number GSE12431.	Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	13	541	565	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1851	1854		10.1126/science.1164096	http://dx.doi.org/10.1126/science.1164096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056938				2022-12-24	WOS:000261799400057
J	Hartl, TA; Smith, HF; Bosco, G				Hartl, Tom A.; Smith, Helen F.; Bosco, Giovanni			Chromosome Alignment and Transvection Are Antagonized by Condensin II	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; BITHORAX-COMPLEX; TRANS; GENE; EXPRESSION; PROTEINS; CIS	Polytene chromosome structure is a characteristic of some polyploid cells where several to thousands of chromatids are closely associated with perfect alignment of homologous DNA sequences. Here, we show that Drosophila condensin II promotes disassembly of polytene structure into chromosomal components. Condensin II also negatively regulates transvection, a process whereby certain alleles are influenced transcriptionally via interallelic physical associations. We propose that condensin II restricts trans- chromosomal interactions that affect transcription through its ability to spatially separate aligned interphase chromosomes.	[Hartl, Tom A.; Smith, Helen F.; Bosco, Giovanni] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Bosco, G (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, 1007 E Lowell St, Tucson, AZ 85721 USA.	gbosco@email.arizona.edu		Bosco, Giovanni/0000-0002-8889-9895	NIH [GM069462]; University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics; Graduate Training in Biochemistry and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics(National Science Foundation (NSF)); Graduate Training in Biochemistry and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge T. Orr-Weaver for supporting the initial screen. We are grateful to the following individuals: C. Boswell ( microscopy), V. Lien ( UAS- Cap- H2- mCherry transgenics), M. Hart ( mitotic index), P. Jansma ( fly imaging), and J. Blumenstiel ( FISH). We thank S. Hawley, T. Orr- Weaver, M. Lilly, E. Kelleher, and the JMST student forum for critical reading of the manuscript and, especially, C.- T. Wu for exceptional guidance with transvection studies. We are grateful to J. Sedat, J. Vazquez, C. Zuker, P. O'Farrell, and C.- T. Wu for fly stocks. Support was from NIH (GM069462) grant to G. B., and T. H. was funded by the University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics and NIH Grant for Graduate Training in Biochemistry and Molecular Biology.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; CABRERA CV, 1985, NATURE, V318, P569, DOI 10.1038/318569a0; CASTELLIGAIR JE, 1990, GENETICS, V126, P177; Dej KJ, 1999, DEVELOPMENT, V126, P293; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; Golic MM, 1996, GENETICS, V143, P385; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Savarese F, 2006, CELL, V126, P248, DOI 10.1016/j.cell.2006.07.008; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032	20	94	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1384	1387		10.1126/science.1164216	http://dx.doi.org/10.1126/science.1164216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039137				2022-12-24	WOS:000261170600040
J	Murase, K; Hirano, Y; Sun, TP; Hakoshima, T				Murase, Kohji; Hirano, Yoshinori; Sun, Tai-ping; Hakoshima, Toshio			Gibberellin-induced DELLA recognition by the gibberellin receptor GID1	NATURE			English	Article							BOX PROTEIN TIR1; F-BOX; ARABIDOPSIS-THALIANA; FLORAL DEVELOPMENT; SIGNALING PATHWAY; SEED-GERMINATION; GENE ENCODES; EXPRESSION; REPRESSOR; TARGETS	Gibberellins control a range of growth and developmental processes in higher plants and have been widely used in the agricultural industry. By binding to a nuclear receptor, GIBBERELLIN INSENSITIVE DWARF1 (GID1), gibberellins regulate gene expression by promoting degradation of the transcriptional regulator DELLA proteins, including GIBBERELLIN INSENSITIVE ( GAI). The precise manner in which GID1 discriminates and becomes activated by bioactive gibberellins for specific binding to DELLA proteins remains unclear. Here we present the crystal structure of a ternary complex of Arabidopsis thaliana GID1A, a bioactive gibberellin and the amino- terminal DELLA domain of GAI. In this complex, GID1A occludes gibberellin in a deep binding pocket covered by its N- terminal helical switch region, which in turn interacts with the DELLA domain containing DELLA, VHYNP and LExLE motifs. Our results establish a structural model of a plant hormone receptor that is distinct from the mechanism of the hormone perception and effector recognition of the known auxin receptors.	[Murase, Kohji; Hirano, Yoshinori; Hakoshima, Toshio] Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan; [Sun, Tai-ping] Duke Univ, Dept Biol, Durham, NC 27708 USA	Nara Institute of Science & Technology; Duke University	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp	Hirano, Yoshinori/ABC-6876-2020	Hirano, Yoshinori/0000-0001-9888-1616	Mitsubishi Foundation, Japan; Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Science Foundation of the United States [IBN-0348814]; Young Scientists from the Japan Society for the Promotion of Science; Global COE Program in NAIST; MEXT of Japan.	Mitsubishi Foundation, Japan; Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Science Foundation of the United States(National Science Foundation (NSF)); Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program in NAIST(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Terawaki and T. Mori for technical advice and J. Tsukamoto for technical support in performing the matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy analysis, and the beamline staff of BL41XU of SPring-8 at Harima for help with the data collection. We also acknowledge A. Isogai for advice and encouragement. This work was supported by a research grant in the natural sciences from the Mitsubishi Foundation, Japan ( to T.H.), and in part by a Grant-in-Aid for Scientific Research (A) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T. H.). This work was also supported in part by grants from the National Science Foundation of the United States (IBN-0348814 to T.-p.S.). K.M. is a recipient of a postdoctoral fellowship for Young Scientists from the Japan Society for the Promotion of Science and an international research fellowship from the Global COE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment) from MEXT of Japan.	ALBERTS B, 2008, MOL BIOL CELL, P395; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DERKX MPM, 1994, PLANT GROWTH REGUL, V15, P223, DOI 10.1007/BF00029895; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; HAKOSHIMA T, 2003, NATURE ENCY HUMAN GE, V3, P679; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Iuchi S, 2007, PLANT J, V50, P958, DOI 10.1111/j.1365-313X.2007.03098.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; King KE, 2001, GENETICS, V159, P767; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; RADLEY M, 1956, NATURE, V178, P1070, DOI 10.1038/1781070a0; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; TALON M, 1990, P NATL ACAD SCI USA, V87, P7983, DOI 10.1073/pnas.87.20.7983; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Yabuta T., 1938, J AGR CHEM SOC JAPAN, V14, P1526, DOI DOI 10.1271/NOGEIKAGAKU1924.14.12_1526; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999	49	452	513	16	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					459	U15		10.1038/nature07519	http://dx.doi.org/10.1038/nature07519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037309				2022-12-24	WOS:000261170500029
J	Bernstein, AS; Ludwig, DS				Bernstein, Aaron S.; Ludwig, David S.			The Importance of Biodiversity to Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NATURAL-PRODUCTS; DISEASE; EMERGENCE; RISK		[Bernstein, Aaron S.; Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Bernstein, Aaron S.] Harvard Univ, Sch Med, Ctr Hlth & Global Environm, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bernstein, AS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	aaron.bernstein@childrens.harvard.edu	Bernstein, Aaron/AAF-3522-2021	Bernstein, Aaron/0000-0003-1703-1041; Ludwig, David/0000-0003-3307-8544				Becker S, 2008, APPL MICROBIOL BIOT, V79, P1, DOI 10.1007/s00253-008-1385-6; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Chivian E, 2008, SUSTAINING LIFE HUMA; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Oberlies NH, 2004, J NAT PROD, V67, P129, DOI 10.1021/np030498t; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; *PRACT GREENH, WAST RED; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102	14	11	11	4	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2297	2299		10.1001/jama.2008.655	http://dx.doi.org/10.1001/jama.2008.655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017916				2022-12-24	WOS:000260965500030
J	Cella, M; Fuchs, A; Vermi, W; Facchetti, F; Otero, K; Lennerz, JKM; Doherty, JM; Mills, JC; Colonna, M				Cella, Marina; Fuchs, Anja; Vermi, William; Facchetti, Fabio; Otero, Karel; Lennerz, Jochen K. M.; Doherty, Jason M.; Mills, Jason C.; Colonna, Marco			A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity	NATURE			English	Article							GROWTH-FACTOR-BETA; ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; EPITHELIAL-CELLS; HOST-DEFENSE; TGF-BETA; DIFFERENTIATION; INTERLEUKIN-22; INFLAMMATION; CYTOKINES	Natural killer ( NK) cells are classically viewed as lymphocytes that provide innate surveillance against virally infected cells and tumour cells through the release of cytolytic mediators and interferon ( IFN)-gamma. In humans, blood CD56(dim) NKcells specialize in the lysis of cell targets(1). In the lymph nodes, CD56(bright) NK cells secrete IFN-gamma cooperating with dendritic cells and T cells in the generation of adaptive responses(1,2). Here we report the characterization of a human NK cell subset located in mucosa- associated lymphoid tissues, such as tonsils and Peyer's patches, which is hard- wired to secrete interleukin (IL)- 22, IL- 26 and leukaemia inhibitory factor. TheseNKcells, whichwe refer to as NK- 22 cells, are triggered by acute exposure to IL- 23. In vitro, NK- 22- secreted cytokines stimulate epithelial cells to secrete IL- 10, proliferate and express a variety of mitogenic and anti- apoptotic molecules. NK- 22 cells are also found in mouse mucosa- associated lymphoid tissues and appear in the small intestine lamina propria during bacterial infection, suggesting that NK- 22 cells provide an innate source of IL- 22 that may help constrain inflammation and protect mucosal sites.	[Cella, Marina; Fuchs, Anja; Otero, Karel; Lennerz, Jochen K. M.; Doherty, Jason M.; Mills, Jason C.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Vermi, William; Facchetti, Fabio] Univ Brescia, Dept Pathol 1, Spedali Civili, I-25123 Brescia, Italy	Washington University (WUSTL); University of Brescia	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/ABA-8564-2020; Facchetti, Fabio/E-7190-2010; Mills, Jason/AAA-6688-2021; Cella, Marina/G-8850-2011	Facchetti, Fabio/0000-0003-4975-2388; Mills, Jason/0000-0002-0402-4662; Colonna, Marco/0000-0001-5222-4987; VERMI, WILLIAM/0000-0002-2291-2997; Cella, Marina/0000-0003-1230-1313	National Institutes of Health [R01AI056139-05, R21AI067748-02]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK079798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056139, R21AI067748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Hughes, B. Eades and S. Schloehmann for cell sorting; R. Clary and the nursing staff at the Children's Hospital, Washington University School of Medicine, for providing tonsil specimens; S. Lonardi for assistance in immunohistochemistry; J. Pfeifer for providing gut specimens; A. Rapaport and S. McCartney for help in gene chip analysis; and S. Gilfillan for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grants R01AI056139-05 and R21AI067748-02 (to M.Co.) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK079798 (to J.C.M.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH and NIDDK.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Candiago E, 2000, AM J DERMATOPATH, V22, P1, DOI 10.1097/00000372-200002000-00001; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Kusam S, 2007, IMMUNOL RES, V37, P177, DOI 10.1007/BF02697368; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	30	960	997	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					722	725		10.1038/nature07537	http://dx.doi.org/10.1038/nature07537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	18978771	Green Accepted			2022-12-24	WOS:000263064700041
J	O'Gorman, CM; Fuller, HT; Dyer, PS				O'Gorman, Celine M.; Fuller, Hubert T.; Dyer, Paul S.			Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus	NATURE			English	Article							POLYMORPHIC DNA MARKERS; MATING-TYPE; SEQUENCE; SYSTEMS; HETEROTHALLISM; TELEOMORPH; BIOLOGY	Aspergillus fumigatus is a saprotrophic fungus whose spores are ubiquitous in the atmosphere(1). It is also an opportunistic human pathogen in immunocompromised individuals, causing potentially lethal invasive infections(2,3), and is associated with severe asthma and sinusitis(4). The species is only known to reproduce by asexual means(5), but there has been accumulating evidence for recombination and gene flow from population genetic studies(5-8), genome analysis(9,10), the presence of mating- type genes(8,10) and expression of sex- related genes(8) in the fungus. Here we show that A. fumigatus possesses a fully functional sexual reproductive cycle that leads to the production of cleistothecia and ascospores, and the teleomorph Neosartorya fumigata is described. The species has a heterothallic breeding system; isolates of complementary mating types are required for sex to occur. We demonstrate increased genotypic variation resulting from recombination between mating type and DNA fingerprint markers in ascospore progeny from an Irish environmental subpopulation. The ability of A. fumigatus to engage in sexual reproduction is highly significant in understanding the biology and evolution of the species. The presence of a sexual cycle provides an invaluable tool for classical genetic analyses and will facilitate research into the genetic basis of pathogenicity and fungicide resistance in A. fumigatus, with the aim of improving methods for the control of aspergillosis. These results also yield insights into the potential for sexual reproduction in other supposedly 'asexual' fungi.	[O'Gorman, Celine M.; Fuller, Hubert T.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland; [O'Gorman, Celine M.; Dyer, Paul S.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University College Dublin; University of Nottingham	O'Gorman, CM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland.	celine.ogorman@ucd.ie; paul.dyer@nottingham.ac.uk	O'Gorman, Celine M/E-7732-2010	O'Gorman, Celine M/0000-0001-9618-8981; Dyer, Paul/0000-0003-0237-026X	IRCSET Postgraduate Research Scholarship; EC Marie Curie Training Fellowship; British Mycological Society	IRCSET Postgraduate Research Scholarship(Irish Research Council for Science, Engineering and Technology); EC Marie Curie Training Fellowship(European Commission); British Mycological Society	We thank S. A. Balajee for access to unpublished data, C. Duggan for assistance with the Latin diagnosis, and C.O'Connell for taking the scanning electron micrographs. This work was supported by an IRCSET Postgraduate Research Scholarship, an EC Marie Curie Training Fellowship and a grant from the British Mycological Society to C.O'G.	Anderson M.J., 2003, GENOMICS PLANTS FUNG, P1; Anderson MJ, 1996, J CLIN MICROBIOL, V34, P87, DOI 10.1128/JCM.34.1.87-93.1996; AUFAUVREBROWN A, 1992, J CLIN MICROBIOL, V30, P2991, DOI 10.1128/JCM.30.11.2991-2993.1992; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Dyer Paul S., 2007, P123; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Dyer PS, 2005, MED MYCOL, V43, pS7, DOI 10.1080/13693780400029015; DYER PS, 1993, PHYSIOL MOL PLANT P, V43, P403, DOI 10.1006/pmpp.1993.1068; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fisher R. A., 1938, STAT METHODS RES WOR; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Honegger R, 2004, MYCOL RES, V108, P480, DOI 10.1017/s0953756204009682; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Kema GHJ, 1996, CURR GENET, V30, P251, DOI 10.1007/s002940050129; Klich M.A., 2002, IDENTIFICATION COMMO; KORNERUP A., 1967, Methuen handbook of colour.; KWONCHUN.KJ, 1974, MYCOLOGIA, V66, P628, DOI 10.2307/3758166; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LIN DM, 1995, J CLIN MICROBIOL, V33, P1596, DOI 10.1128/JCM.33.6.1596-1601.1995; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Lucas JA, 2000, ADV BOT RES, V33, P225, DOI 10.1016/S0065-2296(00)33044-0; Magee PT, 2004, CURR OPIN MICROBIOL, V7, P661, DOI 10.1016/j.mib.2004.10.003; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Murtagh GJ, 2000, NATURE, V404, P564, DOI 10.1038/35007142; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2008, ATMOS ENVIRON, V42, P4355, DOI 10.1016/j.atmosenv.2008.01.009; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Pyrzak W, 2008, EUKARYOT CELL, V7, P1029, DOI 10.1128/EC.00380-07; Robert V, 2007, CBS YEASTS DATABASE; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Seymour FA, 2005, FUNGAL GENET BIOL, V42, P554, DOI 10.1016/j.fgb.2005.03.006; TAKADA M, 1985, MYCOTAXON, V24, P395; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varga J, 2003, INFECT GENET EVOL, V3, P3, DOI 10.1016/S1567-1348(02)00156-9; Ware SB, 2007, FUNGAL GENET BIOL, V44, P389, DOI 10.1016/j.fgb.2006.12.005; Weising K., 1995, DNA FINGERPRINTING P	47	339	358	1	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					471	U5		10.1038/nature07528	http://dx.doi.org/10.1038/nature07528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043401				2022-12-24	WOS:000262519200045
J	Bednarek, P; Pislewska-Bednarek, M; Svatos, A; Schneider, B; Doubsky, J; Mansurova, M; Humphry, M; Consonni, C; Panstruga, R; Sanchez-Vallet, A; Molina, A; Schulze-Lefert, P				Bednarek, Pawel; Pislewska-Bednarek, Mariola; Svatos, Ales; Schneider, Bernd; Doubsky, Jan; Mansurova, Madina; Humphry, Matt; Consonni, Chiara; Panstruga, Ralph; Sanchez-Vallet, Andrea; Molina, Antonio; Schulze-Lefert, Paul			A Glucosinolate Metabolism Pathway in Living Plant Cells Mediates Broad-Spectrum Antifungal Defense	SCIENCE			English	Article							GLUTATHIONE-DEFICIENT MUTANT; ARABIDOPSIS-THALIANA; SECONDARY METABOLISM; DISEASE RESISTANCE; NONHOST RESISTANCE; BIOSYNTHESIS; MYROSINASE; CAMALEXIN; DATABASE; ENZYME	Selection pressure exerted by insects and microorganisms shapes the diversity of plant secondary metabolites. We identified a metabolic pathway for glucosinolates, known insect deterrents, that differs from the pathway activated by chewing insects. This pathway is active in living plant cells, may contribute to glucosinolate turnover, and has been recruited for broad- spectrum antifungal defense responses. The Arabidopsis CYP81F2 gene encodes a P450 monooxygenase that is essential for the pathogen- induced accumulation of 4- methoxyindol- 3- ylmethylglucosinolate, which in turn is activated by the atypical PEN2 myrosinase ( a type of beta-thioglucoside glucohydrolase) for antifungal defense. We propose that reiterated enzymatic cycles, controlling the generation of toxic molecules and their detoxification, enable the recruitment of glucosinolates in defense responses.	[Bednarek, Pawel; Pislewska-Bednarek, Mariola; Humphry, Matt; Consonni, Chiara; Panstruga, Ralph; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Svatos, Ales; Schneider, Bernd; Doubsky, Jan; Mansurova, Madina] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [Sanchez-Vallet, Andrea; Molina, Antonio] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, E-28223 Madrid, Spain	Max Planck Society; Max Planck Society; Universidad Politecnica de Madrid	Bednarek, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	bednarek@mpiz-koeln.mpg.de; schlef@mpiz-koeln.mpg.de	Humphry, Matthew/A-8136-2008; Bruening, Stefan/B-8505-2011; Svatos, Ales/A-3305-2014; Sánchez-vallet, Andrea/B-6128-2019; Bednarek, Pawel/D-2561-2009; Molina, Antonio/G-9789-2015; Schneider, Bernd/A-3287-2014; Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011; Humphry, Matt/E-8072-2010; Mansurova, Madina/F-7118-2015	Svatos, Ales/0000-0003-1032-7288; Sánchez-vallet, Andrea/0000-0002-3668-9503; Bednarek, Pawel/0000-0002-3064-7775; Molina, Antonio/0000-0003-3137-7938; Schneider, Bernd/0000-0003-4788-1565; Panstruga, Ralph/0000-0002-3756-8957; Pislewska-Bednarek, Mariola/0000-0001-9241-3328; Mansurova, Madina/0000-0001-6284-8283	Max Planck Chemical Genomics Center; Spanish Ministerio de Educacion y Ciencia [BIO200600488]	Max Planck Chemical Genomics Center; Spanish Ministerio de Educacion y Ciencia(Spanish Government)	We thank J. Meier for the TGG4 antiserum and S. Rosahl and L. Westphal for pen2 pad3 seeds. Partially supported by the Max Planck Chemical Genomics Center, Spanish Ministerio de Educacion y Ciencia (MEC; grant BIO200600488) and a Ph. D. fellowship (A.S.-V.).	Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; BRUSEWITZ G, 1977, BIOCHEM J, V162, P99; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Cejpek K, 2001, ROY SOC CH, P480; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; MONDE K, 1994, J AM CHEM SOC, V116, P6650, DOI 10.1021/ja00094a021; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedras MSC, 2008, ORG BIOMOL CHEM, V6, P51, DOI 10.1039/B714743K; Pedras MSC, 2007, NAT PROD COMMUN, V2, P319; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sherameti I, 2008, PLANT J, V54, P428, DOI 10.1111/j.1365-313X.2008.03424.x; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	39	697	730	5	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					101	106		10.1126/science.1163732	http://dx.doi.org/10.1126/science.1163732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19095900				2022-12-24	WOS:000262104100049
J	Greenfield, JR; Miller, JW; Keogh, JM; Henning, E; Satterwhite, JH; Cameron, GS; Astruc, B; Mayer, JP; Brage, S; See, TC; Lomas, DJ; O'Rahilly, S; Farooqi, IS				Greenfield, Jerry R.; Miller, Jeffrey W.; Keogh, Julia M.; Henning, Elana; Satterwhite, Julie H.; Cameron, Gregory S.; Astruc, Beatrice; Mayer, John P.; Brage, Soren; See, Teik Choon; Lomas, David J.; O'Rahilly, Stephen; Farooqi, I. Sadaf			Modulation of Blood Pressure by Central Melanocortinergic Pathways	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; OBESITY; HYPERTENSION; PREVALENCE; ACTIVATION; MUTATIONS; WEIGHT; LEPTIN; RECEPTORS; MICE	Background Weight gain and weight loss are associated with changes in blood pressure through unknown mechanisms. Central melanocortinergic signaling is implicated in the control of energy balance and blood pressure in rodents, but there is no information regarding such an association with blood pressure in humans. Methods We assessed blood pressure, heart rate, and urinary catecholamines in overweight or obese subjects with a loss-of-function mutation in MC4R, the gene encoding the melanocortin 4 receptor, and in equally overweight control subjects. We also examined the effects of an MC4R agonist administered for 7 days in 28 overweight or obese volunteers. Results The prevalence of hypertension was markedly lower in the MC4R- deficient subjects than in the control subjects ( 24% vs. 53%, P = 0.009). After the exclusion of subjects taking antihypertensive medications, blood- pressure levels were significantly lower in MC4R- deficient subjects than in control subjects, with mean (+/-SE) systolic blood pressures of 123+/-14 mm Hg and 131+/-12 mm Hg, respectively ( P = 0.02), and mean diastolic blood pressures of 73+/-10 mm Hg and 79+/-7 mm Hg, respectively ( P = 0.03). As compared with control subjects, MC4R- deficient subjects had a lower increase in heart rate on waking ( P = 0.007), a lower heart rate during euglycemic hyperinsulinemia ( P< 0.001), and lower 24- hour urinary norepinephrine excretion ( P = 0.04). The maximum tolerated daily dose of 1.0 mg of the MC4R agonist led to significant increases of 9.3+/-1.9 mm Hg in systolic blood pressure and of 6.6+/-1.1 mm Hg in diastolic blood pressure ( P< 0.001 for both comparisons) at 24 hours, as compared with placebo. Differences in blood pressure were not explained by changes in insulin levels; there were no significant adverse events. Conclusions Results of our genetic and pharmacologic studies implicate melanocortinergic signaling in the control of human blood pressure through an insulin- independent mechanism.	[Greenfield, Jerry R.; Keogh, Julia M.; Henning, Elana; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Cambridge, England; [Brage, Soren] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Cambridge, England; [See, Teik Choon; Lomas, David J.] Addenbrookes Hosp, Inst Metab Sci, Cambridge, England; [See, Teik Choon; Lomas, David J.] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Miller, Jeffrey W.; Satterwhite, Julie H.; Cameron, Gregory S.; Mayer, John P.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Astruc, Beatrice] Biotrial, Rennes, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Eli Lilly	Farooqi, IS (corresponding author), Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Hills Rd,Box 289, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk	Brage, Soren/C-6415-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	Brage, Soren/0000-0002-1265-7355; O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; LOMAS, David/0000-0003-2904-8617	National Health and Medical Research Council of Australia; Royal Australasian College of Physicians; St. Vincent's Clinic Foundation, Sydney; Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research; Medical Research Council; Eli Lilly; MRC [G9824984, MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_U106179473, G9824984] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians(General Electric); St. Vincent's Clinic Foundation, Sydney; Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eli Lilly(Eli Lilly); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the National Health and Medical Research Council of Australia, the Royal Australasian College of Physicians, and St. Vincent's Clinic Foundation, Sydney (to Dr. Greenfield); from the Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research (to Drs. O'Rahilly and Farooqi); and from the Medical Research Council (to Drs. O'Rahilly, Brage, and Farooqi); and by Eli Lilly for the pharmacologic studies.; Drs. Miller, Satterwhite, Cameron, and Mayer report being employed by Eli Lilly and having an equity interest in the company; and Dr. O'Rahilly, receiving consulting fees from Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Alharbi KK, 2007, HUM MUTAT, V28, P294, DOI 10.1002/humu.20404; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; DUSTAN HP, 1979, CIRCULATION, V60, P1566, DOI 10.1161/01.CIR.60.7.1566; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Hall J E, 2000, Curr Hypertens Rep, V2, P139, DOI 10.1007/s11906-000-0073-4; HALL JE, 1994, AM J HYPERTENS, V7, P772, DOI 10.1093/ajh/7.8.772; Hall JE, 2000, BRAZ J MED BIOL RES, V33, P605, DOI 10.1590/S0100-879X2000000600001; Halli RW, 1997, ANQ-Q J SHORT ART N, V10, P55; Haynes WG, 1997, HYPERTENSION, V30, P619, DOI 10.1161/01.HYP.30.3.619; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KASSAB S, 1995, HYPERTENSION, V25, P893, DOI 10.1161/01.HYP.25.4.893; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; ROCCHINI AP, 1989, HYPERTENSION, V13, P922, DOI 10.1161/01.HYP.13.6.922; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Song CK, 2005, AM J PHYSIOL-REG I, V289, pR1467, DOI 10.1152/ajpregu.00348.2005; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vaz M, 1997, CIRCULATION, V96, P3423	28	346	356	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					44	52		10.1056/NEJMoa0803085	http://dx.doi.org/10.1056/NEJMoa0803085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19092146	Bronze			2022-12-24	WOS:000262096800006
J	Xiao, A; Li, HT; Shechter, D; Ahn, SH; Fabrizio, LA; Erdjument-Bromage, H; Ishibe-Murakami, S; Wang, B; Tempst, P; Hofmann, K; Patel, DJ; Elledge, SJ; Allis, CD				Xiao, Andrew; Li, Haitao; Shechter, David; Ahn, Sung Hee; Fabrizio, Laura A.; Erdjument-Bromage, Hediye; Ishibe-Murakami, Satoko; Wang, Bin; Tempst, Paul; Hofmann, Kay; Patel, Dinshaw J.; Elledge, Stephen J.; Allis, C. David			WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity	NATURE			English	Article							DOUBLE-STRAND BREAKS; MASS-SPECTROMETRY; GENOMIC STABILITY; HISTONE H2AX; CHROMATIN; MDC1; COMPLEX; ISWI; ATM; PHOSPHORYLATION	DNA double- stranded breaks present a serious challenge for eukaryotic cells. The inability to repair breaks leads to genomic instability, carcinogenesis and cell death. During the double- strand break response, mammalian chromatin undergoes reorganization demarcated by H2A.X Ser 139 phosphorylation (gamma-H2A.X). However, the regulation of gamma-H2A.X phosphorylation and its precise role in chromatin remodelling during the repair process remain unclear. Here we report a new regulatory mechanism mediated by WSTF ( Williams - Beuren syndrome transcription factor, also known as BAZ1B) - a component of the WICH complex (WSTF-ISWI ATP- dependent chromatin- remodelling complex). We show that WSTF has intrinsic tyrosine kinase activity by means of a domain that shares no sequence homology to any known kinase fold. We show that WSTF phosphorylates Tyr 142 of H2A.X, and that WSTF activity has an important role in regulating several events that are critical for the DNA damage response. Our work demonstrates a new mechanism that regulates the DNA damage response and expands our knowledge of domains that contain intrinsic tyrosine kinase activity.	[Xiao, Andrew; Shechter, David; Ahn, Sung Hee; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Li, Haitao; Ishibe-Murakami, Satoko; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Fabrizio, Laura A.; Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Wang, Bin; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Hofmann, Kay] Miltenyi Biotec GmbH, D-50829 Cologne, Germany	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Miltenyi Biotec	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA.	alliscd@rockefeller.edu	Hofmann, Kay/D-6714-2011; Li, Haitao/B-2668-2012; Shechter, David/B-4660-2008	Hofmann, Kay/0000-0002-2289-9083; Li, Haitao/0000-0001-6741-293X; Shechter, David/0000-0001-9388-6004; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	Susan G. Komen Breast Cancer Foundation; Abby Rockefeller Mauze Trust; Starr Foundation; The Dewitt Wallace and Maloris Foundations; The Irma T. Hirschl Trust; NCI Cancer Center Support Grant [P30 CA08748]; National Institutes of Health; The Rockefeller University; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922, F32GM075486] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Abby Rockefeller Mauze Trust; Starr Foundation; The Dewitt Wallace and Maloris Foundations; The Irma T. Hirschl Trust; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Rockefeller University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Nussenzweig for H2A.X<SUP>-/-</SUP> MEF cells, P. Varga-Weisz for WSTF constructs and antibodies, W. Herr for pBABE-puro vectors, J. Kim and R. Roeder for anti- BAF53 antibodies, D. Reinberg for anti- SNF2H antibodies, Z. Lou for anti- Mdc1 antibodies and Mdc1<SUP>-/-</SUP> MEF cells, L. Liang and Q. Li for their assistance in recombinant protein expression and purification, C. H. McDonald, R. G. Cook and The Rockefeller University Proteomic Core facility for H2A.X peptides. Wewould also like to thank theMillipore antibody development scientists for collaborating with us on the generation of H2A.X Tyr 142( ph) antibodies, catalogue number 07-1590. This study was supported by the following sources: Susan G. Komen Breast Cancer Foundation (A.X.), Abby Rockefeller Mauze Trust and Starr Foundation (H.L. and D.J.P.), The Dewitt Wallace and Maloris Foundations (H.L. and D.J.P.), The Irma T. Hirschl Trust (D.S.), NCI Cancer Center Support Grant P30 CA08748 (L.A.F., H.E.-B. and P.T.), research grants from National Institutes of Health to S.J.E., S.H.A. and C.D.A., and The Rockefeller University (C.D.A.). S.J.E. is an Investigator with the Howard Hughes Medical Institute. We are grateful to E. Bernstein and E. Duncan for critical reading of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BELLARD M, 1989, METHOD ENZYMOL, V170, P317; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Dellaire G, 2007, CELL CYCLE, V6, P1864, DOI 10.4161/cc.6.15.4560; DIMITROV S, 1994, J CELL BIOL, V126, P591, DOI 10.1083/jcb.126.3.591; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KLEINSCHMIDT JA, 1991, EMBO J, V10, P3043, DOI 10.1002/j.1460-2075.1991.tb07855.x; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; LENNOX RW, 1989, METHOD ENZYMOL, V170, P532; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Pear Warren S., 1997, P41; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Sambrook J, 2001, MOL CLONING LAB MANU; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	48	299	311	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					57	U57		10.1038/nature07668	http://dx.doi.org/10.1038/nature07668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19092802	Green Accepted			2022-12-24	WOS:000262104900029
J	Pucadyil, TJ; Schmid, SL				Pucadyil, Thomas J.; Schmid, Sandra L.			Real-Time Visualization of Dynamin-Catalyzed Membrane Fission and Vesicle Release	CELL			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; COPII VESICLE; MECHANOCHEMICAL ENZYME; BILAYER CURVATURE; GTPASE ACTIVITY; INVAGINATION; CONSTRICTION; DEFORMATION; ENDOCYTOSIS; PROTEINS	The GTPase dynamin assembles at the necks of budded vesicles in vivo and functions in membrane fission. We have developed fluid supported bilayers with excess membrane reservoir, (SUPER) templates, to assay vesicle formation and membrane fission. Consistent with previous studies, in the absence of GTP, dynamin assembles in spirals, forming long membrane tubules. GTP addition triggers disassembly, but not membrane fission, arguing against models in which fission is mediated by concerted and global GTP-driven conformational changes. In contrast, under physiological conditions in the constant presence of GTP, dynamin mediates membrane fission. Under these conditions, fluorescently labeled dynamin cooperatively organizes into self-limited assemblies that continuously cycle at the membrane and drive vesicle release. When visualized at the necks of emergent vesicles, self-limited dynamin assemblies display intensity fluctuations and persist for variable time periods before fission. Thus, self-limited assemblies of dynamin generated in the constant presence of GTP catalyze membrane fission.	[Pucadyil, Thomas J.; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu	Pucadyil, Thomas/AAJ-3974-2020; Taylor, Graham/A-4027-2012	Pucadyil, Thomas/0000-0002-2907-9889; Schmid, Sandra/0000-0002-1690-7024	National Institutes of Health [R01.GM042455, R37.MH61345]; The Leukemia and Lymphoma Society; The Scripps Research Institute [19489]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061345, R37MH061345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); The Scripps Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge Malcolm R. Wood for help with electron microscopy, Vadim Frolov for help with the membrane tether-pulling experiments, and Sharmistha Acharya and Marilyn Leonard for technical assistance. We thank William Balch, Vadim Frolov, Shanti Kalipatnapu, Allen Liu, Rajesh Ramachandran, and Joshua Zimmerberg for discussions and critical comments on the manuscript. This work is supported by grants from the National Institutes of Health to S.L.S (R01.GM042455 and R37.MH61345). T.J.P. is a fellow of The Leukemia and Lymphoma Society. This is The Scripps Research Institute manuscript number 19489.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Baksh MM, 2004, NATURE, V427, P139, DOI 10.1038/nature02209; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Galneder R, 2001, BIOPHYS J, V80, P2298, DOI 10.1016/S0006-3495(01)76201-7; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miwako I, 2005, METHOD ENZYMOL, V404, P503, DOI 10.1016/S0076-6879(05)04044-9; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	34	204	206	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1263	1275		10.1016/j.cell.2008.11.020	http://dx.doi.org/10.1016/j.cell.2008.11.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19084268	Green Accepted, Bronze			2022-12-24	WOS:000261989800017
J	Solstad, T; Boccara, CN; Kropff, E; Moser, MB; Moser, EI				Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.			Representation of Geometric Borders in the Entorhinal Cortex	SCIENCE			English	Article							SPATIAL REPRESENTATION; PARIETAL CORTEX; PLACE CELLS; HIPPOCAMPUS; DIRECTION; MEMORY; MAP	We report the existence of an entorhinal cell type that fires when an animal is close to the borders of the proximal environment. The orientation- specific edge- apposing activity of these " border cells" is maintained when the environment is stretched and during testing in enclosures of different size and shape in different rooms. Border cells are relatively sparse, making up less than 10% of the local cell population, but can be found in all layers of the medial entorhinal cortex as well as the adjacent parasubiculum, often intermingled with head- direction cells and grid cells. Border cells may be instrumental in planning trajectories and anchoring grid fields and place fields to a geometric reference frame.	[Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol & Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Boccara, Claude/0000-0002-9603-0700; Kropff, Emilio/0000-0001-5996-8436	Kavli Foundation; Norwegian Research Council; European Commission Framework 7 project (SPACEBRAIN)	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission Framework 7 project (SPACEBRAIN)(European Commission)	We thank N. Burgess and a number of other colleagues for helpful discussion and suggestions; M.P. Witter for advice about electrode location; M. Fyhn for donating an implanted animal; and A.M. Amundsgard, E. Sjulstad, I.M.F. Hammer, K. Haugen, K. Jenssen, R. Skjerpeng, H. Waade, and T.A smul for technical assistance. The work was supported by the Kavli Foundation, the Centre of Excellence scheme of the Norwegian Research Council, and a European Commission Framework 7 project (SPACEBRAIN).	Barry C, 2006, REV NEUROSCIENCE, V17, P71; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006	19	637	652	7	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1865	1868		10.1126/science.1166466	http://dx.doi.org/10.1126/science.1166466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095945				2022-12-24	WOS:000261799400061
J	De Val, S; Chi, NC; Meadows, SM; Minovitsky, S; Anderson, JP; Harris, IS; Ehlers, ML; Agarwal, P; Visel, A; Xu, SM; Pennacchio, LA; Dubchak, I; Krieg, PA; Stainier, DYR; Black, BL				De Val, Sarah; Chi, Neil C.; Meadows, Stryder M.; Minovitsky, Simon; Anderson, Joshua P.; Harris, Ian S.; Ehlers, Melissa L.; Agarwal, Pooja; Visel, Axel; Xu, Shan-Mei; Pennacchio, Len A.; Dubchak, Inna; Krieg, Paul A.; Stainier, Didier Y. R.; Black, Brian L.			Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors	CELL			English	Article							PROMOTER; VASCULOGENESIS; SEQUENCE; ENHANCER; FAMILY; ANGIOGENESIS; CANCER; MEF2C; SCL	Vascular development begins when mesodermal cells differentiate into endothelial cells, which then form primitive vessels. It has been hypothesized that endothelial-specific gene expression may be regulated combinatorially, but the transcriptional mechanisms governing specificity in vascular gene expression remain incompletely understood. Here, we identify a 44 bp transcriptional enhancer that is sufficient to direct expression specifically and exclusively to the developing vascular endothelium. This enhancer is regulated by a composite cis-acting element, the FOX:ETS motif, which is bound and synergistically activated by Forkhead and Ets transcription factors. We demonstrate that coexpression of the Forkhead protein FoxC2 and the Ets protein Etv2 induces ectopic expression of vascular genes in Xenopus embryos, and that combinatorial knockdown of the orthologous genes in zebrafish embryos disrupts vascular development. Finally, we show that FOX: ETS motifs are present in many known endothelial-specific enhancers and that this motif is an efficient predictor of endothelial enhancers in the human genome.	[De Val, Sarah; Chi, Neil C.; Anderson, Joshua P.; Harris, Ian S.; Ehlers, Melissa L.; Agarwal, Pooja; Xu, Shan-Mei; Stainier, Didier Y. R.; Black, Brian L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chi, Neil C.; Stainier, Didier Y. R.; Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Meadows, Stryder M.; Krieg, Paul A.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Minovitsky, Simon; Visel, Axel; Pennacchio, Len A.; Dubchak, Inna] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Black, BL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	brian.black@ucsf.edu	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Stainier, Didier/0000-0002-0382-0026; Pennacchio, Len/0000-0002-8748-3732; Black, Brian/0000-0002-6664-8913	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737, R01HL064658, K08HL089330, P01HL089707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052130] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54737, R01 HL064658-08, HL64658, P01 HL089707-01A1, R01 HL054737, K08 HL089330, R01 HL064658, P01 HL089707] Funding Source: Medline; NIAMS NIH HHS [R01 AR052130, R01 AR052130-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Lin Q, 1998, DEVELOPMENT, V125, P4565; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Patan S, 2004, CANC TREAT, V117, P3; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Topczewska JM, 2001, MECH DEVELOP, V100, P343, DOI 10.1016/S0925-4773(00)00534-7; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wu J, 2005, MOL CELL BIOL, V25, P1458, DOI 10.1128/MCB.25.4.1458-1474.2005	35	234	240	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1053	1064		10.1016/j.cell.2008.10.049	http://dx.doi.org/10.1016/j.cell.2008.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070576	Green Accepted, Bronze			2022-12-24	WOS:000261642800021
J	Brennecke, J; Malone, CD; Aravin, AA; Sachidanandam, R; Stark, A; Hannon, GJ				Brennecke, Julius; Malone, Colin D.; Aravin, Alexei A.; Sachidanandam, Ravi; Stark, Alexander; Hannon, Gregory J.			An Epigenetic Role for Maternally Inherited piRNAs in Transposon Silencing	SCIENCE			English	Article							R-HYBRID DYSGENESIS; MENDELIAN FEMALE STERILITY; DROSOPHILA-MELANOGASTER; I-ELEMENTS; MOLECULAR-BASIS; TRANSGENES; RETROTRANSPOSITION; IDENTIFICATION; REPRESSION; REACTIVITY	In plants and mammals, small RNAs indirectly mediate epigenetic inheritance by specifying cytosine methylation. We found that small RNAs themselves serve as vectors for epigenetic information. Crosses between Drosophila strains that differ in the presence of a particular transposon can produce sterile progeny, a phenomenon called hybrid dysgenesis. This phenotype manifests itself only if the transposon is paternally inherited, suggesting maternal transmission of a factor that maintains fertility. In both P- and I- element- mediated hybrid dysgenesis models, daughters show a markedly different content of Piwi- interacting RNAs ( piRNAs) targeting each element, depending on their parents of origin. Such differences persist from fertilization through adulthood. This indicates that maternally deposited piRNAs are important for mounting an effective silencing response and that a lack of maternal piRNA inheritance underlies hybrid dysgenesis.	[Brennecke, Julius; Malone, Colin D.; Aravin, Alexei A.; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Stark, Alexander/D-1473-2012; Brennecke, Julius/C-1626-2015; sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019; Brennecke, Julius/T-5883-2019	Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459; Brennecke, Julius/0000-0002-5141-0814	The Ernst Schering Foundation; Beckman fellow of the Watson School of Biological Sciences; NSF Graduate Research Fellowship; Human Frontier Science Program fellowship; NIH; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	The Ernst Schering Foundation; Beckman fellow of the Watson School of Biological Sciences; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontier Science Program fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Rooks and D. McCombie (CSHL) for help with deep sequencing, S. Jensen and S. Ronsseray for fly stocks and helpful discussions, and D. Finnegan for the I- element ORF-1 antibody. J.B. is supported by a fellowship from The Ernst Schering Foundation, C.D.M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by an NSF Graduate Research Fellowship, and A.S. is supported by a Human Frontier Science Program fellowship. This work was supported by grants from NIH to G.J.H. and A.A.A. and a kind gift from K.W. Davis (to G.J.H.). Small RNA libraries are deposited at Gene Expression Omnibus ( accession no. GSE13081, data sets GSM327620 to GSM327634).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1978, HEREDITY, V41, P357, DOI 10.1038/hdy.1978.106; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Chambeyron S, 2005, CYTOGENET GENOME RES, V110, P215, DOI 10.1159/000084955; CROZATIER M, 1988, NUCLEIC ACIDS RES, V16, P9199, DOI 10.1093/nar/16.19.9199; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P160, DOI 10.1159/000084948; Dramard X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000304; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; JENSEN S, 1995, MOL GEN GENET, V248, P381, DOI 10.1007/BF02191637; Jensen S, 2002, GENETICS, V162, P1197; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Malinsky S, 2000, GENETICS, V156, P1147; Marin L, 2000, GENETICS, V155, P1841; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; PICARD G, 1976, GENETICS, V83, P107; Picard G, 1971, DIS, V46, P54; RONSSERAY S, 1991, GENETICS, V129, P501; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Seleme MD, 1999, GENETICS, V151, P761; VAURY C, 1990, J MOL EVOL, V31, P424, DOI 10.1007/BF02106056	28	535	555	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1387	1392		10.1126/science.1165171	http://dx.doi.org/10.1126/science.1165171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039138	Green Accepted			2022-12-24	WOS:000261170600041
J	Wilusz, JE; Freier, SM; Spector, DL				Wilusz, Jeremy E.; Freier, Susan M.; Spector, David L.			3 ' End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNA	CELL			English	Article							POLY(A)-LIMITING ELEMENT; MICRORNAS; MECHANISM; SEQUENCE; PROTEIN; IDENTIFICATION; TRANSCRIPTS; INHIBITOR; GENOME; TFEB	MALAT1 is a long noncoding RNA known to be misregulated in many human cancers. We have identified a highly conserved small RNA of 61 nucleotides originating from the MALAT1 locus that is broadly expressed in human tissues. Although the long MALAT1 transcript localizes to nuclear speckles, the small RNA is found exclusively in the cytoplasm. RNase P cleaves the nascent MALAT1 transcript downstream of a genomically encoded poly(A)-rich tract to simultaneously generate the 30 end of the mature MALAT1 transcript and the 50 end of the small RNA. Enzymes involved in tRNA biogenesis then further process the small RNA, consistent with its adoption of a tRNA-like structure. Our findings reveal a 30 end processing mechanism by which a single gene locus can yield both a stable nuclear-retained noncoding RNA with a short poly(A) tail-like moiety and a small tRNA-like cytoplasmic RNA.	[Wilusz, Jeremy E.; Spector, David L.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Freier, Susan M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Spector, DL (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu	Wilusz, Jeremy/AAG-4628-2020	Wilusz, Jeremy/0000-0001-6929-8755	Beckman Graduate Studentship; National Institutes of Health; National Institute of General Medical Sciences [42694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	Beckman Graduate Studentship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Tom Gingeras, Greg Hannon, Adrian Krainer, Kannanganattu Prasanth, Hongjae Sunwoo, Oliver Tam, Jeff Wilusz, Carol Wilusz, Zhenyu Xuan, and members of the Spector laboratory for many helpful discussions. We would also like to thank Chris Black and Frank Bennett for help and discussions regarding the antisense oligonucleotides, Josh Nichols and Walt Lima for performing the sucrose gradients, Sidney Altman and Masayuki Nashimoto for providing tRNA processing reagents, and Philip Leder for providing the EpH4-EV and EpH4-A6 cell lines. We thank Delphine Bernard and Alain Bessis for bringing MALAT1 to our attention. J. E. W. is supported by a Beckman Graduate Studentship at the Watson School of Biological Sciences. The work was supported by a grant to D. L. S. from the National Institutes of Health, National Institute of General Medical Sciences (42694).	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Fechter P, 2001, CELL MOL LIFE SCI, V58, P1547, DOI 10.1007/PL00000795; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Gu HD, 1999, P NATL ACAD SCI USA, V96, P8943, DOI 10.1073/pnas.96.16.8943; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jacobson MR, 1997, J CELL SCI, V110, P829; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Peng J, 2005, RNA, V11, P958, DOI 10.1261/rna.2020805; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Szymanski M, 2005, BBA-REV CANCER, V1756, P65, DOI 10.1016/j.bbcan.2005.07.005; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	486	527	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					919	932		10.1016/j.cell.2008.10.012	http://dx.doi.org/10.1016/j.cell.2008.10.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041754	Green Accepted, Bronze			2022-12-24	WOS:000261183900022
J	Stenman, JM; Rajagopal, J; Carroll, TJ; Ishibashi, M; McMahon, J; McMahon, AP				Stenman, Jan M.; Rajagopal, Jay; Carroll, Thomas J.; Ishibashi, Makoto; McMahon, Jill; McMahon, Andrew P.			Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature	SCIENCE			English	Article							BETA-CATENIN GENE; ENDOTHELIAL-CELLS; MOUSE DEVELOPMENT; RECEPTOR GENE; EXPRESSION; PROLIFERATION; ANGIOGENESIS; INACTIVATION; DISRUPTION; PATHWAY	Every organ depends on blood vessels for oxygen and nutrients, but the vasculature associated with individual organs can be structurally and molecularly diverse. The central nervous system (CNS) vasculature consists of a tightly sealed endothelium that forms the blood- brain barrier, whereas blood vessels of other organs are more porous. Wnt7a and Wnt7b encode two Wnt ligands produced by the neuroepithelium of the developing CNS coincident with vascular invasion. Using genetic mouse models, we found that these ligands directly target the vascular endothelium and that the CNS uses the canonical Wnt signaling pathway to promote formation and CNS- specific differentiation of the organ's vasculature.	[Stenman, Jan M.; Rajagopal, Jay; Carroll, Thomas J.; Ishibashi, Makoto; McMahon, Jill; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rajagopal, Jay] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [McMahon, Andrew P.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	mcmahon@mcb.harvard.edu	McMahon, Andrew P/ABE-7520-2020		Wenner-Gren Foundations (Sweden); National Heart, Lung, and Blood Institute [HL076393]; NIH [DK054364]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054364, R37DK054364] Funding Source: NIH RePORTER	Wenner-Gren Foundations (Sweden); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. D'Amore for helpful discussions. Supported by a Wenner-Gren Foundations (Sweden) postdoctoral fellowship (J.M.S.), National Heart, Lung, and Blood Institute grant HL076393 (J.R.), and NIH grant DK054364 (A.P.M.). The authors have a patent pending on the basis of the results reported in this paper. A.P.M. has been a paid consultant for Merck, Genentech, and Wythe in the past 3 years.	Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Goodwin AM, 2007, GROWTH FACTORS, V25, P25, DOI 10.1080/08977190701272933; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Parr BA, 2001, DEV BIOL, V237, P324, DOI 10.1006/dbio.2001.0373; PARR BA, 1993, DEVELOPMENT, V119, P247; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smith, 2006, DEATHS PRELIMINARY D; Suburo A. M., 2006, V176, P71; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Yano H, 2000, NEUROL RES, V22, P650; Yano H, 2000, NEUROL RES, V22, P527	27	426	433	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1247	1250		10.1126/science.1164594	http://dx.doi.org/10.1126/science.1164594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023080				2022-12-24	WOS:000261033400042
J	Ray, PS; Jia, J; Yao, P; Majumder, M; Hatzoglou, M; Fox, PL				Ray, Partho Sarothi; Jia, Jie; Yao, Peng; Majumder, Mithu; Hatzoglou, Maria; Fox, Paul L.			A stress-responsive RNA switch regulates VEGFA expression	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; TRANSLATIONAL CONTROL; BACILLUS-SUBTILIS; MESSENGER-RNAS; NONCANONICAL FUNCTION; LEADER RNA; HYPOXIA; PROTEIN; RIBOSWITCHES	Ligand binding to structural elements in the non- coding regions of messenger RNA modulates gene expression(1,2). Ligands such as free metabolites or other small molecules directly bind and induce conformational changes in regulatory RNA elements known as riboswitches(1-4). Other types of RNA switches are activated by complexed metabolites - for example, RNA- ligated metabolites such as aminoacyl- charged transfer RNA in the T- box system(5), or protein-bound metabolites in the glucose- or amino- acid- stimulated terminator-anti- terminator systems(6,7). All of these switch types are found in bacteria, fungi and plants(8-10). Here we report an RNA switch in human vascular endothelial growth factor- A ( VEGFA, also known as VEGF) mRNA 39 untranslated region ( UTR) that integrates signals from interferon ( IFN)-gamma and hypoxia to regulate VEGFA translation in myeloid cells. Analogous to riboswitches, the VEGFA 3 ' UTR undergoes a binary conformational change in response to environmental signals. However, the VEGFA 3 ' UTR switch is metabolite independent, and the conformational change is dictated by mutually exclusive, stimulus- dependent binding of proteins, namely, the IFN-gamma-activated inhibitor of translation complex(11,12) and heterogeneous	[Ray, Partho Sarothi; Jia, Jie; Yao, Peng; Fox, Paul L.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol, Kolkata 700106, India; [Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata; Case Western Reserve University	Fox, PL (corresponding author), Cleveland Clin, Dept Cell Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Yao, Peng/G-5218-2015; Yao, Peng/Y-8047-2019; Ray, Partho Sarothi/H-3020-2019; Yao, Peng/J-4492-2013	Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-1145-3967; Ray, Partho Sarothi/0000-0002-8795-3060; Yao, Peng/0000-0002-7029-8629; Jia, Jie/0000-0002-9583-1055	National Institutes of Health [P01 HL29582, R01 HL67725, P01 HL76491, R01 DK60596]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067725, P01HL076491, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to D. Driscoll and T. M. Henkin for helpful discussions. This work was supported by National Institutes of Health grants P01 HL29582, R01 HL67725 and P01 HL76491 ( to P. L. F.), and R01 DK60596 ( to M. H.).	Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; KNAPP G, 1989, METHOD ENZYMOL, V180, P192; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Merrick W C, 2001, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1109s08; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schilling O, 2004, NUCLEIC ACIDS RES, V32, P2853, DOI 10.1093/nar/gkh611; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	31	194	198	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					915	919		10.1038/nature07598	http://dx.doi.org/10.1038/nature07598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19098893	Green Accepted			2022-12-24	WOS:000263266700052
J	Do, MTH; Kang, SH; Xue, T; Zhong, HN; Liao, HW; Bergles, DE; Yau, KW				Do, Michael Tri H.; Kang, Shin H.; Xue, Tian; Zhong, Haining; Liao, Hsi-Wen; Bergles, Dwight E.; Yau, King-Wai			Photon capture and signalling by melanopsin retinal ganglion cells	NATURE			English	Article							CONE PHOTORECEPTORS; LIGHT RESPONSES; MICE; PHOTOPIGMENT; REFLEX; EXPRESSION; RODS; SET	A subset of retinal ganglion cells has recently been discovered to be intrinsically photosensitive, with melanopsin as the pigment. These cells project primarily to brain centres for non- image- forming visual functions such as the pupillary light reflex and circadian photoentrainment. How well they signal intrinsic light absorption to drive behaviour remains unclear. Here we report fundamental parameters governing their intrinsic light responses and associated spike generation. The membrane density of melanopsin is 10(4)-fold lower than that of rod and cone pigments, resulting in a very low photon catch and a phototransducing role only in relatively bright light. Nonetheless, each captured photon elicits a large and extraordinarily prolonged response, with a unique shape among known photoreceptors. Notably, like rods, these cells are capable of signalling single- photon absorption. A flash causing a few hundred isomerized melanopsin molecules in a retina is sufficient for reaching threshold for the pupillary light reflex.	[Do, Michael Tri H.; Kang, Shin H.; Xue, Tian; Zhong, Haining; Liao, Hsi-Wen; Bergles, Dwight E.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Do, Michael Tri H.; Xue, Tian; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Do, MTH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	mdo@jhmi.edu; kwyau@mail.jhmi.edu	Xue, Tian/G-9009-2018; Bergles, Dwight/U-8343-2019; H, Michael Tri/A-5917-2009	Bergles, Dwight/0000-0002-7133-7378; H, Michael Tri/0000-0001-6418-0977; Zhong, Haining/0000-0002-7109-4724	NRSA; VNTP Training Grant; NIH; NATIONAL EYE INSTITUTE [R01EY014596, F32EY016959, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VNTP Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by an NRSA fellowship and a VNTP Training Grant to M. T. H. D., and NIH grants to K.-W.Y. and D. E. B. We thank Y. Koutalos, V. Bhandawat, D.-G. Luo, V. Kefalov, D. Liu, G. Maimon and C.-Y. Su for discussions, and Y. Wang, J. Hsieh and N. Nishiyama for technical assistance. We also thank J. Nathans and R. Reeves for suggestions on transgenic lines, J. Nathans and H. Cahill for the Gnat1<SUP>-/-</SUP> cl mouse line, and T. Shelley for machining. We dedicate this work to the Champalimaud Foundation, Portugal.	BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dartnell HJA, 1972, PHOTOCHEMISTRY VISIO, P122; Dorlochter M, 1997, PROG NEUROBIOL, V53, P451, DOI 10.1016/S0301-0082(97)00046-4; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Grozdanic S, 2003, CURR EYE RES, V26, P371, DOI 10.1076/ceyr.26.5.371.15439; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; HARDIE RC, 2008, COMPREHENSIVE REFERE; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; KRAFT TW, 1988, J PHYSIOL-LONDON, V404, P199, DOI 10.1113/jphysiol.1988.sp017286; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LISMAN JE, 1977, J GEN PHYSIOL, V70, P621, DOI 10.1085/jgp.70.5.621; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; LUO DG, 2008, SENSES COMPREHENSIVE; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; QIU X, 2007, INVEST OPHTHALMOL VI, V48; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; WONG KY, 2008, INVEST OPHTHALMOL VI, V49; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	50	206	215	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					281	U2		10.1038/nature07682	http://dx.doi.org/10.1038/nature07682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19118382	Green Accepted			2022-12-24	WOS:000262440900032
J	Liu, JY; O'Brien, KL; Lynch, DM; Simmons, NL; La Porte, A; Riggs, AM; Abbink, P; Coffey, RT; Grandpre, LE; Seaman, MS; Landucci, G; Forthal, DN; Montefiori, DC; Carville, A; Mansfield, KG; Havenga, MJ; Pau, MG; Goudsmit, J; Barouch, DH				Liu, Jinyan; O'Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, Annalena; Riggs, Ambryice M.; Abbink, Peter; Coffey, Rory T.; Grandpre, Lauren E.; Seaman, Michael S.; Landucci, Gary; Forthal, Donald N.; Montefiori, David C.; Carville, Angela; Mansfield, Keith G.; Havenga, Menzo J.; Pau, Maria G.; Goudsmit, Jaap; Barouch, Dan H.			Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys	NATURE			English	Article							IMMUNODEFICIENCY VIRUS SIVMAC239; SIMIAN-IMMUNODEFICIENCY; ADENOVIRUS VECTORS; REPLICATION; INFECTION; MEMORY; IMMUNOGENICITY; RESPONSES; HIV; MAMU-A-ASTERISK-01	A recombinant adenovirus serotype 5 ( rAd5) vector- based vaccine for HIV-1 has recently failed in a phase 2b efficacy study in humans(1,2). Consistent with these results, preclinical studies have demonstrated that rAd5 vectors expressing simian immunodeficiency virus (SIV) Gag failed to reduce peak or setpoint viral loads after SIV challenge of rhesus monkeys ( Macaca mulatta) that lacked the protective MHC class I allele Mamu-A*01 ( ref. 3). Here we show that an improved T- cell- based vaccine regimen using two serologically distinct adenovirus vectors afforded substantially improved protective efficacy in this challenge model. In particular, a heterologous rAd26 prime/rAd5 boost vaccine regimen expressing SIV Gag elicited cellular immune responses with augmented magnitude, breadth and polyfunctionality as compared with the homologous rAd5 regimen. After SIVMAC251 challenge, monkeys vaccinated with the rAd26/rAd5 regimen showed a 1.4 log reduction of peak and a 2.4 log reduction of setpoint viral loads as well as decreased AIDS- related mortality as compared with control animals. These data demonstrate that durable partial immune control of a pathogenic SIV challenge for more than 500 days can be achieved by a T- cell- based vaccine in Mamu-A*01-negative rhesus monkeys in the absence of a homologous Env antigen. These findings have important implications for the development of next- generation T- cell- based vaccine candidates for HIV- 1.	[Liu, Jinyan; O'Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, Annalena; Riggs, Ambryice M.; Abbink, Peter; Coffey, Rory T.; Grandpre, Lauren E.; Seaman, Michael S.; Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Sch Med, Irvine, CA 92697 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Carville, Angela; Mansfield, Keith G.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Havenga, Menzo J.] TNO Biosci, NL-2301 CE Leiden, Netherlands; [Pau, Maria G.; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Irvine; Duke University; Netherlands Organization Applied Science Research; Johnson & Johnson	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019	Simmons, Nathaniel/0000-0001-6080-2783	NIH [AI066305, AI066924, AI078526, AI030034, RR000168]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066924, R01AI058727, U19AI066305, U19AI078526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vogels, J. Custers, L. Holterman, A. Lemckert, F. Stephens, R. Dolin, N. Letvin, J. Schmitz, M. Lifton, K. Furr, L. Picker and M. Pensiero for generous advice, assistance and reagents. The SIV peptide pools were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from NIH grants AI066305 ( D. H. B.), AI066924 ( D. H. B.), AI078526 ( D. H. B.), AI030034 ( D. C. M.) and RR000168.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; FAUCI AS, 2007, NIH NEWS        1107, P45704; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM, P45704; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Veazey RS, 2008, J VIROL, V82, P5618, DOI 10.1128/JVI.02748-07; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	30	377	420	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					87	91		10.1038/nature07469	http://dx.doi.org/10.1038/nature07469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18997770	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000262104900036
J	Buehr, M; Meek, S; Blair, K; Yang, J; Ure, J; Silva, J; Mclay, R; Hall, J; Ying, QL; Smith, A				Buehr, Mia; Meek, Stephen; Blair, Kate; Yang, Jian; Ure, Janice; Silva, Jose; McLay, Renee; Hall, John; Ying, Qi-Long; Smith, Austin			Capture of Authentic Embryonic Stem Cells from Rat Blastocysts	CELL			English	Article							PRIMORDIAL GERM-CELLS; DIFFERENTIATION INHIBITING ACTIVITY; SELF-RENEWAL; X-CHROMOSOME; TRANSCRIPTIONAL NETWORK; MOUSE EPIBLAST; PLURIPOTENCY; ESTABLISHMENT; LINES; FGF	Embryonic stem (ES) cells have been available from inbred mice since 1981 but have not been validated for other rodents. Failure to establish ES cells from a range of mammals challenges the identity of cultivated stem cells and our understanding of the pluripotent state. Here we investigated derivation of ES cells from the rat. We applied molecularly defined conditions designed to shield the ground state of authentic pluripotency from inductive differentiation stimuli. Undifferentiated cell lines developed that exhibited diagnostic features of ES cells including colonization of multiple tissues in viable chimeras. Definitive ES cell status was established by transmission of the cell line genome to offspring. Derivation of germline-competent ES cells from the rat paves the way to targeted genetic manipulation in this valuable biomedical model species. Rat ES cells will also provide a refined test-bed for functional evaluation of pluripotent stem cell-derived tissue repair and regeneration.	[Blair, Kate; Yang, Jian; Silva, Jose; Hall, John; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Buehr, Mia; Meek, Stephen; Ure, Janice; McLay, Renee; Ying, Qi-Long] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Buehr, Mia; Meek, Stephen] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Blair, Kate; Silva, Jose; Hall, John; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Yang, Jian] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China	University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Cambridge; Fudan University	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk	Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019	Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Blair, Kate/0000-0003-0766-0952; Smith, Austin/0000-0002-3029-4682	National Institute on Drug Abuse at National Institutes of Health; Biotechnology and Biological Sciences Research Council of the United Kingdom; European Commission project EuroStemCell; Gates Cambridge Scholar; Medical Research Council; MRC [G9806702] Funding Source: UKRI; Medical Research Council [G9806702] Funding Source: researchfish	National Institute on Drug Abuse at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission project EuroStemCell(European CommissionEuropean Commission Joint Research Centre); Gates Cambridge Scholar; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Jennifer Nichols provided advice throughout and comments on the manuscript. We thank Carolyn Manson, John Agnew, and Andrew Dyer for expert animal care and Rachel Walker for flow cytometry. We are indebted to Frances Lovell and Willem Rens at the Cambridge Resource Centre for Comparitive Genomics for FISH. We are grateful to Philip Cohen and colleagues at the Division of Signal Transduction Therapy, University of Dundee, for inhibitors and Thomas Jenuwein for H3K27me3 antibody. This research was funded by the National Institute on Drug Abuse at National Institutes of Health, the Biotechnology and Biological Sciences Research Council of the United Kingdom, and the European Commission project EuroStemCell. K. B. is a Gates Cambridge Scholar. A.S. is a Medical Research Council Professor. A.S., Q.L.Y., and M. B. conceived and planned the study. M. B. characterized ICM explants and derived cell lines; S. M. performed molecular expression profiling, transfections, and genotyping; K. B. analyzed feeder-free culture and LIF responsiveness; J.Y., J.S., and J.H. performed additional characterization experiments; J.U. and R.M. generated chimeras; and A.S. wrote the paper. A.S. and Q.-L.Y. are inventors on a patent relating to this study filed by the University of Edinburgh and licensed to Stem Cell Sciences LTD. A.S. is a remunerated scientific advisor to the Stem Cell Sciences LTD.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BATLLEMORERA L, 2008, GENESIS         1006, DOI DOI 10.1002/DVG.20442; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Prelle K, 1999, CELLS TISSUES ORGANS, V165, P220, DOI 10.1159/000016683; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YAMAMURA K, 1981, DEV GENET, V2, P131, DOI 10.1002/dvg.1020020111; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	63	583	658	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1287	1298		10.1016/j.cell.2008.12.007	http://dx.doi.org/10.1016/j.cell.2008.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109897	Bronze			2022-12-24	WOS:000261989800019
J	Blein, T; Pulido, A; Vialette-Guiraud, A; Nikovics, K; Morin, H; Hay, A; Johansen, IE; Tsiantis, M; Laufs, P				Blein, Thomas; Pulido, Amada; Vialette-Guiraud, Aurelie; Nikovics, Krisztina; Morin, Halima; Hay, Angela; Johansen, Ida Elisabeth; Tsiantis, Miltos; Laufs, Patrick			A Conserved Molecular Framework for Compound Leaf Development	SCIENCE			English	Article							RELATIVE CARDAMINE-HIRSUTA; CUP-SHAPED-COTYLEDON; ARABIDOPSIS-THALIANA; ORGAN BOUNDARIES; AUXIN TRANSPORT; APICAL MERISTEM; GENETIC-CONTROL; MORPHOGENESIS; TOMATO	Diversity in leaf shape is produced by alterations of the margin: for example, deep dissection leads to leaflet formation and less- pronounced incision results in serrations or lobes. By combining gene silencing and mutant analyses in four distantly related eudicot species, we show that reducing the function of NAM/CUC boundary genes (NO APICAL MERISTEM and CUP-SHAPED COTYLEDON) leads to a suppression of all marginal outgrowths and to fewer and fused leaflets. We propose that NAM/CUC genes promote formation of a boundary domain that delimits leaflets. This domain has a dual role promoting leaflet separation locally and leaflet formation at distance. In this manner, boundaries of compound leaves resemble boundaries functioning during animal development.	[Blein, Thomas; Pulido, Amada; Vialette-Guiraud, Aurelie; Nikovics, Krisztina; Morin, Halima; Laufs, Patrick] INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Hay, Angela; Tsiantis, Miltos] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Johansen, Ida Elisabeth] Univ Aarhus, Dept Genet & Biotechnol, DK-1871 Frederiksberg C, Denmark	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Aarhus University	Laufs, P (corresponding author), INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	laufs@versailles.inra.fr	Johansen, Ida E/F-7792-2014; Blein, Thomas/L-8508-2019; Pulido, Amada/B-8199-2011	Johansen, Ida E/0000-0001-8660-2018; Blein, Thomas/0000-0001-9788-5201; Pulido, Amada/0000-0003-4241-7042; Laufs, Patrick/0000-0003-4459-3445	Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME [TRIL-046]; Ministere de l'Enseignement Superieur et de la Recherche; Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion); Region Ile-de-France; UK Biotechnology and Biological	Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Region Ile-de-France(Region Ile-de-France); UK Biotechnology and Biological	This work was partly supported by an Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME program TRIL-046. T.B. was supported by a Ph. D. fellowship from the Ministere de l'Enseignement Superieur et de la Recherche, and A.P. was supported by the Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion) and the Region Ile-de-France. M.T. is supported by the UK Biotechnology and Biological	Aida M, 2006, CURR OPIN PLANT BIOL, V9, P72, DOI 10.1016/j.pbi.2005.11.011; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aida M, 1999, DEVELOPMENT, V126, P1563; Aida M, 2006, PLANT MOL BIOL, V60, P915, DOI 10.1007/s11103-005-2760-7; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Brand A, 2007, PLANTA, V226, P941, DOI 10.1007/s00425-007-0540-0; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Champagne C, 2004, DEVELOPMENT, V131, P4401, DOI 10.1242/dev.01338; Champagne CEM, 2007, PLANT CELL, V19, P3369, DOI 10.1105/tpc.107.052886; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203	23	246	268	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1835	1839		10.1126/science.1166168	http://dx.doi.org/10.1126/science.1166168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095941				2022-12-24	WOS:000261799400052
J	Choi, H; Sell, RL; Lenert, L; Muennig, P; Goodman, RR; Gilliam, FG; Wong, JB				Choi, Hyunmi; Sell, Randall L.; Lenert, Leslie; Muennig, Peter; Goodman, Robert R.; Gilliam, Frank G.; Wong, John B.			Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy A Decision Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN UNEXPECTED DEATH; MEDICALLY REFRACTORY EPILEPSY; LIFE EXPECTANCY; RISK-FACTOR; MORTALITY; LOBECTOMY; PREDICTORS; PROGNOSIS; OUTCOMES; THERAPY	Context Patients with pharmacoresistant epilepsy have increased mortality compared with the general population, but patients with pharmacoresistant temporal lobe epilepsy who meet criteria for surgery and who become seizure- free after anterior temporal lobe resection have reduced excess mortality vs those with persistent seizures. Objective To quantify the potential survival benefit of anterior temporal lobe resection for patients with pharmacoresistant temporal lobe epilepsy vs continued medical management. Design Monte Carlo simulation model that incorporates possible surgical complications and seizure status, with 10 000 runs. The model was populated with health-related quality- of- life data obtained directly from patients and data from the medical literature. Insufficient data were available to assess gamma- knife radiosurgery or vagal nerve stimulation. Main Outcome Measures Life expectancy and quality- adjusted life expectancy. Results Compared with medical management, anterior temporal lobe resection for a 35- year- old patient with an epileptogenic zone identified in the anterior temporal lobe would increase survival by 5.0 years ( 95% CI, 2.1- 9.2) with surgery preferred in 100% of the simulations. Anterior temporal lobe resection would increase qualityadjusted life expectancy by 7.5 quality- adjusted life- years ( 95%, CI, - 0.8 to 17.4) with surgery preferred in 96.5% of the simulations, primarily due to increased years spent without disabling seizures, thereby reducing seizure- related excess mortality and improving quality of life. The results were robust to sensitivity analyses. Conclusion The decision analysis model suggests that on average anterior temporal lobe resection should provide substantial gains in life expectancy and qualityadjusted life expectancy for surgically eligible patients with pharmacoresistant temporal lobe epilepsy compared with medical management.	[Choi, Hyunmi; Gilliam, Frank G.] Columbia Univ, Dept Neurol, New York, NY USA; [Goodman, Robert R.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Muennig, Peter] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; [Sell, Randall L.] Drexel Univ, Sch Publ Hlth, Dept Community Hlth & Prevent, Philadelphia, PA 19104 USA; [Lenert, Leslie] Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Informat, Atlanta, GA USA; [Wong, John B.] Tufts Univ, Sch Med, Dept Med, Div Clin Decis Making,Tufts Med Ctr, Boston, MA 02111 USA	Columbia University; Columbia University; Columbia University; Drexel University; Centers for Disease Control & Prevention - USA; Tufts Medical Center; Tufts University	Choi, H (corresponding author), Neurol Inst, Columbia Comprehens Epilepsy Ctr, 710 W 168Th St,Box 210, New York, NY 10032 USA.	hc323@columbia.edu		Wong, John/0000-0003-4203-9010; Muennig, Peter/0000-0002-4234-0498	National Center for Research Resources [KL2 RR024157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157, K12RR017648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS047551] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This publication was made possible by grant KL2 RR024157 (Dr Choi) from the National Center for Research Resources, a component of the National Institutes of Health, and NIH Roadmap for Medical Research.	Annegers JF, 1998, EPILEPSIA, V39, P206, DOI 10.1111/j.1528-1157.1998.tb01360.x; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; BAILEY P, 1951, JAMA-J AM MED ASSOC, V145, P365, DOI 10.1001/jama.1951.02920240001001; Benbadis SR, 2003, SEIZURE-EUR J EPILEP, V12, P167, DOI 10.1016/S1059-1311(02)00320-5; Burneo JG, 2008, SEIZURE-EUR J EPILEP, V17, P314, DOI 10.1016/j.seizure.2007.10.002; Burneo JG, 2006, ARCH NEUROL-CHICAGO, V63, P1106, DOI 10.1001/archneur.63.8.1106; Choi H, 2008, EPILEPSIA, V49, P1440, DOI 10.1111/j.1528-1167.2008.01601.x; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Gennaro G, 2004, CLIN NEUROPHYSIOL, V115, P1212, DOI 10.1016/j.clinph.2003.12.008; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DUCHOWNY MSH, 2008, EPILEPSY COMPREHENSI, V2, P1751; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Engel J, 1999, ARCH NEUROL-CHICAGO, V56, P1338, DOI 10.1001/archneur.56.11.1338; ENGEL J, 1993, NEUROLOGY, V43, P1612, DOI 10.1212/WNL.43.8.1612; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 1998, NEUROLOGY, V51, P1243, DOI 10.1212/WNL.51.5.1243; Engel J, 2008, EPILEPSY COMPREHENSI, V2; Engel Jerome Jr., 1993, P609; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Gilliam F, 1999, NEUROLOGY, V53, P687, DOI 10.1212/WNL.53.4.687; GOLDMAN L, 1988, NEW ENGL J MED, V319, P152, DOI 10.1056/NEJM198807213190306; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Hennessy MJ, 1999, NEUROLOGY, V53, P1276, DOI 10.1212/WNL.53.6.1276; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janszky J, 2005, BRAIN, V128, P395, DOI 10.1093/brain/awh358; Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b; Jeong SW, 2005, EPILEPSIA, V46, P1273, DOI 10.1111/j.1528-1167.2005.33504.x; Kelemen A, 2006, SEIZURE-EUR J EPILEP, V15, P49, DOI 10.1016/j.seizure.2005.10.007; Kelley K, 2005, NEUROLOGY, V64, P1974, DOI 10.1212/01.WNL.0000163998.01543.CF; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langan Y, 2005, NEUROLOGY, V64, P1131, DOI 10.1212/01.WNL.0000156352.61328.CB; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; LEE BI, 2004, NEUROL ASIA, V9, P47; Lhatoo SD, 2003, EPILEPSIA, V44, P673, DOI 10.1046/j.1528-1157.2003.46002.x; Markand ON, 2000, EPILEPSIA, V41, P749, DOI 10.1111/j.1528-1157.2000.tb00238.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Mohanraj R, 2006, EUR J NEUROL, V13, P277, DOI 10.1111/j.1468-1331.2006.01215.x; MUENNIG P, 2002, DESIGNIGN CONDUCTING; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; Nilsson L, 2003, EPILEPSIA, V44, P575, DOI 10.1046/j.1528-1157.2003.03302.x; Pasta DJ, 1999, MED DECIS MAKING, V19, P353, DOI 10.1177/0272989X9901900314; PENFIELD W, 1950, AMA ARCH NEUROL PSY, V64, P491, DOI 10.1001/archneurpsyc.1950.02310280003001; Ryvlin P, 2003, EPILEPSY RES, V56, P105, DOI 10.1016/j.eplepsyres.2003.10.001; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Spencer SS, 2003, NEUROLOGY, V61, P1680, DOI 10.1212/01.WNL.0000098937.35486.A3; Spencer SS, 2008, NEUROLOGY, V70, P1654, DOI 10.1212/01.wnl.0000311272.33720.6b; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Sperling MR, 2004, CNS SPECTRUMS, V9, P106, DOI DOI 10.1017/S1092852900008464; Stephen LJ, 2006, EPILEPSY BEHAV, V8, P434, DOI 10.1016/j.yebeh.2005.11.007; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; Uijl SG, 2008, EPILEPSIA, V49, P1317, DOI 10.1111/j.1528-1167.2008.01695.x; Walczak TS, 2001, EPILEPSIA, V42, P804; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2000, CAN J NEUROL SCI, V27, pS6, DOI 10.1017/S0317167100000561; Wiebe S, 2006, CAN J NEUROL SCI, V33, P365, DOI 10.1017/S031716710000531X; WONG JB, 1990, ANN INTERN MED, V113, P852, DOI 10.7326/0003-4819-113-11-852; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606	68	128	134	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2497	2505		10.1001/jama.2008.771	http://dx.doi.org/10.1001/jama.2008.771			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050193	Bronze			2022-12-24	WOS:000261286200018
J	Heiman, M; Schaefer, A; Gong, S; Peterson, JD; Day, M; Ramsey, KE; Suarez-Farinas, M; Schwarz, C; Stephan, DA; Surmeier, DJ; Greengard, P; Heintz, N				Heiman, Myriam; Schaefer, Anne; Gong, Shiaoching; Peterson, Jayms D.; Day, Michelle; Ramsey, Keri E.; Suarez-farinas, Mayte; Schwarz, Cordelia; Stephan, Dietrich A.; Surmeier, D. James; Greengard, Paul; Heintz, Nathaniel			A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types	CELL			English	Article							INNERVATED BRAIN-REGIONS; CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; RAT-BRAIN; BASAL GANGLIA; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; NUCLEUS-ACCUMBENS; ADENYLYL-CYCLASE	The cellular heterogeneity of the brain confounds efforts to elucidate the biological properties of distinct neuronal populations. Using bacterial artificial chromosome (BAC) transgenic mice that express EGFP-tagged ribosomal protein L10a in defined cell populations, we have developed a methodology for affinity purification of polysomal mRNAs from genetically defined cell populations in the brain. The utility of this approach is illustrated by the comparative analysis of four types of neurons, revealing hundreds of genes that distinguish these four cell populations. We find that even two morphologically indistinguishable, intermixed subclasses of medium spiny neurons display vastly different translational profiles and present examples of the physiological significance of such differences. This genetically targeted translating ribosome affinity purification (TRAP) methodology is a generalizable method useful for the identification of molecular changes in any genetically defined cell type in response to genetic alterations, disease, or pharmacological perturbations.	[Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA; [Heiman, Myriam; Schaefer, Anne; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Schwarz, Cordelia; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Suarez-farinas, Mayte] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Peterson, Jayms D.; Day, Michelle; Surmeier, D. James] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ramsey, Keri E.; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Northwestern University; Feinberg School of Medicine; Translational Genomics Research Institute	Heintz, N (corresponding author), Rockefeller Univ, GENSAT Project, 1230 York Ave, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553; Greengard, Paul/0000-0002-4437-0893	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [5UL1RR024143] Funding Source: Medline; NIA NIH HHS [P01 AG009464-17, P01 AG009464, P01 AG009464-16A1, AG09464] Funding Source: Medline; NIDA NIH HHS [P01 DA010044, 5F32DA021487, F32 DA021487-02, F32 DA021487-01, P01 DA010044-11, F32 DA021487, P01 DA010044-10, DA10044, P01 DA010044-09] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-039002, P50 MH074866-040005, P50 MH074866-02, P50 MH074866-020001, P50 MH074866-030001, P50 MH074866-010005, P50 MH074866-019001, P50 MH074866-029002, P50 MH074866-010001, P50 MH074866-039001, P50 MH074866-030005, P50 MH074866-029001, P50 MH074866-020005, P50 MH074866-049002, P50 MH074866-017204, P50 MH074866-030002, P50 MH074866-019002, P50 MH074866-010002, MH074866, P50 MH074866-040002, P50 MH074866-04, P50 MH074866-01, P50 MH074866-020002, P50 MH074866-049001, P50 MH074866-03, P50 MH074866-040001, P50 MH074866] Funding Source: Medline; NINDS NIH HHS [R37 NS034696-13, R37 NS034696-12, R37 NS034696-11, R37 NS034696, R01 NS034696, NS34696] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021487, P01DA010044] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; DI CG, 1988, P NATL ACAD SCI USA, V85, P5274; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GIRAULT JA, 1990, J NEUROSCI, V10, P1124; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lobo MK, 2007, NAT NEUROSCI, V10, P1395, DOI 10.1038/nn1987; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; OH JD, 1992, NEUROSCIENCE, V47, P807, DOI 10.1016/0306-4522(92)90031-V; OUIMET CC, 1989, J NEUROSCI, V9, P865; POLLI JW, 1992, P NATL ACAD SCI USA, V89, P11079, DOI 10.1073/pnas.89.22.11079; Ramon y Cajal S., 1899, TEXTURE NERVOUS SYST; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Volkow ND, 1998, AM J PSYCHIAT, V155, P200; WALAAS SI, 1984, J NEUROSCI, V4, P84; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477	56	753	761	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					738	748		10.1016/j.cell.2008.10.028	http://dx.doi.org/10.1016/j.cell.2008.10.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013281	Green Accepted, Bronze			2022-12-24	WOS:000260886900023
J	Smyth, DJ; Plagnol, V; Walker, NM; Cooper, JD; Downes, K; Yang, JHM; Howson, JMM; Stevens, H; McManus, R; Wijmenga, C; Heap, GA; Dubois, PC; Clayton, DG; Hunt, KA; van Heel, DA; Todd, JA				Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Cooper, Jason D.; Downes, Kate; Yang, Jennie H. M.; Howson, Joanna M. M.; Stevens, Helen; McManus, Ross; Wijmenga, Cisca; Heap, Graham A.; Dubois, Patrick C.; Clayton, David G.; Hunt, Karen A.; van Heel, David A.; Todd, John A.			Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL MICROBIOTA; RISK VARIANTS; CHEMOKINE; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISMS; PREVALENCE; MULTIPLE; CHILDREN; LOCUS	Background: Two inflammatory disorders, type 1 diabetes and celiac disease, cosegregate in populations, suggesting a common genetic origin. Since both diseases are associated with the HLA class II genes on chromosome 6p21, we tested whether non-HLA loci are shared. Methods: We evaluated the association between type 1 diabetes and eight loci related to the risk of celiac disease by genotyping and statistical analyses of DNA samples from 8064 patients with type 1 diabetes, 9339 control subjects, and 2828 families providing 3064 parent-child trios (consisting of an affected child and both biologic parents). We also investigated 18 loci associated with type 1 diabetes in 2560 patients with celiac disease and 9339 control subjects. Results: Three celiac disease loci - RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, and TAGAP on chromosome 6q25 - were associated with type 1 diabetes (P<1.00 x 10(-4)). The 32-bp insertion-deletion variant on chromosome 3p21 was newly identified as a type 1 diabetes locus (P=1.81 x 10(-8)) and was also associated with celiac disease, along with PTPN2 on chromosome 18p11 and CTLA4 on chromosome 2q33, bringing the total number of loci with evidence of a shared association to seven, including SH2B3 on chromosome 12q24. The effects of the IL18RAP and TAGAP alleles confer protection in type 1 diabetes and susceptibility in celiac disease. Loci with distinct effects in the two diseases included INS on chromosome 11p15, IL2RA on chromosome 10p15, and PTPN22 on chromosome 1p13 in type 1 diabetes and IL12A on 3q25 and LPP on 3q28 in celiac disease. Conclusions: A genetic susceptibility to both type 1 diabetes and celiac disease shares common alleles. These data suggest that common biologic mechanisms, such as autoimmunity-related tissue damage and intolerance to dietary antigens, may be etiologic features of both diseases.	[Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Cooper, Jason D.; Downes, Kate; Yang, Jennie H. M.; Howson, Joanna M. M.; Stevens, Helen; Clayton, David G.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Heap, Graham A.; Dubois, Patrick C.; Hunt, Karen A.; van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; University of Groningen; University of Groningen; University of London; Queen Mary University London	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Wijmenga, Cisca/AAE-7719-2019; McManus, Ross/AAE-9236-2020; Todd, John A/A-3542-2010; Plagnol, Vincent/A-5667-2011; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Todd, John A/0000-0003-2740-8148; Plagnol, Vincent/0000-0002-5597-9215; Heap, Graham/0000-0003-4131-6792; van Heel, David/0000-0002-0637-2265; Howson, Joanna/0000-0001-7618-0050; smyth, deborah/0000-0002-6330-2669; McManus, Ross/0000-0002-0529-9617; Walker, Neil/0000-0001-9796-7688	Juvenile Diabetes Research Foundation International; Wellcome Trust; National Institute for Health Research's Cambridge Biomedical Research Centre; Celiac UK; Celiac Disease Consortium; European Union; Netherlands Organization for Scientific Research; Science Foundation Ireland; Irish Health Research Board; Hitachi Europe; NexPep; MRC [G0000934, G0700545] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0000934, G0700545] Funding Source: researchfish	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research's Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Celiac UK; Celiac Disease Consortium; European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board; Hitachi Europe; NexPep; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Juvenile Diabetes Research Foundation International, the Wellcome Trust, the National Institute for Health Research's Cambridge Biomedical Research Centre, Celiac UK, the Celiac Disease Consortium (an innovative cluster approved by the Netherlands Genomics Initiative and partly funded by the Dutch Government), the European Union, the Netherlands Organization for Scientific Research, the Science Foundation Ireland, and the Irish Health Research Board.; Dr. McManus reports receiving grant support from Hitachi Europe; and Dr. van Heel, having an equity interest in and receiving consulting fees from NexPep. No other potential conflict of interest relevant to this article was reported.; We thank all the patients and control subjects for their participation in the study; the Avon Longitudinal Study of Parents and Children Laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan, and P. Burton for preparing and providing the control DNA samples; the Human Biological Data Interchange and Diabetes UK for data on multiplex families; the Norwegian Study Group for Childhood Diabetes for the collection of the Norwegian families, especially D. Undlien and K. Ronningen; D. Savage, C. Patterson, D. Carson, and P. Maxwell for the Northern Irish samples; J. Tuomilehto, L. Kinnunen, E. TuomilehtoWolf, V. Harjutsalo, and T. Valle of Genetics of Type 1 Diabetes in Finland for the Finnish family samples; C. Guja and C. IonescuTirgoviste for the Romanian family samples; the Irish Blood Transfusion Service - Trinity College Dublin Biobank for DNA from Irish control subjects; the Barts and the London Genome Centre for genotyping support; J. Swift, R. Crimmins, P. Kumar, D. P. Jewell, L. Dinesen, S. P. L. Travis, K. Moriarty, P. Howdle, D. S. Sanders, G. K. T. Holmes, S. Sleet, and Celiac UK for the collection of British celiac samples; A. Monsuur, C. J. Mulder, M. L. Mearin, and W. H. M. Verbeek, for the recruitment of patients; G. Meijer and J. Meijer for their review of histologic analyses; K. Duran for DNA extraction; H. van Someren and F. Mulder for clinical database management; L. Franke, A. Zhernakova, M. Plateel, and the genotyping facilities at University Medical Center Groningen and University Medical Center Utrecht in the Netherlands for their technical assistance; F. M. Stevens, C. O'Morain, N. P. Kennedy, M. Abuzakouk, R. McLoughlin, K. Brophy, C. Feighery, J. McPartlin, D. Kelleher, A. W. Ryan, and G. Turner for sample collection and genotyping; and L. Wicker for comments on the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Buhler MM, 2002, AUTOIMMUNITY, V35, P457, DOI 10.1080/0891693021000041088; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; COOPER JD, 2008, NAT GENET       1102; Frisk G, 2008, MED HYPOTHESES, V70, P1207, DOI 10.1016/j.mehy.2007.05.058; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; HAFLER JP, 2008, GENES IMMUN     1030; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kalev I, 2003, J DIABETES COMPLICAT, V17, P387, DOI 10.1016/S1056-8727(02)00242-8; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Meagher C, 2007, DIABETES, V56, P809, DOI 10.2337/db06-0619; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072; Santin I, 2008, TISSUE ANTIGENS, V71, P247, DOI 10.1111/j.1399-0039.2007.01002.x; Szalai C, 1999, PEDIATR RES, V46, P82, DOI 10.1203/00006450-199907000-00014; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang B, 2004, CYTOKINE, V26, P114, DOI 10.1016/j.cyto.2004.01.005	35	521	536	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2767	2777		10.1056/NEJMoa0807917	http://dx.doi.org/10.1056/NEJMoa0807917			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19073967	Green Accepted			2022-12-24	WOS:000261950800004
J	Colmone, A; Amorim, M; Pontier, AL; Wang, S; Jablonski, E; Sipkins, DA				Colmone, Angela; Amorim, Maria; Pontier, Andrea L.; Wang, Sheng; Jablonski, Elizabeth; Sipkins, Dorothy A.			Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells	SCIENCE			English	Article							STEM-CELLS; C-KIT; MOBILIZATION; ENGRAFTMENT; DIFFERENTIATION; REPOPULATION; EXPRESSION; REGULATOR; DISEASE; CXCR4	The host tissue microenvironment influences malignant cell proliferation and metastasis, but little is known about how tumor- induced changes in the microenvironment affect benign cellular ecosystems. Applying dynamic in vivo imaging to a mouse model, we show that leukemic cell growth disrupts normal hematopoietic progenitor cell ( HPC) bone marrow niches and creates abnormal microenvironments that sequester transplanted human CD34(+) (HPC- enriched) cells. CD34(+) cells in leukemic mice declined in number over time and failed to mobilize into the peripheral circulation in response to cytokine stimulation. Neutralization of stem cell factor ( SCF) secreted by leukemic cells inhibited CD34(+) cell migration into malignant niches, normalized CD34(+) cell numbers, and restored CD34(+) cell mobilization in leukemic mice. These data suggest that the tumor microenvironment causes HPC dysfunction by usurping normal HPC niches and that therapeutic inhibition of HPC interaction with tumor niches may help maintain normal progenitor cell function in the setting of malignancy.	[Colmone, Angela; Amorim, Maria; Pontier, Andrea L.; Wang, Sheng; Jablonski, Elizabeth; Sipkins, Dorothy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Sipkins, DA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	dsipkins@medicine.bsd.uchicago.edu	de Amorim, Maria Galli/K-8259-2016; Colmone, Angela/GXA-0568-2022; wang, sheng/B-1969-2010	de Amorim, Maria Galli/0000-0002-1910-8770; 	Illinois Regenerative Medicine Institute; NIH K08 award [5K08CA112126-02]; NIH Director's DP2 award [1DP2OD002160-01]; NATIONAL CANCER INSTITUTE [K08CA112126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002160] Funding Source: NIH RePORTER	Illinois Regenerative Medicine Institute; NIH K08 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's DP2 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Chenn, K. Cohen, L. Godley, and R. Salgia for critical discussions and reading of the manuscript; A. Chenn for assistance with retroviral cell transduction; A. Wickrema for help with CD34+ purification; V. Bindokas for imaging expertise; and S. Gurbuxani for assistance with histopathology interpretation. Supported by a grant from the Illinois Regenerative Medicine Institute ( IRMI), an NIH ( National Cancer Institute) K08 award (5K08CA112126-02), and an NIH Director's DP2 award ( 1DP2OD002160-01). A patent application related to this work has been filed by the University of Chicago.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bellone G, 2006, INT J ONCOL, V29, P851; BENSINGER W, 1995, J CLIN ONCOL, V13, P2547, DOI 10.1200/JCO.1995.13.10.2547; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Giehl A, 2007, J CUTAN PATHOL, V34, P7, DOI 10.1111/j.1600-0560.2006.00569.x; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Naveiras O, 2006, CELL MOL LIFE SCI, V63, P760, DOI 10.1007/s00018-005-5469-5; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Okumura N, 1996, BLOOD, V87, P4100, DOI 10.1182/blood.V87.10.4100.bloodjournal87104100; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Sharma S, 2006, STEM CELLS DEV, V15, P755, DOI 10.1089/scd.2006.15.755; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Tao M, 2000, CYTOKINE, V12, P699, DOI 10.1006/cyto.2000.0666; Theou-Anton N, 2006, BRIT J CANCER, V94, P1180, DOI 10.1038/sj.bjc.6603063; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zheng R, 2004, LEUKEMIA RES, V28, P121, DOI 10.1016/S0145-2126(03)00184-X	26	446	473	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1861	1865		10.1126/science.1164390	http://dx.doi.org/10.1126/science.1164390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095944				2022-12-24	WOS:000261799400060
J	Koerich, LB; Wang, XY; Clark, AG; Carvalho, AB				Koerich, Leonardo B.; Wang, Xiaoyun; Clark, Andrew G.; Carvalho, Antonio Bernardo			Low conservation of gene content in the Drosophila Y chromosome	NATURE			English	Article							SEX-CHROMOSOME; MELANOGASTER; GENOME; EVOLUTION; SEQUENCE; DEGENERATION; ELEMENTS; REGION; SCALE	Chromosomal organization is sufficiently evolutionarily stable that large syntenic blocks of genes can be recognized even between species as distantly related as mammals and puffer fish ( 450 million years (Myr) of divergence)(1-7). In Diptera, the gene content of the X chromosome and the autosomes is well conserved: in Drosophila more than 95% of the genes have remained on the same chromosome arm in the 12 sequenced species ( 63 Myr of divergence, traversing 400 Myr of evolution) 2,4,6, and the same linkage groups are clearly recognizable in mosquito genomes (260 Myr of divergence)(3,5,7). Here we investigate the conservation of Y- linked gene content among the 12 sequenced Drosophila species. We found that only a quarter of the Drosophila melanogaster Y- linked genes ( 3 out of 12) are Y- linked in all sequenced species, and that most of them ( 7 out of 12) were acquired less than 63 Myr ago. Hence, whereas the organization of other Drosophila chromosomes traces back to the common ancestor with mosquitoes, the gene content of the D. melanogaster Y chromosome is much younger. Gene losses are known to have an important role in the evolution of Y chromosomes(8-10), and we indeed found two such cases. However, the rate of gene gain in the Drosophila Y chromosomes investigated is 10.9 times higher than the rate of gene loss ( 95% confidence interval: 2.3 - 52.5), indicating a clear tendency of the Y chromosomes to increase in gene content. In contrast with the mammalian Y chromosome, gene gains have a prominent role in the evolution of the Drosophila Y chromosome.	[Koerich, Leonardo B.; Carvalho, Antonio Bernardo] Univ Fed Rio de Janeiro, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; [Wang, Xiaoyun; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidade Federal do Rio de Janeiro; Cornell University	Carvalho, AB (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Caixa Postal 68011, BR-21944970 Rio De Janeiro, Brazil.	bernardo@biologia.ufrj.br	Carvalho, Antonio/D-5402-2013; Koerich, Leonardo/J-7004-2014; Koerich, Leonardo/B-8554-2008	Carvalho, Antonio/0000-0001-8959-6469; Koerich, Leonardo/0000-0002-5668-3934; Koerich, Leonardo/0000-0002-5668-3934; Clark, Andrew/0000-0001-7159-8511	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-CAPES; FAPERJ; FIC-NIH [TW007604-02]; NIH [GM64590]; FOGARTY INTERNATIONAL CENTER [R03TW007604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064590] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIC-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kumar, P. O'Grady, T. Markow, A. J. Bhutkar, S. C. Vaz, E. Betran, A. A. Peixoto, P. H. Krieger and P. Paiva for comments on the manuscript and/or for sharing their unpublished results. We also thank T. Pinhao, A. Bastos and F. Krsticevic for help with the experiments, K. Krishnamoorthy for statistical advice and M. Fetchko for help with GenBank submission. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior- CAPES, FAPERJ, FIC-NIH grant TW007604-02 (A.B.C.) and NIH grant GM64590 (A.G.C.).	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ASHBURNER M, 2005, DROSOPHILA LAB HDB, P607; Bachtrog D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r30; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Bhutkar A, 2007, GENOME RES, V17, P1880, DOI 10.1101/gr.7062307; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Carvalho AB, 2003, GENETICA, V117, P227, DOI 10.1023/A:1022900313650; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; CARVALHO AB, 2003, 44 ANN DROS RES C PH, P113; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; GEPNER J, 1993, P NATL ACAD SCI USA, V90, P11132, DOI 10.1073/pnas.90.23.11132; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; HACKSTEIN JHP, 1995, TRENDS GENET, V11, P195, DOI 10.1016/S0168-9525(00)89043-5; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; HURST LD, 1992, GENETICS, V130, P229; KENNISON JA, 1981, GENETICS, V98, P529; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Sturtevant AH, 1941, GENETICS, V26, P517; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Vibranovski MD, 2008, GENETICS, V179, P2325, DOI 10.1534/genetics.108.086819; YEATES DK, 2005, EVOLUTIONARY BIOL FL, P35; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	30	111	121	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					949	951		10.1038/nature07463	http://dx.doi.org/10.1038/nature07463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011613	Green Accepted			2022-12-24	WOS:000261768300045
J	Cotton, RGH; Auerbach, AD; Axton, M; Barash, CI; Berkovic, SF; Brookes, AJ; Burn, J; Cutting, G; den Dunnen, JT; Flicek, P; Freimer, N; Greenblatt, MS; Howard, HJ; Katz, M; Macrae, FA; Maglott, D; Moslein, G; Povey, S; Ramesar, RS; Richards, CS; Seminara, D; Smith, TD; Sobrido, MJ; Solbakk, JH; Tanzi, RE; Tavtigian, SV; Taylor, GR; Utsunomiya, J; Watson, M				Cotton, Richard G. H.; Auerbach, Arleen D.; Axton, Myles; Barash, Carol Isaacson; Berkovic, Samuel F.; Brookes, Anthony J.; Burn, John; Cutting, Garry; den Dunnen, Johan T.; Flicek, Paul; Freimer, Nelson; Greenblatt, Marc S.; Howard, Heather J.; Katz, Michael; Macrae, Finlay A.; Maglott, Donna; Moeslein, Gabriela; Povey, Sue; Ramesar, Rajkumar S.; Richards, Carolyn S.; Seminara, Daniela; Smith, Timothy D.; Sobrido, Maria-Jesus; Solbakk, Jan Helge; Tanzi, Rudolph E.; Tavtigian, Sean V.; Taylor, Graham R.; Utsunomiya, Joji; Watson, Michael			GENETICS The Human Variome Project	SCIENCE			English	Editorial Material									[Cotton, Richard G. H.; Howard, Heather J.; Smith, Timothy D.] Howard Florey Inst Expt Physiol & Med, Genom Disorders Res Ctr, Melbourne, Vic, Australia; [Berkovic, Samuel F.] Univ Melbourne, Austin Hlth W, Epilepsy Res Ctr, Heidelberg, Vic, Australia; [Freimer, Nelson] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Sobrido, Maria-Jesus] Fdn Publ Galega Med Xenomica, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus] Inst Hlth Carlos III, Ctr Network Biomed Res Rare Dis CIBERER, Madrid, Spain; [Tanzi, Rudolph E.] Harvard Univ, Sch Med, Charlestown, MA USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA	Florey Institute of Neuroscience & Mental Health; Austin Research Institute; University of Melbourne; University of California System; University of California Los Angeles; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Harvard University; Harvard University; Massachusetts General Hospital	Cotton, RGH (corresponding author), Howard Florey Inst Expt Physiol & Med, Genom Disorders Res Ctr, Melbourne, Vic, Australia.	cotton@unimelb.edu.au	Ramesar, Raj S/I-6941-2015; Axton, Myles/AAZ-4093-2020; jiang, yu/HGU-0029-2022; dunnen, johan den/ABH-4228-2020; Tanzi, Rudolph/AAE-9622-2019; Smith, Timothy/A-2873-2009	Ramesar, Raj S/0000-0001-5688-1634; Axton, Myles/0000-0002-8042-4131; dunnen, johan den/0000-0002-6304-1710; Tanzi, Rudolph/0000-0002-7032-1454; Flicek, Paul/0000-0002-3897-7955; Auerbach, Arleen/0000-0002-6911-8379; Burn, John/0000-0002-9823-2322; Smith, Timothy/0000-0001-9068-4642; Berkovic, Samuel/0000-0003-4580-841X	NIDDK NIH HHS [R37 DK044003-19, R37 DK044003] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2007, NAT GENET, V39, P423; Baraitser M, 2001, LONDON DYSMORPHOLOGY; COSTA T, 1985, AM J MED GENET, V21, P231, DOI 10.1002/ajmg.1320210205; Cotton RGH, 2007, NAT GENET, V39, P433, DOI 10.1038/ng2024; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Ring Huijun Z, 2006, Pharmacogenomics, V7, P969, DOI 10.2217/14622416.7.7.969	6	46	49	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					861	862		10.1126/science.1167363	http://dx.doi.org/10.1126/science.1167363			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988827	Green Accepted			2022-12-24	WOS:000260674100022
J	Zhao, J; Sun, BK; Erwin, JA; Song, JJ; Lee, JT				Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.			Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome	SCIENCE			English	Article							INACTIVE-X; XIST RNA; DOMAINS; RECRUITMENT; METHYLATION; TSIX	To equalize X- chromosome dosages between the sexes, the female mammal inactivates one of her two X chromosomes. X- chromosome inactivation ( XCI) is initiated by expression of Xist, a 17- kb noncoding RNA ( ncRNA) that accumulates on the X in cis. Because interacting factors have not been isolated, the mechanism by which Xist induces silencing remains unknown. We discovered a 1.6- kilobase ncRNA ( RepA) within Xist and identified the Polycomb complex, PRC2, as its direct target. PRC2 is initially recruited to the X by RepA RNA, with Ezh2 serving as the RNA binding subunit. The antisense Tsix RNA inhibits this interaction. RepA depletion abolishes full- length Xist induction and trimethylation on lysine 27 of histone H3 of the X. Likewise, PRC2 deficiency compromises Xist up- regulation. Therefore, RepA, together with PRC2, is required for the initiation and spread of XCI. We conclude that a ncRNA cofactor recruits Polycomb complexes to their target locus.	[Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02493 USA; [Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	lee@molbio.mgh.harvard.edu	Song, Ji-Joon/C-1721-2011	Sun, Bryan/0000-0002-0740-0125; Erwin, Jennifer/0000-0002-6784-9290	Massachusetts General Hospital Fund for Medical Discovery; NSF predoctoral award; Jane Coffin Childs Fellowship; NIH [R01GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839, R01GM110090] Funding Source: NIH RePORTER	Massachusetts General Hospital Fund for Medical Discovery; NSF predoctoral award(National Science Foundation (NSF)); Jane Coffin Childs Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Spencer and Y. Jeon for unpublished data and technical advice and Y. Ogawa for critical reading of the manuscript. Grant support: Massachusetts General Hospital Fund for Medical Discovery (J.Z.), NSF predoctoral award (J.A.E.), Jane Coffin Childs Fellowship (J.J.S.), and NIH- R01GM58839 (J.T.L.). J.T.L. is an Investigator of the HHMI. The transcript WRepAW for Repeat A has GenBank accession number FJ361197.	BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	19	1203	1290	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					750	756		10.1126/science.1163045	http://dx.doi.org/10.1126/science.1163045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974356	Green Accepted			2022-12-24	WOS:000260605200052
J	Phadnis, N; Orr, HA				Phadnis, Nitin; Orr, H. Allen			A Single Gene Causes Both Male Sterility and Segregation Distortion in Drosophila Hybrids	SCIENCE			English	Article							MEIOTIC-DRIVE; SEX-RATIO; UNISEXUAL STERILITY; PSEUDOOBSCURA; EVOLUTION; BOGOTA; INVIABILITY; EXPLANATION; DIVERGENCE; LOCUS	A central goal of evolutionary biology is to identify the genes and evolutionary forces that cause speciation, the emergence of reproductive isolation between populations. Despite the identification of several genes that cause hybrid sterility or inviability-many of which have evolved rapidly under positive Darwinian selection-little is known about the ecological or genomic forces that drive the evolution of postzygotic isolation. Here, we show that the same gene, Overdrive, causes both male sterility and segregation distortion in F-1 hybrids between the Bogota and U. S. subspecies of Drosophila pseudoobscura. This segregation distorter gene is essential for hybrid sterility, a strong reproductive barrier between these young taxa. Our results suggest that genetic conflict may be an important evolutionary force in speciation.	[Phadnis, Nitin; Orr, H. Allen] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Phadnis, N (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.	pdns@mail.rochester.edu			NIH [GM51932]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051932, R01GM051932] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Aquadro, J. Fry, R. Glor, H. Malik, D. Presgraves, Y. Tao, and the Orr lab for discussions; D. Lambert for advice on molecular techniques; H. Malik and N. Elde for help with PAML; and S. Schaeffer for fly stocks. Financial support was provided by NIH (GM51932). All sequences are available at GenBank (accession numbers FJ349335 to FJ349342 and FJ418600 to FJ418631). The authors declare no conflict of interest.	Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; CHARLESWORTH B, 1993, GENETICS, V133, P421; COYNE JA, 1993, EVOLUTION, V47, P685, DOI 10.1111/j.1558-5646.1993.tb02123.x; Coyne JA, 2004, SPECIATION, V37; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hall DW, 2004, EVOLUTION, V58, P925; HARTL DL, 1975, THEOR POPUL BIOL, V7, P168, DOI 10.1016/0040-5809(75)90012-X; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; HURST LD, 1991, GENETICS, V128, P841; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Montchamp-Moreau C, 2006, GENETICS, V174, P1365, DOI 10.1534/genetics.105.051755; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Orr HA, 2001, GENETICS, V158, P1089; PRAKASH S, 1972, GENETICS, V72, P143; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; SCHAEFFER SW, 1991, P NATL ACAD SCI USA, V88, P6097, DOI 10.1073/pnas.88.14.6097; TAJIMA F, 1989, GENETICS, V123, P585; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; WITTBRODT J, 1992, EMBO J, V11, P4239, DOI 10.1002/j.1460-2075.1992.tb05518.x	27	246	251	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					376	379		10.1126/science.1163934	http://dx.doi.org/10.1126/science.1163934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074311	Green Accepted			2022-12-24	WOS:000262481400037
J	Weavers, H; Prieto-Sanchez, S; Grawe, F; Garcia-Lopez, A; Artero, R; Wilsch-Brauninger, M; Ruiz-Gomez, M; Skaer, H; Denholm, B				Weavers, Helen; Prieto-Sanchez, Silvia; Grawe, Ferdinand; Garcia-Lopez, Amparo; Artero, Ruben; Wilsch-Braeuninger, Michaela; Ruiz-Gomez, Mar; Skaer, Helen; Denholm, Barry			The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm	NATURE			English	Article							CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; NEPHRIN; DROSOPHILA; ORIGIN; CD2AP; BINDS	The nephron is the basic structural and functional unit of the vertebrate kidney. It is composed of a glomerulus, the site of ultrafiltration, and a renal tubule, along which the filtrate is modified. Although widely regarded as a vertebrate adaptation(1), 'nephronlike' features can be found in the excretory systems of many invertebrates, raising the possibility that components of the vertebrate excretory system were inherited from their invertebrate ancestors(2). Here we show that the insect nephrocyte has remarkable anatomical, molecular and functional similarity to the glomerular podocyte, a cell in the vertebrate kidney that forms the main size-selective barrier as blood is ultrafiltered to make urine. In particular, both cell types possess a specialized filtration diaphragm, known as the slit diaphragm in podocytes or the nephrocyte diaphragm in nephrocytes. We find that fly ( Drosophila melanogaster) orthologues of the major constituents of the slit diaphragm, including nephrin, NEPH1 ( also known as KIRREL), CD2AP, ZO-1 (TJP1) and podocin, are expressed in the nephrocyte and form a complex of interacting proteins that closely mirrors the vertebrate slit diaphragm complex. Furthermore, we find that the nephrocyte diaphragm is completely lost in flies lacking the orthologues of nephrin or NEPH1 - a phenotype resembling loss of the slit diaphragm in the absence of either nephrin ( as in human congenital nephrotic syndrome of the Finnish type, NPHS1) or NEPH1. These changes markedly impair filtration function in the nephrocyte. The similarities we describe between invertebrate nephrocytes and vertebrate podocytes provide evidence suggesting that the two cell types are evolutionarily related, and establish the nephrocyte as a simple model in which to study podocyte biology and podocyte- associated diseases.	[Weavers, Helen; Skaer, Helen; Denholm, Barry] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Prieto-Sanchez, Silvia; Ruiz-Gomez, Mar] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Grawe, Ferdinand] Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany; [Garcia-Lopez, Amparo; Artero, Ruben] Univ Valencia, Dept Genet, E-46100 Valencia, Spain; [Wilsch-Braeuninger, Michaela] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Cambridge; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Heinrich Heine University Dusseldorf; University of Valencia; Max Planck Society	Skaer, H (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	hs17@cam.ac.uk	Artero, Ruben/K-6815-2014; Weavers, Helen/AGX-6323-2022; Ruiz-Gómez, Mar/K-9266-2014	Artero, Ruben/0000-0003-1596-047X; Ruiz-Gómez, Mar/0000-0002-9024-1400; Grawe, Ferdi/0000-0001-6448-4989; Weavers, Helen/0000-0002-5383-6085; Prieto Sanchez, Silvia/0000-0001-7950-8162	Wellcome Trust [072441, 079221]; Deutsche Forschungsgemeinschaft SFB 590 [SFB 590]; ARC [1242]; MEC [BFU2007-62201]; Fundacion Ramon Areces; CBMSO; EC [LSHG-CT-2004-511978]; FPU	Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft SFB 590(German Research Foundation (DFG)); ARC(Australian Research Council); MEC(European Commission); Fundacion Ramon Areces; CBMSO; EC(European CommissionEuropean Commission Joint Research Centre); FPU(Spanish Government)	We thank F. Evers, Z. Cseresnyes, M. Guerra and E. Salvador for technical assistance, and S. Abmayr, L. Cooley, C. Doe, M. Affolter, K. Fischbach and K. Tryggvason for reagents. We thank V. Hartenstein, M. Inamdar, A. Woolf, I. Miguel- Aliaga, F. Evers, M. Landgraf and members of the Skaer laboratory for discussions, and E. Knust and W. B. Huttner for their support. This work was supported by Wellcome Trust grants awarded to H.S. (072441 and 079221; H.W., B.D. and H.S.); Deutsche Forschungsgemeinschaft SFB 590 awarded to E. Knust (F.G.) and ARC 1242 (H.W., B.D., H.S. and F.G.); an MEC grant awarded to M.R.-G. (BFU2007-62201; S.P.-S. and M.R.-G.); a Fundacion Ramon Areces grant to the CBMSO (M.R.-G.); EC grant LSHG-CT-2004-511978 to MYORES (M.R.-G.); and an FPU fellowship from the MEC awarded to A.G.-L.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BERRIDGE MJ, 1972, TRANSPORTING EPITHEL, P11; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Crossley A.C., 1985, P487; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; KOWALEVSKY A, 1889, BIOL CENTRALBL, V9, P74; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Locke M, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P687; Nagel AC, 2002, DEV GENES EVOL, V212, P93, DOI 10.1007/s00427-002-0210-y; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; RUPPERT EE, 1994, AM ZOOL, V34, P542; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smith H. W., 1953, FISH PHILOS; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562	32	209	213	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					322	U5		10.1038/nature07526	http://dx.doi.org/10.1038/nature07526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	18971929	Green Accepted, Green Submitted			2022-12-24	WOS:000262440900041
J	Lyssenko, V; Jonsson, A; Almgren, P; Pulizzi, N; Isomaa, B; Tuomi, T; Berglund, G; Altshuler, D; Nilsson, P; Groop, L				Lyssenko, Valeriya; Jonsson, Anna; Almgren, Peter; Pulizzi, Nicolo; Isomaa, Bo; Tuomi, Tiinamaija; Berglund, Goran; Altshuler, David; Nilsson, Peter; Groop, Leif			Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN SENSITIVITY; LOCI; PREDICTION; MELLITUS; GENE; REPLICATION; SECRETION; INDEXES	Background: Type 2 diabetes mellitus is thought to develop from an interaction between environmental and genetic factors. We examined whether clinical or genetic factors or both could predict progression to diabetes in two prospective cohorts. Methods: We genotyped 16 single-nucleotide polymorphisms (SNPs) and examined clinical factors in 16,061 Swedish and 2770 Finnish subjects. Type 2 diabetes developed in 2201 (11.7%) of these subjects during a median follow-up period of 23.5 years. We also studied the effect of genetic variants on changes in insulin secretion and action over time. Results: Strong predictors of diabetes were a family history of the disease, an increased body-mass index, elevated liver-enzyme levels, current smoking status, and reduced measures of insulin secretion and action. Variants in 11 genes (TCF7L2, PPARG, FTO, KCNJ11, NOTCH2, WFS1, CDKAL1, IGF2BP2, SLC30A8, JAZF1, and HHEX) were significantly associated with the risk of type 2 diabetes independently of clinical risk factors; variants in 8 of these genes were associated with impaired beta-cell function. The addition of specific genetic information to clinical factors slightly improved the prediction of future diabetes, with a slight increase in the area under the receiver-operating-characteristic curve from 0.74 to 0.75; however, the magnitude of the increase was significant (P=1.0 x 10(-4)). The discriminative power of genetic risk factors improved with an increasing duration of follow-up, whereas that of clinical risk factors decreased. Conclusions: As compared with clinical risk factors alone, common genetic variants associated with the risk of diabetes had a small effect on the ability to predict the future development of type 2 diabetes. The value of genetic factors increased with an increasing duration of follow-up.	[Lyssenko, Valeriya; Jonsson, Anna; Almgren, Peter; Berglund, Goran; Nilsson, Peter; Groop, Leif] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pulizzi, Nicolo] Univ Pisa, Pisa, Italy; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Boston, MA 02114 USA	Lund University; University of Pisa; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Lyssenko, V (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, CRC, S-20502 Malmo, Sweden.	valeri.lyssenko@med.lu.se		Jonsson, Anna/0000-0003-1252-8673; Altshuler, David/0000-0002-7250-4107; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tuomi, Tiinamaija/0000-0002-8306-6202	Swedish Research Council; Linne [31475113580]; Heart and Lung Foundation; Swedish Diabetes Research Society; Nordic Center of Excellence Grant in Disease Genetics; Diabetes Program at the Lund University; Finnish Diabetes Research Society; Sigrid Juselius Foundation; Pahlsson Foundation; Crafoord Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation; European Network of Genomic and Genetic Epidemiology; Wallenberg Foundation; European Foundation for the Study of Diabetes; Tethys; Merck; Eisai; MPM Capital; Novartis; Bristol-Myers Squibb Foundation; Eli Lilly; GlaxoSmithKline; Aventis; Sanofi	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linne; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Research Society; Nordic Center of Excellence Grant in Disease Genetics; Diabetes Program at the Lund University; Finnish Diabetes Research Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pahlsson Foundation; Crafoord Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Network of Genomic and Genetic Epidemiology; Wallenberg Foundation(European Commission); European Foundation for the Study of Diabetes; Tethys; Merck(Merck & Company); Eisai(Eisai Co Ltd); MPM Capital; Novartis(Novartis); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Aventis(Sanofi-Aventis); Sanofi	Supported by grants from the Swedish Research Council (including Linne grant 31475113580), the Heart and Lung Foundation, the Swedish Diabetes Research Society, a Nordic Center of Excellence Grant in Disease Genetics, the Diabetes Program at the Lund University, the Finnish Diabetes Research Society, the Sigrid Juselius Foundation, the Pahlsson Foundation, the Crafoord Foundation, the Folkhalsan Research Foundation, the Novo Nordisk Foundation, the European Network of Genomic and Genetic Epidemiology, the Wallenberg Foundation, and the European Foundation for the Study of Diabetes. Dr. Lyssenko reports receiving consulting fees from Tethys; Dr. Altshuler, receiving consulting fees from Merck, Eisai, and MPM Capital and grant support from Novartis, receiving an unrestricted grant from the Bristol-Myers Squibb Foundation, and having an equity interest in MPM Capital; and Dr. Groop, receiving consulting fees from Tethys, Eli Lilly, GlaxoSmithKline, Aventis, and Sanofi, lecture fees from Aventis and Sanofi, and grant support from Novartis. No other potential conflict of interest relevant to this article was reported. We thank the patients for their participation and Anna Berglund, Margareta Svensson, and Malin Neptin for their excellent technical assistance.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cohen J., 2003, APPL MULTIPLE REGRES; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; HEDING LG, 1966, LABELLED PROTEINS TR, P345; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLEINTHORSDOTTI.VV, 2007, NAT GENET, V39, P770; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; TANG K, 1995, NUCLEIC ACIDS RES, V23, P3126, DOI 10.1093/nar/23.16.3126; Tirosh A, 2006, NEW ENGL J MED, V354, P2401; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	630	661	0	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2220	2232		10.1056/NEJMoa0801869	http://dx.doi.org/10.1056/NEJMoa0801869			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020324	Bronze			2022-12-24	WOS:000260994000005
J	Meigs, JB; Shrader, P; Sullivan, LM; McAteer, JB; Fox, CS; Dupuis, J; Manning, AK; Florez, JC; Wilson, PWF; D'Agostino, RB; Cupples, LA				Meigs, James B.; Shrader, Peter; Sullivan, Lisa M.; McAteer, Jarred B.; Fox, Caroline S.; Dupuis, Josee; Manning, Alisa K.; Florez, Jose C.; Wilson, Peter W. F.; D'Agostino, Ralph B., Sr.; Cupples, L. Adrienne			Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOSE-TOLERANCE; LIFE-STYLE; LOCI; POLYMORPHISMS; MELLITUS; DISEASE; REPLICATION; FAMILIES; CURVE	Background: Multiple genetic loci have been convincingly associated with the risk of type 2 diabetes mellitus. We tested the hypothesis that knowledge of these loci allows better prediction of risk than knowledge of common phenotypic risk factors alone. Methods: We genotyped single-nucleotide polymorphisms (SNPs) at 18 loci associated with diabetes in 2377 participants of the Framingham Offspring Study. We created a genotype score from the number of risk alleles and used logistic regression to generate C statistics indicating the extent to which the genotype score can discriminate the risk of diabetes when used alone and in addition to clinical risk factors. Results: There were 255 new cases of diabetes during 28 years of follow-up. The mean (+/-SD) genotype score was 17.7+/-2.7 among subjects in whom diabetes developed and 17.1+/-2.6 among those in whom diabetes did not develop (P<0.001). The sex-adjusted odds ratio for diabetes was 1.12 per risk allele (95% confidence interval, 1.07 to 1.17). The C statistic was 0.534 without the genotype score and 0.581 with the score (P=>0.01). In a model adjusted for sex and self-reported family history of diabetes, the C statistic was 0.595 without the genotype score and 0.615 with the score (P=0.11). In a model adjusted for age, sex, family history, body-mass index, fasting glucose level, systolic blood pressure, high-density lipoprotein cholesterol level, and triglyceride level, the C statistic was 0.900 without the genotype score and 0.901 with the score (P=0.49). The genotype score resulted in the appropriate risk reclassification of, at most, 4% of the subjects. Conclusions: A genotype score based on 18 risk alleles predicted new cases of diabetes in the community but provided only a slightly better prediction of risk than knowledge of common risk factors alone.	[Meigs, James B.; Shrader, Peter] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Meigs, James B.; Shrader, Peter; Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McAteer, Jarred B.; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [McAteer, Jarred B.; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Dept Med, Boston, MA 02114 USA; [Sullivan, Lisa M.; Dupuis, Josee; Manning, Alisa K.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [McAteer, Jarred B.; Florez, Jose C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA; [Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Emory Program Cardiovasc Outcomes Res & Epidemiol, Atlanta, GA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University; Boston University	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Fl, Boston, MA 02114 USA.	jmeigs@partners.org	Wilson, Peter W.F./J-2455-2016; Manning, Alisa Knodle/ABC-7711-2021; Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657; Dupuis, Josee/0000-0003-2871-3603; Sullivan, Lisa/0000-0003-0726-7149; Cupples, L. Adrienne/0000-0003-0273-7965	National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; National Institute for Diabetes and Digestive and Kidney Diseases [R01 DK078616, K24 DK080140, K23 DK65978]; Boston University Linux Cluster for Genetic Analysis; National Institutes of Health National Center for Research Resources Shared Instrumentation [1S10RR163736-01A1]; Sanofi-Aventis; GlaxoSmithKline; Merck; Publicis Healthcare Communications Group; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078616, K24DK080140, K23DK065978] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston University Linux Cluster for Genetic Analysis; National Institutes of Health National Center for Research Resources Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Publicis Healthcare Communications Group; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a contract from the National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195), grants from the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) (R01 DK078616 and K24 DK080140, to Dr. Meigs), an NIDDK Research Career Award (K23 DK65978, to Dr. Florez), and the Boston University Linux Cluster for Genetic Analysis, funded by a grant from the National Institutes of Health National Center for Research Resources Shared Instrumentation (1S10RR163736-01A1). Dr. Meigs reports serving on a consultancy board for Interleukin Genetics and receiving grants from Sanofi-Aventis and GlaxoSmithKline; and Dr. Florez, receiving consulting fees from Merck and Publicis Healthcare Communications Group, a global advertising agency engaged by Amylin Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Janssens ACJW, 2006, PLOS MED, V3, P270, DOI 10.1371/journal.pmed.0030114; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; LANGO H, 2008, DIABETES        0630; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Li J, 2007, ARCH INTERN MED, V167, P2528, DOI 10.1001/archinte.167.22.2528-c; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Meigs JB, 2005, J CLIN ENDOCR METAB, V90, P1137, DOI 10.1210/jc.2004-1212; Meigs JB, 1998, ANN INTERN MED, V128, P524, DOI 10.7326/0003-4819-128-7-199804010-00002; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Weijnen CF, 2002, DIABETIC MED, V19, P41, DOI 10.1046/j.1464-5491.2002.00624.x; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zeggini E, 2007, SCIENCE, V317, P1036; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	551	571	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2208	2219		10.1056/NEJMoa0804742	http://dx.doi.org/10.1056/NEJMoa0804742			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020323	Green Accepted			2022-12-24	WOS:000260994000004
J	Hildner, K; Edelson, BT; Purtha, WE; Diamond, M; Matsushita, H; Kohyama, M; Calderon, B; Schraml, BU; Unanue, ER; Diamond, MS; Schreiber, RD; Murphy, TL; Murphy, KM				Hildner, Kai; Edelson, Brian T.; Purtha, Whitney E.; Diamond, Mark; Matsushita, Hirokazu; Kohyama, Masako; Calderon, Boris; Schraml, Barbara U.; Unanue, Emil R.; Diamond, Michael S.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.			Batf3 Deficiency Reveals a Critical Role for CD8 alpha(+) Dendritic Cells in Cytotoxic T Cell Immunity	SCIENCE			English	Article							IN-VIVO DEPLETION; CROSS-PRESENTATION; CUTTING EDGE; CD8(+); ANTIGENS; VIRUS; INFECTION; SUBSETS; POPULATION; EXPRESSION	Although in vitro observations suggest that cross- presentation of antigens is mediated primarily by CD8 alpha(+) dendritic cells, in vivo analysis has been hampered by the lack of systems that selectively eliminate this cell lineage. We show that deletion of the transcription factor Batf3 ablated development of CD8 alpha(+) dendritic cells, allowing us to examine their role in immunity in vivo. Dendritic cells from Batf3(-/-) mice were defective in cross- presentation, and Batf3(-/-) mice lacked virus- specific CD8(+) T cell responses to West Nile virus. Importantly, rejection of highly immunogenic syngeneic tumors was impaired in Batf3(-/-) mice. These results suggest an important role for CD8 alpha(+) dendritic cells and cross- presentation in responses to viruses and in tumor rejection.	[Hildner, Kai; Edelson, Brian T.; Diamond, Mark; Matsushita, Hirokazu; Kohyama, Masako; Calderon, Boris; Schraml, Barbara U.; Unanue, Emil R.; Diamond, Michael S.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hildner, Kai; Kohyama, Masako; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Purtha, Whitney E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Purtha, Whitney E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Diamond, Michael/AAH-1733-2019; Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Diamond, Michael/0000-0002-8791-3165; Schreiber, Robert D/0000-0001-6311-0432; Schraml, Barbara/0000-0002-5801-0151; Calderon, Boris/0000-0003-1575-0739; Edelson, Brian/0000-0003-2856-7650; Schreiber, Robert/0000-0003-1590-2341	Howard Hughes Medical Institute; Emmy Noether Program of the German Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Emmy Noether Program of the German Research Foundation(German Research Foundation (DFG)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	This work was supported by the Howard Hughes Medical Institute (K.M.M.), the Emmy Noether Program of the German Research Foundation (K.H.), and a Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.).	Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wolkers MC, 2001, J IMMUNOL, V167, P3577, DOI 10.4049/jimmunol.167.7.3577; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	29	1305	1343	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1097	1100		10.1126/science.1164206	http://dx.doi.org/10.1126/science.1164206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008445	Green Accepted			2022-12-24	WOS:000260867700036
J	Grace, C; Begum, R; Subhani, S; Kopelman, P; Greenhalgh, T				Grace, Clare; Begum, Reha; Subhani, Syed; Kopelman, Peter; Greenhalgh, Trisha			Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SELF-DETERMINATION THEORY; HEALTH LITERACY; LIFE-STYLE; DISEASE; ADHERENCE; KNOWLEDGE; RISK; INTERVENTION; POPULATION; PAKISTANI	Objective To understand lay beliefs and attitudes, religious teachings, and professional perceptions in relation to diabetes prevention in the Bangladeshi community. Design Qualitative study ( focus groups and semistructured interviews). Setting Tower Hamlets, a socioeconomically deprived London borough, United Kingdom. Participants Bangladeshi people without diabetes ( phase 1), religious leaders and Islamic scholars ( phase 2), and health professionals ( phase 3). Methods 17 focus groups were run using purposive sampling in three sequential phases. Thematic analysis was used iteratively to achieve progressive focusing and to develop theory. To explore tensions in preliminary data fictional vignettes were created, which were discussed by participants in subsequent phases. The PEN- 3 multilevel theoretical framework was used to inform data analysis and synthesis. Results Most lay participants accepted the concept of diabetes prevention and were more knowledgeable than expected. Practical and structural barriers to a healthy lifestyle were commonly reported. There was a strong desire to comply with cultural norms, particularly those relating to modesty. Religious leaders provided considerable support from Islamic teachings for messages about diabetes prevention. Some clinicians incorrectly perceived Bangladeshis to be poorly informed and fatalistic, although they also expressed concerns about their own limited cultural understanding. Conclusion Contrary to the views of health professionals and earlier research, poor knowledge was not the main barrier to healthy lifestyle choices. The norms and expectations of Islam offer many opportunities for supporting diabetes prevention. Interventions designed for the white population, however, need adaptation before they will be meaningful to many Bangladeshis. Religion may have an important part to play in supporting health promotion in this community. The potential for collaborative working between health educators and religious leaders should be explored further and the low cultural understanding of health professionals addressed.	[Grace, Clare] Queen Mary Univ London, Barts & London Sch Med, London E1 2AT, England; [Kopelman, Peter] Univ London St Georges Hosp, London, England; [Greenhalgh, Trisha] Univ London, Dept Primary Care & Populat Sci, London WC1E 7HU, England	University of London; Queen Mary University London; St Georges University London; University of London; University College London	Grace, C (corresponding author), Queen Mary Univ London, Barts & London Sch Med, London E1 2AT, England.	c.m.grace@qmul.ac.uk	Greiver, Michelle/N-8764-2015; Greenhalgh, Trisha/B-1825-2015	Greiver, Michelle/0000-0001-8957-0285; Greenhalgh, Trisha/0000-0003-2369-8088	Diabetes UK [BDA: RD04/0002780]	Diabetes UK(Diabetes UK)	This work was supported by Diabetes UK grant number BDA: RD04/0002780.	Airhihenbuwa C. O., 1995, HLTH CULTURE W PARAD; Ajzen I., 1980, ACTION CONTROL, DOI DOI 10.1007/978-3-642-69746-3_2; Boutin-Foster Carla, 2005, Health Qual Life Outcomes, V3, P52, DOI 10.1186/1477-7525-3-52; Bush H, 1998, SOCIOL HEALTH ILL, V20, P351, DOI 10.1111/1467-9566.00106; Chowdhury TA, 2003, BRIT MED J, V327, P1059, DOI 10.1136/bmj.327.7423.1059; *CLIN EFF GROUP, 2004, CLIN EFF ANN REP 200; Cote J., 2002, IDENTITY FORMATION; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Dhawan J, 1997, HEART, V78, P550, DOI 10.1136/hrt.78.6.550; *DIR PUBL HLTH TOW, 2007, TOW HAML PUBL HLTH R; Eade John, 1997, LIVING GLOBAL CITY G, P127; ERENS B, 2001, HLTH SURVEY ENGLAND; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Freebody P., 1990, PROSPECT AUSTR J TES, V5, P716; GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377; Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; HAWTHORNE K, 1990, BRIT J GEN PRACT, V40, P243; Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Hiller, 1996, RES CULTURAL DIFFERE, P220; Johnson M, 2000, BLACK MINORITY ETHNI; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawton J, 2007, SOCIOL HEALTH ILL, V29, P891, DOI 10.1111/j.1467-9566.2007.01036.x; LEVINE J, 1987, PSYCHOSOM MED, V49, P109, DOI 10.1097/00006842-198703000-00001; MAYCUT P, 1994, BEGINNING QUALITATIV; MIRZA M, 2007, LIVING APART TOGETHE, P53; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; *OFF NAT STAT, 2002, 1 RES POP ENGL WAL 2; PHILLIPSON C, 2003, WOMEN TRANSITION; Rankin J, 2001, PUBLIC HEALTH, V115, P253; REVENSON TA, 1991, SOC SCI MED, V33, P807, DOI 10.1016/0277-9536(91)90385-P; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179; Sher TG, 2002, HEALTH EDUC RES, V17, P597, DOI 10.1093/her/17.5.597; Sherman AM, 2000, CONTROL CLIN TRIALS, V21, p206S, DOI 10.1016/S0197-2456(00)00080-5; SIMMONS D, 1991, DIABETIC MED, V8, P651, DOI 10.1111/j.1464-5491.1991.tb01672.x; SPROTSON K, 2006, HLTH SURVEY ENGLAND; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WHITE M, 1998, EFFECTIVENESS INTERV; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; WILLIAMS R, 1994, INT J EPIDEMIOL, V23, P28, DOI 10.1093/ije/23.1.28; WINTER R, 1986, CAMB J EDUC, V3, P175; [No title captured]	45	77	77	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2008	337								a1931	10.1136/bmj.a1931	http://dx.doi.org/10.1136/bmj.a1931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	377FA	18984633	Green Accepted, hybrid, Green Published, Green Submitted			2022-12-24	WOS:000261235900001
J	Heuer, D; Lipinski, AR; Machuy, N; Karlas, A; Wehrens, A; Siedler, F; Brinkmann, V; Meyer, TF				Heuer, Dagmar; Lipinski, Anette Rejman; Machuy, Nikolaus; Karlas, Alexander; Wehrens, Andrea; Siedler, Frank; Brinkmann, Volker; Meyer, Thomas F.			Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction	NATURE			English	Article							HOST-CELL; ENDOPLASMIC-RETICULUM; TRACHOMATIS INCLUSION; APOPTOSIS; APPARATUS; SPHINGOLIPIDS; INHERITANCE; INHIBITION; PNEUMONIAE; ACTIVATION	The obligate intracellular bacterium Chlamydia trachomatis survives and replicates within a membrane- bound vacuole, termed the inclusion, which intercepts host exocytic pathways to obtain nutrients(1-3). Like many other intracellular pathogens, C. trachomatis has a marked requirement for host cell lipids, such as sphingolipids and cholesterol, produced in the endoplasmic reticulum and the Golgi apparatus(4-6). However, the mechanisms by which intracellular pathogens acquire host cell lipids are not well understood(1-3). In particular, no host cell protein responsible for transporting Golgi-derived lipids to the chlamydial inclusions has yet been identified. Here we show that Chlamydia infection in human epithelial cells induces Golgi fragmentation to generate Golgi ministacks surrounding the bacterial inclusion. Ministack formation is triggered by the proteolytic cleavage of the Golgimatrix protein golgin-84. Inhibition of golgin-84 truncation prevents Golgi fragmentation, causing a block in lipid acquisition and maturation of C. trachomatis. Golgi fragmentation by means of RNA- interference- mediated knockdown of distinct Golgi matrix proteins before infection enhances bacterial maturation. Our data functionally connect bacteria- induced golgin-84 cleavage, Golgi ministack formation, lipid acquisition and intracellular pathogen growth. We show that C. trachomatis subverts the structure and function of an entire host cell organelle for its own advantage.	[Heuer, Dagmar; Lipinski, Anette Rejman; Machuy, Nikolaus; Karlas, Alexander; Wehrens, Andrea; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Brinkmann, Volker] Max Planck Inst Infect Biol, Microscopy Core Facil, D-10117 Berlin, Germany; [Siedler, Frank] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Meyer, Thomas F. F/J-2485-2013	Meyer, Thomas F. F/0000-0002-6120-8679; Karlas, Alexander/0000-0002-2187-2057	Senate of Berlin; BMBF	Senate of Berlin; BMBF(Federal Ministry of Education & Research (BMBF))	The authors would like to thank A. Greiser, C. Goosmann, B. Laube, M. Wicht and E. Ziska for technical support; M.A. De Matteis for the gift of the GFP-GM130 fusion plasmid; H. P. Hauri for the provision of the anti-GPP130 antibody and helpful discussions; and K. Astrahantseff, S. and J. Heuer, T. Wolff and L. Ogilvie for critically reading the manuscript and helpful suggestions. This work was financially supported by the Senate of Berlin and the BMBF through the RiNA Network.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heuer D, 2003, CELL MICROBIOL, V5, P315, DOI 10.1046/j.1462-5822.2003.00278.x; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997	25	205	217	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					731	U8		10.1038/nature07578	http://dx.doi.org/10.1038/nature07578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19060882				2022-12-24	WOS:000263064700043
J	Hitomi, JI; Christofferson, DE; Ng, A; Yao, JH; Degterev, A; Xavier, RJ; Yuan, JY				Hitomi, Junichi; Christofferson, Dana E.; Ng, Aylwin; Yao, Jianhua; Degterev, Alexei; Xavier, Ramnik J.; Yuan, Junying			Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NEGATIVE REGULATOR; L929 CELLS; APOPTOSIS; PROTEIN; DATABASE; DOMAIN; RIP1; CYLD	Stimulation of death receptors by agonists such as FasL and TNF alpha activates apoptotic cell death in apoptotic-competent conditions or a type of necrotic cell death dependent on RIP1 kinase, termed necroptosis, in apoptotic-deficient conditions. In a genomewide siRNA screen for regulators of necroptosis, we identify a set of 432 genes that regulate necroptosis, a subset of 32 genes that act downstream and/or as regulators of RIP1 kinase, 32 genes required for death-receptor-mediated apoptosis, and 7 genes involved in both necroptosis and apoptosis. We show that the expression of subsets of the 432 genes is enriched in the immune and nervous systems, and cellular sensitivity to necroptosis is regulated by an extensive signaling network mediating innate immunity. Interestingly, Bmf, a BH3-only Bcl-2 family member, is required for death-receptor-induced necroptosis. Our study defines a cellular signaling network that regulates necroptosis and the molecular bifurcation that controls apoptosis and necroptosis.	[Hitomi, Junichi; Christofferson, Dana E.; Yao, Jianhua; Degterev, Alexei; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Ng, Aylwin/AAQ-6478-2020		National Institute of Health [DP1OD000580]; National Institute on Aging [R37 AG012859-14]; National Institute on Neurological Disorders and Stroke [U01NS050560]; NIH Director's Pioneer Award; National Institute of Allergy and Infectious Diseases [AI062773, DK43351]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Japan Society for Promotion of Science; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS050560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012859, R37AG012859] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dodzie Sogah, Marta Lipinski, and Caroline Yi for helpful comments on this manuscript. We are grateful for the support of Caroline Shamu, Stewart Rudnicki, Sean Johnston, and David Wrobel at the ICCB Longwood Facility during screening. We thank S. C. Sun (University of Texas, M. D. Anderson Cancer Center) and J. Blenis (Harvard Medical School) for CYLD antibody and FADD def Jurkat cells, respectively. This work was supported in part by grants from the National Institute of Health (DP1OD000580), the National Institute on Aging (R37 AG012859-14), the National Institute on Neurological Disorders and Stroke (U01NS050560), NIH Director's Pioneer Award (to J.Y.), and the National Institute of Allergy and Infectious Diseases (AI062773) and DK43351 (to R. J. X.). J. H. was supported in part by fellowships from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Uehara Memorial Foundation, and the Japan Society for Promotion of Science. A.N. is a recipient of a Fellowship Award from the Crohn's and Colitis Foundation of America.	Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Fiers W., 1995, Journal of Inflammation, V47, P67; Fukushima K, 2004, ARCH BIOCHEM BIOPHYS, V426, P298, DOI 10.1016/j.abb.2004.02.028; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Holmes SE, 2001, NAT GENET, V29, P377, DOI 10.1038/ng760; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim JW, 2000, J CELL SCI, V113, P955; Kurth I, 2006, BIOCHEM J, V393, P277, DOI 10.1042/BJ20051094; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Simonson SJS, 2007, DEV CELL, V13, P601, DOI 10.1016/j.devcel.2007.10.009; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	49	744	783	5	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1311	1323		10.1016/j.cell.2008.10.044	http://dx.doi.org/10.1016/j.cell.2008.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109899	Green Accepted, Bronze			2022-12-24	WOS:000261989800021
J	Ogden, SK; Fei, DL; Schilling, NS; Ahmed, YF; Hwa, J; Robbins, DJ				Ogden, Stacey K.; Fei, Dennis Liang; Schilling, Neal S.; Ahmed, Yashi F.; Hwa, John; Robbins, David J.			G protein G alpha(i) functions immediately downstream of Smoothened in Hedgehog signalling	NATURE			English	Article							HETEROTRIMERIC G-PROTEINS; CUBITUS INTERRUPTUS; DROSOPHILA; EXPRESSION; KINESIN; COMPLEX; TRANSDUCTION; REPRESSOR; ACTIVATOR; RECEPTOR	The hedgehog (Hh) signalling pathway has an evolutionarily conserved role in patterning fields of cells during metazoan development, and is inappropriately activated in cancer(1,2). Hh pathway activity is absolutely dependent on signalling by the seven-transmembrane protein smoothened (Smo), which is regulated by the Hh receptor patched (Ptc). Smo signals to an intracellular multi- protein complex containing the Kinesin related protein Costal2 ( Cos2), the protein kinase Fused ( Fu) and the transcription factor Cubitus interruptus (Ci)(3). In the absence of Hh, this complex regulates the cleavage of full-length Ci to a truncated repressor protein, Ci(75), in a process that is dependent on the proteasome and priming phosphorylations by Protein kinase A (PKA)(4). Binding of Hh to Ptc blocks Ptc-mediated Smo inhibition, allowing Smo to signal to the intracellular components to attenuate Ci cleavage. Because of its homology with the Frizzled family of G-protein-coupled receptors ( GPCR) 5, a likely candidate for an immediate Smo effector would be a heterotrimeric G protein. However, the role that G proteins may have in Hh signal transduction is unclear and quite controversial(6-10), which has led to widespread speculation that Smo signals through a variety of novel G-protein-independent mechanisms. Here we present in vitro and in vivo evidence in Drosophila that Smo activates a G protein to modulate intracellular cyclic AMP levels in response to Hh. Our results demonstrate that Smo functions as a canonical GPCR, which signals through G alpha(i) to regulate Hh pathway activation.	[Ogden, Stacey K.; Fei, Dennis Liang; Schilling, Neal S.; Hwa, John; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Ahmed, Yashi F.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Hwa, John] Dartmouth Med Sch, Dept Med Cardiol, Hanover, NH 03755 USA; [Ahmed, Yashi F.; Robbins, David J.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	david.j.robbins@dartmouth.edu	Ogden, Stacey K/N-2528-2018; Ogden, Stacey K/P-9585-2019	Ogden, Stacey K/0000-0001-8991-3065; Fei, Dennis Liang/0000-0002-1953-0584	National Institutes of Health [CA82628, HL074190]; NATIONAL CANCER INSTITUTE [R01CA082628, R01CA105038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA82628 (D.J.R.) and HL074190 (J.H.). We are grateful to J. Knoblich for the G alpha<INF>i</INF> antibody and G alpha<INF>i</INF> flies; X. Yang and W. Chia for G alpha<INF>i</INF> flies; D. Casso and T. Kornberg for Ptc antibody and UAS-Smo5A flies; J. Hooper for UAS-G alpha<INF>i</INF> and UAS-G alpha<INF>i</INF><SUP>Q205L</SUP> flies; K. Basler, D. Kalderon and P. Ingham for smo alleles; and L. Lum for Smo antibody. All additional fly stocks were provided by the Bloomington Stock Center. G alpha<INF>i</INF> and G alpha<INF>o</INF> cDNAs were obtained from the Drosophila Genomics Resource Center, Bloomington. E. Lee provided G alpha<INF>s</INF> cDNA. We thank the Dartmouth microscopy core for their assistance. We would also like to thank K. Black for technical assistance and members of the Robbins laboratory, E. Lee, J. Hutchinson, R. Taussig, R. Ostrom and C. Pikielny for thoughtful discussion during the course of this work.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Muller B, 2000, DEVELOPMENT, V127, P2999; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PATEL NH, 1989, DEVELOPMENT, V107, P201; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stegman MA, 2004, J BIOL CHEM, V279, P7064, DOI 10.1074/jbc.M311794200; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	37	158	165	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					967	U76		10.1038/nature07459	http://dx.doi.org/10.1038/nature07459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18987629	Green Accepted			2022-12-24	WOS:000261768300049
J	Li, C; Wu, XC; Rieppel, O; Wang, LT; Zhao, LJ				Li, Chun; Wu, Xiao-Chun; Rieppel, Olivier; Wang, Li-Ting; Zhao, Li-Jun			An ancestral turtle from the Late Triassic of southwestern China	NATURE			English	Article							CHELYDRA-SERPENTINA REPTILIA; ORIGIN; SHELL; HISTOLOGY; EVOLUTION; GUIZHOU; OSTEODERMS; AREA	The origin of the turtle body plan remains one of the great mysteries of reptile evolution. The anatomy of turtles is highly derived, which renders it difficult to establish the relationships of turtles with other groups of reptiles. The oldest known turtle, Proganochelys from the Late Triassic period of Germany(1), has a fully formed shell and offers no clue as to its origin. Here we describe a new 220- million- year- old turtle from China, somewhat older than Proganochelys, that documents an intermediate step in the evolution of the shell and associated structures. A ventral plastron is fully developed, but the dorsal carapace consists of neural plates only. The dorsal ribs are expanded, and osteoderms are absent. The new species shows that the plastron evolved before the carapace and that the first step of carapace formation is the ossification of the neural plates coupled with a broadening of the ribs. This corresponds to early embryonic stages of carapace formation in extant turtles, and shows that the turtle shell is not derived from a fusion of osteoderms. Phylogenetic analysis places the new species basal to all known turtles, fossil and extant. The marine deposits that yielded the fossils indicate that this primitive turtle inhabited marginal areas of the sea or river deltas.	[Li, Chun] Chinese Acad Sci, Lab Evolut Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Wu, Xiao-Chun] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Rieppel, Olivier] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; [Wang, Li-Ting] Geol Survey Guizhou Prov, Guiyang 550005, Peoples R China; [Zhao, Li-Jun] Zhejiang Museum Nat Hist, Hangzhou 310012, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Field Museum of Natural History (Chicago)	Li, C (corresponding author), Chinese Acad Sci, Lab Evolut Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	lichun@ivpp.ac.cn; xcwu@mus-nature.ca			Major Basic Research Projects [2006CB806400]; Ministry of Science and Technology of China; National Natural Science Foundation [40772015, 40121202]; Chinese Academy of Sciences; Canadian Museum of Nature [RS 34]; CAS/SAFEA International Partnership Program for Creative Research Teams	Major Basic Research Projects; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Canadian Museum of Nature; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	We thank Z. Tang for his help in collecting the specimens; J. Ding and H. Zhou for preparing the specimens; and W. Gao for taking the photos. C.L. and L.-T. W. were supported by the Major Basic Research Projects (2006CB806400) of the Ministry of Science and Technology of China, the National Natural Science Foundation (40772015, 40121202) of China (NNSFC) and a special grant for fossil excavation and preparation of the Chinese Academy of Sciences. X.-C.W. was supported by grants from the Canadian Museum of Nature (RS 34), NNSFC 40772015 and the CAS/SAFEA International Partnership Program for Creative Research Teams. O. R. was supported by a stipend from M. Tang.	GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; Gilbert Scott F., 2008, P1; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Jiang DY, 2005, ACTA GEOL SIN-ENGL, V79, P729; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2003, P ROY SOC LOND B BIO, V271, P1, DOI DOI 10.1098/RSPB.2003.2523); LEE MSY, 1993, SCIENCE, V261, P1716, DOI 10.1126/science.261.5129.1716; Lee MSY, 1996, NATURE, V379, P812, DOI 10.1038/379812a0; LERVRATCALVIAC V, 1986, AM J ANAT, V176, P437; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; MOSS ML, 1969, ACTA ANAT, V73, P510; Procter JB, 1922, P ZOOL SOC LOND, V1922, P483; REISZ RR, 1991, NATURE, V349, P324, DOI 10.1038/349324a0; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; RIEPPEL O, 1993, J ZOOL, V231, P487, DOI 10.1111/j.1469-7998.1993.tb01933.x; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Scheyer TM, 2008, J MORPHOL, V269, P1008, DOI 10.1002/jmor.10637; Scheyer TM, 2007, P ROY SOC B-BIOL SCI, V274, P1885, DOI 10.1098/rspb.2007.0499; Sheil CA, 2005, J ZOOL, V265, P235, DOI 10.1017/S0952836904006296; Sheil CA, 2003, J MORPHOL, V256, P42, DOI 10.1002/jmor.10074; Versluys J., 1914, Palaeontologische Zeitschrift, V1; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Wang LT, 2001, ACTA GEOL SIN-ENGL, V75, P349; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Wang XF, 2006, LETHAIA, V39, P187, DOI 10.1080/00241160600715321; Weber A, 1945, MON PSYCHIATR NEUROL, V111, P144; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Zangerl R, 1939, J MORPHOL, V65, P383, DOI 10.1002/jmor.1050650302; ZYLBERBERG L, 1985, J MORPHOL, V186, P327, DOI 10.1002/jmor.1051860309	30	244	260	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					497	501		10.1038/nature07533	http://dx.doi.org/10.1038/nature07533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037315	Green Published			2022-12-24	WOS:000261170500037
J	Choi, EY; Chavakis, E; Czabanka, MA; Langer, HF; Fraemohs, L; Economopoulou, M; Kundu, RK; Orlandi, A; Zheng, YY; Prieto, DA; Ballantyne, CM; Constant, SL; Aird, WC; Papayannopoulou, T; Gahmberg, CG; Udey, MC; Vajkoczy, P; Quertermous, T; Dimmeler, S; Weber, C; Chavakis, T				Choi, Eun Young; Chavakis, Emmanouil; Czabanka, Marcus A.; Langer, Harald F.; Fraemohs, Line; Economopoulou, Matina; Kundu, Ramendra K.; Orlandi, Alessia; Zheng, Ying Yi; Prieto, DaRue A.; Ballantyne, Christie M.; Constant, Stephanie L.; Aird, William C.; Papayannopoulou, Thalia; Gahmberg, Carl G.; Udey, Mark C.; Vajkoczy, Peter; Quertermous, Thomas; Dimmeler, Stefanie; Weber, Christian; Chavakis, Triantafyllos			Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; INTEGRINS; MIGRATION; PROTEIN; MOLECULE-1; ICAM-1; LFA-1	Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte- endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 ( developmental endothelial locus-1) as an anti-adhesive factor that interferes with the integrin LFA-1-dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA- 1- dependent leukocyte adhesion in vitro and in vivo. Del-1(-/-) mice displayed significantly higher neutrophil accumulation in lipopolysaccharide- induced lung inflammation in vivo, which was reversed in Del- /LFA-1 double- deficient mice. Thus, Del- 1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte- endothelial interactions in disease.	[Choi, Eun Young; Langer, Harald F.; Zheng, Ying Yi; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Chavakis, Emmanouil; Orlandi, Alessia; Dimmeler, Stefanie] Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Czabanka, Marcus A.; Vajkoczy, Peter] Charite Univ Med Berlin, Dept Neurosurg, D-13353 Berlin, Germany; [Fraemohs, Line; Weber, Christian] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany; [Economopoulou, Matina] NCI, Lab Cellular Oncol, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Kundu, Ramendra K.; Quertermous, Thomas] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Prieto, DaRue A.] NCI, Lab Proteom & Anal Technol, SAIC Frederick, Frederick, MD 21701 USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX 77030 USA; [Constant, Stephanie L.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Aird, William C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Papayannopoulou, Thalia] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Gahmberg, Carl G.] Univ Helsinki, Div Biochem, Fac Biosci, Helsinki, Finland; [Udey, Mark C.] NCI, Dermatol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; RWTH Aachen University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; George Washington University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chavakis, T (corresponding author), NCI, Expt Immunol Branch, Canc Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	chavakist@mail.nih.gov	Chavakis, Triantafyllos/ABE-8845-2020; Gahmberg, Carl/AAE-1876-2019; Ballantyne, Christie/A-6599-2008; Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714; Quertermous, Thomas/0000-0002-7645-9067; Ballantyne, Christie/0000-0002-6432-1730; Gahmberg, Carl/0000-0001-9892-9296; Choi, Eun Young/0000-0002-5484-4925; Dimmeler, Stefanie/0000-0002-1045-2436	Intramural Research Program; NIH [AI067254, RO1 HL082927]; NCI; Deutsche Forschungsgemeinschaft [FOR809, TP6, TR-SFB23, Exc 147/1]; NATIONAL CANCER INSTITUTE [ZIABC010790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067254] Funding Source: NIH RePORTER	Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Feng and M. Sardy for generating the Del-1-Fc protein, N. Hogg for the antibody mAb24, Valentis Inc. for recombinant Del- 1 and the antibody to mouse Del- 1, T. Veenstra for help with mass spectrometry, D. Winkler for help with genotyping, I. Okwumabua for technical assistance, and D. Singer for critically reading the manuscript. This research was supported by the Intramural Research Program of the NIH, NCI (T.C. and M.C.U.); by NIH grants AI067254 (S.L.C.) and RO1 HL082927 (W.C.A.); and by the Deutsche Forschungsgemeinschaft (grants FOR809 and TP6 to C.W.; TR-SFB23 and Exc 147/1 to S.D. and E.C.). A patent application on the anti- inflammatory actions of Del-1 has been filed.	Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Ding ZM, 1999, J IMMUNOL, V163, P5029; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gahmberg CG, 1998, CELL MOL LIFE SCI, V54, P549, DOI 10.1007/s000180050183; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hidai C, 2007, CELL TISSUE RES, V330, P83, DOI 10.1007/s00441-007-0456-9; Ho HKV, 2004, CIRCULATION, V109, P1314, DOI 10.1161/01.CIR.0000118465.36018.2D; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Yonekawa K, 2005, J LEUKOCYTE BIOL, V77, P129, DOI 10.1189/jlb.0804460; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034	23	216	228	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1101	1104		10.1126/science.1165218	http://dx.doi.org/10.1126/science.1165218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008446	Green Accepted			2022-12-24	WOS:000260867700037
J	Chesson, P; Kuang, JJ				Chesson, Peter; Kuang, Jessica J.			The interaction between predation and competition	NATURE			English	Article							APPARENT COMPETITION; ECOLOGICAL COMMUNITIES; TOP PREDATORS; RESOURCE; COEXISTENCE; PREY; DIVERSITY; SYSTEMS; MODELS	Competition and predation are the most heavily investigated species interactions in ecology, dominating studies of species diversity maintenance. However, these two interactions are most commonly viewed highly asymmetrically. Competition for resources is seen as the primary interaction limiting diversity, with predation modifying what competition does(1), although theoretical models have long supported diverse views(1-5). Here we show, using a comprehensive three- trophic- level model, that competition and predation should be viewed symmetrically: these two interactions are equally able to either limit or promote diversity. Diversity maintenance requires within- species density feedback loops to be stronger than between- species feedback loops. We quantify the contributions of predation and competition to these loops in a simple, interpretable form, showing their equivalent potential to strengthen or weaken diversity maintenance. Moreover, we show that competition and predation can undermine each other, with the tendency of the stronger interaction to promote or limit diversity prevailing. The past failure to appreciate the symmetrical effects and interactions of competition and predation has unduly restricted diversity maintenance studies. A multitrophic perspective should be adopted to examine a greater variety of possible effects of predation than generally considered in the past. Conservation and management strategies need to be much more concerned with the implications of changes in the strengths of trophic interactions.	[Chesson, Peter; Kuang, Jessica J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Chesson, P (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	pchesson@u.arizona.edu; jjkuang@u.arizona.edu	Chesson, Peter/GRO-6970-2022; Chesson, Peter/GLN-5790-2022	Chesson, Peter/0000-0001-8931-8012; 	National Science Foundation [DEB-0542991, DEB-0717222]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants DEB-0542991 and DEB-0717222.	Abrams PA, 1998, AM NAT, V152, P114, DOI 10.1086/286153; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON P, 1990, THEOR POPUL BIOL, V37, P26, DOI 10.1016/0040-5809(90)90025-Q; Chesson P., 2008, UNITY DIVERSITY REFL, P119; EITHAUS MR, 2008, TRENDS ECOL EVOL, V23, P202; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; Haygood R, 2002, THEOR POPUL BIOL, V61, P215, DOI 10.1006/tpbi.2001.1566; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; KOTLER BP, 1989, OIKOS, V54, P256, DOI 10.2307/3565279; Krivan V, 2003, EVOL ECOL RES, V5, P1163; Kuang JJ, 2008, AM NAT, V171, pE119, DOI 10.1086/527484; KUANG JJ, ECOLOGY IN PRESS; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Sala E, 2006, TRENDS ECOL EVOL, V21, P479, DOI 10.1016/j.tree.2006.07.006; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Soule ME, 1999, BIOSCIENCE, V49, P809, DOI 10.2307/1313572	24	313	325	8	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					235	238		10.1038/nature07248	http://dx.doi.org/10.1038/nature07248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005554				2022-12-24	WOS:000261039300039
J	Karklin, Y; Lewicki, MS				Karklin, Yan; Lewicki, Michael S.			Emergence of complex cell properties by learning to generalize in natural scenes	NATURE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; RECEPTIVE-FIELDS; AREA V4; V1; RESPONSES; MODELS; IMAGES; NORMALIZATION; ORGANIZATION	A fundamental function of the visual system is to encode the building blocks of natural scenes - edges, textures and shapes - that subserve visual tasks such as object recognition and scene understanding. Essential to this process is the formation of abstract representations that generalize from specific instances of visual input. A common view holds that neurons in the early visual system signal conjunctions of image features(1,2), but how these produce invariant representations is poorly understood. Here we propose that to generalize over similar images, higher- level visual neurons encode statistical variations that characterize local image regions. We present a model in which neural activity encodes the probability distribution most consistent with a given image. Trained on natural images, the model generalizes by learning a compact set of dictionary elements for image distributions typically encountered in natural scenes. Model neurons show a diverse range of properties observed in cortical cells. These results provide a new functional explanation for nonlinear effects in complex cells(3-6) and offer insight into coding strategies in primary visual cortex (V1) and higher visual areas.	[Karklin, Yan; Lewicki, Michael S.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Karklin, Yan; Lewicki, Michael S.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Karklin, Y (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	yan.karklin@nyu.edu; michael.lewicki@case.edu			Department of Energy; Computational Science Graduate Fellowship; National Science Foundation [0413152, 0705677]; Office of Naval Research under the Multidisciplinary University Research Initiative [N000140710747]	Department of Energy(United States Department of Energy (DOE)); Computational Science Graduate Fellowship(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research under the Multidisciplinary University Research Initiative(MURI)	This work was supported by the Department of Energy through the Computational Science Graduate Fellowship (to Y.K.), the National Science Foundation Grant under grant numbers 0413152 and 0705677 (to M.S.L.) and the Office of Naval Research under the Multidisciplinary University Research Initiative N000140710747.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Connor CE, 2007, CURR OPIN NEUROBIOL, V17, P140, DOI 10.1016/j.conb.2007.03.002; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hurri J, 2003, NEURAL COMPUT, V15, P663, DOI 10.1162/089976603321192121; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Yan KL, 2005, NEURAL COMPUT, V17, P397, DOI 10.1162/0899766053011474	31	141	147	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					83	U85		10.1038/nature07481	http://dx.doi.org/10.1038/nature07481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19020501				2022-12-24	WOS:000262104900035
J	Engelkes, T; Morrien, E; Verhoeven, KJF; Bezemer, TM; Biere, A; Harvey, JA; McIntyre, LM; Tamis, WLM; van der Putten, WH				Engelkes, Tim; Morrien, Elly; Verhoeven, Koen J. F.; Bezemer, T. Martijn; Biere, Arjen; Harvey, Jeffrey A.; McIntyre, Lauren M.; Tamis, Wil L. M.; van der Putten, Wim H.			Successful range-expanding plants experience less above-ground and below-ground enemy impact	NATURE			English	Article							CLIMATE-CHANGE; SOIL BIOTA; BRITISH BUTTERFLIES; NATURAL ENEMIES; INVASIVE PLANTS; FEEDBACK; HERBIVORES; RELEASE; COMMUNITIES; PATHOGENS	Many species are currently moving to higher latitudes and altitudes(1-3). However, little is known about the factors that influence the future performance of range- expanding species in their new habitats. Here we show that range- expanding plant species from a riverine area were better defended against shoot and root enemies than were related native plant species growing in the same area. We grew fifteen plant species with and without non- coevolved polyphagous locusts and cosmopolitan, polyphagous aphids. Contrary to our expectations, the locusts performed more poorly on the range- expanding plant species than on the congeneric native plant species, whereas the aphids showed no difference. The shoot herbivores reduced the biomass of the native plants more than they did that of the congeneric range expanders. Also, the range- expanding plants developed fewer pathogenic effects(4,5) in their root- zone soil than did the related native species. Current predictions forecast biodiversity loss due to limitations in the ability of species to adjust to climate warming conditions in their range(6-8). Our results strongly suggest that the plants that shift ranges towards higher latitudes and altitudes may include potential invaders, as the successful range expanders may experience less control by above- ground or below-ground enemies than the natives.	[Engelkes, Tim; Morrien, Elly; Verhoeven, Koen J. F.; Bezemer, T. Martijn; Biere, Arjen; Harvey, Jeffrey A.; van der Putten, Wim H.] Netherlands Inst Ecol, NIOO KNAW, Dept Multitroph Interact, NL-6666 ZG Heteren, Netherlands; [Bezemer, T. Martijn; van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, NL-6700 ES Wageningen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [McIntyre, Lauren M.] Univ Florida, Dept Stat, Gainesville, FL 32610 USA; [Tamis, Wil L. M.] Natl Herbarium Nederland, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Leiden University; Leiden University - Excl LUMC	van der Putten, WH (corresponding author), Netherlands Inst Ecol, NIOO KNAW, Dept Multitroph Interact, POB 40, NL-6666 ZG Heteren, Netherlands.	w.vanderputten@nioo.knaw.nl	McIntyre, Lauren/J-8414-2012; Biere, Arjen/B-8079-2008; Verhoeven, Koen JF/C-9920-2010; van der Putten, Wim H/C-3707-2011; Bezemer, Martijn/A-4068-2009; Morrien, Elly/H-3527-2011; Harvey, Jeffrey A/B-7439-2008	McIntyre, Lauren/0000-0002-0077-3359; Biere, Arjen/0000-0002-9006-3448; Verhoeven, Koen JF/0000-0003-3002-4102; van der Putten, Wim H/0000-0002-9341-4442; Bezemer, Martijn/0000-0002-2878-3479; Morrien, Elly/0000-0002-6490-2260; Harvey, Jeffrey A/0000-0002-4227-7935	ALW-VICI	ALW-VICI	We thank Staatsbosbeheer Regio Oost for giving us permission to work in Millingerwaard; B. Ode, K. Groen, R. van Grunsven, P. Brinkman and the late R. van der Meijden for discussions; M. Houtekamer for carbon and nitrogen determination; T. Vos, M. Vlag, A. Weerheijm and W. Smant for assistance; L. Koopman for providing the locusts; and L. Young and E. J. Bakker for advice on statistics. This study was funded by an ALW-VICI grant to W.H.v.d.P.	Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; van der Putten WH, 2005, BIOL INVASIONS, V7, P733, DOI 10.1007/s10530-004-1196-3; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	28	209	215	7	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					946	948		10.1038/nature07474	http://dx.doi.org/10.1038/nature07474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19020504				2022-12-24	WOS:000261768300044
J	Clubb, R; Rowcliffe, M; Lee, P; Mar, KU; Moss, C; Mason, GJ				Clubb, Ros; Rowcliffe, Marcus; Lee, Phyllis; Mar, Khyne U.; Moss, Cynthia; Mason, Georgia J.			Compromised Survivorship in Zoo Elephants	SCIENCE			English	Article									[Mason, Georgia J.] Univ Guelph, Dept Anim Sci, Guelph, ON N1G 2M7, Canada; [Clubb, Ros] RSPCA, Southwater RH13 9RS, W Sussex, England; [Rowcliffe, Marcus; Mar, Khyne U.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Lee, Phyllis] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Lee, Phyllis; Moss, Cynthia] Amboseli Trust Elephants, Nairobi, Kenya; [Mar, Khyne U.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Guelph; Zoological Society of London; University of Stirling; University of Sheffield	Mason, GJ (corresponding author), Univ Guelph, Dept Anim Sci, Guelph, ON N1G 2M7, Canada.	gmason@uoguelph.ca	U Mar, Khyne/AAO-8806-2021; Yon, Lisa K/G-4453-2011; Rowcliffe, Marcus/G-3713-2018	Yon, Lisa K/0000-0002-9765-3192; Rowcliffe, Marcus/0000-0002-4286-6887; Lee, Phyllis/0000-0002-4296-3513	Natural Science and Engineering Research Council; Amboseli Elephant Trust; Prospect Burma Foundation; Charles Wallace Burma Trust; Three Oaks Foundation; Whitney- Laing Foundation ( Rufford Small Grants); Toyota Foundation, Fantham Memorial Research Scholarship; University College London	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Amboseli Elephant Trust; Prospect Burma Foundation; Charles Wallace Burma Trust; Three Oaks Foundation; Whitney- Laing Foundation ( Rufford Small Grants); Toyota Foundation, Fantham Memorial Research Scholarship; University College London(General Electric)	J. M. thanks the Natural Science and Engineering Research Council for funding; R. C. and G. J. M. thank R. Ripley for statistical advice; P. L. and C. M. thank many conservation nongovernmental organizations and private donors for supporting the Amboseli Elephant Trust; K. U. M. thanks colleagues at M. T. E. for data compilation and comments. G. J. M. is a visiting professor at The Royal Veterinary College, London, UK. K. U. M. has received funding from Prospect Burma Foundation, Charles Wallace Burma Trust, Three Oaks Foundation, Whitney- Laing Foundation ( Rufford Small Grants), Toyota Foundation, Fantham Memorial Research Scholarship, and University College London. K. U. M. has been a paid consultant for Woburn Safari Park, UK. G. J. M. has been a paid consultant to Disney's Animal Kingdom, USA.	Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; *EUR EL GROUP, 2002, EL ZOOS SAF EUR; Hutchins M, 2006, ZOO BIOL, V25, P219, DOI 10.1002/zoo.20102	4	109	111	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1649	1649		10.1126/science.1164298	http://dx.doi.org/10.1126/science.1164298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074339	Green Accepted, Green Submitted			2022-12-24	WOS:000261608300033
J	Nordborg, M; Weigel, D				Nordborg, Magnus; Weigel, Detlef			Next-generation genetics in plants	NATURE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; ARABIDOPSIS-THALIANA; FLOWERING TIME; COMPLEX TRAITS; STRUCTURAL VARIATION; HAPLOTYPE MAP; MAIZE; DISEQUILIBRIUM; RECOMBINATION	Natural variation presents one of the fundamental challenges of modern biology. Soon, the genome sequences of thousands of individuals will be known for each of several species. But how does the genotypic variation that will be observed among these individuals translate into phenotypic variation? Plants are in many ways ideal for addressing this question, and resources that are unmatched, except in humans, have now been developed.	[Nordborg, Magnus] Univ So Calif, Los Angeles, CA 90089 USA; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	University of Southern California; Max Planck Society	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu; weigel@weigelworld.org	Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748	National Science Foundation; National Institutes of Health; German Research Foundation; German Federal Ministry of Education and Research; European Union's Sixth Framework Programme; Human Frontier Science Program; Max Planck Society	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union's Sixth Framework Programme; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Studies of natural genetic variation are supported by the National Science Foundation and the National Institutes of Health (M.N.), and by the German Research Foundation, the German Federal Ministry of Education and Research, the European Union's Sixth Framework Programme, the Human Frontier Science Program and the Max Planck Society (D.W.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; East EM, 1910, AM NAT, V44, P65, DOI 10.1086/279117; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Macquet A, 2007, PLANT CELL, V19, P3990, DOI 10.1105/tpc.107.050179; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Nilsson-Ehle H, 1909, LUNDS U AARSKR, V5, P1; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sax K, 1923, GENETICS, V8, P552; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; YU J, 2006, NAT GENET, V38, P303; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	35	292	308	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					720	723		10.1038/nature07629	http://dx.doi.org/10.1038/nature07629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079047				2022-12-24	WOS:000261559900034
J	Cohen, AA; Geva-Zatorsky, N; Eden, E; Frenkel-Morgenstern, M; Issaeva, I; Sigal, A; Milo, R; Cohen-Saidon, C; Liron, Y; Kam, Z; Cohen, L; Danon, T; Perzov, N; Alon, U				Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Sigal, A.; Milo, R.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U.			Dynamic Proteomics of Individual Cancer Cells in Response to a Drug	SCIENCE			English	Article							PROTEIN EXPRESSION; INDUCED APOPTOSIS; GENE-EXPRESSION; SYSTEMS BIOLOGY; TOPOISOMERASE-I; GLOBAL ANALYSIS; BUDDING YEAST; SINGLE-CELL; NOISE; DNA	Why do seemingly identical cells respond differently to a drug? To address this, we studied the dynamics and variability of the protein response of human cancer cells to a chemotherapy drug, camptothecin. We present a dynamic- proteomics approach that measures the levels and locations of nearly 1000 different endogenously tagged proteins in individual living cells at high temporal resolution. All cells show rapid translocation of proteins specific to the drug mechanism, including the drug target ( topoisomerase- 1), and slower, wide- ranging temporal waves of protein degradation and accumulation. However, the cells differ in the behavior of a subset of proteins. We identify proteins whose dynamics differ widely between cells, in a way that corresponds to the outcomes- cell death or survival. This opens the way to understanding molecular responses to drugs in individual cells.	[Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Sigal, A.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Milo, R.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; California Institute of Technology; Weizmann Institute of Science	Issaeva, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	ariel.cohen@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021; Sigal, Alex/GWC-7488-2022	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sigal, Alex/0000-0001-8571-2004; Frenkel-Morgenstern, Milana/0000-0002-0329-4599; Milo, Ron/0000-0003-1641-2299	Kahn Family Foundation; Israel Science Foundation; Yeshaya Horowitz Association; Center for Complexity Science	Kahn Family Foundation; Israel Science Foundation(Israel Science Foundation); Yeshaya Horowitz Association; Center for Complexity Science	We thank the Kahn Family Foundation and the Israel Science Foundation for support. We thank E. Zalckvar, J. Bar, I. Glinert, T. Shlapok, and members of the Alon laboratory for discussions. The work of M.F.-M. and E.E. is supported by the Yeshaya Horowitz Association through the Center for Complexity Science.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Clyne PJ, 2003, GENETICS, V165, P1433; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; MULLER MT, 1985, EMBO J, V4, P1237, DOI 10.1002/j.1460-2075.1985.tb03766.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	34	436	447	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1511	1516		10.1126/science.1160165	http://dx.doi.org/10.1126/science.1160165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19023046	Green Accepted			2022-12-24	WOS:000261377400041
J	Yadav, VK; Ryu, JH; Suda, N; Tanaka, KF; Gingrich, JA; Schuetz, GN; Glorieux, FH; Chiang, CY; Zajac, JD; Insogna, KL; Mann, JJ; Hen, R; Ducy, P; Karsenty, G				Yadav, Vijay K.; Ryu, Je-Hwang; Suda, Nina; Tanaka, Kenji F.; Gingrich, Jay A.; Schuetz, Guenther; Glorieux, Francis H.; Chiang, Cherie Y.; Zajac, Jeffrey D.; Insogna, Karl L.; Mann, J. John; Hen, Rene; Ducy, Patricia; Karsenty, Gerard			Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum	CELL			English	Article							BETA-CATENIN; RECEPTOR; MASS; PROTEINS; MUTATION; MICE	Loss- and gain-of-function mutations in the broadly expressed gene Lrp5 affect bone formation, causing osteoporosis and high bone mass, respectively. Although Lrp5 is viewed as a Wnt coreceptor, osteoblast-specific disruption of beta-Catenin does not affect bone formation. Instead, we show here that Lrp5 inhibits expression of Tph1, the rate-limiting biosynthetic enzyme for serotonin in enterochromaffin cells of the duodenum. Accordingly, decreasing serotonin blood levels normalizes bone formation and bone mass in Lrp5-deficient mice, and gut-but not osteoblast-specific Lrp5 inactivation decreases bone formation in a beta-Catenin-independent manner. Moreover, gut-specific activation of Lrp5, or inactivation of Tph1, increases bone mass and prevents ovariectomy-induced bone loss. Serotonin acts on osteoblasts through the Htr1b receptor and CREB to inhibit their proliferation. By identifying duodenum-derived serotonin as a hormone inhibiting bone formation in an Lrp5-dependent manner, this study broadens our understanding of bone remodeling and suggests potential therapies to increase bone mass.	[Ducy, Patricia] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Yadav, Vijay K.; Ryu, Je-Hwang; Suda, Nina; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Tanaka, Kenji F.; Mann, J. John; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gingrich, Jay A.] Columbia Univ, Dept Psychiat Dev Psychobiol, New York, NY 10032 USA; [Schuetz, Guenther] German Canc Res Ctr, Dept Mol Biol Cell, D-69120 Heidelberg, Germany; [Glorieux, Francis H.] McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Chiang, Cherie Y.; Zajac, Jeffrey D.] Univ Melbourne, Dept Med, Heidelberg, Vic 3010, Australia; [Insogna, Karl L.] Yale Sch Med, Dept Internal Med, New Haven, CT 06519 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; University of Melbourne; Yale University	Karsenty, G (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.	pd2193@columbia.edu; gk2172@columbia.edu	Zajac, Jeffrey/ABC-3767-2021; yadav, VIJAY k/Q-2540-2016; Chiang, Cherie/AAR-3793-2021	Zajac, Jeffrey/0000-0003-3933-5708; yadav, VIJAY k/0000-0003-2345-2846; Tanaka, Kenji/0000-0003-2511-0057; Insogna, Karl/0000-0001-6973-5679	March of Dimes Foundation; National Institutes of Health; Shriners of North America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067936] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners of North America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. J. P. Bilezikian, S. Cremers, D. A. Mackey, M. Zacharin, R. Lang, S. Rao, H. Schubert, and J. Tosi for patient samples and eye analysis; G. Ren and Yung-yu Huang for superb technical assistance; and Dr. M. Gershon for his critical reading of this manuscript. This work was supported by grants from the March of Dimes Foundation and the National Institutes of Health (to G. K.) and by the Shriners of North America (F. H. G.).	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Basselin M, 2005, NEUROPSYCHOPHARMACOL, V30, P461, DOI 10.1038/sj.npp.1300611; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FU L, 2007, GASTROENTEROLOGY, V132, P397; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HEATH MJS, 1995, CURR BIOL, V5, P997, DOI 10.1016/S0960-9822(95)00199-0; Hediger ML, 2008, J AUTISM DEV DISORD, V38, P848, DOI 10.1007/s10803-007-0453-6; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubera M, 2000, NEUROPSYCHOPHARMACOL, V23, P89, DOI 10.1016/S0893-133X(99)00150-5; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RAND M, 1951, NATURE, V168, P385, DOI 10.1038/168385b0; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	37	600	660	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					825	837		10.1016/j.cell.2008.09.059	http://dx.doi.org/10.1016/j.cell.2008.09.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041748	Green Accepted, Bronze			2022-12-24	WOS:000261183900015
J	Stricker, J; Cookson, S; Bennett, MR; Mather, WH; Tsimring, LS; Hasty, J				Stricker, Jesse; Cookson, Scott; Bennett, Matthew R.; Mather, William H.; Tsimring, Lev S.; Hasty, Jeff			A fast, robust and tunable synthetic gene oscillator	NATURE			English	Article							ESCHERICHIA-COLI; TOGGLE SWITCH; EXPRESSION; NETWORKS; CIRCUITS; BIOLOGY; PROTEIN; CELLS	One defining goal of synthetic biology is the development of engineering- based approaches that enable the construction of gene- regulatory networks according to 'design specifications' generated from computational modelling(1-6). This approach provides a systematic framework for exploring how a given regulatory network generates a particular phenotypic behaviour. Several fundamental gene circuits have been developed using this approach, including toggle switches(7) and oscillators(8-10), and these have been applied in new contexts such as triggered biofilm development(11) and cellular population control(12). Here we describe an engineered genetic oscillator in Escherichia coli that is fast, robust and persistent, with tunable oscillatory periods as fast as 13 min. The oscillator was designed using a previously modelled network architecture comprising linked positive and negative feedback loops(1,13). Using a microfluidic platform tailored for single- cell microscopy, we precisely control environmental conditions and monitor oscillations in individual cells through multiple cycles. Experiments reveal remarkable robustness and persistence of oscillations in the designed circuit; almost every cell exhibited large- amplitude fluorescence oscillations throughout observation runs. The oscillatory period can be tuned by altering inducer levels, temperature and the media source. Computational modelling demonstrates that the key design principle for constructing a robust oscillator is a time delay in the negative feedback loop, which can mechanistically arise from the cascade of cellular processes involved in forming a functional transcription factor. The positive feedback loop increases the robustness of the oscillations and allows for greater tunability. Examination of our refined model suggested the existence of a simplified oscillator design without positive feedback, and we construct an oscillator strain confirming this computational prediction.	[Stricker, Jesse; Cookson, Scott; Bennett, Matthew R.; Mather, William H.; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bennett, Matthew R.; Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu	Bennett, Matthew/B-3700-2008	Bennett, Matthew/0000-0002-4975-8854; Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health [GM69811-01]; US Department of Defense; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bujard, C. Yang, and Z. Zhang for gifts of reagents, and D. Volfson and M. Simpson for discussions. This work was supported by grants from the National Institutes of Health (GM69811-01) and the US Department of Defense.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rateitschak K, 2007, MATH BIOSCI, V205, P163, DOI 10.1016/j.mbs.2006.08.010; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	773	808	8	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					516	U39		10.1038/nature07389	http://dx.doi.org/10.1038/nature07389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18971928	Green Accepted			2022-12-24	WOS:000261170500041
J	Walker, AS; Spiegelhalter, D; Crook, DW; Wyllie, D; Morris, J; Peto, TEA				Walker, A. Sarah; Spiegelhalter, David; Crook, Derrick W.; Wyllie, David; Morris, James; Peto, Tim E. A.			Fairness of financial penalties to improve control of Clostridium difficile	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; STRAIN; REGRESSION; INFECTION; EPIDEMIC; QUALITY; DISEASE; PAY		[Walker, A. Sarah; Crook, Derrick W.; Morris, James; Peto, Tim E. A.] John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England; [Walker, A. Sarah] MRC, Clin Trials Unit, London NW1 2DA, England; [Spiegelhalter, David] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Spiegelhalter, David] Ctr Math Sci, Stat Lab, Cambridge CB3 0WB, England; [Wyllie, David] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; Medical Research Council Clinical Trials Unit; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; University of Oxford	Walker, AS (corresponding author), John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England.	asw@ctu.mrc.ac.uk	Walker, Sarah/HDM-8717-2022	peto, tim/0000-0003-3477-8307	Medical Research Council [MC_U105260557] Funding Source: Medline; MRC [MC_U105260557] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Duckett SJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-72; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; *HEALTHC COMM, STAT BAND NAT TARG I; HEALY MJR, 1978, ANN HUM BIOL, V5, P277, DOI 10.1080/03014467800002891; *HLTH PROT AG, CLOSTR DIFF; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Morton V, 2003, BRIT MED J, V326, P1083, DOI 10.1136/bmj.326.7398.1083; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; *UK DEP HLTH, NAT TARG RED CLOSTR; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258	15	4	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2097	10.1136/bmj.a2097	http://dx.doi.org/10.1136/bmj.a2097			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HS	19022838				2022-12-24	WOS:000262654100001
J	Sanz-Moreno, V; Gadea, G; Ahn, J; Paterson, H; Marra, P; Pinner, S; Sahai, E; Marshall, CJ				Sanz-Moreno, Victoria; Gadea, Gilles; Ahn, Jessica; Paterson, Hugh; Marra, Pierfrancesco; Pinner, Sophie; Sahai, Erik; Marshall, Christopher J.			Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement	CELL			English	Article							PRESENILIN-BINDING-PROTEIN; PERICELLULAR PROTEOLYSIS; ARP2/3 COMPLEX; CANCER-CELLS; RHO-GTPASES; MIGRATION; INVASION; KINASE; PHOSPHORYLATION; METASTASIS	Tumor cells exhibit two different modes of individual cell movement. Mesenchymal-type movement is characterized by an elongated cellular morphology and requires extracellular proteolysis. In amoeboid movement, cells have a rounded morphology, are less dependent on proteases, and require high Rho-kinase signaling to drive elevated levels of actomyosin contractility. These two modes of cell movement are interconvertible. We show that mesenchymal-type movement in melanoma cells is driven by activation of the GTPase Rac through a complex containing NEDD9, a recently identified melanoma metastasis gene, and DOCK3, a Rac guanine nucleotide exchange factor. Rac signals through WAVE2 to direct mesenchymal movement and suppress amoeboid movement through decreasing actomyosin contractility. Conversely, in amoeboid movement, Rho-kinase signaling activates a Rac GAP, ARH-GAP22, that suppresses mesenchymal movement by inactivating Rac. We demonstrate tight interplay between Rho and Rac in determining different modes of tumor cell movement, revealing how tumor cells switch between different modes of movement.	[Sanz-Moreno, Victoria; Gadea, Gilles; Ahn, Jessica; Paterson, Hugh; Marra, Pierfrancesco; Marshall, Christopher J.] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; [Pinner, Sophie; Sahai, Erik] London Res Inst Canc Res UK, Tumor Cell Biol Lab, London WC2A 3PX, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Marshall, CJ (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	chris.marshall@icr.ac.uk	Gilles, Gadea/M-9966-2015; Acton, Sophie/G-9784-2012	Gilles, Gadea/0000-0001-6325-4866; Acton, Sophie/0000-0003-2704-716X; Sahai, Erik/0000-0002-3932-5086; Sanz-Moreno, Victoria/0000-0002-5096-9456	Cancer Research UK; European Union	Cancer Research UK(Cancer Research UK); European Union(European Commission)	This work was supported by Cancer Research UK and the European Union. V. S. M. is a Marie Curie Intra-European Fellow, and C.J.M. a Cancer Research UK Gibb Fellow. We thank Demelza Bird for technical help, Annette Self for technical advice, Imanol Arozarena, Richard Marais, Mike Olson, and David Schubert for reagents, and Clare Isacke, Pascal Peschard, and Anna Peyker for helpful comments.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Namekata K, 2002, J NEUROCHEM, V82, P819, DOI 10.1046/j.1471-4159.2002.01039.x; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; ROSAI M, 2004, ROSAI ACKERMANS SURG, P166; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2003, MOL CELL BIOL, V23, P3079, DOI 10.1128/MCB.23.9.3079-3090.2003; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Tsuji K, 2006, CANCER RES, V66, P303, DOI 10.1158/0008-5472.CAN-05-2958; Wang WG, 2002, CANCER RES, V62, P6278; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	38	693	707	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					510	523		10.1016/j.cell.2008.09.043	http://dx.doi.org/10.1016/j.cell.2008.09.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984162	Bronze			2022-12-24	WOS:000260536300021
J	Yang, FC; Ingram, DA; Chen, S; Zhu, Y; Yuan, J; Li, XH; Yang, XL; Knowles, S; Horn, W; Li, Y; Zhang, SB; Yang, YZ; Vakili, ST; Yu, MG; Burns, D; Robertson, K; Hutchins, G; Parada, LF; Clapp, DW				Yang, Feng-Chun; Ingram, David A.; Chen, Shi; Zhu, Yuan; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Knowles, Scott; Horn, Whitney; Li, Yan; Zhang, Shaobo; Yang, Yanzhu; Vakili, Saeed T.; Yu, Menggang; Burns, Dennis; Robertson, Kent; Hutchins, Gary; Parada, Luis F.; Clapp, D. Wade			Nf1-Dependent Tumors Require a Microenvironment Containing Nf1(+/-) and c-kit-Dependent Bone Marrow	CELL			English	Article							MAST-CELLS; GROWTH-FACTOR; NEUROFIBROMATOSIS TYPE-1; GENE-PRODUCT; IN-VIVO; RECEPTOR; CANCER; NF1; CARCINOGENESIS; PROLIFERATION	Interactions between tumorigenic cells and their surrounding microenvironment are critical for tumor progression yet remain incompletely understood. Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a common genetic disorder characterized by complex tumors called neurofibromas. Genetic studies indicate that biallelic loss of Nf1 is required in the tumorigenic cell of origin in the embryonic Schwann cell lineage. However, in the physiologic state, Schwann cell loss of heterozygosity is not sufficient for neurofibroma formation and Nf1 haploinsufficiency in at least one additional nonneoplastic lineage is required for tumor progression. Here, we establish that Nf1 heterozygosity of bone marrow-derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell Nf1 deficiency. Further, genetic or pharmacologic attenuation of c-kit signaling in Nf1(+/-) hematopoietic cells diminishes neurofibroma initiation and progression. Finally, these studies implicate mast cells as critical mediators of tumor initiation.	[Zhu, Yuan; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yang, Feng-Chun; Chen, Shi; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Knowles, Scott; Horn, Whitney; Li, Yan; Yang, Yanzhu; Robertson, Kent; Clapp, D. Wade] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ingram, David A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hutchins, Gary] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA; [Clapp, D. Wade] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhang, Shaobo; Vakili, Saeed T.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yu, Menggang] Indiana Univ, Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Yang, Feng-Chun; Ingram, David A.; Chen, Shi; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Li, Yan; Yang, Yanzhu; Robertson, Kent; Clapp, D. Wade] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Burns, Dennis] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu; dclapp@iupui.edu	Zhu, Yuan/ABF-8405-2020; Knowles, Scott/F-8197-2015; Parada, luis F/B-9400-2014		Department of Defense [NF020026]; P50 Center of Excellence in Neurofibromatosis [P50 NS 052606]; NCI-MMHC; Anna Fuller Foundation;  [R01 CA74177]; NATIONAL CANCER INSTITUTE [R01CA074177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); P50 Center of Excellence in Neurofibromatosis; NCI-MMHC; Anna Fuller Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Department of Defense (NF020026) to D. W. C. and L.F.P., a P50 Center of Excellence in Neurofibromatosis P50 NS 052606 (L.F.P., D.W.C., F.C.Y., D.A.I., and G.H.) and R01 CA74177 to D.W.C.L.F.P. is an American Cancer Society Professor and also acknowledges support from the NCI-MMHC. Novartis supplied imatinib mesylate to D.W.C. for these studies. The work was also supported by the Anna Fuller Foundation.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; CHANG TL, 1993, PEDIATR DERMATOL, V10, P224, DOI 10.1111/j.1525-1470.1993.tb00366.x; CLAPP DW, 1995, BLOOD, V86, P2113, DOI 10.1182/blood.V86.6.2113.bloodjournal8662113; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; GALLI SJ, 1993, AM J PATHOL, V142, P965; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haneline LS, 1999, BLOOD, V94, P1; Hiatt K, 2004, AM J PATHOL, V164, P1471, DOI 10.1016/S0002-9440(10)63233-6; HIROTA S, 1993, ARCH PATHOL LAB MED, V117, P996; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KACINSKI BM, 1995, ANN MED, V27, P79, DOI 10.3109/07853899509031941; Li F, 2006, HUM MOL GENET, V15, P1921, DOI 10.1093/hmg/ddl114; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mashour GA, 2004, CLIN CANCER RES, V10, P5677, DOI 10.1158/1078-0432.CCR-03-0769; Munchhof AM, 2006, HUM MOL GENET, V15, P1858, DOI 10.1093/hmg/ddl108; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; RYAN JJ, 1994, J NEUROSCI RES, V37, P415, DOI 10.1002/jnr.490370314; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Tay YK, 1998, DERMATOLOGY, V197, P401, DOI 10.1159/000018046; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	33	242	266	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					437	448		10.1016/j.cell.2008.08.041	http://dx.doi.org/10.1016/j.cell.2008.08.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984156	Green Accepted, Bronze			2022-12-24	WOS:000260536300015
J	Saavedra, S; Reed-Tsochas, F; Uzzi, B				Saavedra, Serguei; Reed-Tsochas, Felix; Uzzi, Brian			A simple model of bipartite cooperation for ecological and organizational networks	NATURE			English	Article							FOOD; EMBEDDEDNESS; EXPLOITATION; PATTERNS; RULES	In theoretical ecology, simple stochastic models that satisfy two basic conditions about the distribution of niche values and feeding ranges have proved successful in reproducing the overall structural properties of real food webs, using species richness and connectance as the only input parameters(1-4). Recently, more detailed models have incorporated higher levels of constraint in order to reproduce the actual links observed in real food webs(5,6). Here, building on previous stochastic models of consumer - resource interactions between species(1-3), we propose a highly parsimonious model that can reproduce the overall bipartite structure of cooperative partner - partner interactions, as exemplified by plant - animal mutualistic networks(7). Our stochastic model of bipartite cooperation uses simple specialization and interaction rules, and only requires three empirical input parameters. We test the bipartite cooperation model on ten large pollination data sets that have been compiled in the literature, and find that it successfully replicates the degree distribution, nestedness and modularity of the empirical networks. These properties are regarded as key to understanding cooperation in mutualistic networks(8-10). We also apply our model to an extensive data set of two classes of company engaged in joint production in the garment industry. Using the same metrics, we find that the network of manufacturer - contractor interactions exhibits similar structural patterns to plant - animal pollination networks. This surprising correspondence between ecological and organizational networks suggests that the simple rules of cooperation that generate bipartite networks may be generic, and could prove relevant in many different domains, ranging from biological systems to human society(11-14).	[Saavedra, Serguei; Reed-Tsochas, Felix] Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England; [Saavedra, Serguei] Univ Oxford, Corp Reputat Ctr, Oxford OX1 1HP, England; [Reed-Tsochas, Felix] Univ Oxford, James Martin Inst, Said Business Sch, Oxford OX1 1HP, England; [Saavedra, Serguei] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Uzzi, Brian] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Uzzi, Brian] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Uzzi, Brian] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Northwestern University; Northwestern University; University of California System; University of California Berkeley	Reed-Tsochas, F (corresponding author), Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England.	felix.reed-tsochas@sbs.ox.ac.uk			European Commission; MMCOMNET; CONACYT; Oxford University Corporate Reputation Centre; CABDyN Complexity Centre	European Commission(European CommissionEuropean Commission Joint Research Centre); MMCOMNET; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Oxford University Corporate Reputation Centre; CABDyN Complexity Centre	We thank J. Dunne, R. Guimera, J. Kertesz, M. Sales-Pardo, D. Stouffer and R. Williams for comments and suggestions. F.R.-T. acknowledges funding from the European Commission under the FP6 NEST Pathfinder Initiative 'Tackling Complexity in Science' (MMCOMNET project, contract no. 012999). S.S. held a Doctoral Research Studentship funded by MMCOMNET and CONACYT, and currently is supported by a Postdoctoral Fellowship at the Oxford University Corporate Reputation Centre in conjunction with the CABDyN Complexity Centre.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2006, SFI S SCI C, P143; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Carroll G. R., 2004, DEMOGRAPHY CORPORATI; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimaraes PR, 2007, J THEOR BIOL, V249, P181, DOI 10.1016/j.jtbi.2007.08.004; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hammerstein P., 2003, GENETIC CULTURAL EVO; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Podolny Joel M., 2005, STATUS SIGNALS SOCIO; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	30	116	116	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					463	466		10.1038/nature07532	http://dx.doi.org/10.1038/nature07532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19052545				2022-12-24	WOS:000262519200043
J	Ebert, AD; Yu, JY; Rose, FF; Mattis, VB; Lorson, CL; Thomson, JA; Svendsen, CN				Ebert, Allison D.; Yu, Junying; Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.; Thomson, James A.; Svendsen, Clive N.			Induced pluripotent stem cells from a spinal muscular atrophy patient	NATURE			English	Article							MOTOR-NEURON GENE; VALPROIC ACID INCREASES; PROTEIN-LEVEL; SMN; SURVIVAL; COMPLEX; MOUSE; NORMALIZATION; SPECIFICATION; PRODUCT	Spinal muscular atrophy is one of the most common inherited forms of neurological disease leading to infant mortality. Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death. Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiology which may underlie their vulnerability to the disease process. Here we report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy. These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother. This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathology seen in a genetically inherited disease. As such, it represents a promising resource to study disease mechanisms, screen new drug compounds and develop new therapies.	[Ebert, Allison D.; Svendsen, Clive N.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Ebert, Allison D.; Thomson, James A.; Svendsen, Clive N.] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI 53705 USA; [Yu, Junying; Thomson, James A.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA; [Yu, Junying; Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.] Univ Missouri, Dept Vet Pathobiol, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Thomson, James A.; Svendsen, Clive N.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Neurol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ebert, AD (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	ebert@waisman.wisc.edu; cnsvendsen@wisc.edu			Amyotrophic Lateral Sclerosis Association; National Institutes of Neurological Disorders and Stroke [P01NS057778, R01NS41584]; National Institutes of Child Health and Human Development [R01HD054413]; National Institutes of General Medical Sciences [T32GM008396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041584, P01NS057778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG027566] Funding Source: NIH RePORTER	Amyotrophic Lateral Sclerosis Association; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Meyer for helpful discussions and B. Shelley, B. Heins and E. McMillan for technical assistance. We also thank WiCell Research Institute for karyotypeanalysis, Cell LineGenetics for DNA fingerprinting, R. Stewart, S. Tian and V. Ruotti at the Morgridge Institute for Research for microarray analysis, and Promega Corp. for qRT-PCR analysis (all at Madison, Wisconsin). The MNR2/HB9 (81.5C10) and the ISLET1 (40.2D6) monoclonal antibodies (both developed by T. Jessell) were obtained from the Developmental Studies HybridomaBank. Funding support was provided by the Amyotrophic Lateral Sclerosis Association (to C.N.S.), the National Institutes of Neurological Disorders and Stroke (P01NS057778 to C.N.S. and R01NS41584 to C.L.L.), National Institutes of Child Health and Human Development (R01HD054413 to C.L.L.), and National Institutes of General Medical Sciences (T32GM008396 for F.F.R.).	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Carriedo SG, 1996, J NEUROSCI, V16, P4069; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	41	1074	1207	2	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					277	U1		10.1038/nature07677	http://dx.doi.org/10.1038/nature07677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19098894	Green Accepted			2022-12-24	WOS:000262440900031
J	Thum, T; Gross, C; Fiedler, J; Fischer, T; Kissler, S; Bussen, M; Galuppo, P; Just, S; Rottbauer, W; Frantz, S; Castoldi, M; Soutschek, J; Koteliansky, V; Rosenwald, A; Basson, MA; Licht, JD; Pena, JTR; Rouhanifard, SH; Muckenthaler, MU; Tuschl, T; Martin, GR; Bauersachs, J; Engelhardt, S				Thum, Thomas; Gross, Carina; Fiedler, Jan; Fischer, Thomas; Kissler, Stephan; Bussen, Markus; Galuppo, Paolo; Just, Steffen; Rottbauer, Wolfgang; Frantz, Stefan; Castoldi, Mirco; Soutschek, Jurgen; Koteliansky, Victor; Rosenwald, Andreas; Basson, M. Albert; Licht, Jonathan D.; Pena, John T. R.; Rouhanifard, Sara H.; Muckenthaler, Martina U.; Tuschl, Thomas; Martin, Gail R.; Bauersachs, Johann; Engelhardt, Stefan			MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts	NATURE			English	Article							CARDIAC-HYPERTROPHY; HEART-FAILURE; IN-VIVO; EXPRESSION; REGULATOR; MECHANISM; SPROUTY2; MICE; PLAY	MicroRNAs comprise a broad class of small non- coding RNAs that control expression of complementary target messenger RNAs(1,2). Dysregulation of microRNAs by several mechanisms has been described in various disease states(3-5) including cardiac disease(6-10). Whereas previous studies of cardiac disease have focused on microRNAs that are primarily expressed in cardiomyocytes, the role of microRNAs expressed in other cell types of the heart is unclear. Here we show that microRNA-21 (miR-21, also known as Mirn21) regulates the ERK - MAP kinase signalling pathway in cardiac fibroblasts, which has impacts on global cardiac structure and function. miR-21 levels are increased selectively in fibroblasts of the failing heart, augmenting ERK - MAP kinase activity through inhibition of sprouty homologue 1 ( Spry1). This mechanism regulates fibroblast survival and growth factor secretion, apparently controlling the extent of interstitial fibrosis and cardiac hypertrophy. In vivo silencing of miR- 21 by a specific antagomir in a mouse pressure- overload- induced disease model reduces cardiac ERK - MAP kinase activity, inhibits interstitial fibrosis and attenuates cardiac dysfunction. These findings reveal that microRNAs can contribute to myocardial disease by an effect in cardiac fibroblasts. Our results validate miR- 21 as a disease target in heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a cardiovascular disease setting.	[Thum, Thomas; Fiedler, Jan; Galuppo, Paolo; Frantz, Stefan; Bauersachs, Johann] Univ Wurzburg, Dept Med 1, D-97080 Wurzburg, Germany; [Thum, Thomas; Fiedler, Jan] Univ Wurzburg, Jr Res Grp, IZKF, D-97080 Wurzburg, Germany; [Gross, Carina; Fischer, Thomas; Kissler, Stephan; Engelhardt, Stefan] Univ Wurzburg, Rudolf Virchow Ctr, DFG, Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Bussen, Markus] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Just, Steffen; Rottbauer, Wolfgang] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Castoldi, Mirco; Muckenthaler, Martina U.] Univ Heidelberg, Dept Pediat Hematol Oncol & Immunol, D-69120 Heidelberg, Germany; [Castoldi, Mirco; Muckenthaler, Martina U.] Univ Heidelberg, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Soutschek, Jurgen] Regulus Therapeut, Carlsbad, CA 92008 USA; [Koteliansky, Victor] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Pena, John T. R.; Rouhanifard, Sara H.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10065 USA; [Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany	University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; University of California System; University of California San Francisco; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Isis Pharmaceuticals Inc; University of London; King's College London; Northwestern University; Feinberg School of Medicine; Rockefeller University; Technical University of Munich	Bauersachs, J (corresponding author), Univ Wurzburg, Dept Med 1, D-97080 Wurzburg, Germany.	j.bauersachs@medizin.uni-wuerzburg.de; stefan.engelhardt@tum.de	Engelhardt, Stefan/AAA-9329-2019; Licht, Jonathan/L-4239-2019; Basson, M. Albert/C-5565-2009; Licht, Jonathan/AAL-9184-2020; Frantz, Stefan/G-1723-2012	Engelhardt, Stefan/0000-0001-5378-8661; Licht, Jonathan/0000-0002-3942-1369; Muckenthaler, Martina/0000-0002-3778-510X; /0000-0003-3062-7800; Basson, M. Albert/0000-0001-9834-7528; Rouhanifard, Sara/0000-0002-6991-4877; Thum, Thomas/0000-0003-4360-1511	IZKF [E-31]; Deutsche Forschungsgemeinschaft [DFG TH903/7-1]; Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine; Bavarian Ministry of Technology; ProCorde; Sanofi-Aventis; US NIH [R01 CA78711]; The Medical Faculty of the University of Heidelberg; Cancer Research Net [BMBF (NGFN) 201GS0450]; Leopoldina Academy [BMBF-LPD 9901/8-141]; NATIONAL CANCER INSTITUTE [R01CA059998, R01CA078711] Funding Source: NIH RePORTER	IZKF; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine; Bavarian Ministry of Technology; ProCorde; Sanofi-Aventis(Sanofi-Aventis); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Medical Faculty of the University of Heidelberg; Cancer Research Net; Leopoldina Academy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Hemmrich, U. Keller, J. Schittl, C. Dienesch, S. Thum, A. Leupold, M. Kummel, S. Schraut, A. Lauer, S. Marquart, E. Leich and A. Horn for technical assistance. Weacknowledge the contribution of V. Benes and S. Schmidt (miChip microarray Platform, EMBL), D. Fraccarollo and K. Hu (in vivo studies), S. Leierseder and X. Loyer (primary fibroblast preparation), C. Sohn- Lee (in situ hybridization experiments) and M. Manoharan, R. Braich and B. Bhat (antagomir oligonucleotides). We also thank L. Field, T. Brand and M. Gessler for discussions. This work was supported in part by grants from the IZKF (E-31 to T. Thum), the Deutsche Forschungsgemeinschaft (DFG TH903/7-1 to T. Thum and J. B.), the Rudolf Virchow Center/ DFG Research Center for Experimental Biomedicine (S.E., S.K.), the Bavarian Ministry of Technology, ProCorde and Sanofi-Aventis (S.E.), and the US NIH (R01 CA78711 to G. R. M.). M. C. is supported by an Excellence Fellowship of The Medical Faculty of the University of Heidelberg, M.U.M. by a Cancer Research Net grant (BMBF (NGFN) 201GS0450), and M. B. by the Leopoldina Academy (BMBF-LPD 9901/ 8- 141).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudej RK, 1997, J MOL CELL CARDIOL, V29, P2735, DOI 10.1006/jmcc.1997.0508; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li X, 1997, BIOTECHNIQUES, V23, P874, DOI 10.2144/97235st03; Merkle S, 2007, CIRC RES, V100, P645, DOI 10.1161/01.RES.0000260203.55077.61; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; THURN T, 2004, CIRC RES, V94, pE1; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhao CM, 2007, ADV INTEL SYS RES, V2, P317	30	1829	1974	1	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					980	U83		10.1038/nature07511	http://dx.doi.org/10.1038/nature07511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19043405				2022-12-24	WOS:000261768300052
J	Prucca, CG; Slavin, I; Quiroga, R; Elias, EV; Rivero, FD; Saura, A; Carranza, PG; Lujan, HD				Prucca, Cesar G.; Slavin, Ileana; Quiroga, Rodrigo; Elias, Eliana V.; Rivero, Fernando D.; Saura, Alicia; Carranza, Pedro G.; Lujan, Hugo D.			Antigenic variation in Giardia lamblia is regulated by RNA interference	NATURE			English	Article							GENE; PROTEIN; IDENTIFICATION; MECHANISMS; TRANSCRIPTS; EXPRESSION; EUKARYOTE; PLANTS; FUNGI; SENSE	Giardia lamblia ( also called Giardia intestinalis) is one of the most common intestinal parasites of humans. To evade the host's immune response, Giardia undergoes antigenic variation - a process that allows the parasite to develop chronic and recurrent infections. From a repertoire of similar to 190 variant- specific surface protein ( VSP)- coding genes, Giardia expresses only one VSP on the surface of each parasite at a particular time, but spontaneously switches to a different VSP by unknown mechanisms. Here we show that regulation of VSP expression involves a system comprising RNA- dependent RNA polymerase, Dicer and Argonaute, known components of the RNA interference machinery. Clones expressing a single surface antigen efficiently transcribe several VSP genes but only accumulate transcripts encoding the VSP to be expressed. Detection of antisense RNAs corresponding to the silenced VSP genes and small RNAs from the silenced but not for the expressed vsp implicate the RNA interference pathway in antigenic variation. Remarkably, silencing of Dicer and RNA- dependent RNA polymerase leads to a change from single to multiple VSP expression in individual parasites.	[Prucca, Cesar G.; Slavin, Ileana; Quiroga, Rodrigo; Elias, Eliana V.; Rivero, Fernando D.; Saura, Alicia; Carranza, Pedro G.; Lujan, Hugo D.] Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, Cordoba, Argentina	Catholic University of Cordoba	Lujan, HD (corresponding author), Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, X5004ASK, Cordoba, Argentina.	hlujan@ucc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022; Prucca, César/AAQ-4401-2020; Prucca, César Germán/AAC-4630-2021; Elias, Eliana Vanina/AAF-1997-2021; RIVERO, Fernando/AFV-5689-2022	Quiroga, Rodrigo/0000-0001-5015-0531; Prucca, César Germán/0000-0003-4165-4660; 	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Catolica de Cordoba; Howard Hughes Medical Institute; European Union CONTENT	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Catolica de Cordoba; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Union CONTENT(European Commission)	We thank N. Gottig and M. E. Alvarez for technical support. This work was supported by grants from the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (ANPCYT), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Universidad Catolica de Cordoba (UCC), the Howard Hughes Medical Institute (HHMI), and the European Union CONTENT project. H. D. L. is an HHMI International Research Scholar and a Member of the Scientific Investigator's Career of the CONICET.	ADAM RD, 1988, J EXP MED, V167, P109, DOI 10.1084/jem.167.1.109; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cogoni C, 1999, CURR OPIN MICROBIOL, V2, P657, DOI 10.1016/S1369-5274(99)00041-7; Deitsch KW, 1997, MICROBIOL MOL BIOL R, V61, P281, DOI 10.1128/.61.3.281-293.1997; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Green-Willms NS, 1998, MOL CELL BIOL, V18, P1826, DOI 10.1128/MCB.18.4.1826; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2000, RNA, V6, P1445, DOI 10.1017/S1355838200001096; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Kloc M, 2001, INT REV CYTOL, V203, P63; Kulakova L, 2006, MOL MICROBIOL, V61, P1533, DOI 10.1111/j.1365-2958.2006.05345.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; NASH TE, 1990, EXP PARASITOL, V71, P415, DOI 10.1016/0014-4894(90)90067-M; Nash TE, 1997, PHILOS T R SOC B, V352, P1369, DOI 10.1098/rstb.1997.0122; NASH TE, 1988, J IMMUNOL, V141, P636; Nash TE, 2001, INFECT IMMUN, V69, P1922, DOI 10.1128/IAI.69.3.1922-1923.2001; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Touz MC, 2002, J BIOL CHEM, V277, P50557, DOI 10.1074/jbc.M202558200; Ullu E, 2005, EUKARYOT CELL, V4, P1155, DOI 10.1128/EC.4.6.1155-1157.2005; von Allmen N, 2005, PARASITOLOGY, V130, P389, DOI 10.1017/S0031182004006742; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; WHITE TC, 1990, NUCLEIC ACIDS RES, V18, P553, DOI 10.1093/nar/18.3.553; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	38	154	169	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					750	754		10.1038/nature07585	http://dx.doi.org/10.1038/nature07585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079052				2022-12-24	WOS:000261559900040
J	Dello Ioio, R; Nakamura, K; Moubayidin, L; Perilli, S; Taniguchi, M; Morita, MT; Aoyama, T; Costantino, P; Sabatini, S				Dello Ioio, Raffaele; Nakamura, Kinu; Moubayidin, Laila; Perilli, Serena; Taniguchi, Masatoshi; Morita, Miyo T.; Aoyama, Takashi; Costantino, Paolo; Sabatini, Sabrina			A Genetic Framework for the Control of Cell Division and Differentiation in the Root Meristem	SCIENCE			English	Article							ARABIDOPSIS ROOTS; AUXIN RESPONSE; CYTOKININ; EXPRESSION; PROTEINS; SPECIFICITY; REGULATORS; GROWTH; ARR1	Plant growth and development are sustained by meristems. Meristem activity is controlled by auxin and cytokinin, two hormones whose interactions in determining a specific developmental output are still poorly understood. By means of a comprehensive genetic and molecular analysis in Arabidopsis, we show that a primary cytokinin- response transcription factor, ARR1, activates the gene SHY2/IAA3 (SHY2), a repressor of auxin signaling that negatively regulates the PIN auxin transport facilitator genes: thereby, cytokinin causes auxin redistribution, prompting cell differentiation. Conversely, auxin mediates degradation of the SHY2 protein, sustaining PIN activities and cell division. Thus, the cell differentiation and division balance necessary for controlling root meristem size and root growth is the result of the interaction between cytokinin and auxin through a simple regulatory circuit converging on the SHY2 gene.	[Dello Ioio, Raffaele; Moubayidin, Laila; Perilli, Serena; Costantino, Paolo; Sabatini, Sabrina] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Lab Genom & Proteom Funzionale Sistem Mod FGPL, I-00185 Rome, Italy; [Nakamura, Kinu; Taniguchi, Masatoshi; Aoyama, Takashi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Morita, Miyo T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Sapienza University Rome; Kyoto University; Nara Institute of Science & Technology	Sabatini, S (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Lab Genom & Proteom Funzionale Sistem Mod FGPL, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	sabrina.sabatini@uniroma1.it	Costantino, Paolo/K-4753-2015; dello ioio, raffaele/P-6254-2015	Costantino, Paolo/0000-0002-9166-2194; dello ioio, raffaele/0000-0001-8679-9412; Morita, Miyo/0000-0002-6176-5758; SABATINI, Sabrina/0000-0002-9691-6595	Giovanni Armenise-Harvard Foundation; Istituto Pasteur- Fondazione Cenci Bolognetti; Ministero dell'Istruzione; dell'Universita e della Ricerca ( MIUR); Ricerca di Interesse Nazionale; MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area-Plant Genomics	Giovanni Armenise-Harvard Foundation; Istituto Pasteur- Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca ( MIUR)(Ministry of Education, Universities and Research (MIUR)); Ricerca di Interesse Nazionale; MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area-Plant Genomics(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	We thank B. Scheres, O. Leyser, J. Reed, and G. Jurgens for providing material and all members of the FGPL for indispensable and helpful technical support. This work was supported by a Giovanni Armenise-Harvard Foundation career development grant (to S. S.) and by Istituto Pasteur- Fondazione Cenci Bolognetti, Ministero dell'Istruzione, dell'Universita e della Ricerca ( MIUR) progetti di Ricerca di Interesse Nazionale, and MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area- Plant Genomics ( to P. C.).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dello Loio R, 2008, CURR OPIN PLANT BIOL, V11, P23, DOI 10.1016/j.pbi.2007.10.006; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Klee Harry J., 1995, P340; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; MOCKAITIS K, 2008, ANNU REV CELL DEV BI, V10, P453; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tian Q, 1999, DEVELOPMENT, V126, P711; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659	23	635	655	14	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1380	1384		10.1126/science.1164147	http://dx.doi.org/10.1126/science.1164147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039136				2022-12-24	WOS:000261170600039
J	Wei, CL; Wang, XH; Chen, M; Ouyang, K; Song, LS; Cheng, HP				Wei, Chaoliang; Wang, Xianhua; Chen, Min; Ouyang, Kunfu; Song, Long-Sheng; Cheng, Heping			Calcium flickers steer cell migration	NATURE			English	Article							CATION CHANNELS; CHEMOTAXIS; ACTIVATION; DICTYOSTELIUM; TRANSIENT; MOVEMENT; SIGNALS; BACK; LOOP; RAC	Directional movement is a property common to all cell types during development and is critical to tissue remodelling and regeneration after damage(1-3). In migrating cells, calcium has a multifunctional role in directional sensing, cytoskeleton redistribution, traction force generation, and relocation of focal adhesions(1,4) (-7). Here we visualize high- calcium microdomains ('calcium flickers') and their patterned activation in migrating human embryonic lung fibroblasts. Calcium flicker activity is dually coupled to membrane tension ( by means of TRPM7, a stretch-activated Ca2(+)permeant channel of the transient receptor potential superfamily(8)) and chemoattractant signal transduction ( by means of type 2 inositol-1,4,5-trisphosphate-receptors). Interestingly, calcium flickers are most active at the leading lamella of migrating cells, displaying a 4: 1 front- to- rear polarization opposite to the global calcium gradient(6). When exposed to a platelet- derived growth factor gradient perpendicular to cell movement, asymmetric calcium flicker activity develops across the lamella and promotes the turning of migrating fibroblasts. These findings show how the exquisite spatiotemporal organization of calcium microdomains can orchestrate complex cellular processes such as cell migration.	[Wei, Chaoliang; Wang, Xianhua; Chen, Min; Ouyang, Kunfu; Cheng, Heping] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Song, Long-Sheng] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA	Peking University; University of Iowa	Cheng, HP (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	chaoliang.wei@gmail.com; chengp@pku.edu.cn	Wei, Chaoliang/A-9008-2013; Song, Long-Sheng/D-5899-2012; Heping, Cheng/AAE-2680-2019	Heping, Cheng/0000-0002-9604-6702; Song, Long-Sheng/0000-0002-6035-8106; ouyang, kunfu/0000-0003-0292-375X	Major State Basic Research Development Program of China [2007CB512100]; National Natural Science Foundation of China [30630021, 30800371]; NIH [HL090905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank I. C. Bruce, X. Zhu, J. J. Ma, H. Q. Cao, J. Liu, M. Zheng, X. D. Fu and R. P. Xiao for discussions, andM. Gorospe, Z. C. Liang, Q. Du, C. M. Cao, H. Huang, X. M. Lan, N. Lin, Y. R. Wang, R. S. Song and Y. Zhang for technical support. Special thanks to X. D. Fu for making his laboratory facility available to us. This work was supported by the Major State Basic Research Development Program of China (2007CB512100), and the National Natural Science Foundation of China (30630021 and 30800371) and an NIH grant (HL090905).	BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; HAHN K, 1992, NATURE, V359, P736, DOI 10.1038/359736a0; Hamill OP, 1996, PHARMACOL REV, V48, P231; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Thomas GH, 2000, TRENDS MICROBIOL, V8, P15, DOI 10.1016/S0966-842X(99)01668-6; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Ware MF, 1998, J CELL SCI, V111, P2423; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Zou H, 2002, P NATL ACAD SCI USA, V99, P6404, DOI 10.1073/pnas.092654999	30	439	449	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					901	905		10.1038/nature07577	http://dx.doi.org/10.1038/nature07577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19118385	Green Accepted			2022-12-24	WOS:000263266700049
J	Bashkirov, PV; Akimov, SA; Evseev, AI; Schmid, SL; Zimmerberg, J; Frolov, VA				Bashkirov, Pavel V.; Akimov, Sergey A.; Evseev, Alexey I.; Schmid, Sandra L.; Zimmerberg, Joshua; Frolov, Vadim A.			GTPase Cycle of Dynamin Is Coupled to Membrane Squeeze and Release, Leading to Spontaneous Fission	CELL			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; NERVE-TERMINALS; ENDOCYTOSIS; CURVATURE; VESICLES; TENSION; FUSION; DOMAIN; CELLS	The GTPase dynamin is critically involved in membrane fission during endocytosis. How does dynamin use the energy of GTP hydrolysis for membrane remodeling? By monitoring the ionic permeability through lipid nanotubes (NT), we found that dynamin was capable of squeezing NT to extremely small radii, depending on the NT lipid composition. However, long dynamin scaffolds did not produce fission: instead, fission followed GTPase-dependent cycles of assembly and disassembly of short dynamin scaffolds and involved a stochastic process dependent on the curvature stress imposed by dynamin. Fission happened spontaneously upon NT release from the scaffold, without leakage. Our calculations revealed that local narrowing of NT could induce cooperative lipid tilting, leading to self-merger of the inner monolayer of NT (hemifission), consistent with the absence of leakage. We propose that dynamin transmits GTP's energy to periodic assembling of a limited curvature scaffold that brings lipids to an unstable intermediate.	[Bashkirov, Pavel V.; Akimov, Sergey A.; Zimmerberg, Joshua; Frolov, Vadim A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, Bethesda, MD 20892 USA; [Bashkirov, Pavel V.; Akimov, Sergey A.; Evseev, Alexey I.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow 119991, Russia; [Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Scripps Research Institute	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@mail.nih.gov	Akimov, Sergey A/L-2001-2013; Akimov, Sergey/AFV-4270-2022; Akimov, Sergey A./I-6432-2015; Bashkirov, Pavel V/Y-8464-2018; Frolov, Vadim/ABH-3889-2020; Bashkirov, Pavel/J-2385-2012	Akimov, Sergey/0000-0002-7916-6032; Frolov, Vadim/0000-0002-0653-5669; Schmid, Sandra/0000-0002-1690-7024; Bashkirov, Pavel/0000-0003-2250-9759	National Institutes of Health (NIH) [R01GM42455, R37MH61345]; RFBR [08-04-00085]; CRDF GAP [RUB1-1297(5)-MO-05]; Russian Federal Agency for Science and Innovations [02.512.11.0010]; Program of Molecular and Cellular Biology RAS; Leading Scientific Schools of Russian Federation [4181.2008.4]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH061345, R01MH061345] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RFBR(Russian Foundation for Basic Research (RFBR)); CRDF GAP; Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Program of Molecular and Cellular Biology RAS; Leading Scientific Schools of Russian Federation(Leading Scientific Schools Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by the National Institutes of Health (NIH) intramural program (NICHD), and grants NIH R01GM42455 and R37MH61345, RFBR 08-04-00085, and CRDF GAP RUB1-1297(5)-MO-05, Russian Federal Agency for Science and Innovations 02.512.11.0010, Program of Molecular and Cellular Biology RAS, and the grant for State Support of Leading Scientific Schools of Russian Federation 4181.2008.4. The BODIPY-labeled dynamin was generously provided by Rajesh Ramachandran. We are grateful to Vladimir Lizunov and Gennady Kushnir for their technical help and Thomas Pucadyil, Anna Shnyrova, and Yuri Chizmadzhev for a careful reading of the manuscript and fruitful discussions.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Angelova I., 1988, PROG COLL POL SCI S, V76, P59, DOI [DOI 10.1007/BFB0114157, 10.1007/bfb0114171, DOI 10.1007/BFB0114171]; BARZIV R, 1994, PHYS REV LETT, V73, P1392, DOI 10.1103/PhysRevLett.73.1392; Bashkirov PV, 2007, BIOCHEM MOSC SUPPL S, V1, P176, DOI 10.1134/S1990747807020110; Bukman DJ, 1996, PHYS REV E, V54, P5463, DOI 10.1103/PhysRevE.54.5463; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Eliasson L, 1996, J PHYSIOL-LONDON, V493, P755, DOI 10.1113/jphysiol.1996.sp021420; EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2; FOURCADE B, 1994, PHYS REV E, V49, P5276, DOI 10.1103/PhysRevE.49.5276; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Frolov VA, 2008, CELL, V132, P727, DOI 10.1016/j.cell.2008.02.025; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kozlov MM, 2001, TRAFFIC, V2, P51, DOI 10.1034/j.1600-0854.2001.020107.x; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rappoport JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002416; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	42	221	223	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1276	1286		10.1016/j.cell.2008.11.028	http://dx.doi.org/10.1016/j.cell.2008.11.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19084269	Green Accepted, Bronze			2022-12-24	WOS:000261989800018
J	Boussau, B; Blanquart, S; Necsulea, A; Lartillot, N; Gouy, M				Boussau, Bastien; Blanquart, Samuel; Necsulea, Anamaria; Lartillot, Nicolas; Gouy, Manolo			Parallel adaptations to high temperatures in the Archaean eon	NATURE			English	Article							SEQUENCE ALIGNMENT; EVOLUTION; ORIGIN; BOMBARDMENT; BACTERIA; ANCESTOR; ACCURATE; PROTEIN; MODEL; TIME	Fossils of organisms dating from the origin and diversification of cellular life are scant and difficult to interpret(1), for this reason alternative means to investigate the ecology of the last universal common ancestor ( LUCA) and of the ancestors of the three domains of life are of great scientific value. It was recently recognized that the effects of temperature on ancestral organisms left 'genetic footprints' that could be uncovered in extant genomes(2-4). Accordingly, analyses of resurrected proteins predicted that the bacterial ancestor was thermophilic and that Bacteria subsequently adapted to lower temperatures(3,4). As the archaeal ancestor is also thought to have been thermophilic(5), the LUCA was parsimoniously inferred as thermophilic too. However, an analysis of ribosomal RNAs supported the hypothesis of a non- hyperthermophilic LUCA(2). Here we show that both rRNA and protein sequences analysed with advanced, realistic models of molecular evolution(6,7) provide independent support for two environmental- temperature-related phases during the evolutionary history of the tree of life. In the first period, thermotolerance increased from a mesophilic LUCA to thermophilic ancestors of Bacteria and of Archaea Eukaryota; in the second period, it decreased. Therefore, the two lineages descending from the LUCA and leading to the ancestors of Bacteria and Archaea - Eukaryota convergently adapted to high temperatures, possibly in response to a climate change of the early Earth(1,8,9), and/or aided by the transition from an RNA genome in the LUCA to organisms with more thermostable DNA genomes(10,11). This analysis unifies apparently contradictory results(2-4) into a coherent depiction of the evolution of an ecological trait over the entire tree of life.	[Boussau, Bastien; Necsulea, Anamaria; Gouy, Manolo] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Blanquart, Samuel; Lartillot, Nicolas] CNRS, LIRMM, F-34392 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier	Gouy, M (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, 32 Blvd 11 Novembre, F-69622 Villeurbanne, France.	mgouy@biomserv.univ-lyon1.fr		Boussau, Bastien/0000-0003-0776-4460	Action Concertee Incitative IMPBIO-MODELPHYLO; ANR PlasmoExplore	Action Concertee Incitative IMPBIO-MODELPHYLO; ANR PlasmoExplore(French National Research Agency (ANR))	This work was supported by Action Concertee Incitative IMPBIO-MODELPHYLO and ANR PlasmoExplore. We thank C. Brochier-Armanet and A. Lazcano for help and suggestions, the LIRMM Bioinformatics platform ATGC and the computing facilities of IN2P3.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Blanquart S, 2006, MOL BIOL EVOL, V23, P2058, DOI 10.1093/molbev/msl091; Boussau B, 2006, SYSTEMATIC BIOL, V55, P756, DOI 10.1080/10635150600975218; Brooks DJ, 2004, BIOINFORMATICS, V20, P2251, DOI 10.1093/bioinformatics/bth235; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Di Giulio M, 2003, J MOL EVOL, V57, P721, DOI 10.1007/s00239-003-2522-6; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Gowri-Shankar V, 2006, MOL BIOL EVOL, V23, P352, DOI 10.1093/molbev/msj040; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HILL MO, 1974, ROY STAT SOC C-APP, V23, P340; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Islas S, 2003, INT MICROBIOL, V6, P87, DOI 10.1007/s10123-003-0113-4; Kasting JF, 2006, PHILOS T R SOC B, V361, P917, DOI 10.1098/rstb.2006.1839; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shields GA, 2007, NATURE, V447, pE1, DOI 10.1038/nature05830; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wolf YI, 1999, GENOME RES, V9, P689; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhaxybayeva O, 2005, PROTOPLASMA, V227, P53, DOI 10.1007/s00709-005-0135-1	45	149	153	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					942	U74		10.1038/nature07393	http://dx.doi.org/10.1038/nature07393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19037246	Green Submitted			2022-12-24	WOS:000261768300043
J	Chan, PS; Khalid, A; Longmore, LS; Berg, RA; Kosiborod, M; Spertus, JA				Chan, Paul S.; Khalid, Adnan; Longmore, Lance S.; Berg, Robert A.; Kosiborod, Mikhail; Spertus, John A.			Hospital-wide Code Rates and Mortality Before and After Implementation of a Rapid Response Team	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL EMERGENCY TEAM; CARDIAC-ARREST; CONTROLLED-TRIAL; INTENSIVE-CARE; CARDIOPULMONARY ARRESTS; HEART-FAILURE; ANTECEDENTS; REDUCTION; SURVIVAL; DEATH	Context Rapid response teams have been shown in adult inpatients to decrease cardiopulmonary arrest ( code) rates outside of the intensive care unit ( ICU). Because a primary action of rapid response teams is to transfer patients to the ICU, their ability to reduce hospital- wide code rates and mortality remains unknown. Objective To determine rates of hospital- wide codes and mortality before and after implementation of a long- term rapid response team intervention. Design, Setting, and Patients A prospective cohort design of adult inpatients admitted between January 1, 2004, and August 31, 2007, at Saint Luke's Hospital, a 404- bed tertiary care academic hospital in Kansas City, Missouri. Rapid response team education and program rollout occurred from September 1 to December 31, 2005. A total of 24 193 patient admissions were evaluated prior to the intervention ( January 1, 2004, to August 31, 2005), and 24 978 admissions were evaluated after the intervention ( January 1, 2006, to August 31, 2007). Intervention Using standard activation criteria, a 3- member rapid response team composed of experienced ICU staff and a respiratory therapist performed the evaluation, treatment, and triage of inpatients with evidence of acute physiological decline. Main Outcome Measures Hospital- wide code rates and mortality, adjusted for preintervention trends. Results There were a total of 376 rapid response team activations. After rapid response team implementation, mean hospital- wide code rates decreased from 11.2 to 7.5 per 1000 admissions. This was not associated with a reduction in the primary end point of hospital- wide code rates ( adjusted odds ratio [ AOR], 0.76 [ 95% confidence interval {CI}, 0.57- 1.01]; P=. 06), although lower rates of non- ICU codes were observed ( non- ICU AOR, 0.59 [ 95% CI, 0.40- 0.89] vs ICU AOR, 0.95 [ 95% CI, 0.641.43]; P=. 03 for interaction). Similarly, hospital- wide mortality did not differ between the preintervention and postintervention periods ( 3.22 vs 3.09 per 100 admissions; AOR, 0.95 [ 95% CI, 0.81- 1.11]; P=. 52). Secondary analyses revealed few instances of rapid response team undertreatment or underuse that may have affected the mortality findings. Conclusion In this large single- institution study, rapid response team implementation was not associated with reductions in hospital- wide code rates or mortality.	[Chan, Paul S.; Khalid, Adnan; Longmore, Lance S.; Kosiborod, Mikhail; Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Div Cardiol, Kansas City, MO 64111 USA; [Berg, Robert A.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Arizona	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, Div Cardiol, 5th Floor,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Spertus, John/ABD-3075-2021; Kosiborod, Mikhail/HDO-1541-2022	Kosiborod, Mikhail/0000-0002-3750-9789				Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Brilli RJ, 2007, PEDIATR CRIT CARE ME, V8, P236, DOI 10.1097/01.PCC.0000262947.72442.EA; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Kenward G, 2004, RESUSCITATION, V61, P257, DOI 10.1016/j.resuscitation.2004.01.021; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401	21	220	241	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2506	2513		10.1001/jama.2008.715	http://dx.doi.org/10.1001/jama.2008.715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050194	Bronze			2022-12-24	WOS:000261286200019
J	Lenz, G; Wright, G; Dave, SS; Xiao, W; Powell, J; Zhao, H; Xu, W; Tan, B; Goldschmidt, N; Iqbal, J; Vose, J; Bast, M; Fu, K; Weisenburger, DD; Greiner, TC; Armitage, JO; Kyle, A; May, L; Gascoyne, RD; Connors, JM; Troen, G; Holte, H; Kvaloy, S; Dierickx, D; Verhoef, G; Delabie, J; Smeland, EB; Jares, P; Martinez, A; Lopez-Guillermo, A; Montserrat, E; Campo, E; Braziel, RM; Miller, TP; Rimsza, LM; Cook, JR; Pohlman, B; Sweetenham, J; Tubbs, RR; Fisher, RI; Hartmann, E; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Wrench, D; Lister, TA; Jaffe, ES; Wilson, WH; Chan, WC; Staudt, LM				Lenz, G.; Wright, G.; Dave, S. S.; Xiao, W.; Powell, J.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.; Troen, G.; Holte, H.; Kvaloy, S.; Dierickx, D.; Verhoef, G.; Delabie, J.; Smeland, E. B.; Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.; Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Pohlman, B.; Sweetenham, J.; Tubbs, R. R.; Fisher, R. I.; Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. -K; Wrench, D.; Lister, T. A.; Jaffe, E. S.; Wilson, W. H.; Chan, W. C.; Staudt, L. M.		Lymphoma Leukemia Mol Profiling Pr	Stromal Gene Signatures in Large-B-Cell Lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; NON-HODGKINS-LYMPHOMA; TISSUE GROWTH-FACTOR; ANGIOGENIC SWITCH; BREAST-CANCER; TUMOR-GROWTH; MOUSE MODEL; EXPRESSION; SURVIVAL; CHEMOTHERAPY	Background: The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear. Methods: We profiled gene expression in pretreatment biopsy specimens from 181 patients with diffuse large-B-cell lymphoma who received CHOP and 233 patients with this disease who received R-CHOP. A multivariate gene-expression-based survival-predictor model derived from a training group was tested in a validation group. Results: A multivariate model created from three gene-expression signatures - termed ``germinal-center B-cell,'' ``stromal-1,'' and ``stromal-2'' - predicted survival both in patients who received CHOP and patients who received R-CHOP. The prognostically favorable stromal-1 signature reflected extracellular-matrix deposition and histiocytic infiltration. By contrast, the prognostically unfavorable stromal-2 signature reflected tumor blood-vessel density. Conclusions: Survival after treatment of diffuse large-B-cell lymphoma is influenced by differences in immune cells, fibrosis, and angiogenesis in the tumor microenvironment.	[Lenz, G.; Dave, S. S.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Wilson, W. H.; Staudt, L. M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wright, G.] NCI, Biometr Res Branch, Div Canc Treatment & Diagnosis, NIH, Bethesda, MD 20892 USA; [Xiao, W.; Powell, J.] NIH, Bioinformat & Mol Anal Sect, Bethesda, MD 20892 USA; [Jaffe, E. S.] NIH, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; NIH, Computat Biosci & Engn Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Chan, W. C.] Univ Nebraska Med Ctr, Omaha, NE USA; [Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Troen, G.; Delabie, J.] Univ Oslo, Rikshosp Univ Hosp, Pathol Clin, N-0027 Oslo, Norway; [Holte, H.; Kvaloy, S.] Univ Oslo, Rikshosp Univ Hosp, Canc Clin, N-0027 Oslo, Norway; [Smeland, E. B.] Univ Oslo, Rikshosp Univ Hosp, Canc Res Inst, N-0027 Oslo, Norway; [Smeland, E. B.] Univ Oslo, Norwegian Radium Hosp, Ctr Canc Biomed, Fac Div, N-0027 Oslo, Norway; [Dierickx, D.; Verhoef, G.] Katholieke Univ Leuven, Dept Hematol, Louvain, Belgium; [Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Braziel, R. M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Tubbs, R. R.; Fisher, R. I.] SW Oncol Grp, Tucson, AZ USA; [Miller, T. P.; Rimsza, L. M.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Pohlman, B.; Sweetenham, J.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Cook, J. R.; Tubbs, R. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Fisher, R. I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA; [Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. -K] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany; [Ott, G.] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Wrench, D.; Lister, T. A.] St Bartholomews Hosp, Canc Res UK, London, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Nebraska System; University of Nebraska Medical Center; British Columbia Cancer Agency; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; KU Leuven; University of Barcelona; Hospital Clinic de Barcelona; Oregon Health & Science University; Southwest Oncology Group; University of Arizona; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Rochester; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Cancer Research UK; University of London; Queen Mary University London	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bldg 10,Rm 4N114, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Lenz, Georg/I-6844-2012; Wright, George W/M-1660-2017; Staudt, Louis/AAC-5324-2019; Jares, Pedro/T-3778-2019; Connors, Joseph/AAF-5284-2019; Gascoyne, Randy D/A-6009-2013; Holte, Harald/AAO-5647-2020; Martinez, Antonio/D-8188-2012; Lopez-Guillermo, Armando/Z-5684-2019; Jaffe, Elaine/G-8981-2014; Campo, Elias/AAC-5593-2019; Smeland, Erlend/AAO-3214-2020	Connors, Joseph/0000-0002-1361-7531; Gascoyne, Randy D/0000-0002-2610-5690; Martinez, Antonio/0000-0003-0790-9017; Campo, Elias/0000-0001-9850-9793; Delabie, Jan/0000-0001-5023-0689; Iqbal, Javeed/0000-0003-3668-0629; JARES, PEDRO/0000-0002-8401-579X	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; NCI Strategic Partnering to Evaluate Cancer Signature [UO1-CA114778]; German Research Foundation; Genentech; Imedex Future; Ziopharm; L'Oreal; Celgene; Genitope; Biogen Idec; Roche Canada; Schering and Hoffmann-La Roche; Ventana Medical Systems; Roche Molecular Systems; Genentech BioOncology; Genentech BioOncology National Lymphocare Study; Allos Therapeutics; Millennium; Amgen; Pharmion; Roche; Seattle Genetics; Imedex; Eleos; Educational Concepts; Upside Endeavors; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011006, U01CA114778, ZIASC000550] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Strategic Partnering to Evaluate Cancer Signature(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation(German Research Foundation (DFG)); Genentech(Roche HoldingGenentech); Imedex Future; Ziopharm; L'Oreal(L'Oreal Group); Celgene(Bristol-Myers SquibbCelgene Corporation); Genitope; Biogen Idec(Biogen); Roche Canada(Roche Holding); Schering and Hoffmann-La Roche(Hoffmann-La Roche); Ventana Medical Systems; Roche Molecular Systems; Genentech BioOncology; Genentech BioOncology National Lymphocare Study; Allos Therapeutics; Millennium(Takeda Pharmaceutical Company Ltd); Amgen(Amgen); Pharmion; Roche(Roche Holding); Seattle Genetics; Imedex; Eleos; Educational Concepts; Upside Endeavors; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Intramural Research Program of the National Institutes of Health, the National Cancer Institute ( NCI), and the Center for Cancer Research; an NCI Strategic Partnering to Evaluate Cancer Signature grant (UO1-CA114778); and a grant from the German Research Foundation (to Dr. Lenz).; Dr. Vose reports receiving grant support from Genentech; Dr. Greiner, lecture fees from Imedex Future; Dr. Armitage, consulting fees from Ziopharm, L'Oreal, Celgene, Genitope, and Biogen Idec and lecture fees from Genentech; Dr. Gascoyne, consulting fees from Genentech and Roche Canada and lecture fees and grant support from Roche Canada; Dr. Connors, grant support from Roche Canada; Dr. Montserrat, consulting fees from Schering and Hoffmann-La Roche; Dr. Miller, consulting fees and grant support from Genentech and Biogen Idec; Dr. Rimsza, grant support from Ventana Medical Systems; Dr. Cook, consulting fees from Roche Molecular Systems; Dr. Pohlman, consulting fees from Genentech BioOncology and grant support from Genentech BioOncology National Lymphocare Study; Dr. Fisher, consulting fees from Allos Therapeutics, Millennium, Amgen, Pharmion, Celgene, Roche, Genentech, and Seattle Genetics; Dr. Lister, consulting fees from Imedex, Eleos, Educational Concepts, Genentech, and Upside Endeavors and grant support from Millennium; and Dr. Chan, grant support from Roche Molecular Systems. No other potential conflict of interest relevant to this article was reported.; We thank Alexander Kohlmann, Mickey Williams, and Lothar Wieczorek at Roche Molecular Systems for logistical support.	Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Ganjoo KN, 2006, LEUKEMIA LYMPHOMA, V47, P998, DOI 10.1080/10428190600563821; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tagawa H, 2006, BLOOD, V107, P3052; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	33	1244	1279	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2313	2323		10.1056/NEJMoa0802885	http://dx.doi.org/10.1056/NEJMoa0802885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377SG	19038878	Green Accepted, Green Submitted			2022-12-24	WOS:000261270300003
J	Chandra, V; Huang, PX; Hamuro, Y; Raghuram, S; Wang, YJ; Burris, TP; Rastinejad, F				Chandra, Vikas; Huang, Pengxiang; Hamuro, Yoshitomo; Raghuram, Srilatha; Wang, Yongjun; Burris, Thomas P.; Rastinejad, Fraydoon			Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; RETINOID-X-RECEPTOR; REV-ERB-ALPHA; LIGAND-BINDING; ALLOSTERIC CONTROL; DOMAIN; IDENTIFICATION; MECHANISM; POLARITY; AGONISTS	Nuclear receptors are multi- domain transcription factors that bind to DNA elements from which they regulate gene expression. The peroxisome proliferator- activated receptors ( PPARs) form heterodimers with the retinoid X receptor ( RXR), and PPAR-gamma has been intensively studied as a drug target because of its link to insulin sensitization. Previous structural studies have focused on isolated DNA or ligand- binding segments, with no demonstration of how multiple domains cooperate to modulate receptor properties. Here we present structures of intact PPAR-gamma and RXR-alpha as a heterodimer bound to DNA, ligands and coactivator peptides. PPAR-gamma and RXR-alpha form a non- symmetric complex, allowing the ligand- binding domain ( LBD) of PPAR-gamma to contact multiple domains in both proteins. Three interfaces link PPAR-gamma and RXR-alpha, including some that are DNA dependent. The PPAR-gamma LBD cooperates with both DNA- binding domains ( DBDs) to enhance response- element binding. The A/B segments are highly dynamic, lacking folded substructures despite their gene- activation properties.	[Chandra, Vikas; Huang, Pengxiang; Raghuram, Srilatha; Rastinejad, Fraydoon] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [Chandra, Vikas; Huang, Pengxiang; Raghuram, Srilatha; Rastinejad, Fraydoon] Univ Virginia Hlth Syst, Ctr Mol Design, Charlottesville, VA 22908 USA; [Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Wang, Yongjun; Burris, Thomas P.] Louisiana State Univ, Pennington Biomed Res Ctr, Nucl Receptor Biol Lab, Baton Rouge, LA 70808 USA	University of Virginia; University of Virginia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Rastinejad, F (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	fr9c@virginia.edu	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011	Burris, Thomas P/0000-0003-2922-4449; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055217] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055217-11, R01 GM055217] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN F, 1993, BIOCHEM BIOPH RES CO, V196, P671, DOI 10.1006/bbrc.1993.2302; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Greschik I, 2003, CURR TOP MED CHEM, V3, P1573, DOI 10.2174/1568026033451736; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sierk ML, 2001, BIOCHEMISTRY-US, V40, P12833, DOI 10.1021/bi011086r; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Staels B, 2007, THERAPIE, V62, P319, DOI 10.2515/therapie:2007051; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2	49	544	560	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					350	U33		10.1038/nature07413	http://dx.doi.org/10.1038/nature07413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19043829	Green Accepted			2022-12-24	WOS:000261039600035
J	Mitchell, R; Popham, F				Mitchell, Richard; Popham, Frank			Effect of exposure to natural environment on health inequalities: an observational population study	LANCET			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC INEQUALITIES; AIR-POLLUTION; GREEN SPACE; MORTALITY; DETERMINANTS; RESTORATION; URBANITY; WALKING; STRESS	Background Studies have shown that exposure to the natural environment, or so-called green space, has an independent effect on health and health-related behaviours. We postulated that income-related inequality in health would be less pronounced in populations with greater exposure to green space, since access to such areas can modify pathways through which low socioeconomic position can lead to disease. Methods We classified the population of England at younger than retirement age (n=40 813 236) into groups on the basis of income deprivation and exposure to green space. We obtained individual mortality records (n=366348) to establish whether the association between income deprivation, all-cause mortality, and cause-specific mortality (circulatory disease, lung cancer, and intentional self-harm) in 2001-05, varied by exposure to green space measured in 2001, with control for potential confounding factors. We used stratified models to identify the nature of this variation. Findings The association between income deprivation and mortality differed significantly across the groups of exposure to green space for mortality from all causes (p<0.0001) and circulatory disease (p=0.0212), but not from lung cancer or intentional self-harm. Health inequalities related to income deprivation in all-cause mortality and mortality from circulatory diseases were lower in populations living in the greenest areas. The incidence rate ratio (IRR) for all-cause mortality for the most income deprived quartile compared with the least deprived was 1.93 (95% CI 1.86-2.01) in the least green areas, whereas it was 1.43 (1.34-1.53) in the most green. For circulatory diseases, the IRR was 2.19 (2.04-2.34) in the least green areas and 1.54 (1.38-1.73) in the most green. There was no effect for causes of death unlikely to be affected by green space, such as lung cancer and intentional self-harm. Interpretation Populations that are exposed to the greenest environments also have lowest levels of health inequality related to income deprivation. Physical environments that promote good health might be important to reduce socioeconomic health inequalities.	[Mitchell, Richard] Univ Glasgow, Glasgow G12 8RZ, Lanark, Scotland; [Popham, Frank] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland	University of Glasgow; University of St Andrews	Mitchell, R (corresponding author), Univ Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	r.mitchell@clinmed.gla.ac.uk	Mitchell, Rich JL/E-8056-2011; Popham, Frank/E-7770-2012	Popham, Frank/0000-0002-7263-7954				[Anonymous], 2005, GEN LAND US DAT STAT; Bibby P., 2004, DEV NEW CLASSIFICATI; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Giles-Corti B, 2005, AM J PREV MED, V28, P169, DOI 10.1016/j.amepre.2004.10.018; Grahn Patrik, 2003, Urban Forestry & Urban Greening, V2, P001, DOI 10.1078/1618-8667-00019; Groenewegen PP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-149; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; *HLTH COUNC NETH D, 2004, NAT ENV NAT HLTH INF; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Kaczynski AT, 2007, LEISURE SCI, V29, P315, DOI 10.1080/01490400701394865; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Krewski D, 2007, J TOXICOL ENV HEAL A, V70, P275, DOI 10.1080/15287390600884859; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Macintyre S, 2007, 17 MRC SOC PUBL HLTH; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Mitchell R, 2002, INT J EPIDEMIOL, V31, P831, DOI 10.1093/ije/31.4.831; Mitchell R, 2007, J EPIDEMIOL COMMUN H, V61, P681, DOI 10.1136/jech.2006.053553; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Popham F, 2007, PREV MED, V45, P182, DOI 10.1016/j.ypmed.2007.06.012; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Prevention CfDCa, 2008, HLTH PLAC TERM; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Smith GD, 2005, CIRCULATION, V112, P332, DOI 10.1161/CIRCULATIONAHA.104.489088; Smith GD, 2000, BRIT MED J, V320, P582, DOI 10.1136/bmj.320.7234.582; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; Smith GD, 2000, PUBLIC HEALTH, V114, P308, DOI 10.1016/S0033-3506(00)00353-X; Tardon A, 2005, CANCER CAUSE CONTROL, V16, P389, DOI 10.1007/s10552-004-5026-9; *UCLA AC TECHN SER, 2008, AN CORR CLUST DAT; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WILKINSON RG, 1992, AM J PUBLIC HEALTH, V82, P1082, DOI 10.2105/AJPH.82.8.1082; Wilkinson RG., 2001, MIND GAP HIERARCHIES; Wilkinson RG, 2008, AM J PUBLIC HEALTH, V98, P699, DOI 10.2105/AJPH.2007.109637; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Woods LM, 2005, J EPIDEMIOL COMMUN H, V59, P115, DOI 10.1136/jech.2003.013003; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	46	1088	1116	32	445	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1655	1660		10.1016/S0140-6736(08)61689-X	http://dx.doi.org/10.1016/S0140-6736(08)61689-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994663	Green Accepted			2022-12-24	WOS:000260899900027
J	Bentley, DR; Balasubramanian, S; Swerdlow, HP; Smith, GP; Milton, J; Brown, CG; Hall, KP; Evers, DJ; Barnes, CL; Bignell, HR; Boutell, JM; Bryant, J; Carter, RJ; Cheetham, RK; Cox, AJ; Ellis, DJ; Flatbush, MR; Gormley, NA; Humphray, SJ; Irving, LJ; Karbelashvili, MS; Kirk, SM; Li, H; Liu, XH; Maisinger, KS; Murray, LJ; Obradovic, B; Ost, T; Parkinson, ML; Pratt, MR; Rasolonjatovo, IMJ; Reed, MT; Rigatti, R; Rodighiero, C; Ross, MT; Sabot, A; Sankar, SV; Scally, A; Schroth, GP; Smith, ME; Smith, VP; Spiridou, A; Torrance, PE; Tzonev, SS; Vermaas, EH; Walter, K; Wu, XL; Zhang, L; Alam, MD; Anastasi, C; Aniebo, IC; Bailey, DMD; Bancarz, IR; Banerjee, S; Barbour, SG; Baybayan, PA; Benoit, VA; Benson, KF; Bevis, C; Black, PJ; Boodhun, A; Brennan, JS; Bridgham, JA; Brown, RC; Brown, AA; Buermann, DH; Bundu, AA; Burrows, JC; Carter, NP; Castillo, N; Catenazzi, MCE; Chang, S; Cooley, RN; Crake, NR; Dada, OO; Diakoumakos, KD; Dominguez-Fernandez, B; Earnshaw, DJ; Egbujor, UC; Elmore, DW; Etchin, SS; Ewan, MR; Fedurco, M; Fraser, LJ; Fajardo, KVF; Furey, WS; George, D; Gietzen, KJ; Goddard, CP; Golda, GS; Granieri, PA; Green, DE; Gustafson, DL; Hansen, NF; Harnish, K; Haudenschild, CD; Heyer, NI; Hims, MM; Ho, JT; Horgan, AM; Hoschler, K; Hurwitz, S; Ivanov, DV; Johnson, MQ; James, T; Jones, TAH; Kang, GD; Kerelska, TH; Kersey, AD; Khrebtukova, I; Kindwall, AP; Kingsbury, Z; Kokko-Gonzales, PI; Kumar, A; Laurent, MA; Lawley, CT; Lee, SE; Lee, X; Liao, AK; Loch, JA; Lok, M; Luo, SJ; Mammen, RM; Martin, JW; McCauley, PG; McNitt, P; Mehta, P; Moon, KW; Mullens, JW; Newington, T; Ning, ZM; Ng, BL; Novo, SM; O'Neill, MJ; Osborne, MA; Osnowski, A; Ostadan, O; Paraschos, LL; Pickering, L; Pike, AC; Pike, AC; Pinkard, DC; Pliskin, DP; Podhasky, J; Quijano, VJ; Raczy, C; Rae, VH; Rawlings, SR; Rodriguez, AC; Roe, PM; Rogers, J; Bacigalupo, MCR; Romanov, N; Romieu, A; Roth, RK; Rourke, NJ; Ruediger, ST; Rusman, E; Sanches-Kuiper, RM; Schenker, MR; Seoane, JM; Shaw, RJ; Shiver, MK; Short, SW; Sizto, NL; Sluis, JP; Smith, MA; Sohna, JES; Spence, EJ; Stevens, K; Sutton, N; Szajkowski, L; Tregidgo, CL; Turcatti, G; vandeVondele, S; Verhovsky, Y; Virk, SM; Wakelin, S; Walcott, GC; Wang, JW; Worsley, GJ; Yan, JY; Yau, L; Zuerlein, M; Rogers, J; Mullikin, JC; Hurles, ME; McCooke, NJ; West, JS; Oaks, FL; Lundberg, PL; Klenerman, D; Durbin, R; Smith, AJ				Bentley, David R.; Balasubramanian, Shankar; Swerdlow, Harold P.; Smith, Geoffrey P.; Milton, John; Brown, Clive G.; Hall, Kevin P.; Evers, Dirk J.; Barnes, Colin L.; Bignell, Helen R.; Boutell, Jonathan M.; Bryant, Jason; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony J.; Ellis, Darren J.; Flatbush, Michael R.; Gormley, Niall A.; Humphray, Sean J.; Irving, Leslie J.; Karbelashvili, Mirian S.; Kirk, Scott M.; Li, Heng; Liu, Xiaohai; Maisinger, Klaus S.; Murray, Lisa J.; Obradovic, Bojan; Ost, Tobias; Parkinson, Michael L.; Pratt, Mark R.; Rasolonjatovo, Isabelle M. J.; Reed, Mark T.; Rigatti, Roberto; Rodighiero, Chiara; Ross, Mark T.; Sabot, Andrea; Sankar, Subramanian V.; Scally, Aylwyn; Schroth, Gary P.; Smith, Mark E.; Smith, Vincent P.; Spiridou, Anastassia; Torrance, Peta E.; Tzonev, Svilen S.; Vermaas, Eric H.; Walter, Klaudia; Wu, Xiaolin; Zhang, Lu; Alam, Mohammed D.; Anastasi, Carole; Aniebo, Ify C.; Bailey, David M. D.; Bancarz, Iain R.; Banerjee, Saibal; Barbour, Selena G.; Baybayan, Primo A.; Benoit, Vincent A.; Benson, Kevin F.; Bevis, Claire; Black, Phillip J.; Boodhun, Asha; Brennan, Joe S.; Bridgham, John A.; Brown, Rob C.; Brown, Andrew A.; Buermann, Dale H.; Bundu, Abass A.; Burrows, James C.; Carter, Nigel P.; Castillo, Nestor; Catenazzi, Maria Chiara E.; Chang, Simon; Cooley, R. Neil; Crake, Natasha R.; Dada, Olubunmi O.; Diakoumakos, Konstantinos D.; Dominguez-Fernandez, Belen; Earnshaw, David J.; Egbujor, Ugonna C.; Elmore, David W.; Etchin, Sergey S.; Ewan, Mark R.; Fedurco, Milan; Fraser, Louise J.; Fajardo, Karin V. Fuentes; Furey, W. Scott; George, David; Gietzen, Kimberley J.; Goddard, Colin P.; Golda, George S.; Granieri, Philip A.; Green, David E.; Gustafson, David L.; Hansen, Nancy F.; Harnish, Kevin; Haudenschild, Christian D.; Heyer, Narinder I.; Hims, Matthew M.; Ho, Johnny T.; Horgan, Adrian M.; Hoschler, Katya; Hurwitz, Steve; Ivanov, Denis V.; Johnson, Maria Q.; James, Terena; Jones, T. A. Huw; Kang, Gyoung-Dong; Kerelska, Tzvetana H.; Kersey, Alan D.; Khrebtukova, Irina; Kindwall, Alex P.; Kingsbury, Zoya; Kokko-Gonzales, Paula I.; Kumar, Anil; Laurent, Marc A.; Lawley, Cynthia T.; Lee, Sarah E.; Lee, Xavier; Liao, Arnold K.; Loch, Jennifer A.; Lok, Mitch; Luo, Shujun; Mammen, Radhika M.; Martin, John W.; McCauley, Patrick G.; McNitt, Paul; Mehta, Parul; Moon, Keith W.; Mullens, Joe W.; Newington, Taksina; Ning, Zemin; Ng, Bee Ling; Novo, Sonia M.; O'Neill, Michael J.; Osborne, Mark A.; Osnowski, Andrew; Ostadan, Omead; Paraschos, Lambros L.; Pickering, Lea; Pike, Andrew C.; Pike, Alger C.; Pinkard, D. Chris; Pliskin, Daniel P.; Podhasky, Joe; Quijano, Victor J.; Raczy, Come; Rae, Vicki H.; Rawlings, Stephen R.; Rodriguez, Ana Chiva; Roe, Phyllida M.; Rogers, John; Bacigalupo, Maria C. Rogert; Romanov, Nikolai; Romieu, Anthony; Roth, Rithy K.; Rourke, Natalie J.; Ruediger, Silke T.; Rusman, Eli; Sanches-Kuiper, Raquel M.; Schenker, Martin R.; Seoane, Josefina M.; Shaw, Richard J.; Shiver, Mitch K.; Short, Steven W.; Sizto, Ning L.; Sluis, Johannes P.; Smith, Melanie A.; Sohna, Jean Ernest Sohna; Spence, Eric J.; Stevens, Kim; Sutton, Neil; Szajkowski, Lukasz; Tregidgo, Carolyn L.; Turcatti, Gerardo; vandeVondele, Stephanie; Verhovsky, Yuli; Virk, Selene M.; Wakelin, Suzanne; Walcott, Gregory C.; Wang, Jingwen; Worsley, Graham J.; Yan, Juying; Yau, Ling; Zuerlein, Mike; Rogers, Jane; Mullikin, James C.; Hurles, Matthew E.; McCooke, Nick J.; West, John S.; Oaks, Frank L.; Lundberg, Peter L.; Klenerman, David; Durbin, Richard; Smith, Anthony J.			Accurate whole human genome sequencing using reversible terminator chemistry	NATURE			English	Article							STRUCTURAL VARIATION; CHROMATIN; MAPS	DNA sequence information underpins genetic research, enabling discoveries of important biological or medical benefit. Sequencing projects have traditionally used long ( 400 - 800 base pair) reads, but the existence of reference sequences for the human and many other genomes makes it possible to develop new, fast approaches to re- sequencing, whereby shorter reads are compared to a reference to identify intraspecies genetic variation. Here we report an approach that generates several billion bases of accurate nucleotide sequence per experiment at low cost. Single molecules of DNA are attached to a flat surface, amplified in situ and used as templates for synthetic sequencing with fluorescent reversible terminator deoxyribonucleotides. Images of the surface are analysed to generate high- quality sequence. We demonstrate application of this approach to human genome sequencing on flow- sorted X chromosomes and then scale the approach to determine the genome sequence of a male Yoruba from Ibadan, Nigeria. We build an accurate consensus sequence from. 303 average depth of paired 35- base reads. We characterize four million single- nucleotide polymorphisms and four hundred thousand structural variants, many of which were previously unknown. Our approach is effective for accurate, rapid and economical whole- genome re- sequencing and many other biomedical applications.	[Bentley, David R.; Swerdlow, Harold P.; Smith, Geoffrey P.; Milton, John; Brown, Clive G.; Hall, Kevin P.; Evers, Dirk J.; Barnes, Colin L.; Bignell, Helen R.; Boutell, Jonathan M.; Bryant, Jason; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony J.; Ellis, Darren J.; Gormley, Niall A.; Humphray, Sean J.; Irving, Leslie J.; Liu, Xiaohai; Maisinger, Klaus S.; Murray, Lisa J.; Obradovic, Bojan; Ost, Tobias; Parkinson, Michael L.; Rasolonjatovo, Isabelle M. J.; Rigatti, Roberto; Rodighiero, Chiara; Ross, Mark T.; Sabot, Andrea; Smith, Mark E.; Smith, Vincent P.; Spiridou, Anastassia; Torrance, Peta E.; Wu, Xiaolin; Anastasi, Carole; Aniebo, Ify C.; Bailey, David M. D.; Bancarz, Iain R.; Barbour, Selena G.; Benoit, Vincent A.; Benson, Kevin F.; Bevis, Claire; Black, Phillip J.; Boodhun, Asha; Brennan, Joe S.; Brown, Rob C.; Brown, Andrew A.; Bundu, Abass A.; Catenazzi, Maria Chiara E.; Cooley, R. Neil; Crake, Natasha R.; Dada, Olubunmi O.; Diakoumakos, Konstantinos D.; Dominguez-Fernandez, Belen; Earnshaw, David J.; Egbujor, Ugonna C.; Fraser, Louise J.; Fajardo, Karin V. Fuentes; Goddard, Colin P.; Green, David E.; Harnish, Kevin; Heyer, Narinder I.; Hims, Matthew M.; Horgan, Adrian M.; Hoschler, Katya; James, Terena; Jones, T. A. Huw; Kang, Gyoung-Dong; Kersey, Alan D.; Kingsbury, Zoya; Kokko-Gonzales, Paula I.; Kumar, Anil; Lee, Sarah E.; Loch, Jennifer A.; Mammen, Radhika M.; McCauley, Patrick G.; Mehta, Parul; Newington, Taksina; Novo, Sonia M.; Osborne, Mark A.; Osnowski, Andrew; Pickering, Lea; Pike, Andrew C.; Raczy, Come; Rae, Vicki H.; Rawlings, Stephen R.; Rodriguez, Ana Chiva; Roe, Phyllida M.; Rogers, John; Bacigalupo, Maria C. Rogert; Romanov, Nikolai; Rourke, Natalie J.; Ruediger, Silke T.; Sanches-Kuiper, Raquel M.; Schenker, Martin R.; Shaw, Richard J.; Smith, Melanie A.; Sohna, Jean Ernest Sohna; Stevens, Kim; Sutton, Neil; Szajkowski, Lukasz; Tregidgo, Carolyn L.; vandeVondele, Stephanie; Wang, Jingwen; Worsley, Graham J.; McCooke, Nick J.; Smith, Anthony J.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Balasubramanian, Shankar; Barnes, Colin L.; Liu, Xiaohai; Earnshaw, David J.; Furey, W. Scott; Osborne, Mark A.; Klenerman, David] Univ Cambridge, Dept Chem, Univ Chem Lab, Cambridge CB2 1EW, England; [Flatbush, Michael R.; Karbelashvili, Mirian S.; Kirk, Scott M.; Pratt, Mark R.; Reed, Mark T.; Sankar, Subramanian V.; Schroth, Gary P.; Tzonev, Svilen S.; Vermaas, Eric H.; Zhang, Lu; Alam, Mohammed D.; Banerjee, Saibal; Baybayan, Primo A.; Bridgham, John A.; Buermann, Dale H.; Burrows, James C.; Castillo, Nestor; Chang, Simon; Elmore, David W.; Etchin, Sergey S.; Ewan, Mark R.; George, David; Golda, George S.; Granieri, Philip A.; Gustafson, David L.; Haudenschild, Christian D.; Ho, Johnny T.; Hurwitz, Steve; Ivanov, Denis V.; Johnson, Maria Q.; Kerelska, Tzvetana H.; Khrebtukova, Irina; Kindwall, Alex P.; Lee, Xavier; Liao, Arnold K.; Lok, Mitch; Luo, Shujun; Martin, John W.; McNitt, Paul; Moon, Keith W.; Mullens, Joe W.; O'Neill, Michael J.; Ostadan, Omead; Paraschos, Lambros L.; Pike, Alger C.; Pinkard, D. Chris; Pliskin, Daniel P.; Podhasky, Joe; Quijano, Victor J.; Roth, Rithy K.; Rusman, Eli; Seoane, Josefina M.; Shiver, Mitch K.; Short, Steven W.; Sizto, Ning L.; Sluis, Johannes P.; Spence, Eric J.; Verhovsky, Yuli; Virk, Selene M.; Wakelin, Suzanne; Walcott, Gregory C.; Yan, Juying; Yau, Ling; Zuerlein, Mike; West, John S.; Oaks, Frank L.; Lundberg, Peter L.] Illumina Hayward, Hayward, CA 94343 USA; [Li, Heng; Scally, Aylwyn; Walter, Klaudia; Carter, Nigel P.; Ning, Zemin; Ng, Bee Ling; Rogers, Jane; Hurles, Matthew E.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fedurco, Milan; Romieu, Anthony; Turcatti, Gerardo] Manteia Predict Med SA, CH-1267 Coinsins, Switzerland; [Gietzen, Kimberley J.; Laurent, Marc A.; Lawley, Cynthia T.; Ostadan, Omead] Illumina Inc, Corp Headquarters, San Diego, CA 92121 USA; [Hansen, Nancy F.; Mullikin, James C.] NHGRI, NIH, Bethesda, MD 20892 USA	Illumina; University of Cambridge; Illumina; Wellcome Trust Sanger Institute; Illumina; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bentley, DR (corresponding author), Illumina Cambridge Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England.	dbentley@illumina.com	Christian, Haudenschild C/D-1602-2009; Ning, Zemin/D-2411-2013; Li, Heng/D-9344-2011; Romieu, Anthony/AAU-4128-2021; Balasubramanian, Shankar/C-1671-2009; Durbin, Richard/AAE-7178-2019; Osborne, Mark/F-7666-2016	Li, Heng/0000-0003-4874-2874; Romieu, Anthony/0000-0002-2300-4499; Durbin, Richard/0000-0002-9130-1006; Shaw, Richard/0000-0001-8145-1601; Osborne, Mark/0000-0001-6660-2985; Klenerman, David/0000-0001-7116-6954; Lawley, Cynthia/0000-0001-7001-4705; Cox, Anthony/0000-0002-6534-749X; Swerdlow, Harold/0000-0002-9510-160X; Ning, Zemin/0000-0003-4359-776X; Balasubramanian, Shankar/0000-0002-0281-5815; Walter, Klaudia/0000-0003-4448-0301	The Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC Applied Genomics LINK Programme; Intramural Research Program of the National Human Genome Research Institute; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER; Medical Research Council [G0701805] Funding Source: researchfish; MRC [G0701805] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Applied Genomics LINK Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the advice of A. Williamson, T. Rink, S. Benkovic, J. Berriman, J. Todd, R. Waterston, S. Eletr, W. Jack, M. Cooper, T. Brown, C. Reece and R. Cook during this work; E. Margulies for assistance with data analysis; M. Shumway for assistance with data submission; and the contributions of the administrative and support staff at all the institutions. This research was supported in part by The Wellcome Trust (to H.L., A.Sc., K.W., N.P.C, B.N.L., J.R., M.E.H. and R.D.), the Biotechnology and Biological Sciences Research Council (BBSRC) (to S.B. and D.K.), the BBSRC Applied Genomics LINK Programme (to A.Sp. and C.L.B.) and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (to N.F.H. and J.C.M.). S. Balasubramanian and D. Klenerman are inventors and founders of Solexa Ltd.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MILTON J, 2004, WO2004018497 WORLD I; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SMITH GP, 2005, WO2005024010 WORLD I; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	32	2317	2738	10	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					53	59		10.1038/nature07517	http://dx.doi.org/10.1038/nature07517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987734	Green Accepted, hybrid			2022-12-24	WOS:000260674000039
J	Cui, YJ; Costa, RM; Murphy, GG; Elgersma, Y; Zhu, Y; Gutmann, DH; Parada, LF; Mody, I; Silva, AJ				Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Zhu, Yuan; Gutmann, David H.; Parada, Luis F.; Mody, Istvan; Silva, Alcino J.			Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning	CELL			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; ACTIVATED PROTEIN-KINASE; MOUSE MODEL; SYNAPTIC PLASTICITY; DOWN-SYNDROME; MEMORY; TYPE-1; DEFICITS; RATS	We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. An Nf1 heterozygous null mutation, which results in enhanced ERK and synapsin I phosphorylation, increased GABA release in the hippocampus, and this was reversed by pharmacological downregulation of ERK signaling. Importantly, the learning deficits associated with the Nf1 mutation were rescued by a subthreshold dose of a GABAA antagonist. Accordingly, Cre deletions of Nf1 showed that only those deletions involving inhibitory neurons caused hippocampal inhibition, LTP, and learning abnormalities. Importantly, our results also revealed lasting increases in GABA release triggered by learning, indicating that the mechanisms uncovered here are of general importance for learning.	[Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; [Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; [Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA; [Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA; [Murphy, Geoffrey G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Elgersma, Ype] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Zhu, Yuan] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhu, Yuan] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75235 USA; [Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Elgersma, Ype/F-5164-2013; Zhu, Yuan/ABF-8405-2020; Parada, luis F/B-9400-2014; Silva, Alcino/ABD-7684-2021	Elgersma, Ype/0000-0002-3758-1297; Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Gutmann, David/0000-0002-3127-5045; Costa, Rui M./0000-0003-0495-8374	NIH [R01 NS38480]; Neurofibromatosis Inc.; Children's Tumor Foundation; United States Army [W81XWH-06-1-0174]; Coelho Endowment [NS30549]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549, R01NS038480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurofibromatosis Inc.; Children's Tumor Foundation; United States Army(United States Department of DefenseUnited States Army); Coelho Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the NIH (R01 NS38480), Neurofibromatosis Inc., the Children's Tumor Foundation, and United States Army (W81XWH-06-1-0174) to A.J.S. and NS30549 and the Coelho Endowment to I. M. This work was also supported by a generous donation from C. M. Spivak to A. J.S.Y.C. was supported by a fellowship from the Children's Tumor Foundation. We thank P. Greengard and J.N. Jovanovic for the generous gift of the phospho-Syn I antibodies. We are grateful to Steven Kushner, Brandon M. Stell, and Weizheng Wei for fruitful discussions.	Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dilts CV, 1996, J DEV BEHAV PEDIATR, V17, P229; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Guilding C, 2007, EUR J NEUROSCI, V25, P99, DOI 10.1111/j.1460-9568.2006.05238.x; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; INTROINICOLLISON IB, 1994, BEHAV NEURAL BIOL, V61, P150, DOI 10.1016/S0163-1047(05)80068-8; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; Lynch TM, 2002, NEUROL CLIN, V20, P841, DOI 10.1016/S0733-8619(01)00019-6; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; McElroy MW, 2005, LEARN MEMORY, V12, P150, DOI 10.1101/lm.86205; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Stenman J, 2003, J NEUROSCI, V23, P167; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Wiltgen BJ, 2005, LEARN MEMORY, V12, P327, DOI 10.1101/lm.89705; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	43	295	303	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					549	560		10.1016/j.cell.2008.09.060	http://dx.doi.org/10.1016/j.cell.2008.09.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984165	Green Accepted, Bronze			2022-12-24	WOS:000260536300024
J	Compston, A; Coles, A				Compston, Alastair; Coles, Alasdair			Multiple sclerosis	LANCET			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STEM-CELL TRANSPLANTATION; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; NEUROMYELITIS-OPTICA; IN-VITRO; DIAGNOSTIC-CRITERIA; RECURRENCE RISKS; AXONAL DAMAGE	Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initially, inflammation is transient and remyelination occurs but is not durable. Hence, the early course of disease is characterised by episodes of neurological dysfunction that usually recover. However, over time the pathological changes become dominated by widespread microglial activation associated with extensive and chronic neurodegeneration, the clinical correlate of which is progressive accumulation of disability. Paraclinical investigations show abnormalities that indicate the distribution of inflammatory lesions and axonal loss (MRI); interference of conduction in previously myelinated pathways (evoked electrophysiological potentials); and intrathecal synthesis of oligoclonal antibody (examination by lumbar puncture of the cerebrospinal fluid). Multiple sclerosis is triggered by environmental factors in individuals with complex genetic-risk profiles. Licensed disease modifying agents reduce the frequency of new episodes but do not reverse fixed deficits and have questionable effects on the long-term accumulation of disability and disease progression. We anticipate that future studies in multiple sclerosis will provide a new taxonomy on the basis of mechanisms rather than clinical empiricism, and so inform strategies for improved treatment at all stages of the disease.	[Compston, Alastair; Coles, Alasdair] Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Clin Neurosci, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Coles, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Clin Neurosci, Hills Rd, Cambridge CB2 2QQ, England.	ajc1020@medschl.cam.ac.uk		Coles, Alasdair/0000-0003-4738-0760				Achiron A, 2004, CLIN IMMUNOL, V113, P155, DOI 10.1016/j.clim.2004.06.004; ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; ALTER M, 1962, ARCH NEUROL-CHICAGO, V7, P253, DOI 10.1001/archneur.1962.04210040005001; ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Anderson JM, 2008, BRAIN, V131, P1736, DOI 10.1093/brain/awn119; Barbellion W. N. P., 1919, J DISAPPOINTED MAN; Barbellion W. N. P., 1920, LAST DIARY; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Black JA, 2006, BRAIN, V129, P3196, DOI 10.1093/brain/awl216; Breij ECW, 2008, ANN NEUROL, V63, P16, DOI 10.1002/ana.21311; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; BROPHY P, 1987, BAROQUE N ROLL, P1; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; *CAMMS223 TRIAL IN, 2008, NEW ENGL J MED, V359, P30; Carswell R., 1838, PATHOLOGICAL ANATOMY; Carton H, 1997, J NEUROL NEUROSUR PS, V62, P329, DOI 10.1136/jnnp.62.4.329; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Cohen JA, 2007, NEUROLOGY, V68, P939, DOI 10.1212/01.wnl.0000257109.61671.06; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Comi G, 2008, J NEUROL, V255, P10; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Compston A, 2004, CLIN MED, V4, P346, DOI 10.7861/clinmedicine.4-4-346; COMPSTON DAS, 1976, LANCET, V2, P1261; COMPSTON DAS, 2005, MCALPINES MULTIPLE S, P1; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Davie CA, 1995, BRAIN, V118, P1583, DOI 10.1093/brain/118.6.1583; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Dean G, 2008, NEUROLOGY, V70, P101, DOI 10.1212/01.wnl.0000284598.98525.d7; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; DETELS R, 1977, AM J EPIDEMIOL, V105, P303, DOI 10.1093/oxfordjournals.aje.a112387; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Edan G, 1997, J NEUROL NEUROSUR PS, V62, P112, DOI 10.1136/jnnp.62.2.112; Eikelenboom MJ, 2003, NEUROLOGY, V60, P219, DOI 10.1212/01.WNL.0000041496.58127.E3; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filippi M, 2008, J NEUROL, V255, P9; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; FIRTH D, 1984, CASE A DESTE; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Francis G, 2001, NEUROLOGY, V56, P1628; *GAME COLL GROUP, 2006, J NEUROIMMUNOL, V179, P108; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hensiek AE, 2007, NEUROLOGY, V68, P376, DOI 10.1212/01.wnl.0000252822.53506.46; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; King J, 2001, NEUROLOGY, V56, P1496; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kira J, 1999, J NEUROL SCI, V166, P53, DOI 10.1016/S0022-510X(99)00115-X; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; KURTZKE JF, 1975, ACTA NEUROL SCAND, V51, P110; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Le Page E, 2008, J NEUROL NEUROSUR PS, V79, P52, DOI 10.1136/jnnp.2007.124958; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MAGLIOZZI R, 2007, J EXP MED, V204, P2899; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; MARROSU MG, 1992, NEUROLOGY, V42, P883, DOI 10.1212/WNL.42.4.883; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; Mikaeloff Y, 2007, BRAIN, V130, P2589, DOI 10.1093/brain/awm198; Miller DH, 1999, ANN NEUROL, V46, P850, DOI 10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q; Miller DM, 2000, MULT SCLER, V6, P267, DOI 10.1191/135245800678827770; MINDEN SL, 1990, ARCH NEUROL-CHICAGO, V47, P98, DOI 10.1001/archneur.1990.00530010124031; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Munari LM, 2004, LANCET NEUROL, V3, P641, DOI 10.1016/S1474-4422(04)00899-3; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Panitch H, 2004, NEUROLOGY, V63, P1788; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; PANITCH HS, 1987, LANCET, V1, P893; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Robertson NP, 1997, LANCET, V349, P1587, DOI 10.1016/S0140-6736(96)07317-5; Robertson NP, 1996, NEUROLOGY, V47, P347, DOI 10.1212/WNL.47.2.347; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301; SADOVNICK AD, 1988, NEUROLOGY, V38, P990, DOI 10.1212/WNL.38.6.990; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Schmied M, 2003, CLIN IMMUNOL, V106, P163, DOI 10.1016/S1521-6616(03)00020-2; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Smith KJ, 2006, BRAIN, V129, P3147, DOI 10.1093/brain/awl323; SMITH KJ, 1981, BRAIN, V104, P383, DOI 10.1093/brain/104.2.383; Smith KJ, 2001, ANN NEUROL, V49, P470; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Stadelmann C, 2005, BRAIN, V128, P979, DOI 10.1093/brain/awh457; TERASAKI PI, 1976, SCIENCE, V193, P1245, DOI 10.1126/science.1085490; Tienari PJ, 1998, J NEUROIMMUNOL, V81, P158, DOI 10.1016/S0165-5728(97)00171-9; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; *US FDA, 2008, NAT MARK TYS INF; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; Wolswijk G, 1998, PROG BRAIN RES, V117, P233; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291	174	3370	3465	26	885	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1502	1517		10.1016/S0140-6736(08)61620-7	http://dx.doi.org/10.1016/S0140-6736(08)61620-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18970977				2022-12-24	WOS:000260801300027
J	Chan, CKF; Chen, CC; Luppen, CA; Kim, JB; DeBoer, AT; Wei, K; Helms, JA; Kuo, CJ; Kraft, DL; Weissman, IL				Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; Kim, Jae-Beom; DeBoer, Anthony T.; Wei, Kevin; Helms, Jill A.; Kuo, Calvin J.; Kraft, Daniel L.; Weissman, Irving L.			Endochondral ossification is required for haematopoietic stem-cell niche formation	NATURE			English	Article							BONE-FORMATION; ENDOTHELIAL-CELLS; C-KIT; EXPRESS; ANGIOGENESIS; OSTERIX; MICE	Little is known about the formation of niches, local micro- environments required for stem- cell maintenance. Here we develop an in vivo assay for adult haematopoietic stem- cell ( HSC) niche formation(1,2). With this assay, we identified a population of progenitor cells with surface markers CD45(-)Tie2(-)alpha(+)(V)CD105(+)Thy1.1(-) (CD105(+)Thy1(-)) that, when sorted from 15.5 days post- coitum fetal bones and transplanted under the adult mouse kidney capsule, could recruit host- derived blood vessels, produce donor- derived ectopic bones through a cartilage intermediate and generate a marrow cavity populated by host- derived long- term reconstituting HSC (LT-HSC). In contrast, CD45(-)Tie2(-)alpha(+)(V)CD105(+)Thy1(+) (CD105(+)Thy1(+)) fetal bone progenitors form bone that does not contain a marrow cavity. Suppressing expression of factors involved in endochondral ossification, such as osterix and vascular endothelial growth factor ( VEGF), inhibited niche generation. CD105(+)Thy1(-) progenitor populations derived from regions of the fetal mandible or calvaria that do not undergo endochondral ossification formed only bone without marrow in our assay. Collectively, our data implicate endochondral ossification, bone formation that proceeds through a cartilage intermediate, as a requirement for adult HSC niche formation.	[Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kim, Jae-Beom; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Wei, Kevin; Kuo, Calvin J.] Stanford Univ, Dept Hematol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Chan, CKF (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	chazchan@stanford.edu; c3chen@stanford.edu	Chen, Ching-Cheng/C-1259-2009	Helms, Jill/0000-0002-0463-396X; Kuo, Calvin/0000-0002-7427-5985; Chen, Ching-Cheng/0000-0003-4499-0889	USPHS National Institutes of Health [2R01HL058770-08, 5R01CA086065-09, 1R01HL074267-01, 1R01NS052830-01]; NIH Pathway to Independence [5K99HL087936-02]; NIH Career Development [K08-HL076335]; Hope Street Kids; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076335, R00HL087936, R01HL058770, R01HL074267, K99HL087936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052830] Funding Source: NIH RePORTER	USPHS National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Street Kids; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Peault for suggestions; L. Jerabek for laboratory management; C. Muscat for antibody production and conjugation; Y. Park, J. K. Lee and A. K. Bershad for technical support; and T. Serwold and L. Richie for advice and reading the manuscript. This study was supported in part by a USPHS National Institutes of Health ( NIH) grant (2R01HL058770-08) and in part by a NIH grant (5R01CA086065-09), terminated by NIH Study Section, and in part by the Virginia and Daniel K. Ludwig Professorship to I.L.W. C.K.F.C. and C.A.L. are supported by an NIH Regenerative Medicine training grant. C.-C.C. is supported by an NIH Pathway to Independence award (5K99HL087936-02). D.L.K. is supported by an NIH Career Development award (K08-HL076335) and a Hope Street Kids research award, K.W. and C.J.K. are supported by NIH grants (1R01HL074267-01 and 1R01NS052830-01).	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AYE MT, 1992, EXP HEMATOL, V20, P523; Blair HC, 1999, BIOCHEM BIOPH RES CO, V255, P778, DOI 10.1006/bbrc.1999.0260; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; GARVEY W, 1986, STAIN TECHNOL, V61, P60, DOI 10.3109/10520298609110708; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; WEISS B, 2005, CONTEMP OBSTET GYNEC, V50, P34; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	29	313	321	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					490	U9		10.1038/nature07547	http://dx.doi.org/10.1038/nature07547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19078959	Green Accepted			2022-12-24	WOS:000262519200049
J	Bocquet, N; Nury, H; Baaden, M; Le Poupon, C; Changeux, JP; Delarue, M; Corringer, PJ				Bocquet, Nicolas; Nury, Hugues; Baaden, Marc; Le Poupon, Chantal; Changeux, Jean-Pierre; Delarue, Marc; Corringer, Pierre-Jean			X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP; CRYSTAL-STRUCTURE; GATING MECHANISM; BINDING-SITE; AMINO-ACIDS; DOMAIN; IDENTIFICATION; SELECTIVITY; PERMEATION	Pentameric ligand-gated ion channels from the Cys- loop family mediate fast chemo-electrical transduction(1-3), but the mechanisms of ion permeation and gating of these membrane proteins remain elusive. Here we present the X- ray structure at 2.9 angstrom resolution of the bacterial Gloeobacter violaceus pentameric ligand- gated ion channel homologue(4) ( GLIC) at pH 4.6 in an apparently open conformation. This cationic channel is known to be permanently activated by protons(5). The structure is arranged as a funnel- shaped transmembrane pore widely open on the outer side and lined by hydrophobic residues. On the inner side, a 5 angstrom constriction matches with rings of hydrophilic residues that are likely to contribute to the ionic selectivity(6-9). Structural comparison with ELIC, a bacterial homologue from Erwinia chrysanthemi solved in a presumed closed conformation(10), shows a wider pore where the narrow hydrophobic constriction found in ELIC is removed. Comparative analysis of GLIC and ELIC reveals, in concert, a rotation of each extracellular beta-sandwich domain as a rigid body, interface rearrangements, and a reorganization of the transmembrane domain, involving a tilt of the M2 and M3 alpha-helices away from the pore axis. These data are consistent with a model of pore opening based on both quaternary twist and tertiary deformation.	[Nury, Hugues; Delarue, Marc] Inst Pasteur, Unit Struct Dynam & Macromol, CNRS, URA 2185, F-75015 Paris, France; [Bocquet, Nicolas; Nury, Hugues; Le Poupon, Chantal; Changeux, Jean-Pierre; Corringer, Pierre-Jean] Inst Pasteur, Grp Channel Receptor G5, CNRS, URA 2182, F-75015 Paris, France; [Baaden, Marc] CNRS, Inst Biol Physicochim, UPR 9080, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Delarue, M (corresponding author), Inst Pasteur, Unit Struct Dynam & Macromol, CNRS, URA 2185, F-75015 Paris, France.	marc.delarue@pasteur.fr; pjcorrin@pasteur.fr	Baaden, Marc/C-6623-2008	Baaden, Marc/0000-0001-6472-0486; Nury, Hugues/0000-0002-3433-256X	Region Ile-de-France; Association Francaise contre les Myopathies; College de France; Commission of the European Communities; Network of European Neuroscience Institutes	Region Ile-de-France(Region Ile-de-France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); College de France; Commission of the European Communities(European Commission); Network of European Neuroscience Institutes	We thank P. Koehl for his program Aquasol and help with electrostatic calculations; P. Delepelaire and S. Edelstein for discussions; the staff of ESRF (Grenoble) ID14 and ID23 beamlines for data collection; facilities of the Pasteur Institute (A. Haouz for crystallogenesis, P. England for ultracentrifugation experiments, J. d'Alayer for mass spectroscopy controls and J. Bellalou for help in protein expression); and B. De Foresta (CEA, Orsay) for a gift of the two brominated DDM analogues. The latter diffraction data sets were collected at SLS and PSI (Villingen, Switzerland). We thank M. Fuchs for assistance during data collection; and the IDRIS supercomputer centre and its support staff for allocating CPU time at very short notice (project 082292). This work was supported by the Region Ile-de-France (N.B.), the Association Francaise contre les Myopathies, the College de France (C.L.P.), the Commission of the European Communities (Neurocypres project; H.N.) and the Network of European Neuroscience Institutes (ENI-NET).	Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer P.-J., 2008, SCHOLARPEDIA, V3, P3468; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1	30	580	585	7	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					111	114		10.1038/nature07462	http://dx.doi.org/10.1038/nature07462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18987633				2022-12-24	WOS:000262104900041
J	Carmona-Fontaine, C; Matthews, HK; Kuriyama, S; Moreno, M; Dunn, GA; Parsons, M; Stern, CD; Mayor, R				Carmona-Fontaine, Carlos; Matthews, Helen K.; Kuriyama, Sei; Moreno, Mauricio; Dunn, Graham A.; Parsons, Maddy; Stern, Claudio D.; Mayor, Roberto			Contact inhibition of locomotion in vivo controls neural crest directional migration	NATURE			English	Article							PLANAR CELL-POLARITY; GASTRULATION; XENOPUS; MORPHOGENESIS; CHEMOTAXIS; ZEBRAFISH; MOVEMENTS; BEHAVIOR; WNT11	Contact inhibition of locomotion was discovered by Abercrombie more than 50 years ago and describes the behaviour of fibroblast cells confronting each other in vitro, where they retract their protrusions and change direction on contact(1,2). Its failure was suggested to contribute to malignant invasion(3-6). However, the molecular basis of contact inhibition of locomotion and whether it also occurs in vivo are still unknown. Here we show that neural crest cells, a highly migratory and multipotent embryonic cell population, whose behaviour has been likened to malignant invasion(6-8), demonstrate contact inhibition of locomotion both in vivo and in vitro, and that this accounts for their directional migration. When two migrating neural crest cells meet, they stop, collapse their protrusions and change direction. In contrast, when a neural crest cell meets another cell type, it fails to display contact inhibition of locomotion; instead, it invades the other tissue, in the same manner as metastatic cancer cells(3,5,9). We show that inhibition of non-canonical Wnt signalling abolishes both contact inhibition of locomotion and the directionality of neural crest migration. Wnt- signalling members localize at the site of cell contact, leading to activation of RhoA in this region. These results provide the first example of contact inhibition of locomotion in vivo, provide an explanation for coherent directional migration of groups of cells and establish a previously unknown role for noncanonical Wnt signalling.	[Carmona-Fontaine, Carlos; Matthews, Helen K.; Kuriyama, Sei; Moreno, Mauricio; Stern, Claudio D.; Mayor, Roberto] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; [Dunn, Graham A.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; University College London; University of London; King's College London	Mayor, R (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	r.mayor@ucl.ac.uk	Matthews, Helen/A-3204-2009; Mayor, Roberto/C-6688-2008; Stern, Claudio D/C-6265-2008; Zebrafish, UCL/A-3125-2009; Carmona-Fontaine, Carlos/D-1581-2009; Ladoux, Benoit/A-9879-2013; Stern, Claudio/AAZ-7381-2021; Kuriyama, Sei/AAV-2368-2020; Parsons, Maddy/B-2203-2013	Stern, Claudio D/0000-0002-9907-889X; Stern, Claudio/0000-0002-9907-889X; Kuriyama, Sei/0000-0002-5502-7177; Parsons, Maddy/0000-0002-2021-8379; Mayor, Roberto/0000-0001-9053-9613; Matthews, Helen/0000-0001-6660-9685	Medical Research Council; Biotechnology and Biological Sciences Research Council; MRC; Boehringer Ingelheim Fonds; BBSRC [BB/D017521/1] Funding Source: UKRI; MRC [G117/506, G0100152, G0401026, G0400559] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D017521/1] Funding Source: researchfish; Medical Research Council [G0401026, G117/506, G0100152, G0400559] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Tada, M. Tawk, J. Clarke, C.- P. Heisenberg, R. Kelsh, L. Dale and S. Fraser for reagents, constructs and fish lines; C. F. Riaz for scanning electron microscopy images; and M. Bronner- Fraser, M. Raff, J. Green and A. Ridley for comments on the manuscript. This study was supported by grants to R.M. from the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council. H. K. M. and C.C.-F. are MRC and Boehringer Ingelheim Fonds PhD scholarship holders, respectively, and M.M. is an EMBO postdoctoral fellow.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, NATURE, V174, P697, DOI 10.1038/174697a0; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; DAVIS EM, 1981, J EMBRYOL EXP MORPH, V63, P29; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DUNN GA, 1982, PHILOS T ROY SOC B, V299, P147, DOI 10.1098/rstb.1982.0121; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; HEAYSMAN JE, 1970, EXPERIENTIA, V26, P1344, DOI 10.1007/BF02113020; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Matthews HK, 2008, DEV DYNAM, V237, P3404, DOI 10.1002/dvdy.21758; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; PADDOCK SW, 1986, J CELL SCI, V81, P163; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Tada M, 2000, DEVELOPMENT, V127, P2227; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	29	408	411	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					957	961		10.1038/nature07441	http://dx.doi.org/10.1038/nature07441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19078960	Green Accepted			2022-12-24	WOS:000261768300047
J	Sytina, OA; Heyes, DJ; Hunter, CN; Alexandre, MT; van Stokkum, IHM; van Grondelle, R; Groot, ML				Sytina, Olga A.; Heyes, Derren J.; Hunter, C. Neil; Alexandre, Maxime T.; van Stokkum, Ivo H. M.; van Grondelle, Rienk; Groot, Marie Louise			Conformational changes in an ultrafast light-driven enzyme determine catalytic activity	NATURE			English	Article							PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; DIHYDROFOLATE-REDUCTASE; DYNAMICS; SPECTROSCOPY; CHLOROPHYLLIDE; IDENTIFICATION; MUTAGENESIS; COMPLEX; PROTEIN; NADPH	The role of conformational changes in explaining the huge catalytic power of enzymes is currently one of the most challenging questions in biology(1-7). Although it is now widely regarded that enzymes modulate reaction rates by means of short- and long- range protein motions(3-7), it is almost impossible to distinguish between conformational changes and catalysis. We have solved this problem using the chlorophyll biosynthetic enzyme NADPH: protochlorophyllide ( Pchlide) oxidoreductase, which catalyses a unique light- driven reaction involving hydride and proton transfers(8). Here we report that prior excitation of the enzyme- substrate complex with a laser pulse induces a more favourable conformation of the active site, enabling the coupled hydride and proton transfer reactions to occur. This effect, which is triggered during the Pchlide excited-state lifetime and persists on a long timescale, switches the enzyme into an active state characterized by a high rate and quantum yield of formation of a catalytic intermediate. The corresponding spectral changes in the mid- infrared following the absorption of one photon reveal significant conformational changes in the enzyme, illustrating the importance of flexibility and dynamics in the structure of enzymes for their function.	[Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sytina, Olga A.; Alexandre, Maxime T.; van Stokkum, Ivo H. M.; van Grondelle, Rienk; Groot, Marie Louise] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Heyes, Derren J.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Sheffield; Vrije Universiteit Amsterdam; University of Manchester	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Firth Court, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	van Stokkum, Ivo HM/E-7175-2015; Groot, Marie Louise/E-8954-2010	van Stokkum, Ivo HM/0000-0002-6143-2021; Heyes, Derren/0000-0002-7453-1571; Groot, Marie Louise/0000-0001-5360-6987	The Netherlands Organization for Scientific Research; Dutch Foundation for Earth and Life Sciences [834.01.002]; NWO-ALW [831.00.004]; NWO-CW [700.53.307]; Biotechnology and Biological Sciences Research Council, UK	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Foundation for Earth and Life Sciences; NWO-ALW(Netherlands Organization for Scientific Research (NWO)); NWO-CW(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by The Netherlands Organization for Scientific Research through the Dutch Foundation for Earth and Life Sciences ( Investment Grant no. 834.01.002). M. L. G. is grateful to NWO-ALW for providing financial support with a long-term fellowship (Grant no. 831.00.004) and O. S. received support from NWO-CW ( Grant no. 700.53.307). D.J.H. and C.N.H. gratefully acknowledge support from the Biotechnology and Biological Sciences Research Council, UK. We thank H. Fidder and F. van Mourik for reading the manuscript.	Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Flomenbom O, 2005, P NATL ACAD SCI USA, V102, P2368, DOI 10.1073/pnas.0409039102; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Groot ML, 2004, J PHYS CHEM B, V108, P8001, DOI 10.1021/jp037966s; HARTWICH G, 1995, J AM CHEM SOC, V117, P7784, DOI 10.1021/ja00134a025; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Iwaki M, 2006, J AM CHEM SOC, V128, P2621, DOI 10.1021/ja0556272; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MANTELE WG, 1988, P NATL ACAD SCI USA, V85, P8468, DOI 10.1073/pnas.85.22.8468; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; NABEDRYK E, 1990, BIOCHEMISTRY-US, V29, P3242, DOI 10.1021/bi00465a015; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	31	108	110	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					1001	U89		10.1038/nature07354	http://dx.doi.org/10.1038/nature07354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092933				2022-12-24	WOS:000261768300057
J	Licatalosi, DD; Mele, A; Fak, JJ; Ule, J; Kayikci, M; Chi, SW; Clark, TA; Schweitzer, AC; Blume, JE; Wang, XN; Darnell, JC; Darnell, RB				Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Ule, Jernej; Kayikci, Melis; Chi, Sung Wook; Clark, Tyson A.; Schweitzer, Anthony C.; Blume, John E.; Wang, Xuning; Darnell, Jennifer C.; Darnell, Robert B.			HITS-CLIP yields genome-wide insights into brain alternative RNA processing	NATURE			English	Article							PRE-MESSENGER-RNA; BINDING PROTEIN; NOVA; POLYADENYLATION; GENE; IDENTIFICATION; NETWORK; DISEASE; ANTIGEN; TARGET	Protein - RNA interactions have critical roles in all aspects of gene expression. However, applying biochemical methods to understand such interactions in living tissues has been challenging. Here we develop a genome- wide means of mapping protein - RNA binding sites in vivo, by high- throughput sequencing of RNA isolated by crosslinking immunoprecipitation ( HITS- CLIP). HITS- CLIP analysis of the neuron- specific splicing factor Nova revealed extremely reproducible RNA- binding maps in multiple mouse brains. These maps provide genome- wide in vivo biochemical footprints confirming the previous prediction that the position of Nova binding determines the outcome of alternative splicing; moreover, they are sufficiently powerful to predict Nova action de novo. HITS- CLIP revealed a large number of Nova - RNA interactions in 39 untranslated regions, leading to the discovery that Nova regulates alternative polyadenylation in the brain. HITS- CLIP, therefore, provides a robust, unbiased means to identify functional protein - RNA interactions in vivo.	[Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Chi, Sung Wook; Wang, Xuning; Darnell, Jennifer C.; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Chi, Sung Wook; Darnell, Jennifer C.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Ule, Jernej; Kayikci, Melis] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Clark, Tyson A.; Schweitzer, Anthony C.; Blume, John E.] Affymetrix Inc, Express Res, Santa Clara, CA 95051 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; MRC Laboratory Molecular Biology; Affymetrix	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Ule, Jernej/C-6315-2013	Darnell, Robert B/0000-0002-5134-8088; Ule, Jernej/0000-0002-2452-4277; Blume, John/0000-0003-3026-953X; Clark, Tyson/0000-0002-7779-3227	NIH [R01 NS34389]; Howard Hughes Medical Institute; Medical Research Council [MC_U105185858] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R01NS040955] Funding Source: NIH RePORTER; MRC [MC_U105185858] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to members of the Darnell and Ule laboratories and J. Richter for critical discussions and review of the manuscript, B. Friedman for suggesting the use of exon arrays, F. Allain for communicating unpublished results, and M. Suarez- Farinas for help with statistics. This work was supported by NIH R01 NS34389 ( R. B. D.) and the Howard Hughes Medical Institute. R. B. D. is an HHMI Investigator.	Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell RB, 2006, COLD SPRING HARB SYM, V71, P321, DOI 10.1101/sqb.2006.71.002; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; DEDUVE C, 1993, GENE, V135, P29, DOI 10.1016/0378-1119(93)90045-5; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; MAIZELS N, 1987, NATURE, V330, P616, DOI 10.1038/330616a0; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	48	962	981	2	114	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					464	U22		10.1038/nature07488	http://dx.doi.org/10.1038/nature07488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18978773	Green Accepted			2022-12-24	WOS:000261170500030
J	Miller, W; Drautz, DI; Ratan, A; Pusey, B; Qi, J; Lesk, AM; Tomsho, LP; Packard, MD; Zhao, FQ; Sher, A; Tikhonov, A; Raney, B; Patterson, N; Lindblad-Toh, K; Lander, ES; Knight, JR; Irzyk, GP; Fredrikson, KM; Harkins, TT; Sheridan, S; Pringle, T; Schuster, SC				Miller, Webb; Drautz, Daniela I.; Ratan, Aakrosh; Pusey, Barbara; Qi, Ji; Lesk, Arthur M.; Tomsho, Lynn P.; Packard, Michael D.; Zhao, Fangqing; Sher, Andrei; Tikhonov, Alexei; Raney, Brian; Patterson, Nick; Lindblad-Toh, Kerstin; Lander, Eric S.; Knight, James R.; Irzyk, Gerard P.; Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon; Pringle, Tom; Schuster, Stephan C.			Sequencing the nuclear genome of the extinct woolly mammoth	NATURE			English	Article							DNA; HUMANS; SIZE	In 1994, two independent groups extracted DNA from several Pleistocene epoch mammoths and noted differences among individual specimens(1,2). Subsequently, DNA sequences have been published for a number of extinct species. However, such ancient DNA is often fragmented and damaged(3), and studies to date have typically focused on short mitochondrial sequences, never yielding more than a fraction of a per cent of any nuclear genome. Here we describe 4.17 billion bases ( Gb) of sequence from several mammoth specimens, 3.3 billion ( 80%) of which are from the woolly mammoth ( Mammuthus primigenius) genome and thus comprise an extensive set of genome- wide sequence from an extinct species. Our data support earlier reports(4) that elephantid genomes exceed 4 Gb. The estimated divergence rate between mammoth and African elephant is half of that between human and chimpanzee. The observed number of nucleotide differences between two particular mammoths was approximately one- eighth of that between one of them and the African elephant, corresponding to a separation between the mammoths of 1.5 - 2.0 Myr. The estimated probability that orthologous elephant and mammoth amino acids differ is 0.002, corresponding to about one residue per protein. Differences were discovered between mammoth and African elephant in amino- acid positions that are otherwise invariant over several billion years of combined mammalian evolution. This study shows that nuclear genome sequencing of extinct species can reveal population differences not evident from the fossil record, and perhaps even discover genetic factors that affect extinction.	[Miller, Webb; Drautz, Daniela I.; Ratan, Aakrosh; Pusey, Barbara; Qi, Ji; Lesk, Arthur M.; Tomsho, Lynn P.; Packard, Michael D.; Zhao, Fangqing; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Sher, Andrei] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; [Tikhonov, Alexei] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Raney, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Patterson, Nick; Lindblad-Toh, Kerstin; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon] Roche Diagnost Corp, Indianapolis, IN 46250 USA; [Pringle, Tom] Sperling Fdn, Eugene, OR 97405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of California System; University of California Santa Cruz; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Roche Holding	Miller, W (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, 310 Wartik Bldg, University Pk, PA 16802 USA.	webb@bx.psu.edu; scs@bx.psu.edu	QI, JI/E-2797-2016; Raney, Brian/ABE-6267-2020; Tikhonov, Alexei/G-7478-2016; Zhao, Fangqing/A-9992-2009; Zhao, Fangqing/P-6309-2019	Tikhonov, Alexei/0000-0002-7227-5797; Lesk, Arthur/0000-0002-2596-0601; Fredrikson, Karin/0000-0001-7360-4276; Zhao, Fangqing/0000-0002-6216-1235	National Human Genome Research Institute [HG002238]; Gordon and Betty Moore Foundation; Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This sequencing-by-synthesis study was made possible through generous funding from Penn State University and Roche Applied Sciences. W. M. was supported by grant HG002238 from the National Human Genome Research Institute and S. C. S. is supported in part by the Gordon and Betty Moore Foundation. This project is funded in part under a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. We thank T. Gilbert for introducing us to the use of hair shafts as a source of ancient DNA, C. Grondahl for providing Asian elephant hair samples, and M. Wilson for suggestions. This paper is dedicated to the memory of Andrei Sher.	Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; HAGELBERG E, 1994, NATURE, V370, P333, DOI 10.1038/370333b0; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANDER E S, 1988, Genomics, V2, P231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Redi CA, 2007, J MOL EVOL, V64, P484, DOI 10.1007/s00239-006-0237-1; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TABERLET P, 1995, CONSERV BIOL, V9, P1255, DOI 10.1046/j.1523-1739.1995.951255.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	38	216	227	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					387	U51		10.1038/nature07446	http://dx.doi.org/10.1038/nature07446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020620	Bronze			2022-12-24	WOS:000261039600043
J	Formisano, E; De Martino, F; Bonte, M; Goebel, R				Formisano, Elia; De Martino, Federico; Bonte, Milene; Goebel, Rainer			"Who" Is Saying "What"? Brain-Based Decoding of Human Voice and Speech	SCIENCE			English	Article							AUDITORY-CORTEX; TEMPORAL CORTEX; PERCEPTION; CLASSIFICATION; STIMULI; FMRI; REPRESENTATIONS; ORGANIZATION; EXTRACTION; RESPONSES	Can we decipher speech content ("what" is being said) and speaker identity ("who" is saying it) from observations of brain activity of a listener? Here, we combine functional magnetic resonance imaging with a data- mining algorithm and retrieve what and whom a person is listening to from the neural fingerprints that speech and voice signals elicit in the listener's auditory cortex. These cortical fingerprints are spatially distributed and insensitive to acoustic variations of the input so as to permit the brain- based recognition of learned speech from unknown speakers and of learned voices from previously unheard utterances. Our findings unravel the detailed cortical layout and computational properties of the neural populations at the basis of human speech recognition and speaker identification.	[Formisano, Elia; De Martino, Federico; Bonte, Milene; Goebel, Rainer] Univ Maastricht, Dept Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands	Maastricht University	Formisano, E (corresponding author), Univ Maastricht, Dept Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands.	e.formisano@psychology.unimaas.nl	De Martino, Federico/ABF-9850-2021; De Martino, Federico/I-1817-2012	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Formisano, Elia/0000-0001-5008-2460; Bonte, Milene/0000-0002-0203-8913; Goebel, Rainer/0000-0003-1780-2467	Maastricht University; Netherlands Organization for Scientific Research; Innovational Research Incentives Scheme Vidi [452-04-337]; Veni [451-07-002]	Maastricht University; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Innovational Research Incentives Scheme Vidi(Netherlands Organization for Scientific Research (NWO)); Veni(Netherlands Organization for Scientific Research (NWO))	Work supported by Maastricht University and the Netherlands Organization for Scientific Research (NWO), Innovational Research Incentives Scheme Vidi grant 452-04-337(E.F.) and Veni grant 451-07-002 (M.B.). We thank J. Obleser, U. Hasson, J.-D. Haynes, N. Kriegeskorte, J. Ashburner, and G. Valente for comments and discussions.	Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Davis MH, 2003, J NEUROSCI, V23, P3423; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Desai R, 2008, J COGNITIVE NEUROSCI, V20, P1174, DOI 10.1162/jocn.2008.20081; EGINEER CT, 2008, NAT NEUROSCI, V11, P603; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Obleser J, 2004, J COGNITIVE NEUROSCI, V16, P31, DOI 10.1162/089892904322755539; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034	28	375	385	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					970	973		10.1126/science.1164318	http://dx.doi.org/10.1126/science.1164318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988858	Green Submitted			2022-12-24	WOS:000260674100055
J	Adabag, AS; Therneau, TM; Gersh, BJ; Weston, SA; Roger, VL				Adabag, A. Selcuk; Therneau, Terry M.; Gersh, Bernard J.; Weston, Susan A.; Roger, Veronique L.			Sudden Death After Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; COMMUNITY-WIDE PERSPECTIVE; CARDIAC DEATH; TEMPORAL TRENDS; OLMSTED COUNTY; RISK-FACTORS; NATIONAL REGISTRY; CLINICAL-TRIALS; TIME-DEPENDENCE	Context Sudden cardiac death after myocardial infarction (MI) has not been assessed recently in the community. Risk stratification for sudden cardiac death after MI commonly relies on baseline characteristics and little is known about the relationship between recurrent ischemia or heart failure and sudden cardiac death. Objective To evaluate the risk of sudden cardiac death after MI and the impact of recurrent ischemia and heart failure on sudden cardiac death. Design, Setting, and Participants Population- based surveillance study of 2997 residents ( mean [ SD] age, 67 [ 14] years; 59% were men) experiencing an MI in Olmsted County, Minnesota, between 1979 and 2005, and followed up through February 29, 2008. Main Outcome Measures Sudden cardiac death defined as out- of- hospital death due to coronary disease; and observed survival free of sudden cardiac death compared with that expected in Olmsted County, Minnesota. Results During a median follow- up of 4.7 years ( 25th- 75th percentile, 1.6- 7.1 years), 1160 deaths occurred, 282 from sudden cardiac death ( 24%). The 30- day cumulative incidence of sudden cardiac death was 1.2% ( 95% confidence interval [ CI], 0.8%1.6%). Thereafter, the rate of sudden cardiac death was constant at 1.2% per year yielding a 5- year cumulative incidence of 6.9% ( 95% CI, 5.9%- 7.9%). The 30- day incidence of sudden cardiac death was 4- fold higher than expected ( standardized mortality ratio, 4.2; 95% CI, 2.9- 5.8). The risk of sudden cardiac death has declined significantly over time ( hazard ratio [ HR], 0.62 [ 95% CI, 0.44- 0.88] for MIs that occurred between 1997 and 2005 compared with between 1979 and 1987; P=. 03). The recurrent events of ischemia ( n= 842), heart failure ( n= 365), or both ( n= 873) occurred in 2080 patients. After adjustment for baseline characteristics, recurrent ischemia was not associated with sudden cardiac death ( HR, 1.26 [ 95% CI, 0.96- 1.65]; P=. 09), while heart failure markedly increased the risk of sudden cardiac death ( HR, 4.20 [ 95% CI, 3.10- 5.69]; P <. 001). Conclusions The risk of sudden cardiac death following MI in community practice has declined significantly over the past 30 years. Sudden cardiac death is independently associated with heart failure but not with recurrent ischemia.	[Therneau, Terry M.; Weston, Susan A.; Roger, Veronique L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Adabag, A. Selcuk] Vet Affairs Med Ctr, Div Cardiol, Minneapolis, MN USA; [Gersh, Bernard J.; Roger, Veronique L.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Mayo Clinic	Roger, VL (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020	Adabag, Selcuk/0000-0003-2154-8596	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072435, R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL072435-06, R01 HL059205, R01 HL 59205, R01 HL 72435, R01 HL059205-10A1, R01 HL072435] Funding Source: Medline; NIAMS NIH HHS [R01 AR030582, AR30582, R01 AR030582-43] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abildstrom SZ, 2002, HEART, V88, P573, DOI 10.1136/heart.88.6.573; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; BERGER CJ, 1992, JAMA-J AM MED ASSOC, V268, P1545, DOI 10.1001/jama.268.12.1545; Bunch TJ, 2007, CIRCULATION, V115, P2451, DOI 10.1161/CIRCULATIONAHA.106.683235; Bursi F, 2007, AM J MED, V120, P616, DOI 10.1016/j.amjmed.2006.07.039; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Devlin G, 2005, HEART, V91, P1394, DOI 10.1136/hrt.2004.054007; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Gandy A, 2008, STAT MED, V27, P831, DOI 10.1002/sim.2972; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Goraya TY, 2000, MAYO CLIN PROC, V75, P681; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Guidry UC, 1999, CIRCULATION, V100, P2054, DOI 10.1161/01.CIR.100.20.2054; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hohnloser SH, 2003, CIRCULATION, V107, P941, DOI 10.1161/01.CIR.0000054211.00668.9B; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Jordaens L, 2001, EUR HEART J, V22, P1214, DOI 10.1053/euhj.2000.2464; KANNEL WB, 1979, AM J CARDIOL, V44, P53, DOI 10.1016/0002-9149(79)90250-9; Lloyd-Jones DM, 2006, ARCH INTERN MED, V166, P1342, DOI 10.1001/archinte.166.13.1342; Makikallio TH, 2006, AM J CARDIOL, V97, P480, DOI 10.1016/j.amjcard.2005.09.077; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Myerburg RJ, 1998, CIRCULATION, V97, P1514; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prineas R., 1982, MINNESOTA CODE MANUA; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Roger VL, 2002, J CLIN EPIDEMIOL, V55, P593, DOI 10.1016/S0895-4356(02)00390-6; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Salukhe TV, 2004, CIRCULATION, V109, P1848, DOI 10.1161/01.CIR.0000125522.10053.29; Singh JP, 2005, J AM COLL CARDIOL, V46, P1712, DOI 10.1016/j.jacc.2005.05.088; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Spencer FA, 1999, J AM COLL CARDIOL, V34, P1378, DOI 10.1016/S0735-1097(99)00390-3; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Watkins S, 2005, AM J CARDIOL, V96, P1349, DOI 10.1016/j.amjcard.2005.07.037; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Wiviott SD, 2006, J AM COLL CARDIOL, V47, P1553, DOI 10.1016/j.jacc.2005.11.075; Yap YG, 2005, EUR HEART J, V26, P1385, DOI 10.1093/eurheartj/ehi268	52	173	179	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2022	2029		10.1001/jama.2008.553	http://dx.doi.org/10.1001/jama.2008.553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984889	Green Accepted, Bronze			2022-12-24	WOS:000260605400022
J	Robbiani, DF; Bothmer, A; Callen, E; Reina-San-Martin, B; Dorsett, Y; Difilippantonio, S; Bolland, DJ; Chen, HT; Corcoran, AE; Nussenzweig, A; Nussenzweig, MC				Robbiani, Davide F.; Bothmer, Anne; Callen, Elsa; Reina-San-Martin, Bernardo; Dorsett, Yair; Difilippantonio, Simone; Bolland, Daniel J.; Chen, Hua Tang; Corcoran, Anne E.; Nussenzweig, Andre; Nussenzweig, Michel C.			AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations	CELL			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; HEAVY-CHAIN LOCUS; CENTER B-CELLS; SOMATIC HYPERMUTATION; BURKITT-LYMPHOMA; IN-VIVO; ANTIBODY DIVERSIFICATION; MURINE PLASMACYTOMAS	Chromosomal translocation requires formation of paired double-strand DNA breaks (DSBs) on heterologous chromosomes. One of the most well characterized oncogenic translocations juxtaposes c-myc and the immunoglobulin heavy-chain locus (IgH) and is found in Burkitt's lymphomas in humans and plasmacytomas in mice. DNA breaks in IgH leading to c-myc/IgH translocations are created by activation-induced cytidine deaminase ( AID) during antibody class switch recombination or somatic hypermutation. However, the source of DNA breaks at c-myc is not known. Here, we provide evidence for the c-myc promoter region being required in targeting AID-mediated DNA damage to produce DSBs in c-myc that lead to c-myc/IgH translocations in primary B lymphocytes. Thus, in addition to producing somatic mutations and DNA breaks in antibody genes, AID is also responsible for the DNA lesions in oncogenes that are required for their translocation.	[Robbiani, Davide F.; Bothmer, Anne; Reina-San-Martin, Bernardo; Dorsett, Yair; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Callen, Elsa; Difilippantonio, Simone; Chen, Hua Tang; Nussenzweig, Andre] NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; [Bolland, Daniel J.; Corcoran, Anne E.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Bolland, Daniel/AAE-5185-2020; Nussenzweig, Michel/AAE-7292-2019; Reina-San-Martin, Bernardo/I-9484-2016; Robbiani, Davide F./AAF-7662-2019	Bolland, Daniel/0000-0003-3674-9913; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Robbiani, Davide F./0000-0001-7379-3484	NIH; National Cancer Institute; Center for Cancer Research; Leukemia and Lymphoma Society; Howard Hughes Medical Institute Investigator; Biotechnology and Biological Sciences Research Council [BB/F012217/1, BBS/E/B/0000C163] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526] Funding Source: NIH RePORTER; BBSRC [BB/F012217/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All members of the Nussenzweig lab for discussions. Dr. Barry Stoddard ( Fred Hutchinson Cancer Research Center, Seattle) for suggestions on catalytically inactive I-SceI*. The Rockefeller University Gene Targeting Facility, Klara Velinzon, and Tamara Shengelia for FACSorting, Matthias Muellenbeck and Nancy Wong for technical assistance, and David Bosque and Tom Eisenreich for help in managing the mouse colonies. The work was supported in part by NIH grants to M. C. N. The A. N. lab was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. D. F. R. is a Fellow of the Leukemia and Lymphoma Society, and M. C. N. is a Howard Hughes Medical Institute Investigator.	ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; BOLES TC, 1987, BIOCHEMISTRY-US, V26, P367, DOI 10.1021/bi00376a006; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; CORY S, 1983, EMBO J, V2, P213, DOI 10.1002/j.1460-2075.1983.tb01407.x; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Egli D, 2004, GENOME RES, V14, P1382, DOI 10.1101/gr.2279804; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reddy MC, 2005, RADIAT RES, V164, P345, DOI 10.1667/RR3419.1; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1	77	324	333	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1028	1038		10.1016/j.cell.2008.09.062	http://dx.doi.org/10.1016/j.cell.2008.09.062			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070574	Green Accepted, Bronze			2022-12-24	WOS:000261642800019
J	Fleming, J; Brayne, C				Fleming, Jane; Brayne, Carol		CC75C Study Grp	Inability to get up after falling, subsequent time on floor, and summoning help: prospective cohort study in people over 90	BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY RESPONSE SYSTEMS; OLDER-ADULTS; RISK-FACTORS; INJURIOUS FALLS; ELDERLY PEOPLE; COMMUNITY; HOME; PREVENTION; DEMENTIA; VIEWS	Objectives To describe the incidence and extent of lying on the floor for a long time after being unable to get up from a fall among people aged over 90; to explore their use of call alarm systems in these circumstances. Design 1 year follow- up of participants in a prospective cohort study of ageing, using fall calendars, phone calls, and visits. Setting Participants' usual place of residence ( own homes or care homes), mostly in Cambridge. Participants 90 women and 20 men aged over 90 ( n= 110), surviving participants of the Cambridge City over-75s Cohort, a population based sample. Main outcome measures Inability to get up without help, lying on floor for a long time after falling, associated factors; availability and use of call alarm systems; participants' views on using call alarms to summon help if needed after falling. Results In one year's intensive follow- up, 54% ( 144/ 265) of fall reports described the participant as being found on the floor and 82% ( 217/ 265) of falls occurred when the person was alone. Of the 60% who fell, 80% ( 53/ 66) were unable to get up after at least one fall and 30% ( 20/ 66) had lain on the floor for an hour or more. Difficulty in getting up was consistently associated with age, reported mobility, and severe cognitive impairment. Cognition was the only characteristic that predicted lyingonthe floor for a long time. Lying on the floor for a long time was strongly associated with serious injuries, admission to hospital, and subsequent moves into long term care. Call alarms were widely available but were not used in most cases of falls that led to lying on the floor for a long time. Comments from older people and carers showed the complexity of issues around the use of call alarms, including perceptions of irrelevance, concerns about independence, and practical difficulties. Conclusions Lying on the floor for a long time after falling is more common among the "oldest old" than previously thought and is associated with serious consequences. Factors indicating higher risk and comments from participants suggest practical implications. People need training in strategies to get up from the floor. Work is needed on access and activation issues for design of call	[Fleming, Jane; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England.	jane.fleming@phpc.cam.ac.uk; carol.brayne@medschl.cam.ac.uk	Fleming, Jane/L-5300-2015; Matthews, Fiona/O-6932-2015; Dening, Tom/E-1335-2013; Brayne, Carol/AAA-4285-2020	Fleming, Jane/0000-0002-8127-2061; Matthews, Fiona/0000-0002-1728-2388; Dening, Tom/0000-0003-3387-4241; Brayne, Carol/0000-0001-5307-663X	Medical Research Council [MC_U105292687] Funding Source: Medline; MRC [MC_U105292687] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander NB, 1997, J AM GERIATR SOC, V45, P564, DOI 10.1111/j.1532-5415.1997.tb03088.x; Asbjornsen G, 2000, Tidsskr Nor Laegeforen, V120, P3119; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bergland A, 2005, AGING CLIN EXP RES, V17, P181; Bernstein M, 2000, Manag Care Q, V8, P38; Brownsell S, 2004, J TELEMED TELECARE, V10, P262, DOI 10.1258/1357633042026251; CAMERON ID, 1994, ARCH GERONTOL GERIAT, V19, P273, DOI 10.1016/0167-4943(94)00573-7; Demiris G, 2004, MED INFORM INTERNET, V29, P87, DOI 10.1080/14639230410001684387; FLEMING J, 2006, THESIS U CAMBRIDGE C; Fleming J, 2007, INT J EPIDEMIOL, V36, P40, DOI 10.1093/ije/dyl293; Fleming Jane, 2008, BMC Geriatr, V8, P6, DOI 10.1186/1471-2318-8-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Gooberman-Hill, 2004, REV CLIN GERONTOLOGY, V14, P63, DOI [10.1017/S0959259804001212, DOI 10.1017/S0959259804001212]; Halter M, 2000, FALLS OLDER POPULATI; Hofmeyer MR, 2002, J AM GERIATR SOC, V50, P1702, DOI 10.1046/j.1532-5415.2002.50463.x; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; LEVINE DA, 1995, MT SINAI J MED, V62, P293; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Mann WC, 2005, ASSIST TECHNOL, V17, P82, DOI 10.1080/10400435.2005.10132098; Miskelly FG, 2001, AGE AGEING, V30, P455, DOI 10.1093/ageing/30.6.455; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; REECE A, 1996, PHYSIOTHERAPY, V82, P27; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Shaw FE, 1998, AGE AGEING, V27, P7, DOI 10.1093/ageing/27.1.7; SIMPSON JM, 1993, AGE AGEING, V22, P294, DOI 10.1093/ageing/22.4.294; Skelton D, 2005, AGE AGEING, V34, P636, DOI 10.1093/ageing/afi174; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	36	165	167	0	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2008	337								a2227	10.1136/bmj.a2227	http://dx.doi.org/10.1136/bmj.a2227			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HP	19015185	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000262653800002
J	Canman, JC; Lewellyn, L; Laband, K; Smerdon, SJ; Desai, A; Bowerman, B; Oegema, K				Canman, Julie C.; Lewellyn, Lindsay; Laband, Kimberley; Smerdon, Stephen J.; Desai, Arshad; Bowerman, Bruce; Oegema, Karen			Inhibition of Rac by the GAP Activity of Centralspindlin Is Essential for Cytokinesis	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEIN; CAENORHABDITIS-ELEGANS; CONTRACTILE RING; GENE-PRODUCT; COMPLEX; RHOA; MGCRACGAP; SPINDLE; ORGANIZATION; REQUIRE	During cytokinesis, the guanosine triphosphatase ( GTPase) RhoA orchestrates contractile ring assembly and constriction. RhoA signaling is controlled by the central spindle, a set of microtubule bundles that forms between the separating chromosomes. Centralspindlin, a protein complex consisting of the kinesin-6 ZEN-4 and the Rho family GTPase activating protein ( GAP) CYK- 4, is required for central spindle assembly and cytokinesis in Caenorhabditis elegans. However, the importance of the CYK- 4 GAP activity and whether it regulates RhoA remain unclear. We found that two separation- of- function mutations in the GAP domain of CYK- 4 lead to cytokinesis defects that mimic centralspindlin loss of function. These defects could be rescued by depletion of the GTPase Rac or its effectors, but not by depletion of RhoA. Thus, inactivation of Rac by centralspindlin functions in parallel with RhoA activation to drive contractile ring constriction during cytokinesis.	[Canman, Julie C.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Canman, Julie C.; Lewellyn, Lindsay; Laband, Kimberley; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Smerdon, Stephen J.] Natl Inst Med Res, London NW7 1AA, England	University of Oregon; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; MRC National Institute for Medical Research	Canman, JC (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	jcanman@ucsd.edu; koegema@ucsd.edu	Canman, Julie C/A-3875-2016	Canman, Julie C/0000-0001-8135-2072; Laband, Kimberley/0000-0002-8535-2050; Smerdon, Stephen/0000-0001-5688-8465; Lewellyn, Lindsay/0000-0001-6444-5699	Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society; National Institute of General Medical Sciences [T32 GM008666]; National Cancer Institute [T32 CA067754]; Ludwig Institute for Cancer Research; NIH [GM058017]; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, R01GM049869, T32GM007752, R01GM058017] Funding Source: NIH RePORTER; Medical Research Council [MC_U117584228] Funding Source: researchfish; MRC [MC_U117584228] Funding Source: UKRI	Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all members of the Oegema, Desai, and Bowerman labs; A. Maddox, J. Dumont, and R. Green for reading this manuscript; J. Dumont for making double- stranded RNAs; Y. Kohara for cDNA clones; and the Caenorhabditis Genetics Center for strains. Supported by the Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society (J.C.C.), National Institute of General Medical Sciences grant T32 GM008666 and National Cancer Institute grant T32 CA067754 (L.L.), the Ludwig Institute for Cancer Research (K.O. and A.D.), and NIH grant GM058017 (B.B.).	AHMED S, 1994, J BIOL CHEM, V269, P17642; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawashima T, 2000, BLOOD, V96, P2116; LUNDQUIST EA, WORMBOOK; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; RAPPAPORT R, 1997, CYTOKINESIS ANIMAL C; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	28	127	142	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1543	1546		10.1126/science.1163086	http://dx.doi.org/10.1126/science.1163086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056985	Green Accepted			2022-12-24	WOS:000261377400049
J	Coleman, HR; Chan, CC; Ferris, FL; Chew, EY				Coleman, Hanna R.; Chan, Chi-Chao; Ferris, Frederick L., III; Chew, Emily Y.			Age-related macular degeneration	LANCET			English	Review							COMPLEMENT FACTOR-H; VITAMIN-E SUPPLEMENTATION; 3RD NATIONAL-HEALTH; BODY-MASS INDEX; VISUAL IMPAIRMENT; RISK-FACTORS; GEOGRAPHIC ATROPHY; DIETARY-FAT; CIGARETTE-SMOKING; 5-YEAR INCIDENCE	Age-related macular degeneration is the leading cause of blindness in elderly populations of European descent. The most consistent risk factors associated with this ocular condition are increasing age and cigarette smoking. Genetic investigations have shown that complement factor H, a regulator of the alternative complement pathway, and LOC387715/HtrA1 are the most consistent genetic risk factors for age-related macular degeneration. Although the pathogenesis of this disease is unknown, oxidative stress might have an important role. Treatment with antioxidant vitamins and zinc can reduce the risk of developing advanced age-related macular degeneration by about a quarter in those at least at moderate risk. Intravitreal injections of ranibizumab, a monoclonal antibody that inhibits all forms of vascular endothelial growth factor, have been shown to stabilise loss of vision and, in some cases, improve vision in individuals with neovascular age-related macular degeneration. These findings, combined with assessments of possible environmental and genetic interactions and new approaches to modulate inflammatory pathways, will hopefully further expand our ability to understand and treat age-related macular degeneration.	[Coleman, Hanna R.; Ferris, Frederick L., III; Chew, Emily Y.] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA; [Chan, Chi-Chao] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NEI, Div Epidemiol & Clin Res, NIH, Bldg 10,CRC,Room 3-2531,10 Ctr Dr,MSC-1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov		Ferris, Frederick/0000-0002-4933-0639	Intramural NIH HHS [Z01 EY000418-04, Z99 EY999999, Z01 EY000222-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000418, ZIAEY000222, ZICEY000461] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albanes D, 2007, JAMA-J AM MED ASSOC, V298, P400, DOI 10.1001/jama.298.4.400-a; Allikmets R, 2008, NAT GENET, V40, P820, DOI 10.1038/ng0708-820; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; [Anonymous], 1993, Arch Ophthalmol, V111, P104; [Anonymous], 2005, ARCH OPHTHALMOL-CHIC, V123, P1570, DOI DOI 10.1001/ARCHOPHT.123.11.1570; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; BRESSLER NM, 1994, RETINA-J RET VIT DIS, V14, P130, DOI 10.1097/00006982-199414020-00006; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; BRESSLER NM, 1989, ARCH OPHTHALMOL-CHIC, V107, P847, DOI 10.1001/archopht.1989.01070010869032; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; Chan Chi-Chao, 2007, Trans Am Ophthalmol Soc, V105, P92; Chen J, 2007, J CLIN INVEST, V117, P2758, DOI 10.1172/JCI33513; Chew EY, 2005, ARCH OPHTHALMOL-CHIC, V123, P395, DOI 10.1001/archopht.123.3.395; Cho E, 2001, AM J CLIN NUTR, V73, P209; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; Chua B, 2006, ARCH OPHTHALMOL-CHIC, V124, P981, DOI 10.1001/archopht.124.7.981; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Cruickshanks KJ, 1997, ARCH OPHTHALMOL-CHIC, V115, P242, DOI 10.1001/archopht.1997.01100150244015; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; DASTGHEIB K, 1994, ARCH OPHTHALMOL-CHIC, V112, P813, DOI 10.1001/archopht.1994.01090180111045; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2001, ARCH OPHTHALMOL-CHIC, V119, P1463; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FINE SL, 1982, ARCH OPHTHALMOL-CHIC, V100, P912; Flood V, 2002, OPHTHALMOLOGY, V109, P2272, DOI 10.1016/S0161-6420(02)01263-0; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Friberg TR, 2006, OPHTHALMOLOGY, V113, P612, DOI 10.1016/j.ophtha.2005.10.066; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; GASS JD, 1973, T AM ACAD OPHTHALMOL, V77; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; Gottfredsdottir MS, 1999, ACTA OPHTHALMOL SCAN, V77, P422, DOI 10.1034/j.1600-0420.1999.770413.x; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Green W R, 1999, Mol Vis, V5, P27; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HAWKINS BS, 1986, ARCH OPHTHALMOL-CHIC, V104, P694; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heuberger RA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1833, DOI 10.1001/archopht.119.12.1833; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Huang HY, 2007, JAMA-J AM MED ASSOC, V298, P400, DOI 10.1001/jama.298.4.400-b; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P471, DOI 10.1097/00006982-200208000-00012; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P464, DOI 10.1097/00006982-200208000-00011; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; KLEIN ML, 1994, ARCH OPHTHALMOL-CHIC, V112, P932, DOI 10.1001/archopht.1994.01090190080025; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; KLEIN R, 1999, AGE RELATED MACULAR, P31; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Lamb LE, 2004, PHOTOCHEM PHOTOBIOL, V79, P127, DOI 10.1562/0031-8655(2004)079<0127:AACOOL>2.0.CO;2; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Lau LI, 2006, INVEST OPHTH VIS SCI, V47, P3242, DOI 10.1167/iovs.05-1532; Gluud LL, 2007, JAMA-J AM MED ASSOC, V298, P402, DOI 10.1001/jama.298.4.402; Lutty G, 1999, MOL VIS, V5; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Mares-Perlman JA, 2001, AM J EPIDEMIOL, V153, P424, DOI 10.1093/aje/153.5.424; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; MARESPERLMAN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P743, DOI 10.1001/archopht.1995.01100060069034; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; MEYERS SM, 1995, AM J OPHTHALMOL, V120, P757, DOI 10.1016/S0002-9394(14)72729-1; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Mukesh BN, 2004, OPHTHALMOLOGY, V111, P1176, DOI 10.1016/j.ophtha.2003.08.042; Mullins RF, 1997, OPHTHALMOLOGY, V104, P288, DOI 10.1016/S0161-6420(97)30322-4; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okamoto H, 2006, MOL VIS, V12, P156; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Owens SL, 2006, AM J OPHTHALMOL, V141, P276, DOI 10.1016/j.ajo.2005.08.019; Park DW, 2006, OPHTHALMOLOGY, V113, P1974, DOI 10.1016/j.ophtha.2006.08.015; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Sarks JP, 1997, EYE, V11, P515, DOI 10.1038/eye.1997.137; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Sarks S, 2007, INVEST OPHTH VIS SCI, V48, P968, DOI 10.1167/iovs.06-0443; SCHACHAT AP, 1995, ARCH OPHTHALMOL-CHIC, V113, P728, DOI 10.1001/archopht.1995.01100060054032; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmitz-Valckenberg S, 2006, INVEST OPHTH VIS SCI, V47, P2648, DOI 10.1167/iovs.05-0892; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Smith W, 1998, AUST NZ J OPHTHALMOL, V26, P203, DOI 10.1111/j.1442-9071.1998.tb01311.x; Snellen ELM, 2002, ACTA OPHTHALMOL SCAN, V80, P368, DOI 10.1034/j.1600-0420.2002.800404.x; Souied EH, 2005, MOL VIS, V11, P1135; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Tan JSL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1089, DOI 10.1001/archopht.125.8.1089; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; *VERT ROUNDT 2000, 2002, RETINA, V22, P6; VINDING T, 1992, ACTA OPHTHALMOL, V70, P66; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vingerling JR, 1996, ARCH OPHTHALMOL-CHIC, V114, P1193, DOI 10.1001/archopht.1996.01100140393005; Vu HTV, 2006, BRIT J OPHTHALMOL, V90, P389, DOI 10.1136/bjo.2005.078055; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; Weih LM, 2000, ARCH OPHTHALMOL-CHIC, V118, P264; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yates YR, 2007, NEW ENGL J MED, V357, P19; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	163	405	421	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1835	1845		10.1016/S0140-6736(08)61759-6	http://dx.doi.org/10.1016/S0140-6736(08)61759-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027484	Green Accepted			2022-12-24	WOS:000261112000026
J	Chambouvet, A; Morin, P; Marie, D; Guillou, L				Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure			Control of Toxic Marine Dinoflagellate Blooms by Serial Parasitic Killers	SCIENCE			English	Article							18S RDNA SEQUENCES; CHESAPEAKE BAY; EUKARYOTIC DIVERSITY; AMOEBOPHRYA-CERATII; PICOPLANKTON; SURVIVAL; PLANKTON; STRAINS; TIME; SITE	The marine dinoflagellates commonly responsible for toxic red tides are parasitized by other dinoflagellate species. Using culture- independent environmental ribosomal RNA sequences and fluorescence markers, we identified host- specific infections among several species. Each parasitoid produces 60 to 400 offspring, leading to extraordinarily rapid control of the host's population. During 3 consecutive years of observation in a natural estuary, all dinoflagellates observed were chronically infected, and a given host species was infected by a single genetically distinct parasite year after year. Our observations in natural ecosystems suggest that although bloom- forming dinoflagellates may escape control by grazing organisms, they eventually succumb to parasite attack.	[Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure] CNRS, Biol Stn, UMR 7144, F-29682 Roscoff, France; [Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure] Univ Paris 06, Lab Adapt & Divers Milieu Marin, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Guillou, L (corresponding author), CNRS, Biol Stn, UMR 7144, Pl Georges Teissier, F-29682 Roscoff, France.	lguillou@sb-roscoff.fr	Morin, Pascal/A-1112-2016	Morin, Pascal/0000-0003-2766-1821; Chambouvet, Aurelie/0000-0003-3932-0098; Guillou, Laure/0000-0003-1032-7958	Groupement d'Interet Scientifique Genomique Marine; French Agence National de la Recherche project Aquaparadox	Groupement d'Interet Scientifique Genomique Marine; French Agence National de la Recherche project Aquaparadox(French National Research Agency (ANR))	We thank A. Carlier, D. Charruaud, A. Groisillier, and S. Maury for their earlier contributions to this work; D. Vaulot, P. von Dassow, and A. Worden for critically reading this manuscript; P. Falkowski for his help with corrections and discussions; W. Coats for cultures of Amoebophrya spp. that greatly helped us to test the oligonucleotide probes and for constructive discussions; D. Jollivet for his help with genetic population analysis; The Service Mer et Observation of the Roscoff Biological Station; and E. Mace for sample collections and nutrient acquisition parameters. This work was financially supported by the Groupement d'Interet Scientifique Genomique Marine and the French Agence National de la Recherche project Aquaparadox. We also thank Zeiss for help in the acquisition of the confocal micrographs. Sequences have been deposited in GenBank under accession numbers FJ356776 to FJ357007. The authors declare no competing financial interests.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; [Anonymous], [No title captured]; CHACHON J, 1964, ANN SCI NAT ZOOL, V6, P1; Chatton E., 1920, Archives de Zoologie Experimentale Paris, V59; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; COATS DW, 1994, J EUKARYOT MICROBIOL, V41, P586, DOI 10.1111/j.1550-7408.1994.tb01520.x; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Gunderson JH, 2002, J EUKARYOT MICROBIOL, V49, P469, DOI 10.1111/j.1550-7408.2002.tb00230.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Maguer JF, 2004, LIMNOL OCEANOGR, V49, P1108, DOI 10.4319/lo.2004.49.4.1108; Medlin LK, 2006, MICROB ECOL, V52, P53, DOI 10.1007/s00248-005-0062-x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Nishitani L., 1985, P225; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Salomon PS, 2003, ENVIRON MICROBIOL, V5, P1046, DOI 10.1046/j.1462-2920.2003.00511.x; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; TAYLOR FJR, 1968, J FISH RES BOARD CAN, V25, P2241, DOI 10.1139/f68-197; Zingone A, 2000, OCEAN COAST MANAGE, V43, P725, DOI 10.1016/S0964-5691(00)00056-9	23	209	215	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1254	1257		10.1126/science.1164387	http://dx.doi.org/10.1126/science.1164387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023082				2022-12-24	WOS:000261033400044
J	Holt, JW; Safaeinili, A; Plaut, JJ; Head, JW; Phillips, RJ; Seu, R; Kempf, SD; Choudhary, P; Young, DA; Putzig, NE; Biccari, D; Gim, Y				Holt, John W.; Safaeinili, Ali; Plaut, Jeffrey J.; Head, James W.; Phillips, Roger J.; Seu, Roberto; Kempf, Scott D.; Choudhary, Prateek; Young, Duncan A.; Putzig, Nathaniel E.; Biccari, Daniela; Gim, Yonggyu			Radar Sounding Evidence for Buried Glaciers in the Southern Mid-Latitudes of Mars	SCIENCE			English	Article							POLAR LAYERED DEPOSITS; LOBATE DEBRIS APRONS; CLIMATE-CHANGE; ICE; SUBSURFACE; OBLIQUITY; ACCUMULATION; REGION; FLOW	Lobate features abutting massifs and escarpments in the middle latitudes of Mars have been recognized in images for decades, but their true nature has been controversial, with hypotheses of origin such as ice- lubricated debris flows or glaciers covered by a layer of surface debris. These models imply an ice content ranging from minor and interstitial to massive and relatively pure. Soundings of these deposits in the eastern Hellas region by the Shallow Radar on the Mars Reconnaissance Orbiter reveal radar properties entirely consistent with massive water ice, supporting the debris- covered glacier hypothesis. The results imply that these glaciers formed in a previous climate conducive to glaciation at middle latitudes. Such features may collectively represent the most extensive nonpolar ice yet recognized on Mars.	[Holt, John W.; Kempf, Scott D.; Choudhary, Prateek; Young, Duncan A.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Safaeinili, Ali; Plaut, Jeffrey J.; Gim, Yonggyu] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Phillips, Roger J.; Putzig, Nathaniel E.] SW Res Inst, Boulder, CO 80302 USA; [Seu, Roberto; Biccari, Daniela] Univ Roma La Sapienza, INFOCOM Dept, I-00184 Rome, Italy	University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; Sapienza University Rome	Holt, JW (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	jack@ig.utexas.edu	Young, Duncan A./G-6256-2010; Holt, John/C-4896-2009	Young, Duncan A./0000-0002-6866-8176; Putzig, Nathaniel/0000-0003-4485-6321	Institute for Geophysics of the Jackson School of Geosciences and NASA [NAG5-12693]	Institute for Geophysics of the Jackson School of Geosciences and NASA	We thank F. Russo, M. Cutigni, O. Fuga, and E. Giacomoni of the SHARAD Operations Center for their role in acquiring the data over these targets; F. Bernardini for his assistance in the U. S. data processing effort; and two anonymous reviewers for their comments and suggestions. Work at the University of Texas was supported by the Institute for Geophysics of the Jackson School of Geosciences and NASA grant NAG5-12693 (J.W.H.). MRO is operated for NASA by Caltech's Jet Propulsion Laboratory. SHARAD was provided to MRO by the Italian Space Agency through a contract with Thales Alenia Space Italia and is operated by the INFOCOM Department, University of Rome. This is UTIG contribution 2006.	Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr M.H, 1996, WATER MARS; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Forget F, 2006, SCIENCE, V311, P368, DOI 10.1126/science.1120335; GUDMANDSEN P, 1971, ELECTROMAGNETIC PROB, P329; Head JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024360; Head JW, 2006, EARTH PLANET SC LETT, V241, P663, DOI 10.1016/j.epsl.2005.11.016; Head JW, 2005, NATURE, V434, P346, DOI 10.1038/nature03359; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Heggy E., 2007, LUNAR PLANET SCI, VXXXVIII; Holt JW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002525; KRESS AM, 2008, LUNAR PLANET SCI C, V39, P1293; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Li H, 2005, ICARUS, V176, P382, DOI 10.1016/j.icarus.2005.02.011; Lucchitta B. K., 1984, Journal of Geophysical Research, V89, P409, DOI 10.1029/JB089iS02p0B409; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; Marchant DR, 2007, ICARUS, V192, P187, DOI 10.1016/j.icarus.2007.06.018; Mest SC, 2001, ICARUS, V153, P89, DOI 10.1006/icar.2001.6655; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; PLAUT JJ, 2008, LUNAR PLANET SCI, V39, P2290; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SQUYRES SW, 1979, J GEOPHYS RES, V84, P8087, DOI 10.1029/JB084iB14p08087	30	231	236	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1235	1238		10.1126/science.1164246	http://dx.doi.org/10.1126/science.1164246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023078				2022-12-24	WOS:000261033400038
J	Kaplan, N; Moore, IK; Fondufe-Mittendorf, Y; Gossett, AJ; Tillo, D; Field, Y; LeProust, EM; Hughes, TR; Lieb, JD; Widom, J; Segal, E				Kaplan, Noam; Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Gossett, Andrea J.; Tillo, Desiree; Field, Yair; LeProust, Emily M.; Hughes, Timothy R.; Lieb, Jason D.; Widom, Jonathan; Segal, Eran			The DNA-encoded nucleosome organization of a eukaryotic genome	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HIGH-RESOLUTION; MULTIPLE ALIGNMENT; PROMOTER ELEMENT; YEAST GENOME; SEQUENCE; HISTONE; TRANSCRIPTION; SITES; CORE	Nucleosome organization is critical for gene regulation(1). In living cells this organization is determined by multiple factors, including the action of chromatin remodellers(2), competition with site-specific DNA-binding proteins(3), and the DNA sequence preferences of the nucleosomes themselves(4-8). However, it has been difficult to estimate the relative importance of each of these mechanisms in vivo(7,9-11), because in vivo nucleosome maps reflect the combined action of all influencing factors. Here we determine the importance of nucleosome DNA sequence preferences experimentally by measuring the genome-wide occupancy of nucleosomes assembled on purified yeast genomic DNA. The resulting map, in which nucleosome occupancy is governed only by the intrinsic sequence preferences of nucleosomes, is similar to in vivo nucleosome maps generated in three different growth conditions. In vitro, nucleosome depletion is evident at many transcription factor binding sites and around gene start and end sites, indicating that nucleosome depletion at these sites in vivo is partly encoded in the genome. We confirm these results with a micrococcal nuclease-independent experiment that measures the relative affinity of nucleosomes for similar to 40,000 double-stranded 150-base-pair oligonucleotides. Using our in vitro data, we devise a computational model of nucleosome sequence preferences that is significantly correlated with in vivo nucleosome occupancy in Caenorhabditis elegans. Our results indicate that the intrinsic DNA sequence preferences of nucleosomes have a central role in determining the organization of nucleosomes in vivo.	[Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Widom, Jonathan] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Kaplan, Noam; Field, Yair; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tillo, Desiree; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [LeProust, Emily M.] Genom LSSU, Agilent Technol Inc, Santa Clara, CA 95051 USA; [Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Hughes, Timothy R.] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Northwestern University; Weizmann Institute of Science; Weizmann Institute of Science; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Agilent Technologies; University of Toronto; University of Toronto	Widom, J (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-widom@northwestern.edu; eran.segal@weizmann.ac.il	Kaplan, Noam/K-4383-2019; Kaplan, Noam/A-3544-2011; Segal, Eran/AAF-4855-2019	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Segal, Eran/0000-0002-6859-1164; Gossett, Andrea/0000-0002-9471-3970; Lieb, Jason/0000-0001-7601-8061	CIHR; NIH; European Research Council (ERC); NSERC; Lineberger Comprehensive Cancer Center; University Cancer Research Funds; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054692, R01GM058617, R01GM072518] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Lineberger Comprehensive Cancer Center; University Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kelkar for bioinformatics support in handling the sequencing files, P. Mieczkowski and J. McPherson for Illumina sequencing ( library preparation and instrument operation), and the members of our respective laboratories for technical assistance, discussions and comments on the manuscript. The UNC sequencing facility is funded by the Lineberger Comprehensive Cancer Center and University Cancer Research Funds. J. W. acknowledges the use of instruments at Northwestern University's Keck Biophysics Facility. This work was supported by a grant from CIHR to T. R. H. and C. Nislow, a grant from the NIH to J. D. L., a grant from the NIH to J. W., and grants from the European Research Council (ERC) and NIH to E. S. D. T. holds an NSERC postgraduate scholarship. N.K. is a Clore scholar. E. S. is the incumbent of the Soretta and Henry Shapiro career development chair.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Bolshoy A, 1996, COMPUT APPL BIOSCI, V12, P383; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Graber JH, 1999, NUCLEIC ACIDS RES, V27, P888, DOI 10.1093/nar/27.3.888; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	37	885	902	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					362	U129		10.1038/nature07667	http://dx.doi.org/10.1038/nature07667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19092803	Green Accepted, Green Submitted, hybrid			2022-12-24	WOS:000264285600046
J	Mekhail, K; Seebacher, J; Gygi, SP; Moazed, D				Mekhail, Karim; Seebacher, Jan; Gygi, Steven P.; Moazed, Danesh			Role for perinuclear chromosome tethering in maintenance of genome stability	NATURE			English	Article							RIBOSOMAL-RNA GENES; SACCHAROMYCES-CEREVISIAE; RENT COMPLEX; YEAST RDNA; PROTEIN; DNA; RECOMBINATION; REPLICATION; SIR2; TRANSCRIPTION	Repetitive DNA sequences, which constitute half the genome in some organisms, often undergo homologous recombination. This can instigate genomic instability resulting from a gain or loss of DNA(1). Assembly of DNA into silent chromatin is generally thought to serve as a mechanism ensuring repeat stability by limiting access to the recombination machinery(2). Consistent with this notion is the observation, in the budding yeast Saccharomyces cerevisiae, that stability of the highly repetitive ribosomal DNA( rDNA) sequences requires a Sir2- containing chromatin silencing complex that also inhibits transcription from foreign promoters and transposons inserted within the repeats by a process called rDNA silencing(2-5). Here we describe a protein network that stabilizes rDNA repeats of budding yeast by means of interactions between rDNA- associated silencing proteins and two proteins of the inner nuclear membrane (INM). Deletion of either the INM or silencing proteins reduces perinuclear rDNA positioning, disrupts the nucleolus nucleoplasm boundary, induces the formation of recombination foci, and destabilizes the repeats. In addition, artificial targeting of rDNA repeats to the INM suppresses the instability observed in cells lacking an rDNA- associated silencing protein that is typically required for peripheral tethering of the repeats. Moreover, in contrast to Sir2 and its associated nucleolar factors, the INM proteins are not required for rDNA silencing, indicating that Sir2-dependent silencing is not sufficient to inhibit recombination within the rDNA locus. These findings demonstrate a role for INM proteins in the perinuclear localization of chromosomes and show that tethering to the nuclear periphery is required for the stability of rDNA repeats. The INM proteins studied here are conserved and have been implicated in chromosome organization in metazoans(6,7). Our results therefore reveal an ancient mechanism in which interactions between INM proteins and chromosomal proteins ensure genome stability.	[Mekhail, Karim; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mekhail, Karim; Seebacher, Jan; Gygi, Steven P.; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	danesh@hms.harvard.edu		Mekhail, Karim/0000-0002-6084-020X	National Institutes of Health; Howard Hughes Medical Institute; Canadian Institutes of Health Research Institute of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research Institute of Aging(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Yip, T. Walz, J. Huang, M. Buhler, D. Koshland, A. Palazzo, D. E. Libuda, F. Winston, L. Vasiljeva, S. Buratowski, J. E. Warner, C. Anderson, G. A. Beltz, M. Lisby, T. Daniel, L. Ding and the Harvard NeuroDiscovery Optical Imaging Center for technical assistance or materials, and T. Rapoport, T. Iida, M. Motamedi, A. Johnson, M. Onishi, E. Gerace, S. Buker, M. Halic and members of the Moazed laboratory for helpful discussions and comments. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute (D.M.), and the Canadian Institutes of Health Research Institute of Aging (K.M.). D.M. is a scholar of the Leukemia and Lymphoma Society.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KEIL RL, 1984, CELL, V39, P377, DOI 10.1016/0092-8674(84)90016-3; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775	36	179	183	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					667	U98		10.1038/nature07460	http://dx.doi.org/10.1038/nature07460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18997772	Green Accepted			2022-12-24	WOS:000261340000047
J	Biver, S; Belge, H; Bourgeois, S; Van Vooren, P; Nowik, M; Scohy, S; Houillier, P; Szpirer, J; Szpirer, C; Wagner, CA; Devuyst, O; Marini, AM				Biver, Sophie; Belge, Hendrica; Bourgeois, Soline; Van Vooren, Pascale; Nowik, Marta; Scohy, Sophie; Houillier, Pascal; Szpirer, Josiane; Szpirer, Claude; Wagner, Carsten A.; Devuyst, Olivier; Marini, Anna Maria			A role for Rhesus factor Rhcg in renal ammonium excretion and male fertility	NATURE			English	Article							TUBULAR-ACIDOSIS; RHAG PROTEIN; TRANSPORT; GLYCOPROTEIN; KIDNEY; RHBG; EXPRESSION; MECHANISMS; MOUSE; IDENTIFICATION	The kidney has an important role in the regulation of acid - base homeostasis. Renal ammonium production and excretion are essential for net acid excretion under basal conditions and during metabolic acidosis. Ammonium is secreted into the urine by the collecting duct, a distal nephron segment where ammonium transport is believed to occur by non- ionic NH3 diffusion coupled to H+ secretion. Here we show that this process is largely dependent on the Rhesus factor Rhcg. Mice lacking Rhcg have abnormal urinary acidification due to impaired ammonium excretion on acid loading - a feature of distal renal tubular acidosis. In vitro microperfused collecting ducts of Rhcg(-/-) acid- loaded mice show reduced apical permeability to NH3 and impaired transepithelial NH3 transport. Furthermore, Rhcg is localized in epididymal epithelial cells and is required for normal fertility and epididymal fluid pH. We anticipate a critical role for Rhcg in ammonium handling and pH homeostasis both in the kidney and the male reproductive tract.	[Biver, Sophie; Van Vooren, Pascale; Scohy, Sophie; Szpirer, Josiane; Szpirer, Claude; Marini, Anna Maria] Univ Libre Bruxelles, Inst Biol & Med Mol, Labs Biol Dev & Physiol Mol Cellule, B-6041 Gosselies, Belgium; [Belge, Hendrica; Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium; [Bourgeois, Soline; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Houillier, Pascal] INSERM, UMS 872, F-75006 Paris, France; [Bourgeois, Soline; Houillier, Pascal] Univ Paris 06, F-75006 Paris, France; [Bourgeois, Soline; Houillier, Pascal] Univ Paris 05, F-75006 Paris, France	Universite Libre de Bruxelles; Universite Catholique Louvain; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Marini, AM (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Labs Biol Dev & Physiol Mol Cellule, Rue Prof Jeener & Brachet 12, B-6041 Gosselies, Belgium.	ammarini@dbm.ulb.ac.be	Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Biver, Sophie/0000-0002-7903-2413; Devuyst, Olivier/0000-0003-3744-4767	Belgian agencies FNRS; FRSM [3.4.546.04. F, 3.4.635.05. F, 3.4592.06. F]; Fonds Brachet-recherche; Fonds Van Buuren; Fondation Alphonse Jean Forton; Concerted Research Action [05/10-328]; Inter-university Attraction Pole [IUAP P6/05]; Swiss National Science Foundation [31-109677]; INSERM; EuReGene; EUNEFRON [GA#201590]; European Community [FP6, FP7]; FRIA fellowship	Belgian agencies FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); Fonds Brachet-recherche; Fonds Van Buuren; Fondation Alphonse Jean Forton; Concerted Research Action; Inter-university Attraction Pole(Belgian Federal Science Policy Office); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EuReGene; EUNEFRON; European Community(European Commission); FRIA fellowship(Fonds de la Recherche Scientifique - FNRS)	We are grateful to P. Dreze, B. Andre and P. Gabant for their contribution to the initial step of this study. We thank H. Mezdour, L. Pouilly and P. Persoons for microinjection experiments, B. Pajak for help in broad- spectrum histological assessment, V. Beaujean, Y. Cnops, H. Debaix and T. Nishino for excellent technical assistance, and A. Tamah and M.-F. Vincent for amino acid chromatography. These studies were supported by the Belgian agencies FNRS and FRSM (3.4.546.04. F, 3.4.635.05. F, 3.4592.06. F), the 'Fonds Brachet-recherche', the 'Fonds Van Buuren', the 'Fondation Alphonse & Jean Forton', a Concerted Research Action (05/10-328), an Inter-university Attraction Pole (IUAP P6/05), the Swiss National Science Foundation (31-109677), an INSERM grant, and the EuReGene and EUNEFRON (GA#201590) projects of the European Community (FP6 and FP7). S. Bi. was the recipient of a FRIA fellowship; H.B., A.M.M. and C.S. are Research fellow, Research associate and Research director of the FNRS, respectively.	Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; BEVENSEE MO, 2008, CONTROL INTRACELLULA, P1429; Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P240; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; HAMM LL, 1987, AM J PHYSIOL, V253, pF595, DOI 10.1152/ajprenal.1987.253.4.F595; Ji QM, 2006, P NATL ACAD SCI USA, V103, P5881, DOI 10.1073/pnas.0600901103; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kim SC, 1998, INT J ANDROL, V21, P29; KNEPPER MA, 1991, KIDNEY INT, V40, pS95; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; LEVANKIM C, 1992, P NATL ACAD SCI USA, V89, P10925, DOI 10.1073/pnas.89.22.10925; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Philip L., 1939, JAMA-J AM MED ASSOC, V113, P126; PITTS RF, 1948, FED PROC, V7, P418; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; RIDGWELL K, 1992, BIOCHEM J, V287, P223, DOI 10.1042/bj2870223; SARTORIUS OW, 1949, J CLIN INVEST, V28, P423, DOI 10.1172/JCI102087; Soriano JR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023430.92674.E5; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weiner ID, 2007, ANNU REV PHYSIOL, V69, P317, DOI 10.1146/annurev.physiol.69.040705.142215; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	40	129	131	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					339	343		10.1038/nature07518	http://dx.doi.org/10.1038/nature07518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020613				2022-12-24	WOS:000261039600033
J	Kohanski, MA; Dwyer, DJ; Wierzbowski, J; Cottarel, G; Collins, JJ				Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.			Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death	CELL			English	Article							COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; GENE ONTOLOGY; FTSH HFLB; PERIPLASMIC PROTEASE; BACTERICIDAL ACTION; GYRASE INHIBITORS; AMINOGLYCOSIDES; ENVELOPE	Aminoglycoside antibiotics, such as gentamicin and kanamycin, directly target the ribosome, yet the mechanisms by which these bactericidal drugs induce cell death are not fully understood. Recently, oxidative stress has been implicated as one of the mechanisms whereby bactericidal antibiotics kill bacteria. Here, we use systems-level approaches and phenotypic analyses to provide insight into the pathway whereby aminoglycosides ultimately trigger hydroxyl radical formation. We show, by disabling systems that facilitate membrane protein traffic, that mistranslation and misfolding of membrane proteins are central to aminoglycoside-induced oxidative stress and cell death. Signaling through the envelope stress-response two-component system is found to be a key player in this process, and the redox-responsive two-component system is shown to have an associated role. Additionally, we show that these two-component systems play a general role in bactericidal antibiotic-mediated oxidative stress and cell death, expanding our understanding of the common mechanism of killing induced by bactericidal antibiotics.	[Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Dwyer, Daniel J.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, 44 Cummington St, Boston, MA 02215 USA.	jcollins@bu.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644-02, DP1 OD003644] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; DOUGHERTY TJ, 1985, ANTIMICROB AGENTS CH, V28, P200, DOI 10.1128/AAC.28.2.200; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P429, DOI 10.1093/jac/8.6.429; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; IUCHI S, 1989, J BACTERIOL, V171, P2889, DOI 10.1128/jb.171.5.2889-2893.1989; Jepras RI, 1997, ANTIMICROB AGENTS CH, V41, P2001, DOI 10.1128/AAC.41.9.2001; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; MARTIN JP, 1987, J BACTERIOL, V169, P2516, DOI 10.1128/jb.169.6.2516-2522.1987; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; RAHAL JJ, 1979, ANTIMICROB AGENTS CH, V16, P13, DOI 10.1128/AAC.16.1.13; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Umezawa N, 1997, ARCH BIOCHEM BIOPHYS, V342, P275, DOI 10.1006/abbi.1997.0124; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; WEISBLUM B, 1968, BACTERIOL REV, V32, P493, DOI 10.1128/MMBR.32.4_Pt_2.493-528.1968; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; ZASKE DE, 1982, ANTIMICROB AGENTS CH, V21, P407, DOI 10.1128/AAC.21.3.407	59	380	392	10	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					679	690		10.1016/j.cell.2008.09.038	http://dx.doi.org/10.1016/j.cell.2008.09.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013277	Bronze, Green Accepted			2022-12-24	WOS:000260886900018
J	Ley, TJ; Mardis, ER; Ding, L; Fulton, B; McLellan, MD; Chen, K; Dooling, D; Dunford-Shore, BH; McGrath, S; Hickenbotham, M; Cook, L; Abbott, R; Larson, DE; Koboldt, DC; Pohl, C; Smith, S; Hawkins, A; Abbott, S; Locke, D; Hillier, LW; Miner, T; Fulton, L; Magrini, V; Wylie, T; Glasscock, J; Conyers, J; Sander, N; Shi, XQ; Osborne, JR; Minx, P; Gordon, D; Chinwalla, A; Zhao, Y; Ries, RE; Payton, JE; Westervelt, P; Tomasson, MH; Watson, M; Baty, J; Ivanovich, J; Heath, S; Shannon, WD; Nagarajan, R; Walter, MJ; Link, DC; Graubert, TA; DiPersio, JF; Wilson, RK				Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, LaDeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; Minx, Patrick; Gordon, David; Chinwalla, Asif; Zhao, Yu; Ries, Rhonda E.; Payton, Jacqueline E.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark; Baty, Jack; Ivanovich, Jennifer; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.			DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome	NATURE			English	Article							ADULT PATIENTS; MUTATIONS; AML; NUCLEOPHOSMIN; CANCER; GENES; FLT3	Acute myeloid leukaemia is a highly malignant haematopoietic tumour that affects about 13,000 adults in the United States each year. The treatment of this disease has changed little in the past two decades, because most of the genetic events that initiate the disease remain undiscovered. Whole- genome sequencing is now possible at a reasonable cost and timeframe to use this approach for the unbiased discovery of tumour- specific somatic mutations that alter the protein- coding genes. Here we present the results obtained from sequencing a typical acute myeloid leukaemia genome, and its matched normal counterpart obtained from the same patient's skin. We discovered ten genes with acquired mutations; two were previously described mutations that are thought to contribute to tumour progression, and eight were new mutations present in virtually all tumour cells at presentation and relapse, the function of which is not yet known. Our study establishes whole- genome sequencing as an unbiased method for discovering cancer- initiating mutations in previously unidentified genes that may respond to targeted therapies.	[Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Magrini, Vincent; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Ley, Timothy J.; Zhao, Yu; Ries, Rhonda E.; Westervelt, Peter; Tomasson, Michael H.; Heath, Sharon; Shannon, William D.; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA; [Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, LaDeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; Minx, Patrick; Chinwalla, Asif; Watson, Mark; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Ley, Timothy J.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark; Ivanovich, Jennifer; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Payton, Jacqueline E.; Watson, Mark; Nagarajan, Rakesh] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Baty, Jack] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63108 USA; [Ivanovich, Jennifer] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63108 USA; [Hillier, LaDeana W.; Gordon, David] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Mardis, ER (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA.	emardis@wustl.edu	McGrath, Sean David/AAT-3540-2020; Magrini, Vincent/AAT-5830-2020; Mardis, Elaine/W-2202-2019; Chen, Ken/AAU-1432-2021; Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; Chen, Ken/A-1074-2009	McGrath, Sean David/0000-0001-9064-8449; Magrini, Vincent/0000-0002-2019-4872; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; Tomasson, Michael/0000-0003-4518-7123; Graubert, Timothy/0000-0002-7710-1171; Ries, Rhonda/0000-0002-3702-7923; Chinwalla, Asif/0000-0001-7831-3996; MCLELLAN, MICHAEL/0000-0002-2703-8784; Larson, David/0000-0001-7934-5906; Locke, Devin/0000-0002-2527-0475	National Cancer Institute; National Human Genome Research Institute; Barnes-Jewish Hospital Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002042] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Barnes-Jewish Hospital Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to our AML patients and their families, and to A.J. Siteman, whose generous and visionary gift provided the main funding source for this study. We thank G. Flance, D. Kipnis and K. Polonsky for their support, and C. Bloomfield, M. Caligiuri and J. Vardiman from the Cancer and Leukemia Group B for providing important AML samples for validation studies. We also thank the staff of The Genome Center at Washington University for their support of and their many contributions to this project, and H. Li of the Sanger Institute for assistance with the use of Maq. Further funding was provided by the National Cancer Institute (T.J.L.), the National Human Genome Research Institute (R.K.W.), and the Barnes-Jewish Hospital Foundation (T.J.L.).	Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; den Besten W, 2005, CELL CYCLE, V4, P1593; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Paulsson K, 2006, LEUKEMIA, V20, P840, DOI 10.1038/sj.leu.2404145; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN, P302; Raghavan M, 2005, CANCER RES, V65, P375; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Wendl MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-239; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	29	895	997	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					66	72		10.1038/nature07485	http://dx.doi.org/10.1038/nature07485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987736	Green Accepted, hybrid			2022-12-24	WOS:000260674000041
J	Holzmann, J; Frank, P; Loffler, E; Bennett, KL; Gerner, C; Rossmanith, W				Holzmann, Johann; Frank, Peter; Loeffler, Esther; Bennett, Keiryn L.; Gerner, Christopher; Rossmanith, Walter			RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme	CELL			English	Article							RIBONUCLEASE-P; AQUIFEX-AEOLICUS; PROTEIN; MATURATION; EVOLUTION; SEQUENCES; GENE; DEHYDROGENASE; MUTATIONS; MECHANISM	tRNAs are synthesized as immature precursors, and on their way to functional maturity, extra nucleotides at their 50 ends are removed by an endonuclease called RNase P. All RNase P enzymes characterized so far are composed of an RNA plus one or more proteins, and tRNA 50 end maturation is considered a universal ribozyme-catalyzed process. Using a combinatorial purification/proteomics approach, we identified the components of human mitochondrial RNase P and reconstitutedthe enzymatic activity from three recombinant proteins. We thereby demonstrate that human mitochondrial RNase P is a protein enzyme that does not require a trans-acting RNA component for catalysis. Moreover, the mitochondrial enzyme turns out to be an unexpected type of patchwork enzyme, composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-family member, and a protein of hitherto unknown functional and evolutionary origin, possibly representing the enzyme's metallonuclease moiety. Apparently, animal mitochondria lost the seemingly ubiquitous RNA world remnant after reinventing RNase P from preexisting components.	[Holzmann, Johann; Loeffler, Esther; Rossmanith, Walter] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; [Frank, Peter; Gerner, Christopher] Med Univ Vienna, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria; [Bennett, Keiryn L.] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Austrian Academy of Sciences	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010	Rossmanith, Walter/0000-0003-2337-2248; Gerner, Christopher/0000-0003-4964-0642; Bennett, Keiryn L./0000-0001-9356-7708	Austrian Science Fund [P17453]	Austrian Science Fund(Austrian Science Fund (FWF))	We thank Maria Selmer for comments on the manuscript and Philippe Giege for pointing out a third Arabidopsis homolog of MRPP3. This work was supported by Austrian Science Fund grant P17453 to W. R.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Chen JX, 2007, J ALZHEIMERS DIS, V12, P177; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DANG YL, 1993, J BIOL CHEM, V268, P19791; Dupureur CM, 2008, CURR OPIN CHEM BIOL, V12, P250, DOI 10.1016/j.cbpa.2008.01.012; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Gegenheimer P, 1996, MOL BIOL REP, V22, P147, DOI 10.1007/BF00988720; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; HENTZE MW, 1994, TRENDS BIOCHEM SCI, V19, P101, DOI 10.1016/0968-0004(94)90198-8; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Marszalkowski M, 2008, BIOL CHEM, V389, P395, DOI 10.1515/BC.2008.042; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Prokisch Holger, 2007, Methods Mol Biol, V372, P573, DOI 10.1007/978-1-59745-365-3_39; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; ROBERTSON HD, 1972, J BIOL CHEM, V247, P5243; Rossmanith W, 2001, MOL CELL BIOL, V21, P8236, DOI 10.1128/MCB.21.23.8236-8237.2001; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rossmanith W, 1997, J MOL BIOL, V265, P365, DOI 10.1006/jmbi.1996.0750; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; STARK BC, 1978, P NATL ACAD SCI USA, V75, P3717, DOI 10.1073/pnas.75.8.3717; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUSSMAN JL, 1976, SCIENCE, V192, P853, DOI 10.1126/science.775636; Swanson RV, 2001, METHOD ENZYMOL, V330, P158; Thomas B C, 1995, Nucleic Acids Symp Ser, P95; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; Willkomm DK, 2007, TRENDS BIOCHEM SCI, V32, P247, DOI 10.1016/j.tibs.2007.04.005; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006	48	412	422	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					462	474		10.1016/j.cell.2008.09.013	http://dx.doi.org/10.1016/j.cell.2008.09.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984158	Bronze			2022-12-24	WOS:000260536300017
J	Rouach, N; Koulakoff, A; Abudara, V; Willecke, K; Giaume, C				Rouach, Nathalie; Koulakoff, Annette; Abudara, Veronica; Willecke, Klaus; Giaume, Christian			Astroglial Metabolic Networks Sustain Hippocampal Synaptic Transmission	SCIENCE			English	Article							GAP-JUNCTIONS; ASTROCYTES; EXPRESSION	Astrocytes provide metabolic substrates to neurons in an activity- dependent manner. However, the molecular mechanisms involved in this function, as well as its role in synaptic transmission, remain unclear. Here, we show that the gap- junction subunit proteins connexin 43 and 30 allow intercellular trafficking of glucose and its metabolites through astroglial networks. This trafficking is regulated by glutamatergic synaptic activity mediated by AMPA receptors. In the absence of extracellular glucose, the delivery of glucose or lactate to astrocytes sustains glutamatergic synaptic transmission and epileptiform activity only when they are connected by gap junctions. These results indicate that astroglial gap junctions provide an activity- dependent intercellular pathway for the delivery of energetic metabolites from blood vessels to distal neurons.	[Rouach, Nathalie; Koulakoff, Annette; Abudara, Veronica; Giaume, Christian] Coll France, INSERM, U840, F-75005 Paris, France; [Abudara, Veronica] Univ Republica, Fac Med, Montevideo, Uruguay; [Willecke, Klaus] Univ Bonn, Inst Genet, D-53117 Bonn, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universidad de la Republica, Uruguay; University of Bonn	Rouach, N (corresponding author), Coll France, INSERM, U840, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	nathalie.rouach@college-de-france.fr	Rouach, Nathalie/L-4767-2017	Rouach, Nathalie/0000-0002-5574-888X; KOULAKOFF, Annette/0000-0002-3143-2215	Human Frontier Science Program Organization (Career Development Award); Agence Nationale de la Recherche (Programme Jeunes chercheurs); INSERM; German Research Association [SFB 615, B3]; International Brain Research Organization	Human Frontier Science Program Organization (Career Development Award)(Human Frontier Science Program); Agence Nationale de la Recherche (Programme Jeunes chercheurs)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); German Research Association(German Research Foundation (DFG)); International Brain Research Organization	We thank P. Ezan for technical assistance and R. Nicoll, G. Bonvento, J. Deitmer, and P. Magistretti for helpful discussions. This work was supported by grants from the Human Frontier Science Program Organization (Career Development Award) and Agence Nationale de la Recherche ( Programme Jeunes chercheurs) to N.R.; from INSERM to N.R., A.K., and C.G.; from the German Research Association (SFB 615, B3) to K.W.; and from International Brain Research Organization to V. A. N. R. dedicates this work to her daughter Angela.	Clarke Donald D., 1994, P645; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Kacem K, 1998, GLIA, V23, P1; Matthias K, 2003, J NEUROSCI, V23, P1750; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Simard M, 2003, J NEUROSCI, V23, P9254; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Wallraff A, 2004, GLIA, V48, P36, DOI 10.1002/glia.20040	14	602	626	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1551	1555		10.1126/science.1164022	http://dx.doi.org/10.1126/science.1164022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056987				2022-12-24	WOS:000261377400051
J	Mullighan, CG; Phillips, LA; Su, XP; Ma, J; Miller, CB; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Phillips, Letha A.; Su, Xiaoping; Ma, Jing; Miller, Christopher B.; Shurtleff, Sheila A.; Downing, James R.			Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia	SCIENCE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; MINIMAL RESIDUAL DISEASE; GENE REARRANGEMENTS; YOUNG-CHILDREN; IMMUNOGENOTYPE; EVOLUTION; DIAGNOSIS; SELECTION; DELETION; SUBCLONE	Most children with acute lymphoblastic leukemia ( ALL) can be cured, but the prognosis is dismal for the minority of patients who relapse after treatment. To explore the genetic basis of relapse, we performed genome- wide DNA copy number analyses on matched diagnosis and relapse samples from 61 pediatric patients with ALL. The diagnosis and relapse samples typically showed different patterns of genomic copy number abnormalities ( CNAs), with the CNAs acquired at relapse preferentially affecting genes implicated in cell cycle regulation and B cell development. Most relapse samples lacked some of the CNAs present at diagnosis, which suggests that the cells responsible for relapse are ancestral to the primary leukemia cells. Backtracking studies revealed that cells corresponding to the relapse clone were often present as minor subpopulations at diagnosis. These data suggest that genomic abnormalities contributing to ALL relapse are selected for during treatment, and they point to new targets for therapeutic intervention.	[Mullighan, Charles G.; Phillips, Letha A.; Su, Xiaoping; Miller, Christopher B.; Shurtleff, Sheila A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Ashmun and the St. Jude Flow Cytometry and Cell Sorting Shared Resource for flow sorting of leukemia samples, the St. Jude Clinical Applications Core Technology Laboratory for performing SNP arrays, L. Kiedrowski for lesion mapping and backtracking assays, and J. Stokes for assistance with artwork. Supported by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital and by the National Health and Medical Research Council of Australia (C.G.M.). Primary SNP array data are available from the authors upon request. J.R.D. has participated in gene expression profiling research sponsored by Roche. C.G.M. and J.R.D. have filed a patent application related to this work.	BEISHUIZEN A, 1994, BLOOD, V83, P2238, DOI 10.1182/blood.V83.8.2238.bloodjournal8382238; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Davi F, 1996, BLOOD, V88, P609, DOI 10.1182/blood.V88.2.609.bloodjournal882609; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Ford AM, 2001, BLOOD, V98, P558, DOI 10.1182/blood.V98.3.558; Germano G, 2003, LEUKEMIA, V17, P1573, DOI 10.1038/sj.leu.2403008; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Irving JAE, 2005, CANCER RES, V65, P3053, DOI 10.1158/0008-5472.CAN-04-2604; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Konrad M, 2003, BLOOD, V101, P3635, DOI 10.1182/blood-2002-10-3252; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; MARSHALL GM, 1995, LEUKEMIA, V9, P1847; Moorman AV, 2007, BLOOD, V109, P2327, DOI 10.1182/blood-2006-08-040436; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Panzer-Grumayer ER, 2005, CLIN CANCER RES, V11, P7720, DOI 10.1158/1078-0432.CCR-05-1239; Peham M, 2004, GENE CHROMOSOME CANC, V39, P156, DOI 10.1002/gcc.10305; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RAIMONDI SC, 1993, BLOOD, V82, P576; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; Rosenquist R, 1999, EUR J HAEMATOL, V63, P171; Takeuchi S, 2003, ONCOGENE, V22, P6970, DOI 10.1038/sj.onc.1206974; TAYLOR JJ, 1994, LEUKEMIA, V8, P60; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	27	611	633	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1377	1380		10.1126/science.1164266	http://dx.doi.org/10.1126/science.1164266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039135	Green Accepted			2022-12-24	WOS:000261170600038
J	Doyle, JP; Dougherty, JD; Heiman, M; Schmidt, EF; Stevens, TR; Ma, G; Bupp, S; Shrestha, P; Shah, RD; Doughty, ML; Gong, S; Greengard, P; Heintz, N				Doyle, Joseph P.; Dougherty, Joseph D.; Heiman, Myriam; Schmidt, Eric F.; Stevens, Tanya R.; Ma, Guojun; Bupp, Sujata; Shrestha, Prerana; Shah, Rajiv D.; Doughty, Martin L.; Gong, Shiaoching; Greengard, Paul; Heintz, Nathaniel			Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types	CELL			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE-BRAIN; DIFFERENTIAL EXPRESSION; RECEPTOR SUBUNIT; SPINAL-CORD; TRANSCRIPTION; NETWORKS; FAMILY	Comparative analysis can provide important insights into complex biological systems. As demonstrated in the accompanying paper, translating ribosome affinity purification (TRAP) permits comprehensive studies of translated mRNAs in genetically defined cell populations after physiological perturbations. To establish the generality of this approach, we present translational profiles for 24 CNS cell populations and identify known cell-specific and enriched transcripts for each population. We report thousands of cell-specific mRNAs that were not detected in whole-tissue microarray studies and provide examples that demonstrate the benefits deriving from comparative analysis. To provide a foundation for further biological and in silico studies, we provide a resource of 16 transgenic mouse lines, their corresponding anatomic characterization, and translational profiles for cell types from a variety of central nervous system structures. This resource will enable a wide spectrum of molecular and mechanistic studies of both well-known and previously uncharacterized neural cell populations.	[Doyle, Joseph P.; Dougherty, Joseph D.; Schmidt, Eric F.; Stevens, Tanya R.; Ma, Guojun; Bupp, Sujata; Shrestha, Prerana; Shah, Rajiv D.; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Heiman, Myriam; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Doughty, Martin L.; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Schmidt, Eric F./AAE-8723-2019	Schmidt, Eric F./0000-0002-7869-0270; Dougherty, Joseph/0000-0002-6385-3997; Greengard, Paul/0000-0002-4437-0893	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [P01 AG009464-16A1, P01 AG009464-17, P01 AG009464, AG09464] Funding Source: Medline; NIDA NIH HHS [F32 DA021487, P01 DA010044-11, P01 DA010044-10, F32 DA021487-01, 5F32DA021487, P01 DA010044, F32 DA021487-02, DA10044, P01 DA010044-09] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-010005, P50 MH074866-020005, P50 MH074866-017204, P50 MH074866-030005, P50 MH074866-010002, P50 MH074866-040005, P50 MH074866-02, P50 MH074866-019001, P50 MH074866, P50 MH074866-030002, P50 MH074866-029001, P50 MH074866-019002, P50 MH074866-020002, P50 MH074866-049001, P50 MH074866-03, P50 MH074866-040002, P50 MH074866-039002, P50 MH074866-010001, P50 MH074866-020001, MH074866, P50 MH074866-039001, P50 MH074866-04, P50 MH074866-049002, P50 MH074866-030001, P50 MH074866-029002, P50 MH074866-040001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021487, P01DA010044] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Berthele A, 1999, DEV BRAIN RES, V112, P39, DOI 10.1016/S0165-3806(98)00156-4; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; DENOLORENTE R, 1934, PHYSL NERVOUS SYSTEM, P291; Fuhrman S, 2000, BIOSYSTEMS, V55, P5, DOI 10.1016/S0303-2647(99)00077-5; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Kaelin-Lang A, 1999, NEUROSCI LETT, V261, P189, DOI 10.1016/S0304-3940(99)00022-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Malgaretti N, 1997, J BIOL CHEM, V272, P17632, DOI 10.1074/jbc.272.28.17632; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Nishiyori A, 2004, J COMP NEUROL, V469, P214, DOI 10.1002/cne.11015; Nunzi MG, 2002, J COMP NEUROL, V451, P189, DOI 10.1002/cne.10344; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ramon y Cajal S., 1899, TEXTURE NERVOUS SYST; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Schneider T. D., 2007, INFORM THEORY PRIMER; SHANNON CE, 1969, MATH THEORY COMMUNIC; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Wang SS, 1997, J NEUROSCI, V17, P4149; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Ziambaras K, 1997, WESTERN J MED, V167, P435; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	33	612	618	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					749	762		10.1016/j.cell.2008.10.029	http://dx.doi.org/10.1016/j.cell.2008.10.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013282	Green Accepted, Bronze			2022-12-24	WOS:000260886900024
J	Xu, CQ; Gagnon, E; Call, ME; Schnell, JR; Schwieters, CD; Carman, CV; Chou, JJ; Wucherpfennig, KW				Xu, Chenqi; Gagnon, Etienne; Call, Matthew E.; Schnell, Jason R.; Schwieters, Charles D.; Carman, Christopher V.; Chou, James J.; Wucherpfennig, Kai W.			Regulation of T Cell Receptor Activation by Dynamic Membrane Binding of the CD3 epsilon Cytoplasmic Tyrosine-Based Motif	CELL			English	Article							EFFECTOR DOMAIN; PROTEIN; PHOSPHORYLATION; BICELLES; BILAYER; COMPLEX; ZAP-70; ZETA	Many immune system receptors signal through cytoplasmic tyrosine-based motifs (ITAMs), but how receptor ligation results in ITAM phosphorylation remains unknown. Live-cell imaging studies showed a close interaction of the CD3 epsilon cytoplasmic domain of the T cell receptor (TCR) with the plasma membrane through fluorescence resonance energy transfer between a C-terminal fluorescent protein and a membrane fluorophore. Electrostatic interactions between basic CD3 epsilon residues and acidic phospholipids enriched in the inner leaflet of the plasma membrane were required for binding. The nuclear magnetic resonance structure of the lipid-bound state of this cytoplasmic domain revealed deep insertion of the two key tyrosines into the hydrophobic core of the lipid bilayer. Receptor ligation thus needs to result in unbinding of the CD3 epsilon ITAM from the membrane to render these tyrosines accessible to Src kinases. Sequestration of key tyrosines into the lipid bilayer represents a previously unrecognized mechanism for control of receptor activation.	[Call, Matthew E.; Schnell, Jason R.; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Xu, Chenqi; Gagnon, Etienne; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Carman, Christopher V.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Schwieters, Charles D.] Natl Inst Hlth, Imaging Sci Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Carman, Christopher/L-8108-2016; Chou, James J/N-9840-2013; Chou, James/AAD-6230-2022; Carman, Christopher V./AAX-8995-2020	Carman, Christopher/0000-0001-7358-2548; Chou, James J/0000-0002-4442-0344; Chou, James/0000-0002-4442-0344; Carman, Christopher V./0000-0001-7358-2548; Call, Matthew/0000-0001-5846-6469; Xu, Chenqi/0000-0002-4968-6782	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [R01 AI054520, R01 AI054520-05, AI054520] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	33	313	323	5	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					702	713		10.1016/j.cell.2008.09.044	http://dx.doi.org/10.1016/j.cell.2008.09.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013279	Bronze, Green Accepted			2022-12-24	WOS:000260886900020
J	Barker, N; Ridgway, RA; van Es, JH; van de Wetering, M; Begthel, H; van den Born, M; Danenberg, E; Clarke, AR; Sansom, OJ; Clevers, H				Barker, Nick; Ridgway, Rachel A.; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clarke, Alan R.; Sansom, Owen J.; Clevers, Hans			Crypt stem cells as the cells-of-origin of intestinal cancer	NATURE			English	Article							MOUSE SMALL INTESTINE; BETA-CATENIN; COLORECTAL-CANCER; PANETH CELLS; IN-VIVO; GENE; APC; DIFFERENTIATION; EPITHELIUM; COLON	Intestinal cancer is initiated by Wnt- pathway- activating mutations in genes such as adenomatous polyposis coli ( APC). As in most cancers, the cell of origin has remained elusive. In a previously established Lgr5 ( leucine- rich- repeat containing G- protein-coupled receptor 5) knockin mouse model, a tamoxifen- inducible Cre recombinase is expressed in long- lived intestinal stem cells(1). Here we show that deletion of Apc in these stem cells leads to their transformation within days. Transformed stem cells remain located at crypt bottoms, while fuelling a growing microadenoma. These microadenomas show unimpeded growth and develop into macroscopic adenomas within 3-5 weeks. The distribution of Lgr5(+) cells within stem- cell- derived adenomas indicates that a stem cell/ progenitor cell hierarchy is maintained in early neoplastic lesions. When Apc is deleted in short- lived transit- amplifying cells using a different cre mouse, the growth of the induced microadenomas rapidly stalls. Even after 30 weeks, large adenomas are very rare in these mice. We conclude that stem- cell- specific loss of Apc results in progressively growing neoplasia.	[Barker, Nick; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Clarke, Alan R.] Cardiff Sch Biosci, Cardiff CF10 3US, Wales	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Beatson Institute; Cardiff University	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@niob.knaw.nl	clarke, alan r/P-2820-2014; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021; Clarke, Alan R/A-6256-2008	Barker, Nick/0000-0003-3566-4475; Danenberg, Esther/0000-0002-1799-4457; Clarke, Alan/0000-0002-4281-426X; Sansom, Owen J./0000-0001-9540-3010	Cancer Research UK; KWF program [PF-HUBR-2007-3956]; MRC [G0301154] Funding Source: UKRI; Medical Research Council [G0301154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Cozijnsen, J. Korving, C. Nixon, M. Macdonald and B. Doyle for technical help. O.J.S. is funded by Cancer Research UK. N. B. and H. C. are supported by KWF program grant PF-HUBR-2007-3956.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P65, DOI 10.1002/aja.1001600106; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; POTTEN CS, 1975, B CANCER, V62, P419; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039	30	1526	1569	6	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					608	U119		10.1038/nature07602	http://dx.doi.org/10.1038/nature07602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19092804				2022-12-24	WOS:000262852200047
J	Elde, NC; Child, SJ; Geballe, AP; Malik, HS				Elde, Nels C.; Child, Stephanie J.; Geballe, Adam P.; Malik, Harmit S.			Protein kinase R reveals an evolutionary model for defeating viral mimicry	NATURE			English	Article							POSITIVE SELECTION; SUBSTRATE RECOGNITION; MOLECULAR MIMICRY; ANTIVIRAL PROTEIN; CRYSTAL-STRUCTURE; PKR; YEAST; BACTERIAL; RNA; K3L	Distinguishing self from non- self is a fundamental biological challenge. Many pathogens exploit the challenge of self discrimination by employing mimicry to subvert key cellular processes including the cell cycle, apoptosis and cytoskeletal dynamics(1-5). Other mimics interfere with immunity(6,7). Poxviruses encode K3L, a mimic of eIF2 alpha, which is the substrate of protein kinase R ( PKR), an important component of innate immunity in vertebrates(8,9). The PKR - K3L interaction exemplifies the conundrum imposed by viral mimicry. To be effective, PKR must recognize a conserved substrate (eIF2 alpha) while avoiding rapidly evolving substrate mimics such as K3L. Using the PKR - K3L system and a combination of phylogenetic and functional analyses, we uncover evolutionary strategies by which host proteins can overcome mimicry. We find that PKR has evolved under intense episodes of positive selection in primates. The ability of PKR to evade viral mimics is partly due to positive selection at sites most intimately involved in eIF2 alpha recognition. We also find that adaptive changes on multiple surfaces of PKR produce combinations of substitutions that increase the odds of defeating mimicry. Thus, although it can seem that pathogens gain insurmountable advantages by mimicking cellular components, host factors such as PKR can compete in molecular 'arms races' with mimics because of evolutionary flexibility at protein interaction interfaces challenged by mimicry.	[Elde, Nels C.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Geballe, Adam P.] Univ Washington, Dept Med, Seattle, WA 98115 USA; [Geballe, Adam P.] Univ Washington, Dept Microbiol, Seattle, WA 98115 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Child, Stephanie/0000-0002-1987-9540	NIH [AI026672]; Searle Scholar; Burroughs Wellcome Investigator Award; Ellison Medical Foundation Fellow of the Life Sciences Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026672, R29AI026672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar; Burroughs Wellcome Investigator Award(Burroughs Wellcome Fund); Ellison Medical Foundation Fellow of the Life Sciences Research Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Dever for yeast strains and advice; J. Tartaglia and B. Jacobs for valuable reagents; and S. Biggins and S. Furuyama for yeast expression plasmids and advice, and M. Emerman, S. Henikoff, S. Biggins, A. Turkewitz, D. Gottschling, D. Koshland, E. Smith, J. Kerns, S. Sawyer and D. Vermaak for comments and suggestions. We are supported by NIH grant AI026672 (A.P.G.) and a Searle Scholar and Burroughs Wellcome Investigator Award (H.S.M.). N.C.E. is an Ellison Medical Foundation Fellow of the Life Sciences Research Foundation.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Babkin IV, 2006, MOL BIOL+, V40, P20; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DeLano WL, 2004, PYMOL USERS MANUAL; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Earl PL, 2001, CURR PROTOCOLS PROTE, DOI [10.1002/0471140864.ps0512s13, DOI 10.1002/0471140864.PS0512S13]; Essbauer S, 2001, VIRUS GENES, V23, P347, DOI 10.1023/A:1012533625571; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Sawyer SL, 2006, P NATL ACAD SCI USA, V103, P17614, DOI 10.1073/pnas.0605468103; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; TARTAGLIA J, 1992, AIDS RES HUM RETROV, V8, P1445, DOI 10.1089/aid.1992.8.1445; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	172	176	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					485	U8		10.1038/nature07529	http://dx.doi.org/10.1038/nature07529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043403	Green Accepted			2022-12-24	WOS:000262519200048
J	Martin, AC; Kaschube, M; Wieschaus, EF				Martin, Adam C.; Kaschube, Matthias; Wieschaus, Eric F.			Pulsed contractions of an actin-myosin network drive apical constriction	NATURE			English	Article							CELL-SHAPE CHANGES; DROSOPHILA GASTRULATION; FOLDED-GASTRULATION; ADHERENS JUNCTIONS; MORPHOGENESIS; MICROFILAMENTS; LOCALIZATION; MICROTUBULES; NEURULATION; MECHANISM	Apical constriction facilitates epithelial sheet bending and invagination during morphogenesis(1,2). Apical constriction is conventionally thought to be driven by the continuous purse- string- like contraction of a circumferential actin and non- muscle myosin- II ( myosin) belt underlying adherens junctions(3-7). However, it is unclear whether other force- generating mechanisms can drive this process. Here we show, with the use of real- time imaging and quantitative image analysis of Drosophila gastrulation, that the apical constriction of ventral furrow cells is pulsed. Repeated constrictions, which are asynchronous between neighbouring cells, are interrupted by pauses in which the constricted state of the cell apex is maintained. In contrast to the purse- string model, constriction pulses are powered by actin - myosin network contractions that occur at the medial apical cortex and pull discrete adherens junction sites inwards. The transcription factors Twist and Snail differentially regulate pulsed constriction. Expression of snail initiates actin - myosin network contractions, whereas expression of twist stabilizes the constricted state of the cell apex. Our results suggest a new model for apical constriction in which a cortical actin - myosin cytoskeleton functions as a developmentally controlled subcellular ratchet to reduce apical area incrementally.	[Martin, Adam C.; Wieschaus, Eric F.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Martin, Adam C.; Wieschaus, Eric F.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kaschube, Matthias] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kaschube, Matthias] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University; Princeton University	Wieschaus, EF (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	efw@princeton.edu			American Cancer Society [PF-06-143-01-DDC]; National Institutes of Health/National Institute of General Medical Sciences [P50 GM071508]; National Institute of Child Health and Human Development [5R37HD15587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kiehart and R. Karess for providing flies; J. Goodhouse for assisting with microscopy; and S. De Renzis, X. Lu, T. Schupbach, A. Sokac, F. Ulrich and Y.-C. Wang for helpful comments on the manuscript. This work is supported by grant PF-06-143-01-DDC from the American Cancer Society to A. C. M., National Institutes of Health/National Institute of General Medical Sciences grant P50 GM071508 to M. K., and by National Institute of Child Health and Human Development grant 5R37HD15587 to E.F. W.E.F.W. is an investigator of the Howard Hughes Medical Institute.	Alberts B, 2008, MOL BIOL CELL; Arziman Z, 2005, NUCLEIC ACIDS RES, V33, pW582, DOI 10.1093/nar/gki468; BAKER PC, 1967, DEV BIOL, V15, P432, DOI 10.1016/0012-1606(67)90036-X; BURNSIDE B, 1971, DEV BIOL, V26, P416, DOI 10.1016/0012-1606(71)90073-X; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; KARFUNKEL P, 1972, J EXP ZOOL, V181, P289, DOI 10.1002/jez.1401810302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Oda H, 2001, J CELL SCI, V114, P493; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SWEETON D, 1991, DEVELOPMENT, V112, P775; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; YOUNG PE, 1991, DEVELOPMENT, V111, P1	29	782	791	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					495	U11		10.1038/nature07522	http://dx.doi.org/10.1038/nature07522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19029882	Green Accepted			2022-12-24	WOS:000262519200050
J	Clay, NK; Adio, AM; Denoux, C; Jander, G; Ausubel, FM				Clay, Nicole K.; Adio, Adewale M.; Denoux, Carine; Jander, Georg; Ausubel, Frederick M.			Glucosinolate Metabolites Required for an Arabidopsis Innate Immune Response	SCIENCE			English	Article							GLUTATHIONE-DEFICIENT MUTANT; METAL-BINDING PEPTIDES; NONHOST RESISTANCE; DISEASE RESISTANCE; ABC TRANSPORTER; ABSCISIC-ACID; ETHYLENE; THALIANA; DEFENSE; IDENTIFICATION	The perception of pathogen or microbe- associated molecular pattern molecules by plants triggers a basal defense response analogous to animal innate immunity and is defined partly by the deposition of the glucan polymer callose at the cell wall at the site of pathogen contact. Transcriptional and metabolic profiling in Arabidopsis mutants, coupled with the monitoring of pathogen- triggered callose deposition, have identified major roles in pathogen response for the plant hormone ethylene and the secondary metabolite 4- methoxy- indol- 3- ylmethylglucosinolate. Two genes, PEN2 and PEN3, are also necessary for resistance to pathogens and are required for both callose deposition and glucosinolate activation, suggesting that the pathogen- triggered callose response is required for resistance to microbial pathogens. Our study shows that well-studied plant metabolites, previously identified as important in avoiding damage by herbivores, are also required as a component of the plant defense response against microbial pathogens.	[Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Adio, Adewale M.; Jander, Georg] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Cornell University; Boyce Thompson Institute for Plant Research	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu	Bruening, Stefan/B-8505-2011; Jander, Georg/E-7101-2012		NIH National Research Service Award-Kirschstein Postdoctoral Fellowship [R37-GM48707]; NSF [IOS-0718733, DBI-0500550, MCB-0519898]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI066817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH National Research Service Award-Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Abel for ugt74B1-2; J.L. Celenza for atr1-3, atr4-1/cyp83B1, cyp79B2 cyp79B3, and trp3-1; C.S. Cobbett for cad1-3/pcs1 and cad2-1/gsh1; P.L. Conklin for vtc1-1 and vtc2-1; R. Blum for pcs1-1, pcs2-1, and pcs1-1 pcs2-1; S. C. Somerville for pcs1-2; and Arabidopsis Biological Resource Center for insertion lines. Ph. D. stipend support to N.K.C. comes from NIH National Research Service Award-Kirschstein Postdoctoral Fellowship. Support to A.M.A. and G.J. comes from NSF grants IOS-0718733 and DBI-0500550. Support to F.M.A. comes from NSF grant MCB-0519898 and NIH grant R37-GM48707.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Cazale AC, 2001, FEBS LETT, V507, P215, DOI 10.1016/S0014-5793(01)02976-3; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Conklin PL, 2000, GENETICS, V154, P847; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; HOWDEN R, 1992, PLANT PHYSIOL, V100, P100, DOI 10.1104/pp.100.1.100; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedras MSC, 2007, CHEM COMMUN, P368, DOI 10.1039/b615424g; Radwanski ER, 1996, MOL GEN GENET, V253, P353; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; SONGNUAN W, 2008, BIOL PLANT MICROBE I, V6; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; 2007, PLOS GENET, V3, P1687	59	764	801	10	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					95	101		10.1126/science.1164627	http://dx.doi.org/10.1126/science.1164627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19095898	Green Accepted			2022-12-24	WOS:000262104100048
J	Ayalon, G; Davis, JQ; Scotland, PB; Bennett, V				Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann			An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan	CELL			English	Article							BRONCHIAL EPITHELIAL-CELLS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; NEUROMUSCULAR SYNAPSE; BETA-DYSTROGLYCAN; LATERAL MEMBRANE; SPECTRIN; SARCOLEMMA; DYNACTIN	beta-dystroglycan (DG) and the dystrophin- glycoprotein complex (DGC) are localized at costameres and neuromuscular junctions in the sarcolemma of skeletal muscle. We present evidence for an ankyrin-based mechanism for sarcolemmal localization of dystrophin and beta-DG. Dystrophin binds ankyrin-B and ankyrin-G, while beta-DG binds ankyrin-G. Dystrophin and beta-DG require ankyrin- G for retention at costameres but not delivery to the sarcolemma. Dystrophin and beta-DG remain intracellular in ankyrin- B-depleted muscle, where beta-DG accumulates in a juxta-TGN compartment. The neuromuscular junction requires ankyrin- B for localization of dystrophin/utrophin and beta-DG and for maintenance of its postnatal morphology. A Becker muscular dystrophy mutation reduces ankyrin binding and impairs sarcolemmal localization of dystrophin-Dp71. Ankyrin-B also binds to dynactin-4, a dynactin subunit. Dynactin-4 and a subset of microtubules disappear from sarcolemmal sites in ankyrin-B-depleted muscle. Ankyrin-B thus is an adaptor required for sarcolemmal localization of dystrophin, as well as dynactin-4.	[Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	v.bennett@cellbio.duke.edu			Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	We thank K. Kizhatil for the plasmid-siRNA constructs, K. P. Campbell for his gift of beta-DG antibody, and L. Davis, J. Hostettler, and J. Hoffman for technical assistance. We also acknowledge P. Mohler and K. Abdi for performing the yeast two-hybrid screen that revealed ankB binding by dyn4/p62. This study was funded in part by the Muscular Dystrophy Association. Author contributions: G.A.: Figures 1-7, Figures S1-S5; J.Q.D.: Figures 5 and 6, Figure S3; P.B.S.: Figure 5; G.A. and V.B. wrote the paper.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Bloch RJ, 2004, J MUSCLE RES CELL M, V25, P590; BOUDRIAU S, 1993, J HISTOCHEM CYTOCHEM, V41, P1013, DOI 10.1177/41.7.8515044; Brancaccio A, 2005, NEUROMUSCULAR DISORD, V15, P825, DOI 10.1016/j.nmd.2005.08.003; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; JOE V, 2003, BIOESSAYS, V25, P25; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Koch I, 2008, NEURON, V58, P210, DOI 10.1016/j.neuron.2008.03.019; Kordeli E, 1998, J CELL SCI, V111, P2197; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; NELSON WJ, 1984, P NATL ACAD SCI-BIOL, V81, P3292, DOI 10.1073/pnas.81.11.3292; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Percival JM, 2007, TRAFFIC, V8, P1424, DOI 10.1111/j.1600-0854.2007.00622.x; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Roma J, 2004, ACTA NEUROPATHOL, V108, P443, DOI 10.1007/s00401-004-0908-1; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SCHROER TA, 2004, J CELL BIOL, V143, P1305; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; VYBIRAL T, 1992, CELL MOTIL CYTOSKEL, V21, P293, DOI 10.1002/cm.970210405; Williams MW, 2001, J CELL SCI, V114, P751; WINDHOLZ M, 1983, MERCK INDEX, P206	52	102	109	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1189	1200		10.1016/j.cell.2008.10.018	http://dx.doi.org/10.1016/j.cell.2008.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109891	Bronze			2022-12-24	WOS:000261989800011
J	Kang, RJ; Wan, JM; Arstikaitis, P; Takahashi, H; Huang, K; Bailey, AO; Thompson, JX; Roth, AF; Drisdel, RC; Mastro, R; Green, WN; Yates, JR; Davis, NG; El-Husseini, A				Kang, Rujun; Wan, Junmei; Arstikaitis, Pamela; Takahashi, Hideto; Huang, Kun; Bailey, Aaron O.; Thompson, James X.; Roth, Amy F.; Drisdel, Renaldo C.; Mastro, Ryan; Green, William N.; Yates, John R., III; Davis, Nicholas G.; El-Husseini, Alaa			Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation	NATURE			English	Article							DENDRITIC SPINE DEVELOPMENT; RHO-FAMILY GTPASES; PROTEIN PALMITOYLATION; NEURONAL EXCITABILITY; MORPHOGENESIS; CDC42; SYNAPSES; TRAFFICKING; PLASTICITY; STABILITY	Palmitoylation regulates diverse aspects of neuronal protein trafficking and function. Here a global characterization of rat neural palmitoyl- proteomes identifies most of the known neural palmitoyl proteins - 68 in total, plus more than 200 new palmitoyl- protein candidates, with further testing confirming palmitoylation for 21 of these candidates. The new palmitoyl proteins include neurotransmitter receptors, transporters, adhesion molecules, scaffolding proteins, as well as SNAREs and other vesicular trafficking proteins. Of particular interest is the finding of palmitoylation for a brain- specific Cdc42 splice variant. The palmitoylated Cdc42 isoform ( Cdc42- palm) differs from the canonical, prenylated form ( Cdc42- prenyl), both with regard to localization and function: Cdc42- palm concentrates in dendritic spines and has a special role in inducing these post- synaptic structures. Furthermore, assessing palmitoylation dynamics in drug- induced activity models identifies rapidly induced changes for Cdc42 as well as for other synaptic palmitoyl proteins, suggesting that palmitoylation may participate broadly in the activity- driven changes that shape synapse morphology and function.	[Wan, Junmei; Roth, Amy F.; Davis, Nicholas G.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Kang, Rujun; Arstikaitis, Pamela; Takahashi, Hideto; Huang, Kun; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Bailey, Aaron O.; Thompson, James X.; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; [Drisdel, Renaldo C.; Mastro, Ryan; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Wayne State University; University of British Columbia; Scripps Research Institute; University of Chicago	Davis, NG (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	rkang@interchange.ubc.ca; ndavis@med.wayne.edu	Bailey, Aaron/ABB-8522-2021; Takahashi, Hideto/T-2650-2018	Bailey, Aaron/0000-0001-8063-3032; Takahashi, Hideto/0000-0002-6473-5060	Canadian Institutes for Health Research [A.E.H-20R90479, A.E.H-20R91909]; Michael Smith foundation for Health Research [A.E.-H., 20R52464]; EJLB Foundation and Neuroscience Canada [A.E.-H., 20R61933]; National Institutes of Health [GM65525, RR011823, NS043782, DA13602, DA019695]; Peter F. McManus Trust; Uehara Memorial Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043782, R01NS043782, R01NS032693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA019695, R01DA013602] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith foundation for Health Research(Michael Smith Foundation for Health Research); EJLB Foundation and Neuroscience Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peter F. McManus Trust; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This paper is dedicated to the memory of our friend and colleague, Alaa El-Husseini, whose ideas about palmitoylation and plasticity inspired this work (deceased 23 Dec 2007). We thank J. Levinson, M.-F. Lise, C. Jiang and E. Yu for technical assistance. This work was supported by grants to A.E.-H. from the Canadian Institutes for Health Research (CIHR) (A.E.-H., 20R90479 and 20R91909), the Michael Smith foundation for Health Research (A.E.-H., 20R52464), the EJLB Foundation and Neuroscience Canada (A.E.-H., 20R61933), as well as from grants from the National Institutes of Health to N.G.D. (GM65525), J.R.Y. (RR011823) and W.N.G.(NS043782, DA13602 and DA019695), and the Peter F. McManus Trust. H. T. was supported by a research fellowship from the Uehara Memorial Foundation. We thank L. Raymond, Y.T. Wang, K. Gerrow, R. Hines, M. Prior and I. Papanayotou for comments on manuscript.	Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hering H, 2003, J NEUROSCI, V23, P3262; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Marks PW, 1996, GENOMICS, V38, P13, DOI 10.1006/geno.1996.0586; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOLLNER S, 1995, FEBS LETT, V371, P241, DOI 10.1016/0014-5793(95)00864-6; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Scott EK, 2003, J NEUROSCI, V23, P3118; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wilson AL, 1998, BIOCHEM J, V333, P497, DOI 10.1042/bj3330497	32	407	411	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					904	909		10.1038/nature07605	http://dx.doi.org/10.1038/nature07605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092927	Green Accepted			2022-12-24	WOS:000261768300035
J	Rancati, G; Pavelka, N; Fleharty, B; Noll, A; Trimble, R; Walton, K; Perera, A; Staehling-Hampton, K; Seidel, CW; Li, R				Rancati, Giulia; Pavelka, Norman; Fleharty, Brian; Noll, Aaron; Trimble, Rhonda; Walton, Kendra; Perera, Anoja; Staehling-Hampton, Karen; Seidel, Chris W.; Li, Rong			Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor	CELL			English	Article							HSP90 MOLECULAR CHAPERONE; WHOLE-GENOME DUPLICATION; LARGE POPULATIONS; BUDDING YEAST; GENE; PROTEIN; ORGANIZATION; PERSPECTIVE; POLYPLOIDY; RING	The ability to evolve is a fundamental feature of biological systems, but the mechanisms underlying this capacity and the evolutionary dynamics of conserved core processes remain elusive. We show that yeast cells deleted of MYO1, encoding the only myosin II normally required for cytokinesis, rapidly evolved divergent pathways to restore growth and cytokinesis. The evolved cytokinesis phenotypes correlated with specific changes in the transcriptome. Polyploidy and aneuploidy were common genetic alterations in the best evolved strains, and aneuploidy could account for gene expression changes due directly to altered chromosome stoichiometry as well as to downstream effects. The phenotypic effect of aneuploidy could be recapitulated with increased copy numbers of specific regulatory genes in myo1 Delta cells. These results demonstrate the evolvability of even a well-conserved process and suggest that changes in chromosome stoichiometry provide a source of heritable variation driving the emergence of adaptive phenotypes when the cell division machinery is strongly perturbed.	[Rancati, Giulia; Pavelka, Norman; Fleharty, Brian; Noll, Aaron; Trimble, Rhonda; Walton, Kendra; Perera, Anoja; Staehling-Hampton, Karen; Seidel, Chris W.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Phys, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers-institute.org	Pavelka, Norman/G-4577-2018	Pavelka, Norman/0000-0003-4542-9970; Rancati, Giulia/0000-0003-0835-0139	NIH [GM058864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors thank W. Bosl, O. Rando, and B. Rubinstein for stimulating discussions, J. Haug and J. Wunderlich for technical assistance with flow cytometry, F. Guo for technical assistance with electron microscopy, K. Zueckert-Gaudenz and A. Peak for suggestions and assistance in the preparation of genomic DNA samples and in microarray hybridizations, G. Hattem for help with bioinformatics analysis, A. Paulson for assistance in microarray data submission to public repositories, P. Baumann and X. Wang for suggestions and assistance with pulsed-field gel electrophoresis, G. Chen for help with strain construction, T. Nichols and M. Toth for media preparation and laboratory management, J. Rine for plasmids, and A. Murray, B. Slaughter, and S. Wai for critical reading of the manuscript. This paper is dedicated to the memory of Karen A. Pavelka. This work was supported by NIH GM058864 to R. L.	ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Buscemi G, 2000, J CELL SCI, V113, P1199; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Carter AJR, 2002, P ROY SOC B-BIOL SCI, V269, P953, DOI 10.1098/rspb.2002.1968; Darwin C., 1859, ORIGIN SPECIES MEANS; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; GILLESPIE JH, 1984, SCIENCE, V224, P732, DOI 10.1126/science.224.4650.732; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; Nagasaki A, 2002, J CELL SCI, V115, P2241; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Oeffinger M, 2003, EMBO J, V22, P6573, DOI 10.1093/emboj/cdg616; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schmidt M, 2002, J CELL SCI, V115, P293; Shafaatian R, 1996, MOL GEN GENET, V252, P101, DOI 10.1007/BF02173210; Sherman F., 1974, METHODS YEAST GENETI; Spence JM, 2006, CHROMOSOMA, V115, P60, DOI 10.1007/s00412-005-0032-6; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; WAGNER A, 2005, ROBUSTNESS EVOLVABIL, V1; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Weinreich DM, 2005, EVOLUTION, V59, P1175; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	48	233	236	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					879	893		10.1016/j.cell.2008.09.039	http://dx.doi.org/10.1016/j.cell.2008.09.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041751	Green Accepted, Bronze			2022-12-24	WOS:000261183900019
J	Simpson, SW; Quade, J; Levin, NE; Butler, R; Dupont-Nivet, G; Everett, M; Semaw, S				Simpson, Scott W.; Quade, Jay; Levin, Naomi E.; Butler, Robert; Dupont-Nivet, Guillaume; Everett, Melanie; Semaw, Sileshi			A Female Homo erectus Pelvis from Gona, Ethiopia	SCIENCE			English	Article							MIDDLE PLEISTOCENE; BRAIN GROWTH; BODY-SIZE; DMANISI; GEORGIA; MALES; GAIT; EAST	Analyses of the KNM- WT 15000 Homo erectus juvenile male partial skeleton from Kenya concluded that this species had a tall thin body shape due to specialized locomotor and climatic adaptations. Moreover, it was concluded that H. erectus pelves were obstetrically restricted to birthing a small- brained altricial neonate. Here we describe a nearly complete early Pleistocene adult female H. erectus pelvis from the Busidima Formation of Gona, Afar, Ethiopia. This obstetrically capacious pelvis demonstrates that pelvic shape in H. erectus was evolving in response to increasing fetal brain size. This pelvis indicates that neither adaptations to tropical environments nor endurance running were primary selective factors in determining pelvis morphology in H. erectus during the early Pleistocene.	[Everett, Melanie; Semaw, Sileshi] Stone Age Inst, Gosport, IN 47433 USA; [Everett, Melanie; Semaw, Sileshi] Indiana Univ, CRAFT, Bloomington, IN 47405 USA; [Simpson, Scott W.] Case Western Reserve Univ, Dept Anat, Cleveland, OH 44106 USA; [Simpson, Scott W.] Cleveland Museum Nat Hist, Lab Phys Anthropol, Cleveland, OH 44106 USA; [Quade, Jay] Univ Arizona, Dept Geosci, Desert Lab, Tucson, AZ 85721 USA; [Levin, Naomi E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Levin, Naomi E.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Butler, Robert] Univ Portland, Dept Phys, Portland, OR 97203 USA; [Dupont-Nivet, Guillaume] Univ Utrecht, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [Everett, Melanie] Indiana Univ, Dept Geol Sci, Bloomington, IN 47407 USA	Indiana University System; Indiana University Bloomington; Case Western Reserve University; Cleveland Museum of Natural History; University of Arizona; Utah System of Higher Education; University of Utah; California Institute of Technology; University of Portland; Utrecht University; Indiana University System; Indiana University Bloomington	Semaw, S (corresponding author), Stone Age Inst, 1392 W Dittemore Rd, Gosport, IN 47433 USA.	ssemaw@indiana.edu	DUPONT-NIVET, Guillaume/HII-9066-2022; Levin, Naomi E/B-4124-2010; Simpson, Scott/GRS-0081-2022; Semaw, Sileshi/M-7021-2018	Levin, Naomi E/0000-0001-5703-3717; Dupont-Nivet, Guillaume/0000-0001-9905-9739; Semaw, Sileshi/0000-0001-8377-8288	L. S. B. Leakey Foundation; National Geographic Society; Wenner-Gren Foundation; NSF	L. S. B. Leakey Foundation; National Geographic Society(National Geographic Society); Wenner-Gren Foundation; NSF(National Science Foundation (NSF))	The Gona Project thanks the Authority for Research and Conservation of Cultural Heritage of the Ministry of Culture and Tourism, and the National Museum of Ethiopia, for research permits and support. Support for this research was provided by the L. S. B. Leakey Foundation, National Geographic Society, Wenner-Gren Foundation, and NSF.	Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Bondioli L, 2006, J HUM EVOL, V50, P479, DOI 10.1016/j.jhevol.2006.01.001; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Coqueugniot H, 2004, NATURE, V431, P299, DOI 10.1038/nature02852; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; DeSilva J, 2006, J HUM EVOL, V51, P207, DOI 10.1016/j.jhevol.2006.05.006; Holloway RL, 2004, BRAIN ENDOCASTS PALE, V3; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; RAK Y, 1987, AM J PHYS ANTHROPOL, V73, P227, DOI 10.1002/ajpa.1330730209; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rosenberg KR, 2006, P NATL ACAD SCI USA, V103, P3552, DOI 10.1073/pnas.0508681103; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff C, 2007, AM J PHYS ANTHROPOL, V133, P698, DOI 10.1002/ajpa.20568; Ruff Christopher B., 1993, P234; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Tague RG, 1998, J HUM EVOL, V35, P75, DOI 10.1006/jhev.1998.0223; Tague RG, 2005, AM J PHYS ANTHROPOL, V127, P392, DOI 10.1002/ajpa.20226; TAGUE RG, 1989, AM J PHYS ANTHROPOL, V80, P59, DOI 10.1002/ajpa.1330800108; Walker Alan, 1993, P221; WALRATH D, 1997, THESIS U PENNSYLVANI	25	185	189	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1089	1092		10.1126/science.1163592	http://dx.doi.org/10.1126/science.1163592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371YD	19008443				2022-12-24	WOS:000260867700034
J	Long, MA; Fee, MS				Long, Michael A.; Fee, Michale S.			Using temperature to analyse temporal dynamics in the songbird motor pathway	NATURE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; CENTRAL PATTERN GENERATOR; VOCAL CONTROL; BRAIN-STEM; SEQUENCE GENERATION; MEMBRANE-PROPERTIES; FOREBRAIN; BIRDSONG; SYSTEM	Many complex behaviours, like speech or music, have a hierarchical organization with structure on many timescales, but it is not known how the brain controls the timing of behavioural sequences, or whether different circuits control different timescales of the behaviour. Here we address these issues by using temperature to manipulate the biophysical dynamics in different regions of the songbird forebrain involved in song production. We find that cooling the premotor nucleus HVC ( formerly known as the high vocal centre) slows song speed across all timescales by up to 45 per cent but only slightly alters the acoustic structure, whereas cooling the downstream motor nucleus RA ( robust nucleus of the arcopallium) has no observable effect on song timing. Our observations suggest that dynamics within HVC are involved in the control of song timing, perhaps through a chain- like organization. Local manipulation of brain temperature should be broadly applicable to the identification of neural circuitry that controls the timing of behavioural sequences and, more generally, to the study of the origin and role of oscillatory and other forms of brain dynamics in neural systems.	[Long, Michael A.; Fee, Michale S.] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu		Fee, Michale/0000-0001-7539-1745	US National Institutes of Health [MH067105, DC009280]; Human Frontiers Science Project; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009280, K99DC009280] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Project; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Aronov, T. Gardner, J. Goldberg, L. Las, B. Olveczky, S. Seung and M. Wilson for their comments on earlier versions of this manuscript. This work is supported by funding from the US National Institutes of Health to M. S. F. (MH067105) and to M. A. L. (DC009280) as well as funding from the Human Frontiers Science Project.	ABELES M, 1991, CORTICONICS NEURAL C, P208; ARBAS EA, 1984, J COMP PHYSIOL, V155, P783, DOI 10.1007/BF00611595; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROSCI, V28, P2613, DOI 10.1523/JNEUROSCI.4547-07.2008; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; HERRMANN K, 1991, J NEUROSCI, V11, P2063; JAMES W, 2001, PSYCHOL BRIEFER COUR, P1; Janata P, 1999, J NEUROSCI, V19, P5108; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Katz PS, 2004, J NEUROPHYSIOL, V92, P1904, DOI 10.1152/jn.00864.2003; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Laje R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288102; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; MOONEY R, 1992, J NEUROSCI, V12, P2464; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; THOMPSON SM, 1985, J NEUROSCI, V5, P817; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Volgushev M, 2000, NEUROSCIENCE, V98, P9, DOI 10.1016/S0306-4522(00)00109-3; VU ET, 1994, J NEUROSCI, V14, P6924; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; [No title captured]	45	309	312	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					189	194		10.1038/nature07448	http://dx.doi.org/10.1038/nature07448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005546	Green Accepted			2022-12-24	WOS:000261039300030
J	Hou, C; Zuo, WY; Moses, ME; Woodruff, WH; Brown, JH; West, GB				Hou, Chen; Zuo, Wenyun; Moses, Melanie E.; Woodruff, William H.; Brown, James H.; West, Geoffrey B.			Energy Uptake and Allocation During Ontogeny	SCIENCE			English	Article							DYNAMIC ACTION; GROWTH; MODEL; SDA	All organisms face the problem of how to fuel ontogenetic growth. We present a model, empirically grounded in data from birds and mammals, that correctly predicts how growing animals allocate food energy between synthesis of new biomass and maintenance of existing biomass. Previous energy budget models have typically had their bases in rates of either food consumption or metabolic energy expenditure. Our model provides a framework that reconciles these two approaches and highlights the fundamental principles that determine rates of food assimilation and rates of energy allocation to maintenance, biosynthesis, activity, and storage. The model predicts that growth and assimilation rates for all animals should cluster closely around two universal curves. Data for mammals and birds of diverse body sizes and taxa support these predictions.	[Hou, Chen; Woodruff, William H.; Brown, James H.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Zuo, Wenyun; Brown, James H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Woodruff, William H.; West, Geoffrey B.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	The Santa Fe Institute; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory	Hou, C (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	houc@santafe.edu	Woodruff, William/AAH-6890-2021	Hou, Chen/0000-0002-3665-225X; ZUO, WENYUN/0000-0002-7623-0481	NIH [P20 RR-018754, DK36263]; NSF [DEB-0083422, CCF0621900, PHY 0706174, PHY 0202180]; Thaw Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Thaw Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants P20 RR-018754 (for M.E.M.) and DK36263 (for W.H.W.) and by NSF grants DEB-0083422 and CCF0621900 (for J.H.B.) and PHY 0706174 and PHY 0202180 (for G.B.W.) G.B.W. also acknowledges the Thaw Charitable Trust for its support.	ASHWORTH A, 1969, NATURE, V223, P407, DOI 10.1038/223407a0; BLAXTER KL, 1989, ENERGY METABOLISM AN; Brody S, 1964, BIOENERGETICS GROWTH; Cummins K. W, 1971, Mitt int Verein theor angew Limnol, VNo. 18, P1; EVANS E, 1968, P NUTR SOC, V27, P121, DOI 10.1079/PNS19680036; JOBLING M, 1983, J FISH BIOL, V23, P549, DOI 10.1111/j.1095-8649.1983.tb02934.x; KIRKWOOD JK, 1991, J NUTR S, V121, P29; Kleiber M., 1961, FIRE LIFE INTRO ANIM; KRIEGER I, 1978, AM J CLIN NUTR, V31, P764, DOI 10.1093/ajcn/31.5.764; Makarieva AM, 2004, ECOL MODEL, V176, P15, DOI 10.1016/j.ecolmodel.2003.09.037; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; Moses ME, 2008, AM NAT, V171, P632, DOI 10.1086/587073; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; RICKLEFS R. E., 1974, NUTTALL ORNITHOLOGIC, p[152, 15]; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Robbins C.T., 1983, WILDLIFE FEEDING NUT; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WITHERS PC, 1992, COMP ANIMAL PHYSL	19	128	134	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					736	739		10.1126/science.1162302	http://dx.doi.org/10.1126/science.1162302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974352	Green Accepted			2022-12-24	WOS:000260605200047
J	Williams, BR; Prabhu, VR; Hunter, KE; Glazier, CM; Whittaker, CA; Housman, DE; Amon, A				Williams, Bret R.; Prabhu, Vineet R.; Hunter, Karen E.; Glazier, Christina M.; Whittaker, Charles A.; Housman, David E.; Amon, Angelika			Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells	SCIENCE			English	Article							DOWNS-SYNDROME; COLORECTAL ADENOMAS; SOLID TUMORS; TRISOMY; MOUSE; METABOLISM; EXPRESSION; STRESS; YEAST; MICE	Aneuploidy, an incorrect number of chromosomes, is the leading cause of miscarriages and mental retardation in humans and is a hallmark of cancer. We examined the effects of aneuploidy on primary mouse cells by generating a series of cell lines that carry an extra copy of one of four mouse chromosomes. In all four trisomic lines, proliferation was impaired and metabolic properties were altered. Immortalization, the acquisition of the ability to proliferate indefinitely, was also affected by the presence of an additional copy of certain chromosomes. Our data indicate that aneuploidy decreases not only organismal but also cellular fitness and elicits traits that are shared between different aneuploid cells.	[Williams, Bret R.; Prabhu, Vineet R.; Hunter, Karen E.; Glazier, Christina M.; Whittaker, Charles A.; Housman, David E.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Williams, Bret R.; Hunter, Karen E.; Glazier, Christina M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu		Whittaker, Charles/0000-0002-2400-0094; Amon, Angelika/0000-0001-9837-0314	Howard Hughes Medical Institute; David Koch Research Award; Curt W. and Kathy Marble Cancer Research Fund; David Koch Graduate Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); David Koch Research Award; Curt W. and Kathy Marble Cancer Research Fund; David Koch Graduate Fellowship	We thank E. Vazile in the Koch Institute Microscopy and Imaging Facility for help with SKY analysis; M. Luo in the MIT BioMicro Center for help with microarray analysis; L. Chan for assistance with the double linear fit models for immortalization kinetics; A. Regev and M. Guttman for advice and assistance with statistical analysis; and M. Dunham, M. Hemann, J. Lees, F. Solomon, and members of the Amon lab for critical reading of this manuscript. This work was supported by the Howard Hughes Medical Institute, a David Koch Research Award, a grant from the Curt W. and Kathy Marble Cancer Research Fund, and a David Koch Graduate Fellowship (V.R.P.). All microarray data are provided in final processed form in table S1 and as raw data through the Gene Expression Omnibus (www.ncbi.nlm.nih. gov/geo) under accession number GSE12501.	ABERCROMBIE M., 1961, EXPTL CELL RES SUPPL, V8, P188, DOI 10.1016/0014-4827(61)90348-2; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bomme L, 1998, CANCER GENET CYTOGEN, V106, P66, DOI 10.1016/S0165-4608(98)00047-8; Bomme L, 2001, INT J CANCER, V92, P816, DOI 10.1002/ijc.1275; Boveri T., 1902, Verb Ges Wurzburg, Vxxxv, P67; Dyban A.P., 1987, CYTOGENETICS MAMMALI; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; FARBER E, 1990, BIOCHEM PHARMACOL, V39, P1837, DOI 10.1016/0006-2952(90)90599-G; GROPP A, 1983, J EXP ZOOL, V228, P253, DOI 10.1002/jez.1402280210; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; Haddow A., 1938, ACTA UNION INT CONTR, V3, P342; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Larson PS, 2006, J PATHOL, V209, P307, DOI 10.1002/path.1973; LINDSLEY DL, 1972, GENETICS, V71, P157; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; McClintock B, 1929, GENETICS, V14, P180; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; NIELSEN K, 1985, HEREDITAS, V102, P77, DOI 10.1111/j.1601-5223.1985.tb00468.x; NIWA O, 1985, CURR GENET, V9, P463, DOI 10.1007/BF00434051; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Pai GS., 2003, HDB CHROMOSOMAL SYND; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Rosner M, 2003, J NEURAL TRANSM-SUPP, P51; Satge D, 2003, INT J CANCER, V106, P297, DOI 10.1002/ijc.11212; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh K, 1996, GENETICS, V143, P517; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sung HM, 2003, J BACTERIOL, V185, P2153, DOI 10.1128/JB.185.7.2153-2160.2003; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Tannock I., 2013, BASIC SCI ONCOLOGY; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Warburg O, 1924, BIOCHEM Z, V152, P309; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	37	419	427	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					703	709		10.1126/science.1160058	http://dx.doi.org/10.1126/science.1160058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974345	Green Accepted			2022-12-24	WOS:000260605200038
